Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	0.2	1.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.0	0.2	0.3	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	5.1	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2	0.0	0.6	0.0	0.2	0.1	14.3	0.8	0.0	2.7	0.0	7.0	424.1	0.1	0.0	0.0	8.5	0.8	0.0	0.0	0.0	1.1	0.2	1.5	0.0	0.0	0.1	9.5	0.0	0.6	0.0	15.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	455.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141888	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	31.4	4.3	1.4	2.0	6.6	0.4	12.1	0.7	1.9	12.3	9.9	4.7	2.9	1.8	7.9	6.9	10.5	4.9	7.2	13.2	1.5	0.9	3.0	53.9	9.3	3.6	10.9	0.2	22.0	1.9	1.1	6.0	1.8	11.2	8.0	3.4	4.2	7.1	1.9	6.6	5.0	3.9	9.8	21.0	1.8	4.4	5.0	9.3	0.0	6.7	6.6	2.5	16.6	11.7	0.0	1.2	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	20.7	30.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	13.1	0.0	1.6	0.4	0.8	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.3	1.4	6.6	0.7	1.9	1.5	0.9	10.9	0.2	11.2	9.3	0.0	0.0	2.7	0.9	2.7	13.9	4.8	0.0	0.0	1.2	3.5	5.9	0.0	0.0	0.2	2.9	2.2	0.5	0.0	0.2	0.0	27.1	0.1	0.0	95.4	1.2	0.0	2.4	2.5	1.8	2.2	47.5	2.8	5.0	1.0	0.1	3.9	0.5	0.0	11.3	0.6	13.8	0.0	1.7	0.9	1.0	2.5	0.0	0.0	0.0	0.3
ABCC12	MRP9	ENSG00000140798	"ATP binding cassette subfamily C member 12"	Q96J65	16	48082973-48156018	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 3.5;testis: 13.4"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 3.1;Late spermatids: 1.9;Spermatocytes: 1.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPMI-8226: 2.2;T-47d: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA043100	Uncertain					NA	NA					"HPA043100: AB_10794922"	"unprognostic (1.53e-1)"			"unprognostic (6.87e-2)"	"unprognostic (2.37e-2)"			"unprognostic (4.62e-3)"		"unprognostic (1.88e-1)"		"unprognostic (1.59e-2)"		"unprognostic (2.65e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.23e-1)"		0.1	0.0	0.6	0.1	0.1	0.0	1.9	0.3	3.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	13.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	3.5	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	0.0	0.0
ABLIM1	"abLIM, LIMAB1, limatin"	ENSG00000099204	"Actin binding LIM protein 1"	O14639	10	114431113-114685003	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 294.8;Cardiomyocytes: 567.5;Peritubular cells: 388.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 84.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 43.9"	"Group enriched"	"Detected in many"	11	"B-cells: 14.8;NK-cells: 17.1;T-cells: 43.9"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 42.8;OE19: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038951, HPA038952"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA038951: AB_10673017, HPA038952: AB_10670915"	"unprognostic (2.25e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.23e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.87e-2)"	66.7	23.6	11.2	16.8	14.1	3.0	21.2	84.9	14.1	18.7	14.7	6.8	10.7	9.6	16.9	9.8	73.5	13.7	14.1	55.9	10.0	9.2	14.1	7.3	15.7	13.8	10.1	5.6	64.4	7.4	12.8	22.7	8.3	12.8	14.0	15.3	26.6	53.8	18.6	18.6	25.3	16.0	15.4	9.9	8.4	31.3	17.2	3.1	38.3	75.8	44.3	70.4	20.3	28.0	14.8	0.1	2.3	0.0	17.1	43.9	12.7	11.6	8.5	31.0	7.0	0.3	0.1	0.3	2.4	0.8	0.6	1.4	11.7	18.8	15.5	33.4	2.7	4.1	25.6	10.2	16.5	0.7	5.2	9.0	0.1	24.8	32.1	0.1	6.0	0.1	0.4	42.8	4.1	13.6	12.9	12.2	5.4	0.0	23.9	0.1	4.3	1.2	2.7	11.8	39.9	9.9	0.5	6.5	20.0	9.9	26.4	10.8	13.4	10.0	15.3	5.6	14.6	7.8	0.0	8.3	0.0	11.2	0.2	4.5	0.1	0.0	35.9	0.5	13.5	0.2	2.3	0.0	0.2	8.8	0.0	17.0	12.4	16.5	9.9	0.1	14.8	43.9	27.8	0.7	17.1	0.0	0.1	8.9	12.7	11.2	14.1	84.9	11.1	10.0	9.2	10.1	5.6	12.8	3.1	294.8	29.0	14.3	27.1	77.0	38.7	567.5	48.4	101.7	104.6	50.6	17.7	0.8	29.9	34.2	88.3	105.0	50.6	0.0	48.7	0.8	28.6	31.2	1.1	36.6	0.6	55.6	16.1	37.4	1.0	104.4	210.9	5.9	20.3	1.8	87.8	58.6	40.5	31.7	388.2	31.6	105.4	0.0	16.5	3.6	3.9	165.6	0.6	20.3	46.1	115.5
AC008763.3		ENSG00000269711			19	7678501-7682854	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"blood: 51.4;bone marrow: 17.2"	"Group enriched"	"Detected in some"	42	"Alveolar cells type 2: 3.5;Ciliated cells: 4.0;Club cells: 6.8;granulocytes: 2.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 2.8"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 51.4;neutrophil: 22.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"EFO-21: 9.1;HMC-1: 14.6;NB-4: 8.3;THP-1: 22.4;U-937: 16.6"															NA	NA																							0.4	0.1	0.2	3.8	2.8	17.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	6.5	0.7	0.2	0.2	0.4	1.1	0.2	0.2	0.1	0.2	1.5	6.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.8	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.4	1.5	0.2	0.2	2.9	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	10.6	22.2	51.4	0.1	0.3	23.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	51.4	0.3	0.0	4.5	0.0	0.0	0.1	0.0	10.6	0.0	0.0	0.3	22.2	0.1	0.4	0.4	0.2	23.0	0.2	2.8	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011462.1		ENSG00000255730			19	41350853-41425001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 24.8"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 2: 1.7;Ciliated cells: 1.4;granulocytes: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"basal ganglia: 19.9"	"Cell type enhanced"	"Detected in many"		"classical monocyte: 24.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.3;SK-MEL-30: 8.3;THP-1: 14.7"					"Low region specificity"	"Detected in all"			HPA036640	Approved					NA	NA					"HPA036640: AB_10671964"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-1)"			"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"		"unprognostic (2.65e-1)"		"unprognostic (3.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-8)"	"unprognostic (8.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.97e-2)"	5.0	5.8	1.7	6.2	19.9	10.5	3.6	1.5	8.0	6.6	3.5	0.8	0.6	1.3	5.4	2.1	3.9	5.3	0.7	3.1	1.5	2.6	4.7	3.3	5.9	3.8	2.4	2.9	3.1	3.5	3.3	3.1	2.5	3.1	5.5	0.7	2.3	1.7	1.9	9.0	9.2	1.9	5.4	2.3	4.5	2.5	7.3	2.6	0.0	2.9	1.7	3.2	10.5	7.5	1.0	11.8	8.2	24.8	1.4	5.6	15.7	3.0	0.0	5.9	2.5	1.6	0.2	1.7	1.7	1.4	0.8	0.0	0.0	3.9	0.0	3.2	2.1	1.9	0.1	0.0	0.9	1.2	1.6	1.6	3.9	0.1	1.1	4.8	0.7	0.4	3.8	3.6	1.5	7.6	9.3	2.8	0.0	0.9	5.6	0.0	0.0	4.2	5.1	0.8	0.0	0.0	1.7	0.0	0.3	0.5	0.0	0.0	3.7	0.8	0.0	8.3	2.8	1.1	14.7	0.5	0.0	2.8	0.4	0.0	4.7	0.0	0.1	1.8	3.8	0.1	6.2	24.8	1.5	3.9	9.2	4.3	0.6	3.7	2.9	11.8	1.0	5.6	3.1	8.2	1.4	7.2	8.1	4.0	15.7	1.7	19.9	1.5	5.0	1.5	2.6	2.4	2.9	3.1	2.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 7.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.5	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.1	3.3	0.0	4.7	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.8	0.0	0.0	0.3	0.1	0.0	0.0	6.1	0.2	0.7	0.0	0.3	0.8	0.4	1.1	0.1	0.1	0.3	1.7	0.1	2.5	0.5	3.2	0.1	0.1	0.0	1.1	0.1	0.1	0.1	0.2	5.6	0.1	0.2	0.1	3.2	4.8	8.9	2.1	0.5	0.2	0.1	4.6	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	6	"Muller glia cells: 16.4;Rod photoreceptor cells: 8.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"	Yes	NA			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	12.5	0.0	0.5	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4	0.0	0.0	0.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
ADAMTS20	GON-1	ENSG00000173157	"ADAM metallopeptidase with thrombospondin type 1 motif 20"	P59510	12	43353866-43551921	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3"	"Cell type enhanced"	"Detected in single"	24	"Bipolar cells: 2.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;SuSa: 4.4;U-266/70: 7.4;U-266/84: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027608, HPA027609"	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA027608: AB_10600098, HPA027609: AB_10599024"	"unprognostic (3.18e-2)"			"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.04e-1)"		"unprognostic (9.61e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.26e-1)"		"unprognostic (1.05e-4)"	"unprognostic (7.42e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.57e-1)"	0.2	0.0	0.7	0.1	1.4	0.1	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.2	0.0	3.6	5.1	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	2.3	1.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.6	0.2	0.0	0.0	2.9	5.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	4.4	1.4	0.0	0.0	0.0	0.7	0.0	0.0	7.4	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	1.2	0.3	0.7	0.6	0.0	5.1	1.1	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell type enriched"	"Detected in many"	7	"Smooth muscle cells: 356.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0.0	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.3	0.0	10.9	0.1	0.0	13.2	0.1	0.1	0.3	0.3	0.1	0.0	0.2	4.9	0.0	0.0	0.1	4.8	0.1	0.0	0.1	0.1	7.4	0.0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7	0.0	5.5	0.0	2.3	27.7	2.2	2.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	43.0	0.0	0.0	0.0	0.2	33.3	8.7	0.0	0.8	0.8	3.2	0.0	48.5	1.5	0.0	0.3	6.0	33.7	1.8	0.0	0.3	0.0	0.0	1.1	0.0	1.0	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0.0	4.4
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809388-167914215	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"liver: 14.9;testis: 38.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 64.6;Late spermatids: 64.3"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;T-47d: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015243, HPA017749"	Approved					NA	NA					"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.1	0.2	0.1	0.3	0.0	1.3	1.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.3	14.9	0.1	0.1	0.2	0.3	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	38.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.4	0.6	0.0	0.3	0.4	0.3	0.1	0.2	0.2	0.6	0.5	2.7	0.1	1.0	0.3	1.1	1.6	0.1	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.2	0.4	1.6	0.5	0.3	0.7	0.1	0.0	0.0	0.1	1.9	0.8	0.6	0.3	0.0	0.7	1.2	0.1	0.1	0.0	0.5	0.8	1.0	0.8	0.0	0.1	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.5	1.6	5.0	0.8	0.1	0.2	0.0	0.3	0.1	1.2	0.6	0.8	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.4	0.2	0.3	1.6	0.3	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	64.6	0.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	5.9	0.1	0.0	0.0	1.3	0.0	64.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	4.1	0.7	0.4	1.5	0.0	0.0	0.1
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 121.8;Early spermatids: 236.9;Late spermatids: 53.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.9"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2	3.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	121.8	14.8	0.0	3.9	0.0	0.0	0.0	236.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.2	2.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.2	3.0	0.0	0.0	0.0	0.0	0.0
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell type enhanced"	"Detected in single"	21	"Ciliated cells: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;U-87 MG: 3.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain					NA	NA					"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442360	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0"	"Cell type enriched"	"Detected in single"	25	"monocytes: 19.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 43.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.4;Karpas-707: 21.2;RPMI-8226: 15.0;SK-BR-3: 30.4;U-266/70: 21.2;U-266/84: 27.7;U-698: 21.7"	"Region enriched"	"Detected in some"	10	"basal ganglia: 357.5"	"Region enriched"	"Detected in single"	92	"basal ganglia: 166.0"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA					"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	1.0	2.4	1.9	10.4	43.9	28.1	1.5	3.4	3.8	0.8	2.0	1.7	0.3	5.4	1.4	1.4	1.0	0.9	2.4	3.5	2.4	1.8	3.5	4.3	5.1	14.8	2.6	1.6	1.2	0.8	0.0	2.1	1.4	2.3	1.6	0.8	3.3	2.7	1.5	1.2	0.9	2.6	0.7	1.3	7.5	2.8	2.0	5.7	59.0	1.3	0.9	8.6	3.8	1.3	17.7	1.1	13.7	9.0	2.2	22.8	11.2	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.2	9.5	0.5	1.0	1.7	0.1	15.4	1.0	0.3	1.0	0.3	0.9	0.0	0.0	1.8	2.7	0.2	0.0	2.2	0.2	0.3	7.7	0.1	0.0	2.9	0.0	0.2	3.4	2.2	0.1	21.2	0.0	0.2	5.3	1.6	0.6	2.0	0.0	0.2	0.7	15.0	0.0	0.1	1.5	8.9	0.4	30.4	0.1	0.4	0.4	1.5	0.2	0.9	1.5	0.2	0.1	21.2	27.7	21.7	4.8	5.2	0.1	3.0	0.8	4.8	8.6	2.6	20.1	9.6	16.1	16.9	1.1	17.7	22.8	18.3	13.7	2.2	9.0	1.1	21.4	11.2	1.9	43.9	3.4	3.8	2.4	1.8	2.6	1.6	2.3	5.7	0.0	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADRA1D	"ADRA1, ADRA1A, ADRA1R"	ENSG00000171873	"Adrenoceptor alpha 1D"	P25100	20	4220631-4249074	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in single"	18	"Smooth muscle cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.4;hippocampal formation: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.8;BJ: 12.0;CAPAN-2: 5.4;fHDF/TERT166: 7.1"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 23.5;hippocampal formation: 31.8;olfactory region: 11.0"	"Low region specificity"	"Detected in many"			HPA038789	Uncertain					NA	NA					"HPA038789: AB_10673475"	"unprognostic (5.37e-2)"	"unprognostic (4.65e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.75e-11)"	"unprognostic (7.83e-3)"	"unprognostic (1.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.82e-4)"	"unprognostic (4.41e-3)"	"unprognostic (8.37e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.71e-7)"	"unprognostic (5.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.32e-5)"	2.5	1.1	1.9	0.5	2.8	0.3	1.0	0.1	7.4	9.1	2.4	1.4	1.1	0.6	4.7	1.8	0.9	3.5	1.2	0.4	17.7	1.7	0.5	0.4	2.9	1.5	0.5	1.1	1.0	1.2	0.4	0.0	0.7	2.9	8.8	1.0	0.0	0.8	6.0	1.2	0.4	0.8	1.6	0.5	3.6	2.5	1.5	0.0	0.0	0.9	0.0	0.4	3.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	12.0	2.1	0.8	0.3	0.5	5.4	0.0	0.0	7.1	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.8	0.1	7.4	17.7	1.7	0.5	1.1	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.1"	"Cell type enhanced"	"Detected in some"	13	"Collecting duct cells: 12.2;Muller glia cells: 5.2;Smooth muscle cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 11.1;MCF7: 18.4;NTERA-2: 6.5;OE19: 7.3;SCLC-21H: 7.1;SH-SY5Y: 8.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 41.4"	HPA057688	Uncertain					NA	NA					"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	6.5	2.4	2.1	1.0	9.8	0.4	9.2	0.5	2.6	35.1	1.5	0.6	12.8	1.0	20.3	18.0	2.1	6.4	5.5	3.0	1.2	1.0	9.2	1.3	2.0	1.2	0.7	1.6	7.6	4.1	0.5	4.2	27.6	1.1	7.3	0.6	3.6	0.8	24.6	2.6	2.1	0.9	3.0	0.7	7.5	0.7	6.2	2.0	0.2	0.8	1.9	0.5	2.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.1	0.5	0.0	0.2	0.4	0.0	0.0	0.0	2.0	1.2	0.0	2.1	0.3	0.7	0.0	0.2	0.0	0.0	0.0	5.7	0.0	0.0	11.1	0.6	0.0	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.7	18.4	0.0	0.0	6.5	7.3	0.0	0.0	6.0	0.0	0.0	0.3	7.1	8.5	2.5	0.0	0.1	1.7	6.1	0.1	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	9.8	0.5	1.4	1.2	1.0	0.7	1.6	1.1	2.0	0.0	0.0	0.0	0.1	0.0	1.4	0.9	2.5	0.0	0.0	12.2	0.0	0.8	3.3	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.3	3.2	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.2	0.2	0.0	3.5	1.8	0.0	0.0	4.1	0.0	0.7	0.0	1.4	0.0	0.0	0.1
ADRB3		ENSG00000188778	"Adrenoceptor beta 3"	P13945	8	37962991-37966965	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 23.9;ovary: 15.7;smooth muscle: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 1.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;Karpas-707: 1.0;U-2 OS: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA061969	Uncertain					NA	NA					"HPA061969: AB_2732674"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.64e-3)"	"unprognostic (5.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.07e-1)"		"unprognostic (1.14e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.10e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.06e-3)"	0.4	0.1	1.3	1.9	0.3	0.3	0.3	0.0	0.8	1.6	2.3	0.0	0.0	0.4	0.9	1.9	1.7	5.3	23.9	0.1	0.2	0.1	0.1	0.0	0.2	1.2	0.0	0.0	15.7	0.0	0.0	0.0	4.7	0.0	4.1	0.4	0.0	0.0	0.1	0.0	0.1	0.9	10.8	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.1	9.9	1.5	0.9	0.2	1.2	0.4	0.8	0.5	0.0	0.2	0.2	0.1	0.1	0.3	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	2.4	0.4	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.2	0.1	0.4	0.4	0.4	1.3	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	1.0	0.3	0.3	0.1	0.1	0.4	0.7	0.2	0.1	0.0	0.9	0.2	0.2	1.2	0.8	0.4	0.2	0.5	0.0	1.3	0.3	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.7	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.5	0.3	1.6	0.8	0.0	0.7	0.3	1.1	0.7	0.0	4.8	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.9	3.6	10.5	7.5	35.9	0.2	8.6	0.0	1.2	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.1	13.5	0.7	0.1	0.0	0.1	0.6	0.0	0.3	1.3	0.0	0.3	19.4	12.9	0.9	0.3	1.0	0.5	15.2	0.0	2.7	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1	0.0	1.4	1.5	0.2	4.5	0.0	0.0	0.0	0.0	3.4	5.2	0.0	0.1	44.7	0.7	109.7	0.1	113.2	23.3	2.2	0.1	1.0	0.5	5.7	0.0	8.9	0.0	5.2	0.0	0.3	127.1	1.7	1.3	1.7	47.7	36.6	0.0	5.0	73.7	0.7	0.0	0.0	0.0	1.0	1.5	0.8	5.0	0.1	5.7	46.8	0.4
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 99.9;Proximal tubular cells: 38.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	190	"Hep G2: 219.7"	"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	219.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.3	0.0	2.4	0.7	0.3	0.0	0.0	99.9	2.1	0.0	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.9;lymphoid tissue: 18.8"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 7.5;Horizontal cells: 7.9;Sertoli cells: 32.3;T-cells: 12.1"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.3;basal ganglia: 40.2;cerebellum: 48.2;cerebral cortex: 35.4;hippocampal formation: 37.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 18.0;Karpas-707: 17.5;RH-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	3.8	1.8	34.3	11.8	40.2	8.1	0.7	48.2	55.9	0.6	2.1	1.2	0.0	2.0	1.5	0.9	1.6	0.8	2.8	4.3	37.6	8.9	1.2	0.8	2.2	13.5	6.3	3.1	1.2	2.4	1.7	1.2	1.7	2.5	1.0	1.2	0.7	4.5	0.9	8.3	2.1	2.2	0.8	2.1	10.0	2.1	0.9	0.7	18.8	0.9	1.5	16.6	2.9	0.6	1.9	1.4	6.3	1.2	2.3	6.3	1.7	3.0	4.5	8.7	2.5	0.0	0.0	5.0	2.1	0.4	0.0	0.2	0.5	2.9	7.9	0.6	0.0	1.6	1.9	0.0	0.0	0.0	8.6	1.3	8.7	0.7	1.4	0.0	8.9	18.0	0.0	0.0	0.0	0.0	3.7	0.0	9.3	0.0	17.5	0.0	5.3	15.7	5.7	1.4	0.9	4.6	6.5	43.8	5.7	0.0	2.6	2.5	9.1	1.1	1.6	1.8	0.0	1.1	6.3	4.8	2.4	4.1	4.6	1.5	7.4	4.4	3.9	4.4	5.9	4.1	6.0	0.8	1.0	4.8	1.2	5.1	1.9	4.8	5.1	1.4	1.6	2.0	3.0	6.3	2.3	0.7	1.2	6.3	1.7	34.3	40.2	48.2	35.4	37.6	8.9	6.3	3.1	2.5	0.7	3.0	0.6	4.1	0.2	0.0	7.5	2.2	2.5	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.0	1.4	7.9	0.0	0.6	0.6	0.7	0.0	1.6	0.0	3.6	0.3	0.1	0.1	0.0	0.7	0.0	1.9	32.3	1.2	0.7	0.4	0.4	0.0	12.1	0.1	0.0
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483813	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.4;epididymis: 49.8"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 3.3;Hofbauer cells: 9.2;Leydig cells: 2.8;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	13	"hypothalamus: 19.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;CAPAN-2: 2.8;HeLa: 1.5;Hep G2: 2.2;HMC-1: 1.8"	"Region enriched"	"Detected in single"	16	"hypothalamus: 18.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 3.9"	HPA041017	Enhanced	Supported			"Secreted in other tissues"	NA	NA	255000				"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.1	9.6	0.1	0.1	1.4	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	49.8	0.1	0.0	0.1	0.1	0.1	19.4	0.5	0.1	2.1	0.3	0.1	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	2.1	1.4	3.8	0.3	3.2	1.0	0.1	0.0	0.4	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	2.8	0.8	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.4	1.5	2.2	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.2	0.0	1.5	0.1	1.0	0.0	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.0	0.1	1.0	0.5	1.0	0.0	0.4	0.3	0.0	3.8	1.4	3.2	2.3	1.6	2.2	0.8	1.1	1.5	1.9	2.1	2.2	0.6	0.3	1.2	2.1	1.3	1.0	0.1	1.4	0.1	0.2	0.1	19.4	0.1	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170722-116174972	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 2: 17.8"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"HSkMC: 1.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 3.8"							NA	NA									"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.3	1.6	0.1	0.8	0.1	0.0	0.1	1.0	0.1	5.3	0.4	0.1	0.1	0.0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0.0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AJM1	"ajm-1, C9orf172"	ENSG00000232434	"Apical junction component 1 homolog"	C9J069	9	136844415-136848801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7;testis: 15.0"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 5.2;Ductal cells: 1.4;granulocytes: 1.1;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 22.7"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.9;monocytes: 1.6;T-cells: 1.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA021200	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"		"HPA021200: AB_10601695"	"unprognostic (3.30e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.68e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.00e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.72e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.07e-3)"	"unprognostic (7.27e-2)"	1.1	1.9	4.6	1.3	6.3	1.4	1.1	22.7	7.9	1.1	4.0	1.1	1.1	3.3	1.2	1.1	1.1	0.3	1.1	1.2	4.4	3.1	1.1	1.1	1.1	1.1	2.1	1.1	1.1	7.6	1.1	5.2	1.1	1.1	2.6	1.1	1.1	2.0	2.2	3.9	1.5	4.3	1.1	1.3	3.6	2.3	15.0	1.1	1.1	1.1	1.1	1.1	2.6	1.1	0.2	3.9	0.1	1.6	0.2	1.9	0.8	3.7	3.0	0.4	1.1	0.5	0.4	4.9	3.0	0.5	0.4	0.2	1.0	2.0	2.3	2.6	0.8	1.0	4.2	0.4	1.1	0.0	5.8	2.2	0.6	5.6	0.9	1.7	1.3	4.2	0.9	1.5	0.5	0.3	2.5	0.2	1.1	3.5	1.5	0.7	4.1	0.4	4.5	1.2	3.1	3.9	2.8	0.9	7.3	0.9	0.7	7.4	2.6	1.9	7.6	4.0	0.6	6.0	2.8	3.1	5.0	3.5	1.7	1.8	6.6	4.5	0.8	8.8	4.6	1.2	0.0	1.6	0.1	1.9	1.0	0.4	0.2	0.5	0.9	1.5	0.0	0.2	0.9	0.1	0.2	1.5	3.9	0.1	0.8	4.6	6.3	22.7	6.8	4.4	3.1	2.1	1.1	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AKAIN1	C18orf42	ENSG00000231824	"A-kinase anchor inhibitor 1"	P0CW23	18	5145285-5197503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 21.6;brain: 40.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 40.8"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;Hep G2: 1.0;Karpas-707: 1.0;NTERA-2: 2.2;SCLC-21H: 3.9;SK-MEL-30: 2.5;U-2197: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049365	Uncertain					NA	NA					"HPA049365: AB_2680729"					"unprognostic (4.86e-1)"						"unprognostic (1.49e-3)"				"unprognostic (7.05e-2)"			0.2	21.6	0.4	0.1	0.8	0.1	0.1	40.8	3.1	0.1	0.3	0.4	0.0	0.2	0.1	0.1	0.1	0.2	0.3	0.1	5.4	0.6	0.4	2.3	0.1	0.2	1.1	0.9	0.3	1.2	1.1	3.1	0.1	3.7	0.2	0.3	0.6	0.1	0.6	0.1	0.5	0.2	0.3	1.3	0.1	0.3	1.3	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.8	40.8	3.1	5.4	0.6	1.1	0.9	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AKAP14	AKAP28	ENSG00000186471	"A-kinase anchoring protein 14"	Q86UN6	X	119895837-119920716	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.1;fallopian tube: 31.0;testis: 33.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 412.7;Late spermatids: 944.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.5"	"Region enriched"	"Detected in many"	7	"pons and medulla: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;LHCN-M2: 1.8;SCLC-21H: 6.3;SuSa: 4.2"									HPA060999	Enhanced					NA	NA					"HPA060999: AB_2684407"	"unprognostic (1.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.68e-2)"		"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.80e-1)"	0.0	0.0	2.6	0.1	1.5	0.2	0.1	0.2	0.6	1.0	0.1	2.4	0.0	0.3	0.6	9.0	0.0	31.0	0.0	0.0	1.3	2.9	0.1	0.1	7.5	0.1	0.6	0.2	4.2	0.0	0.0	0.3	0.1	21.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.1	0.2	0.1	0.0	33.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.3	1.8	0.2	0.0	0.5	0.2	0.4	0.0	1.5	0.0	0.0	0.0	0.6	6.3	0.2	0.0	0.0	0.0	4.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	1.5	0.2	0.6	1.3	2.9	0.6	0.2	21.1	0.5	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	145.9	9.1	0.0	0.0	0.0	0.0	0.0	412.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	944.7	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	12.9	0.0	5.7	2.2	0.0	0.0	0.0	0.0	0.0
AL121758.1		ENSG00000270299			20	646626-675800	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 19.1;retina: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebral cortex: 19.1"	"Group enriched"	"Detected in some"	6	"naive CD8 T-cell: 1.0;neutrophil: 2.0;non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	14	"granulocytes: 2.0;monocytes: 2.1;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 10.7;Hep G2: 14.3;Karpas-707: 8.4;SK-BR-3: 8.8"															NA	NA						"unprognostic (2.38e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.42e-3)"	"unprognostic (4.14e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.87e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.42e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.03e-2)"	0.3	2.4	0.9	0.0	0.8	0.3	0.3	3.6	19.1	0.3	0.3	0.8	0.0	0.0	2.9	0.0	2.3	0.3	0.9	4.7	1.0	0.9	0.3	0.4	0.4	0.3	0.7	0.0	0.3	0.4	0.0	0.5	0.4	3.3	0.4	0.0	6.0	2.2	0.0	0.7	0.7	0.4	0.0	0.8	0.5	0.6	2.6	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	2.0	2.1	0.0	1.0	0.0	0.3	4.3	0.0	1.8	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.6	0.3	0.6	0.2	0.0	10.7	0.0	0.0	0.8	0.0	0.5	0.1	6.3	0.9	14.3	0.0	1.1	3.2	0.0	0.0	0.7	0.0	0.5	0.0	5.0	0.4	8.4	0.0	0.0	0.0	0.0	3.1	5.1	0.2	0.0	2.0	2.7	0.0	0.5	1.0	2.4	1.4	8.8	1.5	2.6	1.1	2.6	5.1	0.8	1.2	0.0	1.5	0.5	4.0	0.3	0.4	0.1	3.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	2.0	0.0	2.1	0.0	0.0	0.0	0.9	0.8	3.6	19.1	1.0	0.9	0.7	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL355102.2		ENSG00000258691			14	96204844-96263929	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebellum: 8.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.9;BJ hTERT+: 9.9;HaCaT: 4.6;U-87 MG: 6.6"															NA	NA						"unprognostic (6.82e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.28e-2)"			"unprognostic (6.16e-3)"		"unprognostic (7.02e-2)"			"unprognostic (5.97e-2)"		"unprognostic (4.71e-2)"	"unprognostic (2.46e-1)"		"unprognostic (3.57e-3)"	"unprognostic (9.07e-2)"	4.2	0.8	0.8	2.1	0.8	0.2	2.4	8.9	1.3	6.1	4.7	0.3	2.5	0.9	5.3	8.3	9.9	1.5	14.2	2.4	0.9	0.8	7.9	0.8	1.0	0.5	0.8	0.0	2.7	3.2	0.2	0.8	1.5	3.4	4.2	4.0	0.1	2.2	7.3	1.3	2.3	6.7	7.3	0.8	0.6	1.2	1.7	0.0	0.0	1.4	9.2	2.5	9.3	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	3.9	0.0	2.4	9.9	0.2	1.5	0.0	0.4	0.0	0.0	1.5	0.9	4.6	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	2.8	3.2	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.6	1.9	0.0	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.8	0.0	0.4	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	8.9	0.8	0.9	0.8	0.8	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL662899.1		ENSG00000204422			6	31686962-31714072	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 3.8;brain: 5.3"	"Cell type enriched"	"Detected in single"	7	"Club cells: 2.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	25	"HEL: 10.9"															NA	NA								"unprognostic (1.83e-1)"							"unprognostic (2.84e-1)"						"unprognostic (3.49e-1)"		0.1	0.0	2.9	0.1	0.5	3.8	0.1	0.1	5.3	0.4	0.7	0.1	0.1	0.0	0.5	0.7	0.9	0.2	0.4	0.1	1.8	0.2	0.1	0.1	1.1	0.1	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.7	0.1	0.5	0.1	0.2	0.1	0.1	2.7	0.1	0.1	0.1	1.7	0.0	0.9	0.1	0.6	2.3	0.1	0.1	0.1	0.8	0.8	1.3	2.9	1.5	0.7	0.9	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	10.9	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	1.3	1.7	0.9	1.5	0.6	0.5	0.6	0.6	1.3	0.8	0.4	0.4	2.9	0.7	1.4	1.1	0.6	1.5	2.9	0.5	0.1	5.3	1.8	0.2	0.1	0.1	0.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALOXE3	"E-LOX, eLOX3"	ENSG00000179148	"Arachidonate lipoxygenase 3"	Q9BYJ1	17	8095900-8119047	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Isomerase, Lyase, Oxidoreductase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"skin 1: 30.2"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.9"	"Group enriched"	"Detected in many"	8	"basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1"	"Group enriched"	"Detected in some"	5	"gdT-cell: 1.0;naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	28	"T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA023120, HPA078597"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023120: AB_10959300, HPA078597: AB_2732385"	"unprognostic (2.40e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.87e-3)"	"unprognostic (2.09e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.06e-2)"		"unprognostic (3.56e-4)"	"unprognostic (3.60e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.66e-5)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	0.1	0.0	0.1	0.1	1.1	0.0	1.6	1.4	2.3	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	1.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	2.7	0.2	6.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.4	0.1	0.5	0.2	0.2	0.1	3.2	0.5	0.9	10.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.2	15.1	0.0	0.0	1.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.7	0.0	0.0	4.8	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	1.4	2.3	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.9	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	1.6	0.9	0.0	0.0	0.7
ALS2	ALS2CR6	ENSG00000003393	"ALS2, alsin Rho guanine nucleotide exchange factor"	Q96Q42	2	201700554-201781189	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.8"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 66.8"	"Group enriched"	"Detected in many"	6	"basophil: 19.0;eosinophil: 5.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 19.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 158.8"	HPA046588	Enhanced		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"		"HPA046588: AB_2679709"	"unprognostic (3.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.04e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.84e-1)"	6.9	5.3	8.2	4.2	14.7	7.8	8.1	66.8	15.6	5.9	5.6	10.1	5.5	7.4	10.3	10.7	4.7	6.7	6.4	19.9	8.3	7.3	10.4	18.3	7.9	4.1	6.8	11.0	6.8	5.6	8.8	16.8	7.2	13.6	6.6	6.0	8.5	5.2	5.5	12.2	6.9	8.4	7.4	8.3	5.3	6.7	6.1	9.0	3.5	7.5	5.9	4.5	5.5	5.3	1.2	1.0	19.0	1.2	1.7	1.8	0.7	5.1	3.6	8.8	8.2	6.0	6.5	6.6	9.2	12.4	12.2	14.2	8.4	5.1	0.6	4.0	9.6	8.3	5.3	5.0	9.3	15.5	1.7	5.1	12.2	3.5	4.8	7.4	9.6	53.0	5.6	5.2	10.2	8.8	9.5	12.3	4.9	5.8	3.7	9.2	4.1	3.4	12.7	7.3	3.2	5.5	2.8	4.9	1.8	7.7	7.1	4.1	5.4	5.3	5.8	8.2	22.1	3.7	4.0	7.3	10.8	5.2	3.7	4.6	4.1	5.6	2.1	7.9	1.9	6.8	19.0	0.7	5.5	1.7	1.2	1.8	1.2	1.2	1.2	1.0	1.2	1.3	1.5	0.6	1.7	0.8	0.5	1.8	0.7	8.2	14.7	66.8	15.6	8.3	7.3	6.8	11.0	13.6	9.0	11.9	18.4	1.9	3.3	4.7	14.7	26.3	7.6	13.4	3.4	8.7	27.5	4.6	0.0	5.6	13.0	7.7	5.2	0.0	2.8	2.4	5.9	3.8	45.1	17.1	4.9	7.9	4.6	15.4	3.5	5.3	7.2	5.3	0.0	1.0	6.7	6.8	5.9	3.7	7.8	4.8	14.7	0.0	4.1	6.5	2.8	5.3	5.6	4.3	3.8	3.3
ALS2CR12		ENSG00000155749	"Amyotrophic lateral sclerosis 2 chromosome region 12"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.3;epididymis: 14.4;testis: 29.9"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 99.0;Early spermatids: 82.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 14.3"	"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.0;U-2197: 9.6"					"Low region specificity"	"Detected in many"			HPA035793			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.8	0.9	1.5	0.7	3.6	4.3	0.5	0.7	1.1	0.9	0.6	7.6	0.4	0.3	0.7	14.4	1.1	9.9	0.9	4.7	2.1	2.6	1.3	0.7	3.7	1.4	1.0	1.3	5.3	0.7	1.2	1.3	0.9	14.3	0.4	0.9	0.5	0.7	0.7	1.4	1.1	0.9	0.9	0.9	0.8	0.5	29.9	1.3	0.4	1.7	0.4	0.5	0.6	0.4	1.8	0.5	7.3	1.1	2.8	1.5	0.4	0.3	0.4	2.1	1.5	5.7	2.2	0.1	1.5	0.5	1.3	0.9	0.0	0.5	0.7	1.2	2.2	1.0	2.0	0.8	0.2	0.6	1.2	0.2	0.3	2.5	0.7	1.1	2.1	1.9	1.1	0.6	1.3	0.3	1.7	0.2	2.5	1.0	2.9	1.3	0.0	1.1	1.8	0.6	0.8	1.2	0.5	1.0	1.3	0.8	0.5	0.5	1.3	1.6	0.0	7.0	2.2	1.5	2.5	1.6	2.9	1.7	9.6	1.0	1.6	3.1	1.0	2.8	1.0	1.3	5.4	1.1	1.0	1.5	0.5	0.7	0.6	1.0	0.9	0.5	1.8	1.2	1.4	7.3	2.8	0.6	0.4	0.6	0.4	1.5	3.6	0.7	1.0	2.1	2.6	1.0	1.3	14.3	1.3	0.0	0.3	0.0	0.0	0.5	5.4	5.7	0.0	99.0	9.1	0.0	9.8	0.0	3.3	0.0	82.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.3	1.6	0.0	0.0	0.0	16.0	0.6	0.0	0.0	1.0	0.0	0.8	0.1	0.0	0.0	0.0	1.4	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.1
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.1;OE19: 1.5"														"Secreted in other tissues"	NA	NA								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755435-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.1"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 6.2;Horizontal cells: 3.2;Intestinal endocrine cells: 14.6;Rod photoreceptor cells: 5.0"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 30.1"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.5	2.4	4.8	0.7	6.0	0.8	0.5	30.1	13.9	0.5	0.8	0.0	0.0	2.0	0.6	0.5	0.5	0.5	0.5	0.5	2.7	4.3	0.5	0.5	0.5	0.6	1.8	5.6	0.6	3.3	0.4	3.4	0.5	3.0	0.6	0.8	0.7	0.5	0.5	0.5	0.7	1.2	0.5	0.8	0.6	2.5	1.6	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.3	0.3	1.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.2	1.5	0.2	0.1	0.3	0.1	0.0	4.8	6.0	30.1	10.3	2.7	4.3	1.8	5.6	3.0	0.7	0.0	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	14.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189341-11195981	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 22.9"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.2;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enriched"	"Detected in single"	6	"cerebellum: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"	NA	NA		490000				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	12.8	3.7	0.1	2.0	0.2	0.0	4.8	3.2	0.2	5.4	8.0	0.3	9.3	1.3	1.4	4.3	7.0	1.7	5.9	10.4	0.1	0.3	6.5	0.4	2.1	1.0	0.1	0.4	1.9	0.6	0.0	7.8	0.9	0.5	4.7	2.4	5.3	4.2	11.4	22.9	5.9	2.6	16.5	3.5	0.4	2.2	3.9	0.5	0.1	0.7	13.8	1.4	6.2	4.5	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.2	0.2	0.1	0.3	0.1	0.4	0.5	0.5	3.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 153.6;Cone photoreceptor cells: 82.5;Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Group enriched"	"Detected in some"	4	"HEL: 38.0;K-562: 39.9;RH-30: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		33000000			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.1	0.1	0.0	0.0	0.9	0.0	1.5	10.2	0.5	0.2	0.0	0.0	2.3	0.4	1.0	0.1	0.8	0.2	0.1	0.2	0.9	0.0	38.0	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.2	0.0	0.0	39.9	0.8	0.6	0.1	0.0	0.5	0.5	0.0	0.0	0.3	50.5	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	1.9	0.6	0.9	0.2	0.1	0.2	8.7	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0	0.0	0.0	3.2	1.3	0.6	7.4	153.6	0.0	0.0	0.0	0.0	82.5	0.7	1.7	0.1	6.6	2.1	0.0	210.2	0.0	0.7	0.6	2.2	0.0	0.0	14.9	3.2	1.2	0.0	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.4	0.2	4.7	0.0	3.6	0.2	0.7	0.0	0.3	0.0	0.0	1.5
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 8.3;lymphoid tissue: 12.9"	"Group enriched"	"Detected in some"	7	"Erythroid cells: 23.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.0;dendritic cells: 2.2;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.8;HEL: 12.6;HL-60: 13.5;NB-4: 17.4;U-937: 24.2"					"Low region specificity"	"Detected in all"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.6	0.5	1.0	12.9	3.1	22.6	0.6	8.3	1.4	0.7	0.7	0.6	0.2	0.3	0.9	1.3	0.5	0.8	0.5	0.2	1.0	1.2	0.5	0.5	1.3	3.7	1.6	0.7	1.7	0.2	0.6	0.9	1.1	1.4	1.0	0.5	0.4	0.7	0.6	0.9	1.4	1.2	0.9	1.2	5.7	0.3	1.0	0.5	8.9	0.6	0.2	5.3	1.0	0.7	3.0	2.2	0.7	4.3	0.0	0.4	0.8	0.1	0.3	1.5	0.8	0.0	0.3	1.5	0.5	0.1	0.3	0.2	7.0	0.4	30.8	0.3	0.1	0.0	0.6	11.9	0.1	0.3	9.3	1.6	12.6	4.9	0.0	0.1	13.5	5.2	0.1	0.4	1.2	0.0	0.3	0.2	2.6	1.6	3.6	0.1	0.2	9.3	17.4	3.8	0.1	1.1	7.5	0.0	3.1	0.1	0.1	0.4	2.7	3.0	0.2	0.2	0.3	0.0	8.9	0.6	0.1	0.5	0.6	0.3	0.3	0.3	10.9	0.1	24.2	0.6	0.0	1.8	0.7	0.0	4.3	0.0	3.0	0.0	0.4	2.2	1.7	0.1	0.0	0.0	0.0	3.1	1.1	0.0	0.8	1.0	3.1	8.3	1.4	1.0	1.2	1.6	0.7	1.4	0.5	0.0	0.3	0.8	0.8	0.7	2.0	0.8	0.0	1.4	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.2	0.0	23.3	0.2	0.4	0.4	0.3	1.1	0.0	0.7	0.0	0.0	0.0	0.8	0.0	1.7	1.2	0.0	1.0	0.7	0.2	0.4	0.0	1.4	0.0	1.5	6.5	0.4	0.5	0.9	0.4	0.3	0.0	0.0	0.1
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.9;testis: 26.9"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 16.0;Early spermatids: 23.8;Muller glia cells: 23.4;Spermatocytes: 37.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8"									"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Approved	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA046346: AB_2679631, HPA046695: , HPA049923: AB_2680954, HPA051288: AB_2681421"	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	1.5	0.9	4.3	0.1	0.4	0.2	1.3	12.9	3.9	0.3	0.2	0.2	0.1	0.0	0.5	1.0	2.1	1.0	0.9	0.3	2.1	1.3	0.1	0.4	0.7	0.1	1.0	1.4	0.1	0.1	0.1	1.6	1.3	2.6	2.0	0.3	0.2	0.2	0.1	1.4	5.5	0.2	0.1	1.0	0.9	0.0	26.9	0.1	0.1	0.9	1.6	0.7	1.2	1.1	0.5	0.8	0.1	0.2	0.0	0.8	0.1	7.5	8.5	0.7	0.2	0.3	1.4	0.7	1.6	1.7	2.1	2.3	1.6	0.2	0.2	0.4	0.2	2.3	1.7	4.6	1.6	2.9	0.1	4.6	8.2	9.9	3.1	0.0	2.7	0.6	1.1	4.5	2.9	7.6	0.9	3.9	0.0	4.5	2.1	2.6	1.3	0.2	20.8	7.3	0.3	3.7	0.0	10.5	1.5	1.2	1.8	0.2	7.3	3.5	0.4	0.6	6.8	6.0	10.1	3.9	1.7	7.6	3.5	3.0	1.2	0.8	0.1	0.8	0.1	1.2	0.0	0.1	0.1	0.3	0.1	0.7	0.4	0.2	0.6	0.0	0.5	0.4	0.8	0.1	0.0	0.2	0.8	0.1	0.1	4.3	0.4	12.9	3.9	2.1	1.3	1.0	1.4	2.6	0.1	0.0	0.0	0.0	4.4	1.8	2.6	2.4	2.5	16.0	3.4	1.8	0.0	0.0	0.0	0.6	23.8	0.0	0.3	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.6	0.6	0.1	0.0	0.0	1.6	23.4	0.3	1.4	0.7	0.0	4.3	0.0	0.0	37.6	1.7	2.9	0.0	0.0	1.0	3.5
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 31.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enriched"	"Detected in many"	6	"basal ganglia: 31.0"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.2"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.1	0.3	0.9	1.5	31.0	5.7	0.3	0.0	0.9	0.5	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.0	4.1	2.8	0.1	0.2	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.4	1.0	0.1	1.0	5.1	0.0	0.1	0.0	4.6	0.1	0.0	0.0	0.0	7.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	46.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.9	31.0	0.0	0.9	1.0	4.1	1.2	0.2	0.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.7	0.0	3.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
ANKRD63		ENSG00000230778	"Ankyrin repeat domain 63"	C9JTQ0	15	40281444-40282586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HEK 293: 5.5;HEL: 2.7;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 4.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 50.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.3"	HPA066743			Approved	Mitochondria		NA	NA			Mitochondria		"HPA066743: "					"unprognostic (9.36e-2)"					"unprognostic (7.45e-2)"				"unprognostic (8.32e-2)"	"unprognostic (4.42e-1)"			0.2	0.2	1.8	0.4	22.4	0.2	0.2	0.3	4.7	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.2	0.7	0.3	0.5	0.3	0.4	1.3	0.2	0.2	0.3	0.3	1.1	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.5	0.2	0.0	0.7	0.3	0.7	1.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.5	2.7	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.1	0.0	0.0	0.2	1.9	0.2	0.0	0.4	1.4	0.0	0.4	0.0	0.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	22.4	0.3	2.8	0.3	0.4	0.3	1.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 210.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	6	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.1	0.2	2.0	0.2	4.3	0.1	0.2	0.0	0.6	1.7	0.1	5.9	0.0	0.1	0.9	12.1	0.1	36.0	0.1	0.1	3.0	3.0	0.1	0.1	7.1	0.2	0.0	0.0	11.1	0.1	0.1	0.5	0.2	15.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0.0	0.2	0.1	0.2	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.3	0.0	0.6	3.0	3.0	0.0	0.0	15.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	210.1	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.2;lung: 11.9;ovary: 10.4"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 100.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.2"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.8"	"Cell line enhanced"	"Detected in some"		"OE19: 4.6"					"Low region specificity"	"Detected in all"			HPA053749	Uncertain					NA	NA					"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.2	1.2	0.6	0.0	0.0	0.3	2.1	0.0	1.8	0.0	0.2	0.9	0.1	0.0	12.2	0.1	0.0	1.5	1.7	0.0	0.0	11.9	0.1	0.0	0.0	10.4	0.1	0.0	1.1	0.1	5.2	0.1	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.2	0.8	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.3	4.8	0.4	0.2	0.3	0.0	0.4	0.6	0.6	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.9	0.9	0.8	0.2	0.0	0.2	1.4	0.4	0.4	0.2	0.5	0.3	0.8	1.9	0.4	0.0	0.4	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.8	0.0	0.3	0.5	0.8	0.4	4.6	0.5	0.9	0.6	0.5	0.0	0.8	0.5	0.1	0.4	0.4	0.0	0.3	0.7	0.2	0.0	0.6	0.5	0.2	0.3	0.5	0.4	0.8	0.4	0.7	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0.0	0.8	1.2	0.0	0.3	1.5	1.7	0.0	0.0	5.2	0.8	0.0	1.7	0.0	0.6	0.5	0.0	0.3	0.0	100.4	20.5	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	3.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26309599-26663288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 83.1;epididymis: 47.3"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 13.7;Early spermatids: 7.9;Horizontal cells: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"basal ganglia: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;HDLM-2: 10.4;U-2 OS: 2.8;U-2197: 7.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 142.2"	"Region enriched"	"Detected in all"	5	"basal ganglia: 149.8"	HPA041629	Uncertain					NA	NA					"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	2.8	1.2	6.4	0.5	83.1	0.4	0.6	0.2	13.3	1.1	0.6	0.1	0.0	0.6	0.6	47.3	0.5	0.7	2.0	0.5	7.0	0.6	1.4	1.4	0.8	0.5	1.1	5.4	0.5	0.7	0.5	0.3	0.5	5.9	0.5	0.6	0.0	0.6	0.6	0.4	0.5	0.5	0.7	0.5	0.8	0.5	1.9	9.0	0.0	1.4	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	2.1	2.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.8	7.6	0.0	0.7	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	83.1	0.2	13.3	7.0	0.6	1.1	5.4	5.9	9.0	0.0	1.3	0.0	0.0	0.0	0.7	0.8	0.0	4.0	0.0	0.0	13.7	0.2	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.0	7.9	0.0	3.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.3	2.8	1.1	0.0	0.2	0.0	0.0	0.0
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 23.8;HDLM-2: 12.3"					"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	1.4	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.3	180.9	5.3	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	43.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	139.9	0.0	0.1	18.7	0.0	18.5	9.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	20.0	0.0
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.6	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	0.1	28.1	1.3	0.1	0.0	13.4	1.3	0.9	51.2	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.0	0.1	28.8	14.3	13.0	1.5	6.2	12.8	5.0	1.1	19.2	0.1	0.2	21.3	2.3	0.2	47.6	0.4	1.1	7.1	32.9	0.0	1.9	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.1	44.2	3.2	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0	35.7	265.4	2.2	608.6	1708.5	1.4	2.1	104.4	136.5	215.0	1526.7	2.0	0.6	0.0	27.2	1.3	40.5	4.2	93.5	41.7	1.3	46.3	959.6	19.7	111.7	2.2	0.0	7.9	16.0	3.8	0.0	30.8	32.1	150.1	1.0	63.7	0.3	32.0	2.9	1.1	28.8	0.4	0.0	42.2	0.0	1.0	2172.4	42.0	43.3	3.5	2008.6
ARHGAP36	FLJ30058	ENSG00000147256	"Rho GTPase activating protein 36"	Q6ZRI8	X	131058242-131089883	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 58.4;brain: 25.5;pituitary gland: 50.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	21	"thyroid cancer: 62.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	164	"SH-SY5Y: 64.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 104.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.8;hypothalamus: 57.8;midbrain: 27.1;pons and medulla: 20.1"	"HPA002064, HPA076209"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		Yes	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA002064: AB_1078891, HPA076209: "	"unprognostic (2.92e-2)"			"unprognostic (7.71e-9)"	"unprognostic (2.19e-1)"	"unprognostic (8.15e-2)"				"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.73e-1)"		"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.31e-1)"		6.9	58.4	1.4	0.2	3.6	0.1	1.0	0.0	2.7	0.5	0.2	0.0	0.0	0.1	0.1	2.0	0.3	0.2	0.2	0.1	1.0	25.5	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	50.3	0.3	5.4	0.3	0.2	0.6	0.2	0.2	13.7	0.1	0.1	0.1	0.8	0.1	0.2	0.6	0.0	0.5	0.5	4.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	64.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.6	0.0	0.4	1.0	25.5	0.5	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57619379	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 17.5;Leydig cells: 23.0;Peritubular cells: 43.2;Sertoli cells: 25.8;Smooth muscle cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 26.2;cerebellum: 54.2;cerebral cortex: 47.7;hippocampal formation: 59.8;olfactory region: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.8;RH-30: 49.9;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	10.4	7.6	26.2	6.1	11.1	0.5	10.5	54.2	47.7	15.4	41.1	3.6	19.8	6.3	40.0	27.0	17.9	24.3	13.9	11.5	59.8	10.5	4.6	1.7	7.6	3.6	7.5	39.3	22.6	3.7	4.9	7.8	5.8	11.2	23.5	12.0	6.1	7.9	49.2	6.3	3.5	10.3	40.7	8.9	7.9	15.0	4.6	6.2	0.0	4.2	3.7	3.1	21.8	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	15.9	9.9	0.0	0.0	1.3	4.8	14.1	6.3	7.8	1.9	3.0	1.3	4.1	8.7	2.9	0.1	6.1	0.2	5.3	4.3	5.3	2.7	2.1	4.1	4.6	0.0	7.4	4.5	1.3	2.8	0.4	22.8	2.4	0.7	5.6	6.1	4.6	1.1	0.9	0.1	10.2	0.1	0.1	0.0	49.9	0.2	0.3	0.2	9.3	22.7	0.9	0.4	1.7	5.9	1.6	3.2	0.0	5.7	5.5	3.7	1.7	12.9	1.9	0.0	4.8	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	11.1	54.2	47.7	59.8	10.5	7.5	39.3	11.2	6.2	0.0	0.0	0.0	1.8	1.8	17.5	12.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.7	0.2	2.1	0.0	0.0	1.2	0.4	8.7	0.7	0.0	0.0	0.4	7.9	0.0	10.4	0.0	0.2	23.0	0.0	0.0	0.0	0.0	3.5	0.5	0.0	43.2	0.3	2.8	25.8	30.9	0.5	1.1	1.0	0.2	0.0	0.0	0.4
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 25.0;Late spermatids: 21.2;Spermatocytes: 30.7;Spermatogonia: 34.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Group enriched"	"Detected in some"	4	"BEWO: 9.0;HeLa: 4.0;SiHa: 11.2"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in all"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	9.0	0.8	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.3	4.0	0.3	0.7	0.4	0.3	0.8	1.0	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.5	0.3	11.2	0.4	0.0	1.1	0.0	0.3	0.6	0.2	1.5	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4	0.0	1.0	0.0	0.1	0.0	2.5	0.4	0.0	5.3	1.2	0.0	0.0	0.8	0.0	0.1	25.0	0.3	0.0	0.0	0.0	1.3	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	21.2	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.2	0.2	3.1	0.0	0.7	30.7	34.3	0.1	0.5	0.0	0.0	0.2
ARMC3	"CT81, FLJ32827"	ENSG00000165309	"Armadillo repeat containing 3"	Q5W041	10	22928024-23038523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 40.2;fallopian tube: 38.6;testis: 25.7"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 236.9;Early spermatids: 288.3;Late spermatids: 68.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 40.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037823, HPA037824"	Enhanced					NA	NA					"HPA037823: AB_2675689, HPA037824: AB_10671634"	"unprognostic (8.11e-3)"	"unprognostic (5.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"		"unprognostic (5.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.37e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.21e-3)"	"unprognostic (9.53e-4)"	"unprognostic (1.40e-2)"	0.3	0.4	3.5	0.3	10.1	0.3	0.4	0.0	1.0	1.9	0.3	11.3	0.0	0.3	1.7	9.0	0.5	38.6	0.3	0.4	4.7	4.1	0.7	0.3	4.1	0.3	1.9	2.2	4.5	0.6	0.3	4.1	0.3	40.2	0.3	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.4	1.0	0.3	0.3	25.7	6.3	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.9	2.3	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.3	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	3.5	10.1	0.0	1.0	4.7	4.1	1.9	2.2	40.2	6.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	236.9	31.8	0.0	5.9	0.0	0.0	0.4	288.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.0	0.8	0.0	0.0	27.1	1.9	0.0	0.0	0.0	0.0	0.0
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 2.8;Cardiomyocytes: 3.4;Early spermatids: 1.6;Late spermatids: 2.2"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 46.2;MOLT-4: 27.1;REH: 15.0;RH-30: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.2	0.0	46.2	0.0	0.1	1.1	0.0	27.1	0.0	0.0	0.0	1.1	15.0	8.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 65.9;Spermatocytes: 192.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Group enriched"	"Detected in some"	8	"NB-4: 6.2;NTERA-2: 16.9;SK-MEL-30: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.2	16.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2	0.0	0.0	0.0	0.4	0.5	0.4	65.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	1.7	0.0	1.7	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.0	3.1	192.9	19.4	0.3	0.0	0.0	0.0	0.4
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.2;ovary: 58.7;skeletal muscle: 16.9"	"Group enriched"	"Detected in some"	6	"Intestinal endocrine cells: 80.5;Leydig cells: 122.0;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;PC-3: 6.2;THP-1: 2.6;U-266/70: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.5	0.5	9.5	0.5	6.7	0.5	0.7	0.3	25.2	0.5	1.1	1.9	0.0	2.9	0.5	1.8	0.5	1.1	0.5	0.5	10.4	2.6	0.6	0.5	0.8	0.5	0.9	17.1	58.7	2.7	4.4	0.5	0.5	0.0	0.7	1.1	0.0	0.5	0.5	16.9	0.5	1.0	0.5	0.3	0.6	4.9	13.6	3.1	0.0	0.5	0.5	0.8	0.5	0.5	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	3.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	6.2	0.7	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.6	0.0	0.0	0.2	0.0	0.0	13.1	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	9.5	6.7	0.3	25.2	10.4	2.6	0.9	17.1	0.0	3.1	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	14.7	3.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.1	0.0	80.5	0.0	0.0	1.3	122.0	0.0	0.0	0.0	2.9	0.0	0.5	0.0	65.7	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	1.2	1.1
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179083	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.4;tongue: 17.6"	"Cell type enhanced"	"Detected in some"	13	"Horizontal cells: 1.6;Ito cells: 1.3;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"cerebellum: 11.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.9	0.6	0.2	1.3	0.3	1.2	0.5	11.4	0.7	0.6	1.2	0.3	0.9	1.3	1.3	1.9	1.1	1.0	0.6	12.6	0.7	0.4	0.8	0.4	0.7	1.9	0.6	0.2	1.1	7.0	1.6	1.8	0.3	0.8	1.7	0.0	2.7	1.2	0.1	38.4	1.9	1.3	4.1	0.2	1.8	1.3	0.6	0.3	0.0	0.9	17.6	1.1	1.6	1.5	4.4	2.9	9.6	2.4	4.0	4.5	2.7	2.1	4.1	4.9	4.6	0.0	0.0	4.0	4.5	0.0	0.0	0.0	3.1	2.4	3.3	2.8	0.0	1.0	5.1	0.0	0.0	0.0	5.1	7.3	2.1	7.1	3.4	0.0	2.2	6.6	0.0	0.0	0.0	0.0	1.3	0.0	5.0	3.8	8.3	0.0	3.5	2.6	4.1	1.5	0.8	4.9	8.3	4.8	4.9	0.0	3.3	5.1	2.8	2.1	0.6	0.7	1.5	6.4	2.1	2.2	6.2	5.7	3.8	2.8	12.7	6.2	3.1	1.4	3.2	4.1	4.0	2.4	9.6	3.1	2.2	3.7	4.4	3.3	3.0	1.2	3.8	4.5	2.8	7.3	4.0	1.9	2.9	3.2	2.7	0.2	0.3	11.4	0.6	0.7	0.4	0.6	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.4	0.9	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.6	0.1	2.4	0.5	0.7	0.0	0.4	0.0	0.0	0.0	0.2	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.4	0.0	0.0	0.0	0.3	0.0	1.6	1.2	2.0	0.0	0.7	0.5	3.5	0.0	0.3	1.4	0.7	0.6	3.0	0.0	0.2	0.6	0.6	0.0	0.4	3.9	1.1	0.7	0.4	0.8	1.2	1.2	0.2	0.6	0.8	0.8	4.0	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3	0.0	1.1	0.0	0.0	2.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.0	1.3	0.0	0.0	0.0	0.1	2.3	0.0	0.0	4.0	12.3	0.0	0.0	4.3	0.3	0.2	11.5	1.7	1.7	0.0	0.0	0.0	0.1	0.0	9.9	4.4	0.0	6.5	1.0	1.6	1.3	2.8	0.7	0.0	0.0	0.0
ASMT	"ASMTY, HIOMT, HIOMTY"	ENSG00000196433	"Acetylserotonin O-methyltransferase"	P46597	X	1615001-1643081	"Enzymes, Predicted intracellular proteins"	"Melatonin biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 8.8;epididymis: 7.0"	"Cell type enhanced"	"Detected in single"	28	"Alveolar cells type 2: 2.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	4	"memory B-cell: 2.2;memory CD8 T-cell: 2.0;naive B-cell: 3.8;NK-cell: 1.0"	"Group enriched"	"Detected in many"	4	"B-cells: 3.8;NK-cells: 1.0;T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NTERA-2: 1.5;U-266/70: 2.2;U-266/84: 3.7"															NA	NA						"unprognostic (1.84e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	0.6	2.3	0.6	1.2	0.7	2.4	0.8	1.2	0.6	1.3	0.8	0.6	0.6	0.3	1.4	7.0	0.6	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.8	0.8	1.8	0.6	0.7	1.3	0.7	3.8	0.6	8.8	1.0	0.2	0.6	1.2	1.0	0.8	1.6	0.7	0.9	4.1	1.4	0.6	0.6	0.6	0.6	1.1	0.6	0.6	0.6	0.9	3.8	0.0	0.5	0.0	1.0	2.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.2	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.8	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.4	0.0	0.0	0.0	1.3	0.0	2.2	3.7	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.5	2.0	0.0	3.8	0.2	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.6	0.7	1.2	0.6	0.8	0.7	1.8	0.6	8.8	0.6	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	8	"SuSa: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	5.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.2
ATP13A5	FLJ16025	ENSG00000187527	"ATPase 13A5"	Q4VNC0	3	193274790-193378843	"Predicted membrane proteins"		Translocase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 17.5;salivary gland: 28.9"	"Cell type enhanced"	"Detected in some"	25	"Club cells: 2.3;Early spermatids: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Region enriched"	"Detected in many"	10	"pons and medulla: 15.2"	"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.7;SK-BR-3: 5.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA031771, HPA031774"	Uncertain					NA	NA					"HPA031771: AB_2674038, HPA031774: AB_2674039"	"unprognostic (7.98e-2)"	"unprognostic (3.01e-4)"		"unprognostic (2.06e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.93e-1)"		"unprognostic (1.67e-4)"	"unprognostic (3.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.14e-2)"		"unprognostic (1.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.10e-2)"		0.1	0.0	1.4	0.1	1.5	0.1	17.5	0.3	0.9	0.1	0.1	2.8	0.1	0.0	0.3	0.9	0.9	0.0	0.1	0.1	1.0	0.7	0.1	0.1	0.4	0.1	0.9	0.1	0.2	0.1	0.1	0.2	0.1	15.2	0.3	0.0	0.4	28.9	0.1	1.3	5.1	0.1	0.1	0.3	0.1	1.4	0.3	0.1	0.4	1.4	1.3	0.7	0.1	0.1	0.4	0.4	4.1	0.3	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.7	1.0	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.0	0.0	0.0	0.2	0.7	0.0	1.7	0.3	1.0	0.0	0.0	0.4	0.7	0.0	0.0	5.8	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.3	1.0	0.0	0.3	0.4	0.3	0.4	0.3	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	4.1	0.3	0.0	0.4	0.1	0.1	1.4	1.5	0.3	0.9	1.0	0.7	0.9	0.1	15.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 61.6;Intestinal endocrine cells: 94.0;Mucus-secreting cells: 112.7;Paneth cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;HMC-1: 58.2;JURKAT: 32.7;MOLT-4: 52.0;SK-BR-3: 42.3"	"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved					NA	NA		100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.3	2.4	0.1	0.0	0.1	0.6	0.0	0.0	4.8	0.4	20.5	1.2	0.0	0.3	22.3	58.2	0.0	0.0	0.1	0.0	0.0	0.0	32.7	4.1	25.4	0.0	24.4	52.0	24.0	0.2	11.1	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.3	0.0	0.2	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2	0.0	3.4	44.0	0.4	0.8	0.0	2.2	5.1	1.4	2.3	22.7	0.0	0.2	0.0	1.7	0.1	3.6	61.6	0.0	10.8	0.2	2.0	6.5	33.4	0.8	2.8	0.0	94.0	7.4	3.5	0.0	0.0	2.6	11.8	0.0	112.7	0.2	17.0	46.0	0.7	0.2	0.1	0.0	3.1	0.0	0.7	0.3	0.0	20.8	41.2	2.5
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting beta subunit"	P51164	13	113648804-113658186	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 156.3"	"Cell type enriched"	"Detected in single"	6	"Distal tubular cells: 1.7"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced					NA	NA					"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.1	2.0	0.1	0.0	0.1	0.1	1.5	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	6.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	156.3	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.9	0.0	1.6	0.0	0.0	2.6	0.9	0.2	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AVIL	"ADVIL, DOC6, FLJ12386, p92"	ENSG00000135407	Advillin	O75366	12	57797376-57818704	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.4"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 26.7;Rod photoreceptor cells: 20.0"	"Cancer enhanced"	"Detected in all"		"glioma: 9.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 9.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.7;RH-30: 12.8;U-266/84: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058864	Approved					NA	NA					"HPA058864: AB_2683838"	"unprognostic (3.86e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.79e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-4)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.71e-4)"	1.0	4.0	0.9	1.9	1.4	0.2	1.1	9.8	1.2	0.9	13.6	0.9	0.9	3.0	0.9	3.4	0.9	1.3	2.6	1.2	0.9	0.6	1.4	1.3	2.2	0.9	0.9	0.9	2.0	3.9	0.0	2.1	1.0	1.9	1.6	1.3	1.4	1.4	1.0	9.3	6.0	21.4	0.9	1.5	1.1	1.0	0.9	1.3	0.9	3.4	0.9	0.9	1.7	1.1	2.3	1.3	9.0	1.4	0.6	2.0	0.1	0.5	0.6	4.4	3.0	1.1	2.1	0.3	0.4	0.2	0.0	0.3	0.1	1.6	6.7	0.6	0.7	0.0	2.4	0.1	0.0	0.5	0.0	2.1	0.7	1.5	1.4	0.4	2.7	0.1	1.5	1.1	0.2	0.6	0.1	0.6	0.7	0.5	2.9	0.0	0.6	0.0	2.9	0.4	0.0	1.4	0.1	12.8	0.5	0.2	1.3	0.9	0.1	0.5	0.4	1.5	1.0	1.0	0.0	0.3	1.9	0.2	1.4	0.0	1.3	4.8	0.8	0.8	0.5	0.5	0.4	1.4	2.3	1.2	0.6	1.3	1.2	2.0	1.0	0.6	2.3	1.9	1.4	9.0	0.6	1.0	1.3	0.6	0.1	0.9	1.4	9.8	1.2	0.9	0.6	0.9	0.9	1.9	1.3	3.0	11.4	2.7	2.9	2.6	26.7	0.6	10.2	1.4	4.5	3.5	17.7	0.9	0.0	4.0	5.0	4.0	2.9	0.0	5.3	0.8	3.1	2.9	1.1	2.4	1.9	7.9	7.5	12.3	3.2	2.0	3.7	2.6	3.3	1.8	4.3	16.9	4.0	4.2	0.7	0.5	20.0	6.5	2.5	0.9	1.5	3.6	2.4	2.5	4.0	2.5
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"brain: 270.1"	"Group enriched"	"Detected in some"	5	"Late spermatids: 18.7;Proximal tubular cells: 32.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	18	"hypothalamus: 270.1"	"Cell type enriched"	"Detected in some"	6	"eosinophil: 6.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.1"	"Cell line enriched"	"Detected in single"	13	"NB-4: 7.1"	"Region enriched"	"Detected in some"	10	"hypothalamus: 273.6"	"Group enriched"	"Detected in some"	633	"basal ganglia: 1065.4;hypothalamus: 1058.2"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"	NA	NA	19300				"CAB025318: , HPA071892: AB_2732190"										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.7	0.9	11.7	0.4	15.0	4.2	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	270.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.1	11.7	15.0	0.0	0.9	3.4	270.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.8	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 85.3;Intestinal endocrine cells: 27.7;Mucus-secreting cells: 45.4;Paneth cells: 85.2;Undifferentiated cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 15.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.6;RPTEC TERT1: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA					"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.1	0.3	0.5	3.1	15.8	0.1	1.8	0.3	1.5	3.0	16.2	0.6	0.0	19.4	1.4	1.6	2.3	1.0	12.9	0.2	1.3	1.5	0.6	0.3	0.2	0.1	0.7	0.1	0.7	6.2	0.1	7.9	0.7	2.2	1.0	27.1	2.2	5.5	0.1	0.2	1.1	23.4	0.7	2.0	0.2	3.8	0.6	3.6	1.8	1.1	0.8	14.8	1.1	5.9	0.2	0.2	1.0	0.2	0.3	0.2	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.0	0.1	0.5	0.0	2.1	0.1	22.0	1.4	3.7	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.0	0.2	0.0	0.0	0.5	15.8	0.3	1.5	1.3	1.5	0.7	0.1	2.2	3.6	0.0	0.0	0.0	0.2	0.0	6.7	1.7	10.2	1.4	7.9	5.2	0.0	0.0	0.0	6.5	0.3	0.0	85.3	0.0	4.1	0.0	0.0	0.4	4.6	0.0	0.0	0.0	27.7	0.0	0.0	0.6	0.6	0.0	0.0	0.0	45.4	1.4	6.0	85.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	35.9	6.7
BARHL1		ENSG00000125492	"BarH like homeobox 1"	Q9BZE3	9	132582185-132590266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	44	"brain: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"cerebellum: 23.8;pons and medulla: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	105	"SCLC-21H: 19.8"	"Group enriched"	"Detected in some"	5	"cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 16.3"	HPA004809	Enhanced					NA	NA					"HPA004809: AB_1078266"					"unprognostic (2.29e-1)"					"unprognostic (6.42e-2)"	"unprognostic (8.07e-2)"			"unprognostic (9.31e-2)"				0.3	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.0	40.1	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.5	2.2	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717237	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 29.3"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 22.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	42	"cerebellum: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5"	"Region enriched"	"Detected in some"	5	"cerebellum: 14.5"	"Region enriched"	"Detected in many"	20	"cerebellum: 48.3"							NA	NA										"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	8.9	1.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.0
BARX1		ENSG00000131668	"BARX homeobox 1"	Q9HBU1	9	93951622-93955372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 59.7"	"Cell type enhanced"	"Detected in single"	23	"Early spermatids: 2.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 19.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 15.6;HMC-1: 37.3;NTERA-2: 11.0;THP-1: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055858			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA055858: AB_2682947"	"unprognostic (6.19e-4)"	"unprognostic (4.81e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.16e-6)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.23e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.68e-13)"	"unprognostic (7.02e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.16e-2)"	4.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.2	2.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.4	1.5	0.0	0.2	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	59.7	5.6	0.0	0.0	0.5	12.3	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	11.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	3.2	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.4	7.8	0.0	1.9	0.0	60.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	1.5	0.0	2.3	0.0	0.0	0.0	7.7	0.3	0.0	0.0	14.7	0.0	0.1	0.1	0.0	0.0	7.4	0.0	0.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2	0.0	1.4	0.0	99.1	38.2	0.4	0.4	2.5	6.7	6.8	0.0	0.0	10.6	6.6	18.2	6.5	0.3	27.5	0.0	0.6	6.4	2.3	15.2	0.0	0.0	1.6	0.0	1.7	0.0	0.0	1.3	0.0	0.8	10.1	0.0	12.2	0.8	5.0	22.1	0.4	1.4	0.2	0.0	0.7	0.0	1.1	72.1	3.5	0.0	15.8	102.1
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Group enriched"	"Detected in many"	8	"Basal keratinocytes: 55.8;Suprabasal keratinocytes: 62.4;T-cells: 48.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Group enriched"	"Detected in some"	6	"JURKAT: 24.7;MOLT-4: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.0	24.7	0.0	2.8	0.0	1.6	29.5	0.4	0.3	2.2	0.0	4.6	0.0	0.0	0.0	1.6	2.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.8	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6	3.0	0.0	2.7	1.6	55.8	0.1	3.1	5.1	0.0	1.2	0.0	0.0	0.1	1.7	0.3	0.0	0.1	4.3	0.0	0.4	0.0	1.1	0.2	4.7	0.0	0.2	0.0	1.2	4.3	1.2	0.2	0.6	0.7	5.0	0.0	2.6	0.0	0.7	4.3	0.0	0.3	0.0	0.0	3.3	0.7	4.9	62.4	0.0	48.4	6.9	0.6
BCL2L10	"BCL-B, Boo, Diva"	ENSG00000137875	"BCL2 like 10"	Q9HD36	15	52109263-52112775	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 15.3"	"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 5.5;Distal tubular cells: 11.6;Proximal tubular cells: 7.5;Suprabasal keratinocytes: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.0"	"Group enriched"	"Detected in some"	6	"basophil: 4.1;memory B-cell: 1.6;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	28	"B-cells: 1.6;dendritic cells: 2.6;granulocytes: 4.1"	"Cell line enriched"	"Detected in some"	8	"NB-4: 27.5"									HPA042222	Approved					NA	NA					"HPA042222: AB_10794271"	"unprognostic (5.33e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.18e-9)"	"unprognostic (9.59e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.20e-2)"	1.0	3.5	1.0	2.4	6.0	0.3	2.1	1.4	1.6	2.8	3.6	0.1	0.0	3.9	1.1	1.2	6.1	1.3	3.4	0.1	0.5	1.7	6.5	15.3	0.1	1.2	0.3	1.1	0.9	4.2	0.8	3.7	0.2	0.3	2.5	1.7	0.3	1.8	0.4	0.3	10.0	8.1	0.5	0.3	1.6	1.8	0.9	0.5	0.5	0.8	4.3	1.0	2.3	3.9	1.6	2.6	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.1	3.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	1.0	6.0	1.4	1.6	0.5	1.7	0.3	1.1	0.3	0.5	0.0	0.0	0.0	4.2	5.5	0.9	0.3	2.5	0.0	0.0	0.0	0.0	0.0	11.6	2.0	0.0	0.0	4.6	0.0	1.3	0.2	0.1	1.7	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.6	0.0	0.4	7.5	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	2.2	4.7
BDKRB1	"B1BKR, BKR1, bradyb1"	ENSG00000100739	"Bradykinin receptor B1"	P46663	14	96255824-96268967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 16.1;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"	20	"Basal keratinocytes: 36.2;Fibroblasts: 10.8;Suprabasal keratinocytes: 15.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Cell type enriched"	"Detected in single"	19	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.8;HHSteC: 12.2;hTEC/SVTERT24-B: 11.4;U-2197: 12.6;U-87 MG: 41.9"	"Low region specificity"	"Detected in single"							HPA002935	Approved					NA	NA					"HPA002935: AB_1078274"	"unprognostic (6.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.96e-6)"	"unprognostic (2.33e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.66e-2)"	7.3	0.0	0.2	17.1	0.2	0.0	0.8	2.1	0.6	5.4	3.7	0.2	0.2	1.8	0.7	2.8	10.4	4.8	16.1	2.3	0.2	0.0	2.4	0.6	3.7	0.2	0.2	0.2	4.5	7.9	0.0	0.2	3.0	0.4	2.2	2.8	0.7	1.5	1.1	0.4	2.4	3.7	5.7	0.2	0.6	3.3	2.3	0.2	0.2	0.8	4.6	2.0	13.7	5.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.6	0.0	0.4	1.1	4.0	0.0	1.0	11.8	1.2	0.2	0.0	0.2	0.0	0.0	6.9	0.6	1.1	0.0	0.1	1.9	0.1	0.0	0.0	1.2	0.0	12.2	0.0	0.0	0.4	1.0	11.4	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	0.0	3.6	0.0	0.1	0.0	0.4	0.0	3.3	1.1	0.0	0.1	0.0	0.0	0.0	4.5	0.2	12.6	0.7	2.2	4.1	0.0	41.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	2.1	0.6	0.2	0.0	0.2	0.2	0.4	0.2	0.0	0.3	0.0	1.5	36.2	0.2	0.4	0.0	2.7	0.0	0.0	0.0	0.2	6.6	1.6	0.7	0.1	2.9	0.0	1.1	0.3	10.8	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	3.5	0.4	0.0	0.0	0.0	1.0	0.5	1.5	15.1	1.3	0.0	0.0	2.6
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 15.3;Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.5;pons and medulla: 5.7"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.8;BJ hTERT+: 41.8;U-87 MG: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	9.0	1.2	1.5	3.7	1.0	0.0	4.7	13.5	1.1	12.2	9.0	1.3	4.4	5.6	8.5	12.7	14.9	5.1	21.1	4.3	0.8	0.7	12.1	0.7	2.2	0.4	0.9	0.3	4.7	6.8	0.9	1.1	2.9	5.7	6.9	9.2	0.9	3.1	11.3	2.7	4.0	10.3	11.3	1.3	0.4	4.2	3.2	0.0	0.6	3.6	13.9	4.4	16.7	13.5	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.7	2.7	0.0	4.9	7.4	22.8	0.0	2.4	41.8	1.4	1.7	0.1	4.6	0.0	0.1	3.8	1.6	6.5	0.0	1.0	1.2	0.5	0.0	0.0	0.5	0.0	3.6	0.0	0.0	6.9	3.3	4.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	8.8	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.5	0.8	6.9	0.0	1.0	0.4	0.0	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.0	18.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	1.0	13.5	1.1	0.8	0.7	0.9	0.3	5.7	0.0	3.0	1.9	0.0	0.5	8.1	0.0	0.5	15.3	13.4	9.1	8.7	0.0	0.5	6.6	10.2	0.0	4.2	8.9	0.0	3.5	1.9	6.1	0.8	0.0	0.0	0.2	0.0	6.8	3.1	0.0	0.0	0.9	0.6	5.0	0.0	5.0	0.0	4.5	4.5	1.1	0.0	0.0	0.0	2.0	0.0	0.0	5.1	3.3	0.0	0.7	2.4
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 455.1;Proximal tubular cells: 647.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;NTERA-2: 3.6;SCLC-21H: 2.3"					"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		9200000	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.3	0.0	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	2.5	0.0	0.0	15.7	0.0	0.0	66.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	455.1	0.0	0.0	0.0	3.7	9.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	647.0	0.1	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753645-55875564	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7;prostate: 29.4;retina: 21.2"	"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 22.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA						"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	2.1	0.6	0.2	3.3	0.2	0.1	1.5	0.7	0.7	0.2	4.3	0.0	0.0	5.0	0.1	0.2	1.9	0.2	1.5	3.4	0.3	0.2	1.6	1.9	14.3	0.2	2.0	1.4	0.2	1.2	0.1	5.0	42.7	5.2	29.4	4.7	21.2	1.7	0.0	7.0	0.2	10.2	5.5	3.6	0.1	1.9	0.2	0.0	0.0	1.5	5.0	0.1	11.8	1.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.7	0.3	0.2	2.0	1.4	5.2	0.0	0.0	4.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.4	12.4	0.0	0.0	0.0	2.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0
BRICD5	"C16orf79, MGC21830"	ENSG00000182685	"BRICHOS domain containing 5"	Q6PL45	16	2209253-2211950	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 29.7;testis: 42.8"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 10.7;Cone photoreceptor cells: 23.6;Rod photoreceptor cells: 11.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA063522			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Actin filaments"	Nucleoplasm	"HPA063522: AB_2685029"	"prognostic favorable (9.74e-4)"	"unprognostic (7.12e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.34e-3)"	"unprognostic (7.56e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (9.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (8.06e-5)"	2.0	4.0	3.2	3.7	4.9	3.0	2.0	29.7	5.3	2.0	2.0	2.0	2.0	5.4	2.8	2.0	2.0	1.6	2.0	2.9	3.5	4.4	2.9	2.0	2.1	4.6	3.1	2.8	2.0	3.0	2.2	3.6	2.9	2.5	2.4	0.5	9.9	3.7	4.0	9.1	2.7	5.2	2.0	3.3	6.3	2.7	42.8	2.0	2.4	6.1	2.0	2.0	2.0	2.0	0.8	0.6	2.3	0.8	0.8	1.7	0.4	2.8	5.6	7.7	4.4	1.2	1.3	14.1	2.7	0.5	1.5	2.3	7.1	7.0	1.6	1.8	0.5	1.8	7.6	1.0	1.0	1.1	5.2	3.4	1.7	13.4	1.8	0.7	0.7	4.4	1.5	2.1	2.3	0.5	2.3	0.9	6.4	1.9	4.0	0.6	7.6	4.8	10.8	7.5	0.9	3.2	14.8	5.8	5.0	1.7	2.2	5.4	4.9	2.7	3.4	2.6	3.7	3.4	4.0	2.2	7.4	6.0	6.4	2.3	12.1	5.2	4.0	1.4	4.5	3.5	0.4	0.7	2.2	0.6	0.8	0.3	0.3	0.3	0.1	0.6	0.8	1.7	0.4	2.3	0.8	0.2	0.4	0.4	0.4	3.2	4.9	29.7	5.3	3.5	4.4	3.1	2.8	2.5	2.0	3.0	4.1	0.0	0.5	0.3	10.7	0.4	0.0	4.0	0.0	5.2	23.6	1.6	0.0	0.8	2.1	1.1	1.8	0.0	0.5	0.7	1.0	0.8	4.6	1.0	1.1	4.8	1.2	1.8	2.2	5.9	1.1	2.5	1.7	1.0	1.2	4.3	0.7	0.0	2.5	0.3	11.0	0.0	0.5	3.9	1.9	1.0	0.7	0.0	2.3	0.4
BRS3	"BB3, BB3R"	ENSG00000102239	"Bombesin receptor subtype 3"	P32247	X	136487887-136493780	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"epididymis: 27.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 3.6;hypothalamus: 2.8"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.2;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"B-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;hypothalamus: 7.1"	"Low region specificity"	"Detected in all"									NA	NA							"unprognostic (1.49e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"		"unprognostic (3.73e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"		"unprognostic (5.59e-2)"	0.1	0.1	0.1	0.1	3.6	0.0	0.5	0.4	0.4	0.3	0.1	0.1	0.1	0.0	0.2	27.4	0.1	2.4	0.1	0.1	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.3	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.4	0.4	0.1	2.8	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 67.7;salivary gland: 68.2"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 59.2;Exocrine glandular cells: 58.0;Pancreatic endocrine cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"basal ganglia: 20.8"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"A-431: 18.1;CAPAN-2: 11.6;MCF7: 27.0;OE19: 31.4;RPMI-8226: 14.1;SK-BR-3: 13.6;T-47d: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.2	1.6	1.0	4.6	20.8	2.1	6.1	4.1	1.4	2.9	5.4	0.4	7.9	3.6	1.0	6.4	14.2	1.9	8.5	1.4	0.6	0.7	9.3	0.4	4.1	0.6	0.7	1.3	0.3	37.8	67.7	10.1	1.7	0.6	2.4	4.5	2.7	68.2	4.8	0.1	12.4	6.8	0.4	0.3	0.3	10.4	2.1	1.8	1.2	28.2	10.7	5.4	1.5	3.2	0.0	8.0	0.0	0.0	0.0	0.4	0.1	18.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	3.8	11.6	0.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	2.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	9.4	0.1	0.0	0.0	27.0	0.3	0.0	0.4	31.4	0.0	0.4	0.0	14.1	1.8	3.9	6.2	0.0	0.0	13.6	0.0	0.8	13.7	1.9	0.0	0.0	0.0	0.0	0.0	4.4	5.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.1	1.0	20.8	4.1	1.4	0.6	0.7	0.7	1.3	0.6	1.8	6.0	5.8	2.4	1.7	0.9	0.6	1.6	15.3	2.7	4.5	26.2	5.9	8.1	33.2	59.2	0.1	0.1	12.9	0.0	58.0	0.7	0.4	15.4	3.5	0.8	1.2	0.0	19.7	0.0	0.0	0.2	0.0	0.1	10.1	1.8	19.3	0.3	56.5	14.0	0.0	15.3	9.1	0.0	0.0	0.5	2.3	12.4	5.6	0.5	24.3	13.9
BTG1	APRO2	ENSG00000133639	"BTG anti-proliferation factor 1"	P62324	12	92140278-92145897	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 190.7"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 2444.1;Suprabasal keratinocytes: 2626.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005972			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005972: AB_1078303"	"prognostic favorable (4.36e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.81e-2)"	52.0	22.1	11.5	58.3	13.4	126.9	114.4	66.8	10.4	41.7	40.1	5.5	21.9	15.5	30.1	22.0	28.7	27.9	39.9	49.2	11.9	8.1	22.2	58.1	85.6	190.7	10.4	8.2	29.1	64.2	17.6	17.1	23.4	13.3	28.7	18.1	21.0	19.0	25.9	31.6	70.6	34.3	26.0	24.6	77.1	26.4	19.0	8.9	148.9	15.7	14.3	58.2	54.2	35.2	58.3	6.6	94.3	14.0	47.1	95.2	26.1	7.0	8.8	9.7	1.1	36.3	50.4	4.2	7.9	17.4	5.3	5.3	5.2	2.4	7.5	1.6	8.3	8.4	4.8	3.2	8.8	9.9	9.0	6.8	1.5	6.1	2.7	36.8	5.5	2.6	43.0	26.7	12.1	37.5	23.5	10.6	5.0	5.2	10.0	6.0	7.2	3.9	17.7	2.3	7.7	10.0	13.4	5.4	2.3	16.3	14.6	5.4	10.8	9.8	7.6	25.5	7.8	32.0	12.8	3.4	6.0	1.8	4.6	4.8	13.8	7.4	12.5	4.7	4.4	6.7	22.3	13.6	94.3	17.0	10.6	20.1	44.5	34.3	29.8	6.6	58.3	95.2	39.1	52.3	47.1	14.0	6.2	39.2	26.1	11.5	13.4	66.8	10.4	11.9	8.1	10.4	8.2	13.3	8.9	89.3	164.0	1133.8	898.4	2444.1	509.3	99.7	695.5	18.7	63.7	165.7	184.6	344.9	271.9	357.5	306.7	258.8	666.0	140.2	222.2	261.3	225.7	728.6	288.8	235.3	359.2	400.5	434.2	206.2	468.4	134.9	265.8	682.9	933.0	1485.2	192.1	767.8	308.3	596.2	227.4	96.3	342.5	530.3	1116.5	68.9	113.5	2626.0	1122.8	1563.2	226.0	1040.3
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.7;U-266/70: 28.3"									HPA051504	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.0	12.4	3.2	22.6	5.2	2.7	7.5	29.0	5.2	8.5	5.7	5.1	4.8	5.2	10.2	10.6	7.4	6.7	7.9	9.5	4.1	3.7	7.5	6.1	15.6	21.8	4.4	3.3	10.3	5.8	12.9	5.5	2.8	9.7	8.8	8.0	11.5	9.3	7.9	2.7	8.0	9.9	8.2	5.3	18.0	7.2	5.1	4.2	13.0	7.0	6.2	26.0	8.5	7.6	20.2	14.9	7.8	9.1	5.1	6.3	4.7	4.8	3.1	6.3	6.7	2.1	3.3	0.4	5.3	14.0	8.4	14.5	1.9	1.9	4.4	5.8	9.5	6.8	4.5	5.0	4.1	11.2	13.7	8.4	6.9	5.8	3.8	4.4	1.5	2.4	7.1	1.3	16.1	5.5	10.0	7.7	8.7	5.5	34.7	3.7	2.1	5.4	2.0	2.3	0.2	3.1	12.8	9.0	13.5	6.0	2.7	6.0	8.5	3.4	1.3	14.5	3.8	6.4	3.0	9.1	3.1	3.6	2.7	8.1	28.3	17.3	7.7	3.1	6.2	7.7	1.2	8.7	1.5	4.2	9.1	3.9	16.2	3.3	3.7	14.9	20.2	2.8	3.4	7.8	5.1	3.6	6.2	6.3	4.7	3.2	5.2	29.0	5.2	4.1	3.7	4.4	3.3	9.7	4.2	8.9	9.3	13.7	6.2	3.4	0.4	2.2	2.5	4.0	9.1	3.5	0.0	2.0	0.0	8.2	0.2	14.0	1.0	23.3	4.9	0.9	2.1	6.9	18.5	2.5	8.1	0.0	1.7	5.5	8.8	0.0	6.1	18.0	6.8	12.6	7.0	17.3	6.6	0.0	4.6	1.7	0.7	0.0	3.9	0.5	1.3	4.0	0.8	7.5	1.6	3.1
C11orf16		ENSG00000176029	"Chromosome 11 open reading frame 16"	Q9NQ32	11	8920076-8933006	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 19.1;lymphoid tissue: 10.8"	"Cell type enriched"	"Detected in some"	17	"Ciliated cells: 135.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.0;T-reg: 1.6"	"Group enriched"	"Detected in many"	9	"monocytes: 1.0;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;CACO-2: 1.6;EFO-21: 1.6"	"Low region specificity"	"Detected in some"													NA	NA						"unprognostic (5.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.09e-3)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.94e-5)"	"unprognostic (6.40e-4)"	"unprognostic (1.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.13e-3)"	0.0	0.2	0.5	0.0	0.8	0.0	0.2	0.0	0.3	2.3	0.0	0.7	0.0	0.1	0.6	3.1	0.0	19.1	0.0	0.0	0.8	1.3	0.4	0.0	5.2	0.0	0.0	0.0	2.8	0.0	0.0	1.6	0.0	2.9	0.0	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.7	0.0	10.8	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	0.9	1.3	1.3	0.5	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.6	0.2	0.1	1.6	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.4	0.0	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	1.2	0.1	0.0	0.0	0.6	0.9	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.7	0.0	1.1	0.0	0.0	0.3	0.4	0.0	0.7	1.0	0.5	0.3	0.2	0.0	0.3	0.0	0.2	0.6	1.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.5	0.8	0.0	0.3	0.8	1.3	0.0	0.0	2.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	135.1	7.9	5.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0
C11orf42	MGC34805	ENSG00000180878	"Chromosome 11 open reading frame 42"	Q8N5U0	11	6205566-6211132	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 27.9"	"Group enriched"	"Detected in some"	136	"Early spermatids: 149.9;Late spermatids: 529.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.2;HeLa: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063404	Enhanced		Approved	"Nuclear membrane,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane, Vesicles"	"HPA063404: AB_2685006"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.49e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.30e-2)"	"unprognostic (6.47e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	1.0	1.2	0.1	0.2	0.1	0.1	1.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.0	0.9	0.1	0.1	0.1	0.3	27.9	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.5	2.5	0.4	1.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.8	0.6	0.1	0.0	0.3	1.9	0.0	0.0	0.0	0.6	4.2	0.0	4.8	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.9	0.4	0.0	0.8	0.9	0.4	1.5	0.3	1.3	0.8	1.2	0.2	0.0	0.4	1.2	0.3	0.2	1.1	0.5	0.6	0.4	0.9	0.4	1.0	0.4	2.0	0.3	0.5	1.1	0.4	0.7	1.8	0.4	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	529.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	0.0	0.0	0.0
C11orf70	MGC13040	ENSG00000137691	"Chromosome 11 open reading frame 70"	Q9BRQ4	11	102047443-102084560	"Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.5;testis: 54.7"	"Group enriched"	"Detected in many"	9	"Ciliated cells: 186.0;Early spermatids: 270.4;Spermatocytes: 221.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038585	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA038585: AB_10795357"	"unprognostic (9.70e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.77e-6)"	"unprognostic (1.76e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.94e-2)"	"unprognostic (6.73e-3)"	2.5	3.7	2.9	1.1	4.2	0.1	3.1	0.7	1.4	5.9	1.6	5.4	11.6	0.8	5.3	11.9	2.3	25.5	4.9	1.7	3.9	4.5	3.0	0.3	7.2	1.2	1.7	1.3	7.5	0.8	3.7	13.7	4.0	16.0	5.6	0.8	4.2	1.1	7.0	0.5	1.6	0.8	5.5	1.9	0.2	1.6	54.7	2.2	0.0	3.3	1.1	0.8	3.8	2.5	0.6	0.3	2.3	0.6	0.3	0.4	0.2	0.0	6.7	6.8	0.0	6.1	14.8	0.2	2.6	6.8	3.7	5.2	0.5	8.7	0.0	1.6	5.2	1.8	1.7	1.6	0.8	2.7	0.0	1.0	0.0	1.1	0.0	4.3	0.0	0.0	6.3	8.5	9.5	6.4	7.2	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	10.0	1.9	7.5	0.0	8.6	0.1	0.0	0.0	7.6	0.0	1.0	0.9	2.9	8.9	2.1	0.1	0.0	0.0	3.0	0.0	0.4	1.6	0.6	0.4	0.3	0.2	0.2	0.5	0.3	0.3	0.1	0.6	0.4	0.3	2.3	0.3	0.2	0.3	0.2	0.2	2.9	4.2	0.7	1.4	3.9	4.5	1.7	1.3	16.0	2.2	0.0	3.4	0.0	5.8	10.2	0.3	0.0	2.5	186.0	13.6	0.0	2.0	6.6	0.0	0.0	270.4	0.1	0.0	0.0	0.0	0.2	8.0	1.2	1.1	0.0	0.4	0.0	9.1	1.3	0.0	24.5	10.6	1.1	5.0	0.0	0.4	7.8	0.0	0.0	5.3	0.0	0.8	12.9	2.8	221.4	17.7	4.0	1.6	0.0	0.0	1.8
C11orf88	FLJ46266	ENSG00000183644	"Chromosome 11 open reading frame 88"	Q6PI97	11	111514785-111537031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.8;fallopian tube: 53.7"	"Cell type enriched"	"Detected in some"	10	"Ciliated cells: 1019.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Region enriched"	"Detected in many"	4	"pons and medulla: 48.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.6;Karpas-707: 4.9;SuSa: 3.7;U-266/70: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.25e-1)"	"unprognostic (3.07e-5)"	"unprognostic (3.85e-4)"	"unprognostic (4.16e-2)"	"unprognostic (4.44e-5)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.86e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.80e-3)"	"unprognostic (7.57e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	0.2	0.2	5.7	0.3	10.9	0.3	0.2	0.2	1.0	5.8	0.2	5.7	0.0	0.4	2.2	13.1	0.2	53.7	0.4	0.2	7.3	7.6	0.2	0.2	13.9	0.3	0.6	0.2	8.3	0.2	0.2	0.5	0.4	48.8	0.3	0.2	0.0	0.3	0.3	0.2	0.3	0.3	0.2	1.1	0.3	0.3	13.5	1.5	0.1	0.7	0.0	0.2	0.2	0.0	0.7	0.6	2.6	0.5	0.6	0.4	0.0	0.3	1.0	0.1	0.1	0.0	0.0	0.6	1.6	0.0	0.1	0.0	4.6	2.1	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.2	0.4	0.4	0.0	0.5	0.0	0.4	0.0	0.7	0.1	4.9	0.0	0.5	0.3	0.2	0.2	0.0	0.5	0.0	0.8	0.0	0.1	0.2	0.2	0.5	0.3	0.1	0.0	3.7	0.9	0.0	0.0	0.7	0.6	0.7	0.9	2.8	0.4	0.2	0.4	0.3	0.9	1.7	0.5	1.2	0.3	0.2	0.4	0.5	0.2	0.1	0.4	0.7	0.3	0.3	2.6	0.6	0.5	0.6	0.4	0.0	5.7	10.9	0.2	1.0	7.3	7.6	0.6	0.2	48.8	1.5	3.0	6.9	0.0	0.2	0.0	0.0	4.4	0.0	1019.8	70.5	0.0	0.0	0.1	0.0	0.0	106.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	31.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.1	7.1	0.0	0.0	0.0	0.0	0.5
C12orf56		ENSG00000185306	"Chromosome 12 open reading frame 56"	Q8IXR9	12	64264762-64391192	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.9;testis: 15.0"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 49.8;Late spermatids: 26.6;Muller glia cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"hTEC/SVTERT24-B: 10.1;SCLC-21H: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA056986	Enhanced					NA	NA					"HPA056986: AB_2683300"	"unprognostic (5.85e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.79e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.38e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.69e-2)"	0.3	0.1	0.1	0.0	0.5	0.2	0.1	1.3	0.2	1.8	0.4	0.9	1.0	0.0	0.1	0.0	1.8	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.4	0.2	0.1	2.7	0.5	0.0	0.0	1.6	0.1	0.0	0.1	0.2	0.1	15.0	0.0	8.9	0.0	0.6	0.9	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.1	8.5	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	4.9	5.0	0.0	49.8	0.0	0.0	0.0	0.0	3.6	0.4	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	26.6	0.0	0.4	0.0	0.0	1.0	11.8	0.2	0.0	0.4	7.1	0.7	0.0	0.0	4.2	1.3	0.3	1.5	0.0	0.6	1.4
C14orf180	"C14orf77, NRAC"	ENSG00000184601	"Chromosome 14 open reading frame 180"	Q8N912	14	104579684-104590515	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;heart muscle: 55.1"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 2.6;Cardiomyocytes: 6.1;Horizontal cells: 3.2;Ito cells: 3.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Region enriched"	"Detected in single"	11	"pons and medulla: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"ASC diff: 8.4"															NA	NA						"unprognostic (2.48e-2)"				"unprognostic (1.55e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"		"unprognostic (1.60e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.80e-2)"		23.2	1.2	0.0	1.7	0.2	0.1	9.8	0.0	0.1	0.5	3.8	0.7	6.7	0.3	0.3	4.7	0.2	0.4	0.7	55.1	0.0	0.3	0.7	1.9	0.2	0.3	0.0	0.0	0.3	0.7	0.1	0.6	0.7	3.9	0.4	0.2	2.0	1.7	1.2	2.5	0.1	0.5	0.5	0.0	0.2	0.5	0.4	0.0	0.0	0.2	1.3	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 70.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA059518: AB_2684049"	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.6	0.0	0.1	0.0	21.7	0.0	0.0	1.6	0.0	17.6	0.2	2.3	0.0	1.1	0.0	4.8	0.0	0.3	1.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.6	0.0	1.4	5.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	3.2	0.0	0.0	0.0	5.1	0.3	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.7	0.0	1.0	0.0	0.0	70.5	6.1	0.0	0.0	0.0	0.0	0.1
C15orf53	FLJ35695	ENSG00000175779	"Chromosome 15 open reading frame 53"	Q8NAA6	15	38628005-39180499	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 8.0;gallbladder: 6.3"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.1;Distal tubular cells: 1.7;granulocytes: 1.1;Intestinal endocrine cells: 1.7;Pancreatic endocrine cells: 1.0;T-cells: 2.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Cell type enriched"	"Detected in single"	10	"T-reg: 8.0"	"Lineage enriched"	"Detected in single"	81	"T-cells: 8.0"	"Group enriched"	"Detected in some"	9	"HEL: 4.7;HMC-1: 3.6"									HPA041914	Uncertain					NA	NA					"HPA041914: AB_10794640"	"unprognostic (9.94e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.30e-1)"			"unprognostic (5.38e-5)"	"unprognostic (1.02e-1)"	"unprognostic (8.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (3.58e-1)"		"unprognostic (4.30e-5)"	"unprognostic (2.59e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.49e-3)"	0.2	0.1	0.1	2.8	0.1	0.2	0.2	0.4	0.1	0.3	1.9	0.0	0.0	0.3	0.3	1.8	0.7	0.3	6.3	0.2	0.1	0.1	0.3	0.2	2.3	0.5	0.3	0.0	1.3	0.1	0.0	0.1	0.0	1.2	0.2	0.3	0.0	1.3	0.1	0.2	0.6	1.0	0.8	0.7	1.7	0.5	0.2	0.0	0.1	0.2	2.4	3.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0
C19orf71	LOC100128569	ENSG00000183397	"Chromosome 19 open reading frame 71"	A6NCJ1	19	3539154-3544030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 88.8"	"Group enriched"	"Detected in some"	58	"Early spermatids: 515.2;Late spermatids: 237.4"	"Cancer enriched"	"Detected in all"	5	"melanoma: 23.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HeLa: 27.3;SK-MEL-30: 16.6;WM-115: 59.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048654	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Endoplasmic reticulum"	"HPA048654: AB_2680480"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.74e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.13e-2)"	"prognostic favorable (2.03e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (2.02e-5)"	"unprognostic (5.52e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-3)"	1.6	2.3	1.6	4.1	2.2	5.1	1.6	9.8	2.2	1.7	1.6	2.0	1.6	4.7	2.5	1.9	1.6	2.6	1.6	1.6	1.6	1.3	3.5	1.6	2.1	4.9	1.8	1.9	2.8	4.2	0.0	4.5	1.6	1.7	2.2	0.0	1.6	7.6	1.6	1.6	7.4	3.9	1.6	1.6	5.2	3.2	88.8	1.8	1.6	6.3	1.6	1.6	1.7	1.6	0.3	0.5	0.0	0.2	0.0	0.7	0.1	5.3	4.4	1.4	2.0	0.0	0.0	2.9	3.4	0.0	0.0	0.0	2.7	1.6	0.9	2.6	0.0	7.4	4.8	0.0	0.2	0.0	5.4	2.6	0.7	27.3	0.8	0.0	0.7	3.4	0.0	0.0	0.1	0.0	1.6	0.0	2.5	3.7	4.9	0.0	3.8	1.1	1.7	1.2	0.1	1.3	1.8	2.1	5.0	0.0	2.1	3.4	3.1	5.9	3.0	16.6	0.7	3.3	1.7	4.5	2.7	3.6	8.2	3.1	3.9	1.0	1.4	8.1	3.2	59.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.2	0.5	0.0	0.1	1.6	2.2	9.8	2.2	1.6	1.3	1.8	1.9	1.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	515.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	6.5	0.0	2.8	1.5	0.0	0.1	0.0	0.0	0.0
C1orf141		ENSG00000203963	"Chromosome 1 open reading frame 141"	Q5JVX7	1	67092165-67231853	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 14.9;fallopian tube: 12.8;testis: 18.7"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 84.3;Early spermatids: 83.3;Late spermatids: 78.9;Muller glia cells: 34.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 14.9"	"Group enriched"	"Detected in some"	5	"basophil: 2.5;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Cell line enriched"	"Detected in single"	37	"HEL: 18.1"					"Low region specificity"	"Detected in all"			HPA035316			Uncertain	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA035316: AB_10600886"					"unprognostic (1.48e-1)"			"unprognostic (8.09e-2)"		"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"			"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"			0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.1	1.3	0.3	0.1	1.9	0.0	0.0	0.1	1.1	0.0	12.8	0.2	0.0	2.6	1.8	0.1	0.1	2.0	0.1	0.3	0.7	1.8	0.0	0.0	1.0	0.0	14.9	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.5	0.0	0.2	18.7	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	2.5	0.1	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	18.1	0.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.5	1.1	2.6	0.1	1.3	2.6	1.8	0.3	0.7	14.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	84.3	15.9	0.0	0.0	0.0	0.0	0.0	83.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	78.9	1.7	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.7	0.0	1.3	0.0	0.0	6.0	0.7	0.0	0.1	0.0	0.0	0.0
C1orf158	MGC35194	ENSG00000157330	"Chromosome 1 open reading frame 158"	Q8N1D5	1	12746215-12763699	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 23.5;testis: 74.6"	"Group enriched"	"Detected in some"	13	"Ciliated cells: 105.7;Early spermatids: 148.7;Late spermatids: 65.2"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.6;glioma: 1.0;ovarian cancer: 0.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028396			Uncertain	Cytosol		NA	NA			Cytosol		"HPA028396: AB_10603451"	"unprognostic (1.11e-2)"			"unprognostic (4.94e-3)"	"unprognostic (4.62e-1)"			"unprognostic (8.00e-2)"		"unprognostic (4.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.45e-1)"		"unprognostic (3.51e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"		0.0	0.0	0.7	0.0	2.4	0.3	0.0	0.0	0.2	0.9	0.0	6.2	0.0	0.0	0.4	4.2	0.1	23.5	0.1	0.0	1.0	1.4	0.0	0.0	2.8	0.1	0.2	0.1	4.8	0.1	0.0	0.4	0.1	9.3	0.0	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.2	0.1	0.1	74.6	0.9	0.0	0.5	0.0	0.1	0.0	0.0	0.9	0.6	2.3	0.6	1.1	0.8	0.1	0.5	1.3	1.1	0.7	0.6	0.0	1.0	0.1	0.3	0.2	0.2	1.3	0.7	1.1	0.3	0.3	0.4	0.4	0.1	0.1	0.2	0.2	0.7	1.1	1.9	0.5	0.0	0.9	1.0	0.1	0.7	0.3	0.1	0.4	0.1	0.5	0.9	1.4	0.3	0.5	0.2	0.7	1.5	0.3	0.5	0.6	0.3	0.9	0.1	0.5	1.9	0.8	0.5	0.6	0.3	1.4	0.7	0.2	0.5	0.5	0.8	0.4	0.8	0.6	0.5	1.2	1.0	1.1	0.5	1.6	0.6	0.5	0.7	0.5	0.6	0.5	0.5	0.5	0.1	0.9	0.8	0.7	2.3	1.1	0.6	0.6	0.4	0.1	0.7	2.4	0.0	0.2	1.0	1.4	0.2	0.1	9.3	0.9	3.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	105.7	7.9	0.0	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	65.2	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.0	7.9	1.3	0.0	0.0	0.0	0.0	0.1
C1orf194		ENSG00000179902	"Chromosome 1 open reading frame 194"	Q5T5A4	1	109105951-109113857	"Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.5;fallopian tube: 60.2;testis: 77.6"	"Group enriched"	"Detected in some"	10	"Ciliated cells: 776.3;Early spermatids: 1757.0;Late spermatids: 2679.4"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 19.1;glioma: 5.0;ovarian cancer: 5.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 36.5"	"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in some"		"AF22: 4.5;RPTEC TERT1: 1.1;SCLC-21H: 6.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031144, HPA049684"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA031144: AB_10602109, HPA049684: AB_2680849"	"unprognostic (9.91e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.91e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.08e-6)"	"unprognostic (4.18e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.27e-3)"	0.3	0.4	1.5	0.3	6.8	0.3	0.4	0.3	2.6	1.8	0.3	12.3	0.0	0.4	1.0	11.1	0.4	60.2	0.3	0.3	3.0	1.6	0.3	0.3	7.5	0.4	0.5	1.8	10.3	0.7	0.4	2.7	0.3	36.5	0.4	0.4	0.0	0.3	0.3	0.3	0.3	0.4	0.4	0.7	0.3	0.5	77.6	2.3	0.0	0.5	0.0	0.3	0.5	0.2	0.2	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	6.3	0.3	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	6.8	0.3	2.6	3.0	1.6	0.5	1.8	36.5	2.3	0.0	2.6	0.0	0.2	0.0	0.6	2.0	0.0	776.3	56.9	0.0	0.0	0.0	0.0	0.0	1757.0	0.0	0.0	0.0	0.2	0.0	0.2	1.6	3.5	0.0	0.1	0.0	0.0	0.0	0.0	2679.4	19.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	17.7	0.0	0.0	6.5	0.0	176.3	13.0	0.1	0.0	0.0	0.0	0.0
C1orf87	"CREF, MGC34837"	ENSG00000162598	"Chromosome 1 open reading frame 87"	Q8N0U7	1	59987269-60073770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;fallopian tube: 33.4"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 156.6;Early spermatids: 60.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 19.1;pons and medulla: 17.7"	"Cell type enriched"	"Detected in single"	19	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;HSkMC: 3.3;SCLC-21H: 1.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA031366, HPA031368"	Enhanced					NA	NA					"HPA031366: AB_2673847, HPA031368: AB_10600795"				"unprognostic (1.16e-2)"	"unprognostic (9.87e-2)"			"unprognostic (3.83e-2)"		"unprognostic (1.92e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.11e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"			0.3	0.3	3.2	0.3	19.1	0.3	0.3	0.0	0.9	1.7	0.3	3.4	0.0	0.3	0.9	4.8	0.3	33.4	0.3	0.3	3.8	4.5	0.5	0.3	6.8	0.3	1.3	0.7	5.1	0.4	0.7	0.8	0.3	17.7	0.4	0.3	2.5	3.4	0.6	0.3	0.3	0.3	0.3	0.9	0.3	0.3	1.2	3.6	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.2	19.1	0.0	0.9	3.8	4.5	1.3	0.7	17.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	156.6	19.4	1.8	0.0	0.0	0.0	0.0	60.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.0
C1QL4	"C1QTNF11, CTRP11"	ENSG00000186897	"Complement C1q like 4"	Q86Z23	12	49332411-49337188	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;testis: 7.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 21.0;Horizontal cells: 23.8;Late spermatids: 67.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.9;HAP1: 4.3;PC-3: 4.7;U-2 OS: 7.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.4"	"Group enriched"	"Detected in some"	5	"midbrain: 5.1;pons and medulla: 9.7"						"Secreted in brain"	NA	NA						"unprognostic (1.97e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.64e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.11e-3)"	"unprognostic (7.62e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (9.73e-2)"	"unprognostic (2.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.72e-2)"	0.4	0.3	2.0	0.1	1.0	0.1	0.4	0.4	2.3	0.7	0.1	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.6	2.4	0.8	0.2	0.1	0.1	1.4	0.0	0.6	0.1	0.1	0.4	0.1	9.2	0.2	0.1	0.8	0.1	0.1	0.4	1.7	0.1	0.2	2.1	0.4	0.1	7.4	0.9	0.0	3.6	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.3	27.9	0.0	0.0	0.1	0.0	0.1	0.4	1.5	0.7	0.1	0.3	1.6	0.0	1.6	0.0	4.3	0.0	0.5	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.6	0.0	0.0	0.5	0.1	4.7	0.1	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.2	1.3	0.0	0.6	0.1	0.0	0.4	7.4	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.4	2.1	0.6	2.4	1.4	0.0	9.2	0.9	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.0	0.0	67.3	0.9	0.0	3.3	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.8	0.0	0.5	1.6	1.4	0.1	0.0	0.0	0.0	0.0
C20orf27	FLJ20550	ENSG00000101220	"Chromosome 20 open reading frame 27"	Q9GZN8	20	3753508-3768387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 64.7"	"Group enriched"	"Detected in many"	5	"classical monocyte: 28.1;intermediate monocyte: 46.6;myeloid DC: 38.5;non-classical monocyte: 42.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 38.5;monocytes: 46.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		87000	"Nucleoplasm, Cytosol"		"HPA047483: AB_2680064"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (8.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	23.1	9.7	10.2	11.8	64.7	51.9	17.2	4.9	15.8	12.0	22.6	7.7	3.7	10.3	16.9	10.9	14.4	18.7	26.6	7.3	9.2	14.4	5.0	5.4	8.4	13.5	14.5	6.1	20.9	8.5	3.9	5.3	6.7	13.7	18.3	4.9	5.0	9.0	7.1	11.2	9.6	9.4	22.3	5.7	13.4	21.2	6.0	13.2	6.0	5.4	7.9	6.1	27.4	10.3	7.8	38.5	1.1	46.6	5.8	8.5	13.8	34.4	36.4	5.7	24.3	11.9	6.5	9.0	8.9	5.9	16.5	12.1	24.9	13.1	21.6	8.7	10.4	22.0	29.7	15.3	22.3	6.3	5.0	27.4	12.2	7.4	44.4	8.5	17.5	5.4	9.2	9.4	21.0	10.5	5.7	11.1	15.8	21.7	13.6	8.5	48.7	23.1	41.7	24.6	24.1	49.5	17.9	14.0	25.5	10.3	12.6	25.7	11.7	8.1	36.1	17.8	2.7	8.0	22.0	6.8	23.1	16.0	36.6	27.2	10.5	17.5	16.0	6.8	33.3	11.3	0.2	28.1	0.4	5.9	46.6	8.5	7.8	7.0	7.8	38.5	7.3	8.0	7.8	1.1	5.8	42.2	7.3	6.4	13.8	10.2	64.7	4.9	15.8	9.2	14.4	14.5	6.1	13.7	13.2	0.0	3.5	24.6	18.0	21.5	9.4	2.8	7.6	1.4	2.3	10.4	2.0	15.9	24.9	31.1	8.2	25.0	10.5	70.0	26.1	38.9	26.3	9.4	23.0	14.7	123.1	1.6	15.1	13.5	94.5	13.7	30.2	60.1	35.4	4.6	10.2	20.0	28.5	16.4	23.3	27.0	12.7	64.7	66.1	18.7	30.1	28.7	6.1	16.2	30.3	20.0
C20orf85	"bA196N14.1, LLC1"	ENSG00000124237	"Chromosome 20 open reading frame 85"	Q9H1P6	20	58150904-58161150	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 113.6;testis: 62.8"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 1056.0;Early spermatids: 339.0;Late spermatids: 299.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 57.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 3.5"	"Region enriched"	"Detected in single"	5	"basal ganglia: 1.5"	"Low region specificity"	"Detected in many"			"HPA058271, HPA065540"	Enhanced					NA	NA					"HPA058271: AB_2683661, HPA065540: AB_2685510"				"unprognostic (4.50e-3)"				"unprognostic (1.87e-1)"		"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.46e-2)"		"unprognostic (3.62e-1)"	"unprognostic (2.79e-2)"			0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	7.4	0.0	0.5	0.2	0.0	1.4	26.9	0.0	113.6	0.0	0.0	0.1	0.8	0.0	0.0	29.4	0.3	0.0	0.0	29.0	0.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	62.8	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.8	0.0	0.0	1.5	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1056.0	97.8	0.0	0.0	0.0	0.0	0.0	339.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	299.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	78.9	1.9	0.0	0.0	0.0	0.0	0.0
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 40.8;Distal tubular cells: 19.9"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"AF22: 7.2;RPTEC TERT1: 4.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"	NA	NA					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1	0.0	0.0	0.5	0.8	0.8	5.1	0.1	40.8	0.0	0.0	5.2	5.9	1.1	19.9	0.0	1.2	0.6	0.0	0.0	0.0	0.4	1.1	0.3	0.0	0.0	0.2	0.0	2.9	2.5	0.6	0.0	3.7	0.0	3.3	0.0	0.0	5.6	0.0	0.0	1.8	2.1	6.2	0.0	0.4	0.9	1.1	0.9	0.2	1.7	0.0	0.3
C22orf42		ENSG00000205856	"Chromosome 22 open reading frame 42"	Q6IC83	22	32149006-32159322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 12.9;testis: 28.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 73.0;Late spermatids: 23.6"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 0.8;prostate cancer: 1.0"	"Group enriched"	"Detected in some"	14	"hypothalamus: 12.9;pons and medulla: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.5"									HPA019531	Enhanced					NA	NA					"HPA019531: AB_1853016"					"unprognostic (5.67e-2)"						"unprognostic (6.13e-3)"	"unprognostic (8.21e-3)"		"unprognostic (7.06e-2)"	"unprognostic (4.54e-2)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.1	0.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.4	0.0	3.8	0.0	5.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.5	1.0	28.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.1	12.9	0.6	0.0	5.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0
C2orf40	"augurin, ECRG4"	ENSG00000119147	"Chromosome 2 open reading frame 40"	Q9H1Z8	2	106063246-106078159	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ciliated cells: 481.8;Early spermatids: 894.2"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 72.8"	"Region enriched"	"Detected in all"	7	"pons and medulla: 44.8"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.0;naive CD8 T-cell: 8.2"	"Lineage enriched"	"Detected in single"	77	"T-cells: 10.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HSkMC: 1.0;NB-4: 1.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 44.8;cerebellum: 37.1;hippocampal formation: 85.7;pons and medulla: 114.2;thalamus: 69.1"	"Low region specificity"	"Detected in many"			HPA008546	Uncertain				"Secreted to blood"	NA	NA					"HPA008546: AB_2066524"	"prognostic favorable (4.58e-4)"	"unprognostic (3.91e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.61e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.30e-4)"	27.5	14.0	1.6	7.6	3.2	0.4	12.7	4.1	4.1	21.8	11.0	18.7	19.9	2.9	19.5	25.8	16.5	15.9	10.3	6.5	3.2	5.1	14.7	1.4	8.4	1.0	6.2	3.7	7.9	3.4	1.0	27.6	4.2	44.8	37.1	3.0	33.9	10.2	50.7	4.1	3.2	6.4	66.8	9.6	12.0	50.6	11.0	1.9	0.1	44.2	8.2	2.5	46.6	26.8	0.1	0.0	0.0	0.0	0.1	10.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	2.4	1.6	0.0	0.0	10.0	8.2	0.0	0.1	0.0	0.0	0.7	1.7	1.6	3.2	4.1	4.1	3.2	5.1	6.2	3.7	44.8	1.9	0.0	1.4	0.0	1.8	7.1	0.1	6.3	0.0	481.8	40.9	19.2	0.0	1.4	0.0	0.6	894.2	5.8	0.0	0.0	0.0	0.7	22.3	1.6	1.1	0.0	2.3	3.2	10.2	11.1	0.3	110.5	19.0	2.7	1.7	0.0	0.0	0.2	0.0	0.0	59.4	0.0	0.2	38.8	97.8	9.7	3.6	0.9	2.6	0.5	0.0	1.8
C2orf50	FLJ25143	ENSG00000150873	"Chromosome 2 open reading frame 50"	Q96LR7	2	11133053-11146790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.3;fallopian tube: 21.1"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 38.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 17.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.1;JURKAT: 3.3;T-47d: 3.6"					"Not detected"	"Not detected"			HPA062894	Enhanced					NA	NA					"HPA062894: AB_2684897"	"unprognostic (6.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.53e-4)"	"unprognostic (1.92e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.97e-4)"	"unprognostic (7.03e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.25e-3)"	"unprognostic (7.36e-2)"	0.4	0.5	2.1	0.5	2.7	0.7	0.6	0.5	4.0	1.2	0.3	2.2	0.0	0.6	0.7	5.5	0.2	21.1	0.4	0.2	4.1	3.2	0.6	0.3	4.0	0.6	1.0	1.7	5.0	0.5	0.3	3.8	0.4	17.3	0.5	0.3	0.0	1.1	0.3	0.4	0.6	0.4	0.4	0.6	0.6	0.4	0.6	0.5	0.0	0.5	0.0	0.5	0.2	0.0	1.1	0.8	2.0	0.7	1.3	2.4	0.4	0.3	1.7	0.8	0.4	0.1	0.2	0.8	0.2	0.4	0.6	0.5	0.8	4.1	0.3	0.6	0.3	0.6	0.8	2.5	0.2	0.5	1.7	0.5	0.3	0.2	0.5	0.0	0.2	0.8	0.1	0.3	0.1	0.3	0.6	0.0	3.3	0.2	1.4	0.0	2.9	0.7	0.4	0.6	0.7	0.5	1.7	0.0	0.3	0.4	0.6	1.2	0.7	0.2	0.8	0.6	0.6	3.6	0.7	1.2	0.4	0.5	0.2	0.4	1.2	0.4	0.2	0.6	0.2	0.6	1.8	0.6	0.5	0.5	0.3	0.4	0.9	0.8	0.7	0.8	1.1	2.4	0.7	2.0	1.3	0.7	0.5	0.8	0.4	2.1	2.7	0.5	4.0	4.1	3.2	1.0	1.7	17.3	0.5	0.0	2.6	0.0	0.4	0.0	0.2	0.3	0.0	38.8	5.7	0.0	7.9	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.4	0.0	3.2	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.1
C2orf91		ENSG00000205086	"Chromosome 2 open reading frame 91"	Q6ZV80	2	41935368-41954266	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;lung: 4.7"	"Cell type enhanced"	"Detected in single"	22	"Alveolar cells type 1: 3.0"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 0.8"	"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AN3-CA: 5.2;HDLM-2: 17.9"									HPA042517	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center, Cytosol"	Nucleoplasm	"HPA042517: AB_10795508"	"unprognostic (9.49e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	0.3	2.1	0.3	0.3	1.3	1.5	0.3	0.3	0.8	0.4	0.3	0.8	0.2	0.0	0.4	1.0	0.3	0.3	0.3	0.5	0.3	0.4	0.9	0.3	4.7	0.9	5.1	0.2	0.4	0.4	0.4	0.5	0.2	1.9	0.8	0.2	0.8	3.5	0.2	0.2	1.3	0.3	0.2	2.2	0.6	1.3	1.1	0.2	0.2	0.2	0.2	0.6	0.2	0.3	1.2	1.4	2.8	1.2	1.2	0.9	0.3	0.2	0.4	0.7	5.2	0.2	0.1	0.3	0.1	0.1	0.0	0.3	0.4	0.3	0.3	0.3	0.2	0.2	0.2	0.0	0.1	0.1	17.9	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.8	0.1	0.3	0.1	0.1	0.3	0.4	0.1	0.0	0.6	0.1	0.1	0.3	0.2	1.8	0.0	0.0	0.2	0.9	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.1	0.2	0.2	0.0	0.2	1.3	1.2	1.4	0.6	0.9	0.5	0.6	0.7	0.5	1.4	1.2	0.7	0.9	2.8	1.2	1.0	1.3	0.4	0.3	0.3	1.3	0.3	0.8	0.3	0.4	5.1	0.2	1.9	0.2	3.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell type enhanced"	"Detected in some"	25	"Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	1.9	0.0	4.0	0.7	0.1	0.1	0.0	0.0	1.1	0.0	1.4	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	1.0	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.0	163.3	23.9	0.0	0.0	0.0	0.0	0.0	74.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	40.9	2.3	0.0	0.0	0.0	0.0	0.0
C4orf36	MGC26744	ENSG00000163633	"Chromosome 4 open reading frame 36"	Q96KX1	4	86876205-86892422	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 14.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 140.3;Late spermatids: 253.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 1.8;cerebral cortex: 1.6;hippocampal formation: 3.3;pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.8;CAPAN-2: 4.6;hTCEpi: 3.8;hTERT-HME1: 5.5"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.76e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.69e-5)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.75e-2)"	0.6	0.2	0.1	0.7	1.8	0.0	2.1	0.4	1.6	1.7	0.3	0.7	0.0	0.3	1.0	0.4	1.0	0.4	0.0	1.4	3.3	0.2	0.6	0.5	0.9	0.0	0.2	0.4	1.7	0.5	0.0	2.6	0.2	1.4	1.3	0.3	0.1	0.6	0.3	0.1	4.2	0.1	0.6	0.3	0.8	0.2	14.0	0.0	0.0	0.8	0.0	0.4	0.5	0.8	0.1	0.9	0.3	0.0	0.0	0.1	0.0	5.8	0.5	0.3	0.2	0.0	0.3	1.2	2.9	0.8	0.7	0.0	0.3	4.6	0.0	0.5	0.0	0.1	2.6	0.4	2.6	0.7	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	5.5	0.1	0.0	0.2	0.4	0.1	0.0	2.7	1.8	0.2	0.8	1.2	0.0	1.4	0.0	0.0	0.9	2.4	0.7	1.8	0.8	0.4	0.0	0.5	1.1	0.0	0.0	0.6	1.0	0.3	0.4	0.2	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.4	1.6	3.3	0.2	0.2	0.4	1.4	0.0	0.0	0.0	3.4	9.5	4.4	4.8	18.1	12.7	0.0	0.0	0.0	9.8	0.9	0.0	0.0	140.3	7.1	10.2	0.0	0.0	1.6	3.8	3.9	0.0	2.4	2.8	1.6	2.9	4.3	5.4	253.3	4.9	1.5	1.7	0.0	7.4	6.3	0.3	9.3	3.2	0.0	6.8	6.5	3.1	3.7	7.0	8.9	8.1	2.2	5.2	3.9
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 262.3;Late spermatids: 107.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058999, HPA079692"	Supported		Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"	NA	NA			"Nuclear speckles"	Mitochondria	"HPA058999: , HPA079692: "	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.1	5.1	0.0	0.0	0.0	4.6	25.5	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	8.7	25.5	0.0	0.0	1.8	0.0	0.1	0.0	12.4	262.3	0.0	0.0	0.0	2.9	0.1	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	107.1	1.7	0.0	3.3	1.0	0.0	6.7	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.8	18.1	1.1	0.0	0.0	0.1
C5orf67		ENSG00000225940	"Chromosome 5 open reading frame 67"	F2Z3F1	5	56511567-56606232	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;kidney: 9.3;retina: 16.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Proximal tubular cells: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in some"	5	"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.2;EFO-21: 9.3;U-266/70: 10.4"									HPA054214			Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Nucleoli	"Nucleoplasm, Vesicles"	"HPA054214: "	"unprognostic (7.28e-2)"	"unprognostic (1.41e-1)"		"unprognostic (2.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.69e-2)"		"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.62e-2)"		0.4	0.0	0.2	0.2	1.2	0.4	1.0	0.2	0.2	0.4	0.8	0.4	0.2	1.5	0.6	17.9	0.4	0.4	0.2	0.2	0.6	0.2	9.3	0.2	0.4	0.6	0.7	0.2	0.2	0.2	0.0	0.2	0.2	6.1	0.2	0.0	16.3	1.1	0.2	0.2	0.8	1.6	0.2	0.2	1.5	0.1	0.2	0.2	0.2	2.1	0.2	0.2	0.2	0.2	0.1	1.5	3.3	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.3	0.0	9.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	3.3	0.0	1.9	1.5	0.4	0.1	0.2	1.2	0.2	0.2	0.6	0.2	0.7	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.6;gallbladder: 18.9"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 36.7;Ductal cells: 32.6;Intestinal endocrine cells: 102.0;Suprabasal keratinocytes: 31.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"basal ganglia: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 8.0;HaCaT: 8.8;HeLa: 7.0;hTCEpi: 6.9;PC-3: 12.0;T-47d: 7.5"									HPA036199	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA036199: AB_2675002"	"prognostic favorable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.7	0.2	1.0	3.0	30.6	0.0	4.9	3.1	1.8	3.7	2.1	0.3	4.4	10.5	4.4	3.6	2.9	1.9	18.9	0.4	0.3	0.4	0.3	1.1	0.6	0.6	0.5	0.1	0.5	3.3	0.0	2.0	0.2	2.8	1.1	1.4	0.0	2.2	0.9	1.2	4.6	1.4	1.4	0.3	0.1	9.1	3.1	2.9	0.0	1.1	0.4	0.8	1.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	3.1	0.0	0.0	0.0	0.0	1.6	0.8	0.9	0.0	0.0	0.2	3.3	0.0	0.5	1.5	8.0	8.8	1.0	2.3	0.0	0.0	5.6	0.0	7.0	0.0	0.3	0.0	0.0	0.3	6.9	0.0	5.0	2.7	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.3	1.2	12.0	0.0	0.0	0.0	1.6	5.2	0.2	0.0	2.2	0.0	0.0	0.4	7.5	0.0	2.7	0.4	0.0	0.0	5.7	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	30.6	3.1	1.3	0.3	0.4	0.5	0.1	2.8	2.9	0.0	1.9	0.0	22.6	36.7	0.0	2.0	7.6	5.3	12.5	0.0	0.0	2.9	0.0	32.6	0.2	8.8	2.0	0.0	8.1	15.4	0.9	2.7	0.0	0.0	0.8	0.0	102.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	7.8	7.0	0.4	0.0	0.0	0.0	0.9	0.5	0.5	31.5	1.7	0.0	1.7	13.2
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;fallopian tube: 20.9;testis: 11.4"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 143.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 20.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"GAMG: 6.2;hTERT-HME1: 9.8;U-266/70: 5.8;U-698: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced					NA	NA					"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"	0.2	0.2	2.3	0.2	5.0	0.5	0.3	0.1	1.0	0.8	0.2	3.5	0.0	0.3	0.9	7.1	1.4	20.9	0.2	0.3	3.7	4.0	0.3	0.2	4.3	0.3	0.1	0.4	1.6	0.1	0.7	0.4	0.2	20.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.7	0.2	0.2	11.4	2.1	0.0	0.5	1.8	0.4	0.2	0.5	0.0	0.1	0.0	0.0	0.6	2.3	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.4	0.0	2.4	0.0	0.2	0.1	6.2	0.3	0.0	1.0	0.7	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.8	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.9	0.1	0.1	0.0	0.3	0.8	0.0	0.0	0.1	0.6	0.9	0.4	0.6	5.8	0.8	3.3	1.4	0.0	0.9	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.6	0.6	0.1	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1	2.3	5.0	0.1	1.0	3.7	4.0	0.1	0.4	20.0	2.1	0.0	4.8	0.0	0.0	0.0	0.0	0.8	0.0	143.2	22.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.4	0.4	0.0	0.0	0.0	0.0	0.0
C9orf135		ENSG00000204711	"Chromosome 9 open reading frame 135"	Q5VTT2	9	69820793-69906232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.6;fallopian tube: 31.8;pituitary gland: 35.4;testis: 18.4"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 279.7;Cone photoreceptor cells: 72.6;Early spermatids: 105.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 7.8"	"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Group enriched"	"Detected in some"	5	"naive CD4 T-cell: 3.3;naive CD8 T-cell: 4.0;T-reg: 3.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 4.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.5;NTERA-2: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021261, HPA021325"	Uncertain					NA	NA					"HPA021261: AB_1845811, HPA021325: AB_1845812"	"unprognostic (1.05e-2)"			"unprognostic (4.39e-1)"	"unprognostic (1.97e-1)"			"unprognostic (1.39e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.22e-3)"	"unprognostic (5.72e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.60e-2)"		0.1	0.5	3.2	0.1	2.4	0.1	0.1	0.0	0.1	0.8	0.1	3.1	0.0	0.1	0.6	9.8	0.1	31.8	1.3	0.1	2.2	2.2	1.3	0.3	7.0	0.1	0.3	0.0	3.2	0.7	3.1	35.4	0.1	17.6	0.1	0.1	0.4	0.2	0.4	0.5	0.1	0.1	0.1	0.4	0.1	0.2	18.4	0.4	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.0	0.0	3.3	4.0	0.0	0.0	0.0	0.0	3.6	0.1	3.2	2.4	0.0	0.1	2.2	2.2	0.3	0.0	17.6	0.4	0.0	1.3	0.0	0.0	0.3	0.0	2.4	0.0	279.7	35.2	1.8	72.6	0.1	14.9	0.3	105.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.1	0.0	1.7	0.0	0.0	5.6	2.3	0.6	0.0	0.0	0.0	0.4	0.3	0.0	0.7	1.9	0.3	0.0	0.0	16.4	1.1	0.1	0.0	0.0	0.0	0.3
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149936-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.7"	"Cell type enriched"	"Detected in many"	43	"Paneth cells: 2128.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 50.1"	"Cell type enriched"	"Detected in some"	7	"neutrophil: 37.0"	"Lineage enriched"	"Detected in single"	370	"granulocytes: 37.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 336.9"	"Low region specificity"	"Detected in many"			"HPA011089, HPA017258"	Enhanced					NA	NA		190000			"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2.0	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12.0	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3.0	2.4	54.9	20.3	4.8	24.0	10.0	1.0	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5.0	0.2	1.7	7.9	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.3	0.0	0.0	0.3	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	3.9	0.0	0.0	0.2	1.3	1.9	0.0	0.7	0.3	0.2	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3.0	0.3	0.0	3.7	0.0	0.2	1.3	0.0	9.2	0.0	1.4	1.2	14.0	0.0	0.0	28.2	3.1	0.2	15.8	49.7	0.0	0.2	0.0	1.5	0.1	11.5	0.0	0.5	0.0	18.6	1.8	0.0	0.0	0.6	0.8	0.0	0.0	27.9	0.0	0.1	2128.8	0.0	18.6	0.0	6.5	17.9	0.0	0.0	1.0	0.0	0.0	32.8	0.3
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
CABP1		ENSG00000157782	"Calcium binding protein 1"	Q9NZU7	12	120640552-120667324	"Predicted intracellular proteins"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 90.6"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 128.1;Horizontal cells: 305.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 90.6"	"Cell type enhanced"	"Detected in single"		"myeloid DC: 3.1"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.9;NTERA-2: 9.3;RT4: 5.3;SCLC-21H: 4.4;U-87 MG: 11.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 177.9"	HPA051438	Uncertain				"Intracellular and membrane"	NA	NA					"HPA051438: AB_2681486"	"unprognostic (2.57e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.13e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.12e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.85e-1)"	9.0	2.0	26.2	1.0	18.1	0.4	1.1	13.1	90.6	1.8	2.0	0.3	0.2	1.1	2.6	3.6	1.7	2.0	1.3	3.7	29.3	5.7	8.9	0.5	0.9	0.6	6.7	18.4	1.2	0.9	3.7	1.0	1.4	3.5	1.9	1.9	1.0	0.8	3.9	2.6	0.8	1.4	2.5	2.5	1.0	1.6	0.9	0.0	0.0	0.6	0.0	0.6	2.1	0.6	0.0	3.1	0.5	0.4	0.0	0.0	0.2	0.2	0.7	3.9	1.2	0.0	0.1	0.0	0.1	0.4	0.2	0.2	0.3	0.0	0.0	0.6	0.0	1.6	0.3	3.4	0.0	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.4	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.3	0.4	0.1	9.3	2.9	0.6	2.3	0.0	0.0	3.7	5.3	4.4	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.9	0.0	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.0	0.2	26.2	18.1	13.1	90.6	29.3	5.7	6.7	18.4	3.5	0.0	0.0	0.0	0.0	0.2	0.1	128.1	1.6	0.0	0.0	0.0	1.8	0.0	0.1	26.6	0.0	1.5	3.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.0	0.2	305.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.4	8.2	0.0	0.0	2.1	2.2	10.1	19.4	13.3	0.2	1.9	0.3	0.2	0.0	0.0	0.1
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720084-29731839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 30.3;pancreas: 9.6"	"Cell type enriched"	"Detected in some"	24	"Cardiomyocytes: 24.3"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.9"	"Region enhanced"	"Detected in all"		"hippocampal formation: 30.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"HEL: 12.7;SCLC-21H: 12.6;SH-SY5Y: 4.0;U-2 OS: 4.2"	"Group enriched"	"Detected in many"	5	"cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1"	"Region enhanced"	"Detected in all"		"hippocampal formation: 65.6"	HPA016439	Uncertain					NA	NA					"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.4	6.0	2.7	0.5	2.6	0.8	0.3	7.2	6.5	0.3	0.5	1.2	0.0	1.5	0.3	1.8	0.7	0.4	0.5	0.3	30.3	2.0	0.3	0.3	0.4	0.5	3.9	1.2	0.4	9.6	0.3	0.1	0.3	16.9	0.4	0.5	2.4	0.8	0.4	0.6	1.0	3.8	0.4	4.1	0.5	0.4	1.2	2.8	0.0	0.7	0.0	0.3	0.4	0.0	0.6	0.6	1.8	1.6	0.5	1.4	0.6	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.7	12.7	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.4	0.0	0.0	12.6	4.0	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.2	4.2	0.1	0.2	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.8	1.8	0.8	1.3	0.5	0.6	1.1	0.5	0.6	0.4	1.0	1.4	1.3	0.5	1.6	0.6	0.5	0.6	2.7	2.6	7.2	3.0	30.3	2.0	3.9	1.2	16.9	2.8	0.0	0.0	0.0	0.0	0.0	0.2	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 31.2;U-87 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.9	0.1	0.3	0.0	1.6	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.1	31.2	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8	6.0	2.7	1.3	1.4	0.6	68.3	2.2	0.0	6.7	2.3	1.8	15.7	0.0	0.0	0.6	22.1	4.2	0.0	0.0	0.3	0.1	2.1	0.8	1.1	0.0	0.5	235.2	205.4	1.8	1.3	17.9	1.1	2.1	0.0	1.0	1.1	2.9	1.9	0.0	0.4	2.0	6.2	0.0	4.2	4.1	5.1	0.1	0.2	4.3	0.8	0.9
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832768-152099475	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.7"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 38.2;Glandular cells: 25.1;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 21.2"									HPA015601	Approved					NA	NA					"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	1.6	1.7	5.2	1.3	28.0	1.7	3.2	35.7	28.0	1.4	1.2	2.6	0.0	1.2	1.4	1.7	3.1	1.1	2.1	1.1	4.5	4.4	2.8	0.9	3.9	1.1	4.3	10.9	1.3	1.2	1.0	3.8	2.1	9.8	3.9	1.4	0.9	2.1	3.9	0.8	11.7	1.1	4.2	3.0	1.2	1.6	4.1	3.4	0.0	3.1	0.0	2.2	3.5	0.8	0.4	1.3	7.0	0.6	0.2	0.1	0.1	0.0	0.0	0.7	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.9	0.0	2.0	0.0	0.1	0.3	3.3	0.0	0.2	4.1	0.0	0.2	21.2	0.2	0.1	0.4	0.0	1.6	0.0	0.8	0.0	0.5	0.2	0.0	0.2	0.3	0.5	0.1	0.6	1.8	0.2	0.6	1.2	0.6	1.4	0.8	0.0	0.0	0.0	0.1	3.4	0.9	0.0	1.9	2.2	0.7	0.4	0.4	0.0	0.0	0.5	4.9	0.1	1.2	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.4	0.1	0.1	7.0	0.2	0.0	1.3	0.0	0.1	5.2	28.0	35.7	21.7	4.5	4.4	4.3	10.9	9.8	3.4	11.9	38.2	0.8	10.5	11.0	3.1	0.9	0.0	1.4	5.7	3.5	3.9	0.1	3.3	0.3	0.8	0.6	0.0	0.0	1.3	0.0	3.9	25.1	0.0	0.0	2.6	19.1	0.0	0.6	0.8	1.7	3.1	2.4	1.7	0.0	0.0	1.9	1.2	0.0	4.2	0.6	3.3	0.0	0.7	0.5	0.0	7.2	0.0	0.7	0.0	12.2
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24255553-24362801	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"brain: 32.2"	"Cell type enriched"	"Detected in some"	46	"Horizontal cells: 166.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced					NA	NA					"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.4	1.8	12.8	0.4	13.1	0.5	0.3	0.2	32.2	0.3	0.4	0.1	0.0	0.3	0.3	0.4	0.3	0.4	0.3	0.3	12.7	2.2	0.3	0.4	0.3	0.4	1.8	2.3	0.4	0.3	0.3	0.0	0.4	0.3	0.4	0.4	0.1	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.2	0.9	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.8	13.1	0.2	20.0	12.7	2.2	1.8	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53963040-53990215	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 7.9;brain: 22.8"	"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 47.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4"	"Cell type enriched"	"Detected in some"	7	"basophil: 7.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.9"	"Group enriched"	"Detected in some"	5	"AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced					NA	NA					"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.4	0.4	9.4	0.4	9.1	0.6	0.4	0.7	22.8	0.3	0.3	2.1	0.0	0.4	0.5	0.4	0.3	0.4	0.4	0.3	20.3	5.4	0.3	0.3	0.4	0.4	2.3	2.0	0.4	0.3	0.5	0.0	0.3	1.5	0.4	0.4	0.0	0.4	0.3	0.9	0.7	0.4	0.4	0.9	0.4	0.6	1.5	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.4	0.3	7.9	0.2	0.3	0.3	0.1	0.0	2.1	6.4	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.4	0.3	0.0	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.9	2.4	0.5	0.0	1.0	0.0	21.3	0.3	0.0	0.0	0.2	7.6	2.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	1.3	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	0.0	13.0	0.1	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	7.9	0.2	1.1	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.3	0.1	0.1	9.4	9.1	0.7	13.6	20.3	5.4	2.3	2.0	1.5	0.0	0.0	0.0	0.0	1.0	1.4	0.9	2.8	0.0	4.0	1.2	1.8	0.0	0.0	0.0	1.4	0.4	1.9	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	47.7	0.0	3.1	1.5	1.1	0.0	0.0	0.0	0.0	0.4	1.0	0.1	0.0	0.4	0.0	1.5	0.0	0.8	5.0	6.4	1.0	0.1	0.0	0.5	1.0
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318425-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 105.4"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 325.7"	HPA056398			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056398: AB_2683117"	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	5.1	11.2	5.1	1.9	7.1	0.0	9.5	105.4	21.1	16.5	5.3	1.4	13.3	6.1	16.3	16.4	5.7	5.7	8.0	4.6	6.8	8.8	20.3	6.2	9.0	1.3	14.0	9.3	5.2	13.2	15.4	17.7	2.7	7.0	10.4	5.4	4.7	23.0	11.5	2.6	2.4	4.7	11.2	4.1	3.3	9.8	1.9	1.4	0.4	9.4	2.4	1.6	4.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.4	2.5	0.1	0.2	6.3	1.4	6.4	0.0	5.9	0.0	0.0	2.9	0.2	0.0	0.2	0.8	0.6	0.0	5.2	2.0	0.0	11.4	8.2	0.0	0.1	2.6	1.1	1.0	0.8	5.7	20.3	0.0	0.0	26.5	0.1	13.9	0.0	0.0	5.9	29.0	10.0	0.0	0.0	10.5	0.3	6.6	10.3	0.0	0.2	11.5	0.5	1.6	4.4	0.0	5.8	2.2	1.5	0.0	4.1	7.9	0.3	0.0	8.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	105.4	21.1	6.8	8.8	14.0	9.3	7.0	1.4	8.9	31.6	0.0	7.7	1.9	0.0	10.1	5.1	8.1	17.0	38.4	0.0	0.2	14.9	4.7	5.5	19.6	4.5	0.0	9.4	0.3	3.8	16.7	1.1	10.2	0.3	3.2	4.6	16.0	2.7	5.3	8.9	1.1	3.3	0.0	11.6	28.4	6.6	2.9	9.6	6.9	1.3	0.0	5.1	0.5	2.5	1.3	0.2	0.0	7.6	7.4
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Group enriched"	"Detected in many"	6	"Exocrine glandular cells: 89.2;granulocytes: 237.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.7	6.6	0.0	0.2	0.0	1.3	0.2	0.1	0.2	0.0	0.0	8.2	0.0	0.1	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.2	0.0	0.0	52.2	0.0	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	14.9	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5	8.9	11.1	0.0	0.0	0.2	3.5	0.3	0.0	2.7	0.0	0.0	5.9	0.0	0.0	1.7	2.1	0.1	0.0	0.0	89.2	0.1	0.4	0.1	237.6	0.0	0.1	28.6	0.0	0.0	0.0	2.3	5.8	0.0	5.0	0.0	0.0	2.5	10.4	0.0	0.0	0.0	6.7	0.0	0.3	0.3	3.6	0.0	0.1	0.0	0.0	0.1
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 34.9"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;hTERT-HME1: 1.8;Karpas-707: 1.8;SCLC-21H: 3.5"	"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500				"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	34.9	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	6.5	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.5	0.0	0.0	0.0	1.3
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell type enhanced"	"Detected in some"	23	"Basal keratinocytes: 1.1;Melanocytes: 5.0;Spermatogonia: 2.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.3;Karpas-707: 11.3;SH-SY5Y: 3.9;U-266/70: 16.9"	"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"	NA	NA					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.3	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.1	0.4	0.1	0.0	11.3	0.0	0.0	0.0	0.7	3.0	0.1	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	16.9	0.6	0.4	2.3	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0
CALCR	CTR	ENSG00000004948	"Calcitonin receptor"		7	93424487-93574730	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 10.8;kidney: 7.5"	"Group enriched"	"Detected in some"	14	"Early spermatids: 13.2;Late spermatids: 4.4"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 1.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 10.8"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.1"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.1"	"Group enriched"	"Detected in some"	7	"MCF7: 2.4;RPTEC TERT1: 4.0;SuSa: 7.7;T-47d: 7.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;hypothalamus: 28.7"	"Low region specificity"	"Detected in all"			"HPA028962, HPA061428"	Enhanced	Supported				NA	NA					"HPA028962: AB_10602339, HPA061428: AB_2732661"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.73e-5)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.05e-2)"	0.3	0.7	1.4	0.0	2.1	0.0	1.3	0.1	1.5	0.5	0.2	0.0	0.0	0.1	0.1	0.5	0.3	0.1	0.4	0.4	2.1	10.8	7.5	0.1	0.9	0.0	0.8	0.0	0.7	0.1	0.3	3.2	2.1	5.9	0.1	0.2	0.2	1.4	0.0	3.7	0.1	0.2	0.3	2.5	0.1	0.1	2.3	0.7	0.0	0.1	2.5	0.7	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	2.1	0.1	1.5	2.1	10.8	0.8	0.0	5.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"placenta: 29.7;skin 1: 9.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 45.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 2.8;SuSa: 6.2"														"Intracellular and membrane"	NA	NA															"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	29.7	1.4	0.0	0.0	0.2	0.0	0.0	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.1	0.0	2.8	0.0	0.3	0.2	0.2	0.3	0.0	0.3	0.6	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.2	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1"	"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.6	0.0	0.1	0.2	0.3	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3	0.0	0.0	0.0	0.0	3.1	0.1	11.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.2	1.3	0.2	0.0	0.0	0.0
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 58.8;Late spermatids: 64.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 125.5"	"Group enriched"	"Detected in many"	5	"classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol		NA	NA			Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9.0	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.5	9.4	7.0	13.5	21.1	19.7	10.7	10.4	11.0	8.5	7.8	9.8	5.4	19.4	8.7	21.0	6.0	10.4	8.6	11.2	6.7	13.3	16.9	9.6	6.3	9.6	14.3	21.9	9.2	12.7	16.6	8.0	18.2	11.5	19.9	14.8	11.1	10.5	8.2	12.1	24.3	18.0	5.1	10.5	10.7	15.8	8.2	17.2	8.2	14.0	26.9	10.8	13.6	7.3	8.6	5.9	18.2	26.8	14.5	7.0	5.7	5.9	5.7	40.3	23.9	14.7	13.1	15.4	6.9	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8	8.9	3.5	4.1	5.1	7.0	21.6	7.0	20.4	8.1	6.8	8.7	2.0	7.4	3.3	8.7	15.7	17.5	18.2	0.0	9.0	6.7	12.5	10.8	5.8	18.3	7.1	58.8	33.0	12.9	13.9	64.8	19.0	13.7	8.5	15.4	15.9	5.1	7.5	11.5	29.7	8.4	6.4	19.4	21.3	0.7	2.4	5.3	2.9	7.1	15.6	5.8
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 24.5;gallbladder: 21.0;liver: 21.8;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 27.1;Cholangiocytes: 50.9;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	7	"basophil: 24.5;NK-cell: 12.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.5;NK-cells: 12.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 17.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.6"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.6	0.4	0.2	4.7	0.2	0.2	0.7	0.2	0.3	4.2	4.1	0.1	5.6	1.2	1.1	1.0	1.2	3.6	21.0	0.7	1.0	0.4	7.1	21.8	2.0	1.8	0.2	0.1	0.4	5.0	0.2	0.7	0.5	2.4	2.2	0.7	0.4	34.3	3.0	0.3	4.5	1.9	0.5	0.4	4.9	1.6	0.6	0.1	0.4	0.4	1.6	5.2	1.5	1.0	1.7	0.0	24.5	0.0	12.7	2.6	0.7	0.2	1.8	0.1	0.0	0.3	0.1	2.2	0.1	0.0	0.0	0.1	3.2	0.1	0.7	0.1	0.0	0.3	1.3	0.0	0.8	0.0	0.1	0.0	0.3	0.7	0.9	0.0	0.0	17.6	0.8	2.5	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.4	0.1	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.4	0.9	0.7	0.0	0.1	0.0	0.7	24.5	0.0	1.8	2.6	0.0	2.5	1.5	0.7	1.3	0.0	1.7	0.0	0.6	0.4	12.7	0.0	0.0	0.5	0.7	0.2	0.2	0.2	0.3	1.0	0.4	0.2	0.1	2.4	0.1	11.9	27.1	15.9	8.0	8.4	1.2	0.6	50.9	5.3	5.7	5.2	0.0	1.5	0.0	9.1	0.4	1.8	4.2	0.0	6.3	8.2	1.1	2.3	4.7	12.7	0.9	0.0	3.5	1.3	1.0	0.2	0.6	2.0	3.3	0.0	18.8	1.7	4.0	3.5	0.4	16.5	0.6	0.0	1.7	0.3	2.4	8.3	2.4	25.4	16.4	4.3
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine		19	5911707-5915877	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"brain: 71.4;fallopian tube: 116.0"	"Cell type enriched"	"Detected in many"	8	"Ciliated cells: 1030.6"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Region enhanced"	"Detected in all"		"pons and medulla: 71.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.6;U-266/70: 10.1"					"Low region specificity"	"Detected in many"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	2.6	4.1	8.0	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116.0	13.6	2.0	13.4	6.6	8.9	5.0	25.4	4.4	8.0	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2.0	3.3	7.7	12.7	2.0	5.7	5.0	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4.0	5.2	2.2	5.3	4.8	2.4	1.1	1.1	0.7	3.5	1.3	1.8	2.2	0.6	0.4	0.2	0.3	0.8	7.5	0.8	2.2	0.9	0.5	1.4	0.3	0.3	0.1	2.4	1.0	0.6	2.2	2.0	1.2	0.6	1.8	2.3	2.1	0.2	0.5	2.5	0.5	2.6	0.5	2.9	0.4	2.1	1.4	2.0	0.6	8.8	5.7	1.7	0.3	2.3	1.0	3.2	0.7	2.6	0.5	36.6	3.7	2.0	2.3	2.3	1.0	0.6	0.4	2.7	9.7	10.1	3.4	0.7	4.3	1.0	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3.0	3.6	2.1	4.9	2.4	2.0	5.2	5.3	1.6	4.0	3.2	2.4	8.0	14.7	1.4	3.3	13.4	6.6	8.0	7.8	71.4	17.9	11.9	16.8	0.8	29.9	4.2	2.2	1.9	0.0	1030.6	124.0	115.1	3.9	21.6	29.9	26.7	4.7	3.8	3.9	0.0	5.2	16.2	21.6	27.6	5.8	0.0	4.6	6.4	18.4	0.0	0.0	4.0	4.4	4.4	10.1	1.8	19.7	7.2	24.2	2.9	4.6	3.6	3.9	6.5	4.2	0.5	0.4	3.6	17.2	0.0	7.4	100.9
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904295-35938779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 34.9;epididymis: 18.3;fallopian tube: 59.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 455.0;Early spermatids: 136.1;Late spermatids: 117.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 14.1;ovarian cancer: 3.4"	"Region enriched"	"Detected in many"	7	"pons and medulla: 34.9"	"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 7.5;BJ hTERT+ SV40 Large T+ RasG12V: 6.4;HBF TERT88: 4.9;REH: 7.8;U-698: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules		No	No			"Nucleoplasm, Microtubules"		"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.1	0.2	3.6	0.1	4.4	0.2	0.2	0.0	0.5	2.4	0.1	4.3	0.4	0.1	1.3	18.3	0.2	59.4	0.2	0.2	5.2	5.3	0.7	0.1	11.8	0.1	0.3	0.0	6.7	0.4	0.1	17.0	0.2	34.9	0.2	0.1	0.0	0.4	0.4	0.2	0.2	0.1	0.2	0.8	0.1	0.2	5.4	0.5	0.5	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.5	6.4	0.0	0.0	2.2	0.0	0.9	0.1	0.0	0.1	0.0	4.9	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.0	0.0	1.3	2.2	0.0	0.5	0.0	0.0	19.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	4.4	0.0	0.3	5.2	5.3	0.3	0.0	34.9	0.5	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	455.0	51.2	1.8	0.0	0.0	1.7	0.0	136.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	117.8	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0
CARD18	"ICEBERG, pseudo-ICE, UNQ5804"	ENSG00000255501	"Caspase recruitment domain family member 18"	P57730	11	105137721-105139726	"Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 8.2;skin 1: 26.7;tongue: 6.6"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 2.9;Early spermatids: 8.2;Late spermatids: 4.2;Suprabasal keratinocytes: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.1"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.5;hTCEpi: 5.5;OE19: 4.4;U-2 OS: 5.8"									HPA038582	Approved					NA	NA					"HPA038582: AB_10960549"		"unprognostic (3.90e-1)"				"unprognostic (2.95e-1)"			"unprognostic (1.77e-1)"					"unprognostic (2.88e-1)"	"unprognostic (3.42e-1)"			0.1	0.0	0.1	0.1	1.2	0.0	8.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.0	0.1	0.3	0.1	0.1	26.7	0.1	0.1	0.1	0.1	0.0	0.5	0.1	1.8	0.1	6.6	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.8	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.9	0.0	0.0	0.0
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	0.2	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.0	36.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	16.7	0.0	1.4	0.0	0.0	2.0	1.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	13.0	0.0	0.8	1.4	1.0	0.0	3.8	0.0	0.0	0.3
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 43.7"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 239.5;Rod photoreceptor cells: 241.8;Spermatocytes: 77.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.8"															NA	NA						"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.1	0.9	1.1	1.1	1.4	3.2	1.3	9.0	1.1	1.1	1.7	1.1	1.1	2.7	1.1	5.2	1.9	1.1	1.1	1.1	1.1	1.3	1.1	1.1	1.1	1.3	1.1	1.1	1.4	1.1	4.0	3.0	1.1	1.1	1.3	1.9	1.1	1.1	1.9	1.1	4.8	3.1	1.1	1.6	1.1	1.3	43.7	1.1	1.1	1.7	1.1	1.1	1.2	1.1	3.3	1.8	2.3	1.2	1.8	2.9	0.2	2.5	3.5	1.5	5.6	0.0	0.0	2.6	0.9	2.2	1.6	3.8	0.8	1.4	3.0	1.3	0.6	1.9	5.4	1.4	4.9	1.5	2.5	6.8	8.6	12.8	1.2	2.3	2.0	2.8	0.3	3.9	2.2	5.5	4.2	2.0	5.4	3.4	3.2	0.5	0.6	1.6	3.4	0.5	3.3	1.5	2.3	1.8	1.4	3.1	4.0	3.4	1.2	1.5	2.1	0.1	2.1	4.1	2.0	0.5	4.0	1.7	0.0	2.3	0.6	0.3	5.9	2.7	6.1	1.4	0.4	1.2	0.5	1.3	0.5	1.6	3.3	1.1	1.8	0.8	1.7	1.5	2.9	2.3	1.8	1.2	1.8	0.5	0.2	1.1	1.4	9.0	1.1	1.1	1.3	1.1	1.1	1.1	1.1	0.0	5.0	4.4	7.4	6.3	51.5	2.9	2.5	8.1	7.9	7.0	239.5	4.4	3.3	2.4	53.6	4.5	3.9	0.0	2.3	1.9	2.6	5.8	9.2	3.4	3.7	36.5	20.6	7.4	2.2	22.9	5.8	5.0	1.7	1.8	4.4	11.3	1.8	3.5	6.7	4.2	241.8	0.0	3.1	77.5	8.3	6.9	2.5	3.2	8.2	7.1
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 translocation partner 3"	O75081	16	88874858-88977204	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.9"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 11.5;Mucus-secreting cells: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 26.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 21.4;K-562: 37.4;MCF7: 17.3;MOLT-4: 19.0;NB-4: 23.1;REH: 37.6;T-47d: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575"	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	10.0	1.7	3.6	11.3	7.4	8.2	6.1	26.0	5.4	2.3	3.9	1.3	1.4	3.9	3.2	2.1	2.1	1.9	2.5	6.2	3.0	3.0	0.7	2.0	6.4	9.5	2.0	3.8	0.9	24.9	0.7	2.7	3.8	2.3	3.7	1.5	3.1	4.5	2.9	14.2	2.6	5.5	1.5	1.2	14.7	3.5	3.2	2.2	75.9	2.4	2.0	10.3	3.6	4.8	3.7	11.6	3.6	4.9	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.4	0.0	0.0	0.0	5.6	10.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	37.4	0.2	0.0	17.3	19.0	23.1	0.4	0.0	0.0	37.6	0.3	3.7	0.0	0.0	7.4	1.6	0.8	0.1	0.1	0.1	17.1	6.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	12.4	0.0	6.5	0.0	1.1	2.7	2.7	0.0	3.2	0.0	3.7	0.0	0.0	7.1	2.1	0.0	0.0	3.6	0.1	4.9	11.6	0.0	1.7	3.6	7.4	26.0	5.4	3.0	3.0	2.0	3.8	2.3	2.2	0.0	1.4	11.5	5.1	2.3	7.7	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.2	0.0	3.6	0.9	0.0	2.4	0.1	1.6	2.5	5.8	5.7	2.4	0.0	3.5	2.5	2.8	0.0	2.0	6.4	0.0	1.0	13.5	0.1	1.4	0.0	0.7	0.5	1.2	19.4	11.2	0.2	4.5	1.9	0.2	1.0	0.8	3.8
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281831	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 106.6"	"Group enriched"	"Detected in some"	6	"Early spermatids: 80.9;Late spermatids: 214.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enriched"	"Detected in many"	12	"cerebellum: 106.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"NTERA-2: 16.7;SCLC-21H: 53.2"	"Region enriched"	"Detected in many"	9	"cerebellum: 688.3"	"Region enriched"	"Detected in all"	15	"cerebellum: 300.1"						"Secreted in brain"	NA	NA		2900000				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.60e-2)"	9.9	0.8	0.9	0.1	1.0	0.0	1.2	106.6	4.9	2.0	0.4	0.4	0.4	0.6	5.9	1.4	0.8	0.9	9.0	4.2	0.7	9.2	0.2	0.7	0.1	0.9	4.5	1.0	0.5	2.4	0.0	0.9	0.4	4.6	0.3	0.4	1.1	0.7	3.0	0.5	0.3	0.5	1.5	2.3	0.1	0.5	16.0	0.4	0.2	0.6	0.6	2.4	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	1.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.2	1.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	106.6	1.4	0.7	9.2	4.5	1.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	3.3	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	80.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.6	12.7	0.0	0.0	214.3	2.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	1.5	25.8	4.4	17.6	4.5	0.1	0.0	0.0	0.0	0.0
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426532-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 105.2"	"Cell type enhanced"	"Detected in some"	8	"Fibroblasts: 2.3;Leydig cells: 2.3;monocytes: 3.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	23	"cerebellum: 105.2"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.5;naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.9;HDLM-2: 12.7;HSkMC: 18.9;Karpas-707: 14.2;U-266/70: 9.9"	"Region enriched"	"Detected in some"	25	"cerebellum: 481.8"	"Region enriched"	"Detected in some"	47	"cerebellum: 583.0"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	2.1	7.7	1.2	4.5	1.3	0.0	1.2	105.2	1.7	1.8	1.1	1.9	1.0	0.6	1.3	4.8	1.0	1.2	3.1	1.6	1.0	1.1	1.2	1.4	1.3	7.9	1.3	1.4	3.3	1.0	1.0	1.3	1.7	4.6	1.2	0.7	1.7	1.6	1.6	1.4	1.6	1.3	1.3	2.0	7.4	1.4	1.6	1.1	1.1	1.2	1.5	5.3	1.9	1.3	2.3	0.3	0.1	0.8	0.0	0.3	0.0	1.1	1.0	0.5	1.9	5.0	10.9	0.3	4.2	8.6	1.7	2.2	0.5	2.0	1.8	0.9	2.6	1.9	0.3	0.6	2.3	1.1	12.7	0.4	0.0	3.5	0.8	2.8	0.3	0.7	18.9	1.0	2.1	1.7	7.0	1.5	0.8	0.5	14.2	2.1	0.6	0.0	0.5	0.1	1.1	1.1	0.0	0.0	1.3	1.0	0.4	0.7	0.4	0.3	0.1	0.6	0.3	0.6	0.4	6.6	6.1	1.2	2.5	0.2	9.9	2.3	2.0	0.3	0.8	1.0	0.0	0.0	0.1	0.0	0.8	0.3	1.5	0.1	0.1	0.0	2.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	1.3	105.2	1.7	1.0	1.1	1.3	1.4	4.6	1.1	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.5	0.0	1.0	0.5	2.3	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	3.6	0.2	0.8	0.8	0.0	1.4	0.5	0.3	0.0	1.2	0.0	0.1	0.5	0.7	0.0	0.4	0.5
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 14.3;Ito cells: 12.3;Rod photoreceptor cells: 42.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Cell line enhanced"	"Detected in many"		"BJ: 26.8;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+ RasG12V: 25.7;HBF TERT88: 30.8;hTERT-HME1: 41.8;LHCN-M2: 46.9;TIME: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.2	0.4	0.0	0.0	4.2	13.1	8.2	26.8	27.5	19.5	25.7	0.0	0.1	0.1	0.0	10.6	4.6	0.5	0.0	17.3	30.8	0.1	0.1	0.0	0.1	0.1	9.7	0.1	0.0	8.8	0.7	15.2	41.8	8.4	0.9	0.0	0.0	0.1	46.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	2.0	0.0	0.1	25.2	0.0	2.7	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3	3.0	2.2	0.0	1.1	4.0	7.2	0.8	2.5	1.4	3.4	0.0	7.9	0.6	0.0	0.1	0.5	0.7	0.0	0.0	0.2	0.6	3.1	1.1	1.1	0.0	0.3	14.3	0.0	12.3	1.5	0.2	8.9	0.5	6.8	0.0	0.0	1.1	0.5	0.0	0.4	0.0	42.0	0.0	4.1	0.0	0.7	3.8	0.7	0.0	0.0	0.7
CCDC129	FLJ38344	ENSG00000180347	"Coiled-coil domain containing 129"	Q6ZRS4	7	31514071-31658720	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.2;salivary gland: 10.9"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 8.2;Intestinal endocrine cells: 1.7;Late spermatids: 5.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 7.9;midbrain: 5.0;pons and medulla: 17.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;CACO-2: 1.3;RH-30: 2.1;T-47d: 2.7;U-2 OS: 5.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA024103	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024103: AB_1846132"	"unprognostic (1.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.78e-5)"	"unprognostic (9.72e-3)"	"unprognostic (1.78e-1)"		"unprognostic (3.89e-2)"	"unprognostic (6.42e-3)"		"unprognostic (1.01e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"		0.1	0.0	0.1	0.6	2.0	0.1	3.3	7.9	0.3	3.7	0.9	1.2	0.0	2.1	1.1	0.2	0.1	0.1	0.1	0.0	0.4	1.4	0.1	0.0	0.4	0.0	5.0	0.0	0.0	0.2	0.0	0.4	0.9	17.2	0.1	0.2	0.0	10.9	0.0	0.0	4.5	0.9	1.1	0.2	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.8	0.8	1.1	0.0	0.1	1.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.5	0.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.1	2.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	2.7	0.0	0.0	0.0	5.6	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.2	0.1	0.1	0.8	1.0	0.4	1.1	0.1	0.0	0.8	0.0	0.1	0.1	2.0	7.9	0.3	0.4	1.4	5.0	0.0	17.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0
CCDC146	KIAA1505	ENSG00000135205	"Coiled-coil domain containing 146"	Q8IYE0	7	77122434-77329533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;fallopian tube: 27.9"	"Cell type enhanced"	"Detected in many"	22	"Ciliated cells: 570.2;Early spermatids: 154.6;Spermatocytes: 113.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons and medulla: 32.7"	"Cell type enhanced"	"Detected in many"		"eosinophil: 12.5;neutrophil: 14.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.0;NK-cells: 5.0;T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020082, HPA020105"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020082: AB_1852410, HPA020105: AB_2072056"	"unprognostic (3.07e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.02e-3)"	"unprognostic (4.05e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.58e-3)"	1.8	0.8	6.5	1.9	7.2	1.3	1.9	1.8	8.3	4.3	3.2	4.5	2.7	1.9	3.7	9.1	3.5	27.9	2.6	1.4	7.4	3.4	4.2	1.3	4.9	2.2	1.6	4.2	6.4	1.8	2.9	10.9	1.5	32.7	3.4	2.2	4.4	3.9	1.8	1.6	7.4	2.2	2.4	2.8	2.8	2.5	22.2	2.9	0.5	6.3	0.9	2.0	3.1	3.4	1.0	1.8	14.0	0.7	5.0	4.4	0.6	1.0	1.5	4.5	2.4	2.9	3.0	0.5	1.1	1.1	1.1	1.9	0.0	7.6	2.5	0.2	0.3	4.6	1.6	0.6	1.4	1.9	3.0	0.5	2.9	2.0	1.3	0.9	3.3	2.4	1.8	2.2	2.0	0.3	3.7	1.0	2.5	0.0	2.8	0.3	0.3	2.6	4.7	0.5	1.0	1.1	7.0	0.8	0.3	4.6	0.8	3.4	2.3	1.7	1.5	0.9	1.4	1.4	1.1	1.4	1.7	0.7	2.4	0.7	4.5	6.9	2.1	4.0	4.9	4.0	0.6	0.5	12.5	4.4	0.7	3.1	1.0	1.9	3.0	0.8	0.2	1.2	1.9	14.0	5.0	0.3	1.8	1.4	0.6	6.5	7.2	1.8	8.3	7.4	3.4	1.6	4.2	32.7	2.9	3.0	8.9	2.4	2.2	6.4	7.3	28.3	2.5	570.2	84.2	5.2	58.9	0.9	18.3	2.3	154.6	4.9	2.7	0.0	1.4	0.4	13.1	3.6	5.8	0.8	1.4	4.8	1.7	35.6	5.6	25.2	11.2	6.0	5.0	0.0	1.0	10.6	1.5	5.1	6.0	14.1	53.5	6.5	15.8	113.3	10.8	3.0	2.1	5.1	3.0	4.2
CCDC155	"FLJ32658, KASH5"	ENSG00000161609	"Coiled-coil domain containing 155"	Q8N6L0	19	49388218-49417994	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 51.2"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 33.3;Early spermatids: 16.4;Spermatocytes: 87.2;Spermatogonia: 19.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enriched"	"Detected in single"	39	"cerebellum: 7.7"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.1;U-266/70: 8.6;U-698: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA019937, HPA019940"	Enhanced					NA	NA					"HPA019937: AB_1848877, HPA019940: AB_1848879"	"unprognostic (1.31e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.31e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.11e-9)"	"unprognostic (6.50e-2)"	"unprognostic (4.18e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.2	0.6	0.0	1.7	0.1	0.9	0.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	8.6	1.3	2.1	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	33.3	1.2	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	10.2	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	9.7	0.0	0.0	87.2	19.0	0.0	0.0	0.0	0.0	0.0
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6"	"Cell type enriched"	"Detected in many"	12	"Ciliated cells: 291.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA028338	Enhanced					NA	NA					"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	3.2	0.1	0.4	0.0	0.2	0.5	24.5	0.0	31.0	0.0	0.0	0.2	0.1	0.0	0.1	23.0	0.1	0.0	0.0	9.6	0.1	0.0	1.6	0.2	1.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.1	1.1	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	2.3	0.1	0.4	1.0	1.3	0.3	0.0	0.1	0.0	0.4	0.3	2.3	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.8	0.1	1.0	0.2	0.0	0.1	0.0	3.0	1.1	0.0	0.2	0.4	0.0	0.0	0.2	0.3	0.9	0.0	0.0	2.0	1.2	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.3	3.0	2.6	0.0	0.2	1.0	0.0	1.6	0.0	291.7	25.0	0.0	0.0	0.3	5.0	0.4	0.0	0.7	3.2	0.0	0.8	0.1	0.4	0.4	1.1	0.9	0.6	0.0	1.2	0.6	0.8	0.2	1.1	1.4	0.0	1.0	1.6	0.3	0.9	1.9	2.1	0.6	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.0	1.5	0.3
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Cell type enriched"	"Detected in many"	8	"Ciliated cells: 481.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 14.2;T-47d: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.1	8.3	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5	3.0	1.0	0.5	0.2	0.6	0.3	0.8	0.0	481.8	62.6	0.0	21.6	0.1	0.0	0.2	38.6	0.3	0.4	0.0	1.0	0.1	1.7	1.0	3.5	1.1	9.6	0.0	0.0	1.3	14.3	64.1	6.6	18.9	0.0	1.8	0.0	2.5	1.7	2.9	0.0	3.5	0.7	0.0	1.2	2.4	1.0	0.9	0.0	0.0	0.0	0.4
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 17.1;pituitary gland: 6.6;testis: 8.2"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 13.4;Cone photoreceptor cells: 7.9;Early spermatids: 7.0;Rod photoreceptor cells: 11.8;Spermatocytes: 16.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;SCLC-21H: 1.7"									HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.2	0.1	0.9	0.2	2.9	0.5	0.2	17.1	3.3	0.2	0.9	1.2	0.0	0.3	0.2	1.0	0.2	1.3	0.5	0.2	0.8	0.5	0.4	0.2	0.5	0.2	0.8	0.9	0.2	0.1	0.3	6.6	0.1	3.0	0.2	1.8	0.6	0.2	0.2	0.2	0.3	0.9	0.2	0.4	0.4	0.2	8.2	1.5	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.4	0.9	2.9	17.1	3.3	0.8	0.5	0.8	0.9	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.4	1.2	0.0	7.9	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	11.8	0.0	0.0	16.5	1.3	0.0	0.0	0.0	2.6	0.0
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 54.1;Distal tubular cells: 58.0;Proximal tubular cells: 165.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"A549: 9.3;RPTEC TERT1: 27.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA029202: AB_10600754"		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavorable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favorable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.3	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.3	0.1	0.2	0.1	0.2	0.1	0.0	0.2	27.7	0.4	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0	3.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	58.0	18.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	165.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC60	MGC39827	ENSG00000183273	"Coiled-coil domain containing 60"	Q8IWA6	12	119334712-119541047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0;fallopian tube: 21.1;smooth muscle: 17.5;testis: 25.7"	"Cell type enhanced"	"Detected in some"	19	"Ciliated cells: 56.2;Early spermatids: 123.2;Late spermatids: 58.3;Urothelial cells: 34.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HBEC3-KT: 1.7;HeLa: 1.2;RT4: 1.8;SuSa: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-3)"		"unprognostic (1.00e-1)"		"unprognostic (2.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.92e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.54e-1)"	0.1	0.0	1.8	0.6	3.3	0.0	0.0	0.0	0.1	6.9	2.1	5.2	3.6	0.2	1.4	4.9	2.8	21.1	0.2	0.1	2.4	2.6	0.1	0.1	3.2	0.1	0.1	0.0	5.3	0.1	0.0	0.1	0.6	22.0	5.4	5.7	8.9	3.5	2.1	0.2	0.2	0.2	17.5	0.4	0.1	0.4	25.7	0.3	0.0	0.1	0.4	2.6	10.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	5.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.3	0.0	0.1	2.4	2.6	0.1	0.0	22.0	0.3	0.0	0.0	0.0	21.4	0.7	0.2	0.3	0.0	56.2	3.4	0.0	13.7	0.0	0.0	0.0	123.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	0.9	0.0	0.0	0.0	7.2	0.2	0.1	0.0	0.4	0.0	0.9	0.0	0.0	9.9	1.9	0.0	0.0	0.0	0.5	34.1
CCDC65	"CFAP250, CILD27, DRC2, FAP250, FLJ35732, NYD-SP28"	ENSG00000139537	"Coiled-coil domain containing 65"	Q8IXS2	12	48904110-48931840	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 22.5;testis: 53.2"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 180.7;Early spermatids: 85.1;Spermatocytes: 50.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	11	"gdT-cell: 8.9;MAIT T-cell: 9.5;memory CD4 T-cell: 7.6;memory CD8 T-cell: 7.1;naive CD4 T-cell: 4.7;naive CD8 T-cell: 6.3;T-reg: 4.1"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038520, HPA057573"	Uncertain		Approved	"Vesicles,Centriolar satellite"		NA	NA			Vesicles	"Centriolar satellite"	"HPA038520: AB_10672714, HPA057573: AB_2683473"	"unprognostic (3.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.23e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.03e-4)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.16e-2)"	0.3	0.4	2.2	0.6	5.1	1.1	0.5	0.6	2.2	1.6	0.3	4.5	0.5	0.4	1.3	5.1	0.3	22.5	1.1	0.3	2.9	3.2	2.0	0.2	5.0	0.8	0.6	2.0	2.7	0.7	1.1	3.9	0.2	13.7	0.3	0.1	2.1	0.4	0.5	0.3	1.3	0.5	0.2	0.7	1.0	0.3	53.2	1.0	0.0	2.2	0.0	0.3	0.3	0.2	0.3	0.0	0.1	0.0	0.6	9.5	2.2	1.2	4.8	2.2	4.2	0.1	0.0	2.2	1.1	0.1	0.6	2.1	5.8	2.9	1.6	1.7	0.0	0.7	1.4	0.0	0.1	0.9	2.7	2.3	2.6	7.3	2.1	0.3	2.1	2.4	0.0	0.1	1.2	0.0	3.5	0.0	1.4	1.1	0.6	0.1	2.8	0.7	2.8	4.7	1.7	1.2	1.5	1.0	1.8	3.5	3.1	1.2	2.0	1.3	1.7	1.6	3.5	4.5	1.8	2.0	1.6	1.7	1.8	0.9	2.2	2.2	1.5	1.7	1.8	0.4	0.0	0.0	0.0	8.9	0.0	9.5	0.3	7.6	7.1	0.0	0.3	4.7	6.3	0.1	0.6	0.0	0.0	4.1	2.2	2.2	5.1	0.6	2.2	2.9	3.2	0.6	2.0	13.7	1.0	0.0	0.6	0.0	0.1	0.8	1.2	0.4	0.0	180.7	17.0	0.0	11.8	0.1	6.6	0.6	85.1	0.1	0.0	0.0	0.5	0.1	0.3	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	10.8	1.4	0.0	1.7	0.0	0.0	1.9	0.4	0.0	2.1	2.4	10.7	0.0	0.4	50.9	4.7	0.1	0.1	7.5	0.0	0.1
CCDC81	"FLJ16339, FLJ23514"	ENSG00000149201	"Coiled-coil domain containing 81"	Q6ZN84	11	86374736-86423109	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.2;fallopian tube: 28.9"	"Cell type enhanced"	"Detected in some"	20	"Ciliated cells: 56.2;Early spermatids: 14.1;Extravillous trophoblasts: 30.4;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.5"	"Region enriched"	"Detected in many"	8	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.5;BJ hTERT+: 4.1;HBF TERT88: 4.3;SuSa: 4.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.02e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.00e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.14e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	0.5	0.3	0.9	0.3	1.6	0.3	0.3	0.4	0.7	1.6	0.3	7.4	0.8	0.0	2.0	4.5	0.3	28.9	0.5	0.3	1.5	1.8	0.2	0.1	1.5	1.1	0.5	0.6	4.3	0.1	0.3	5.5	3.1	15.2	0.6	0.3	0.8	0.1	0.9	0.7	0.2	0.2	1.1	0.7	0.3	0.2	5.6	1.7	0.0	0.5	0.4	0.4	0.6	0.3	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.3	2.4	0.0	0.8	0.3	0.9	7.5	4.1	1.2	0.9	0.8	0.7	0.4	3.0	1.1	0.3	0.5	1.2	0.2	4.3	0.5	0.4	0.8	0.2	0.7	0.4	0.4	0.5	0.2	1.4	2.2	0.6	1.2	1.4	0.6	0.4	0.1	1.0	1.2	1.0	2.2	0.2	1.0	0.0	0.4	0.2	0.7	0.6	0.0	0.4	0.4	0.3	0.6	0.0	4.7	0.4	0.9	0.4	1.9	1.0	1.7	0.2	0.1	0.6	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.6	0.4	0.7	1.5	1.8	0.5	0.6	15.2	1.7	3.0	0.3	0.0	0.2	0.2	0.8	0.9	0.0	56.2	9.1	0.0	0.0	0.9	0.0	0.1	14.1	0.2	0.0	0.0	0.0	30.4	0.3	0.3	0.0	0.0	2.1	0.0	0.0	3.1	0.0	2.1	1.4	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.7	0.0	0.7	12.9	0.4	0.4	0.2	0.5	2.3	0.0	0.0	0.1
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 127.2;T-cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 18.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 19.6;SCLC-21H: 23.8;U-266/70: 20.9;U-266/84: 29.4"	"Low region specificity"	"Detected in all"							HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	3.6	0.9	2.7	31.1	18.7	15.0	6.9	0.9	2.3	3.0	8.9	1.8	15.5	9.6	4.7	4.0	8.9	9.7	11.8	2.2	2.0	2.4	5.0	2.6	11.1	34.5	2.0	0.3	2.0	14.8	6.7	4.0	1.8	1.6	6.4	4.7	4.1	12.1	11.7	1.5	4.5	9.6	6.0	2.9	14.5	8.1	4.8	3.7	18.5	2.5	6.0	27.6	7.1	5.3	2.3	1.8	5.2	3.2	3.1	11.0	2.8	3.1	2.9	3.3	3.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	3.0	4.7	13.5	2.5	0.0	0.1	0.1	4.8	2.7	0.0	11.3	1.8	3.5	1.9	4.2	0.3	7.0	3.0	0.0	4.0	0.0	0.0	0.2	3.7	19.6	4.1	16.9	0.0	10.2	7.0	9.3	3.3	2.4	4.4	5.8	0.1	4.5	0.8	4.5	23.8	5.3	2.0	6.9	1.6	2.5	3.7	6.5	1.1	0.0	0.0	0.0	0.0	20.9	29.4	6.9	0.0	6.3	0.0	5.2	3.2	1.3	9.0	1.8	8.7	2.3	6.1	9.3	1.8	1.9	3.9	5.8	2.6	3.1	2.5	1.5	11.0	2.8	2.7	18.7	0.9	2.3	2.0	2.4	2.0	0.3	1.6	3.7	3.0	27.4	43.1	14.2	8.2	0.0	18.3	10.2	127.2	21.6	14.0	0.0	2.8	0.0	4.0	6.8	12.6	18.6	0.0	5.1	1.7	4.1	16.5	2.3	1.0	5.4	0.0	23.0	16.5	20.3	14.0	3.7	5.0	1.7	1.0	13.4	7.0	6.2	20.1	2.8	11.5	0.0	0.0	4.4	4.1	22.2	8.3	1.5	71.0	16.1	16.3
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266207	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 95.1;intestine: 71.6"	"Group enriched"	"Detected in some"	5	"Glandular cells: 57.6;Melanocytes: 38.8;Muller glia cells: 33.0"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 72.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 565.3"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"	NA	NA					"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.9	1.1	59.0	1.1	29.8	0.8	0.9	0.2	95.1	0.8	11.3	1.4	0.0	71.6	0.8	0.8	0.9	0.9	0.9	0.9	35.8	10.8	0.8	0.9	1.1	0.8	8.0	26.9	0.8	1.1	0.8	4.1	9.4	1.3	13.5	0.9	0.0	0.8	1.0	0.8	0.9	10.5	1.0	1.3	0.8	1.7	1.7	0.5	0.0	0.8	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.0	0.0	0.3	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	29.8	0.2	95.1	35.8	10.8	8.0	26.9	1.3	0.5	0.0	0.0	0.0	1.0	5.0	1.1	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	57.6	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	38.8	0.0	0.0	33.0	0.5	0.0	0.0	0.0	3.2	0.0	2.1	0.0	0.4	1.1	8.8	0.0	0.0	3.3
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363231	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 9.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.0;intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	20	"monocytes: 2.0"	"Cell line enriched"	"Detected in some"	41	"HMC-1: 128.7"					"Region enriched"	"Detected in single"	4	"hippocampal formation: 2.2"	HPA049861	Uncertain				"Secreted to blood"	NA	NA	84400				"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.1	0.0	0.2	0.2	2.5	0.0	0.1	0.1	0.9	0.1	0.5	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.4	0.1	0.5	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.8	0.1	6.7	0.1	3.2	0.5	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	2.5	0.1	0.8	0.5	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCNJL	FLJ14166	ENSG00000135083	"Cyclin J like"	Q8IV13	5	160249106-160345396	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 48.9"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 25.5;Mucus-secreting cells: 27.9;Paneth cells: 20.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	19	"cerebellum: 48.9"	"Group enriched"	"Detected in some"	19	"neutrophil: 13.5;NK-cell: 4.1"	"Group enriched"	"Detected in many"	35	"granulocytes: 13.5;NK-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 26.8;WM-115: 20.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049970	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA049970: AB_2680974"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.60e-4)"	"unprognostic (1.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.10e-4)"	"prognostic favorable (8.02e-4)"	1.0	3.0	0.9	3.4	1.2	1.3	2.1	48.9	1.5	2.1	9.0	0.9	1.5	1.8	1.1	1.5	0.8	1.0	1.0	4.4	2.5	0.8	2.7	1.2	9.0	2.5	1.5	1.1	5.3	0.2	0.0	17.0	1.7	2.1	2.0	7.9	3.9	7.6	2.0	0.6	0.4	2.7	1.0	0.9	5.8	4.4	10.7	1.2	4.8	8.4	1.7	2.6	4.0	5.4	0.1	0.2	13.5	0.0	4.1	0.0	0.2	3.0	11.3	9.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.4	4.9	8.8	0.0	8.7	0.1	7.7	3.8	1.2	26.8	0.7	0.0	0.2	4.8	4.0	3.5	0.1	0.0	1.0	0.0	2.3	1.5	6.7	5.7	6.8	3.1	0.0	0.0	2.9	1.6	0.0	7.9	8.5	0.0	6.3	1.8	3.0	1.0	7.1	14.3	3.1	8.3	1.5	2.3	10.2	3.6	5.1	0.5	8.2	1.6	10.3	0.0	5.6	0.0	0.0	0.0	0.0	0.0	20.3	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	13.5	4.1	0.0	0.2	0.0	0.2	0.9	1.2	48.9	1.5	2.5	0.8	1.5	1.1	2.1	1.2	20.8	25.5	0.0	1.2	0.2	0.6	4.8	0.0	1.4	7.9	3.5	0.0	0.0	5.0	2.6	0.7	0.9	3.6	0.0	0.2	0.0	1.3	0.8	1.1	0.0	0.1	0.0	2.4	1.8	0.0	3.0	2.0	0.1	5.0	1.0	27.9	7.3	1.1	20.1	2.5	0.0	0.0	0.0	1.0	0.5	5.7	0.4	0.0	0.0	2.3	1.6
CD160	"BY55, NK1, NK28"	ENSG00000117281	"CD160 molecule"	O95971	1	145719471-145739288	"CD markers, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4"	"Cell type enriched"	"Detected in some"	5	"T-cells: 48.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 15.2"	"Group enriched"	"Detected in many"	9	"gdT-cell: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2"	"Group enriched"	"Detected in many"	11	"NK-cells: 23.2;T-cells: 33.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 4.7"	"Not detected"	"Not detected"												"Intracellular and membrane"	NA	NA						"unprognostic (6.54e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.25e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.48e-5)"	"unprognostic (4.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-4)"	0.6	0.2	2.2	3.6	2.6	5.1	0.6	15.2	3.1	0.8	9.3	0.4	0.3	5.6	0.8	1.4	0.9	0.6	1.2	0.6	1.6	2.2	0.5	5.9	3.8	6.0	1.6	0.3	1.1	2.2	0.0	0.4	1.8	0.6	1.3	1.0	0.9	3.0	0.4	1.0	1.1	19.9	1.4	1.0	17.4	0.8	0.8	0.3	2.9	0.4	0.3	3.1	0.7	0.3	0.2	0.3	2.7	0.4	23.2	33.9	20.2	1.4	1.0	1.6	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.1	0.6	0.1	1.7	1.3	0.2	0.1	1.7	0.2	0.2	0.1	3.5	1.7	3.1	4.7	1.3	0.1	2.1	3.2	0.2	0.4	0.1	0.3	0.7	0.0	1.7	0.8	1.5	0.1	1.5	1.2	4.0	1.2	0.8	2.9	0.3	0.2	1.1	0.0	0.6	1.2	1.6	0.9	1.3	0.6	1.2	1.5	2.0	1.8	1.4	0.6	0.8	3.0	2.4	1.6	0.6	0.7	2.4	0.2	2.7	0.1	0.1	33.9	0.1	14.4	0.2	0.4	22.9	0.0	0.2	0.2	27.3	1.7	23.2	0.4	0.3	0.0	20.2	2.2	2.6	15.2	3.1	1.6	2.2	1.6	0.3	0.6	0.3	0.0	0.0	0.0	0.2	0.1	2.1	0.2	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.0	2.8	0.1	0.5	0.0	0.4	0.0	0.0	0.3	2.3	0.5	0.0	6.4	0.0	1.8	3.1	6.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	2.6	0.0	0.2	0.0	0.1	0.1	0.1	48.4	0.0	0.1
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823387-64844569	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Club cells: 12.5;Enterocytes: 10.6;Paneth cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.4"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.5;HaCaT: 14.6;MCF7: 19.7;RT4: 12.0;SK-BR-3: 12.1;T-47d: 11.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 5.9"	"Low region specificity"	"Detected in single"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	2.7	0.8	2.1	0.5	1.1	3.5	19.4	0.8	2.9	9.1	0.8	6.3	8.2	1.0	8.0	14.3	2.9	10.5	0.5	0.7	0.0	3.5	0.5	4.2	0.7	0.5	0.5	1.5	7.9	7.0	6.5	13.0	2.0	4.4	3.4	1.0	14.3	7.6	0.5	22.4	19.7	1.6	0.8	0.8	8.5	2.5	0.7	1.8	3.9	8.1	7.7	5.4	6.3	0.4	0.0	0.0	0.0	0.2	1.0	0.1	5.6	0.8	0.5	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	7.6	4.8	0.1	2.8	0.0	0.2	14.6	0.9	5.7	0.0	0.2	2.2	0.4	3.1	2.4	0.0	0.1	1.4	0.0	7.2	0.1	0.1	0.0	0.0	2.3	3.8	0.0	0.0	19.7	0.1	1.0	1.8	5.3	0.8	0.8	0.3	2.7	3.4	12.0	10.4	0.5	1.8	12.1	0.3	2.9	11.9	0.2	0.0	0.0	2.1	0.0	0.0	1.4	1.3	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.8	0.5	19.4	0.8	0.7	0.0	0.5	0.5	2.0	0.7	8.9	6.4	0.0	2.3	5.8	0.0	1.6	2.5	6.7	12.5	1.8	0.0	4.8	0.0	1.7	0.5	0.0	10.6	0.0	5.3	4.1	0.6	2.1	1.1	0.0	0.9	0.0	3.5	0.0	0.0	0.4	0.0	0.2	0.0	1.8	3.3	0.9	2.8	14.0	0.0	0.3	0.0	0.0	0.5	1.7	1.1	7.0	5.6	0.0	3.8	2.0
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6852066	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.6;lymphoid tissue: 51.0"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 53.0;Erythroid cells: 46.7;Extravillous trophoblasts: 60.9;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.8"	"Cell type enhanced"	"Detected in many"		"T-reg: 7.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026587			Approved	Cytosol		NA	Yes			Cytosol		"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.51e-5)"	"prognostic unfavorable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.6	1.9	1.0	19.2	1.8	9.9	1.9	8.8	2.2	2.0	17.3	1.2	1.2	15.5	2.3	2.0	6.9	1.0	2.9	2.2	1.1	1.6	1.3	0.9	1.9	10.8	1.3	0.7	3.7	0.6	0.3	6.9	4.7	1.2	2.2	5.3	0.7	2.4	0.4	0.7	4.3	34.6	2.0	1.4	5.2	2.4	18.2	1.1	51.0	1.3	8.5	15.1	1.6	2.8	1.6	2.3	0.5	0.6	0.8	7.7	0.9	30.1	21.8	22.3	13.5	1.3	2.0	25.9	19.9	12.2	32.8	22.9	32.3	26.0	16.7	2.5	15.0	23.8	20.8	14.3	13.7	32.6	25.1	15.9	15.0	14.6	21.0	0.2	11.1	14.3	0.9	1.1	17.6	9.6	8.0	13.9	11.8	12.4	10.9	31.2	23.6	16.2	12.9	26.1	20.3	16.9	16.4	19.4	9.4	10.9	8.5	3.4	6.7	18.0	16.8	6.2	24.9	6.6	10.8	6.1	16.0	20.7	10.4	33.4	5.6	5.6	26.1	7.5	13.9	28.1	0.0	0.6	0.0	0.5	0.3	0.8	1.6	1.3	1.9	0.7	0.8	0.6	1.2	0.5	0.8	0.5	2.3	7.7	0.9	1.0	1.8	8.8	2.2	1.1	1.6	1.3	0.7	1.2	1.1	0.0	0.3	0.8	1.2	2.6	10.5	1.0	0.0	0.0	0.0	0.0	53.0	3.3	0.0	0.9	5.9	0.4	9.5	46.7	0.3	60.9	2.6	1.0	4.6	0.8	15.7	6.4	1.2	3.1	3.5	5.4	1.7	2.7	0.0	1.8	5.7	1.4	0.3	0.8	0.4	0.7	18.0	6.5	0.4	57.5	14.9	1.6	7.1	0.8	10.9	0.6
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082278-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Ductal cells: 84.9;Pancreatic endocrine cells: 100.0;Urothelial cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	5	"pons and medulla: 5.5"	"Group enriched"	"Detected in some"	5	"myeloid DC: 4.0;neutrophil: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.0;granulocytes: 1.8;NK-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.8;HBEC3-KT: 27.2;hTEC/SVTERT24-B: 67.5;hTERT-HME1: 45.8;PC-3: 21.1;RPTEC TERT1: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, CAB025637"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401"	"unprognostic (9.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (9.98e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-1)"	2.3	0.7	0.5	5.6	1.0	0.2	4.4	0.3	0.7	6.9	17.4	1.1	10.1	11.4	3.2	11.1	28.6	2.4	9.8	0.8	1.0	0.5	4.4	0.8	7.1	1.4	0.6	0.3	1.6	13.9	0.0	2.3	4.0	5.5	5.2	11.3	0.5	11.4	13.0	0.6	15.2	29.8	1.8	1.3	0.8	10.8	1.3	0.5	1.0	21.8	19.2	19.1	7.3	11.7	0.2	4.0	1.8	0.9	7.1	0.3	0.3	12.3	3.7	0.0	0.0	0.0	0.6	3.0	2.2	0.4	1.1	1.0	5.2	23.8	0.0	2.8	0.7	0.6	10.0	0.0	27.2	2.3	0.0	0.0	0.0	4.2	0.0	2.0	0.0	0.9	0.9	14.3	67.5	45.8	4.1	0.2	0.0	7.2	0.0	3.4	0.0	0.0	0.2	1.8	6.0	21.1	0.0	0.0	2.1	20.8	10.0	0.8	0.0	4.6	1.2	0.0	1.2	5.8	0.1	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	4.0	0.2	0.2	0.1	1.8	7.1	0.0	0.1	0.0	0.3	0.5	1.0	0.3	0.7	1.0	0.5	0.6	0.3	5.5	0.5	3.0	13.3	0.0	52.1	107.6	0.0	0.4	12.7	26.8	18.2	8.7	0.0	4.5	0.0	84.9	0.0	0.6	30.4	0.0	61.1	6.7	5.8	52.2	8.1	0.0	10.2	0.0	36.0	0.0	4.8	0.0	2.8	26.8	3.3	18.0	34.1	0.0	100.0	28.8	0.0	0.0	0.0	0.0	3.3	0.0	0.4	65.6	2.7	0.0	22.5	90.5
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171767-89195492	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 44.2;skeletal muscle: 60.3"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	24	"cerebellum: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 57.9"	"Region enriched"	"Detected in some"	7	"cerebellum: 17.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 17.9"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		390000	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.8	0.2	0.0	0.1	0.0	0.1	0.1	44.2	0.2	0.7	0.1	0.0	0.0	0.2	0.1	2.8	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.8	1.8	0.5	0.1	0.0	0.3	0.2	60.3	0.1	0.1	0.1	0.3	0.6	0.1	0.3	0.0	0.0	0.1	6.5	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	57.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	44.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.6	0.3	0.0	0.0	1.3	0.0	0.4	0.0	0.0	1.7	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	4.3	0.0	0.1	0.0	0.0	0.0
CDH18	"CDH14, EY-CADHERIN"	ENSG00000145526	"Cadherin 18"	Q13634	5	19472951-20575873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 105.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 68.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 105.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.8;GAMG: 10.1;hTERT-RPE1: 5.3;U-2 OS: 9.1;U-2197: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014416	Uncertain				"Intracellular and membrane"	NA	NA					"HPA014416: AB_2668996"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"		"unprognostic (5.26e-7)"	"unprognostic (6.36e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.44e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.30e-2)"		"unprognostic (1.51e-2)"	"unprognostic (8.69e-2)"		"unprognostic (1.76e-2)"	0.7	9.3	6.9	0.7	7.1	0.7	0.6	105.4	23.2	1.0	0.6	0.0	0.0	0.7	0.6	0.6	0.7	0.7	0.7	0.6	4.6	8.1	0.9	0.6	0.7	0.8	1.8	8.3	0.7	1.2	2.1	11.3	0.6	7.1	0.8	0.7	2.2	0.6	0.8	0.9	0.8	0.7	0.6	2.2	0.7	0.6	3.7	1.3	0.0	0.6	0.0	0.6	0.6	0.3	0.7	0.3	1.2	0.5	0.6	0.4	0.5	1.5	0.0	0.3	0.0	0.9	3.8	3.4	0.2	2.1	0.1	0.6	0.0	0.0	0.0	5.8	0.0	10.1	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	2.3	5.3	0.0	0.1	0.2	0.7	0.4	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.0	1.8	9.1	8.0	0.0	2.2	0.0	0.0	2.6	0.0	0.0	1.1	0.5	0.3	0.4	0.1	0.2	0.3	0.2	0.2	0.2	0.7	0.4	0.4	1.2	0.6	0.4	0.3	0.2	0.5	6.9	7.1	105.4	14.1	4.6	8.1	1.8	8.3	7.1	1.3	0.0	0.0	0.0	0.8	0.0	3.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	68.6	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.3	0.0	0.0	2.1	2.4	0.0	0.2	0.0	0.0	0.0
CDH22	"C20orf25, dJ998H6.1"	ENSG00000149654	"Cadherin 22"	Q9UJ99	20	46173733-46308498	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.8"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 9.4;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 6.8;Late spermatids: 5.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 55.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012164, HPA012715"	Uncertain	Supported				NA	NA					"HPA012164: AB_1845902, HPA012715: "	"unprognostic (2.41e-4)"	"unprognostic (1.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.39e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.50e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.09e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.83e-2)"	0.7	4.2	10.2	0.5	5.7	0.5	0.8	55.8	15.5	0.7	0.6	1.0	0.0	0.6	0.7	0.7	1.2	4.0	0.5	1.0	3.5	3.7	0.7	0.5	0.6	0.5	1.2	8.7	0.9	4.2	0.5	1.1	0.5	3.0	1.5	0.7	1.8	1.0	1.8	1.2	10.4	0.9	0.5	1.9	0.5	0.9	1.4	1.3	0.0	0.7	0.0	0.5	0.5	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	10.2	5.7	55.8	14.8	3.5	3.7	1.2	8.7	3.0	1.3	0.0	0.0	0.0	1.1	0.7	9.4	2.8	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.9	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.9	9.3	0.0	0.1	0.0	0.0	69.1	0.6	33.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.6	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	1.3	0.2	2.1	0.0	0.0	0.0	29.9	11.3	0.1	0.0	0.2	0.0	11.8	12.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1	14.9	2.9	0.0	49.5	54.0	0.8	1.2	0.0	4.0	13.6	14.0	2.0	21.3	0.0	31.6	0.2	0.5	0.0	0.0	28.5	1.2	3.3	13.1	1.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.6	1.2	57.3	1.8	1.4	0.2	60.0	0.0	8.9	0.0	0.4	0.0	1.9	0.2	0.7	26.8	5.3	0.0	0.4	48.9
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880600-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 46.8"	"Cell type enhanced"	"Detected in single"	37	"Proximal tubular cells: 3.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;granulocytes: 8.3"	"Cell line enhanced"	"Detected in some"		"K-562: 9.4;NTERA-2: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.7	0.5	46.8	1.0	24.6	2.8	0.7	0.5	23.7	0.5	0.8	0.0	0.0	0.6	0.9	1.2	0.7	0.5	0.7	0.5	15.9	3.5	10.5	0.5	0.6	1.6	1.2	15.6	0.6	1.1	1.0	0.5	0.8	1.5	1.0	1.2	0.0	0.5	0.1	0.5	1.9	1.5	0.8	0.6	0.8	0.9	3.7	2.6	0.0	1.9	0.0	1.7	0.5	0.5	4.1	0.9	8.3	1.1	0.1	0.8	1.1	2.5	0.9	0.5	0.8	0.4	0.0	1.6	0.0	0.9	0.3	0.7	0.0	0.9	1.3	0.3	0.3	0.2	0.3	0.1	0.6	0.0	0.1	0.3	0.5	0.7	2.5	0.0	0.0	1.6	0.6	0.7	0.0	0.0	0.0	0.2	0.8	9.4	2.3	0.0	1.5	0.8	0.5	13.9	0.2	0.5	0.3	0.3	0.4	0.5	0.5	3.1	0.3	0.0	0.4	0.5	2.7	0.5	0.9	1.7	0.1	0.8	0.8	0.3	2.8	1.0	4.4	1.0	1.0	0.8	1.3	0.2	0.4	0.2	0.7	0.6	4.1	0.4	0.2	0.1	2.5	0.3	0.5	8.3	0.1	1.1	0.9	0.8	1.1	46.8	24.6	0.5	23.7	15.9	3.5	1.2	15.6	1.5	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194635-84219621	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 357.4;Rod photoreceptor cells: 231.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 31.2"	"Cell type enriched"	"Detected in single"	11	"NK-cell: 10.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.5;HEK 293: 5.4;HEL: 6.3;K-562: 4.5;NTERA-2: 4.6;RPTEC TERT1: 17.2"	"Region enriched"	"Detected in some"	21	"olfactory region: 408.8"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"	NA	NA					"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.3	1.2	1.9	0.7	31.2	0.5	2.3	0.9	7.7	2.8	12.3	2.2	0.0	0.3	0.6	2.2	4.8	0.6	0.5	0.9	3.4	2.1	0.5	0.5	0.4	0.7	1.5	3.1	0.8	0.4	0.3	1.5	0.4	9.3	0.9	22.6	42.5	1.0	2.2	0.7	86.8	5.3	0.9	1.2	3.0	0.4	0.4	3.0	2.4	0.4	3.3	0.9	0.4	1.5	0.0	0.0	0.0	0.0	10.5	0.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	2.0	0.0	0.0	5.4	6.3	0.0	0.0	0.2	0.0	0.2	0.0	2.3	0.0	0.8	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.5	4.6	0.0	0.0	0.0	0.0	1.4	17.2	0.0	3.6	0.8	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	1.9	31.2	0.9	7.7	3.4	2.1	1.5	3.1	9.3	3.0	0.0	0.3	0.0	0.3	45.4	19.5	1.0	0.0	0.0	1.2	0.0	357.4	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	4.8	12.2	0.0	0.3	0.0	0.0	0.0	3.3	0.0	35.5	25.1	0.0	24.6	0.0	0.1	231.3	0.0	0.2	0.0	0.0	59.0	0.0	2.9	47.2	0.1
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106033773	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 51.9;lung: 28.9;ovary: 22.3"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 341.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 15.9"	"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 6.9;granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.9;Daudi: 10.1;WM-115: 6.8"	"Low region specificity"	"Detected in many"							HPA011218	Supported		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12.0	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.9	1.4	2.8	2.7	0.2	0.7	0.6	0.3	0.2	0.0	0.1	10.1	0.0	0.5	1.1	0.1	1.9	0.0	0.3	0.9	1.2	0.0	0.2	0.7	0.0	0.2	0.4	1.0	0.3	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.1	1.8	2.8	0.6	0.0	0.0	0.4	0.1	0.1	0.6	2.9	0.0	0.8	0.5	1.4	0.0	0.0	0.4	1.4	0.5	1.5	0.0	0.0	0.0	3.3	0.2	0.3	6.8	0.1	0.1	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2	3.0	7.2	0.0	1.6	2.4	4.5	1.2	2.5	341.3	55.7	0.0	0.0	0.5	5.0	0.5	5.4	1.0	2.8	0.0	0.5	0.2	1.5	0.5	3.5	1.7	0.1	0.0	28.7	0.0	0.0	2.5	2.6	0.6	8.5	0.0	3.6	9.5	0.2	2.9	1.4	4.4	1.0	6.5	1.7	1.4	3.1	1.8	0.2	0.7	2.9	0.4
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799835	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 37.8;fallopian tube: 42.7"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 132.5"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 5.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.7;HeLa: 4.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 17.7"	"Low region specificity"	"Detected in single"			HPA076277	Enhanced				"Intracellular and membrane"	NA	NA					"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0.0	0.0	4.9	0.2	1.9	0.0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0.0	0.0	8.0	0.0	0.0	0.8	0.6	5.7	0.1	0.1	0.0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0.0	0.1	3.9	0.0	0.0	0.0	0.5	0.2	0.2	0.1	1.1	1.5	3.0	4.1	1.3	0.4	5.8	0.5	1.8	0.5	0.3	0.5	4.7	0.3	0.4	0.1	1.0	1.0	0.0	2.7	0.0	0.2	1.1	0.6	0.5	0.1	0.0	0.3	0.3	0.3	0.8	4.5	1.0	0.0	0.3	0.5	0.7	1.5	0.8	0.3	1.2	0.0	0.3	0.2	0.7	0.0	0.0	0.0	0.8	0.3	0.6	0.2	0.8	0.2	0.0	0.0	0.3	0.1	0.1	1.6	1.1	0.0	0.1	0.2	0.1	0.0	0.6	0.2	0.7	0.1	0.7	2.4	0.1	2.2	1.3	0.0	3.0	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0.0	0.0	0.7	0.9	0.0	0.0	5.7	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.4	0.0	132.5	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.4	0.5	0.0	0.0	0.0	0.0	0.1
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616565-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 296.7"	"Group enriched"	"Detected in many"	6	"Enterocytes: 1223.0;Paneth cells: 645.3"	"Group enriched"	"Detected in many"	17	"colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		170000000			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.3	0.1	8.1	0.1	0.0	0.1	0.1	0.1	0.1	118.7	0.4	0.0	34.3	0.1	0.8	0.1	0.2	12.1	0.1	0.2	0.1	10.9	43.8	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	1.6	0.1	21.3	5.1	0.1	0.0	0.1	0.1	296.7	0.8	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	14.9	0.0	0.1	0.1	2.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.8	10.2	0.0	0.0	1.8	0.0	0.0	11.6	0.3	2.6	0.0	1223.0	0.0	1.2	0.0	0.0	0.0	13.8	103.1	0.1	0.0	89.1	4.9	5.0	13.1	0.0	0.0	0.0	0.0	152.8	0.0	2.0	645.3	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	129.4	0.0
CDON	"CDO, CDON1, ORCAM"	ENSG00000064309	"Cell adhesion associated, oncogene regulated"	Q4KMG0	11	125955796-126063335	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 15.7;Muller glia cells: 39.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 26.8"	"Cell type enhanced"	"Detected in some"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 23.1;ASC diff: 29.3;RH-30: 39.9;SuSa: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB012422, HPA017377"	Uncertain					NA	NA		9400000			"CAB012422: AB_2260246, HPA017377: AB_1846453"	"prognostic favorable (1.35e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.25e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"	"unprognostic (5.77e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (5.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.86e-4)"	10.4	0.9	1.2	7.9	2.9	0.1	5.3	26.8	4.2	14.6	10.5	2.3	1.5	1.4	16.4	6.3	5.0	14.1	12.6	4.1	1.0	1.5	1.1	1.2	3.7	1.3	0.9	1.9	28.5	1.3	4.1	4.1	3.2	3.6	4.8	2.1	7.2	1.7	4.1	1.2	12.8	3.8	20.6	1.0	0.8	5.6	4.1	1.0	3.0	27.1	2.8	1.8	6.6	6.7	0.5	0.4	2.8	0.3	0.4	0.7	0.1	1.4	1.7	23.1	2.6	29.3	12.4	0.5	0.5	2.8	0.9	0.3	0.7	9.0	1.2	6.5	0.5	2.7	0.3	5.3	1.0	0.8	4.1	4.3	0.4	4.6	2.8	7.0	0.4	1.5	4.0	1.5	0.7	0.2	9.8	0.2	4.8	0.1	1.5	3.0	0.6	2.8	0.8	2.8	0.6	3.6	0.8	39.9	0.9	1.7	0.5	2.2	10.2	2.7	0.4	3.5	20.0	1.9	1.1	0.2	3.0	2.3	5.6	3.5	2.2	3.6	0.3	1.7	1.6	2.9	2.8	0.3	0.3	0.3	0.1	0.2	0.2	0.4	0.4	0.0	0.5	0.7	0.5	1.8	0.4	0.3	0.4	0.3	0.1	1.2	2.9	26.8	4.2	1.0	1.5	0.9	1.9	3.6	1.0	6.0	6.9	0.0	1.3	13.5	3.8	3.9	0.0	4.0	7.9	0.0	15.7	0.3	0.0	0.9	2.2	3.8	0.0	0.0	0.6	0.4	12.7	1.4	0.0	2.4	0.2	0.0	7.5	1.8	0.0	2.3	13.8	0.0	3.3	0.0	0.0	39.8	1.5	0.0	10.6	0.3	4.9	0.0	3.3	1.1	2.5	9.4	0.6	0.0	0.4	1.0
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Group enriched"	"Detected in some"	4	"HL-60: 59.4;NB-4: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	30.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.6	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722717	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;epididymis: 5.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Group enriched"	"Detected in many"	8	"basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 6.4;NTERA-2: 11.8;SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019917	Uncertain				"Secreted - unknown location"	NA	NA					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.1	0.0	0.1	0.1	2.5	0.1	0.2	2.2	1.1	0.1	0.2	0.1	0.1	0.7	0.7	5.5	0.1	0.0	0.4	0.2	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.2	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.2	1.1	0.1	0.2	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CERKL	RP26	ENSG00000188452	"Ceramide kinase like"	Q49MI3	2	181536676-181680665	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5"	"Cell type enhanced"	"Detected in some"	21	"Ciliated cells: 52.2;Cone photoreceptor cells: 17.7;Rod photoreceptor cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"cerebellum: 49.5;pons and medulla: 13.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 26.5;HL-60: 14.7;JURKAT: 17.0;MOLT-4: 35.5;NB-4: 31.3;SCLC-21H: 23.9;THP-1: 14.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 31.8"	"HPA035443, HPA035444, HPA043203"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035443: AB_2674625, HPA035444: AB_10672093, HPA043203: "	"unprognostic (7.52e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.45e-2)"	1.2	0.6	1.2	9.2	2.0	14.4	1.1	49.5	2.5	3.7	1.7	4.2	0.4	3.1	1.0	5.3	0.6	5.8	4.1	0.5	2.9	1.3	8.1	1.3	5.0	13.8	0.6	1.4	2.9	0.8	0.1	2.1	2.0	13.7	1.0	0.0	6.8	1.0	0.4	0.5	0.5	6.4	0.4	1.0	17.9	2.8	1.1	1.1	0.4	0.9	0.4	1.1	4.3	1.3	4.0	5.2	12.6	12.7	4.7	6.9	4.2	0.0	0.5	0.6	0.0	0.0	0.1	0.0	4.2	0.1	0.1	0.1	0.0	0.1	4.4	0.0	0.1	2.6	2.6	0.1	0.1	0.1	0.0	0.4	26.5	0.3	0.0	0.1	14.7	0.7	0.2	0.3	0.1	0.2	4.0	0.0	17.0	0.0	4.7	0.0	0.0	35.5	31.3	0.6	0.0	0.2	7.6	2.2	0.6	0.3	0.0	23.9	0.7	0.0	0.0	0.1	0.2	0.0	14.8	2.4	1.2	0.6	0.1	1.0	11.4	6.4	2.0	0.9	9.9	10.8	2.0	4.7	12.6	4.5	12.7	3.7	4.0	6.4	6.9	5.2	3.4	3.5	4.5	0.7	4.7	10.9	2.9	1.4	4.2	1.2	2.0	49.5	2.5	2.9	1.3	0.6	1.4	13.7	1.1	3.0	0.3	0.0	0.1	0.0	0.4	0.7	0.0	52.2	7.9	0.0	17.7	0.0	8.3	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	7.8	20.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
CFAP100	"CCDC37, FLJ40083, MIA1"	ENSG00000163885	"Cilia and flagella associated protein 100"	Q494V2	3	126394939-126436556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 38.7;fallopian tube: 29.2;testis: 21.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 282.0;Late spermatids: 505.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 14.7;pons and medulla: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BEWO: 1.4;HaCaT: 1.2;Hep G2: 1.1;NTERA-2: 1.2"	"Low region specificity"	"Detected in all"							HPA046354	Enhanced					NA	NA					"HPA046354: AB_2679634"	"unprognostic (1.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (7.17e-5)"	"unprognostic (1.61e-3)"	"unprognostic (6.75e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-5)"	"unprognostic (3.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.58e-4)"	0.3	0.3	1.6	0.3	14.7	0.3	0.3	0.0	0.8	3.2	0.3	10.9	0.0	0.3	1.5	12.0	0.3	29.2	0.3	0.3	4.5	3.0	0.4	0.3	8.2	0.4	0.1	1.1	3.4	0.3	0.3	1.9	0.3	38.7	0.3	0.3	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	21.9	4.5	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	14.7	0.0	0.8	4.5	3.0	0.1	1.1	38.7	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	88.3	21.6	0.0	0.0	0.0	0.0	0.0	282.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	505.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	6.5	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0
CFAP126	"C1orf192, Flattop, Fltp"	ENSG00000188931	"Cilia and flagella associated protein 126"	Q5VTH2	1	161364731-161367874	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 53.4;fallopian tube: 85.7"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 370.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	7	"pons and medulla: 53.4"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;RPTEC TERT1: 2.5;SCLC-21H: 2.5;T-47d: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045904	Enhanced					NA	NA					"HPA045904: AB_10960411"																		0.7	0.7	5.8	0.7	7.5	0.7	1.1	1.2	2.7	3.0	0.7	23.3	0.0	0.7	2.7	14.8	0.7	85.7	0.8	0.7	7.0	8.0	1.8	0.8	8.1	0.7	4.1	3.9	11.2	0.8	0.7	3.3	0.7	53.4	0.8	0.7	0.0	0.7	1.2	2.8	0.7	0.7	0.7	3.3	0.7	0.7	15.3	4.3	0.0	2.7	0.1	0.8	0.7	0.0	0.0	0.1	0.6	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.8	7.5	1.2	2.7	7.0	8.0	4.1	3.9	53.4	4.3	6.0	2.6	0.0	0.5	0.0	0.4	0.0	0.0	370.7	35.2	0.0	0.0	0.0	0.0	0.3	53.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	1.1	1.0	0.1	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 348.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.3	0.9	1.2	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	2.3	4.6	0.0	0.0	0.0	3.4	1.1	0.9	7.6	2.3	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.5	0.0	2.8	3.1	0.7	0.0	6.6	1.3	0.5	0.9	1.7	4.9	2.0	0.9	1.5	0.0	0.4	6.4	1.1	1.9	3.6	0.7	0.2	3.2	0.3	1.7	1.9	1.5	5.0	0.8	1.0	2.6	1.2	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5	8.9	10.9	0.0	0.2	0.0	0.6	0.0	0.0	348.0	51.2	0.0	0.0	0.0	1.7	0.3	44.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.3	0.2	0.2	0.0	0.0	0.0	0.3	61.4	0.3	0.4	0.0	0.0	0.6	0.8	0.0	0.0	0.7	0.3	0.2	0.0	0.0	11.4	1.1	0.0	0.0	0.0	0.2	0.1
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2"	"Cell type enhanced"	"Detected in some"	27	"Ciliated cells: 42.8;Club cells: 6.8;Early spermatids: 13.4;Spermatocytes: 11.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HEL: 42.4;K-562: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076975	Supported					NA	NA					"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.8	0.4	2.3	0.4	5.2	0.9	0.6	0.4	1.1	1.5	0.4	6.8	0.2	0.2	1.1	5.4	0.4	22.4	0.5	1.1	3.3	3.3	0.5	0.5	4.0	0.3	0.6	1.1	4.2	2.7	0.2	9.9	2.1	18.0	0.4	0.3	14.9	0.5	0.5	0.5	0.9	0.4	0.6	0.8	0.9	0.5	18.2	1.5	0.0	1.0	0.0	0.6	0.5	0.2	0.0	0.3	2.3	0.4	0.0	0.7	7.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	42.4	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.1	0.5	0.0	0.9	0.0	14.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.5	0.4	0.0	0.2	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.1	2.3	0.0	0.1	0.1	0.0	7.3	2.3	5.2	0.4	1.1	3.3	3.3	0.6	1.1	18.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	42.8	6.8	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	11.9	2.5	0.0	0.0	0.0	0.0	0.1
CFAP44	"FLJ11142, WDR52"	ENSG00000206530	"Cilia and flagella associated protein 44"	Q96MT7	3	113286947-113441610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;epididymis: 20.2;testis: 20.3"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 192.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA067258	Uncertain					NA	NA					"HPA067258: AB_2685814"	"unprognostic (2.83e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-6)"	"unprognostic (8.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-2)"	"prognostic favorable (7.09e-6)"	1.5	1.2	2.8	1.5	10.1	1.4	3.6	3.9	2.3	2.8	2.3	15.4	0.7	1.1	3.2	20.2	1.6	11.1	1.6	1.7	6.1	1.3	2.6	1.9	7.0	2.1	1.2	1.0	8.8	4.0	6.0	5.8	1.1	38.2	3.9	3.9	0.8	5.7	1.9	1.3	3.7	2.9	1.2	2.0	1.8	3.5	20.3	5.9	0.9	3.4	0.7	1.9	2.6	2.6	1.3	0.3	0.8	0.2	0.1	0.7	0.0	3.9	2.6	4.2	4.5	2.8	4.0	5.6	1.8	0.9	1.2	2.3	1.3	2.3	4.4	0.6	1.1	1.5	4.8	2.8	1.4	2.4	1.9	3.0	3.0	7.9	1.5	0.1	4.9	3.0	0.9	3.3	1.0	1.1	4.5	0.9	4.3	1.2	2.8	1.5	2.5	2.7	4.9	2.7	5.3	6.1	3.3	1.1	0.7	2.1	6.3	4.3	4.7	2.7	0.6	2.6	2.5	3.3	3.5	2.8	3.4	3.7	1.3	1.7	3.9	2.2	0.4	2.1	3.0	2.7	0.0	0.2	0.8	0.4	0.1	0.4	0.4	0.5	0.0	0.0	1.3	0.7	0.4	0.6	0.1	0.0	0.3	0.2	0.0	2.8	10.1	3.9	2.3	6.1	1.3	1.2	1.0	38.2	5.9	8.9	10.7	0.0	1.8	0.0	7.0	5.3	0.0	192.7	34.2	3.5	19.6	0.8	0.0	1.9	46.7	2.2	1.0	0.0	2.6	0.8	0.7	3.3	10.5	3.0	0.5	7.9	0.0	0.6	1.2	38.2	5.8	0.0	0.0	0.0	5.2	5.3	2.0	0.0	6.3	1.1	20.3	0.0	0.9	25.0	4.8	0.0	0.7	0.0	3.7	1.7
CFAP52	"FLJ37528, WDR16, WDRPUH"	ENSG00000166596	"Cilia and flagella associated protein 52"	Q8N1V2	17	9576627-9643459	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 29.5;fallopian tube: 46.9;testis: 26.8"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 149.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023247, HPA030635"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023247: AB_1858797, HPA030635: "	"unprognostic (1.76e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.09e-2)"	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6.0	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.6	1.9	0.0	0.7	1.3	0.9	0.9	0.0	0.1	0.0	0.0	0.1	3.9	0.0	0.4	0.0	1.4	2.2	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	4.8	0.0	0.7	0.3	6.2	0.2	3.3	0.0	0.1	0.4	0.9	0.8	0.0	0.7	1.3	0.0	0.9	2.9	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	8.4	0.3	2.5	5.9	6.0	0.5	0.5	29.5	3.5	0.0	2.9	0.0	0.2	0.0	0.4	0.3	0.0	149.9	18.2	0.0	5.9	0.5	1.7	0.0	21.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	1.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.8	0.2	2.0	0.0	0.0	25.2	0.3	0.0	0.8	0.0	0.0	0.1
CFAP53	"CCDC11, FLJ32743"	ENSG00000172361	"Cilia and flagella associated protein 53"	Q96M91	18	50227193-50266522	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;fallopian tube: 19.7;testis: 44.9"	"Group enriched"	"Detected in many"	11	"Ciliated cells: 397.5;Early spermatids: 589.3;Late spermatids: 341.5;Spermatocytes: 416.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 17.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.5"	"Low region specificity"	"Detected in some"							"HPA041069, HPA066142"	Enhanced		Approved	Midbody		Yes	No			Midbody		"HPA041069: AB_10805835, HPA066142: AB_2732739"	"unprognostic (1.73e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.85e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.61e-3)"	0.4	1.0	2.1	0.4	4.8	0.6	1.0	2.9	1.0	1.6	0.3	4.9	1.7	0.4	1.0	9.3	0.3	19.7	0.7	0.4	2.7	3.3	2.2	0.4	4.5	0.4	1.0	1.1	4.8	1.6	2.7	12.3	0.4	17.1	1.1	0.3	1.2	0.8	2.5	1.4	0.9	0.4	0.5	1.4	0.4	0.5	44.9	2.2	0.2	4.3	0.0	0.4	0.5	0.4	2.1	1.0	2.2	1.0	1.4	1.2	0.4	2.4	1.6	1.0	2.0	1.4	2.7	1.8	0.5	0.3	0.3	0.4	0.2	2.1	1.4	1.4	0.5	0.6	1.0	0.8	1.0	0.5	1.1	1.5	0.5	0.8	0.2	0.8	1.0	0.9	0.8	4.1	1.1	9.5	2.2	0.7	3.8	2.7	0.7	0.6	2.3	2.3	0.5	0.5	0.5	1.0	0.3	0.5	2.0	2.9	0.0	1.7	1.3	0.3	0.1	0.8	2.8	1.3	0.2	0.1	1.4	1.0	0.9	0.8	4.3	1.5	0.3	1.6	1.1	0.3	2.2	0.4	0.0	0.9	1.0	0.5	0.5	0.4	0.9	0.4	2.1	1.2	0.8	0.1	1.4	0.4	1.0	1.0	0.4	2.1	4.8	2.9	1.0	2.7	3.3	1.0	1.1	17.1	2.2	6.0	3.4	0.0	1.6	0.0	3.9	0.4	0.0	397.5	38.7	8.7	7.9	1.4	8.3	2.0	589.3	0.6	0.0	0.0	0.6	0.4	0.7	1.4	1.1	0.9	0.4	1.6	0.0	1.8	0.0	341.5	7.8	0.6	0.0	1.8	0.1	3.4	1.2	0.0	5.3	14.3	8.3	6.5	0.0	416.0	28.2	0.0	0.6	0.0	0.3	0.9
CFAP54	"C12orf55, C12orf63, FLJ31514, FLJ44112"	ENSG00000188596	"Cilia and flagella associated protein 54"	Q96N23	12	96489571-96875555	"Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;testis: 15.1"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 65.5;Alveolar cells type 2: 54.7;Ciliated cells: 195.4;Club cells: 78.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 16.5;pons and medulla: 30.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.8;TIME: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039897	Enhanced		Approved	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"HPA039897: AB_10674427"	"unprognostic (1.87e-4)"	"unprognostic (3.63e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.55e-5)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.00e-2)"	1.0	0.9	3.4	1.9	16.5	4.5	1.4	1.0	3.4	2.0	1.4	9.5	1.8	2.3	3.3	8.6	1.2	8.9	1.5	0.9	5.3	3.6	1.4	1.5	8.1	1.9	1.3	3.1	3.8	0.7	1.3	11.7	0.9	30.7	1.7	1.5	0.3	1.8	1.9	1.8	2.9	1.5	1.9	1.7	1.9	1.6	15.1	5.2	0.0	2.4	0.5	1.6	1.0	1.1	2.7	1.6	3.7	1.4	1.5	1.7	0.1	1.6	0.8	1.4	1.8	0.8	1.2	1.2	1.4	0.3	0.4	0.6	0.8	2.4	1.4	2.1	0.5	1.3	1.3	0.7	0.4	0.5	2.3	1.0	1.4	3.1	0.8	0.2	2.7	1.7	0.4	0.5	2.0	0.8	2.9	10.8	1.3	0.7	5.0	1.4	0.7	1.2	2.4	2.4	0.6	1.5	1.5	1.5	1.7	3.1	1.9	2.4	1.7	1.3	0.8	1.5	1.6	2.3	0.7	12.9	2.5	3.0	2.2	2.4	5.6	2.4	1.1	1.7	1.2	1.7	3.7	1.4	1.4	1.7	0.9	1.4	1.4	1.3	1.3	0.4	2.7	1.6	1.5	3.7	1.5	1.1	1.6	1.0	0.1	3.4	16.5	1.0	3.4	5.3	3.6	1.3	3.1	30.7	5.2	65.5	54.7	0.9	0.2	0.0	3.0	0.8	0.0	195.4	78.5	0.0	21.6	0.2	0.0	0.0	22.0	1.6	0.0	0.0	0.0	0.2	0.3	0.2	34.9	0.0	0.2	0.0	1.2	0.0	0.6	12.3	0.3	0.0	0.0	0.0	0.0	10.9	0.2	0.0	0.0	0.0	7.8	0.0	0.0	11.1	6.9	0.0	0.0	0.0	0.0	0.3
CFAP57	"FLJ32000, WDR65"	ENSG00000243710	"Cilia and flagella associated protein 57"	Q96MR6	1	43172149-43254358	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 25.6;testis: 29.2"	"Cell type enriched"	"Detected in some"	7	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 6.9;HDLM-2: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002736, HPA028623"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA002736: AB_2272982, HPA028623: AB_10603234"	"unprognostic (1.15e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.50e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.78e-2)"	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0.0	0.3	1.0	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0.0	1.9	0.0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1.0	0.8	0.6	0.2	0.2	0.9	1.1	1.8	1.4	1.4	0.9	1.2	0.3	1.3	2.4	0.8	6.9	0.4	0.9	2.6	4.5	0.2	0.4	0.6	0.6	0.5	0.0	0.3	0.2	1.2	1.1	0.4	1.9	2.0	0.4	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.2	0.1	0.4	1.0	0.2	3.0	0.5	1.2	0.5	1.4	0.2	1.1	0.8	1.7	0.5	3.9	0.2	1.5	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.9	0.5	1.1	0.7	1.4	2.0	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0.0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4	6.0	0.3	0.0	0.1	0.0	0.4	0.4	0.0	156.6	10.3	0.0	5.9	0.8	0.0	0.3	22.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.1	1.6	0.0	0.6	0.0	21.6	0.9	0.0	0.0	3.6	0.0	0.5	0.2	0.0	0.7	1.4	0.8	0.0	0.0	18.7	3.3	0.0	0.0	0.0	0.0	0.1
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353764-104455090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 10.9;testis: 17.5"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 104.4;Early spermatids: 40.7;Late spermatids: 47.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	55	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.2;U-2 OS: 10.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA036555, HPA071938"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.3	0.5	0.8	0.6	2.0	0.4	0.3	0.7	1.0	3.0	0.3	2.9	0.3	0.1	2.3	0.3	0.3	10.9	0.3	3.0	1.4	1.5	0.3	0.3	2.1	0.3	0.3	0.3	2.0	0.3	1.5	1.9	0.4	6.8	0.4	0.0	0.6	0.3	0.4	1.4	0.2	0.3	0.8	0.3	0.3	0.1	17.5	0.7	0.3	0.8	0.3	0.4	0.3	0.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.2	0.6	0.2	1.7	5.2	1.0	2.8	0.0	0.0	4.0	0.4	0.6	3.0	0.3	0.0	0.3	3.2	0.4	0.2	0.9	1.2	0.0	0.6	0.5	0.7	0.6	2.2	0.8	2.8	2.2	1.7	0.1	1.1	1.2	1.4	0.0	0.0	1.1	0.3	0.0	0.0	0.4	0.3	0.5	0.6	0.0	0.6	0.4	0.0	0.2	0.9	1.2	0.3	0.6	3.4	1.1	10.9	0.6	3.0	0.4	0.1	0.2	1.2	1.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	2.0	0.7	1.0	1.4	1.5	0.3	0.3	6.8	0.7	0.0	0.3	0.0	0.1	0.0	0.0	6.1	0.0	104.4	17.0	0.0	0.0	0.1	0.0	0.2	40.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.0	47.0	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	1.1	0.0	0.3	0.0	0.6	14.9	1.9	0.0	0.1	0.0	0.0	0.1
CFAP65	"CCDC108, DKFZp434O0527, MGC35338"	ENSG00000181378	"Cilia and flagella associated protein 65"	Q6ZU64	2	219002846-219041527	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 29.2;testis: 20.4"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.1"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 13.1"	"HPA055156, HPA063406"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"HPA055156: AB_2682720, HPA063406: "	"unprognostic (3.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (6.08e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.71e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.62e-3)"	"unprognostic (8.04e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.60e-2)"	0.2	0.4	1.8	0.3	6.4	0.3	0.3	0.0	2.1	2.2	0.4	5.4	0.3	0.3	0.9	6.0	0.2	29.2	0.6	0.2	2.9	3.2	0.5	0.2	3.6	0.3	0.4	1.2	4.2	0.6	0.3	6.1	0.2	16.3	0.3	0.5	2.8	0.4	0.4	0.2	0.2	0.7	0.2	0.6	0.3	0.6	20.4	2.5	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.5	0.0	1.1	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	2.4	0.1	0.0	0.0	0.0	1.2	0.0	1.5	4.0	0.0	0.1	0.7	0.6	1.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.8	6.4	0.0	2.1	2.9	3.2	0.4	1.2	16.3	2.5	0.0	3.4	0.0	0.1	0.0	0.7	0.0	7.6	53.5	12.5	0.0	11.8	0.0	0.0	0.4	163.7	0.0	0.5	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.1	0.0	28.1	0.0	0.0	138.9	0.6	0.0	0.0	0.0	25.9	0.8	1.4	0.0	0.7	0.9	20.7	0.0	0.0	15.4	4.1	0.0	0.0	0.0	3.4	0.0
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;epididymis: 17.8;fallopian tube: 35.5"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 42.8;Club cells: 11.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 27.2"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.0;naive CD4 T-cell: 1.3"	"Group enriched"	"Detected in many"	9	"B-cells: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.4;REH: 3.3;T-47d: 3.9;U-698: 13.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.3	4.3	0.5	16.9	2.0	0.3	0.5	0.9	3.1	0.3	15.3	1.0	0.5	1.0	17.8	0.6	35.5	0.4	0.2	5.8	6.1	0.6	0.2	5.7	0.9	0.2	0.9	6.8	0.3	0.7	0.9	0.2	27.2	0.3	0.3	0.0	2.2	0.9	0.5	4.5	0.6	0.2	1.1	0.5	3.9	1.5	4.7	0.0	0.5	0.5	1.3	0.4	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	3.1	6.4	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.5	0.3	2.2	0.2	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.4	0.0	0.0	1.1	0.3	1.1	0.4	1.2	0.2	3.3	0.0	0.5	0.9	0.7	0.6	0.1	0.0	0.9	0.0	0.3	3.9	0.0	0.2	0.1	1.1	0.3	0.2	0.6	0.2	13.0	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.3	16.9	0.5	0.9	5.8	6.1	0.2	0.9	27.2	4.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	42.8	11.4	3.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49665104	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;placenta: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NB-4: 15.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 7.7;pons and medulla: 8.1"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA					"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.2	0.0	0.2	0.3	5.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	1.6	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.9	0.0	0.2	10.4	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	1.1	0.2	0.4	0.2	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	1.0	0.3	0.2	0.6	1.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	1.1	15.9	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.7	0.4	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.0	0.2	0.3	0.4	0.1	0.5	0.3	1.0	0.4	0.1	0.6	0.5	0.3	0.0	0.6	0.1	1.0	0.2	0.0	0.2	5.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923080-92935293	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 577.6"	"Cell type enriched"	"Detected in many"	49	"Intestinal endocrine cells: 6314.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 97.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	134	"SCLC-21H: 44.3;SH-SY5Y: 120.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	78000000	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	2.0	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4.0	0.0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14.0	1.3	1.2	1.4	1.2	8.0	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2.0	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0.0	5.9	0.0	1.2	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.3	120.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.6	18.7	0.5	97.9	11.2	14.0	8.0	36.1	17.1	0.7	0.0	0.0	0.0	0.2	0.8	10.3	2.2	0.0	0.0	0.0	0.0	27.5	0.3	0.0	0.0	1.0	0.1	14.4	0.0	0.3	0.1	0.2	4.0	0.0	0.0	1.2	15.9	6314.9	0.0	0.0	3.6	36.8	0.0	6.8	3.6	28.7	3.2	76.4	23.0	129.0	0.0	11.3	0.0	0.3	4.9	2.2	0.0	0.2	0.0	9.0	0.1
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 59.6"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 3.5;Early spermatids: 2.2;Late spermatids: 3.1;Leydig cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.8;hypothalamus: 8.2;pons and medulla: 8.6"	"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"U-266/70: 4.1;U-266/84: 10.0;U-87 MG: 11.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.1;hypothalamus: 14.3;pons and medulla: 11.4"	"Region enriched"	"Detected in all"	6	"olfactory region: 208.8"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	2.3	1.9	0.8	2.1	6.8	0.0	1.1	0.5	0.8	0.3	2.3	0.5	4.0	1.5	0.7	1.1	1.4	0.5	0.8	3.4	1.3	8.2	4.7	0.0	0.3	0.3	1.4	0.8	0.5	0.0	0.5	2.1	1.7	8.6	8.2	3.4	1.4	0.6	1.8	1.3	2.1	0.9	0.4	2.2	12.3	0.7	59.6	1.1	0.1	0.9	4.3	1.1	1.1	1.1	0.4	0.6	0.0	0.1	0.4	4.9	0.3	0.0	0.0	1.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.1	0.0	2.5	0.2	0.4	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.6	0.1	2.1	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.3	0.0	1.1	0.9	1.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.1	10.0	0.3	11.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	4.9	0.4	0.3	0.8	0.1	0.2	0.0	1.1	0.0	0.4	0.1	0.6	1.0	0.3	0.8	6.8	0.5	0.8	1.3	8.2	1.4	0.8	8.6	1.1	0.0	0.0	0.0	0.6	3.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.2	2.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	2.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	1.1	1.7	1.9	0.5	1.0	0.0	0.3
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.7;prostate: 28.2;salivary gland: 25.3"	"Group enriched"	"Detected in some"	6	"Glandular cells: 2.0;Melanocytes: 3.3;Mucus-secreting cells: 2.1"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	10	"amygdala: 13.2;basal ganglia: 22.0;cerebral cortex: 34.7;hippocampal formation: 14.2;olfactory region: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 4.9;OE19: 15.2"	"Group enriched"	"Detected in many"	9	"amygdala: 74.1;basal ganglia: 65.6;cerebral cortex: 83.5;hippocampal formation: 100.4;olfactory region: 36.8"					"HPA014101, CAB022366"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022366: , HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.5	3.7	13.2	0.8	22.0	0.5	3.2	0.2	34.7	0.6	1.3	0.5	0.0	1.0	0.7	0.6	0.8	0.8	0.7	0.6	14.2	1.7	0.7	0.6	2.9	0.6	1.4	14.0	0.5	1.2	1.0	0.1	0.8	0.1	28.2	1.3	1.3	25.3	0.6	0.6	2.6	1.3	0.6	0.3	0.6	1.9	0.6	1.8	0.0	0.8	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	22.0	0.2	34.7	14.2	1.7	1.4	14.0	0.1	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868669-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 45.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 44.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022338, HPA029795"	Approved					NA	NA					"CAB022338: , HPA029795: AB_10601357"			"unprognostic (3.51e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.77e-2)"			"unprognostic (1.78e-2)"		"unprognostic (1.97e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.43e-2)"	"unprognostic (1.80e-1)"		"unprognostic (1.35e-3)"	0.8	0.9	3.6	7.2	1.9	0.3	0.8	0.8	6.0	0.9	8.9	0.0	0.0	0.9	0.8	0.3	0.8	0.8	25.5	35.0	0.9	0.9	0.8	1.2	1.0	0.2	0.9	2.2	0.8	0.8	0.2	0.9	1.7	15.7	5.4	3.9	0.0	0.8	0.2	0.8	0.8	3.7	32.8	5.0	0.8	2.7	2.3	1.5	0.0	0.8	0.0	0.2	14.0	1.8	0.0	0.2	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	9.2	0.1	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.2	0.0	0.0	3.6	1.9	0.8	6.0	0.9	0.9	0.9	2.2	15.7	1.5	0.0	0.0	0.0	0.0	0.0	4.9	45.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.8"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 17.2;Early spermatids: 14.2;Exocrine glandular cells: 14.9;Paneth cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 8.7"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Group enriched"	"Detected in many"	18	"monocytes: 1.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 10.2;SH-SY5Y: 32.5;U-266/70: 13.5;U-266/84: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.8	0.0	2.1	1.4	1.8	0.0	0.8	0.8	8.7	0.8	5.9	0.8	0.8	0.8	1.4	0.8	6.6	0.3	0.8	0.8	2.5	1.8	0.8	0.8	1.5	0.8	0.8	1.1	4.3	8.7	0.2	0.8	0.8	0.8	3.8	2.2	39.8	13.7	2.5	0.8	0.7	1.2	3.3	0.8	1.0	4.8	1.7	0.8	1.3	1.3	0.8	1.6	7.1	0.8	0.0	0.0	0.0	1.2	0.0	2.3	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.5	0.3	2.3	1.6	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.6	5.6	0.5	0.8	0.0	0.0	2.9	2.7	5.1	0.0	0.7	10.2	0.4	0.5	0.0	32.5	0.0	0.1	0.1	2.7	1.1	0.0	0.0	1.3	0.5	0.1	0.3	13.5	9.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	1.2	0.7	0.0	0.5	0.4	0.0	0.0	2.3	0.7	0.0	0.0	0.7	0.0	0.5	0.2	2.1	1.8	0.8	8.7	2.5	1.8	0.8	1.1	0.8	0.8	0.0	3.0	0.0	1.4	0.0	17.2	0.8	0.0	2.7	1.2	0.0	0.0	2.6	1.7	0.3	14.2	1.1	2.6	0.0	14.9	0.8	0.5	2.3	1.1	0.0	0.4	0.0	3.4	1.3	0.0	2.6	0.0	0.0	6.8	0.0	2.4	0.2	3.7	23.2	0.4	0.7	0.4	0.0	0.3	5.2	2.0	0.0	0.5	0.0	6.6	0.1
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 96.7"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 1.6;Melanocytes: 1.7;T-cells: 1.8"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Cell type enriched"	"Detected in single"	27	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	18	"LHCN-M2: 89.4;RH-30: 73.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	4.5	0.0	0.5	0.5	0.1	0.0	0.6	0.0	0.4	0.7	1.7	0.0	0.1	0.2	0.0	4.6	1.2	0.0	0.0	0.3	2.0	0.1	0.0	0.2	0.7	0.9	0.1	0.0	0.0	0.0	0.0	12.1	0.2	0.0	2.4	1.0	0.0	1.5	0.0	96.7	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.5	0.0	4.5	1.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	89.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.1	0.0	0.4	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1"	"Cell type enriched"	"Detected in some"	18	"Cone photoreceptor cells: 155.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 86.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced					NA	NA					"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.4	33.6	0.8	4.0	2.4	0.1	0.3	6.0	0.4	0.5	8.2	0.7	0.2	1.2	0.5	0.1	0.5	0.1	0.8	0.4	0.2	0.8	0.1	0.1	0.3	2.8	0.4	0.0	0.1	0.2	0.1	1.5	0.2	1.2	0.6	3.4	74.1	0.2	0.6	0.1	0.6	2.9	2.8	0.2	0.2	3.6	0.9	0.5	57.2	0.2	0.2	0.7	0.8	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	16.4	86.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.4	6.0	0.4	0.2	0.8	0.4	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	4.2	0.6	0.0	0.0	0.0	0.0	155.1	0.0	1.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.7	2.5	0.1	0.0	0.0	0.0	8.5	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.1
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335329-40355217	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;fallopian tube: 3.9;pituitary gland: 4.6;salivary gland: 2.7;skin 1: 2.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"glioma: 3.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 19.2"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.2	4.6	0.7	2.6	0.0	0.0	0.0	2.7	0.0	0.0	2.7	0.0	0.0	3.3	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.5	0.0	0.3	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.0	1.4	0.2	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNB3		ENSG00000147432	"Cholinergic receptor nicotinic beta 3 subunit"	Q05901	8	42697376-42737407	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.6;pancreas: 6.8;testis: 5.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 19.6;midbrain: 8.2"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.5;T-reg: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Group enriched"	"Detected in some"	6	"NTERA-2: 3.3;U-266/84: 7.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	32	"cerebellum: 21.0;midbrain: 30.4"	HPA045555	Enhanced					NA	NA					"HPA045555: AB_10960891"					"unprognostic (8.63e-2)"						"unprognostic (4.12e-1)"			"unprognostic (7.29e-2)"	"unprognostic (1.62e-1)"			0.1	0.1	0.3	0.1	0.8	0.1	0.1	19.6	2.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.4	0.1	0.1	0.1	0.8	8.2	2.3	0.1	6.8	0.1	0.9	0.1	1.1	0.1	0.1	3.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.8	19.6	2.7	0.4	0.4	8.2	2.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
CIDEA	CIDE-A	ENSG00000176194	"Cell death-inducing DFFA-like effector a"	O60543	18	12254319-12277595	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 79.9;breast: 32.6"	"Cell type enhanced"	"Detected in some"	15	"Late spermatids: 2.7;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.7;cerebral cortex: 1.9;olfactory region: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"hTEC/SVTERT24-B: 5.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 12.2"							NA	NA						"unprognostic (2.96e-2)"	"unprognostic (2.43e-2)"			"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"		"unprognostic (8.93e-3)"	"unprognostic (3.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.72e-2)"			"unprognostic (1.91e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.96e-1)"	79.9	1.5	0.1	5.8	1.7	0.2	32.6	0.0	1.9	1.1	8.0	0.0	0.6	0.2	0.2	0.2	2.1	0.2	4.9	2.4	0.2	0.0	0.2	0.3	0.2	0.3	0.1	1.5	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.5	0.0	2.1	0.3	1.0	3.0	0.8	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.3	3.4	0.3	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.9	0.2	0.0	0.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.9	0.0	0.0	0.0	0.4
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 13.8;Late spermatids: 28.3;Sertoli cells: 12.9"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"AN3-CA: 17.9;SK-MEL-30: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (6.10e-4)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.9	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	6.4	0.4	0.0	1.8	2.5	0.3	0.2	0.0	0.0	0.1	3.5	0.3	0.2	0.2	0.3	0.0	0.0	0.1	0.7	0.1	0.1	0.2	0.0	1.4	1.0	0.1	1.2	0.0	1.2	0.9	0.0	0.2	8.1	4.2	0.1	1.6	71.3	0.1	0.5	0.4	0.0	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0	0.0	0.0	0.0	1.0	0.1	3.2	0.3	2.5	0.0	0.0	3.5	5.9	0.1	0.0	0.0	13.8	0.2	0.1	0.0	0.7	0.0	0.2	8.6	0.0	0.0	0.1	0.0	1.2	0.0	0.0	28.3	6.9	0.0	3.3	0.0	0.1	0.8	0.4	7.2	2.8	0.3	3.5	12.9	0.3	6.8	3.7	0.0	0.0	0.0	0.1	0.9
CLCNKA	hClC-Ka	ENSG00000186510	"Chloride voltage-gated channel Ka"	P51800	1	16018875-16034050	"Disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.9;parathyroid gland: 15.4"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 171.7"	"Group enriched"	"Detected in some"	7	"renal cancer: 4.4;thyroid cancer: 1.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 13.0"									HPA057717	Approved					NA	NA					"HPA057717: AB_2683509"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.28e-1)"	0.2	0.7	0.2	0.2	0.2	0.0	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	46.9	0.2	0.2	0.2	0.2	0.2	0.2	1.2	15.4	5.8	0.2	0.2	0.2	0.0	0.2	4.4	0.2	0.2	0.0	0.2	0.2	0.2	0.2	1.6	1.1	0.2	0.2	6.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.4	3.1	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.3	0.0	0.0	0.1	0.6	3.5	0.0	0.0	1.2	24.4	0.0	0.4	21.6	0.1	38.8	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.1	12.7	1.2	0.0	0.0	171.7	0.3	0.0	1.7	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.7	0.7	0.0	0.6	0.0	0.0	0.1
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 58.4;salivary gland: 25.7"	"Group enriched"	"Detected in some"	10	"Collecting duct cells: 22.7;Distal tubular cells: 49.7;Early spermatids: 20.7;Late spermatids: 76.4"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;CAPAN-2: 2.2;EFO-21: 5.1;HeLa: 3.1;K-562: 2.0;SuSa: 2.1"									HPA057717	Approved					NA	NA					"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.1	0.5	0.2	0.1	0.2	0.0	0.1	2.8	0.2	0.7	0.1	0.1	2.2	0.0	0.5	0.5	0.1	0.1	0.4	1.2	0.1	0.1	58.4	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.9	0.8	0.4	0.3	0.5	0.0	1.2	25.7	0.7	0.1	0.0	0.2	0.3	0.5	0.1	0.1	0.7	0.1	0.1	11.5	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	2.2	0.0	5.1	0.7	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	3.1	0.1	0.6	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	1.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.1	2.1	0.4	0.8	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.8	0.2	0.1	0.1	0.1	0.1	0.3	0.1	3.0	1.1	0.0	0.0	0.0	0.5	4.3	0.0	1.4	2.3	22.7	0.0	0.3	49.7	0.5	20.7	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	76.4	0.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.1	0.2	0.0	0.0	0.1	1.4	0.6	0.0	0.5	0.0	0.6	0.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 192.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4"	"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	1.2	12.2	0.0	9.1	28.2	0.0	0.0	0.0	0.0	0.0	0.0	192.3	0.2	0.1	0.0	0.0	4.4	0.0	0.0	0.6	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Cell type enhanced"	"Detected in some"	21	"Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 81.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	13.3	67.3	0.0	0.0	1.0	0.0	42.5	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	2.8	0.1	0.9	28.7	2.9	0.0	138.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 2133.6;Mucus-secreting cells: 1109.4;Paneth cells: 1932.3;Undifferentiated cells: 955.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;MCF7: 66.5;PC-3: 14.2;RPMI-8226: 11.4;SCLC-21H: 17.6;T-47d: 31.6"	"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA		15000	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	10.6	0.0	3.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.1	0.3	0.6	2.6	14.2	0.0	0.0	11.4	0.6	0.0	17.6	0.2	0.0	10.1	0.0	0.0	31.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0	35.7	34.4	4.2	34.2	0.1	0.7	0.5	206.4	104.4	48.9	120.4	3.9	47.1	8.3	212.5	0.0	0.0	2133.6	23.3	15.9	8.6	0.5	498.9	28.7	32.7	4.3	0.0	581.8	0.0	0.0	0.0	2.3	0.9	10.1	3.6	1109.4	10.8	59.3	1932.3	0.0	42.3	8.5	0.0	0.4	0.0	0.0	0.0	60.5	2.9	955.0	455.4
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Cell type enhanced"	"Detected in some"	12	"Cholangiocytes: 10.2;Ductal cells: 8.3;Pancreatic endocrine cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.7;MCF7: 19.5;SCLC-21H: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.3	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	19.5	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.1	15.3	0.1	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3	0.0	0.0	0.0	1.8	0.1	1.4	0.3	10.2	2.7	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.7	0.0	0.0	0.1	0.0	1.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	5.9	1.1	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.4	0.9	0.0	0.2	1.7
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728957-7733906	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 63.1;lymphoid tissue: 53.5"	"Cell type enriched"	"Detected in some"	13	"Ito cells: 979.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.8"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 13.9;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	19	"B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.3;RT4: 1.2;TIME: 2.7;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003789, HPA014044"	Enhanced					NA	NA					"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	11.2	0.1	0.9	1.5	1.2	0.9	2.6	11.8	1.6	0.2	1.5	0.2	0.2	0.4	0.2	1.3	5.2	2.7	1.0	7.3	2.6	1.0	0.3	63.1	0.5	53.5	0.8	0.2	0.5	0.8	0.0	0.2	0.8	0.2	0.8	0.7	0.3	4.9	0.5	0.2	0.4	0.7	0.7	0.2	1.3	0.3	0.7	0.2	0.3	0.5	0.6	0.2	2.0	0.6	4.1	11.9	0.5	13.9	0.4	0.1	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.3	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.7	2.7	0.0	0.1	0.7	0.0	0.1	0.0	0.3	0.0	2.2	0.1	0.0	13.9	0.0	0.0	3.3	0.0	0.3	0.0	0.0	11.9	4.1	0.1	0.0	0.5	0.4	0.4	0.6	0.0	2.8	0.9	1.2	11.8	1.6	2.6	1.0	0.8	0.2	0.2	0.2	0.0	0.0	9.3	0.0	0.1	0.0	0.4	7.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.7	0.0	0.0	979.0	76.3	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.2	0.0	0.0	0.0
CLIC6	"CLIC1L, CLIC5"	ENSG00000159212	"Chloride intracellular channel 6"	Q96NY7	21	34669389-34718227	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.3;retina: 85.1;stomach 1: 45.1"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 30.6;Ciliated cells: 72.3;Club cells: 52.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 63.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;NTERA-2: 5.9;T-47d: 12.0;THP-1: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065285	Enhanced					NA	NA					"HPA065285: AB_2685454"	"prognostic favorable (6.11e-5)"	"unprognostic (2.17e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (3.15e-5)"	"unprognostic (4.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-3)"	7.7	0.0	0.8	3.0	1.7	0.0	5.7	0.6	2.3	8.7	1.8	12.4	0.6	0.9	1.0	5.2	1.2	6.1	4.5	6.3	5.4	1.0	0.9	0.6	6.4	0.4	0.4	0.5	2.3	1.2	0.0	1.3	0.6	63.3	4.0	1.3	85.1	10.9	3.8	1.9	2.3	1.1	1.9	0.6	0.7	45.1	1.1	0.6	2.4	8.2	0.9	1.8	7.5	2.0	0.3	0.1	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.4	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	1.7	12.0	5.3	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.1	0.8	1.7	0.6	2.3	5.4	1.0	0.4	0.5	63.3	0.6	6.0	20.2	0.0	4.6	0.6	0.0	5.3	30.6	72.3	52.4	8.7	0.0	0.0	1.7	6.3	0.0	0.0	0.2	0.0	0.8	0.0	3.8	9.0	1.1	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.3	0.0	6.8	1.0	1.0	0.0	15.9	0.0	2.8	0.0	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	3.3	13.7
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell type enriched"	"Detected in some"	15	"Proximal tubular cells: 679.1"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.1	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.7	0.0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	6.5	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.5	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	26.2	0.0	1.9	46.4	19.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	679.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CNPY1		ENSG00000146910	"Canopy FGF signaling regulator 1"	Q3B7I2	7	155474206-155555450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"brain: 21.1;pancreas: 8.5"	"Cell type enriched"	"Detected in single"	17	"Spermatogonia: 4.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.6"	"Region enriched"	"Detected in some"	17	"cerebellum: 21.1"	"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"AF22: 26.6"	"Region enriched"	"Detected in single"	29	"cerebellum: 215.6"					HPA047400	Uncertain					NA	NA					"HPA047400: AB_10960413"					"unprognostic (4.28e-3)"	"unprognostic (2.12e-1)"					"unprognostic (4.18e-2)"		"unprognostic (8.27e-12)"	"unprognostic (1.44e-1)"	"unprognostic (2.16e-1)"			0.1	0.0	0.2	0.1	0.3	0.7	0.1	21.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.9	0.1	0.2	8.5	0.0	0.2	0.1	1.2	0.1	0.1	0.5	0.2	0.1	0.1	1.2	0.5	0.1	0.5	0.1	0.2	2.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	21.1	0.5	0.2	0.2	0.9	0.1	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.0	0.0	0.0
CNTD2	"CCNP, FLJ13265"	ENSG00000105219	"Cyclin N-terminal domain containing 2"	Q9H8S5	19	40222208-40226697	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 8.0;brain: 12.0;liver: 7.9"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 8.7;Early spermatids: 3.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 12.0"	"Cell type enriched"	"Detected in single"	81	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	81	"granulocytes: 8.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.8;Karpas-707: 1.4;SCLC-21H: 6.7;T-47d: 1.5"					"Low region specificity"	"Detected in single"			HPA045615	Uncertain					NA	NA					"HPA045615: AB_2679390"	"unprognostic (1.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.79e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.43e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	3.9	1.0	0.7	0.1	1.2	0.3	1.4	12.0	1.8	1.0	0.2	0.4	0.0	0.4	0.3	2.1	0.1	1.9	0.7	1.5	1.1	0.8	5.6	7.9	0.3	0.2	0.5	0.0	0.4	0.1	0.1	3.5	2.8	1.3	1.5	0.5	0.4	0.4	0.3	0.7	0.6	0.6	0.4	0.8	0.6	0.7	1.0	0.0	0.0	1.4	0.7	0.1	0.2	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.9	0.7	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	1.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.2	1.1	0.4	0.1	0.0	0.2	0.1	0.0	6.7	0.4	0.6	0.0	0.7	0.3	1.5	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.4	0.0	0.3	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	12.0	1.8	1.1	0.8	0.5	0.0	1.3	0.0	0.0	0.0	0.5	0.1	2.1	1.9	1.4	0.0	1.4	0.0	8.7	0.0	0.5	0.0	0.1	3.9	0.4	0.9	0.0	0.5	0.0	0.2	0.3	1.1	0.8	0.2	1.6	0.0	0.6	0.3	1.0	0.9	0.0	1.7	0.0	0.1	2.4	0.3	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	2.5	3.2	0.0	0.5	0.1
CNTF	HCNTF	ENSG00000242689	"Ciliary neurotrophic factor"	P26441	11	58622673-58625733	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell type enriched"	"Detected in single"	5	"Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"midbrain: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 12.9"	"Low region specificity"	"Detected in many"							HPA019654	Approved		Approved	Vesicles		NA	NA	69200		Vesicles		"HPA019654: AB_1859050"	"unprognostic (1.88e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-4)"	"unprognostic (5.42e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.67e-2)"	2.0	0.7	1.4	0.9	4.8	10.0	0.8	1.2	1.6	0.3	0.9	2.5	1.1	1.4	0.3	1.4	0.9	8.3	0.8	2.5	1.8	1.6	0.9	0.9	0.8	0.6	47.5	0.9	0.3	0.5	1.2	0.5	0.6	9.3	0.6	1.3	3.1	1.3	0.4	3.7	0.9	0.9	0.6	22.8	0.6	0.5	0.7	1.2	0.2	1.0	3.7	0.6	0.6	0.3	0.4	0.0	0.0	0.3	0.0	0.7	0.2	2.1	0.8	3.4	3.6	1.1	0.3	1.7	1.6	2.2	1.6	1.2	3.0	3.0	4.4	1.2	2.2	1.8	3.9	3.7	3.9	3.3	3.1	2.1	2.3	4.4	1.6	0.4	3.4	4.3	1.0	1.4	5.3	1.7	0.7	1.7	3.1	3.4	1.0	2.0	0.9	3.3	3.2	2.1	1.5	1.6	2.2	2.4	3.0	1.9	2.5	1.6	4.3	2.3	2.4	5.9	2.6	3.0	2.5	1.2	2.5	2.0	12.9	4.0	2.4	5.0	3.8	6.7	1.7	2.9	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	1.2	1.4	1.8	1.6	47.5	0.9	9.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CNTN6	NB-3	ENSG00000134115	"Contactin 6"	Q9UQ52	3	1092576-1404217	"Predicted membrane proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 41.4;thyroid gland: 18.9"	"Cell type enriched"	"Detected in some"	6	"Alveolar cells type 1: 32.8"	"Group enriched"	"Detected in some"	15	"renal cancer: 2.7;thyroid cancer: 3.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 41.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"AF22: 5.1;GAMG: 2.4;SH-SY5Y: 5.9;SuSa: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016645	Uncertain					NA	NA		2100000			"HPA016645: AB_1847149"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"		"unprognostic (2.27e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-2)"	0.2	4.7	1.6	0.2	2.2	0.2	0.4	41.4	6.3	0.3	0.3	0.1	0.0	0.2	0.3	0.8	0.3	0.4	0.2	0.4	1.5	3.0	0.5	0.2	5.6	0.2	2.4	2.6	0.2	0.3	0.2	0.5	3.4	7.8	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	1.7	0.2	0.2	0.4	0.3	0.0	18.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	41.4	6.3	1.5	3.0	2.4	2.6	7.8	0.3	32.8	2.2	0.0	0.0	0.0	2.6	0.4	0.0	1.4	5.7	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell type enhanced"	"Detected in many"	12	"Exocrine glandular cells: 52.5;Horizontal cells: 79.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.6;Hep G2: 20.0;K-562: 39.4;NB-4: 32.7;SCLC-21H: 36.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.2	1.0	0.0	0.2	0.0	7.0	0.0	0.0	2.1	5.6	6.6	0.4	0.1	0.5	0.0	0.4	0.0	7.1	0.0	3.5	0.0	30.6	5.6	2.6	20.0	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.0	0.1	12.7	39.4	1.6	0.5	0.2	2.8	32.7	3.8	0.0	1.2	8.3	0.0	0.2	0.3	1.0	36.3	9.8	0.8	0.1	0.0	4.1	0.0	15.3	0.2	0.0	0.0	0.1	0.0	1.8	4.8	3.5	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9	0.0	0.3	11.3	1.6	16.9	1.9	0.4	2.5	0.0	1.2	0.0	3.9	3.9	1.7	0.4	1.3	2.1	0.2	0.0	52.5	9.8	3.8	3.0	1.1	3.9	3.1	79.4	16.4	4.3	8.6	1.3	1.4	1.5	18.6	4.6	0.0	14.5	5.7	0.0	5.6	7.9	3.9	0.0	15.6	3.9	6.6	11.8	5.5	2.9	0.4	1.0
COL13A1		ENSG00000197467	"Collagen type XIII alpha 1 chain"	Q5TAT6	10	69801867-69964275	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Osteogenesis"	"Developmental protein, Heparin-binding"	"Congenital myasthenic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.6;epididymis: 22.3"	"Cell type enhanced"	"Detected in some"	21	"Fibroblasts: 4.1;granulocytes: 19.7;Melanocytes: 5.0;Smooth muscle cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	18	"cerebellum: 54.6"	"Group enriched"	"Detected in some"	18	"gdT-cell: 1.9;NK-cell: 1.9"	"Group enriched"	"Detected in many"	18	"NK-cells: 1.9;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 19.6;BJ hTERT+: 18.2;hTERT-RPE1: 25.5;HUVEC TERT2: 31.8;PC-3: 29.2;TIME: 45.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050392	Approved					NA	NA					"HPA050392: AB_2681110"	"unprognostic (2.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.93e-2)"	0.7	1.2	0.5	3.3	1.0	0.0	1.3	54.6	1.3	3.5	3.1	0.6	4.3	1.8	1.4	22.3	1.3	2.0	2.7	2.7	0.6	0.5	1.3	0.5	8.2	0.7	0.9	0.7	1.1	1.2	0.9	2.7	0.9	3.0	10.7	2.3	3.8	1.0	6.2	2.7	3.1	2.9	2.0	1.7	5.0	3.9	0.9	0.7	0.3	1.0	1.1	0.6	2.2	1.2	0.0	0.0	0.1	0.0	1.9	1.9	0.4	0.4	0.1	7.0	0.0	0.0	1.3	0.0	19.6	18.2	3.3	1.6	0.0	0.4	0.0	3.3	8.7	0.3	0.7	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	2.8	0.0	8.3	2.6	25.5	31.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	29.2	0.0	0.0	3.5	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.2	0.0	0.0	45.4	0.1	5.4	1.7	14.9	4.3	0.0	0.0	11.6	0.0	16.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.4	0.5	1.0	54.6	1.3	0.6	0.5	0.9	0.7	3.0	0.7	0.0	1.1	0.0	0.3	3.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	4.1	0.3	19.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	5.2	0.5	0.5	2.6	0.1	0.0	0.0	0.1
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell type enriched"	"Detected in some"	5	"B-cells: 16.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.7;RH-30: 14.5;SCLC-21H: 4.1;SK-MEL-30: 12.2;WM-115: 10.2"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.5	0.0	0.0	0.0	4.1	3.0	0.0	0.0	12.2	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0	0.0	0.0	16.7	0.2	0.1	2.8	2.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.9	1.7	0.9	0.0	0.0	0.0	0.0	0.1
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.2	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1	0.0	0.0	0.0	2.8	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	30.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	26.2	2.1	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.8	0.0	0.0	0.0	0.0	1.3
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155560-114312511	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9;cervix, uterine: 41.9"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 73.9;Extravillous trophoblasts: 60.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 56.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.2;Hep G2: 25.5"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	23	"cerebellum: 141.7"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	4.7	4.2	6.0	4.2	4.6	0.1	4.1	56.9	5.7	41.9	4.4	2.6	5.7	2.9	25.9	17.0	3.6	6.4	6.3	3.3	4.9	1.7	11.0	16.5	4.4	2.9	5.8	1.8	13.1	12.9	0.7	2.2	9.0	8.6	9.8	1.0	9.6	4.1	11.3	4.0	11.9	3.5	8.4	7.3	3.0	9.7	2.7	5.1	2.8	6.1	5.2	3.2	5.7	17.9	0.9	0.4	2.0	0.2	0.5	0.3	0.1	2.0	4.1	9.8	3.5	0.7	1.1	30.2	4.7	3.2	3.4	2.9	4.3	0.1	0.0	1.2	2.3	2.6	4.9	3.3	4.4	1.9	0.0	0.4	0.0	3.4	25.5	1.0	0.0	10.9	2.7	1.2	4.2	1.9	1.9	5.1	4.0	0.0	1.0	1.9	0.9	0.0	1.8	3.5	8.0	1.1	13.6	9.9	1.9	8.1	2.2	0.1	0.1	0.2	0.1	0.5	3.9	0.9	3.1	4.7	3.0	6.1	0.4	7.3	0.5	0.0	0.0	2.5	0.0	4.6	0.6	0.2	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.1	0.9	0.3	0.2	2.0	0.5	0.1	0.4	0.2	0.1	6.0	4.6	56.9	5.7	4.9	1.7	5.8	1.8	8.6	5.1	3.0	16.5	1.5	4.6	24.2	0.6	24.9	73.9	0.0	6.8	8.7	5.9	0.7	3.3	9.2	1.1	3.6	0.0	0.0	4.3	60.6	14.4	5.3	0.0	35.8	5.2	1.6	4.6	6.2	1.0	0.9	17.8	0.6	21.9	0.0	1.6	6.1	5.4	0.8	4.2	5.7	1.0	25.8	35.4	0.2	1.9	19.6	1.9	0.0	2.2	1.6
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Group enriched"	"Detected in some"	5	"BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.2	1.5	1.0	17.3	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.3	0.1	0.2	0.3	0.4	0.5	5.6	1.2	0.6	0.7	0.2	0.2	0.4	1.2	0.8	0.4	0.8	0.3	0.8	0.3	1.5	0.0	0.6	0.8	0.3	0.6	1.8	0.2	0.0	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.8	0.2	0.1	0.4	1.9	1.2	0.8	0.1	0.2	1.1	1.9	0.6	1.7	1.5	0.1	0.1	8.7	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4	0.0	1.1	0.0	0.1	0.2	0.3	0.7	0.0	6.7	2.3	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.8	0.2	6.4	1.2	2.5	0.0	11.3	1.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	4.2	0.0	0.6	0.0	0.2	0.7	0.2	0.1	1.9	1.3	0.0	0.0
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791314	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cell adhesion"	Heparin-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.1;skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 32.0;Fibroblasts: 20.3;Late spermatids: 53.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 138.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		1100000000	"Golgi apparatus"		"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (9.08e-5)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (6.95e-4)"	39.1	0.2	0.0	1.0	0.0	0.0	4.1	1.8	0.2	2.7	2.0	0.1	2.5	0.0	3.0	24.2	4.7	0.4	16.2	21.6	0.2	0.0	4.5	0.4	2.9	2.7	0.0	0.6	0.9	3.3	0.1	0.1	8.2	0.2	8.7	0.0	0.1	6.0	7.4	59.6	31.8	0.3	13.0	0.2	0.1	0.9	11.5	0.0	0.3	8.9	27.6	0.9	10.8	11.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	138.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.0	0.6	0.2	0.0	3.0	0.3	0.0	0.5	10.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.0	0.7	0.0	0.0	0.2	0.2	20.3	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	53.4	0.9	0.0	10.1	0.0	0.0	1.8	0.1	0.0	0.7	0.0	0.3	6.5	6.4	3.1	1.5	6.1	0.5	0.0	0.0	0.3
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 50.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 32.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.5	32.6	0.0	1.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	6.9	0.0	0.2	3.4	0.8	50.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.8	4.4	0.0	5.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.1	0.0	4.2	3.0	4.6	2.4	0.0	0.0	0.0	0.2
CPLX4	CPX-IV	ENSG00000166569	"Complexin 4"	Q7Z7G2	18	59275156-59318649	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 61.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 55.6;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 128.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 6.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047627	Enhanced					NA	NA					"HPA047627: "					"unprognostic (1.85e-1)"		"unprognostic (4.46e-1)"			"unprognostic (4.20e-2)"		"unprognostic (4.05e-2)"		"unprognostic (9.90e-3)"				0.1	0.3	0.2	0.0	0.1	2.8	0.1	6.3	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.1	0.0	61.9	0.3	0.0	0.3	1.9	0.1	0.0	0.2	0.3	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.6	0.7	1.7	0.3	0.8	0.7	0.1	0.2	0.8	0.5	0.8	0.7	0.2	0.9	0.9	0.0	0.1	0.0	0.3	0.6	0.5	0.1	0.2	0.2	1.1	0.2	0.0	1.2	0.3	0.0	0.2	1.6	0.9	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.7	0.7	0.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.2	0.0	0.9	0.0	0.6	0.1	0.3	0.6	0.6	0.2	0.9	0.0	0.8	0.4	0.4	0.1	0.2	0.7	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.4	0.3	0.0	0.6	0.2	0.7	1.7	0.8	0.1	0.7	0.2	0.1	0.2	0.1	6.3	0.1	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	55.6	0.3	0.0	0.0	0.0	0.0	106.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36840002	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;brain: 50.3;heart muscle: 28.6"	"Cell type enhanced"	"Detected in many"	16	"B-cells: 43.6;Cardiomyocytes: 20.4;granulocytes: 11.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.3"	"Group enriched"	"Detected in some"	82	"memory B-cell: 27.1;naive B-cell: 12.9"	"Lineage enriched"	"Detected in single"	111	"B-cells: 27.1"	"Group enriched"	"Detected in some"	4	"Daudi: 33.0;HUVEC TERT2: 13.6;U-266/70: 11.4;U-266/84: 9.1;U-698: 15.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 100.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 166.9"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	1.8	1.1	8.1	12.5	50.3	1.1	1.7	1.9	49.4	1.8	4.2	1.3	0.0	3.9	3.7	1.0	1.8	11.3	1.7	28.6	3.7	4.9	1.3	0.5	1.5	14.3	3.6	12.8	2.3	1.0	0.8	3.6	1.3	3.3	2.9	3.6	4.1	2.0	2.2	0.5	1.0	2.9	3.6	3.0	7.1	3.4	11.8	6.2	0.1	1.4	0.0	20.3	5.5	1.9	27.1	0.1	0.2	0.1	0.0	0.1	2.2	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.1	33.0	0.3	0.4	1.6	0.3	0.1	0.2	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	2.4	13.6	0.1	0.1	0.9	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.6	0.1	0.0	0.5	3.1	0.2	0.4	0.0	1.3	11.4	9.1	15.5	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.1	0.1	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	2.2	8.1	50.3	1.9	20.4	3.7	4.9	3.6	12.8	3.3	6.2	0.0	5.1	43.6	0.1	0.6	9.8	20.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.9	2.8	5.1	0.0	0.2	0.0	0.6	0.2	11.6	0.4	0.4	0.0	4.1	3.7	1.5	3.5	0.0	0.2	3.3	0.0	0.8	1.0	0.2	10.5	0.4	0.0	1.1	0.0	0.3	0.6	1.4	0.1	0.0	0.5	1.5	0.1
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703807-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 46.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 13.5;Late spermatids: 33.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.6"	"Group enriched"	"Detected in all"	4	"cerebellum: 26.6;cerebral cortex: 17.0;pons and medulla: 46.9"	"Group enriched"	"Detected in some"	7	"classical monocyte: 1.2;intermediate monocyte: 3.5;non-classical monocyte: 2.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	25	"dendritic cells: 1.4;monocytes: 3.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.9;U-937: 5.3"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.7	1.4	1.7	0.8	3.1	2.8	0.6	26.6	18.2	0.7	0.8	2.3	0.0	1.1	0.7	0.5	0.6	0.6	0.8	0.4	1.9	7.2	0.8	0.6	1.1	1.0	7.0	5.1	0.6	0.5	0.4	3.4	0.7	46.9	0.5	0.8	0.3	0.8	1.0	0.4	4.2	1.1	0.8	2.3	0.9	0.7	3.0	1.4	0.0	0.4	0.0	0.7	0.8	0.1	0.0	1.4	0.0	3.5	0.0	0.0	0.4	0.1	0.9	0.2	0.0	0.9	0.2	1.0	0.3	0.3	0.1	0.0	0.1	0.3	5.9	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.5	1.8	0.6	0.1	0.0	0.7	0.8	0.9	0.0	0.7	0.3	0.0	0.3	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.7	0.1	0.1	0.0	0.5	0.0	0.7	1.6	1.3	0.1	0.0	0.6	1.2	2.0	2.4	0.0	0.0	0.2	0.8	0.1	0.3	1.8	1.2	0.8	5.3	0.4	0.0	1.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.4	1.7	3.1	26.6	17.0	1.9	7.2	7.0	5.1	46.9	1.4	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.3	33.6	0.0	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.9	0.4	0.0	0.0	0.0	0.0
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 85.6;Late spermatids: 150.5;Peritubular cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 9.8;fHDF/TERT166: 38.3;SuSa: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA					"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	17.0	4.1	0.8	5.0	2.1	0.1	12.3	1.3	1.6	6.4	40.9	6.7	5.7	3.8	12.2	37.8	20.0	9.1	9.4	14.3	1.7	4.0	6.6	1.5	4.6	3.7	6.1	0.7	12.8	3.2	1.9	7.1	11.6	16.9	14.7	4.5	26.5	5.6	8.3	5.0	4.5	9.1	45.5	21.6	13.8	14.4	7.7	3.4	2.6	9.5	11.9	4.0	32.5	20.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	2.1	1.3	1.6	1.7	4.0	6.1	0.7	16.9	3.4	0.0	1.1	0.0	0.0	1.9	0.0	1.4	0.0	0.0	0.0	1.8	0.0	6.6	1.7	0.1	85.6	13.5	0.0	0.0	0.2	0.2	2.3	0.0	0.0	0.0	0.3	1.6	0.0	13.5	0.0	150.5	10.0	0.0	3.3	0.0	0.5	0.0	0.2	0.0	74.3	0.0	0.0	0.0	2.8	1.1	1.9	1.8	4.2	0.0	1.1	0.0
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176382-66178725	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 209.9"	"Cell type enriched"	"Detected in some"	6	"Syncytiotrophoblasts: 134.3"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 1.4;SuSa: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10000									"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0.0	6.7	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.1	0.0	6.7	2.7	28.4	0.4	1.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	134.3	0.0	0.0	0.1
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76952713-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;liver: 99.9"	"Cell type enriched"	"Detected in some"	15	"Ito cells: 1768.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 24.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 5.0;BJ hTERT+ SV40 Large T+ RasG12V: 4.9;HBF TERT88: 8.9;RPMI-8226: 3.0;U-698: 9.7;U-87 MG: 5.4;WM-115: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	NA	NA		43000000			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0.0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4.0	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0.0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0.0	1.9	0.9	0.4	0.5	0.2	0.0	0.0	1.2	0.1	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	5.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	2.6	0.0	0.1	0.0	9.7	5.4	0.0	4.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	3.5	5.4	0.0	7.8	4.0	24.9	2.7	5.4	1.8	1.2	0.0	0.0	23.4	0.0	0.3	0.0	0.6	22.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	18.4	0.0	0.0	0.2	0.3	0.4	0.0	0.0	4.9	1.6	0.0	0.0	1768.4	116.1	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.3	0.0	0.0
CROCC2		ENSG00000226321	"Ciliary rootlet coiled-coil, rootletin family member 2"	H7BZ55	2	240906330-240993311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 9.5;epididymis: 19.4;fallopian tube: 14.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 6.5;Ciliated cells: 24.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;hippocampal formation: 4.2;pons and medulla: 9.5"	"Group enriched"	"Detected in some"	18	"intermediate monocyte: 1.1;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	26	"monocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.0;HDLM-2: 2.3;Hep G2: 1.2;HSkMC: 2.8;Karpas-707: 1.0;RPMI-8226: 7.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA048678	Enhanced					NA	NA					"HPA048678: AB_2680491"	"unprognostic (4.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.68e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.75e-4)"	"unprognostic (2.84e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.90e-3)"	"unprognostic (7.19e-2)"	0.2	0.1	0.6	0.3	5.0	0.2	0.0	0.0	0.1	2.4	0.1	3.8	0.0	0.5	0.4	19.4	0.0	14.9	0.1	0.0	4.2	1.4	0.1	0.5	2.3	1.4	0.0	0.0	3.2	0.1	0.0	2.1	0.1	9.5	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.8	0.1	0.0	4.7	0.3	0.4	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.6	5.0	0.0	0.1	4.2	1.4	0.0	0.0	9.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	24.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.6	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872639	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 140.8"	"Cell type enhanced"	"Detected in some"	25	"Hofbauer cells: 6.2;Kupffer cells: 9.1;Macrophages: 7.2;T-cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	24	"cerebellum: 140.8"	"Cell type enhanced"	"Detected in many"		"NK-cell: 25.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 25.7;T-cells: 16.7"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 17.4"	"Region enriched"	"Detected in single"	44	"cerebellum: 115.2"	"Low region specificity"	"Detected in all"									NA	NA		3200000				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.4	0.3	0.3	2.7	0.4	1.9	0.4	140.8	0.4	0.3	0.4	0.2	0.1	0.4	0.8	0.4	0.3	0.3	1.8	0.3	0.3	0.3	0.3	1.0	2.2	10.6	0.4	0.1	0.3	0.3	0.0	0.3	0.2	5.8	0.3	0.5	0.3	0.7	0.1	0.3	0.3	1.3	0.2	1.2	4.4	0.7	0.3	0.1	3.3	0.3	0.2	4.3	1.1	0.3	0.1	1.7	0.6	4.4	25.7	16.7	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.2	6.7	2.7	6.5	0.0	0.7	13.5	1.7	0.1	2.2	16.7	0.6	25.7	4.4	0.1	0.0	2.8	0.3	0.4	140.8	0.4	0.3	0.3	0.4	0.1	5.8	0.1	0.0	1.4	0.0	0.4	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.1	0.0	6.2	0.0	0.0	0.6	9.1	0.6	0.0	7.2	3.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.6	0.1	34.1	0.0	0.3
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246863-29254494	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5"	"Cell type enhanced"	"Detected in single"	33	"Syncytiotrophoblasts: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"AF22: 6.8;BEWO: 8.8;SuSa: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022016	Supported					NA	NA					"HPA022016: AB_2732426"	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	1.5	0.3	1.4	0.0	0.0	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.6	0.0	0.0	0.0	1.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.4	0.0	0.7	0.1	0.0	0.0	6.8	0.1	0.0	0.0	8.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.3	1.4	0.4	0.4	0.7	0.1	0.8	1.0	0.3	0.1	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.3	0.0	2.8	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Group enriched"	"Detected in many"	11	"Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1"	"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Low region specificity"	"Detected in single"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.6	0.0	0.0	0.0	9.0	32.1	3.3	1.5	11.8	3.4	3.2	0.7	3.8	16.7	0.7	7.3	4.8	17.2	0.1	40.2	1.7	22.7	0.7	0.0	0.5	5.2	4.2	10.1	0.0	16.0	23.5	6.5	31.1	0.0	14.7	13.2	0.5	2.4	9.2	1.2	2.9	4.0	0.1	0.0	7.1	5.0	0.1	0.1	5.4	25.3	0.7	0.0	6.5	11.1	0.1	1.0	5.5	7.7	4.2	3.9	0.5	0.0	10.6	1.8	1.4	18.2	18.4	12.8	8.3	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5	11.9	11.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	23.9	31.4	0.0	184.0	3.3	8.8	0.0	0.0	0.0	0.0	10.8	7.2	0.0	0.0	1.1	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	16.4	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	501.8	0.0	0.0	0.0
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.7;brain: 61.3;heart muscle: 45.9"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 521.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 23.7"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.7"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 31.2"	"Group enriched"	"Detected in many"	12	"amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		110000	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.4	0.5	7.6	0.5	61.3	0.5	1.0	15.6	21.2	1.8	2.2	0.0	0.0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1.0	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1.0	4.8	0.3	4.0	1.4	1.0	2.0	0.9	0.5	0.6	1.6	1.2	0.0	0.5	0.0	1.5	8.3	0.8	0.9	23.7	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.2	1.6	0.0	0.0	0.0	0.4	7.2	0.0	0.7	0.0	0.0	0.7	0.3	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	3.2	0.5	0.1	0.0	0.0	0.2	31.2	0.0	1.2	1.7	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.2	0.2	2.7	0.0	0.0	0.0	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1.0	15.5	0.1	1.2	0.0	15.3	1.5	24.8	2.1	5.8	124.1	5.1	20.1	22.7	14.0	3.9	0.0	14.9	0.1	17.0	1.0	5.3	0.0	0.0	0.0	2.2	17.1	1.1	6.0	0.1	1.6	12.6	0.6	0.0	9.6	0.0	0.9	32.1	1.0	19.3	521.3	0.2	0.0	0.0	111.6	17.7	0.0	1.0	4.4	6.3	1.1	0.1	0.0	7.9	58.9
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 27.9;lung: 60.9"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 2: 122.0;Basal keratinocytes: 30.7;Club cells: 33.0;Melanocytes: 37.1;Suprabasal keratinocytes: 29.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 19.9;U-87 MG: 78.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	6170					"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	12.4	1.5	1.0	13.8	1.3	3.0	2.8	0.8	1.6	27.9	3.0	1.4	0.0	0.2	2.3	2.2	5.9	2.9	2.1	6.9	1.1	1.0	0.2	0.5	60.9	0.5	1.2	0.1	3.3	4.1	0.2	3.8	2.6	7.4	4.3	0.7	1.6	0.6	0.3	20.6	0.4	1.4	1.6	2.6	1.0	2.0	1.1	1.2	0.1	0.7	8.8	7.0	7.2	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	3.2	0.0	2.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.3	0.8	1.6	1.1	1.0	1.2	0.1	7.4	1.2	20.8	122.0	0.0	4.6	30.7	0.0	0.1	0.0	14.7	33.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.0	8.9	8.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	37.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.7	29.4	0.0	0.0	0.1	5.4
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883766-118897799	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"B-cell activation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 35.5;lymphoid tissue: 45.6"	"Cell type enriched"	"Detected in some"	26	"B-cells: 71.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 4.0"	"Group enriched"	"Detected in some"	8	"memory B-cell: 24.2;naive B-cell: 35.5"	"Lineage enriched"	"Detected in many"	9	"B-cells: 35.5"	"Group enriched"	"Detected in some"	10	"Daudi: 10.6;U-698: 37.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026149, HPA042432"	Enhanced					NA	NA					"CAB026149: , HPA042432: AB_2677995"	"unprognostic (8.51e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-1)"		"unprognostic (4.02e-5)"		"unprognostic (2.08e-2)"	"unprognostic (3.23e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-5)"	"unprognostic (4.21e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	0.4	0.8	0.6	31.8	0.6	7.3	0.1	4.0	0.9	0.1	3.6	0.2	0.1	0.1	0.2	0.1	2.6	0.0	0.5	0.9	0.7	0.5	0.8	1.0	0.9	31.5	0.3	0.1	0.3	0.5	0.0	0.9	0.1	0.2	2.9	0.3	0.3	3.6	0.1	1.3	0.9	8.6	0.1	0.3	45.6	1.3	0.1	0.1	1.9	0.7	1.3	41.8	3.9	0.9	35.5	0.0	0.0	0.0	0.0	3.9	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	10.6	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.5	0.4	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.1	0.5	0.0	0.2	0.5	0.0	0.0	0.2	0.0	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	24.2	3.9	1.0	0.0	35.5	0.4	0.3	0.0	0.0	0.0	0.0	0.5	1.9	0.6	0.6	4.0	0.9	0.7	0.5	0.3	0.1	0.2	0.1	0.0	2.6	71.5	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.0
CXorf67		ENSG00000187690	"Chromosome X open reading frame 67"	Q86X51	X	51406915-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 14.3;testis: 21.4"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.2"	"Cell line enriched"	"Detected in single"	46	"U-2 OS: 27.7"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.1	0.2	0.3	0.2	0.6	0.1	0.1	2.8	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.2	0.2	0.2	0.1	0.7	0.1	0.0	1.5	14.3	0.1	0.4	0.1	0.1	0.9	0.2	0.1	0.2	0.2	0.1	0.4	0.7	0.1	21.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.7	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	2.8	0.4	0.3	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	6.5	0.0	4.9	15.6	0.0	1.6	0.0	0.0	0.0
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367740	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 145.3;placenta: 157.2"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 305.6;Syncytiotrophoblasts: 1214.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	36	"basal ganglia: 14.8"	"Cell type enriched"	"Detected in single"	37	"basophil: 15.8"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 15.8"	"Group enriched"	"Detected in some"	4	"BEWO: 44.0;HEL: 35.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA016436	Enhanced					NA	NA					"HPA016436: AB_1847423"	"unprognostic (8.89e-2)"	"unprognostic (6.96e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.31e-2)"	"unprognostic (9.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-3)"	"unprognostic (8.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (9.66e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.95e-2)"	0.4	145.3	0.4	0.1	14.8	0.0	0.4	0.3	0.3	0.2	0.2	7.6	0.1	0.0	0.3	0.5	1.5	0.3	0.0	0.3	0.3	0.2	0.1	0.7	0.1	0.0	0.3	0.2	9.2	0.1	0.0	0.4	157.2	0.2	0.2	0.0	0.3	0.1	0.6	0.3	0.1	0.1	0.3	0.3	5.7	0.1	20.4	0.1	0.0	0.1	0.3	0.7	0.2	0.2	0.0	0.0	15.8	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	44.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	35.0	1.0	0.3	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	8.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	14.8	0.3	0.3	0.3	0.2	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.5	0.0	0.0	0.0	0.0	139.8	1.7	0.0	1.4	0.0	0.0	0.0	0.0	305.6	0.6	0.1	0.0	3.4	19.4	0.0	0.0	0.0	0.0	2.9	45.1	0.0	0.0	1.0	0.0	5.1	0.2	0.0	163.4	0.0	0.0	0.0	0.0	3.2	3.1	0.0	1214.3	0.0	0.0	0.0
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837533	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 425.4"	"Cell type enhanced"	"Detected in some"	17	"Distal tubular cells: 18.3;Early spermatids: 40.8;Proximal tubular cells: 39.5"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Region enriched"	"Detected in single"	103	"basal ganglia: 19.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 8.0;SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced				"Intracellular and membrane"	NA	NA					"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.0	425.4	0.0	0.1	19.7	0.0	0.0	0.1	0.1	0.1	0.0	78.5	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.4	1.7	0.1	0.0	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	82.3	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	3.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	19.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.1	0.6	0.6	0.0	0.0	0.0	1.8	0.0	0.3	18.3	0.0	40.8	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	3.2	0.1	1.6	0.0	0.0	0.0	8.3	1.7	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.0	39.5	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338610	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"placenta: 440.1"	"Cell type enriched"	"Detected in some"	36	"Syncytiotrophoblasts: 1678.9"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.9"	"Cell type enriched"	"Detected in single"	17	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	9.0	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3.0	0.2	0.3	3.0	0.2	0.2	1.2	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	45.7	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.3	0.1	3.7	0.3	0.0	0.0	15.3	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	8.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.4	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.0	0.0	13.4	0.0	0.0	0.0	1.6	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.3	7.7	0.2	0.0	1678.9	0.0	0.0	0.0
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.2"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 58.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.9;hTCEpi: 15.5;OE19: 6.7;SiHa: 9.3;U-698: 10.9"	"Region enhanced"	"Detected in many"		"olfactory region: 24.1"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	2.6	2.0	1.7	2.9	1.9	0.0	2.9	19.3	1.9	3.6	1.9	1.5	6.4	0.4	1.9	12.0	4.9	2.3	3.4	4.8	1.6	1.1	3.3	52.2	2.6	0.2	2.3	0.9	6.5	8.7	8.6	8.3	0.2	2.3	8.2	1.9	8.0	21.0	1.8	0.5	8.5	1.4	1.7	2.2	0.6	2.7	3.3	0.9	0.0	9.4	2.3	2.1	2.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	2.0	0.3	0.0	0.0	0.0	1.2	0.4	0.1	0.0	0.6	6.9	5.0	0.0	1.0	1.9	0.9	1.6	0.0	0.0	3.0	0.0	1.8	2.0	4.7	0.0	0.0	0.5	15.5	0.0	1.8	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.7	1.7	0.5	1.3	0.1	3.3	4.4	0.8	0.0	9.3	0.0	0.2	0.5	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.9	19.3	1.9	1.6	1.1	2.3	0.9	2.3	0.9	14.9	1.0	0.0	7.1	3.5	0.2	4.6	10.2	8.1	4.5	3.5	2.0	0.0	5.0	1.6	11.8	2.3	0.5	0.0	0.3	0.9	1.7	12.3	0.0	58.9	0.2	0.0	0.0	0.0	1.9	15.3	5.8	0.2	3.3	0.0	3.1	8.0	0.9	2.9	8.9	4.1	1.5	0.0	2.1	0.7	0.1	13.4	0.0	0.0	2.3	6.0
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enriched"	"Detected in some"	8	"RT4: 81.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1	1140.4	70.0	0.0	114.6	0.5	0.0	4.8	0.0	602.3	304.8	0.0	0.0	0.9	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.2	4.7	3.9	5.8	0.0	0.6	0.0	0.0	2.5	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.6	0.7	0.0	0.0	142.5
DAB1		ENSG00000173406	"DAB1, reelin adaptor protein"	O75553	1	56994778-58546734	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4;intestine: 20.8"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 20.8;Early spermatids: 6.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 31.4"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.5"	"Group enriched"	"Detected in many"	16	"granulocytes: 1.4;T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;fHDF/TERT166: 30.0;HeLa: 10.8;NTERA-2: 13.3;RT4: 17.7;WM-115: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	1.8	1.7	5.8	0.3	3.8	0.0	0.7	31.4	6.2	1.7	1.0	1.8	0.5	15.0	1.0	1.0	0.6	1.6	0.8	1.8	5.3	1.4	0.7	7.5	0.8	0.2	1.1	4.2	1.2	0.7	0.0	0.7	0.0	2.0	4.0	0.3	2.9	5.2	10.2	0.6	0.6	20.8	0.3	1.1	0.6	1.0	0.9	0.7	0.0	0.8	0.0	0.1	1.9	1.0	0.0	0.0	1.4	0.0	0.2	5.5	0.1	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	13.3	0.0	0.0	3.2	0.0	0.1	0.0	17.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	1.4	0.5	0.0	5.5	0.0	2.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	5.8	3.8	31.4	6.2	5.3	1.4	1.1	4.2	2.0	0.7	0.0	0.0	0.0	0.0	0.0	20.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.1	20.6	0.0	1.3	0.0	4.3	3.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.0
DAB2IP	"AF9Q34, AIP1, DIP1/2, KIAA1743"	ENSG00000136848	"DAB2 interacting protein"	Q5VWQ8	9	121567057-121785530	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Cell cycle, Growth regulation, Immunity, Inflammatory response, Innate immunity, Stress response, Unfolded protein response"	"Developmental protein, GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 81.4"	"Cell type enriched"	"Detected in single"	16	"MAIT T-cell: 2.8"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 34.2;HDLM-2: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (4.00e-15)"	"unprognostic (1.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.81e-2)"	13.0	8.1	17.4	6.9	18.1	0.2	12.2	81.4	24.5	11.2	15.8	6.0	23.0	12.7	15.9	9.0	14.1	12.2	10.4	17.6	13.6	8.5	12.1	4.7	13.1	2.4	7.6	13.6	11.4	8.8	8.9	6.0	9.8	8.4	9.9	10.5	6.0	26.4	21.3	29.5	9.8	14.2	15.5	5.5	10.2	12.1	12.8	6.6	1.8	8.0	8.9	4.2	12.6	10.7	0.0	0.0	0.0	0.0	0.1	2.8	0.0	5.6	6.7	7.4	6.5	1.6	0.8	9.7	4.6	12.0	4.4	2.2	4.8	6.1	0.0	7.3	4.7	6.2	34.2	6.9	19.3	1.1	25.1	3.9	0.1	9.3	9.7	1.8	1.1	0.0	0.6	13.8	1.5	3.0	3.6	6.6	0.4	0.1	0.1	1.1	7.4	5.3	1.5	7.9	20.9	2.6	2.5	5.1	11.2	4.5	11.2	7.6	13.8	3.0	18.0	9.9	4.5	21.4	0.9	5.8	5.4	6.2	1.0	4.5	0.1	0.1	0.3	0.6	0.2	5.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	17.4	18.1	81.4	24.5	13.6	8.5	7.6	13.6	8.4	6.6	41.7	9.4	2.0	14.7	4.4	17.9	19.2	30.6	1.4	9.1	10.4	0.0	4.8	8.3	32.4	5.1	19.6	18.4	0.0	27.7	8.5	9.9	17.4	0.0	9.0	1.0	14.3	5.8	12.9	0.0	5.8	11.8	0.8	13.5	1.0	17.4	42.0	31.4	5.8	9.2	6.8	2.4	6.5	16.5	3.9	10.0	2.5	22.2	1.7	20.8	15.3
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 14.2;placenta: 54.8"	"Cell type enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 180.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5"	"Low region specificity"	"Detected in many"							HPA030251	Enhanced	Supported				NA	NA					"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	1.0	1.3	0.5	0.4	14.2	0.0	0.4	1.5	1.4	2.3	1.1	1.2	1.0	0.9	3.7	2.2	0.7	2.2	2.9	2.7	0.9	0.5	2.2	2.4	2.0	0.4	1.1	0.9	0.9	1.6	0.0	0.4	54.8	1.7	6.1	0.4	1.6	5.3	0.5	0.4	5.6	0.8	0.8	0.7	0.4	0.5	1.0	0.7	0.9	0.4	0.4	0.8	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	15.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	14.2	1.5	1.4	0.9	0.5	1.1	0.9	1.7	0.7	0.0	1.3	0.0	1.8	2.7	9.8	0.5	2.5	0.0	2.3	1.8	0.0	38.3	0.0	1.5	0.0	0.1	0.0	0.0	0.2	4.7	1.1	0.8	0.0	0.0	4.6	0.0	5.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	1.1	22.6	0.4	0.0	0.0	4.9	0.7	0.0	0.0	0.0	0.0	1.3	180.9	0.0	1.8	0.0
DAO	DAMOX	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"brain: 37.0;kidney: 39.0;liver: 64.2"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 41.2;Proximal tubular cells: 75.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Group enriched"	"Detected in many"	5	"cerebellum: 37.0;pons and medulla: 31.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;ASC TERT1: 1.3;BEWO: 1.5;Hep G2: 4.5;HL-60: 1.8;HMC-1: 1.3;RH-30: 1.2"	"Group enriched"	"Detected in some"	10	"cerebellum: 74.4;pons and medulla: 21.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 54.0;midbrain: 31.9;pons and medulla: 55.4;thalamus: 16.3"	"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.3	0.2	0.0	0.2	2.7	0.2	0.2	37.0	0.7	0.2	0.9	11.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	39.0	64.2	0.3	0.2	6.4	0.5	0.2	0.3	0.2	0.0	0.2	31.2	0.2	1.1	0.0	0.2	0.2	0.2	0.2	0.2	0.3	35.9	0.2	0.2	0.2	0.4	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	37.0	0.5	0.8	0.9	6.4	0.5	31.2	0.4	0.0	0.0	0.9	0.0	0.0	0.5	0.4	0.0	0.0	0.0	1.8	0.0	0.6	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.2	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	75.6	5.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCDC1		ENSG00000170959	"Doublecortin domain containing 1"	P59894	11	30830369-31369810	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;pituitary gland: 26.7"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 56.2;Cone photoreceptor cells: 19.6;Early spermatids: 31.2;Rod photoreceptor cells: 20.7;Spermatocytes: 15.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 5.6;pons and medulla: 19.2"	"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.8;U-266/70: 5.5"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.01e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.61e-1)"	0.6	0.6	1.0	0.1	5.6	0.2	1.0	0.4	1.0	1.3	0.5	2.7	3.3	0.1	1.3	13.3	0.4	9.9	4.3	0.5	1.9	1.6	3.4	6.4	4.8	0.2	0.6	0.2	4.2	2.4	3.9	26.7	0.2	19.2	0.6	0.2	2.8	0.7	2.0	0.4	0.5	0.4	0.2	0.6	0.4	0.5	11.5	1.1	0.0	2.8	0.0	0.2	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.9	0.0	0.2	1.1	0.8	0.6	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	1.0	0.4	0.1	0.1	1.0	0.4	0.6	0.0	0.1	1.5	0.0	0.2	0.3	0.7	0.0	0.3	0.3	0.3	0.0	1.0	0.3	0.1	0.2	0.1	0.2	0.0	1.4	0.4	0.0	0.0	0.3	0.0	2.8	0.0	0.8	0.1	1.4	0.0	0.1	0.2	0.2	0.0	0.1	0.5	0.8	1.1	0.2	5.5	0.3	0.2	1.2	0.0	0.3	1.4	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.6	0.4	1.0	1.9	1.6	0.6	0.2	19.2	1.1	0.0	1.0	0.0	0.1	0.2	1.9	0.8	0.0	56.2	6.8	0.0	19.6	0.0	0.0	0.6	31.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.6	13.2	1.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.4	1.0	20.7	0.0	0.0	15.2	3.7	0.0	0.0	0.0	0.0	0.0
DCLK3	"DCAMKL3, DCDC3C, KIAA1765"	ENSG00000163673	"Doublecortin like kinase 3"	Q9C098	3	36712422-36764349	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.0;testis: 8.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 24.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;SCLC-21H: 3.3;SH-SY5Y: 2.7;U-2 OS: 1.9;U-2197: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040685	Approved					NA	NA					"HPA040685: AB_2732487"	"unprognostic (9.09e-3)"	"unprognostic (1.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.11e-5)"	"unprognostic (7.94e-3)"	"unprognostic (5.80e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.36e-2)"	1.1	0.4	2.6	1.4	10.0	0.3	0.1	0.1	2.3	0.5	0.2	0.3	0.0	0.5	0.3	0.1	0.1	0.2	0.6	0.9	1.4	0.9	0.0	0.1	0.3	0.2	0.6	0.0	0.0	0.2	0.4	1.8	1.1	0.4	0.3	0.3	1.3	1.7	0.2	2.7	0.4	0.4	0.9	0.7	0.1	0.0	8.0	3.2	0.0	0.9	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	2.7	0.1	0.3	0.0	0.2	0.0	0.4	0.3	0.0	1.9	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	10.0	0.1	2.3	1.4	0.9	0.6	0.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adipose tissue: 28.8;lung: 18.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 7.5;Macrophages: 2.5"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Region enriched"	"Detected in single"	4	"amygdala: 3.5"	"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.1;RPMI-8226: 1.2;SuSa: 1.4;U-87 MG: 4.5;U-937: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	28.8	0.1	3.5	0.3	0.2	0.4	1.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.3	0.0	0.8	0.2	0.1	1.0	18.2	0.8	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.5	1.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	3.5	0.2	0.0	0.6	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	7.5	0.0	0.0	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in many"	5	"Intestinal endocrine cells: 394.4;Proximal tubular cells: 366.2;Rod photoreceptor cells: 456.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 17.2;Hep G2: 15.1;OE19: 26.4;SCLC-21H: 43.6;SH-SY5Y: 45.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		380000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.4	0.0	0.0	0.0	0.2	0.4	0.0	43.6	45.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5	0.0	9.8	0.8	0.0	0.0	81.1	0.4	5.1	0.0	1.2	3.5	39.3	0.0	21.6	0.0	3.6	0.0	72.8	0.0	0.7	0.1	0.0	0.4	0.0	58.7	0.1	3.2	394.4	1.3	1.3	4.3	0.0	0.0	0.0	0.0	30.4	24.1	0.2	26.6	0.0	366.2	456.4	0.0	0.0	3.6	0.4	0.0	0.1	0.0	46.0	0.0
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 77.6;Collecting duct cells: 78.5;Intestinal endocrine cells: 53.2;Undifferentiated cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Group enriched"	"Detected in some"	16	"OE19: 29.1;T-47d: 45.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046644			Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.7	0.1	0.1	0.0	29.1	0.0	0.1	0.0	1.5	0.0	0.7	2.2	0.0	0.0	1.3	0.0	0.0	45.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7	3.0	5.3	0.0	2.8	1.5	4.4	0.4	38.2	77.6	11.4	78.5	0.0	5.9	1.7	13.4	1.0	0.9	31.3	0.0	1.3	1.5	0.3	1.1	9.2	0.2	1.6	0.0	53.2	0.6	1.9	1.5	0.3	1.0	0.0	0.0	43.3	1.2	2.8	43.8	0.0	0.1	24.4	0.0	0.2	0.9	1.9	13.4	31.2	1.3	46.7	17.4
DHH	"HHG-3, MGC35145"	ENSG00000139549	"Desert hedgehog"	O43323	12	49089421-49094819	"Disease related genes, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 35.7"	"Cell type enhanced"	"Detected in single"	17	"Endothelial cells: 1.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"midbrain: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;EFO-21: 7.3;HUVEC TERT2: 2.9;K-562: 12.2;TIME: 6.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"midbrain: 2.1"						"Secreted in male reproductive system"	NA	NA						"unprognostic (7.56e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.36e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.21e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	0.9	0.4	0.2	1.2	0.6	0.1	1.4	0.3	0.6	0.6	0.5	0.2	0.3	0.3	1.0	0.9	0.5	0.6	1.7	0.9	0.2	0.2	0.6	0.2	0.9	0.2	5.2	0.0	0.4	0.2	0.2	0.8	1.5	1.2	0.7	0.2	1.3	0.7	0.8	0.6	0.3	0.5	1.0	1.2	0.3	0.3	35.7	0.0	0.0	0.4	1.3	0.2	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.9	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.6	0.2	0.2	5.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 40.9;placenta: 17.6"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"AF22: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073684			Supported	Vesicles		NA	NA			Vesicles		"HPA073684: "	"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	4.5	0.2	0.2	1.7	1.8	0.0	3.5	0.1	0.8	40.9	1.6	0.1	1.0	0.0	3.4	2.2	1.9	3.5	2.9	1.6	0.7	0.0	0.9	2.7	1.4	7.1	0.1	0.1	9.2	4.1	0.0	0.6	17.6	0.3	1.6	0.4	12.6	0.8	2.5	2.2	1.9	0.7	0.9	0.1	2.5	0.7	1.0	0.1	0.1	3.6	1.1	0.4	6.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.1	0.6	0.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.1	0.0	0.9	0.0	0.0	2.1	8.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.0	0.0	6.6	0.6	0.0	7.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	23.7	0.0	0.0	0.1
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045896-68051631	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 33.2;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 16.7;Distal tubular cells: 54.7;Exocrine glandular cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 49.9"	"Group enriched"	"Detected in some"	18	"plasmacytoid DC: 2.1;T-reg: 1.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.5;HSkMC: 15.7;TIME: 9.7;U-251 MG: 7.9;U-87 MG: 15.2"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favorable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.0	10.2	2.0	0.2	49.9	0.0	2.4	0.9	2.9	2.3	1.6	1.0	0.0	3.4	1.2	5.4	1.3	1.3	5.9	5.7	1.3	8.7	3.2	4.5	2.3	0.0	1.3	1.1	33.2	9.9	8.8	35.2	0.0	17.3	2.3	0.1	2.4	1.3	1.1	1.0	1.1	1.2	0.3	1.7	1.2	1.9	2.4	0.5	0.0	1.6	0.3	0.1	1.2	1.9	0.0	2.1	0.0	0.0	0.0	1.8	0.0	0.0	1.3	1.4	0.0	4.8	3.6	0.5	4.0	1.4	0.3	1.1	0.0	0.7	0.0	0.2	4.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	7.5	0.0	0.0	15.7	0.1	0.6	0.0	0.0	0.9	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	0.1	0.5	0.1	0.0	9.7	0.0	0.4	0.2	7.9	2.5	0.0	0.0	15.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	0.0	2.0	49.9	0.9	2.9	1.3	8.7	1.3	1.1	17.3	0.5	0.0	2.6	0.0	16.7	2.9	0.6	4.8	10.2	1.4	3.4	3.5	9.8	0.7	54.7	2.0	0.0	0.6	0.0	0.0	17.0	0.1	10.6	3.2	0.0	2.6	0.1	0.0	15.5	1.8	0.0	0.0	6.4	0.2	5.0	0.0	0.3	0.7	3.6	0.0	1.4	5.0	5.6	0.0	2.6	0.0	0.2	2.5	0.3	0.0	0.6	2.1
DKK1	"DKK-1, SK"	ENSG00000107984	"Dickkopf WNT signaling pathway inhibitor 1"	O94907	10	52314296-52318042	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 153.6"	"Cell type enhanced"	"Detected in many"	19	"Basal glandular cells: 400.3;Glandular cells: 95.5;Pancreatic endocrine cells: 113.3;Urothelial cells: 308.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 113.4;BJ hTERT+: 62.2;CACO-2: 99.0;fHDF/TERT166: 156.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in female reproductive system"	NA	NA						"unprognostic (5.65e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.35e-8)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (1.54e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-2)"	15.6	0.1	0.5	0.3	0.4	0.0	4.0	0.4	0.6	26.2	0.3	0.6	1.8	0.1	2.1	0.5	5.3	0.1	2.8	0.6	0.8	1.7	0.5	0.2	0.6	0.3	0.7	0.3	0.9	0.1	0.1	0.2	153.6	15.2	4.2	0.1	0.7	1.6	1.3	0.6	11.7	0.2	1.2	0.2	0.4	0.8	1.6	0.4	0.1	0.2	0.1	0.5	10.6	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.3	21.3	0.0	3.2	15.5	3.1	0.0	113.4	62.2	39.0	20.8	99.0	6.4	0.0	0.1	156.8	9.5	24.3	0.0	12.9	37.1	0.0	0.0	0.0	0.4	2.5	3.3	0.0	0.0	3.1	1.6	8.4	50.0	2.0	3.5	0.0	0.0	0.0	25.6	13.1	0.0	0.0	0.0	1.3	54.5	0.0	3.5	0.0	14.9	2.5	0.0	34.8	10.2	0.1	1.6	0.0	0.1	0.0	7.8	0.0	0.0	34.2	20.6	0.0	0.0	0.0	0.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.8	1.7	0.7	0.3	15.2	0.4	23.8	0.0	0.0	400.3	4.7	0.1	0.4	0.0	1.4	1.2	0.0	0.0	3.4	0.0	3.5	1.1	0.3	0.4	0.0	3.6	4.7	77.0	95.5	4.6	0.0	8.5	0.0	0.0	1.8	0.0	0.4	0.0	0.8	0.0	0.0	0.3	5.8	113.3	0.0	0.0	0.0	0.3	0.0	1.4	0.2	0.9	2.8	7.0	0.0	0.4	308.8
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374068-42377232	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.6;gallbladder: 9.9"	"Group enriched"	"Detected in some"	10	"Basal glandular cells: 3.4;Early spermatids: 1.1;Glandular cells: 1.4;Pancreatic endocrine cells: 2.5;Spermatocytes: 1.2;Urothelial cells: 4.3"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"OE19: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052916	Uncertain				"Secreted in other tissues"	NA	NA					"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.2	0.0	0.1	0.1	0.1	0.2	1.6	2.8	0.1	2.3	0.1	0.1	0.1	5.1	1.6	2.3	10.6	0.7	9.9	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.5	1.4	0.0	0.1	1.7	1.9	0.2	0.2	0.9	0.5	0.1	0.1	2.2	2.9	0.1	1.8	0.1	5.9	1.6	2.5	4.3	0.7	0.7	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.1	0.1	2.8	0.1	0.1	1.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	4.3
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 527.9;Leydig cells: 1256.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1"	"Group enriched"	"Detected in some"	5	"hypothalamus: 2.6;pons and medulla: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 23.1;Hep G2: 77.0;SH-SY5Y: 91.7"	"Region enhanced"	"Detected in some"		"hypothalamus: 65.4"	"Region enhanced"	"Detected in many"		"midbrain: 159.6"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		160000	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			0.3	157.6	0.2	0.7	0.8	0.0	0.9	0.0	0.1	0.5	0.0	1.8	0.2	0.2	0.2	4.4	0.3	0.3	0.8	2.7	0.1	2.6	0.1	0.1	0.1	0.1	0.8	0.0	34.9	4.6	0.0	143.1	244.9	6.0	0.2	0.0	0.2	8.2	0.0	2.0	0.1	0.2	0.2	0.3	0.2	0.2	14.2	0.0	0.5	0.0	10.0	1.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	77.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.1	6.5	91.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.8	0.0	0.0	0.1	2.6	0.8	0.0	6.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.0	52.1	0.0	2.9	4.0	0.0	0.0	0.0	527.9	35.4	1.3	0.5	0.0	0.0	73.1	0.0	0.0	0.0	0.0	11.5	1256.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	162.3	0.0	0.0	58.2	0.0	6.5	56.6	0.4	88.4	0.0	0.0	0.1
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005548-97011039	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.2;placenta: 11.3;testis: 10.4"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 24.7;Extravillous trophoblasts: 48.9;Sertoli cells: 12.9;Syncytiotrophoblasts: 14.5"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 23.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.3;BEWO: 24.3;HAP1: 10.9;SH-SY5Y: 8.0;SuSa: 14.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 44.2"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.9	0.4	1.8	0.3	23.2	0.9	0.4	0.3	6.1	5.7	0.6	0.5	0.0	0.4	7.0	2.4	0.3	1.5	0.3	0.5	3.9	2.6	0.4	0.3	0.3	1.0	0.5	2.8	0.9	0.3	0.4	0.4	11.3	0.0	0.7	0.3	0.0	1.7	2.5	0.5	1.6	0.3	0.9	0.3	0.5	0.4	10.4	4.2	0.1	0.7	0.0	0.8	0.9	0.6	0.4	0.6	1.5	0.7	0.5	0.7	0.3	0.0	0.0	0.0	7.3	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	1.3	10.9	0.0	0.0	0.0	2.8	0.0	4.1	4.9	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.8	1.1	0.0	0.0	0.0	0.0	1.5	5.3	8.0	0.7	0.0	0.2	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.8	0.6	1.1	0.5	0.6	0.2	0.3	0.5	0.4	0.4	0.3	0.3	0.4	0.7	0.6	1.5	0.5	0.7	0.6	0.5	0.3	1.8	23.2	0.3	6.1	3.9	2.6	0.5	2.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	9.5	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	12.9	0.0	1.7	7.1	0.0	14.5	0.0	0.0	0.1
DMBX1	"OTX3, PAXB"	ENSG00000197587	"Diencephalon/mesencephalon homeobox 1"	Q8NFW5	1	46506996-46514226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.7;testis: 3.5"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 1.5;Cone photoreceptor cells: 2.0;Spermatogonia: 1.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"hypothalamus: 1.2;midbrain: 1.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.7;CAPAN-2: 5.0;GAMG: 4.0;K-562: 5.1;SiHa: 5.1;T-47d: 4.4"	"Group enriched"	"Detected in some"	7	"midbrain: 1.8;pons and medulla: 1.0"	"Region enhanced"	"Detected in some"		"thalamus: 5.1"	HPA026811	Uncertain					NA	NA					"HPA026811: AB_10603660"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (7.13e-5)"	"unprognostic (2.33e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.00e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.12e-12)"	"unprognostic (7.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.35e-2)"	0.3	1.8	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	3.5	0.1	0.1	1.4	0.1	0.1	0.9	0.1	0.6	0.3	1.9	0.2	0.0	0.1	0.0	2.2	1.5	0.0	15.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.8	0.0	4.0	1.4	3.0	0.0	0.0	1.1	1.8	0.0	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	5.1	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	1.9	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.2	1.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.7	0.3	0.0	0.0	0.0	0.1
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell type enriched"	"Detected in many"	5	"Suprabasal keratinocytes: 7442.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	NA	NA		29000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	32.0	5.2	0.0	0.0	1.3	2.0	9.0	0.1	4.3	0.2	0.3	39.6	34.0	0.0	13.0	0.3	1.6	18.0	9.8	51.9	0.4	0.1	9.5	0.0	0.0	8.8	1.5	0.0	0.1	17.8	14.0	0.9	30.2	3.0	0.0	0.0	0.1	0.0	0.1	28.0	0.0	0.0	28.8	23.3	2.1	0.0	0.0	1.3	51.3	21.2	0.1	0.0	7.8	0.0	3.1	8.6	13.0	0.0	0.0	5.0	15.2	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3	98.3	94.2	3.7	121.7	1442.2	1.4	15.2	94.3	261.0	92.1	193.7	0.0	0.7	195.6	125.9	15.0	6.0	1.3	0.0	120.1	1.1	57.3	55.5	7.0	2.0	1.0	0.0	47.4	5.5	0.8	67.8	12.0	5.1	290.1	4.6	4.2	9.3	137.6	5.8	14.9	4.4	0.7	0.0	14.2	7.1	16.4	7442.2	1.9	5.3	11.0	72.7
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976964-991731	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 34.2;testis: 11.7;thyroid gland: 11.5"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 3.0;Spermatocytes: 14.4;Spermatogonia: 5.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.6"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;HEK 293: 3.8;hTERT-RPE1: 5.7;SCLC-21H: 2.3;SuSa: 2.2;THP-1: 6.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	HPA077685	Approved					NA	NA					"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	4.0	0.0	0.4	0.0	0.2	0.0	6.4	0.0	1.1	0.2	0.0	1.8	0.0	0.0	0.1	1.0	0.6	0.7	0.0	1.4	8.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.5	0.7	0.0	0.2	0.4	0.0	0.0	11.7	0.0	0.2	11.5	0.6	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.7	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	6.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.4	5.1	0.0	0.0	0.0	0.0	0.0
DNAAF1	"CILD13, FLJ25330, LRRC50, ODA7, swt"	ENSG00000154099	"Dynein axonemal assembly factor 1"	Q8NEP3	16	84145287-84178767	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.3;testis: 49.6"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 520.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.1"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA041166, HPA074239"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA041166: AB_10794190, HPA074239: AB_2732250"	"unprognostic (5.25e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.77e-2)"	"prognostic favorable (2.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-5)"	"unprognostic (2.70e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-4)"	"unprognostic (7.51e-4)"	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1.0	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2.0	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1.0	7.2	0.5	49.6	1.2	0.0	1.2	0.0	0.4	0.8	0.0	0.5	1.0	5.5	0.8	0.9	2.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.0	2.5	0.1	0.1	0.9	0.0	0.0	0.4	0.0	0.0	0.0	7.4	4.8	0.7	0.2	0.4	0.0	3.6	0.8	0.4	0.4	0.6	0.1	0.0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1.0	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2	0.0	17.2	2.2	1.6	0.6	1.4	0.6	2.5	520.6	108.1	3.5	51.1	0.2	0.0	1.0	67.6	1.4	0.0	0.0	0.3	0.4	0.9	0.8	3.5	0.4	1.9	0.0	0.0	3.1	2.7	16.2	1.1	4.8	82.7	1.0	0.0	2.1	1.3	0.0	0.4	0.7	53.5	0.0	0.4	118.6	19.6	0.3	0.3	0.0	0.0	0.7
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123936206	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 104.4;Club cells: 20.5;Early spermatids: 27.9;Late spermatids: 49.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.8;pons and medulla: 10.0"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.6;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 3.9;SuSa: 2.4"									HPA039066	Enhanced					NA	NA					"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"	0.4	0.2	0.7	0.2	4.8	3.1	0.3	1.2	0.6	1.9	0.7	3.9	0.5	0.5	0.6	10.1	0.2	9.5	0.2	0.2	1.4	1.7	0.4	0.2	11.8	0.2	0.5	0.0	6.2	0.2	0.1	0.2	0.4	10.0	1.1	0.2	0.0	0.2	0.2	0.1	0.2	1.1	0.2	1.5	0.3	0.2	16.4	0.3	0.0	0.5	0.0	0.2	0.4	0.9	0.1	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.1	2.3	3.9	1.7	0.6	1.0	0.3	0.0	0.2	0.0	0.4	0.1	0.2	1.2	0.4	0.4	0.0	0.0	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	1.1	1.3	0.0	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.8	2.4	0.0	0.2	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	4.8	1.2	0.5	1.4	1.7	0.5	0.0	10.0	0.3	0.0	5.6	0.0	0.0	0.0	0.2	2.0	0.0	104.4	20.5	0.0	0.0	0.0	1.7	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	1.4	0.8	12.9	0.0	7.6	1.9	0.0	0.0	0.0	0.0	0.1
DNAH11	"CILD7, DNAHBL, Dnahc11, DNHBL, DPL11"	ENSG00000105877	"Dynein axonemal heavy chain 11"	Q96DT5	7	21543215-21901839	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.2;parathyroid gland: 62.2"	"Cell type enriched"	"Detected in some"	9	"Ciliated cells: 111.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.5;pons and medulla: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.6;HUVEC TERT2: 2.4;U-2 OS: 2.7;U-2197: 3.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA045880, HPA056474"	Approved					NA	NA					"HPA045880: AB_10962003, HPA056474: AB_2683145"	"unprognostic (2.24e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (4.79e-3)"	3.2	4.6	0.8	0.5	5.5	0.4	0.4	0.2	1.0	1.6	0.9	6.7	3.0	0.4	0.8	22.2	2.5	9.3	0.5	1.1	2.5	1.2	0.5	0.8	7.7	0.4	0.2	0.6	7.2	0.5	62.2	0.8	2.9	15.5	1.1	0.5	0.0	0.4	1.0	1.5	0.9	0.6	0.4	0.3	0.4	0.5	0.9	2.1	0.7	5.2	0.3	0.5	0.4	3.4	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.7	0.0	0.6	0.9	0.0	0.1	0.1	0.0	0.4	0.0	0.1	7.6	0.1	0.0	0.7	1.5	0.0	1.7	0.0	0.5	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.4	0.7	0.2	0.3	0.0	0.0	0.6	0.0	0.1	0.7	0.0	1.4	0.0	0.0	1.7	0.7	2.7	3.4	0.4	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	5.5	0.2	1.0	2.5	1.2	0.2	0.6	15.5	2.1	6.0	3.8	0.0	3.5	2.2	0.0	3.3	0.0	111.1	12.5	0.0	0.0	0.0	0.0	0.1	2.5	0.3	0.0	0.0	0.0	1.3	0.2	2.3	0.0	0.2	0.1	6.4	0.0	0.0	0.0	1.5	0.3	0.0	1.7	1.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.3	1.4	0.0	0.0	0.7
DNAH12	"DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19"	ENSG00000174844	"Dynein axonemal heavy chain 12"	Q6ZR08	3	57293699-57544344	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 439.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enriched"	"Detected in many"	8	"pons and medulla: 23.0"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1"									"HPA037493, HPA058203, HPA061365"	Enhanced					NA	NA					"HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493"	"unprognostic (4.85e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.43e-5)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.47e-2)"	0.2	0.3	0.6	0.1	3.0	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0.0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0.0	7.6	3.1	0.1	8.9	0.1	23.0	0.2	0.2	0.0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1.0	0.0	0.3	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.0	1.2	0.9	0.1	0.3	0.7	0.0	0.0	0.9	0.3	0.1	0.0	0.2	0.3	0.0	3.1	0.3	0.1	0.0	0.4	1.9	0.4	0.0	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.1	0.4	0.4	0.2	0.6	0.2	0.1	2.1	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.9	0.1	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.5	0.2	0.0	0.0	1.2	0.0	0.5	0.0	0.1	0.6	3.0	0.2	0.3	2.9	0.8	0.4	0.0	23.0	1.0	3.0	1.4	0.0	0.2	0.0	0.2	0.8	0.0	439.0	70.5	0.0	0.0	0.1	0.0	0.1	38.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.0	0.1	0.0	1.7	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.4	0.0	0.0	0.0	24.4	2.6	0.0	0.0	0.0	0.0	0.0
DNAJC5G	"CSP-gamma, FLJ40417"	ENSG00000163793	"DnaJ heat shock protein family (Hsp40) member C5 gamma"	Q8N7S2	2	27275421-27281499	"Predicted membrane proteins"		Chaperone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"epididymis: 35.8;testis: 58.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 52.3;Late spermatids: 63.1;Spermatocytes: 116.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 2.8;HAP1: 3.6;JURKAT: 3.7;SH-SY5Y: 1.9"	"Not detected"	"Not detected"							HPA041445	Approved					NA	NA					"HPA041445: AB_2677485"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.97e-2)"	0.1	0.7	0.5	0.1	0.1	0.0	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.0	0.3	35.8	0.1	0.2	0.1	1.3	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	58.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.9	2.4	0.9	0.4	0.7	0.8	2.8	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	1.0	0.3	0.0	1.4	0.1	0.9	1.6	0.0	0.0	0.0	0.6	0.5	0.5	3.7	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	1.5	1.5	0.4	0.0	0.4	0.2	1.9	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.6	0.9	0.6	0.3	0.5	0.2	0.2	0.3	0.3	0.1	0.5	0.7	0.3	2.4	0.4	0.6	0.9	0.2	0.8	0.5	0.1	0.1	2.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	116.2	14.0	0.0	0.0	0.0	0.0	0.0
DNASE2B	DLAD	ENSG00000137976	"Deoxyribonuclease 2 beta"	Q8WZ79	1	84398532-84415018	"Enzymes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"salivary gland: 98.7"	"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 1.4;Early spermatids: 1.6;Glandular cells: 2.3;Hofbauer cells: 5.7;Late spermatids: 2.4;Paneth cells: 1.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HL-60: 1.0;HUVEC TERT2: 2.1;SK-MEL-30: 2.6;U-266/70: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (2.24e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.62e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	16.2	0.1	0.2	0.1	2.2	0.1	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.6	0.1	0.2	13.0	1.2	0.3	0.0	0.3	0.4	0.0	0.4	0.1	0.2	2.9	0.3	0.0	98.7	0.1	1.8	0.0	0.1	0.1	1.7	0.5	0.6	0.3	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.6	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.3	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	5.7	0.0	1.2	0.0	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"kidney: 7.8;liver: 20.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 17.3;Proximal tubular cells: 13.5"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Group enriched"	"Detected in some"	16	"memory B-cell: 3.2;naive B-cell: 1.1;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.2;dendritic cells: 1.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 31.2"									"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.1	0.0	0.1	0.2	0.1	0.3	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	7.8	20.5	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	4.1	0.0	0.0	4.6	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.1	2.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	0.1	1.0	0.0	3.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	27.8	0.0	1.1	0.2	1.2	0.1	0.0	5.4	0.2	1.8	2.4	0.5	0.1	2.3	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4	0.0	1.0	0.0	3.2	0.0	0.2	11.9	0.0	1.4	4.5	5.2	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	3.8	0.0	0.3	1.8	0.0	0.0	0.1	0.0	5.8	0.0	0.0	4.8	0.9	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.4	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.3;skeletal muscle: 28.4"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 33.3;Cone photoreceptor cells: 102.1;Early spermatids: 36.1;Rod photoreceptor cells: 86.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 56.3"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.7;BJ hTERT+ SV40 Large T+: 9.4;HEL: 23.3;Karpas-707: 9.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.7	2.2	6.2	1.1	10.3	3.2	0.8	56.3	7.6	0.9	2.7	8.4	0.0	0.8	0.8	0.5	1.2	0.7	1.0	16.8	6.4	2.5	2.2	4.3	0.8	1.5	8.9	4.5	17.8	0.7	8.4	0.9	0.9	10.4	0.7	2.4	3.4	0.8	0.7	28.4	1.1	1.7	1.2	10.1	1.4	1.1	6.6	10.7	0.0	0.8	6.3	1.8	0.8	0.7	1.9	0.0	0.0	0.3	0.4	0.8	0.2	1.5	0.0	1.2	0.1	0.2	2.3	13.7	4.1	3.9	9.4	3.6	0.0	0.1	0.2	0.2	1.2	0.2	0.1	1.3	0.6	5.8	0.2	0.5	23.3	0.1	0.0	0.3	0.1	0.4	0.6	0.2	2.2	1.6	1.6	3.0	2.5	2.0	9.5	3.0	0.1	1.9	0.2	0.0	0.0	1.3	5.1	0.6	0.3	1.6	0.0	0.9	0.5	0.0	0.1	0.0	0.4	0.0	0.0	6.5	4.6	0.0	1.7	0.5	3.4	0.9	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	6.2	10.3	56.3	7.6	6.4	2.5	8.9	4.5	10.4	10.7	0.0	0.0	0.9	0.0	0.6	4.7	33.3	0.0	0.0	0.0	0.0	102.1	2.2	1.7	0.0	36.1	1.8	3.9	23.3	0.3	1.2	0.8	0.1	4.6	4.2	0.4	6.4	0.0	0.6	1.5	22.2	0.3	0.9	0.0	0.0	3.3	8.1	0.5	4.0	4.6	9.9	86.0	0.0	0.8	1.7	0.7	0.3	0.1	2.5	6.3	0.0
DRC1	"C2orf39, CCDC164, CILD21, FLJ32660, MGC16372"	ENSG00000157856	"Dynein regulatory complex subunit 1"	Q96MC2	2	26401916-26456711	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.5;fallopian tube: 36.8;testis: 29.6"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 339.9;Early spermatids: 110.1;Late spermatids: 214.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.3"	"Region enriched"	"Detected in many"	4	"pons and medulla: 20.5"	"Cell type enriched"	"Detected in single"	64	"neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	64	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.7;SCLC-21H: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.28e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.56e-3)"	"unprognostic (7.02e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.06e-3)"	"unprognostic (8.19e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-2)"	0.3	0.4	2.4	0.3	3.6	1.0	0.3	0.1	2.1	2.0	0.3	7.7	0.0	0.3	1.3	11.3	0.3	36.8	0.3	0.3	3.6	4.8	0.4	0.3	6.0	0.3	1.3	1.8	5.2	0.3	0.3	4.8	0.3	20.5	0.4	0.3	0.0	0.3	0.7	0.3	0.3	0.3	0.3	1.0	0.3	0.4	29.6	2.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	11.2	0.1	0.0	0.0	0.0	0.2	0.6	0.6	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.8	4.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	2.4	3.6	0.1	2.1	3.6	4.8	1.3	1.8	20.5	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	339.9	21.6	1.8	0.0	0.0	0.0	0.0	110.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	214.9	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	33.5	1.1	0.0	0.0	0.0	0.0	0.0
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440039-175444208	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"brain: 34.5"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 40.8;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 24.2"	"Region enriched"	"Detected in many"	9	"basal ganglia: 147.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 95.6"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.7	1.5	1.9	0.2	34.5	0.0	0.1	0.1	12.0	0.7	0.7	0.4	0.0	0.5	0.4	0.7	0.7	0.6	1.1	0.3	1.0	0.6	0.7	2.6	1.8	0.1	0.5	1.6	0.3	0.0	0.0	0.1	2.5	0.3	2.7	0.9	2.1	0.1	1.2	0.1	0.1	0.3	0.4	0.1	0.4	0.4	0.1	6.8	0.1	0.1	0.0	0.4	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	24.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	34.5	0.1	5.3	1.0	0.6	0.5	1.6	0.3	6.8	0.0	0.0	0.0	0.0	0.1	40.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	31.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409615-113475691	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 45.2"	"Region enriched"	"Detected in many"	10	"basal ganglia: 183.8"	"Group enriched"	"Detected in many"	8	"basal ganglia: 126.7;midbrain: 41.7"	"HPA015139, HPA015691"	Supported	Supported				NA	NA					"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.6	17.3	0.9	0.5	52.0	0.2	2.1	0.2	3.3	1.3	0.6	1.5	0.0	0.3	2.3	0.4	0.9	2.1	0.6	0.5	0.3	4.1	0.3	0.2	0.6	0.2	9.9	0.2	0.3	0.4	0.3	51.6	0.2	2.4	1.5	0.9	3.9	5.1	1.7	1.7	0.3	0.5	3.2	0.2	0.2	0.5	1.6	9.5	0.0	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	45.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.9	52.0	0.2	3.3	0.3	4.1	9.9	0.2	2.4	9.5	0.0	0.0	0.0	0.0	0.0	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364181-49396016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"adrenal gland: 13.9;brain: 8.0"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5"	"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low region specificity"	"Detected in all"			HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.2	13.9	0.0	0.4	0.2	0.3	0.1	0.4	3.3	0.0	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.1	2.0	0.6	0.0	0.0	0.0	0.9	0.0	4.8	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.3	0.0	8.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.3	0.2	0.3	2.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSC1	CDHF1	ENSG00000134765	"Desmocollin 1"	Q08554	18	31129236-31162856	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 78.4"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 145.5"	"Group enriched"	"Detected in some"	17	"head and neck cancer: 7.3;melanoma: 4.1"	"Region enriched"	"Detected in single"	13	"cerebral cortex: 7.0"	"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.7"	"Cell line enriched"	"Detected in single"	4	"hTERT-RPE1: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075379	Enhanced					NA	NA		18000000			"HPA075379: AB_2732290"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-6)"	"unprognostic (5.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.74e-5)"	0.2	0.1	0.1	0.3	0.5	0.0	3.5	0.1	7.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	2.8	0.1	0.0	9.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.1	0.0	1.3	1.2	0.0	0.2	78.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.1	0.1	16.6	1.5	0.1	0.2	0.0	0.0	0.7	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	5.7	5.2	0.7	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.1	7.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	12.6	0.4	29.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	145.5	0.3	0.0	0.0	0.1
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498043-31549008	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.7"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 208.8;Mucus-secreting cells: 176.4;Pancreatic endocrine cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"pons and medulla: 6.9"	"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 36.3;HaCaT: 56.6;HBEC3-KT: 42.0;hTERT-HME1: 45.7;OE19: 47.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		94000000	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	17.3	1.1	0.6	11.6	0.7	0.0	21.1	0.7	0.7	3.9	50.2	1.3	4.0	18.1	3.8	5.6	6.3	4.9	14.2	15.7	0.7	0.6	22.4	10.8	7.0	2.4	0.6	0.9	8.8	15.5	39.9	2.7	39.8	6.9	10.4	23.8	4.5	27.3	1.5	2.2	5.3	70.7	3.1	0.5	0.6	17.3	2.3	0.5	13.6	20.8	3.2	5.8	18.5	7.7	0.1	0.9	9.5	0.0	0.0	0.3	0.0	24.2	9.4	0.8	0.0	0.1	1.5	30.5	0.0	0.0	0.0	0.0	6.5	36.3	0.0	13.8	0.0	11.6	56.6	11.5	42.0	0.0	0.0	7.1	0.0	10.8	7.3	4.4	3.0	0.0	2.1	29.2	0.9	45.7	22.0	0.0	7.2	9.6	0.0	0.0	6.4	6.4	0.4	11.7	47.1	4.8	10.8	0.0	15.5	14.1	12.1	5.1	0.0	18.4	13.1	0.0	26.3	9.3	2.6	0.0	0.0	5.4	0.0	6.0	1.2	0.0	0.0	4.3	0.0	5.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.6	0.7	0.7	0.7	0.7	0.6	0.6	0.9	6.9	0.5	50.6	38.4	0.5	64.3	11.9	0.2	51.1	89.2	42.8	50.0	12.2	0.0	70.4	3.3	82.4	0.6	8.7	208.8	23.3	65.2	91.9	9.5	96.7	4.6	22.1	9.0	1.6	76.9	2.5	1.5	1.6	1.4	1.8	16.9	10.8	176.4	4.2	177.3	149.7	0.4	10.0	0.2	0.0	9.5	3.0	8.1	5.3	50.1	1.3	168.5	163.4
DYDC2	"bA36D19.6, MGC16186"	ENSG00000133665	"DPY30 domain containing 2"	Q96IM9	10	80344745-80368073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.3;fallopian tube: 56.4"	"Cell type enriched"	"Detected in some"	9	"Ciliated cells: 337.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 4.4;NTERA-2: 7.0;SCLC-21H: 6.0;SH-SY5Y: 4.0;U-2197: 4.4"					"Low region specificity"	"Detected in all"			"HPA038006, HPA038007"	Enhanced					NA	NA					"HPA038006: AB_10672734, HPA038007: AB_2675783"	"unprognostic (1.60e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.41e-4)"	"unprognostic (9.86e-2)"	"unprognostic (5.40e-2)"	0.2	0.2	6.3	0.2	9.1	0.6	0.4	0.1	1.7	1.6	0.3	3.0	0.1	0.3	1.3	10.0	0.5	56.4	0.4	0.2	7.7	6.8	0.3	0.3	3.6	0.2	0.2	0.4	4.3	0.6	0.2	0.1	0.4	16.3	0.3	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.4	5.2	0.7	0.1	0.3	0.1	0.2	0.2	0.1	0.6	0.6	2.4	0.3	1.2	0.4	0.0	0.2	0.1	4.4	0.1	0.5	0.0	0.1	0.0	0.6	0.4	0.1	0.4	0.7	0.1	0.9	0.1	1.0	0.2	0.3	0.1	0.1	0.2	0.6	0.3	0.2	1.5	0.0	0.0	0.4	0.2	1.1	0.0	0.1	0.0	0.0	1.4	0.2	0.3	0.3	0.3	0.7	0.0	7.0	0.0	0.0	1.8	0.5	1.6	0.0	0.1	6.0	4.0	0.2	0.0	0.7	1.7	0.0	2.7	0.1	0.1	0.3	4.4	0.0	0.1	0.1	0.3	0.4	0.0	0.0	2.4	0.3	0.1	0.3	0.1	0.4	0.3	0.3	0.2	0.0	0.6	0.3	0.4	0.5	1.2	0.2	0.6	0.0	0.0	6.3	9.1	0.1	1.6	7.7	6.8	0.2	0.4	16.3	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	337.3	30.7	0.0	0.0	0.0	1.7	0.4	35.5	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	24.4	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	1.9	2.2	0.0	0.0	0.0	0.0	0.1
EBF1	"EBF, OLF1"	ENSG00000164330	"Early B cell factor 1"	Q9UH73	5	158695916-159099761	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Leydig cells: 264.3;Peritubular cells: 114.2;Sertoli cells: 97.0;Smooth muscle cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 23.6"	"Group enriched"	"Detected in some"	62	"memory B-cell: 11.8;naive B-cell: 10.4"	"Lineage enriched"	"Detected in single"	66	"B-cells: 11.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.4;HSkMC: 15.1;REH: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (7.86e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (9.62e-7)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (5.75e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.37e-3)"	33.7	3.3	1.9	9.7	2.5	3.1	25.0	23.6	2.0	15.9	5.8	1.1	9.0	1.2	19.7	13.0	5.0	8.5	9.4	15.5	2.0	2.4	3.3	0.9	5.2	12.7	3.2	1.2	7.4	3.7	1.8	2.6	10.7	4.7	8.5	3.4	10.4	4.7	10.8	15.5	4.8	4.5	25.7	6.6	5.4	3.4	8.4	1.0	0.1	6.8	13.2	9.1	11.7	12.5	11.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	6.2	0.0	19.4	8.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	5.6	0.0	2.3	1.2	0.0	0.2	0.0	0.1	1.3	0.0	0.0	1.6	0.0	0.3	0.0	0.0	15.1	0.0	6.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	40.6	0.2	0.0	0.0	0.0	3.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.8	8.5	0.1	0.0	0.0	5.6	4.9	0.4	6.7	0.1	0.0	0.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	2.5	23.6	1.6	2.0	2.4	3.2	1.2	4.7	1.0	0.0	0.3	44.7	0.4	10.9	4.1	4.3	0.0	1.4	1.2	1.8	0.0	0.1	0.0	2.4	15.8	55.5	0.0	0.0	0.0	0.3	40.4	0.6	0.0	1.0	0.7	0.0	0.0	2.5	0.8	15.5	264.3	1.0	13.5	16.2	0.0	1.7	0.2	0.0	114.2	0.0	2.0	97.0	110.4	2.2	0.4	6.0	0.3	1.3	0.0	0.5
EBF2	"COE2, FLJ11500"	ENSG00000221818	"Early B cell factor 2"	Q9HAK2	8	25841730-26045397	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.8"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9"	"Low region specificity"	"Detected in some"			"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	25.8	1.1	0.2	3.2	0.9	0.1	14.5	0.2	0.2	3.0	4.2	0.0	2.9	0.2	3.0	14.1	5.2	5.1	3.8	16.4	0.2	0.5	0.9	0.2	1.3	4.4	0.9	0.0	3.9	4.0	3.1	0.6	0.8	2.8	3.7	0.7	0.1	1.7	0.8	11.1	1.8	1.0	5.4	10.1	0.2	1.2	4.2	0.0	0.4	7.4	11.6	0.5	6.2	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.5	25.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	14.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.1	12.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.2	0.2	0.5	0.9	0.0	2.8	0.0	0.0	0.3	0.0	0.1	0.1	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.2	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	38.8	9.5	0.2	0.2	0.3	0.0	0.0	0.0	0.0
EBF3	"COE3, DKFZp667B0210"	ENSG00000108001	"Early B cell factor 3"	Q9H4W6	10	129835283-129963841	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 25.8;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 2.4;Endothelial cells: 3.5;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.5;midbrain: 5.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.1;HAP1: 11.8;LHCN-M2: 18.9;NB-4: 23.8;RH-30: 10.3;SCLC-21H: 24.4;THP-1: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061169			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA061169: AB_2684441"	"unprognostic (2.96e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.50e-3)"	"unprognostic (8.53e-6)"	"unprognostic (2.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.58e-2)"	20.0	0.9	0.3	3.4	0.4	0.1	25.8	0.7	0.5	7.3	3.6	0.2	2.5	0.2	5.4	4.9	4.3	3.8	4.3	10.5	0.3	2.5	0.6	0.4	1.0	29.9	5.0	0.3	1.0	1.2	3.6	0.9	3.8	4.8	4.6	0.8	2.0	3.6	2.2	10.9	2.8	1.0	6.3	9.3	0.2	1.6	4.6	0.1	0.5	6.7	6.3	2.4	4.7	16.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	10.1	7.8	0.1	0.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	11.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.0	0.7	0.0	0.0	18.9	0.1	0.0	23.8	0.1	0.0	0.0	0.3	10.3	0.0	0.0	0.1	24.4	0.3	0.0	0.0	0.0	0.2	0.0	10.0	0.0	0.0	1.2	6.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.5	0.3	2.5	5.0	0.3	4.8	0.1	0.0	0.0	0.0	0.0	1.6	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.6	0.0	11.8	0.0	0.9	0.6	0.0	0.0	0.0	0.0
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	19	"Muller glia cells: 76.3;Peritubular cells: 19.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AN3-CA: 30.1;HeLa: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.7	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.0	0.0	0.0	76.3	0.2	0.0	19.8	0.0	1.7	0.0	2.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0
ECHDC3	FLJ20909	ENSG00000134463	"Enoyl-CoA hydratase domain containing 3"	Q96DC8	10	11742366-11764070	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.1;skeletal muscle: 77.7"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 122.7;Hepatocytes: 134.4;Proximal tubular cells: 172.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 7.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"A-431: 28.6;BEWO: 16.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038306	Enhanced					NA	NA		93000			"HPA038306: AB_10672586"	"unprognostic (8.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (3.91e-4)"	29.9	9.9	0.7	4.7	1.3	2.5	53.8	1.2	1.3	5.1	5.9	1.5	4.4	0.6	3.3	4.9	14.0	3.5	2.3	47.7	0.6	0.5	26.4	64.1	9.8	8.2	0.8	0.4	4.6	23.6	0.8	4.4	6.8	7.5	6.9	1.4	7.7	16.0	6.4	77.7	5.7	3.2	2.5	1.0	6.1	6.7	6.7	0.8	1.4	11.2	10.8	6.2	3.4	4.6	1.2	1.8	14.3	1.8	0.5	0.5	0.3	28.6	4.2	0.0	0.0	0.0	0.0	16.3	3.6	0.0	2.6	2.3	10.6	0.2	0.0	3.3	7.8	0.7	7.0	6.7	1.0	1.1	0.0	0.3	0.0	4.4	0.0	11.9	0.0	4.2	8.1	6.7	2.7	0.0	0.2	5.2	0.0	10.5	0.0	0.8	3.9	0.0	0.1	7.6	0.1	0.0	8.8	0.0	0.0	2.0	0.0	3.1	4.8	0.0	7.4	0.0	9.9	11.5	1.4	1.5	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	1.8	14.3	0.0	0.6	0.1	0.2	0.2	0.5	1.8	1.2	0.3	0.1	3.6	0.5	0.6	0.6	0.0	0.3	0.7	1.3	1.2	1.3	0.6	0.5	0.8	0.4	7.5	0.8	17.9	7.3	4.3	13.8	3.9	0.9	32.5	20.4	0.0	10.3	15.7	2.0	55.7	122.7	29.3	3.7	3.1	0.5	0.0	26.3	26.3	3.1	15.0	0.0	134.4	11.9	0.0	0.0	8.0	12.9	4.4	2.6	7.8	8.5	8.2	0.0	12.9	17.3	0.0	3.2	172.5	2.2	19.4	8.2	13.5	8.7	5.0	24.1	0.5	0.4	4.7
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 133.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 2.8;SCLC-21H: 2.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain					NA	NA					"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.5	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.3	0.0	0.0	0.9	0.2	0.5	2.8	0.2	0.0	0.1	0.9	0.4	1.3	1.0	0.0	0.0	0.6	0.0	0.2	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.2	0.6	0.5	0.3	0.2	0.0	0.7	2.9	0.7	0.2	0.8	0.4	0.5	0.3	1.2	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.8	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8	0.0	0.6	0.0	0.5	0.5	2.2	1.2	0.0	133.8	21.6	0.0	2.0	0.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.3
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.6	0.0	21.7	0.0	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.8	5.1	5.8	0.4	10.4	0.0	0.2	25.8	0.0	0.5	0.5	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1	6.0	1.0	0.0	145.6	27.0	0.0	0.4	5.1	1.4	0.0	66.3	0.0	0.0	0.0	6.2	0.0	0.0	10.9	0.0	0.9	0.0	0.5	63.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	6.7	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.5	0.0	0.0	3.3	23.3
EFCAB12	C3orf25	ENSG00000172771	"EF-hand calcium binding domain 12"	Q6NXP0	3	129401321-129428651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 24.4;fallopian tube: 29.9;testis: 24.8"	"Cell type enhanced"	"Detected in some"	22	"Ciliated cells: 58.9;Early spermatids: 23.2;Late spermatids: 14.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 14.9;pons and medulla: 24.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;RPTEC TERT1: 3.8;SCLC-21H: 2.9"					"Region enhanced"	"Detected in many"		"midbrain: 14.2"	"HPA037694, HPA057532"	Uncertain	Supported	Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		NA	NA			Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA037694: AB_10672605, HPA057532: "	"unprognostic (2.06e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.59e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.59e-2)"	0.7	0.6	2.2	0.7	14.9	1.5	0.9	1.7	3.0	2.0	0.6	7.8	0.0	0.5	1.8	10.1	0.6	29.9	1.5	0.7	4.2	4.3	1.2	2.1	3.6	0.8	0.5	3.5	6.1	1.0	3.1	15.2	0.7	24.4	4.1	0.6	1.5	0.6	0.9	0.5	0.5	0.5	0.6	1.0	0.7	1.0	24.8	1.6	0.0	2.4	0.0	0.9	0.5	0.1	1.4	0.0	1.3	0.4	0.3	0.6	0.0	0.4	2.2	0.7	2.2	0.4	0.1	0.4	0.0	0.2	0.3	0.1	0.8	1.2	0.5	0.4	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.5	0.6	0.6	4.7	0.3	0.3	0.9	0.5	0.0	0.5	0.0	0.4	0.0	1.3	1.4	0.9	0.0	0.3	0.1	1.7	0.3	0.2	0.1	0.8	0.0	0.5	3.8	0.0	2.9	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.5	1.1	0.2	1.4	1.8	2.2	0.5	0.8	0.2	0.0	0.4	0.8	0.1	0.0	0.3	0.3	0.0	0.6	0.0	1.4	0.3	0.2	1.3	0.3	0.0	0.0	0.2	0.0	2.2	14.9	1.7	3.0	4.2	4.3	0.5	3.5	24.4	1.6	3.0	1.7	0.0	0.1	0.5	0.2	1.1	2.5	58.9	2.3	0.0	2.0	0.0	0.0	0.1	23.2	0.3	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.8	0.1	4.8	0.0	0.0	0.0	14.5	0.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	5.2	0.0	0.0	8.2	2.5	0.3	0.0	0.0	0.0	0.1
EFHC2	"FLJ22843, MRX74"	ENSG00000183690	"EF-hand domain containing 2"	Q5JST6	X	44147882-44343672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;fallopian tube: 20.8"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 64.3;Early spermatids: 62.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 20.6"	"Group enriched"	"Detected in some"	5	"basophil: 14.1;NK-cell: 6.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 14.1;NK-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HEL: 5.4;HMC-1: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034492	Approved	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Plasma membrane"	"HPA034492: AB_10671227"	"unprognostic (1.93e-1)"	"unprognostic (7.80e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.07e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.13e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.97e-2)"	0.7	0.6	4.0	0.8	6.2	1.9	1.2	1.6	3.1	4.6	1.6	6.5	3.7	0.6	5.4	12.6	2.9	20.8	3.0	6.0	4.8	3.9	2.0	0.1	4.5	0.5	1.5	2.0	5.2	0.3	0.9	6.9	1.3	20.6	2.9	0.6	0.6	9.6	5.8	0.1	4.7	0.8	2.6	1.4	0.6	1.6	10.1	3.1	0.4	3.7	1.4	0.9	1.7	1.4	0.1	0.4	14.1	0.0	6.6	2.1	1.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	5.2	0.0	0.1	0.0	1.7	0.0	0.4	0.0	0.1	0.0	0.1	5.4	0.0	0.0	0.0	0.0	18.0	0.3	0.3	0.3	0.0	0.2	0.0	0.8	1.5	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.1	0.3	0.0	0.0	1.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	14.1	0.0	0.0	2.1	0.0	0.8	0.1	0.8	0.1	0.4	0.1	0.7	1.0	1.9	6.6	0.0	0.0	0.0	1.4	4.0	6.2	1.6	3.1	4.8	3.9	1.5	2.0	20.6	3.1	0.0	4.6	0.0	5.2	2.7	0.1	12.2	5.1	64.3	2.3	0.0	2.0	0.0	1.7	0.5	62.9	0.0	1.3	0.0	5.3	0.0	1.0	0.7	15.1	0.0	0.2	0.0	0.0	0.0	0.0	12.0	6.4	0.2	0.0	0.0	1.3	4.9	0.7	0.0	6.7	0.0	0.0	6.5	2.1	8.6	10.4	2.5	0.2	0.5	3.5	6.5
EGR3	PILOT	ENSG00000179388	"Early growth response 3"	Q06889	8	22687659-22693302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 102.0;Intestinal endocrine cells: 272.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 11.5;basal ganglia: 33.6;cerebral cortex: 35.0;hippocampal formation: 13.7;olfactory region: 12.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6;HMC-1: 7.5;MCF7: 24.5;SK-MEL-30: 16.4"	"Group enriched"	"Detected in many"	10	"amygdala: 26.1;basal ganglia: 40.1;cerebral cortex: 47.9;hippocampal formation: 32.4;olfactory region: 18.2"	"Group enriched"	"Detected in many"	9	"amygdala: 29.0;basal ganglia: 68.2;cerebral cortex: 57.2;hippocampal formation: 56.6;olfactory region: 75.0"	"HPA006206, CAB009373"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB009373: AB_2097202, HPA006206: AB_10602491"	"prognostic favorable (1.83e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.44e-2)"	"prognostic favorable (4.78e-4)"	"unprognostic (3.48e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.07e-2)"	20.7	17.7	11.5	12.3	33.6	5.6	7.1	0.8	35.0	7.4	3.3	11.1	0.2	0.9	3.8	1.0	4.0	14.6	20.6	8.5	13.7	2.0	3.0	2.0	4.1	7.3	1.9	12.8	10.6	2.9	12.8	5.0	1.2	3.6	10.3	2.2	2.6	2.3	4.0	1.6	28.4	3.6	8.3	1.6	2.8	5.3	4.1	2.1	5.5	5.8	1.3	5.8	12.3	2.5	0.8	0.0	2.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	1.5	4.6	0.1	0.4	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.3	0.3	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.2	0.2	0.0	0.6	0.1	0.1	0.2	0.1	0.0	24.5	0.0	0.2	0.1	1.7	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.1	0.4	0.0	16.4	0.2	1.1	0.0	0.0	0.2	0.1	0.2	0.3	0.3	0.0	0.0	0.7	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	11.5	33.6	0.8	35.0	13.7	2.0	1.9	12.8	3.6	2.1	6.0	18.6	7.5	26.7	20.5	1.6	35.5	0.0	2.7	3.4	0.0	0.0	1.2	0.0	2.5	19.0	17.5	0.9	0.0	3.9	1.1	23.9	18.9	102.0	0.4	3.7	0.0	272.8	20.9	12.3	6.2	2.8	11.0	20.3	0.0	12.8	3.0	2.6	2.9	0.4	0.0	1.1	0.0	23.7	0.0	0.2	43.7	8.1	0.0	4.3	3.1
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.1;Paneth cells: 44.1;Undifferentiated cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;CAPAN-2: 24.9;HaCaT: 23.6;T-47d: 23.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favorable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	1.1	0.8	0.6	7.8	1.8	2.5	4.6	6.7	1.4	2.8	30.3	0.5	32.0	18.9	2.6	9.8	13.1	4.8	16.0	0.9	0.7	0.8	13.3	3.9	6.9	1.4	0.5	0.5	1.2	26.6	6.5	28.7	13.7	1.0	13.2	5.1	0.9	25.1	28.8	0.5	19.1	37.7	1.7	0.5	2.8	12.8	8.7	0.6	1.1	18.2	9.7	9.2	6.8	6.0	1.2	0.8	2.1	0.4	0.4	1.0	0.1	10.8	1.2	1.2	1.5	0.2	0.3	17.0	0.6	0.3	0.8	0.7	7.1	24.9	1.5	0.8	0.3	0.3	23.6	1.1	10.9	0.2	0.7	1.4	1.5	2.0	2.3	0.5	0.9	3.9	0.2	8.0	0.6	0.6	0.8	0.8	1.3	1.5	0.8	0.4	9.0	0.9	4.5	1.6	10.2	1.0	2.2	1.2	2.4	1.0	1.5	8.3	1.9	1.6	7.4	0.7	0.7	23.3	1.7	1.4	1.9	2.3	1.2	1.1	2.5	0.8	2.8	1.0	2.1	0.9	0.0	0.4	1.0	1.0	0.0	0.1	1.2	0.8	0.1	0.5	1.1	0.6	0.2	2.1	0.4	0.1	0.8	0.5	0.1	0.6	1.8	6.7	1.4	0.7	0.8	0.5	0.5	1.0	0.6	0.0	12.5	2.4	11.4	7.8	0.8	1.1	12.7	1.4	2.3	19.2	0.0	26.3	14.9	16.5	19.0	1.4	67.1	0.0	20.8	12.4	1.0	6.3	4.6	3.9	3.1	0.0	12.6	1.3	1.3	26.2	0.9	1.4	3.3	2.8	31.8	0.4	23.9	44.1	0.7	23.7	1.3	0.0	0.4	7.9	2.5	11.8	14.1	0.0	45.7	8.1
ELSPBP1	"E12, EDDM12, HE12"	ENSG00000169393	"Epididymal sperm binding protein 1"	Q96BH3	19	47994651-48025153	"Predicted intracellular proteins, Predicted secreted proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"epididymis: 279.8"	"Cell type enhanced"	"Detected in some"	20	"Cone photoreceptor cells: 15.7;Early spermatids: 23.3;Horizontal cells: 17.5;Late spermatids: 14.5;Muller glia cells: 16.0;Rod photoreceptor cells: 68.3"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.9"	"Region enriched"	"Detected in single"	11	"hypothalamus: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HMC-1: 14.6;NB-4: 7.9"					"Not detected"	"Not detected"			"HPA044256, HPA050341"	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA044256: AB_2678879, HPA050341: AB_2681097"					"unprognostic (1.51e-1)"				"unprognostic (1.11e-1)"						"unprognostic (1.87e-1)"			0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	279.8	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	17.5	0.0	0.0	0.0	14.5	0.6	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.4	0.0	68.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196716-13219939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 240.9;lymphoid tissue: 129.3"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 28.6"	"Cell type enriched"	"Detected in some"	7	"myeloid DC: 7.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051931, HPA056250"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051931: , HPA056250: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (9.69e-8)"	63.3	5.0	2.7	8.0	10.4	2.1	20.8	0.8	3.9	51.3	11.6	5.5	4.0	4.6	14.0	10.4	240.9	9.9	25.2	16.1	7.3	2.8	8.9	4.4	18.1	5.9	5.3	0.9	5.7	10.2	2.9	2.8	10.6	28.6	6.3	6.9	17.8	45.4	2.8	12.0	16.8	10.7	17.6	9.7	8.5	6.0	5.2	3.0	0.6	22.5	99.1	129.3	14.1	80.6	0.0	7.0	0.0	0.5	0.1	0.1	0.0	38.9	2.0	1.0	0.2	63.1	132.0	0.1	28.8	52.9	14.9	19.0	0.2	66.0	0.2	20.6	91.8	6.5	82.1	1.1	3.8	20.2	0.7	0.0	0.1	6.9	0.0	15.2	0.2	0.2	41.4	5.6	47.3	13.9	11.8	34.0	0.0	0.2	0.6	35.0	0.1	0.0	0.8	0.7	7.3	6.7	0.1	4.0	0.3	43.5	0.4	0.0	0.0	12.9	1.9	21.5	7.7	0.3	0.2	37.2	33.5	11.8	31.4	15.5	0.1	0.4	0.2	48.8	0.2	39.3	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.7	10.4	0.8	3.9	7.3	2.8	5.3	0.9	28.6	3.0	190.6	90.0	2.7	198.6	616.6	0.0	9.5	2.5	87.0	247.9	17.4	0.0	0.8	13.3	17.9	0.7	293.7	59.6	0.0	3.9	1.5	489.5	352.1	46.5	2.0	41.5	0.0	45.6	127.7	32.1	0.5	64.5	93.9	448.7	7.2	4.0	2.5	37.6	27.1	102.9	0.2	0.0	6.5	173.1	0.7	0.5	601.1	0.9	5.1	5.6	926.6
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8;kidney: 27.4"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 52.4;Proximal tubular cells: 31.6"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;CACO-2: 5.7;HEK 293: 12.8;HMC-1: 2.5;RPTEC TERT1: 2.2;U-2 OS: 2.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.3	5.2	0.2	3.1	0.1	0.1	0.1	14.8	0.1	0.5	0.0	0.8	1.4	0.1	6.0	0.2	0.1	0.1	0.2	5.0	0.4	27.4	0.2	0.1	0.2	0.4	1.5	0.2	0.4	4.8	0.2	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.2	0.2	1.1	0.1	0.1	0.1	0.3	2.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.8	0.0	0.0	1.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.1	0.1	14.8	5.0	0.4	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	52.4	0.0	0.0	5.0	0.0	0.8	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.6	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 11.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8"	"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA			"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.5	0.2	14.4	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	4.2	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	8.8	0.9	9.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	2.3	0.0	0.0	0.0	0.0
ENC1	"ENC-1, KLHL37, NRPB, PIG10, TP53I10"	ENSG00000171617	"Ectodermal-neural cortex 1"	O14682	5	74627406-74641424	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 106.8"	"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 54.5;Ito cells: 49.7;Pancreatic endocrine cells: 54.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9"	"Group enriched"	"Detected in many"	6	"classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078061			Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA078061: "	"prognostic unfavorable (3.88e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.98e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (9.69e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.65e-2)"	2.2	1.1	39.7	4.7	42.7	5.4	1.8	1.3	106.8	4.2	5.2	2.4	2.1	6.4	2.9	1.6	2.5	1.3	7.5	3.2	44.1	7.7	2.2	6.4	4.8	2.2	4.6	43.9	6.0	12.3	1.0	2.4	4.2	4.9	4.3	8.1	0.8	5.4	7.4	1.7	1.7	8.1	3.0	2.3	4.0	9.8	4.5	1.5	0.5	1.3	0.3	2.0	6.5	1.3	0.4	2.4	3.4	5.4	2.8	3.0	1.4	11.8	14.7	14.6	6.9	6.3	1.5	31.5	7.9	9.0	9.1	6.7	23.6	19.9	0.0	9.9	6.8	14.9	9.6	0.2	15.3	19.8	0.2	1.1	13.0	2.8	10.3	0.6	1.2	0.1	2.4	1.0	24.1	2.3	31.0	7.4	3.0	2.8	7.6	23.7	2.8	1.2	1.7	15.3	10.9	13.2	1.4	9.6	1.2	4.9	9.0	19.7	8.0	1.3	6.5	0.7	18.8	3.1	1.6	17.6	15.4	25.8	9.1	25.5	0.1	0.0	0.2	17.8	1.1	23.5	0.0	5.4	3.4	2.3	4.8	0.0	0.1	0.5	3.0	2.4	0.4	0.2	2.5	1.4	2.8	1.3	0.0	0.0	1.4	39.7	42.7	1.3	86.4	44.1	7.7	4.6	43.9	4.9	1.5	0.0	13.4	5.7	13.3	2.3	0.4	1.1	17.8	5.3	7.9	10.4	2.0	12.1	3.3	54.5	16.1	6.0	12.3	0.0	27.4	3.5	12.2	16.4	20.8	16.3	21.6	0.0	14.9	49.7	10.4	13.6	34.8	5.3	0.0	1.8	18.9	0.5	54.2	10.5	31.5	3.3	1.1	6.5	8.2	0.6	0.4	1.0	2.2	4.4	26.4	13.6
ENTHD1	FLJ25421	ENSG00000176177	"ENTH domain containing 1"	Q8IYW4	22	39743044-39893864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 15.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.8;granulocytes: 9.2;Late spermatids: 12.4;Spermatocytes: 26.1"	"Cancer enriched"	"Detected in single"	30	"melanoma: 7.0"	"Region enriched"	"Detected in single"	20	"basal ganglia: 2.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 7.0"	"Not detected"	"Not detected"							HPA019800	Uncertain					NA	NA					"HPA019800: AB_1848842"	"unprognostic (5.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.97e-4)"	"unprognostic (6.02e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.47e-4)"	"unprognostic (3.60e-2)"	"unprognostic (7.75e-10)"	"unprognostic (3.68e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.06e-1)"	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	15.8	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.2	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	26.1	3.0	0.0	0.0	0.0	0.0	0.0
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.9;brain: 22.6;lymphoid tissue: 21.4"	"Group enriched"	"Detected in some"	8	"Erythroid cells: 23.3;T-cells: 32.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in some"	20	"cerebellum: 22.6"	"Group enriched"	"Detected in many"	7	"gdT-cell: 10.0;MAIT T-cell: 16.5;memory CD8 T-cell: 12.0;naive CD8 T-cell: 7.5;NK-cell: 17.9"	"Group enriched"	"Detected in many"	102	"NK-cells: 17.9;T-cells: 16.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.2;JURKAT: 12.3;SCLC-21H: 5.7"	"Region enriched"	"Detected in some"	8	"olfactory region: 95.2"	"Group enriched"	"Detected in many"	13	"cerebellum: 44.2;olfactory region: 21.9"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.4	0.7	0.5	6.8	0.4	1.6	1.6	22.6	0.4	1.8	0.8	0.0	0.0	0.3	3.2	0.9	1.4	0.6	5.0	0.7	0.4	0.7	1.0	4.9	10.1	15.6	0.5	0.3	1.3	0.9	0.0	0.6	1.6	1.1	2.1	0.9	3.3	2.2	0.1	0.4	0.4	1.8	0.7	0.9	21.4	1.4	0.5	0.0	1.8	1.1	0.9	11.2	3.3	0.8	0.0	0.0	0.1	0.0	17.9	16.5	1.4	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	2.0	0.0	10.2	1.5	0.0	0.1	0.8	0.0	1.2	0.0	0.1	1.2	0.0	1.4	0.5	0.0	12.3	0.3	0.0	0.0	3.0	2.7	0.0	0.3	0.2	1.2	1.9	0.0	0.0	1.0	0.0	5.7	0.0	0.0	0.0	1.2	0.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	10.0	0.0	16.5	0.0	1.9	12.0	0.0	0.0	0.1	7.5	0.1	17.9	0.0	0.0	0.0	1.4	0.5	0.4	22.6	0.4	0.4	0.7	0.5	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	3.7	3.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.6	0.1	0.0	32.6	0.0	0.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell type enriched"	"Detected in many"	15	"Erythroid cells: 186.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	92	"HEL: 43.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		7500000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3	0.0	0.0	0.5	1.2	1.6	3.7	0.3	2.5	0.0	0.0	0.0	5.9	3.3	0.0	0.0	7.7	0.6	1.1	186.9	0.0	1.9	1.7	1.0	4.6	0.5	1.0	6.4	0.0	1.3	0.3	8.0	2.6	0.8	1.7	0.0	0.8	2.8	0.0	1.7	0.7	0.0	7.8	6.5	1.2	12.1	3.8	2.5	5.6	4.4	0.6	1.6
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 104.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.5;HaCaT: 9.8;HBEC3-KT: 8.0;MCF7: 8.7;NTERA-2: 32.7"	"Not detected"	"Not detected"							CAB026144	Uncertain					NA	NA		24000000			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.4	0.4	0.0	2.0	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0.0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0.0	0.0	2.8	10.6	2.9	5.8	0.0	0.0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0.0	5.1	6.0	16.4	17.2	1.6	11.8	0.0	0.7	0.2	0.1	0.2	6.9	1.6	5.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	10.5	4.2	0.0	0.0	0.0	0.0	9.8	0.0	8.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.7	0.0	1.1	32.7	5.1	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	0.0	4.9	0.0	2.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	3.4	0.9	0.4	0.0	6.9	5.1	0.2	0.2	0.0	0.7	0.2	1.6	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	0.0	5.0	1.8	0.0	0.8	2.5	0.0	3.4	7.0	0.0	1.5	0.0	3.9	16.5	0.0	6.5	0.0	3.7	2.0	0.4	2.1	0.0	7.6	0.4	0.0	1.2	0.0	0.0	7.5	0.6	0.0	0.0	0.0	3.7	0.3	5.1	6.8	0.0	1.1	0.0	0.0	0.0	0.2	1.2	3.1	0.8	0.0	6.0	5.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532543-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 17.4;Cytotrophoblasts: 52.4;Mucus-secreting cells: 17.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 6.8;pons and medulla: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HBEC3-KT: 16.6;MCF7: 26.7;OE19: 25.1;RT4: 20.9;SK-BR-3: 10.8;T-47d: 24.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2"	"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.4	7.7	0.5	1.9	0.7	0.4	1.9	1.1	6.8	5.3	7.8	1.5	24.0	5.1	0.7	3.8	26.2	6.0	12.6	6.6	0.5	0.7	10.9	0.4	0.7	0.0	2.0	1.4	10.3	18.3	9.6	0.9	8.4	17.8	9.3	3.4	0.3	16.7	18.7	0.4	19.7	5.1	0.5	0.6	0.3	23.8	2.2	0.0	3.4	1.2	15.9	21.9	8.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.0	12.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	9.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.0	25.1	0.2	0.0	0.0	0.0	0.1	20.9	0.2	0.0	0.0	10.8	0.0	0.1	24.1	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	6.8	0.5	0.7	2.0	1.4	17.8	0.0	0.0	0.0	0.0	3.4	2.1	0.3	4.8	7.6	0.0	0.0	17.4	0.0	52.4	5.0	5.6	0.4	0.1	9.3	0.0	10.0	5.6	0.3	4.4	0.0	0.0	5.1	0.0	3.5	0.0	0.0	1.8	2.6	0.0	0.0	1.0	17.7	0.5	5.2	10.5	0.0	0.0	0.3	0.0	0.3	0.0	0.4	4.8	8.9	0.0	16.6	5.8
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720800-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.9;endometrium 1: 8.7;liver: 29.3"	"Cell type enhanced"	"Detected in some"	16	"Exocrine glandular cells: 3.6;Extravillous trophoblasts: 12.2;Hepatocytes: 8.5;Pancreatic endocrine cells: 6.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 4.4"	"Cell type enriched"	"Detected in single"	13	"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Group enriched"	"Detected in some"	7	"BEWO: 3.6;Hep G2: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300				"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	10.9	0.0	0.0	0.0	0.0	8.7	0.6	0.4	0.0	0.0	0.1	0.0	0.0	2.8	29.3	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.7	0.0	1.6	0.0	0.7	0.9	1.6	0.0	0.7	0.0	0.6	0.0	0.0	0.0	2.4	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.2	0.0	0.0	13.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	12.2	0.0	0.1	0.0	8.5	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	2.4	0.0	0.0	0.0
ERFE	"C1QTNF15, CTRP15, FAM132B, FLJ37034"	ENSG00000178752	Erythroferrone	Q4G0M1	2	238158982-238168900	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.4;testis: 13.8;thyroid gland: 25.6"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 7.5;Ciliated cells: 4.0;Club cells: 4.5;Distal tubular cells: 3.3;granulocytes: 4.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.2"	"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 14.1;hTEC/SVTERT24-B: 13.7;REH: 14.0;RH-30: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	277000					"unprognostic (1.66e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.64e-4)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.84e-1)"	"unprognostic (9.61e-4)"	"unprognostic (4.68e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.31e-4)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (4.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.33e-2)"	1.6	0.0	2.4	2.5	1.0	3.5	0.1	9.2	2.5	2.1	0.5	0.4	0.1	0.6	0.9	3.0	0.8	0.1	0.3	3.2	1.9	0.1	3.3	0.3	0.5	0.1	0.1	0.7	0.4	0.3	0.2	0.1	3.5	0.5	0.4	0.3	0.4	1.5	1.6	12.4	0.0	1.1	0.5	0.1	0.5	0.7	13.8	0.1	0.4	25.6	4.8	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	2.1	0.6	0.9	1.9	0.1	3.4	0.2	1.4	2.0	3.5	5.8	0.1	5.2	0.0	4.0	0.3	6.9	0.2	9.3	0.4	3.1	0.0	14.1	0.0	0.2	0.1	1.2	0.0	1.0	7.3	1.0	13.7	9.8	0.4	0.1	4.5	3.0	0.0	9.0	2.8	0.0	5.8	1.5	0.6	0.9	14.0	17.9	0.6	7.3	0.0	0.3	5.4	2.1	0.4	7.9	1.8	0.3	10.5	0.8	5.5	5.1	2.1	7.2	0.0	0.0	0.6	9.3	2.9	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	1.0	9.2	2.5	1.9	0.1	0.1	0.7	0.5	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	1.8	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.4;liver: 54.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 302.8;Late spermatids: 360.4;Muller glia cells: 292.0;Paneth cells: 221.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.0"	"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.0;Hep G2: 27.1;SK-BR-3: 55.6;T-47d: 18.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	1.4	0.6	2.5	0.8	6.7	2.9	6.0	0.7	13.3	44.8	0.6	9.2	27.1	1.2	19.7	9.9	6.3	1.2	0.6	1.0	0.1	14.3	54.9	1.6	0.6	0.6	0.6	2.4	0.6	12.9	12.1	1.3	0.6	2.6	1.7	19.5	2.9	4.7	0.6	27.1	70.4	1.0	0.6	0.6	0.4	37.7	0.6	1.2	0.7	2.4	3.2	0.8	5.9	0.0	0.0	0.0	0.0	0.0	3.6	0.3	4.6	0.2	0.2	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	10.1	0.5	0.1	2.3	0.0	0.0	11.1	0.8	0.0	0.0	0.6	0.2	0.1	0.2	27.1	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.3	5.7	0.0	0.0	9.4	0.0	0.3	0.2	1.2	4.2	0.0	0.1	3.6	0.0	0.0	7.3	0.3	1.3	55.6	1.7	0.1	18.5	2.4	5.3	0.0	0.2	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.6	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	0.8	6.0	0.7	1.0	0.1	0.6	0.6	0.6	0.6	0.0	1.1	1.4	1.7	6.9	5.5	1.1	5.1	1.4	1.2	8.7	64.8	2.2	11.6	0.3	114.4	0.6	302.8	23.3	2.9	0.4	0.4	1.4	0.0	99.9	0.2	0.0	5.8	3.1	2.9	360.4	3.4	0.3	0.0	0.0	16.1	292.0	0.1	221.0	2.1	91.6	68.8	0.0	0.0	2.6	2.5	19.8	5.5	0.8	19.0	3.2
ESPNL	FLJ42568	ENSG00000144488	"Espin like"	Q6ZVH7	2	238100157-238133287	"Predicted intracellular proteins"	Hearing	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.9;pituitary gland: 8.2"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.7;Muller glia cells: 1.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.9"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"B-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;Daudi: 5.1;fHDF/TERT166: 4.7;HHSteC: 5.4;THP-1: 3.7;U-87 MG: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055103	Uncertain					NA	NA					"HPA055103: AB_2682694"	"unprognostic (8.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-6)"	"unprognostic (3.49e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.67e-2)"	0.6	0.5	0.3	6.0	0.3	0.0	0.6	9.9	0.6	1.2	1.1	0.6	0.3	1.4	1.5	0.3	0.8	2.8	0.3	1.3	0.3	0.0	1.1	3.5	0.7	2.6	0.3	0.3	4.0	1.3	0.0	8.2	0.3	2.0	1.5	0.2	0.6	2.0	3.5	0.3	0.1	4.9	1.6	0.3	3.8	0.8	0.4	0.8	0.3	2.0	0.3	2.8	0.4	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	1.4	0.6	2.0	1.0	1.7	1.8	0.0	0.0	5.1	2.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.9	1.8	5.4	0.0	1.1	1.9	0.0	0.2	0.0	0.0	0.0	1.6	1.7	0.0	2.0	0.0	0.0	2.3	0.4	0.0	0.0	1.6	0.2	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	4.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	9.9	0.6	0.3	0.0	0.3	0.3	2.0	0.8	0.0	0.0	0.8	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ESRRG	NR3B3	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.5;parathyroid gland: 37.2;placenta: 40.8"	"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"pons and medulla: 49.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 15.4;SH-SY5Y: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (6.48e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.06e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.79e-2)"	"prognostic favorable (1.13e-11)"	"unprognostic (3.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.65e-4)"	"unprognostic (2.05e-1)"	0.5	5.1	2.8	0.4	3.3	0.2	2.9	6.9	10.3	1.4	0.7	0.7	2.2	4.0	0.5	1.5	1.4	2.1	0.8	8.3	3.2	2.6	22.0	0.8	0.7	0.4	6.8	1.7	0.8	4.4	37.2	9.9	40.8	49.5	2.6	0.4	10.7	11.0	2.4	6.3	1.5	3.7	0.9	2.6	1.0	22.2	1.0	1.5	0.0	4.6	7.2	0.4	1.0	0.7	0.4	0.2	1.5	0.0	0.2	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	15.4	2.4	1.7	5.5	29.5	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.5	0.2	0.0	0.2	0.0	0.0	2.8	3.3	6.9	10.3	3.2	2.6	6.8	1.7	49.5	1.5	0.0	2.6	0.0	3.3	0.2	26.3	45.0	7.6	18.7	1.2	22.7	55.0	29.1	46.4	3.1	4.5	0.3	0.0	0.0	2.1	3.1	1.5	8.3	0.0	0.8	3.8	46.1	7.9	0.6	0.8	4.6	0.3	0.0	8.5	0.0	0.7	12.3	0.6	0.2	0.7	23.0	34.7	0.0	1.0	1.4	0.1	0.3	179.8	0.0	0.2	1.4
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;skin 1: 13.7"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 35.7;Alveolar cells type 2: 30.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.3;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0;SuSa: 3.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.5"	"Low region specificity"	"Detected in all"			HPA039200	Approved					NA	NA					"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.6	0.8	5.7	0.6	5.8	0.5	2.6	28.5	5.9	1.3	4.9	0.6	0.2	0.7	5.3	0.8	0.9	1.0	2.8	1.1	5.3	3.0	1.8	0.5	12.4	0.5	1.9	4.0	0.9	2.0	3.5	3.0	1.5	4.2	1.0	1.1	0.7	0.8	0.7	0.8	13.7	0.7	4.8	1.2	0.5	2.7	1.4	1.2	0.0	11.5	1.8	1.6	2.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	0.4	0.0	2.0	1.8	0.2	0.6	3.0	0.2	0.0	0.5	0.1	0.2	1.0	1.1	0.3	0.1	0.3	0.1	1.3	0.1	0.1	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.2	0.7	7.5	0.0	0.5	0.0	0.1	0.0	0.8	0.2	8.1	0.0	3.3	0.4	4.0	3.7	0.8	0.3	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	5.8	28.5	5.9	5.3	3.0	1.9	4.0	4.2	1.2	35.7	30.7	0.0	0.7	0.7	1.8	2.0	2.5	1.4	7.9	1.8	3.9	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.4	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.5	0.0	0.0	0.2	2.3	0.0	0.5	2.1	0.5	1.4	0.6	0.0	0.1	0.0
ETV1	ER81	ENSG00000006468	"ETS variant 1"	P50549	7	13891228-13991425	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 90.0;salivary gland: 45.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 90.0"	"Cell type enriched"	"Detected in single"	5	"T-reg: 3.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 418.9"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	2.5	12.4	8.1	1.1	11.7	0.2	4.4	90.0	35.2	1.4	2.4	3.1	0.1	1.2	2.4	1.3	1.5	1.1	9.2	18.0	7.0	4.5	2.1	2.0	14.9	0.7	4.5	6.9	1.0	1.6	11.4	7.4	1.9	8.3	3.1	2.4	0.9	45.8	7.1	0.9	1.5	1.9	2.0	3.5	4.5	1.7	4.5	2.9	0.3	6.5	0.9	4.7	1.8	1.3	0.0	0.0	0.0	0.6	0.0	3.1	0.2	0.0	1.6	11.6	22.2	4.1	12.2	0.0	1.0	3.9	0.6	2.6	0.0	5.3	0.0	1.2	1.8	3.2	0.1	0.4	1.2	1.4	0.3	0.5	0.6	1.0	0.0	2.4	3.8	1.5	3.6	0.0	7.6	0.6	25.6	5.0	0.3	3.4	0.1	4.7	0.0	0.0	0.0	17.5	0.6	11.8	0.0	7.1	0.9	7.9	0.1	26.3	5.1	0.0	0.4	6.3	4.2	0.4	0.1	2.7	2.3	0.7	4.5	4.3	4.0	1.2	0.0	51.8	0.2	25.6	0.0	0.2	0.0	0.1	0.6	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	8.1	11.7	90.0	10.9	7.0	4.5	4.5	6.9	8.3	2.9	17.9	112.4	0.0	2.5	0.9	4.2	72.8	38.2	1.4	1.2	3.5	0.0	0.4	5.0	2.7	18.7	5.2	0.0	0.0	0.8	0.3	4.2	0.2	2.3	11.0	2.6	4.8	190.4	1.8	6.0	6.6	1.4	0.8	11.8	0.0	0.7	12.2	0.9	0.0	32.5	2.7	0.4	19.4	8.2	0.5	1.0	1.1	0.2	0.7	1.1	0.3
ETV3L	FLJ16478	ENSG00000253831	"ETS variant 3 like"	Q6ZN32	1	157092044-157099808	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;breast: 4.4;lymphoid tissue: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.8;pons and medulla: 7.8"	"Group enriched"	"Detected in some"	13	"classical monocyte: 1.5;intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 27.7"					"Not detected"	"Not detected"									NA	NA						"unprognostic (7.39e-4)"	"unprognostic (1.53e-1)"			"unprognostic (3.22e-2)"	"unprognostic (1.79e-5)"		"unprognostic (2.25e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.57e-2)"			"unprognostic (3.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.37e-1)"		0.1	0.0	0.9	2.0	3.8	0.1	4.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.3	0.3	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.0	1.8	0.1	7.8	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.1	0.0	5.0	0.1	0.1	0.1	0.0	5.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.8	0.0	0.7	0.5	0.3	1.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Group enriched"	"Detected in some"	29	"Early spermatids: 49.8;Late spermatids: 47.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"OE19: 21.4;RT4: 13.3"	"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Not detected"	"Not detected"			HPA055132			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	47.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505431-108593738	"Disease related genes, Predicted intracellular proteins"			"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.9;placenta: 45.1;skin 1: 23.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 137.0;Basal keratinocytes: 95.7;Ciliated cells: 87.0;Club cells: 88.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	14	"cerebellum: 74.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.4;hTERT-HME1: 10.6;RT4: 18.5;SK-BR-3: 9.0"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.5;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	10	"cerebellum: 64.1"							NA	NA						"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favorable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.7	0.6	0.8	1.2	2.7	0.1	2.6	74.9	1.1	3.3	3.3	1.4	0.0	0.5	0.9	2.5	9.8	1.5	0.3	0.7	1.1	0.8	3.4	6.7	4.7	0.0	1.6	1.0	0.8	1.4	9.3	2.2	45.1	5.4	1.6	3.8	0.7	6.2	0.1	0.6	23.1	1.1	0.6	2.6	0.6	2.8	1.7	2.4	0.6	1.9	7.1	5.2	1.7	1.9	0.7	0.9	3.0	0.6	3.2	2.2	0.5	3.5	0.4	0.2	0.1	0.0	0.0	3.0	0.2	0.1	0.0	0.6	0.9	5.5	0.0	0.2	0.2	0.8	7.4	5.2	1.9	0.2	0.1	1.6	1.5	0.7	0.0	0.5	0.7	0.1	0.1	3.1	0.0	10.6	0.5	0.0	1.2	2.6	0.0	2.9	0.6	0.9	0.0	0.2	5.8	2.2	0.0	0.1	0.0	0.6	18.5	1.3	0.8	0.9	9.0	0.2	1.1	6.0	0.1	0.1	0.0	2.2	0.0	1.0	0.1	0.0	0.0	0.1	0.3	0.0	2.0	0.6	0.5	0.7	0.3	0.3	0.7	1.1	0.4	0.5	0.7	2.1	2.2	3.0	3.2	0.4	0.9	0.3	0.5	0.8	2.7	74.9	1.1	1.1	0.8	1.6	1.0	5.4	2.4	137.0	48.9	0.0	11.5	95.7	0.5	3.3	5.1	87.0	88.7	19.2	13.7	31.0	3.3	4.4	6.2	2.9	12.0	0.0	4.2	3.9	6.1	19.8	1.1	21.3	3.5	0.0	4.7	1.3	0.6	1.6	0.6	3.3	5.0	1.8	33.3	0.5	3.9	11.5	0.0	3.7	1.6	0.0	1.6	1.1	0.2	63.1	45.7	1.8	19.9	16.0
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.1"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.8"	"Cell type enriched"	"Detected in many"	4	"neutrophil: 24.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 34.7;RPTEC TERT1: 57.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	0.6	1.1	1.0	7.2	1.4	0.1	2.9	0.4	0.8	2.4	34.0	1.1	25.3	17.4	1.0	2.2	6.4	2.9	13.6	3.6	1.1	0.9	28.9	7.4	2.8	3.7	0.8	0.4	1.2	16.6	1.3	3.2	2.8	7.8	6.0	21.4	1.1	7.1	23.7	0.3	24.8	64.1	0.7	1.5	3.5	16.8	0.8	0.5	0.6	9.6	5.8	3.1	5.3	3.9	0.3	2.7	24.9	5.7	0.3	2.3	2.0	8.7	14.4	1.2	0.0	0.4	1.1	9.3	0.4	4.8	0.2	0.7	12.4	22.6	0.0	19.5	1.0	22.3	15.0	7.6	6.7	0.4	0.0	7.1	0.2	0.3	8.8	3.1	0.0	0.0	1.6	19.2	2.2	14.4	2.3	23.9	2.2	0.1	0.0	0.0	4.7	1.0	0.0	1.6	4.9	34.7	0.0	0.0	0.2	57.6	16.2	0.6	0.1	3.4	3.5	0.0	14.5	1.5	0.0	15.7	0.0	9.1	0.0	0.0	1.3	0.2	0.0	5.1	0.0	0.4	4.6	5.7	1.0	0.3	1.9	1.2	0.3	2.3	1.2	2.7	0.1	2.2	1.3	24.9	0.3	0.3	0.3	0.6	2.0	1.0	1.4	0.4	0.8	1.1	0.9	0.8	0.4	7.8	0.5	8.9	3.0	2.0	18.2	97.5	0.0	0.3	35.7	18.7	11.4	29.6	0.0	4.8	1.7	20.1	0.0	0.6	75.9	0.0	13.1	6.2	3.7	19.6	2.3	8.5	0.7	0.0	12.6	1.8	2.4	0.0	0.0	1.1	1.7	0.0	43.8	0.0	29.3	35.1	0.0	20.2	1.6	0.0	1.0	0.0	1.4	147.0	1.7	0.0	39.6	93.4
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell type enhanced"	"Detected in many"	22	"Cholangiocytes: 79.0;Cytotrophoblasts: 65.0;Hepatocytes: 221.3;Syncytiotrophoblasts: 49.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in some"	23	"Hep G2: 13.8;OE19: 52.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1	3.0	1.1	0.0	4.4	0.1	0.1	8.6	79.0	5.3	3.4	0.0	2.0	65.0	0.0	1.6	0.7	1.0	0.0	0.0	0.2	1.6	7.7	0.3	0.0	221.3	4.7	0.0	24.2	3.1	18.7	0.0	0.0	0.2	3.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	49.8	1.3	0.0	9.0
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489196	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.6;pituitary gland: 42.8"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 18.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 13.6"	"Lineage enriched"	"Detected in many"	8	"T-cells: 13.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.7;HDLM-2: 9.6;RPMI-8226: 19.4;U-266/70: 16.3;U-266/84: 8.3"															NA	NA						"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (6.83e-5)"	1.0	1.4	1.0	6.8	1.5	0.0	6.7	18.0	1.0	3.5	3.9	0.2	3.8	2.6	1.4	4.7	5.5	5.8	2.4	0.6	1.2	2.3	9.7	20.1	3.5	5.7	1.1	0.5	1.9	43.6	12.7	42.8	1.4	1.8	9.3	3.6	3.8	9.1	5.3	0.3	10.0	6.4	0.6	1.1	2.3	4.1	0.6	0.3	8.5	15.3	2.7	11.0	3.0	3.6	1.8	1.0	0.3	0.0	0.7	13.6	1.5	2.5	0.2	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.0	0.0	1.8	10.7	0.1	3.1	0.0	0.0	0.4	0.8	1.9	0.0	9.6	5.2	0.3	2.5	0.7	0.0	1.1	0.0	0.0	3.2	0.0	0.0	0.1	0.0	1.0	1.2	4.8	0.0	1.0	0.5	0.0	1.8	2.2	0.0	0.0	1.8	19.4	6.3	3.4	1.8	0.1	0.1	3.0	0.0	4.6	3.0	0.0	0.0	0.0	0.2	0.0	0.1	16.3	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	4.7	1.8	7.7	3.2	0.0	0.6	7.5	0.9	0.3	0.7	0.0	1.0	13.6	1.5	1.0	1.5	18.0	1.0	1.2	2.3	1.1	0.5	1.8	0.3	3.0	5.6	0.0	11.2	2.4	3.1	0.3	2.5	24.1	6.8	5.2	17.7	4.4	8.3	8.3	0.0	0.0	3.9	0.0	12.2	2.1	0.5	10.4	0.0	9.0	0.6	1.6	12.7	0.6	0.0	0.0	0.6	0.0	3.3	1.0	5.6	1.2	11.6	3.4	0.4	4.5	12.2	0.0	0.1	0.0	0.0	5.8	4.7	2.5	4.7	9.0
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 41.1"	"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 16.6;Horizontal cells: 36.5;Muller glia cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 10.8;HEK 293: 7.0;PC-3: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: AB_2673711"	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.7	7.8	5.6	0.6	4.0	0.5	1.1	41.1	9.1	1.1	1.0	7.7	0.0	0.7	1.0	1.4	1.2	1.1	1.4	5.2	5.0	6.5	10.4	2.2	0.6	0.5	10.7	3.8	1.2	7.1	2.0	5.6	0.7	8.7	0.8	0.6	0.8	6.3	1.6	0.6	3.2	0.8	0.9	17.7	0.6	1.6	1.3	4.9	0.0	1.7	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.3	10.8	0.4	0.6	0.0	0.0	0.0	1.0	0.9	1.2	2.7	0.2	2.4	0.0	0.4	0.5	2.7	1.2	1.4	0.3	0.4	0.0	7.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.9	3.8	0.7	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.5	2.2	8.0	0.0	0.0	4.6	0.8	0.0	1.5	3.1	0.4	1.3	0.3	0.0	0.3	0.0	1.7	0.2	3.8	0.0	0.0	1.7	0.1	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.0	41.1	7.1	5.0	6.5	10.7	3.8	8.7	4.9	0.0	0.0	0.0	0.3	0.2	3.5	1.6	2.5	0.0	0.0	8.7	3.9	0.0	16.6	2.6	1.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	36.5	3.4	0.6	0.0	1.3	0.0	0.0	0.0	4.6	0.0	32.7	0.4	0.0	0.0	0.3	2.0	0.0	0.3	0.6	1.9	1.0	0.0	0.0	0.0	0.4
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409216-151663632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 33.6"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 10.5;Horizontal cells: 7.9;Suprabasal keratinocytes: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"amygdala: 3.0;cerebellum: 7.5;pons and medulla: 4.8"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 5.8"	"Cell line enhanced"	"Detected in many"		"A-431: 8.3;HeLa: 10.1;hTERT-HME1: 9.5;SiHa: 9.0;SK-BR-3: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	1.4	1.2	3.0	3.4	0.8	1.5	3.8	7.5	0.9	6.3	5.2	0.6	10.4	1.7	6.1	5.9	13.1	2.8	4.9	6.5	0.7	0.7	7.0	1.6	5.4	0.1	0.6	0.0	3.7	23.7	11.1	9.4	1.8	4.8	4.5	3.3	10.0	11.1	12.5	33.6	12.6	9.0	1.8	0.7	0.7	2.3	3.5	0.0	0.9	11.4	22.0	10.0	6.2	5.0	0.0	5.8	0.4	0.0	0.1	0.1	0.0	8.3	0.7	0.0	0.2	0.0	0.0	3.1	0.4	2.0	0.8	0.2	3.6	3.1	0.0	0.9	0.1	2.8	7.6	2.2	6.3	1.3	0.0	3.6	0.0	10.1	0.8	0.0	0.0	0.1	0.1	6.3	0.0	9.5	1.9	0.1	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.9	2.6	0.8	0.0	2.1	0.3	4.4	5.7	1.4	0.4	9.0	7.9	0.0	2.5	3.4	0.0	0.0	0.6	3.7	0.2	1.4	0.0	0.0	0.0	2.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	0.0	3.0	0.8	7.5	0.9	0.7	0.7	0.6	0.0	4.8	0.0	3.0	1.3	0.0	6.2	10.5	0.0	1.6	0.0	0.0	6.8	0.0	0.0	0.3	0.0	1.3	1.8	0.3	3.4	0.0	1.5	0.5	0.3	5.9	1.1	0.5	0.2	7.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.0	3.7	1.2	0.0	0.0	0.3	4.5	0.0	0.3	2.1	4.1	12.7	1.4	0.0	1.4	6.8
FAM163A	"C1orf76, MGC16664, NDSP"	ENSG00000143340	"Family with sequence similarity 163 member A"	Q96GL9	1	179743163-179816198	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 19.2;lymphoid tissue: 25.5;pituitary gland: 24.2"	"Group enriched"	"Detected in some"	12	"Early spermatids: 27.4;Late spermatids: 35.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 51.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.74e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.67e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.81e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.75e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	0.2	10.9	0.7	2.1	1.5	0.0	0.0	0.4	2.1	0.0	1.3	0.7	0.0	1.9	0.1	1.7	0.0	0.6	5.5	0.3	0.4	0.8	0.1	0.4	0.0	1.0	1.2	1.0	0.4	0.6	0.0	24.2	0.4	19.2	0.4	0.9	0.2	0.0	0.1	0.1	0.1	1.3	0.6	0.2	0.4	1.7	9.0	0.0	25.5	1.5	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	51.2	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.7	1.5	0.4	2.1	0.4	0.8	1.2	1.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0
FAM183A	"hCG23177, LOC440585"	ENSG00000186973	"Family with sequence similarity 183 member A"	A6NL82	1	43145153-43156396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.5;fallopian tube: 55.8"	"Cell type enriched"	"Detected in many"	7	"Ciliated cells: 1011.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 19.3"	"Region enhanced"	"Detected in many"		"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;hTCEpi: 4.4;NTERA-2: 5.4;SCLC-21H: 4.6;SuSa: 9.1"	"Low region specificity"	"Detected in many"							"HPA043382, HPA049120"	Approved					NA	NA					"HPA043382: AB_2678456, HPA049120: AB_2680640"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.56e-2)"	"unprognostic (1.42e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.73e-2)"	0.1	0.1	3.6	0.1	9.8	0.1	0.8	0.0	0.5	2.6	0.3	6.5	0.0	0.2	1.3	16.5	0.5	55.8	0.2	0.1	4.6	4.7	0.3	0.2	14.5	0.2	0.1	0.2	10.1	0.3	1.0	5.5	0.5	25.5	1.4	0.3	0.0	0.9	0.3	0.1	5.5	0.1	0.3	0.6	0.2	0.2	6.7	1.7	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.6	0.6	0.6	1.0	5.9	0.0	0.8	0.4	0.6	0.7	0.0	0.4	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.0	2.3	1.1	4.6	0.0	0.0	0.3	0.0	9.1	1.3	0.0	0.9	0.0	0.7	0.2	0.1	2.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	9.8	0.0	0.5	4.6	4.7	0.1	0.2	25.5	1.7	0.0	6.1	0.0	12.9	1.6	0.0	0.1	0.0	1011.8	135.4	3.5	0.0	1.5	3.3	0.0	89.9	0.1	0.0	0.0	0.0	0.2	0.4	3.8	3.5	0.0	0.1	0.0	4.1	0.0	0.0	153.7	1.7	0.0	3.3	0.0	0.1	0.4	0.2	0.0	0.7	1.3	0.0	0.0	0.0	1.9	2.8	2.3	1.7	0.0	0.4	10.2
FAM20A	DKFZp434F2322	ENSG00000108950	"FAM20A, golgi associated secretory pathway pseudokinase"	Q96MK3	17	68535113-68601389	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.2;salivary gland: 50.4"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 68.0;Early spermatids: 61.3;Hepatocytes: 58.2;Hofbauer cells: 72.2;Late spermatids: 140.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.8"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 2.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.0;granulocytes: 1.8;monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.8;BJ hTERT+: 27.3;HSkMC: 22.8;U-2197: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048964	Approved				"Secreted in other tissues"	NA	NA		10000000			"HPA048964: AB_2680575"	"unprognostic (3.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (9.16e-10)"	"unprognostic (1.25e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.39e-2)"	4.9	1.1	0.2	4.7	0.4	1.0	3.7	0.2	1.5	12.1	3.2	0.7	0.7	1.4	7.6	9.9	2.2	4.1	2.3	6.5	0.3	0.4	19.6	59.2	17.6	14.7	0.3	0.8	6.8	1.0	0.6	4.8	4.2	3.8	3.5	1.0	8.7	50.4	1.7	2.8	1.5	1.2	4.7	2.4	7.3	9.5	9.1	0.2	0.9	8.2	4.0	2.5	3.7	3.4	0.2	1.0	1.8	2.1	0.1	0.3	0.0	0.0	0.1	0.0	0.1	1.3	11.8	0.0	0.5	27.3	0.0	0.0	0.0	0.0	0.0	2.4	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	22.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.9	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.1	1.8	0.1	2.1	1.0	0.0	0.0	0.2	0.4	0.2	1.5	0.3	0.4	0.3	0.8	3.8	0.2	14.9	68.0	0.0	0.1	2.1	3.1	4.8	7.6	1.4	37.5	41.8	0.0	0.5	0.0	0.3	61.3	1.3	0.0	0.0	0.4	2.0	5.8	0.0	1.1	58.2	72.2	39.7	0.0	7.4	20.3	140.0	10.3	11.6	1.7	1.8	0.0	0.2	0.6	0.0	13.8	13.0	2.9	6.5	0.7	1.2	0.2	1.6	2.3	0.0	0.0	0.0
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 348.0"	"Group enriched"	"Detected in some"	10	"endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.5;pons and medulla: 21.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"U-87 MG: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain					NA	NA					"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favorable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3.0	0.3	8.0	0.0	0.3	1.3	18.2	0.2	51.3	0.4	10.0	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0.0	18.3	0.3	0.2	2.0	0.2	21.0	0.2	0.5	0.0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1.0	1.7	0.0	0.2	0.0	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0.0	21.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	7.7	0.0	348.0	42.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
FAM81B	FLJ25333	ENSG00000153347	"Family with sequence similarity 81 member B"	Q96LP2	5	95391344-95450454	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 27.3;testis: 33.8"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 285.0;Early spermatids: 696.2;Late spermatids: 1328.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 1.5;basal ganglia: 1.9;hippocampal formation: 2.2;hypothalamus: 2.6"	"Cell type enriched"	"Detected in single"	37	"basophil: 7.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 5.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA072554	Approved					NA	NA					"HPA072554: AB_2686533"	"unprognostic (2.22e-3)"	"unprognostic (8.86e-3)"		"unprognostic (2.61e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-1)"		"unprognostic (2.63e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.28e-2)"	0.4	0.0	1.5	0.4	1.9	0.1	0.4	0.4	0.4	1.1	0.4	0.4	0.4	0.0	0.4	2.0	0.4	27.3	0.4	2.9	2.2	2.6	0.4	0.4	2.3	0.4	0.4	0.4	0.4	0.4	2.5	1.5	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.5	0.4	0.0	33.8	0.4	0.4	0.8	0.4	0.4	0.4	0.4	0.0	0.2	7.6	0.0	0.0	0.1	0.8	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.5	1.9	0.4	0.4	2.2	2.6	0.4	0.4	0.4	0.4	8.9	2.6	0.0	0.0	0.3	0.0	4.2	0.0	285.0	30.7	5.2	0.0	0.0	0.0	0.3	696.2	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1328.6	7.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.2	0.0	6.5	0.0	8.2	6.8	0.0	0.0	0.0	0.0	0.1
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 61.0;skin 1: 35.1"	"Group enriched"	"Detected in some"	7	"Basal glandular cells: 5.4;Basal keratinocytes: 16.0;Early spermatids: 12.8;Extravillous trophoblasts: 18.5;Late spermatids: 5.5;Melanocytes: 6.8;Suprabasal keratinocytes: 17.1;Urothelial cells: 13.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in some"	34	"cerebellum: 61.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 17.3;EFO-21: 10.4;HaCaT: 25.0;HBEC3-KT: 11.4;hTCEpi: 34.7"	"Region enriched"	"Detected in single"	18	"cerebellum: 35.9"	"Region enriched"	"Detected in some"	66	"cerebellum: 442.8"	CAB033680	Enhanced					NA	NA					"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.0	0.4	0.4	1.7	0.0	2.2	61.0	0.4	2.4	0.4	0.4	0.4	0.0	0.4	1.0	11.8	0.5	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	1.3	0.4	0.0	0.4	0.4	0.9	0.9	0.0	0.4	3.8	3.2	0.4	35.1	0.4	0.4	0.4	0.4	0.0	2.7	0.4	0.4	0.4	0.4	1.9	1.0	4.9	0.2	0.6	0.1	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	17.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	25.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	1.7	61.0	0.4	0.4	0.0	0.4	0.4	0.9	0.4	0.0	0.0	0.0	5.4	16.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	12.8	0.0	0.0	0.0	0.0	18.5	0.4	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	17.1	0.8	0.0	0.0	13.7
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.4	3.4	10.2	21.4	157.8	70.0	46.9	84.6	134.5	7.5	2.8	14.5	0.4	0.0	3.6	3.1	0.2	7.4	6.4	0.2	0.9	0.0	1.7	0.0	18.4	9.7	20.9	0.0	0.0	115.4	1.3	7.5	2.7	0.1	0.0	0.1	0.0	0.1	5.2	0.2	0.0	0.2	14.4	0.3	1.2	0.1	0.0	0.1	3.4	121.1	0.7	13.6	10.4	49.3	0.0	30.3	0.3	0.4	0.6	1.4	9.4	38.9	0.0	0.1	0.0	0.1	0.1	0.0	3.6	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8	6.0	2.2	0.0	92.6	151.8	0.0	8.6	12.7	1.4	13.6	1.8	0.0	571.3	0.0	0.5	8.4	22.5	0.0	0.0	0.2	448.0	795.3	17.7	1.1	0.4	73.2	0.0	0.0	36.2	0.0	18.3	85.4	3.3	161.9	0.0	0.0	0.0	0.7	0.0	28.7	0.3	0.5	116.4	93.7	18.7	76.7	113.9	1016.7	0.0	0.2	69.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell type enhanced"	"Detected in some"	29	"Exocrine glandular cells: 1.2;Spermatogonia: 3.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.1	0.0	0.0	0.1	0.0	3.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	5.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	4.9	1.1	0.0	0.2	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.0
FEV	Pet-1	ENSG00000163497	"FEV, ETS transcription factor"	Q99581	2	218981087-218985657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1"	"Cell type enriched"	"Detected in some"	123	"Intestinal endocrine cells: 716.0"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HMC-1: 19.1;SH-SY5Y: 24.5"	"Group enriched"	"Detected in some"	13	"midbrain: 2.3;pons and medulla: 0.9"	"Group enriched"	"Detected in some"	35	"midbrain: 7.3;pons and medulla: 3.9"	HPA067679		Supported	Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	4.1	0.0	1.2	3.5	0.0	0.0	0.0	2.6	0.0	2.0	0.7	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	5.4	0.0	6.9	4.0	3.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	6.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.6	1.1	0.2	0.2	0.0	6.9	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	716.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	5.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.1
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301394-122310691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.7;testis: 11.0"	"Cell type enriched"	"Detected in single"	5	"Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 58.8;SCLC-21H: 25.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 13.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.9"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0.0	2.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1.0	16.7	0.2	0.2	0.2	0.2	2.0	0.0	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.3	11.0	3.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	58.8	1.4	1.0	0.0	0.0	0.0	0.0	0.1	25.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.9	0.0	2.0	1.0	16.7	2.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
FEZF2	"FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312"	ENSG00000153266	"FEZ family zinc finger 2"	Q8TBJ5	3	62369681-62374324	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"brain: 22.0"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 1.7;Horizontal cells: 1.6;Intestinal endocrine cells: 1.7;Rod photoreceptor cells: 2.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	7	"amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 5.2;NTERA-2: 3.5;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2"							NA	NA										"unprognostic (2.37e-1)"					"unprognostic (1.74e-2)"				"unprognostic (1.70e-1)"				0.7	0.5	12.2	0.4	6.4	0.4	0.5	0.0	18.0	0.4	1.4	1.8	0.0	0.4	0.5	0.4	0.4	0.5	0.5	0.5	22.0	1.8	0.7	0.5	0.5	0.4	1.1	10.0	0.5	0.4	0.4	0.7	0.5	0.0	0.6	0.4	1.1	0.5	0.5	0.8	0.6	0.5	0.4	0.0	0.8	0.9	0.5	0.3	3.3	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	6.4	0.0	11.3	22.0	1.8	1.1	10.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FFAR2	"FFA2R, GPR43"	ENSG00000126262	"Free fatty acid receptor 2"	O15552	19	35443907-35451767	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.2;lymphoid tissue: 22.9"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 5.6;Intestinal endocrine cells: 23.2;Kupffer cells: 6.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Region enhanced"	"Detected in many"		"midbrain: 7.0"	"Group enriched"	"Detected in some"	27	"eosinophil: 18.9;neutrophil: 60.2"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 60.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.7;OE19: 3.9;SK-BR-3: 2.5;THP-1: 2.7;U-937: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023985	Approved					NA	NA					"HPA023985: AB_1849302"	"unprognostic (7.75e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.17e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-2)"	4.3	0.3	1.1	16.5	0.8	16.7	9.2	0.3	1.8	0.4	1.6	0.2	0.0	3.0	0.5	0.9	1.5	1.3	1.2	1.4	0.9	0.3	0.5	1.6	8.9	15.2	7.0	0.5	0.8	0.4	0.3	0.3	1.9	1.3	1.1	0.5	0.8	0.7	0.0	0.3	0.8	4.1	1.0	1.2	22.9	1.0	0.9	0.3	0.8	0.6	1.2	0.7	2.3	4.6	0.0	0.2	60.2	1.4	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.3	0.1	8.7	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.8	0.0	1.3	0.1	3.9	0.1	0.1	0.0	0.0	0.0	0.2	1.7	0.1	0.0	2.5	0.1	0.0	0.3	2.7	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	3.5	0.0	0.6	0.4	18.9	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	60.2	0.0	1.4	0.0	0.0	0.1	1.1	0.8	0.3	1.8	0.9	0.3	7.0	0.5	1.3	0.3	0.0	5.6	0.0	0.4	0.1	0.0	0.0	0.0	4.0	4.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	5.4	4.7	0.0	4.6	0.0	23.2	0.6	6.2	0.0	0.0	4.9	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.4	1.0
FGF14	"FHF4, SCA27"	ENSG00000102466	"Fibroblast growth factor 14"	Q92915	13	101710804-102402457	"Disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 46.4;cervix, uterine: 23.2;fallopian tube: 15.7"	"Cell type enhanced"	"Detected in many"	18	"Bipolar cells: 37.1;Ciliated cells: 96.4;Horizontal cells: 30.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Region enhanced"	"Detected in all"		"cerebellum: 46.4"	"Group enriched"	"Detected in some"	11	"memory CD4 T-cell: 1.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049828			Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA049828: AB_2680901"	"unprognostic (2.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.80e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.86e-2)"	"unprognostic (8.48e-2)"	1.6	4.4	6.0	0.8	12.1	0.4	0.8	46.4	13.6	23.2	0.9	1.0	0.1	1.2	0.8	1.5	2.4	15.7	1.1	3.5	4.5	10.4	1.3	2.1	3.0	0.6	2.3	4.5	0.5	1.5	0.5	4.6	0.6	6.5	0.7	1.1	0.0	1.2	1.4	0.7	1.2	0.8	0.8	1.8	0.6	3.2	3.5	3.6	0.0	0.7	0.0	0.5	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	4.9	20.9	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.3	0.3	0.0	0.3	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	6.0	12.1	46.4	11.4	4.5	10.4	2.3	4.5	6.5	3.6	3.0	1.0	0.0	0.5	0.5	37.1	5.6	5.1	96.4	14.8	0.0	0.0	0.0	0.0	0.1	15.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	2.4	0.1	30.2	18.4	0.0	0.0	22.8	2.3	0.0	1.7	0.0	0.1	5.7	0.2	0.0	0.0	0.3	2.9	0.0	0.5	3.0	7.0	0.5	0.0	0.0	0.0	0.0
FGF16	MF4	ENSG00000196468	"Fibroblast growth factor 16"	O43320	X	77447405-77457278	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.2;seminal vesicle: 4.2"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 22.7"	"Group enriched"	"Detected in some"	6	"basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (4.01e-2)"					"unprognostic (5.30e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"			"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.49e-2)"		3.2	0.0	0.2	0.1	0.2	0.0	2.3	0.1	1.5	0.1	0.5	0.7	0.1	0.0	1.2	0.6	0.5	0.4	0.7	1.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	1.8	0.1	0.2	0.1	0.5	4.2	1.3	0.4	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	2.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.5	0.1	1.1	0.1	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 31.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 8.6;Cone photoreceptor cells: 13.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.2;Hep G2: 2.4;MOLT-4: 2.3;RPMI-8226: 4.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.2"	"Low region specificity"	"Detected in some"			HPA052600	Uncertain				"Secreted in brain"	NA	NA					"HPA052600: AB_2681881"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.4	4.9	2.5	0.4	3.2	0.2	0.4	31.3	7.7	0.5	0.4	0.4	0.4	0.2	2.2	0.6	0.4	0.7	0.6	0.4	2.2	4.7	0.4	0.4	0.5	0.4	1.3	2.9	0.5	2.6	3.6	2.1	0.4	3.3	1.2	0.2	0.4	2.4	0.5	0.4	0.9	0.4	1.0	0.9	3.0	0.8	0.6	0.4	1.6	2.3	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.6	0.6	1.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.2	3.2	0.0	0.0	0.0	0.0	0.9	0.7	0.0	2.4	0.1	0.0	1.5	0.0	0.3	0.0	0.1	1.4	0.0	1.2	0.1	0.1	0.0	0.7	2.3	0.8	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.0	1.6	0.0	0.0	0.2	0.3	0.0	1.2	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.2	31.3	7.7	2.2	4.7	1.3	2.9	3.3	0.4	0.0	0.0	0.0	0.2	0.0	8.6	0.8	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.1	0.1	0.0	1.1	0.0	1.1	0.0	0.3	0.2	0.2	0.0	0.2	0.0	0.0	0.1
FGF3	"HBGF-3, INT2"	ENSG00000186895	"Fibroblast growth factor 3"	P11487	11	69809969-69819024	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 16.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	38	"cerebellum: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CAPAN-2: 4.8"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			HPA012692	Enhanced				"Secreted in brain"	NA	NA					"HPA012692: AB_1848526"				"unprognostic (6.42e-3)"						"unprognostic (7.82e-2)"	"unprognostic (1.89e-1)"			"unprognostic (3.61e-1)"	"unprognostic (7.75e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771016-69775403	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0"	"Cell type enhanced"	"Detected in single"	28	"Early spermatids: 2.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Group enriched"	"Detected in some"	19	"midbrain: 2.6;pons and medulla: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	64	"NTERA-2: 18.6;SuSa: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"	NA	NA	326000				"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.2	0.8	0.1	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 1.2;Distal tubular cells: 1.7;Proximal tubular cells: 2.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.2;BJ hTERT+: 38.1;fHDF/TERT166: 27.5;HBF TERT88: 28.7;LHCN-M2: 25.7;U-138 MG: 35.6;U-251 MG: 17.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	7.2	0.0	20.2	38.1	5.3	3.9	0.0	0.0	0.0	0.0	27.5	0.4	0.0	0.0	7.0	28.7	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	2.0	0.0	15.6	7.5	9.0	1.8	0.0	0.0	0.1	25.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	6.5	35.6	1.4	1.7	17.0	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960243-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.8"	"Group enriched"	"Detected in many"	8	"Melanocytes: 43.9;T-cells: 86.3"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Region enriched"	"Detected in many"	6	"midbrain: 16.0"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.8"	"Lineage enriched"	"Detected in many"	10	"T-cells: 79.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 11.2;T-47d: 5.5;WM-115: 2.2"														"Secreted to blood"	NA	NA	346000000	6900000				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	21.0	1.4	0.3	0.4	1.0	33.4	19.4	0.0	0.9	1.1	7.1	0.2	0.9	0.2	0.6	6.0	3.4	0.7	0.8	16.1	0.4	0.2	0.5	0.8	6.7	1.9	16.0	1.0	0.9	0.2	0.1	0.2	0.8	2.8	3.1	0.8	30.7	5.7	0.9	6.7	14.4	1.8	5.3	5.0	10.4	1.2	11.3	0.0	5.8	0.7	3.8	1.9	1.5	3.7	0.1	0.2	1.2	0.2	8.3	79.8	39.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.2	0.3	5.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.3	79.8	0.1	0.7	0.1	19.7	47.0	0.1	0.0	7.6	47.5	1.2	8.3	0.2	0.2	0.1	39.3	0.3	1.0	0.0	0.9	0.4	0.2	16.0	1.0	2.8	0.0	0.0	7.7	0.9	0.0	8.5	0.0	1.4	0.0	0.0	2.3	5.2	7.9	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	3.5	0.2	0.0	0.0	0.0	4.9	0.3	1.7	0.0	2.2	43.9	0.0	0.0	1.0	0.2	0.0	0.4	0.8	0.3	0.0	0.8	0.3	0.1	6.8	0.8	86.3	0.0	0.0
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 366.7;Early spermatids: 202.9;Late spermatids: 182.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 13.8"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.8;HMC-1: 39.8;K-562: 8.5;U-87 MG: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced					NA	NA					"HPA054284: AB_2682436"	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.4	1.4	0.8	2.0	0.0	1.1	0.2	0.9	2.6	0.4	6.7	0.8	1.0	1.0	16.0	0.2	17.9	0.6	0.2	3.0	2.6	0.6	0.3	7.6	0.2	0.5	0.2	8.2	0.9	1.8	1.1	0.5	13.8	1.0	0.3	0.5	0.6	1.3	0.1	0.3	1.1	0.3	0.6	0.2	2.5	28.5	2.8	0.0	1.4	0.1	0.3	0.9	0.3	0.8	0.4	0.0	1.6	1.2	3.6	0.8	0.9	0.2	0.8	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.6	0.3	0.1	0.1	0.2	0.1	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.2	1.2	39.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	3.5	0.1	4.1	0.0	0.0	4.5	0.0	21.4	0.0	0.1	0.0	1.6	0.0	3.6	0.6	0.1	0.8	0.4	1.2	0.4	0.0	0.0	1.5	0.0	1.2	1.2	0.0	0.0	0.8	1.4	2.0	0.2	0.9	3.0	2.6	0.5	0.2	13.8	2.8	0.0	2.1	0.0	0.6	0.1	0.2	1.2	0.0	366.7	45.5	0.0	0.0	0.0	0.0	1.5	202.9	0.7	0.7	0.0	1.2	0.0	0.7	0.4	0.0	0.0	2.3	3.2	1.7	0.0	1.0	182.6	2.0	1.5	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.4	0.0	12.9	1.4	7.9	11.4	0.0	0.1	0.0	0.3	1.1
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.2	2.3	0.8	0.0	0.0	0.0	0.0	5.0	5.9	0.3	0.8	0.0	2.5	0.0	1.8	0.2	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	0.2	0.0	0.1	2.7	0.0	9.4	0.0	0.0	0.6	0.0	0.0	21.2	0.0	2.2	1.5	15.0	0.5	0.0	4.4	0.3	16.5	0.0	0.1	0.0	0.7	0.0	0.5	0.7	1.3	8.2	0.0	0.9	11.3	0.1	9.2	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	7.7	0.0	0.3	14.5	0.1	4.7	0.0	27.4	0.4	1.8	0.7	0.0	0.0	0.9	3.2	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	12.2	0.8	16.7	3.5	3.2	0.0	0.1	0.0	0.3	1.1	15.1	0.0	3.3	0.0	4.7	1.7
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FMO3		ENSG00000007933	"Flavin containing monooxygenase 3"	P31513	1	171090877-171117819	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 170.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 378.8"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 25.4;ASC TERT1: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA					"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	9.5	2.0	0.0	0.8	0.2	0.0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0.0	0.1	6.4	170.2	3.7	1.5	0.2	0.0	0.9	0.7	0.3	2.7	0.0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0.0	0.8	1.2	2.6	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	19.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	5.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.0	1.4	0.1	11.9	0.3	0.9	0.3	0.3	0.0	0.3	5.1	32.1	27.3	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	378.8	0.0	0.0	0.0	4.9	6.9	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	6.5	3.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell type enhanced"	"Detected in many"	17	"Cholangiocytes: 117.2;Hepatocytes: 260.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Hep G2: 29.0;HMC-1: 6.6;THP-1: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.1	1.9	0.5	0.7	0.4	0.4	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.1	0.3	0.0	0.0	0.0	1.0	0.1	1.2	0.0	29.0	0.6	1.0	6.6	0.9	0.1	0.3	0.0	0.3	0.4	0.2	0.1	0.1	1.1	1.0	0.2	0.5	2.1	3.6	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	2.0	0.9	1.0	1.4	7.4	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0	8.9	48.6	8.5	3.5	1.4	2.0	1.4	117.2	21.4	13.6	14.0	0.0	1.2	6.6	4.3	5.9	2.7	52.0	0.0	5.1	0.9	1.3	4.1	5.7	260.8	3.2	3.2	6.4	3.1	10.1	4.1	2.6	2.6	27.0	0.0	25.3	0.3	5.7	28.1	1.4	41.5	1.3	0.0	0.8	1.8	0.7	1.4	1.1	4.3	16.4	6.2
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169397-159272109	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell type enriched"	"Detected in some"	5	"Fibroblasts: 15.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Region enriched"	"Detected in single"	6	"hippocampal formation: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.2	0.6	0.5	7.6	0.7	0.0	2.5	0.3	0.7	9.7	12.9	3.2	0.0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1.0	1.5	1.2	2.1	0.7	0.0	4.8	1.2	0.0	0.4	0.7	0.5	0.7	1.6	1.0	2.5	0.6	6.2	1.2	7.0	10.2	1.5	0.7	0.7	2.1	0.1	1.0	36.6	11.8	3.6	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.1	2.4	6.6	0.3	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	7.4	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0.0	0.5	0.1	0.0	1.1	0.0	0.0	2.9	0.0	1.4	0.0	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	15.5	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.4	0.3	1.3	0.1	0.0	0.0	0.0
FOCAD	"FLJ20375, KIAA1797"	ENSG00000188352	Focadhesin	Q5VW36	9	20658309-20995955	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 62.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 62.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055015	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA055015: AB_2682673"	"unprognostic (3.05e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.25e-4)"	"unprognostic (3.69e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (9.64e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.09e-8)"	"unprognostic (1.90e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-2)"	3.6	9.0	4.5	3.6	7.2	1.9	3.9	8.7	9.0	4.9	4.8	15.0	3.6	1.8	3.9	6.3	3.6	7.4	3.6	5.3	7.1	7.3	3.8	3.6	3.7	3.6	4.4	3.6	3.6	5.5	10.4	11.8	4.1	62.1	5.6	5.6	6.8	5.8	3.7	5.1	4.2	3.6	4.7	3.6	3.6	4.2	3.6	3.6	3.6	11.8	3.6	3.6	3.6	3.6	3.4	6.9	8.9	5.7	4.5	7.1	3.1	16.3	11.3	12.3	9.2	11.6	13.3	6.5	9.7	15.5	6.9	8.0	7.5	5.6	6.7	5.2	13.9	5.8	5.7	10.7	19.3	12.1	29.8	7.9	5.2	13.9	9.2	6.0	8.7	6.8	12.2	13.3	6.9	11.4	9.7	26.4	5.7	0.1	9.9	11.5	6.3	6.5	16.4	9.7	8.7	11.4	0.0	5.6	4.5	10.8	7.0	8.2	4.1	6.4	11.0	2.6	17.3	6.9	5.1	16.1	0.0	4.5	7.6	8.8	2.4	13.7	7.6	0.0	12.3	4.1	8.9	2.8	8.0	5.3	5.7	7.1	2.7	4.7	5.1	6.9	3.4	4.2	5.0	2.2	4.5	3.1	2.8	4.3	3.1	4.5	7.2	8.7	9.0	7.1	7.3	4.4	3.6	62.1	3.6	8.9	14.3	3.9	2.7	2.6	5.7	10.0	7.6	13.4	7.9	15.7	3.9	4.1	1.7	7.4	11.0	4.4	4.1	0.0	7.4	5.7	6.2	6.5	4.7	3.4	4.6	11.1	16.8	12.3	5.4	3.7	4.6	4.3	8.5	1.0	10.9	7.3	8.1	0.0	3.5	2.8	3.8	6.5	5.7	14.9	7.8	3.1	2.7	3.5	8.9	2.6
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589984-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 47.0;prostate: 44.4"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 103.5;Glandular cells: 100.2;Intestinal endocrine cells: 81.2;Urothelial cells: 133.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 127.0"	"Region enriched"	"Detected in single"	6	"midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.6;MCF7: 36.1;PC-3: 25.2;RT4: 33.8;SK-BR-3: 34.2;T-47d: 48.4"	"Group enriched"	"Detected in some"	15	"hypothalamus: 1.0;midbrain: 1.3;thalamus: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 6.1"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.1	0.0	0.1	6.1	0.1	0.0	23.5	0.1	0.3	1.5	9.4	0.1	0.1	4.6	0.1	0.5	7.2	1.3	6.5	0.1	0.1	0.3	0.4	47.0	13.2	0.1	2.0	0.1	0.6	0.2	0.0	1.1	0.1	0.2	44.4	6.0	0.2	9.4	0.7	0.1	0.7	5.1	2.4	0.1	0.1	13.0	0.6	0.1	0.2	0.1	4.4	9.9	12.5	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.4	0.9	0.0	0.5	0.0	0.0	8.4	4.7	1.1	0.0	0.0	8.3	0.0	1.4	16.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.3	0.0	0.0	36.1	0.0	0.1	0.0	11.0	25.2	0.0	0.4	0.1	3.5	33.8	4.3	0.0	1.6	34.2	0.0	0.0	48.4	0.1	0.0	0.3	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.3	2.0	0.1	0.2	0.1	26.8	38.7	0.0	103.5	0.9	0.0	1.1	25.5	52.2	37.5	3.5	0.0	0.0	0.0	1.8	0.3	0.3	14.7	0.0	2.1	0.0	0.0	100.2	2.3	27.6	0.0	0.0	81.2	1.3	1.2	0.5	0.0	0.1	3.3	1.8	34.4	0.0	3.1	21.0	0.0	0.0	0.0	0.0	0.1	0.5	1.3	0.1	0.0	0.0	25.3	133.4
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004222-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 16.7"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 18.1"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.7"	"Cell type enriched"	"Detected in single"	4	"T-reg: 3.8"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1"	"Region enhanced"	"Detected in some"		"hypothalamus: 7.7"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA073369: AB_2686597"	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	0.3	0.5	4.1	0.2	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.9	0.1	0.2	0.1	6.2	0.0	0.1	0.1	1.8	6.5	0.0	0.0	0.4	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	8.4	0.1	1.8	2.6	3.7	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	2.6	0.0	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.3	11.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.3	4.1	0.6	0.0	0.1	6.2	6.5	0.0	16.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63323041-63325126	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"Melanocytes: 5.0"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Group enriched"	"Detected in some"	11	"midbrain: 1.9;pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 13.8;SK-MEL-30: 11.2;WM-115: 17.2"	"Region enriched"	"Detected in single"	13	"olfactory region: 2.1"	"Region enriched"	"Detected in single"	22	"olfactory region: 18.3"	CAB022455	Uncertain					NA	NA					"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	1.1	2.0	0.0	2.9	0.0	0.2	1.6	0.0	0.1	4.2	9.3	0.0	1.8	1.3	0.7	3.1	8.7	0.8	7.3	3.3	0.1	0.0	0.3	0.2	0.1	0.1	1.9	0.0	1.1	0.3	0.0	0.2	0.0	1.9	4.6	1.2	7.7	2.2	3.9	5.9	2.0	2.7	1.7	0.5	0.1	2.3	2.7	0.0	0.0	0.4	2.0	0.4	5.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.2	0.0	0.0	0.3	0.0	0.0	13.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	11.2	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0
FOXE3	"FKHL12, FREAC8"	ENSG00000186790	"Forkhead box E3"	Q13461	1	47416072-47418052	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cataract, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.9;lymphoid tissue: 4.6;testis: 2.9"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 4.2;Spermatogonia: 1.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.9;cerebellum: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"SuSa: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.11e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-7)"	"unprognostic (2.41e-1)"	"unprognostic (5.46e-2)"		"unprognostic (3.60e-1)"	0.2	0.1	0.2	0.1	2.9	0.1	0.1	1.6	0.4	0.8	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.0	2.9	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	14.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.6	0.4	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0
FOXN4		ENSG00000139445	"Forkhead box N4"	Q96NZ1	12	109277979-109309220	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 13.1"	"Cell type enhanced"	"Detected in some"	21	"Spermatocytes: 1.8;Spermatogonia: 2.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"	"Region enriched"	"Detected in single"	11	"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1"	"Not detected"	"Not detected"							HPA050018	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA050018: AB_2680992"	"unprognostic (1.09e-3)"	"unprognostic (9.63e-2)"		"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"		"unprognostic (6.00e-2)"	0.2	0.0	0.1	0.1	2.7	0.0	0.1	0.2	0.1	1.4	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.9	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.0	13.1	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	6.6	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	9.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.6	0.0	0.0	0.0	0.0	0.0
FREM1	"C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR"	ENSG00000164946	"FRAS1 related extracellular matrix 1"	Q5H8C1	9	14734666-14910995	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 33.3;epididymis: 30.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 69.1;Late spermatids: 99.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 22.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEL: 63.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.13e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.95e-13)"	"unprognostic (2.28e-3)"	"unprognostic (8.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.86e-1)"	4.4	2.5	1.5	3.2	1.4	0.2	4.0	22.2	2.5	10.9	7.5	5.0	22.9	1.8	33.3	30.8	0.9	4.5	3.1	7.3	1.8	2.0	10.4	0.8	2.6	0.1	1.1	1.0	2.3	14.2	6.0	1.2	4.6	4.0	3.1	1.5	5.0	1.0	11.4	0.7	2.6	9.3	12.8	2.7	0.4	1.3	3.5	0.6	1.7	0.8	3.4	1.1	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	22.2	2.5	1.8	2.0	1.1	1.0	4.0	0.6	0.0	1.1	0.0	0.2	1.1	0.7	2.0	5.1	0.0	0.0	1.8	0.0	0.4	0.0	0.2	69.1	0.0	0.7	0.0	0.0	0.2	11.3	0.1	4.7	0.0	0.4	0.0	0.0	6.2	1.2	99.8	0.6	0.0	0.0	1.0	0.1	4.0	0.3	0.0	1.4	1.0	0.0	0.0	1.0	0.7	0.6	1.0	0.2	0.0	0.2	0.0
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 10.8;lymphoid tissue: 29.4"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 26.3;Paneth cells: 59.6;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 4.7;RPMI-8226: 7.5"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			6.4	0.1	0.0	6.0	0.2	0.0	10.8	0.2	0.1	0.2	9.8	0.0	0.0	2.3	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	5.6	0.2	0.1	0.0	1.5	0.2	0.2	0.2	0.0	0.1	0.3	0.6	0.1	6.8	1.1	1.7	0.0	2.6	0.2	4.5	0.1	1.0	2.9	7.5	8.1	0.0	29.4	0.1	1.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.7	0.0	26.3	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	0.0	0.0	10.1	0.6	0.0	0.0	0.0	14.0	0.0	0.0	59.6	1.4	14.4	0.0	0.0	0.0	13.7	4.3	0.0	0.1	0.0	13.7	0.1
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182867162	"Disease related genes, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 265.8"	"Cell type enriched"	"Detected in many"	12	"Muller glia cells: 3160.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 21.7"	"Group enriched"	"Detected in some"	9	"memory B-cell: 3.0;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;ASC diff: 8.6;NTERA-2: 7.2;SH-SY5Y: 6.1"	"Region enhanced"	"Detected in many"		"olfactory region: 69.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		27000				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	4.4	1.4	2.8	4.8	5.4	0.0	5.1	2.9	3.5	7.1	5.1	3.3	2.6	4.5	5.5	3.5	3.6	2.8	12.9	8.4	2.8	2.8	5.5	2.2	3.7	4.8	3.6	3.4	4.4	2.4	0.6	11.3	44.3	21.7	4.0	6.6	265.8	5.1	5.4	8.4	4.3	4.7	10.5	2.9	28.2	12.0	4.2	2.3	3.1	5.0	3.1	3.4	3.5	6.2	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.7	0.2	8.6	0.2	0.1	0.0	0.8	3.1	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	7.2	0.0	0.0	0.6	0.7	0.0	0.0	0.0	1.1	6.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	5.4	2.9	3.5	2.8	2.8	3.6	3.4	21.7	2.3	0.0	0.3	0.0	0.4	7.2	34.0	2.2	0.0	0.0	2.3	0.0	31.4	4.3	0.0	0.1	0.3	2.1	1.0	0.0	7.5	3.0	28.8	1.7	0.0	0.9	6.8	25.4	1.2	4.3	1.5	1.9	3.4	0.8	232.8	0.0	99.8	3160.2	0.1	0.0	13.8	0.0	101.0	271.7	137.0	0.2	0.0	2.8	10.4	0.0	3.3	0.4
FSHR	"FSHRO, LGR1, ODG1"	ENSG00000170820	"Follicle stimulating hormone receptor"	P23945	2	48962157-49154537	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 5.3;ovary: 6.5;testis: 16.3"	"Group enriched"	"Detected in some"	24	"Early spermatids: 1.6;Late spermatids: 4.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.5;cerebral cortex: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SuSa: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA															"unprognostic (5.94e-2)"			"unprognostic (4.06e-3)"		"unprognostic (5.78e-2)"			0.1	0.1	0.1	0.0	1.5	0.1	0.1	0.1	2.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.3	5.3	1.0	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	6.5	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.1	2.9	0.1	0.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 106.9"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 248.5;Cone photoreceptor cells: 435.9;Rod photoreceptor cells: 131.6"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA							"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.5	12.1	3.5	0.6	6.9	0.5	0.5	106.9	19.9	0.5	0.6	0.6	0.0	0.5	0.5	1.7	0.5	0.6	0.5	0.5	3.2	5.9	0.6	0.5	0.5	0.5	3.0	3.0	0.5	1.0	0.5	1.1	0.7	18.2	0.5	0.8	7.1	0.5	0.6	0.5	0.8	0.6	0.6	3.1	0.5	0.5	1.5	2.9	0.0	0.6	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	5.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.9	106.9	6.9	3.2	5.9	3.0	3.0	18.2	2.9	0.0	0.0	0.0	0.0	0.2	248.5	0.1	0.0	0.0	0.0	0.0	435.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	27.0	0.0	0.0	0.0	1.7	0.6	0.0	1.7	0.0	0.0	18.6	0.1	0.0	0.4	0.0	131.6	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell type enhanced"	"Detected in many"	12	"Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 34.7;OE19: 38.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	0.9	0.9	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	34.7	0.3	0.2	0.0	0.2	6.1	0.0	0.0	0.0	0.3	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.4	0.4	0.8	0.2	38.7	0.3	0.3	0.1	1.5	0.0	0.3	1.8	0.2	0.1	0.3	0.0	0.2	5.2	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2	0.0	1.1	0.0	2.5	0.8	2.7	0.4	43.3	12.0	10.3	19.2	2.0	0.0	1.7	5.5	0.5	0.3	109.6	0.0	41.1	0.0	0.2	2.5	0.0	0.0	0.1	0.0	10.9	0.0	0.3	0.0	0.0	0.0	1.7	0.0	39.5	0.8	25.6	73.7	0.0	0.0	3.8	0.0	0.2	0.2	0.2	1.3	0.1	2.2	44.3	14.7
FUT7		ENSG00000180549	"Fucosyltransferase 7"	Q11130	9	137030174-137033010	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 40.4;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Kupffer cells: 7.0;monocytes: 19.8;T-cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 3.2"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 40.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"NB-4: 14.4;THP-1: 18.5;U-937: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042780			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA042780: AB_2678162"	"unprognostic (1.33e-2)"	"unprognostic (4.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (2.50e-1)"	"unprognostic (2.35e-2)"	"unprognostic (6.75e-4)"	"unprognostic (4.68e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.69e-6)"	"unprognostic (3.99e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.75e-2)"	0.4	0.1	0.2	2.5	0.2	5.9	0.2	3.2	0.3	0.2	0.2	0.2	0.2	0.0	1.4	0.2	0.4	0.5	4.4	0.2	0.3	0.3	0.2	0.2	1.5	6.2	1.7	0.2	0.2	0.2	0.0	0.4	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.6	0.2	0.4	10.5	0.3	0.2	0.2	0.2	0.3	0.2	4.6	0.5	0.2	4.2	40.4	18.3	1.5	22.1	16.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.4	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.3	1.5	0.3	2.1	0.3	10.5	4.2	10.3	5.7	4.4	1.2	0.2	0.8	18.3	22.1	0.0	40.4	16.3	3.4	0.2	0.2	3.2	0.3	0.3	0.3	1.7	0.2	0.9	0.2	0.0	0.0	3.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	7.0	0.0	0.0	2.9	0.0	19.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.7	0.2	0.0
FYB2	"ARAP, C1orf168, FLJ43208, RP4-758N20.2"	ENSG00000187889	"FYN binding protein 2"	Q5VWT5	1	56718804-56819696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.5;liver: 22.6;retina: 16.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 1: 20.8;Ciliated cells: 89.7;Collecting duct cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 1.6;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"T-47d: 10.9"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.3"	"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (6.12e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.19e-3)"	"unprognostic (4.77e-3)"		"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-3)"	0.2	0.2	0.2	0.0	0.2	0.0	0.7	0.7	0.7	4.1	0.9	2.0	7.5	0.3	3.7	7.7	0.6	15.5	0.0	3.7	1.6	0.2	10.0	22.6	3.2	0.0	0.2	0.8	4.3	1.2	0.0	12.4	0.2	5.7	2.1	0.5	16.7	3.0	2.1	2.8	0.2	3.0	0.1	0.2	0.2	0.5	2.1	0.0	2.5	0.7	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.4	10.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.3	1.6	0.2	0.2	0.8	5.7	0.0	20.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	89.7	12.5	29.6	0.0	0.4	3.3	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAB4		ENSG00000215568	"GRB2 associated binding protein family member 4"	Q2WGN9	22	16961936-17008222	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	17	"testis: 19.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 6.2;Late spermatids: 17.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.2"									HPA044621	Uncertain					NA	NA					"HPA044621: AB_10967265"																		0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.4	0.6	0.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.7	0.0	0.0	0.0	0.0	0.0
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor alpha6 subunit"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"brain: 96.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	36	"cerebellum: 96.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 1.0;PC-3: 1.5;TIME: 1.1;U-266/70: 2.5"	"Region enriched"	"Detected in some"	40	"cerebellum: 1204.9"	"Region enriched"	"Detected in some"	44	"cerebellum: 189.6"	CAB022462	Approved					NA	NA					"CAB022462: "																"unprognostic (3.79e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor delta subunit"	O14764	1	2019298-2030758	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"brain: 87.0"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 9.3;Ciliated cells: 8.1;Club cells: 11.4;Horizontal cells: 12.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.0"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;HMC-1: 2.5;MCF7: 8.3;NB-4: 5.3;NTERA-2: 2.1;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	1.2	3.4	8.8	0.9	16.8	1.0	1.0	87.0	40.0	1.0	1.2	1.7	0.0	0.9	1.3	1.2	1.3	1.0	1.5	1.7	6.0	1.7	1.1	0.9	1.4	1.3	3.3	11.1	0.9	0.9	1.4	0.7	1.2	17.1	1.0	1.0	0.0	1.1	0.9	1.3	1.4	1.0	1.4	1.4	1.0	1.0	3.3	1.5	0.0	1.6	0.0	1.0	1.2	0.1	0.0	1.2	0.2	0.1	0.0	0.0	0.8	0.0	0.7	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	5.3	2.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.8	8.8	16.8	87.0	40.0	6.0	1.7	3.3	11.1	17.1	1.5	3.0	5.1	0.0	0.0	0.5	9.3	0.8	0.0	8.1	11.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.1	2.3	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	3.1	0.1	13.5	0.0	0.2	0.0	0.0	0.0
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor epsilon subunit"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 36.4;vagina: 27.7"	"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 51.4;Urothelial cells: 32.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"hypothalamus: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.4;EFO-21: 14.9;HeLa: 6.7;SiHa: 7.0"					"Low region specificity"	"Detected in many"			HPA045918	Uncertain					NA	NA					"HPA045918: AB_10961281"	"unprognostic (1.33e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (4.05e-11)"	"unprognostic (1.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.28e-2)"	14.8	1.0	1.5	2.2	2.8	0.3	16.5	1.0	1.6	8.9	5.8	0.0	2.2	1.4	6.0	4.1	5.0	1.5	4.2	16.3	1.0	21.8	1.1	0.9	2.3	0.7	1.1	0.6	1.6	2.5	0.4	4.1	36.4	4.5	5.9	0.8	3.8	2.0	6.3	0.9	5.6	10.1	2.5	1.1	0.9	1.0	0.9	0.4	0.0	2.5	5.9	3.5	2.9	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.4	0.0	0.0	0.6	0.0	1.1	0.5	2.3	0.8	0.0	14.9	3.1	0.0	2.4	0.0	0.8	0.7	0.0	0.5	1.7	6.7	0.9	0.2	0.0	0.2	1.0	0.7	1.2	0.3	1.4	0.6	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	1.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	1.0	1.3	1.0	21.8	1.1	0.6	4.5	0.4	14.9	5.7	0.0	20.6	15.2	0.0	6.4	12.7	2.7	14.8	1.8	0.0	17.3	0.0	3.6	1.7	7.9	9.3	0.0	0.3	2.0	9.7	14.0	0.0	0.8	2.7	0.0	1.7	4.3	0.6	1.8	1.4	0.2	1.7	0.0	1.8	0.5	3.7	8.6	2.1	0.0	0.3	0.0	4.7	1.1	1.7	9.5	51.4	0.5	2.3	32.0
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor rho1 subunit"	P24046	6	89177501-89231278	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"retina: 12.3;testis: 4.6"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 53.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"amygdala: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.4	0.0	2.2	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	1.0	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	6.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	53.4	0.3	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	3.8	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216307-26304558	"Enzymes, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 66.2"	"Cell type enriched"	"Detected in some"	11	"Pancreatic endocrine cells: 35.1"	"Group enriched"	"Detected in some"	21	"glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 66.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"MOLT-4: 5.2;SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced					NA	NA					"CAB078177: AB_2665779, HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			1.0	0.9	6.3	0.9	66.2	1.0	0.9	5.6	28.7	0.9	0.9	1.4	0.0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1.0	0.9	0.9	0.9	5.4	10.0	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1.0	0.0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0.0	0.9	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10.0	6.8	8.1	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	35.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell type enhanced"	"Detected in many"	10	"Ductal cells: 39.1;Exocrine glandular cells: 43.2;Extravillous trophoblasts: 33.3;Glandular cells: 54.2;Pancreatic endocrine cells: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 48.0;HEK 293: 22.4;K-562: 24.8;NB-4: 88.7;SH-SY5Y: 35.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in many"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000		"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	4.5	6.8	0.0	0.1	0.0	48.0	1.8	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	1.1	14.4	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	0.0	1.1	0.0	24.8	0.0	0.0	13.6	0.0	88.7	11.4	0.5	4.3	0.0	0.0	9.1	0.1	0.0	9.4	35.8	4.7	0.2	0.0	5.3	0.2	10.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4	0.0	0.0	0.0	15.3	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.1	0.0	0.2	0.0	0.0	43.2	33.3	2.4	54.2	4.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	13.7	0.4	11.4	3.0	1.6	0.0	0.6	11.9
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807699-98850081	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.7"	"Cell type enhanced"	"Detected in many"	13	"Mucus-secreting cells: 122.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 17.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 41.8;U-2197: 54.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048292	Enhanced				"Intracellular and membrane"	NA	NA		15000			"HPA048292: AB_2680343"	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	7.5	1.7	1.0	9.5	2.3	0.6	3.7	17.7	1.6	4.0	29.6	1.7	7.4	14.6	1.8	34.7	15.2	3.2	20.5	1.1	1.4	1.6	2.9	0.4	13.8	1.1	3.3	1.0	1.0	9.2	4.0	3.1	1.0	2.7	4.2	24.8	4.0	15.2	6.6	1.1	2.6	22.4	15.4	1.3	1.5	23.5	3.4	1.1	2.8	9.3	8.1	23.9	9.0	3.4	0.8	0.4	1.6	0.0	2.2	2.5	0.4	1.7	1.3	1.1	4.5	3.4	2.7	0.0	0.4	0.7	0.7	1.5	0.2	7.2	0.0	1.7	0.3	4.1	12.6	1.0	0.4	0.5	8.4	0.6	0.8	0.0	0.0	0.1	0.5	0.1	1.3	0.3	2.1	0.0	0.9	0.8	6.4	9.6	0.0	0.2	4.5	0.8	1.5	5.6	41.8	1.8	2.1	0.1	0.0	0.8	2.5	4.2	0.4	0.1	10.3	1.0	2.7	1.5	1.4	1.4	0.0	0.1	54.3	0.0	0.7	1.5	0.7	12.7	0.0	0.3	0.0	0.0	1.6	1.4	0.0	2.5	0.1	1.9	0.8	0.2	0.8	2.3	1.5	0.1	2.2	0.0	0.4	0.1	0.4	1.0	2.3	17.7	1.6	1.4	1.6	3.3	1.0	2.7	1.1	3.0	22.6	0.9	1.3	2.2	0.9	0.5	25.5	13.4	14.8	10.4	15.7	0.9	0.0	6.4	1.4	0.7	29.9	0.0	21.7	1.5	5.6	10.5	2.3	0.0	2.1	0.0	19.1	0.0	0.3	1.1	2.0	1.7	0.0	0.0	122.4	0.3	23.8	31.7	7.1	3.0	0.1	0.0	1.2	4.7	12.1	1.1	0.9	3.8	33.7	8.2
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 145.9;Mucus-secreting cells: 66.8;Urothelial cells: 121.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.6;BJ: 15.5;BJ hTERT+: 27.8;CAPAN-2: 13.6;fHDF/TERT166: 32.4;HaCaT: 27.7;K-562: 16.0;LHCN-M2: 27.7;U-138 MG: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		630000	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.6	2.6	0.0	0.0	1.0	8.3	0.0	15.5	27.8	0.2	0.6	1.1	13.6	0.0	0.0	32.4	0.0	27.7	0.5	5.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.5	0.0	0.0	0.0	16.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0	145.9	29.7	0.0	10.3	0.7	0.0	0.4	2.5	5.3	36.4	0.0	0.0	0.0	0.0	0.8	5.1	0.0	18.6	23.3	2.9	0.0	2.1	7.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.6	3.3	2.8	66.8	0.0	31.4	31.7	0.0	0.0	0.0	0.0	0.1	2.6	0.2	0.1	0.0	0.0	20.7	121.3
GALP		ENSG00000197487	"Galanin like peptide"	Q9UBC7	19	56176020-56185775	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Hormone, Neuropeptide"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 4.4;liver: 4.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;EFO-21: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 29.0"	HPA053938	Uncertain				"Secreted in brain"	NA	NA					"HPA053938: AB_2682315"				"unprognostic (8.51e-3)"			"unprognostic (1.22e-2)"			"unprognostic (2.65e-1)"					"unprognostic (7.02e-2)"			0.0	0.2	1.2	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.1	1.1	0.7	0.4	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712326-41715969	"Cancer-related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	61	"stomach 1: 529.2"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 7.3"	"Group enriched"	"Detected in many"	6	"pancreatic cancer: 38.8;stomach cancer: 23.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 27.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	NA	NA		43000			"CAB000038: "		"unprognostic (1.27e-1)"	"unprognostic (4.27e-3)"		"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"		"unprognostic (2.75e-2)"		"unprognostic (5.68e-2)"	"unprognostic (2.11e-1)"			"unprognostic (2.85e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.07e-2)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.2	0.1	1.7	6.9	0.0	2.4	7.3	0.0	0.0	0.0	2.6	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	529.2	0.1	0.0	8.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.1
GBX1		ENSG00000164900	"Gastrulation brain homeobox 1"	Q14549	7	151148589-151174745	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 6.0;skeletal muscle: 16.6;testis: 9.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.9;HEK 293: 2.0;HMC-1: 5.7;PC-3: 1.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Low region specificity"	"Detected in many"			HPA055783	Uncertain					NA	NA					"HPA055783: AB_2682919"		"unprognostic (4.24e-2)"			"unprognostic (3.87e-2)"			"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.95e-1)"				"unprognostic (1.87e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.14e-1)"	1.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	6.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 107.1;smooth muscle: 42.3"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Cardiomyocytes: 2.8;Paneth cells: 3.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.4;pons and medulla: 3.9"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;naive CD4 T-cell: 4.0"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;monocytes: 1.5;T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"HEL: 25.3;RH-30: 7.1;RT4: 8.0;TIME: 10.9"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	6.7	4.6	1.2	1.9	1.4	2.9	10.3	10.4	1.3	4.1	3.6	0.1	2.3	3.6	5.2	1.2	9.9	1.3	2.3	107.1	1.2	1.6	1.2	0.9	7.6	1.7	1.2	0.0	2.3	5.6	0.4	1.0	9.1	3.9	10.2	1.3	0.0	4.6	2.7	7.3	2.6	5.8	42.3	1.0	2.6	3.3	2.5	0.0	0.0	1.1	5.0	4.8	25.3	9.5	3.6	0.5	0.4	1.5	0.0	4.0	4.5	3.3	0.6	0.0	3.3	0.0	0.0	0.8	0.6	2.3	1.1	1.0	2.4	3.3	0.0	0.5	0.0	2.9	2.1	0.0	2.0	0.9	0.0	0.1	25.3	0.7	0.1	0.0	0.1	0.1	0.1	0.1	0.3	5.0	0.1	1.0	0.1	1.3	0.0	0.2	0.4	0.0	0.0	0.1	4.6	0.1	0.0	7.1	0.0	0.0	8.0	0.0	0.8	0.7	0.7	0.0	0.5	3.2	0.0	10.9	0.3	2.1	0.3	0.2	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	1.2	0.7	0.0	0.5	3.6	4.0	0.0	0.4	0.0	1.5	0.0	0.3	4.5	1.2	1.4	10.4	1.3	1.2	1.6	1.2	0.0	3.9	0.0	3.0	0.3	0.0	0.2	0.0	0.0	2.8	0.0	1.4	1.2	0.0	0.0	0.1	0.0	1.4	0.0	0.3	1.3	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	1.3	3.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Cell type enriched"	"Detected in some"	27	"granulocytes: 214.1"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"	"Group enriched"	"Detected in some"	73	"HEL: 28.5;HMC-1: 113.3"					"Low region specificity"	"Detected in single"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	113.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0	0.0	7.9	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	6.7	0.1	0.0	0.0	0.0	0.0	0.3	1.3	214.1	0.0	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.9	1.6	0.5	0.0	0.0	0.0	0.0
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 463.0"	"Cell type enhanced"	"Detected in many"	18	"Glandular cells: 1046.1;Syncytiotrophoblasts: 3600.0;Urothelial cells: 2603.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"pons and medulla: 6.5"	"Cell type enhanced"	"Detected in some"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 72.3;Hep G2: 37.2;HHSteC: 100.5;TIME: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	890000	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	13.4	2.2	0.4	1.0	0.6	0.0	13.1	0.4	0.5	3.9	13.0	1.0	1.9	1.8	5.9	1.9	2.4	1.1	13.1	1.2	0.5	0.0	64.7	24.1	12.6	0.8	0.4	0.5	2.9	21.9	0.3	2.4	463.0	6.5	25.5	11.0	1.6	2.4	5.1	13.6	1.1	1.8	4.8	1.2	1.4	12.0	2.5	0.4	0.4	5.2	0.5	0.8	47.0	2.7	0.2	0.8	6.3	2.3	0.0	0.0	0.3	0.3	16.2	1.6	0.6	3.9	3.3	72.3	5.6	3.0	0.2	3.3	0.7	5.0	0.0	10.2	0.5	16.9	0.1	0.0	2.0	0.8	0.0	0.3	0.2	1.5	37.2	100.5	0.0	6.2	8.6	24.3	15.7	10.2	0.1	17.1	0.0	24.8	0.1	3.9	3.9	0.0	0.1	0.9	5.7	9.0	0.0	0.6	0.0	11.9	15.9	0.1	0.1	0.0	0.9	20.2	6.4	0.4	0.0	36.0	0.0	1.3	0.3	0.2	0.2	0.6	0.0	9.0	0.0	4.7	0.0	1.8	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.3	0.4	0.6	0.4	0.5	0.5	0.0	0.4	0.5	6.5	0.4	32.8	67.9	2.2	222.2	1.1	0.0	0.4	45.9	80.3	68.2	246.0	0.0	48.7	28.2	235.7	0.0	5.8	50.0	0.0	324.0	161.2	17.1	1046.1	28.8	5.0	31.5	0.0	81.4	3.7	1.8	0.0	0.9	5.9	3.3	17.2	220.9	0.2	679.3	95.1	1.4	74.0	0.5	0.0	14.6	0.0	0.6	1.5	3600.0	0.5	186.1	2603.9
GDNF	"ATF1, ATF2, HFB1-GDNF"	ENSG00000168621	"Glial cell derived neurotrophic factor"	P39905	5	37812677-37839686	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes, Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in single"	9	"Fibroblasts: 1.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 25.0;SuSa: 7.8;U-87 MG: 7.6;WM-115: 27.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Low region specificity"	"Detected in many"			"CAB005210, HPA070283"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"CAB005210: AB_2247684, HPA070283: AB_2686246"	"unprognostic (1.08e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.04e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.42e-2)"	1.9	0.3	0.6	1.9	2.3	0.0	0.4	14.1	1.3	0.8	9.4	0.4	0.4	1.6	1.7	3.4	1.0	0.9	0.9	0.9	0.6	0.4	1.0	0.7	0.4	0.4	0.6	1.2	4.5	0.4	0.0	0.4	6.3	1.4	1.6	3.1	1.1	0.4	6.3	12.4	1.4	2.5	2.5	0.5	0.4	1.9	3.9	2.4	0.4	0.4	1.5	0.4	0.6	1.1	0.8	0.4	1.2	0.3	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	3.4	2.1	0.6	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.0	1.0	0.1	25.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.1	1.7	7.8	0.0	0.0	0.0	3.4	0.0	0.8	3.9	2.3	0.0	0.0	7.6	0.0	27.5	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.8	0.2	0.4	1.2	0.9	0.2	0.4	0.1	0.0	0.6	2.3	14.1	1.3	0.6	0.4	0.6	1.2	1.4	2.4	0.0	0.0	0.0	0.0	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.0	0.6	0.0	0.8	0.3	0.1	0.0	0.0	0.5
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252379-138274671	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"granulocytes: 27.5;Intestinal endocrine cells: 51.2;Late spermatids: 11.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 27.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	2.4	2.4	0.3	7.1	1.0	0.0	1.8	7.0	0.6	7.9	13.0	0.1	11.0	3.8	3.0	6.1	9.3	1.2	9.4	6.2	0.3	0.3	0.9	0.4	2.9	0.1	0.6	0.1	4.7	7.0	0.0	2.3	0.1	1.3	4.4	5.8	10.0	7.5	10.9	1.3	3.6	4.7	8.6	1.4	0.1	6.9	8.4	0.5	0.4	1.0	2.8	0.8	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	1.5	0.9	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	27.0	0.4	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	7.0	0.6	0.3	0.3	0.6	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	27.5	0.0	0.1	0.0	51.2	0.0	0.0	11.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	8.1	0.0	0.2	0.0	0.0	0.0
GHRH	GHRF	ENSG00000118702	"Growth hormone releasing hormone"	P01286	20	37251082-37261835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.3"	"Cell type enriched"	"Detected in single"	4	"Cardiomyocytes: 1.1"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 8.5"	"Region enriched"	"Detected in some"	15	"hypothalamus: 37.3"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.6;U-266/84: 12.7"	"Region enriched"	"Detected in some"	9	"hypothalamus: 38.7"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA						"unprognostic (4.78e-2)"				"unprognostic (2.57e-2)"									"unprognostic (1.58e-1)"	"unprognostic (3.10e-1)"			0.1	2.7	0.3	0.1	2.4	0.0	0.6	0.1	1.0	0.1	4.0	0.1	0.1	8.1	0.1	0.1	0.7	0.0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0.0	0.7	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	1.0	0.1	37.3	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.4	43.7	0.0	0.2	0.0	0.3	8.7	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.6	0.5	6.0	0.0	0.0	0.6	0.0	3.2	0.0	0.4	0.3	0.0	0.1	22.7	4.3	0.0	0.0	2.4	0.0	50.8	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2	3.0	0.0	0.8	8.0	62.0	0.0	0.4	5.1	0.0	3.4	1.8	0.0	0.0	0.0	3.5	0.7	0.2	19.0	0.0	8.8	0.2	1.6	7.8	0.0	24.2	0.7	0.0	4.1	0.0	0.8	0.9	0.0	1.2	1.7	8.2	3.9	0.0	8.1	15.0	0.0	14.7	0.0	0.0	2.0	0.2	0.4	25.1	0.1	0.0	19.7	15.6
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 36.2"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 158.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.8;NK-cell: 5.8"	"Group enriched"	"Detected in many"	23	"NK-cells: 5.8;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted - unknown location"	NA	NA			Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6.0	13.5	4.5	8.7	3.6	20.5	6.6	3.0	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7.0	0.3	1.4	15.0	5.2	2.6	5.1	2.9	0.2	0.0	0.0	0.0	5.8	5.8	0.8	6.0	0.6	3.3	1.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.1	19.6	0.0	6.5	0.0	2.7	20.7	9.9	0.1	0.0	0.0	9.4	0.0	2.6	0.2	0.9	0.0	11.4	0.1	0.3	0.0	0.0	0.0	0.0	3.0	9.9	0.0	0.0	5.8	1.6	1.1	1.8	47.6	7.2	0.0	0.0	0.5	5.6	4.3	14.0	5.2	4.4	5.6	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	1.2	0.0	0.0	0.0	5.8	0.0	2.3	0.0	1.3	2.3	0.0	0.2	1.6	2.6	0.0	5.8	0.0	0.0	0.0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3	0.0	2.6	0.0	4.2	1.9	6.1	1.0	2.5	8.1	3.4	0.0	39.3	0.2	0.0	2.0	1.7	0.6	9.7	0.0	2.1	0.9	1.5	7.6	0.0	0.0	0.2	4.8	8.6	0.0	0.0	4.9	1.1	0.0	5.0	0.0	5.8	8.1	1.7	8.2	0.7	8.1	158.9	0.0	1.9	2.3	4.2	0.6	0.1	1.3	10.7	2.6
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"	NA	NA		78000	Mitochondria		"HPA040481: AB_2677004, HPA048216: AB_2680317"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.4	4.2	8.2	7.8	0.8	7.4	9.9	5.8	11.0	2.9	10.0	2.4	3.7	6.0	7.3	6.0	5.2	4.8	11.8	0.9	5.7	4.0	6.7	3.0	7.9	1.7	8.2	5.3	3.3	7.1	8.1	4.2	50.9	1.8	1.6	2.6	10.8	2.4	1.0	3.0	1.2	4.0	2.5	2.4	9.8	3.0	5.3	4.2	7.7	1.6	7.6	4.7	15.7	1.7	3.4	2.4	17.7	5.6	6.9	6.1	6.5	1.1	1.5	0.5	5.6	2.9	8.0	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6	0.0	12.5	5.7	9.1	4.2	10.3	6.2	7.6	25.4	5.7	10.4	9.8	20.3	5.0	10.4	3.2	13.9	15.7	0.0	12.1	9.9	5.9	4.9	2.3	24.6	13.5	7.9	19.5	16.5	14.6	3.3	5.8	7.7	8.5	11.8	26.4	12.9	12.9	23.4	16.6	14.0	15.4	12.9	3.9	13.0	13.4	5.6	27.6	4.4	26.5	12.1
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892102	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.7"	"Cell type enriched"	"Detected in some"	6	"Rod photoreceptor cells: 24.5"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 42.8"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 2.1;hippocampal formation: 2.6"	"Low region specificity"	"Detected in some"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022690: , HPA049244: AB_2680690"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	7.9	0.7	0.6	2.0	2.9	0.0	2.6	0.3	4.3	6.6	14.5	0.0	1.7	12.4	1.9	0.4	5.3	1.4	32.7	0.9	0.6	0.5	0.4	3.2	1.4	0.7	0.6	1.6	0.8	2.1	0.0	0.3	1.5	0.5	8.4	7.5	0.8	0.4	0.2	0.3	0.3	15.4	15.6	0.6	0.3	4.9	1.1	0.2	0.0	0.5	0.1	0.4	13.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	42.8	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.3	4.1	0.6	0.5	0.6	1.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLRA1	STHE	ENSG00000145888	"Glycine receptor alpha 1"	P23415	5	151822513-151924842	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Cell type enhanced"	"Detected in some"	26	"Basal glandular cells: 1.1;Bipolar cells: 4.9;Horizontal cells: 1.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	10	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.4"	"Group enriched"	"Detected in many"	4	"hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6"	"Region enhanced"	"Detected in all"		"pons and medulla: 54.9"	CAB079042		Supported				NA	NA					"CAB079042: "					"unprognostic (3.17e-1)"						"unprognostic (2.47e-1)"		"unprognostic (3.85e-7)"	"unprognostic (8.24e-2)"		"unprognostic (9.45e-3)"		0.3	3.2	1.2	0.1	0.7	0.2	0.1	3.2	0.9	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.2	0.1	0.1	0.1	2.7	0.0	0.1	2.2	0.1	0.1	0.2	31.7	0.1	0.1	1.6	0.1	0.1	0.6	0.1	0.1	0.1	12.6	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.2	0.9	0.1	2.7	2.7	0.0	31.7	0.0	0.0	0.0	0.0	1.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11688956-11885685	"Disease related genes, Predicted intracellular proteins"		Transducer	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.7"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 15.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 82.7"	"Group enriched"	"Detected in some"	4	"basophil: 1.1;gdT-cell: 4.2;memory CD8 T-cell: 2.9;naive CD8 T-cell: 2.2;neutrophil: 1.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.7;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 18.4;HeLa: 18.8;U-2 OS: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	13	"basal ganglia: 183.9"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.2	1.5	17.8	3.0	82.7	0.7	4.2	2.7	18.1	8.0	3.7	3.2	3.3	1.6	6.7	2.4	8.2	4.1	4.6	2.2	7.1	7.6	4.2	1.3	2.5	5.1	6.6	5.3	3.2	1.3	1.0	20.7	2.9	8.8	9.9	3.7	2.1	4.6	18.1	18.3	7.0	2.0	9.9	3.3	1.8	2.1	6.2	11.3	0.9	8.0	1.4	5.7	9.5	7.7	0.4	0.2	1.7	0.2	0.5	4.2	1.4	0.5	6.1	7.4	0.5	0.6	0.1	0.8	0.1	0.2	0.5	0.0	6.5	1.1	18.4	1.2	0.1	4.2	0.3	6.9	5.9	0.0	3.8	6.3	0.1	18.8	3.7	0.0	0.2	0.4	0.9	8.8	0.0	0.1	0.3	0.0	0.2	1.6	0.2	0.2	0.2	0.2	0.5	6.1	5.0	0.1	0.1	1.0	0.2	0.4	0.2	6.9	0.1	8.6	0.4	2.1	1.8	0.2	0.2	1.0	0.7	9.7	0.3	1.8	0.3	0.1	0.1	0.3	0.2	0.2	1.1	0.2	0.4	4.2	0.1	0.1	0.4	0.5	2.9	0.0	0.3	0.2	2.2	1.7	0.5	0.1	0.2	0.1	1.4	17.8	82.7	2.7	12.7	7.1	7.6	6.6	5.3	8.8	11.3	3.0	5.1	0.0	10.1	9.4	6.7	3.4	0.0	13.4	7.9	3.5	15.7	0.4	1.7	0.4	3.6	4.4	1.4	0.0	2.7	2.8	5.6	4.9	5.7	1.3	0.9	3.2	0.0	0.6	0.3	2.2	0.9	1.3	13.5	0.0	0.2	0.9	1.2	2.0	2.8	3.8	3.1	6.5	13.9	1.9	5.3	6.6	0.5	1.3	1.2	12.9
GNG13	"G(gamma)13, h2-35"	ENSG00000127588	"G protein subunit gamma 13"	Q9P2W3	16	798041-800733	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 78.6;retina: 22.9"	"Cell type enriched"	"Detected in some"	20	"Bipolar cells: 323.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"cerebellum: 78.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 11.2;HEK 293: 9.9;HeLa: 5.9;MCF7: 13.9"	"Region enhanced"	"Detected in all"		"cerebellum: 1054.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 43.5;olfactory region: 18.2"	HPA046272	Enhanced					NA	NA					"HPA046272: AB_10960062"	"unprognostic (1.84e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.41e-2)"		"unprognostic (8.47e-2)"	"unprognostic (9.16e-3)"	"unprognostic (4.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.77e-2)"		"unprognostic (7.12e-2)"	"unprognostic (1.55e-1)"		"unprognostic (3.38e-1)"	0.2	0.2	1.8	0.7	3.3	0.9	0.3	78.6	11.3	0.2	2.9	3.4	0.0	5.4	0.2	0.7	0.2	0.2	0.3	0.2	1.1	1.6	0.2	0.2	0.3	0.6	1.3	2.7	0.3	0.2	0.2	0.3	0.4	2.7	0.4	0.6	22.9	0.2	0.2	0.2	0.5	5.1	0.4	1.9	0.4	0.8	1.5	0.2	0.2	0.3	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.5	1.2	0.0	0.0	0.9	1.0	0.0	0.0	0.0	11.2	0.3	1.2	0.3	0.0	0.1	1.7	0.0	0.0	0.0	1.3	9.9	1.4	5.9	0.0	0.0	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.9	0.9	0.0	13.9	1.3	0.8	1.3	0.1	1.2	3.0	3.2	0.7	0.0	1.7	1.0	0.9	1.0	0.4	0.2	0.4	0.8	0.1	0.0	1.5	1.4	1.9	0.3	0.5	2.5	4.5	0.1	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.3	78.6	11.3	1.1	1.6	1.3	2.7	2.7	0.2	0.0	0.0	0.0	0.1	0.0	323.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702709	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 115.9"	"Group enriched"	"Detected in many"	5	"B-cells: 132.4;Cardiomyocytes: 52.7;Distal tubular cells: 104.5;Hofbauer cells: 49.0;Horizontal cells: 160.5;Melanocytes: 49.0;Muller glia cells: 53.2"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 115.9"	"Group enriched"	"Detected in many"	4	"memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	4	"B-cells: 23.9;dendritic cells: 19.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;REH: 31.0;SK-MEL-30: 14.3;U-266/70: 29.8;U-266/84: 13.7"	"Region enriched"	"Detected in many"	6	"basal ganglia: 1142.7"	"Region enriched"	"Detected in all"	6	"basal ganglia: 484.6"	HPA057790	Supported	Supported				NA	NA					"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"	3.1	4.8	19.8	4.5	115.9	5.4	4.1	9.7	28.2	2.6	3.8	23.4	0.8	4.7	4.8	4.9	11.1	6.5	3.3	22.5	20.3	11.4	6.0	2.2	3.0	8.0	20.0	10.0	10.0	7.2	5.4	4.6	1.4	20.9	7.1	3.0	12.2	22.8	5.7	2.9	1.7	4.9	3.4	28.5	11.0	5.8	5.5	22.0	0.1	3.7	0.4	8.2	3.4	1.4	23.9	19.9	5.0	0.6	0.0	0.5	1.3	0.1	0.0	1.5	3.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	10.5	0.5	0.1	0.1	0.1	1.7	0.0	0.0	0.0	1.4	0.2	0.0	1.2	0.8	0.0	6.3	0.2	0.2	0.0	0.1	0.1	0.0	1.2	0.1	6.8	0.0	1.0	0.2	0.6	1.2	0.2	0.6	31.0	0.0	2.8	0.1	0.0	0.0	4.5	0.0	0.0	14.3	1.1	0.2	2.6	0.0	0.0	1.5	0.1	0.1	29.8	13.7	2.2	0.1	3.3	7.9	1.1	0.6	3.2	0.1	0.2	0.4	23.9	0.2	0.1	2.5	20.5	0.5	0.3	5.0	0.0	0.0	19.9	0.0	1.3	19.8	115.9	9.7	20.0	20.3	11.4	20.0	10.0	20.9	22.0	6.0	3.4	132.4	10.1	2.3	5.4	52.7	10.2	5.3	5.7	8.7	7.9	0.5	104.5	10.7	4.3	12.1	0.5	0.0	4.2	0.9	1.7	8.1	12.7	11.6	49.0	160.5	5.8	14.7	7.2	7.4	2.3	6.6	49.0	12.6	2.6	53.2	3.9	1.5	2.5	15.8	10.2	6.5	8.0	1.7	2.9	1.8	2.9	2.2	1.7	6.7
GNRH1	"GNRH, GRH, LHRH"	ENSG00000147437	"Gonadotropin releasing hormone 1"	P01148	8	25419260-25424654	"Disease related genes, Predicted secreted proteins"		Hormone	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Cell type enhanced"	"Detected in many"	6	"Leydig cells: 9.2;Peritubular cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"basal ganglia: 23.5;cerebellum: 6.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 20.8;hypothalamus: 14.2;olfactory region: 8.3"	"Group enriched"	"Detected in some"	30	"basal ganglia: 21.7;hypothalamus: 66.0"	HPA027532	Supported				"Secreted to blood"	NA	NA					"HPA027532: AB_10612111"	"unprognostic (6.49e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.53e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.08e-9)"	"unprognostic (7.98e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.68e-2)"	2.0	1.3	1.7	1.7	23.5	3.6	5.0	6.9	2.3	2.4	2.6	2.1	1.7	2.6	2.5	6.7	2.3	1.9	2.8	2.3	1.7	3.7	2.3	1.7	2.7	2.8	1.7	1.7	4.3	2.8	0.8	2.0	1.9	1.7	3.6	2.5	1.7	3.3	2.4	4.0	12.6	2.9	1.7	1.7	3.1	1.5	1.7	3.2	1.7	1.8	1.7	2.3	1.7	3.9	0.9	1.1	1.7	0.3	0.2	1.9	0.1	1.0	1.7	4.6	2.5	1.6	5.4	2.0	4.0	1.6	1.3	1.9	1.7	1.2	1.3	0.9	2.4	2.9	4.1	1.4	0.3	3.0	1.8	2.4	1.5	6.1	1.8	1.3	0.3	1.5	3.1	2.4	0.9	0.8	4.1	1.0	1.4	1.7	1.3	2.1	0.7	1.5	3.1	1.6	1.4	0.5	1.0	0.6	0.6	1.2	0.7	21.5	0.8	1.1	0.8	1.4	1.8	0.9	1.9	3.8	3.6	1.7	4.1	1.5	0.2	0.3	2.0	1.7	1.1	1.6	0.0	0.0	0.0	1.9	0.1	0.8	0.3	0.2	0.6	0.1	0.9	0.4	0.3	1.7	0.2	0.3	1.1	1.6	0.1	1.7	23.5	6.9	2.3	1.7	3.7	1.7	1.7	1.7	3.2	0.0	0.3	0.0	1.7	4.4	2.8	1.8	0.0	0.0	1.2	3.5	3.9	0.1	0.0	0.2	0.3	1.1	1.6	0.0	0.6	0.2	3.1	3.3	0.0	0.2	0.4	0.0	1.7	1.8	0.3	0.0	9.2	0.2	3.3	0.0	0.6	0.5	0.5	0.0	9.2	0.0	4.5	0.0	1.0	1.9	1.1	2.0	0.1	1.0	1.4	1.3
GOLT1A	"CGI-141, FLJ42654, GOT1, MGC62027, YMR292W"	ENSG00000174567	"Golgi transport 1A"	Q6ZVE7	1	204198160-204214092	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 35.9;liver: 74.9"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 38.2;Hepatocytes: 109.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 80.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 10.8;Hep G2: 13.3;MCF7: 22.5;OE19: 8.5;RT4: 14.7;SK-BR-3: 14.8"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (6.20e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-3)"	"prognostic favorable (1.51e-4)"	0.3	0.0	1.2	0.8	8.8	0.0	1.7	3.8	0.8	3.5	13.7	0.4	1.7	15.5	0.3	3.6	0.3	1.0	3.4	0.3	1.0	3.8	5.9	74.9	3.1	0.3	0.8	0.4	0.4	12.5	7.1	8.7	1.0	0.9	2.9	1.6	0.5	1.0	3.7	0.6	0.0	35.9	1.6	0.6	0.3	1.9	0.5	0.3	0.4	0.6	0.3	0.4	10.9	2.5	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.2	4.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	9.3	10.8	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	2.1	8.5	0.1	0.0	0.0	0.2	4.6	14.7	0.7	1.0	0.4	14.8	0.0	0.4	4.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.4	1.4	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.6	1.2	8.8	3.8	0.8	1.0	3.8	0.8	0.4	0.9	0.3	0.0	17.9	0.0	11.9	0.0	2.5	0.3	38.2	0.0	5.7	15.7	0.0	11.4	11.6	24.4	0.6	0.0	13.1	0.0	16.1	0.2	0.4	10.6	1.1	109.9	1.1	1.6	9.9	3.1	2.8	0.0	0.0	0.0	1.7	0.0	3.2	0.0	18.5	1.7	0.0	10.4	0.1	0.0	0.1	2.3	0.9	0.1	22.1	0.0	7.4	12.9
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 17.5;Cone photoreceptor cells: 64.8;Hepatocytes: 55.7"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 10.5;U-698: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.9	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.4	0.1	10.5	1.2	0.2	0.3	0.0	1.7	0.3	0.2	1.3	3.5	1.5	1.4	4.4	0.0	1.8	0.2	0.1	0.2	0.1	0.0	1.2	0.0	2.6	0.7	0.5	0.3	0.7	1.0	0.6	4.0	0.7	0.5	2.0	0.3	0.1	0.4	5.2	3.3	3.5	1.1	0.1	0.5	0.9	0.5	0.5	0.1	1.3	1.3	0.1	1.4	3.1	4.8	10.7	0.2	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6	0.0	3.0	0.0	0.4	0.0	17.5	10.1	0.0	1.4	2.3	1.8	64.8	0.2	0.0	0.3	3.0	1.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	55.7	0.1	14.3	1.7	0.6	1.3	2.3	2.8	0.0	0.0	0.0	0.3	4.3	0.1	0.0	3.2	0.3	10.5	0.0	0.5	0.5	5.3	0.5	0.0	0.0	0.4	2.2
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 19.1"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 10.0;Muller glia cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.7;pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HHSteC: 53.7;hTCEpi: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	2.3	5.0	0.5	0.6	10.7	0.1	1.7	0.4	1.2	4.1	0.6	4.8	1.6	0.2	1.3	0.7	6.6	1.1	2.7	3.8	1.6	0.5	0.7	0.0	0.5	3.1	0.2	0.3	3.2	0.1	0.0	0.4	19.1	6.6	0.7	0.6	1.1	1.5	0.4	1.5	6.7	0.5	2.3	0.3	0.2	0.2	1.6	1.0	0.0	0.7	2.2	1.2	3.1	7.7	0.5	0.1	1.4	0.2	0.5	0.2	0.6	0.8	0.1	0.7	0.0	0.1	3.0	0.2	5.5	9.5	3.4	2.9	0.0	0.0	0.0	0.3	2.7	0.2	0.1	0.2	0.0	1.1	0.0	0.1	0.0	1.8	0.0	53.7	0.0	0.0	2.2	24.2	4.9	7.9	4.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	2.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.0	0.6	0.0	0.0	0.1	4.1	1.9	4.8	0.4	0.0	0.0	0.0	1.5	0.0	0.1	1.3	0.2	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.5	0.2	0.2	1.4	0.5	0.1	0.1	0.2	0.6	0.5	10.7	0.4	1.2	1.6	0.5	0.2	0.3	6.6	1.0	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.3
GPR149	"IEDA, PGR10, R35"	ENSG00000174948	"G protein-coupled receptor 149"	Q86SP6	3	154337672-154429715	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"brain: 23.5;pituitary gland: 6.5;seminal vesicle: 8.7"	"Cell type enhanced"	"Detected in single"	37	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 23.5;pons and medulla: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 15.0"	"Low region specificity"	"Detected in all"			HPA018020	Uncertain					NA	NA					"HPA018020: AB_1849334"																		0.2	0.3	0.2	0.2	23.5	0.2	0.2	0.0	0.8	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.2	0.8	0.0	0.2	0.2	0.2	6.5	0.2	6.5	0.3	0.3	0.4	0.2	8.7	0.2	0.3	0.3	0.2	0.6	0.2	0.5	1.1	2.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.5	0.0	0.8	0.2	1.9	0.8	0.0	6.5	2.1	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR52		ENSG00000203737	"G protein-coupled receptor 52"	Q9Y2T5	1	174448111-174449198	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"brain: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"basal ganglia: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.0;Daudi: 1.5;Karpas-707: 2.5"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"				"unprognostic (8.60e-2)"		"unprognostic (2.61e-2)"			"unprognostic (3.65e-1)"			"unprognostic (2.27e-1)"			"unprognostic (4.49e-1)"	0.3	0.3	0.8	0.2	28.0	2.2	0.1	0.2	7.4	0.1	0.2	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.6	0.2	0.6	0.0	0.2	0.3	0.4	5.0	0.0	0.1	0.0	0.8	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.0	0.2	3.2	0.2	0.7	0.2	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR55		ENSG00000135898	"G protein-coupled receptor 55"	Q9Y2T6	2	230907318-230961066	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7"	"Cell type enhanced"	"Detected in some"	17	"granulocytes: 1.1;Intestinal endocrine cells: 1.7;T-cells: 4.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (9.88e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.24e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.26e-1)"	0.4	0.1	0.4	6.9	7.8	0.2	0.7	0.1	1.2	0.6	4.8	0.7	0.1	2.1	0.9	0.5	0.8	0.2	1.6	0.1	0.5	0.7	0.9	0.1	0.8	8.8	0.2	0.1	0.1	0.1	0.1	0.5	0.1	0.3	1.2	1.5	0.1	1.9	2.1	0.1	0.6	8.2	0.1	0.3	6.6	0.9	7.7	0.1	7.0	0.4	1.2	13.2	2.2	0.4	3.0	1.9	0.5	0.2	2.2	3.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.5	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.6	27.0	0.0	0.0	0.2	0.7	0.5	0.0	0.8	0.0	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	4.9	0.0	0.0	1.9	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.3	1.2	1.2	0.9	0.4	3.0	0.5	2.3	0.5	2.2	0.2	1.9	3.1	4.6	0.4	7.8	0.1	1.2	0.5	0.7	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.7	0.6	0.8	0.4	0.0	0.5	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.4	0.0	0.0
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	19	"brain: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"basal ganglia: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	22	"SCLC-21H: 4.6"	"Region enriched"	"Detected in some"	11	"basal ganglia: 81.5"											NA	NA										"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.4	0.5	3.5	0.4	42.5	0.5	0.4	0.0	6.5	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.8	0.4	0.4	0.4	0.4	0.1	0.8	0.4	0.4	0.4	2.2	0.4	0.0	0.4	0.4	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.5	4.6	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	42.5	0.0	4.0	1.3	1.8	0.1	0.8	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No			"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.1	25.2	0.0	33.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	44.8	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.1	13.2	0.0	0.0	5.6	0.1	0.0	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	127.1	52.7	0.0	0.0	0.0	4.0	20.5	3.5	0.0	46.3	0.0	1.3	0.1	0.2	0.0	0.0	0.6	10.3	2.1	36.4	1.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	59.6	171.4	0.0	0.0	178.7
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538137-100542018	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 62.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Group enriched"	"Detected in many"	7	"basal ganglia: 62.7;thalamus: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 4.9;SCLC-21H: 6.1"	"Region enriched"	"Detected in many"	11	"basal ganglia: 643.5"	"Region enriched"	"Detected in some"	34	"basal ganglia: 223.4"	HPA007488		Approved				NA	NA					"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.7	0.6	1.2	0.5	62.7	0.2	10.9	0.0	6.8	0.1	0.3	0.8	0.0	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.9	0.8	0.3	13.1	0.2	0.3	0.7	1.1	3.8	0.1	4.6	0.5	0.2	7.0	0.6	0.5	0.3	0.7	0.1	0.3	0.1	0.5	0.3	0.5	13.7	0.4	0.2	32.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	62.7	0.0	6.8	0.9	0.8	0.7	1.1	7.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12890782-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 155.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 3.1"	"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	9.8	1.4	0.2	6.0	0.6	0.4	5.4	0.1	0.3	12.1	19.8	0.5	2.0	6.2	4.3	1.9	9.1	3.0	15.5	7.1	0.1	0.2	5.1	0.6	155.0	0.1	0.5	0.1	18.5	1.1	0.0	0.9	20.1	3.1	10.4	16.9	4.8	9.6	1.5	1.1	2.0	36.9	14.2	1.1	0.1	11.4	4.8	0.3	0.1	54.2	14.9	11.5	32.1	14.0	0.6	0.6	3.1	0.3	0.5	0.4	0.0	42.7	34.2	0.0	0.1	0.4	0.2	2.2	12.9	4.9	8.4	6.4	6.0	164.8	0.0	1.1	10.3	8.9	43.2	0.1	6.2	12.9	0.0	0.5	0.0	14.1	0.2	3.1	0.0	0.0	0.2	8.4	3.5	0.8	10.4	5.1	0.0	0.0	0.0	0.3	30.0	0.0	0.0	0.1	15.6	5.4	0.0	0.9	0.0	16.6	8.5	0.0	0.0	60.6	4.6	1.9	6.9	1.3	0.1	0.5	0.3	10.9	19.6	0.5	0.0	0.0	0.0	4.4	0.0	0.2	3.1	0.3	0.4	0.3	0.2	0.3	0.3	0.2	0.3	0.1	0.6	0.4	0.4	1.3	0.5	0.2	0.6	0.3	0.0	0.2	0.6	0.1	0.3	0.1	0.2	0.5	0.1	3.1	0.3	872.5	165.8	0.0	282.3	11.1	0.0	1.0	5.1	69.6	257.0	43.6	0.0	0.7	0.0	49.3	0.0	7.5	159.2	0.0	63.3	8.9	57.8	325.5	9.3	0.0	1.5	0.0	7.9	4.9	0.0	0.0	12.4	10.7	49.0	1.0	28.8	1.3	368.5	52.7	9.6	0.0	0.2	0.0	24.7	0.0	0.2	8.0	0.9	1.3	79.7	1048.5
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 76.2"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.2;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0"	"Region enriched"	"Detected in many"	9	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	4.3	4.1	5.2	2.2	5.3	0.0	7.7	31.1	5.7	19.7	15.4	4.4	17.0	10.0	5.8	9.9	5.3	12.5	17.6	7.7	5.3	2.6	43.8	46.1	11.5	2.8	4.8	4.9	12.3	76.2	12.0	3.4	4.5	6.1	15.1	6.2	18.0	16.8	11.7	25.4	9.2	15.2	3.9	4.6	5.1	44.7	4.4	4.1	1.9	42.2	10.2	3.5	12.6	8.0	0.7	10.2	0.1	4.7	0.0	0.1	0.3	4.6	16.7	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	21.4	0.0	13.3	0.1	5.4	14.7	2.2	0.3	0.0	0.0	2.7	0.0	1.2	24.0	4.9	0.0	42.2	0.4	7.6	0.0	0.0	22.7	0.0	0.0	1.2	0.3	0.0	5.2	0.1	4.5	2.7	23.1	19.4	0.0	0.0	1.1	56.9	26.3	8.1	0.7	0.8	1.8	0.0	10.9	32.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.6	0.1	0.0	1.7	0.1	0.0	3.4	0.0	0.7	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	4.7	10.2	0.0	0.3	5.2	5.3	31.1	5.7	5.3	2.6	4.8	4.9	6.1	4.1	3.0	48.9	1.5	39.6	12.0	0.8	193.6	68.8	22.7	18.2	129.1	0.0	0.7	24.9	53.1	0.1	8.7	61.7	0.0	58.9	7.1	19.9	46.9	10.3	148.3	9.6	4.8	43.7	25.8	8.5	0.5	16.7	4.2	3.3	5.4	47.3	18.8	37.9	149.7	20.8	51.6	0.8	142.3	56.7	0.4	3.0	9.8	21.2	1.5	44.1	40.9
GPRC5D		ENSG00000111291	"G protein-coupled receptor class C group 5 member D"	Q9NZD1	12	12940775-12952147	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.4;skin 1: 33.9"	"Group enriched"	"Detected in some"	12	"B-cells: 3.9;Early spermatids: 5.3;Late spermatids: 4.5;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.1"	"Cell type enriched"	"Detected in some"	4	"memory B-cell: 18.4"	"Lineage enriched"	"Detected in many"	17	"B-cells: 18.4"	"Group enriched"	"Detected in some"	10	"Karpas-707: 37.5;RPMI-8226: 36.3;U-266/84: 10.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071909	Approved					NA	NA					"HPA071909: AB_2686470"	"unprognostic (4.27e-2)"	"unprognostic (8.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.00e-5)"	"unprognostic (4.06e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.63e-2)"	1.0	0.5	0.4	3.1	0.4	0.3	4.2	0.4	0.4	0.8	3.8	0.4	0.4	2.4	1.0	0.4	3.7	0.3	1.5	0.7	0.4	0.2	0.8	0.7	4.4	5.9	0.4	0.4	0.4	2.9	0.0	1.0	0.9	2.1	0.9	3.4	0.7	8.6	0.4	0.4	33.9	3.8	0.4	0.4	5.1	3.3	3.7	0.4	0.4	1.3	5.2	4.1	1.3	0.7	18.4	0.1	1.0	0.0	0.0	0.2	1.9	0.5	0.6	0.0	0.6	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.5	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	37.5	0.1	1.3	0.0	0.0	0.3	1.6	0.0	0.0	0.0	36.3	0.0	1.5	1.2	0.2	0.8	0.6	0.0	1.6	0.0	0.0	1.0	0.0	1.7	0.0	0.0	1.9	10.3	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	0.1	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	2.1	0.4	0.0	0.0	3.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 75.7;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 47.1;RPMI-8226: 12.1;SCLC-21H: 12.6;U-266/70: 7.3;U-266/84: 5.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoli	Nucleoplasm	"HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902"	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	12.1	0.1	0.0	12.6	0.2	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.3	5.7	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2	0.0	19.9	3.7	0.7	1.0	9.4	14.6	5.1	1.4	9.1	3.5	0.0	0.1	1.7	1.1	0.1	3.6	9.6	0.0	8.2	0.0	2.3	0.2	7.0	0.0	18.9	25.4	75.7	2.5	26.9	0.0	0.3	31.5	1.7	5.4	25.1	0.8	1.7	5.8	1.1	1.8	10.3	77.6	8.2	0.1	0.1	0.9	0.2	34.6	21.8	0.3
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 193.7"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.9	2.8	0.0	0.4	0.0	0.1	2.6	0.0	1.8	0.0	0.0	0.2	0.0	0.6	4.3	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	193.7	0.4	0.0	0.0	1.9	2.2	1.6	1.1	0.0	2.1	42.8	0.0	2.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3	20.8	10.0	0.0	79.7	34.0	0.0	2.0	15.3	17.4	7.9	21.0	0.0	27.0	8.3	29.6	0.0	0.5	18.0	0.0	16.9	18.8	1.9	69.7	1.1	4.0	2.5	0.0	13.8	0.0	0.0	0.0	2.6	0.9	5.0	2.8	16.8	0.3	20.5	24.6	1.1	8.6	0.0	0.0	1.0	0.4	0.2	36.6	82.5	0.9	22.1	65.1
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	16.8	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	25.9	0.0	0.1	1.1	9.4	0.0	0.0	0.0	0.1	2.1	29.6	0.1	0.0	0.0	2.9	0.0	16.3	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1	0.0	1.1	0.0	8.8	12.8	0.0	0.4	0.0	2.7	2.3	1.8	0.0	3.5	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.3	9.1	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.0	86.8	15.4	0.0	0.0	72.5
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 23.6"	"Cell type enhanced"	"Detected in single"	12	"Rod photoreceptor cells: 1.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 23.6"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"REH: 8.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 25.2;thalamus: 7.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7"	HPA045381			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.2	1.7	0.8	0.6	3.6	1.1	1.1	23.6	6.6	0.6	1.4	6.5	0.0	1.8	0.4	0.1	1.2	1.1	0.6	0.3	1.6	1.6	0.7	0.3	1.2	0.5	0.7	1.2	0.9	1.8	3.9	3.0	0.2	5.5	2.3	0.7	0.3	2.1	1.6	0.2	3.4	1.6	0.0	1.5	1.4	2.2	1.2	6.8	2.5	1.6	0.0	0.6	0.9	0.8	0.7	0.2	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.0	0.7	0.7	0.0	0.2	0.8	0.0	8.9	0.3	0.2	0.2	0.3	0.1	1.1	0.0	0.8	0.0	0.3	2.0	0.2	0.1	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.4	0.0	0.0	1.1	0.2	0.2	0.0	0.1	0.8	3.6	23.6	6.6	1.6	1.6	0.7	1.2	5.5	6.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1
GRIN2B	"GluN2B, NMDAR2B"	ENSG00000273079	"Glutamate ionotropic receptor NMDA type subunit 2B"	Q13224	12	13437942-13981957	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 36.5"	"Group enriched"	"Detected in some"	10	"Early spermatids: 36.4;Late spermatids: 25.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 19.5;basal ganglia: 26.0;cerebral cortex: 36.5;hippocampal formation: 19.6;olfactory region: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.4;AF22: 3.4;CACO-2: 3.9;Daudi: 1.6;NTERA-2: 4.9;RPTEC TERT1: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069762	Approved					NA	NA					"HPA069762: AB_2686192"	"unprognostic (2.01e-2)"	"unprognostic (4.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.39e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.48e-5)"	"unprognostic (2.43e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-1)"	1.9	0.9	19.5	0.8	26.0	0.8	0.9	0.9	36.5	0.8	1.9	1.9	0.0	0.8	0.8	0.8	0.9	0.8	0.8	0.8	19.6	3.5	1.0	1.6	0.8	1.4	1.8	15.0	0.9	0.8	0.8	0.4	0.9	2.6	0.8	1.2	0.0	0.8	0.8	0.8	0.8	1.8	0.8	0.8	0.9	1.0	1.5	3.6	0.0	0.8	0.0	1.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	26.0	0.9	36.5	19.6	3.5	1.8	15.0	2.6	3.6	0.0	0.0	0.0	0.0	0.0	0.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.0
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 15.9;Hofbauer cells: 9.4;Muller glia cells: 18.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 43.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.3;RPMI-8226: 4.0;SCLC-21H: 5.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	13	"cerebellum: 65.6"							NA	NA						"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	1.0	1.4	7.8	0.5	9.1	1.0	0.5	43.6	8.9	0.5	0.5	2.4	0.0	0.5	0.5	0.5	0.4	0.6	0.6	13.2	4.5	1.4	0.3	0.2	0.3	0.3	3.2	4.5	0.4	0.2	0.5	0.0	2.7	4.2	0.3	0.4	0.3	14.2	0.5	0.6	0.4	0.6	0.5	1.0	0.4	0.3	2.7	0.9	0.0	12.4	0.0	0.3	0.4	0.0	0.2	1.3	0.3	0.1	0.2	0.7	0.0	0.0	0.4	0.4	0.1	0.1	0.0	11.3	0.0	0.0	0.0	0.0	1.4	0.2	0.5	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.3	0.2	0.3	0.3	0.0	0.8	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.3	0.0	1.7	0.1	0.1	0.1	0.1	0.1	0.3	0.9	4.0	0.0	0.3	5.2	0.4	2.2	0.2	0.8	0.8	0.7	0.1	0.2	0.4	2.0	0.5	0.2	1.1	0.1	0.2	0.5	0.7	0.2	0.1	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.3	0.2	0.3	0.2	0.0	1.3	0.2	0.0	7.8	9.1	43.6	6.3	4.5	1.4	3.2	4.5	4.2	0.9	0.0	0.0	0.0	0.0	0.1	2.5	15.9	2.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.4	1.6	0.0	1.3	0.3	4.3	0.0	0.0	1.7	0.0	0.0	18.3	0.0	0.0	0.4	0.0	2.4	0.0	1.0	3.0	2.5	0.0	0.6	0.0	0.0	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 113.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.1	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	1.8	15.7	0.0	1.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	113.7	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018645-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"brain: 101.6"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 1.8;Early spermatids: 3.4;Intestinal endocrine cells: 2.9;Late spermatids: 1.5;Spermatogonia: 4.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in many"	21	"cerebellum: 101.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 6.5;SCLC-21H: 26.0"	"Region enhanced"	"Detected in all"		"cerebellum: 83.5"	"Region enriched"	"Detected in all"	4	"cerebellum: 252.6"	CAB022096	Enhanced					NA	NA					"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.2	0.1	0.4	0.3	4.9	0.2	0.2	101.6	7.2	0.6	0.1	0.3	0.1	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.5	0.9	0.2	0.3	0.3	0.2	0.3	0.4	0.2	3.5	0.1	0.0	0.3	4.3	0.3	0.2	0.1	0.1	0.2	0.3	0.6	0.8	0.7	1.1	0.1	0.2	1.6	0.5	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.9	101.6	1.0	0.5	0.9	0.3	0.4	4.3	0.5	0.0	0.0	0.0	0.3	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	4.0	0.0	0.1	0.0	0.0	0.1
GSG1L2		ENSG00000214978	"GSG1 like 2"	A8MUP6	17	9802386-9822071	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	36	"brain: 4.8;retina: 3.3;testis: 2.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	95	"renal cancer: 4.7"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.7;olfactory region: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.8"	"Not detected"	"Not detected"													NA	NA																							0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	1.7	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 614.0;Ciliated cells: 837.9;Exocrine glandular cells: 1419.6;Hepatocytes: 628.5;Pancreatic endocrine cells: 1010.1;Proximal tubular cells: 2005.4"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 89.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000		Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	89.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6	6.0	7.7	0.0	2.8	0.0	0.0	0.0	614.0	837.9	106.9	69.8	0.0	0.1	454.3	72.7	8.0	0.0	11.8	46.7	1419.6	0.0	0.0	51.4	2.3	628.5	0.1	0.0	2.9	23.4	22.6	21.8	60.7	4.4	0.0	22.6	33.3	0.0	1010.1	6.0	4.2	2005.4	0.0	0.0	0.0	5.6	3.4	0.0	0.5	4.3	29.3	42.0
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909685	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9"	"Group enriched"	"Detected in some"	8	"Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.2	36.5	0.2	0.2	0.6	0.0	0.7	0.3	0.2	0.9	0.2	1.0	0.2	0.0	0.3	6.6	0.2	32.4	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	0.2	0.2	3.8	0.2	1.1	0.2	51.9	2.1	0.2	0.0	0.5	0.6	0.2	0.2	12.5	0.2	0.2	0.2	0.2	1.0	6.4	0.3	0.2	0.2	0.9	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.2	0.2	0.2	0.2	0.2	2.1	0.3	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	33.5	10.3	0.0	0.0	121.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.4	0.2	0.0	1.1	0.2	13.5	0.0	0.0	0.0	0.0	1.3	1.4	0.0	23.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	8.5	430.9	0.0	0.0	0.0
GSX1	"Gsh-1, GSH1"	ENSG00000169840	"GS homeobox 1"	Q9H4S2	13	27792643-27794768	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"brain: 7.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"glioma: 3.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"JURKAT: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA047096			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA047096: AB_2679929"					"unprognostic (1.62e-1)"													0.1	0.1	1.6	0.1	3.2	0.1	0.1	0.9	4.0	0.1	0.1	2.5	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.7	7.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.9	1.5	0.7	7.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42180056	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 91.2;testis: 62.2"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 10.0"	"Cell type enriched"	"Detected in single"	84	"plasmacytoid DC: 8.4"	"Lineage enriched"	"Detected in single"	84	"dendritic cells: 8.4"	"Group enriched"	"Detected in some"	8	"NTERA-2: 7.2;SH-SY5Y: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.2	0.2	2.7	0.3	10.0	0.2	0.2	0.1	1.6	0.2	0.2	0.1	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	1.5	5.4	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	91.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.1	62.2	0.1	0.1	0.1	0.1	0.5	0.3	0.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	10.0	0.1	0.8	1.5	5.4	1.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	118.0	0.3	0.0	0.0	0.0	0.0	628.3	0.4	0.0	0.0	108.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	62.0	0.0	0.0	0.0	331.5	1.7	0.0	0.0	9.0	0.0	125.6	0.0	0.0	1.8	0.0	949.8	0.0	0.0	2.8	1.9	0.0	0.2	0.0	0.0	0.0
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716892	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 47.7"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 75.5;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 93.0;Urothelial cells: 41.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Group enriched"	"Detected in some"	6	"basophil: 12.1;neutrophil: 47.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	49	"granulocytes: 47.7;monocytes: 21.3"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.2;RT4: 27.9"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	4.8	0.2	0.6	7.9	0.3	20.8	4.0	0.4	0.5	2.3	0.9	0.2	2.2	0.1	0.4	0.4	18.2	0.5	0.5	1.0	0.3	0.3	0.9	2.5	10.2	3.5	3.5	0.0	1.6	0.2	6.6	1.1	3.0	0.7	4.2	0.0	0.3	2.9	4.3	0.6	13.9	0.3	0.4	1.2	21.6	0.5	1.6	0.4	0.3	0.5	12.0	14.9	5.7	7.2	0.0	0.7	47.7	21.3	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	7.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	12.1	0.5	0.2	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	47.7	0.0	21.3	0.0	0.0	0.6	0.6	0.3	0.4	0.5	0.3	0.3	3.5	0.0	0.7	0.4	3.0	10.7	0.0	75.5	83.9	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.1	2.0	5.3	3.5	0.0	6.1	0.0	0.0	0.0	7.3	0.0	0.0	22.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	93.0	11.6	0.0	0.0	41.6
HCRTR2	OX2R	ENSG00000137252	"Hypocretin receptor 2"	O43614	6	55106460-55282620	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 17.4"	"Cell type enhanced"	"Detected in some"	24	"Distal tubular cells: 1.7;Peritubular cells: 3.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"pons and medulla: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"AF22: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054516	Enhanced					NA	NA					"HPA054516: AB_2682513"						"unprognostic (4.86e-1)"		"unprognostic (2.69e-2)"		"unprognostic (1.86e-2)"	"unprognostic (2.32e-1)"			"unprognostic (7.45e-2)"	"unprognostic (7.39e-2)"			0.1	0.2	1.7	0.0	1.3	0.0	0.1	0.6	2.2	0.1	0.1	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.1	1.1	0.9	4.2	3.7	0.1	0.4	0.1	2.6	1.7	1.7	0.0	0.0	0.3	2.2	17.4	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	1.3	0.6	2.2	0.9	4.2	2.6	1.7	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Cell type enriched"	"Detected in some"	7	"granulocytes: 556.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Group enriched"	"Detected in some"	4	"HEL: 61.2;HMC-1: 147.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	61.2	0.0	0.0	0.0	0.1	147.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2	11.9	81.4	0.0	0.0	0.7	0.5	0.3	0.0	8.1	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	556.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0
HELLS	"LSH, Nbla10143, PASG, SMARCA6"	ENSG00000119969	"Helicase, lymphoid specific"	Q9NRZ9	10	94501434-94613905	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	"Developmental protein, Helicase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.4"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 69.2;Spermatogonia: 174.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.1"	"Region enhanced"	"Detected in many"		"cerebellum: 11.9"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004491, HPA063242"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB004491: AB_627895, HPA063242: AB_2684968"	"unprognostic (1.94e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.38e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.76e-5)"	"unprognostic (7.59e-3)"	"unprognostic (7.03e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.05e-2)"	"unprognostic (9.45e-5)"	"unprognostic (9.93e-13)"	"unprognostic (2.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.03e-2)"	1.4	2.0	1.2	28.8	1.5	14.8	3.0	11.9	3.2	4.2	5.0	0.7	3.3	3.5	5.8	6.0	8.6	2.5	3.6	2.1	1.3	2.0	3.9	2.0	2.5	11.9	1.4	1.7	4.3	1.9	2.7	4.7	9.0	1.3	3.4	5.5	3.3	2.8	2.0	0.6	5.2	5.3	2.1	1.7	8.3	3.6	18.7	0.7	46.4	1.7	8.1	15.1	3.6	4.4	13.6	22.0	0.7	0.8	5.6	10.9	1.5	19.9	19.7	25.5	32.3	1.0	2.4	13.8	15.3	9.9	12.8	20.2	26.0	16.2	24.7	6.1	5.1	10.8	20.2	14.6	12.2	18.3	23.9	16.8	13.1	20.0	20.8	0.6	24.7	11.9	1.3	0.7	15.3	7.3	3.5	8.8	16.7	7.1	15.8	15.1	20.1	26.0	12.3	26.4	14.6	8.8	24.3	22.7	5.7	8.7	25.8	10.2	8.3	18.1	5.2	2.7	22.2	22.1	8.0	6.2	14.0	7.1	12.8	18.3	8.2	15.6	26.4	7.0	15.3	6.4	0.1	0.5	0.0	4.4	0.8	1.5	10.9	7.2	6.2	1.3	13.6	3.5	5.0	0.7	5.6	0.6	22.0	10.9	1.5	1.2	1.5	11.9	3.2	1.3	2.0	1.4	1.7	1.3	0.7	8.9	3.8	23.8	8.2	19.2	13.6	0.8	7.6	8.1	17.0	21.0	0.0	25.8	3.3	5.8	0.8	4.9	2.1	23.3	5.5	31.3	11.0	3.1	5.7	2.6	12.8	6.4	10.4	8.0	1.3	3.6	8.3	6.2	1.7	9.0	6.5	5.0	3.9	0.0	5.3	1.4	9.4	19.4	6.2	69.2	174.0	8.7	9.3	12.5	23.7	4.4
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120590-8124092	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;salivary gland: 10.5"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Melanocytes: 3.3;Smooth muscle cells: 4.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;Daudi: 7.2;HAP1: 9.2;HDLM-2: 7.3;HeLa: 13.7"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA072105: AB_2686488"	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.4	0.4	1.0	0.3	1.0	0.2	0.5	9.3	2.4	1.4	0.3	0.6	0.2	0.0	2.0	0.2	0.7	0.6	0.6	1.3	1.5	0.5	1.1	0.2	0.9	0.6	1.0	0.2	1.5	0.5	0.0	0.4	3.6	2.1	0.6	0.2	0.9	10.5	2.5	1.1	0.6	0.3	0.4	1.5	0.3	0.2	2.3	0.2	0.2	0.8	0.2	0.5	1.3	0.9	0.2	0.1	0.0	0.1	0.3	0.2	0.1	6.7	0.5	0.5	2.3	0.2	0.3	0.3	0.4	0.6	0.8	2.4	0.1	0.4	7.2	0.1	0.0	1.1	0.7	9.2	0.6	0.0	7.3	4.4	0.3	13.7	0.1	0.8	0.8	0.9	0.2	1.2	2.0	5.2	1.3	0.1	1.2	0.2	3.2	0.1	0.1	0.1	0.4	0.2	0.5	1.7	0.7	0.4	1.2	0.2	0.0	0.3	3.3	0.4	0.0	0.4	0.1	0.1	0.0	0.7	0.0	1.5	1.6	2.3	4.5	0.9	0.4	0.7	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	1.0	1.0	9.3	2.4	1.5	0.5	1.0	0.2	2.1	0.2	0.0	0.0	0.0	0.9	1.9	2.4	0.9	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.3	1.0	0.0	0.5	0.0	0.0	0.4	0.0	0.8	0.0	4.2	0.0	0.6	1.4	0.2	0.0	0.0	0.1
HIST2H3A	"H3/n, H3/o"	ENSG00000203852	"Histone cluster 2 H3 family member a"	Q71DI3	1	149852619-149854274	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 126.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.6;SiHa: 8.4;U-266/70: 7.4;U-266/84: 7.3"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"					"unprognostic (1.15e-1)"					"unprognostic (1.30e-1)"				"unprognostic (3.99e-2)"				1.3	0.9	1.3	22.4	2.0	4.6	2.1	5.0	3.6	0.5	4.4	0.0	0.0	1.2	0.5	1.5	6.6	0.9	1.3	1.9	1.3	0.6	0.4	1.0	1.6	5.9	0.7	0.0	0.3	2.4	0.2	0.7	4.5	0.0	2.4	0.3	0.0	1.3	0.3	0.6	0.9	2.9	0.2	1.1	6.1	1.5	2.1	0.0	126.9	0.4	8.5	12.6	0.7	0.7	0.4	0.6	1.6	0.2	0.2	0.1	0.2	0.5	3.3	0.6	0.4	0.1	0.0	1.1	0.5	0.1	0.7	0.1	0.5	0.6	0.3	0.5	0.0	0.4	2.6	0.0	0.1	0.2	0.8	5.6	0.5	2.5	0.1	0.0	0.4	1.5	0.0	0.0	0.1	0.2	0.3	0.1	0.6	2.5	3.1	0.1	2.3	1.5	2.1	1.8	4.0	1.3	1.3	0.3	1.5	0.0	0.3	4.9	1.1	8.4	2.3	0.4	1.0	1.5	1.8	0.0	0.6	4.8	0.3	0.4	7.4	7.3	1.7	0.5	0.6	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.1	1.6	0.2	0.2	0.6	0.0	0.2	1.3	2.0	5.0	1.1	1.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HIST3H2A	MGC3165	ENSG00000181218	"Histone cluster 3 H2A"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 35.8;lymphoid tissue: 62.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 18.7;SCLC-21H: 15.8;U-266/70: 18.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	2.5	20.5	4.3	7.0	8.3	11.1	5.8	35.8	8.1	9.9	3.8	2.4	2.0	7.7	5.0	4.4	7.0	4.2	3.8	4.9	5.4	4.6	1.6	1.0	2.5	5.1	5.6	5.3	8.3	4.5	3.5	5.0	3.4	6.5	7.0	2.8	13.9	6.6	3.9	1.0	6.4	4.2	1.5	5.2	6.6	4.7	3.5	4.8	62.3	1.9	5.6	9.3	2.9	9.3	3.4	3.4	5.1	7.1	6.8	11.7	4.3	3.6	1.9	2.6	3.5	2.1	2.2	3.1	1.8	1.7	5.2	3.6	1.9	3.0	1.6	2.2	0.4	0.0	8.9	1.8	0.8	1.2	2.6	18.7	2.6	2.5	0.0	5.0	1.8	5.2	4.8	5.3	1.0	2.2	2.1	2.2	3.4	9.0	0.0	0.0	5.1	2.3	0.0	3.9	2.1	4.8	0.0	0.0	13.6	0.8	2.2	15.8	11.1	6.3	5.6	12.1	0.4	9.9	1.3	0.8	0.0	0.0	7.0	1.6	18.8	13.4	0.0	1.8	1.8	1.3	5.1	1.7	0.0	7.1	3.1	5.1	3.4	6.8	5.3	3.4	2.0	5.3	5.2	0.7	6.8	7.1	0.6	11.7	4.3	4.3	8.3	35.8	5.9	5.4	4.6	5.6	5.3	6.5	4.8	0.0	0.3	7.5	21.8	1.1	18.2	5.5	5.1	18.7	13.6	3.5	45.2	11.8	6.6	3.3	0.6	1.0	6.0	23.3	2.7	9.5	3.1	30.8	13.9	0.0	23.0	39.7	35.1	1.3	8.0	1.1	19.2	14.3	3.3	25.2	26.6	24.1	9.7	17.3	8.1	1.1	6.4	0.0	4.6	0.5	2.7	5.1	45.0	41.5	17.4	32.1
HIST3H2BB		ENSG00000196890	"Histone cluster 3 H2B family member b"	Q8N257	1	228458107-228460470	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 56.0"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 6.0;Cone photoreceptor cells: 5.9;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"U-266/70: 18.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.53e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	2.0	4.7	1.2	12.1	3.1	2.8	1.3	12.8	3.2	8.9	1.3	1.1	0.6	2.1	1.4	2.0	4.1	6.2	1.7	2.2	1.5	2.2	1.3	0.9	2.1	5.4	1.2	1.5	1.6	1.7	1.7	2.0	1.5	4.1	2.2	1.5	3.4	2.0	2.0	1.8	4.8	1.7	1.2	6.2	4.5	2.4	2.1	0.7	56.0	1.7	5.9	11.8	2.0	7.9	1.5	1.1	3.4	1.5	1.1	0.9	0.5	0.2	0.3	0.3	0.2	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.5	1.0	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.3	0.4	0.1	0.4	0.3	0.2	0.0	0.0	0.8	0.0	0.2	1.5	0.5	1.0	0.4	0.3	0.1	3.7	0.1	0.1	0.0	0.0	0.5	0.1	18.5	4.4	0.0	0.2	0.1	0.1	1.7	1.0	0.5	0.5	0.5	0.7	1.3	0.8	0.9	0.2	1.5	0.9	0.7	3.4	1.1	1.5	1.1	0.7	0.5	1.2	3.1	12.8	3.1	1.5	2.2	1.2	1.5	4.1	0.7	6.0	0.0	0.0	1.2	0.1	3.8	0.8	0.0	4.0	0.0	0.0	5.9	0.2	1.7	0.0	0.0	0.0	0.2	23.3	0.0	0.1	0.0	0.5	0.0	0.0	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.7	2.9	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.0	0.1	0.3	0.8	2.5	0.4	0.5
HMX2	NKX5-2	ENSG00000188816	"H6 family homeobox 2"	A2RU54	10	123148122-123150672	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.0;brain: 5.1;kidney: 5.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.9"	"Group enriched"	"Detected in some"	41	"hypothalamus: 5.1;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in some"	13	"REH: 29.0"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.6"	"Group enriched"	"Detected in some"	4	"basal ganglia: 1.1;hypothalamus: 4.0"	"CAB013268, CAB022752"	Approved					NA	NA					"CAB013268: , CAB022752: "	"unprognostic (3.98e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.18e-2)"		"unprognostic (2.73e-2)"		"unprognostic (7.64e-2)"	"unprognostic (3.29e-1)"		"unprognostic (2.10e-3)"	"unprognostic (5.29e-1)"		"unprognostic (5.01e-2)"			"unprognostic (2.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.2	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135962-123137741	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;intestine: 5.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"hypothalamus: 6.8;pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;HEL: 5.6;HeLa: 5.1;K-562: 18.3;NB-4: 6.3;SiHa: 5.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.3;hypothalamus: 8.0"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				1.9	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.9	0.0	0.4	0.2	0.0	0.0	0.9	0.7	0.0	1.3	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.0	0.0	0.0	0.8	0.7	5.6	5.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	18.3	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	6.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXA1	"HOX1, HOX1F"	ENSG00000105991	"Homeobox A1"	P49639	7	27092993-27095996	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 12.9"	"Cell type enhanced"	"Detected in some"	7	"Basal keratinocytes: 2.1;granulocytes: 2.3;Intestinal endocrine cells: 2.9;Ito cells: 3.1;Kupffer cells: 1.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"pons and medulla: 5.0"	"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.0;NK-cell: 6.8;non-classical monocyte: 8.7"	"Group enriched"	"Detected in many"	6	"monocytes: 8.7;NK-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 12.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Group enriched"	"Detected in some"	5	"midbrain: 1.3;pons and medulla: 1.9"							NA	NA						"unprognostic (7.39e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.17e-1)"	1.5	1.2	0.2	3.7	0.4	0.4	2.9	0.2	0.3	1.1	1.9	0.4	0.0	0.4	1.2	3.6	8.2	2.2	2.9	0.9	0.2	0.2	2.9	0.5	0.8	2.1	0.4	0.0	3.8	0.4	3.2	0.3	0.9	5.0	3.7	1.9	0.3	0.3	5.3	0.7	4.1	3.0	2.6	4.9	8.0	1.2	0.8	0.0	3.1	0.4	1.3	5.2	12.9	10.6	0.4	1.2	1.0	8.7	6.8	1.3	0.6	5.4	2.4	0.2	3.1	0.0	0.0	5.0	0.7	3.2	2.1	2.5	12.2	3.5	3.8	7.3	1.9	7.8	11.9	4.3	3.5	1.5	0.3	12.6	4.9	0.2	0.1	0.6	4.1	12.8	2.3	3.5	2.5	5.1	0.0	3.1	3.9	5.3	0.0	4.2	0.1	0.0	6.7	0.0	2.2	0.5	4.7	1.4	0.0	7.0	5.3	0.4	0.0	2.7	0.0	3.3	4.3	0.0	1.9	2.3	0.5	5.0	3.7	0.9	0.0	0.0	1.7	1.9	7.3	5.2	1.0	0.3	0.6	1.2	6.0	1.2	0.4	1.3	1.2	1.2	0.0	0.6	1.2	0.3	6.8	8.7	0.0	1.2	0.6	0.2	0.4	0.2	0.3	0.2	0.2	0.4	0.0	5.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.2	0.2	2.3	0.0	0.1	0.0	2.9	3.1	1.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.1	1.0	0.0	1.0	0.9	1.1
HOXA2	HOX1K	ENSG00000105996	"Homeobox A2"	O43364	7	27100354-27102811	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 18.1"	"Cell type enhanced"	"Detected in some"	17	"Intestinal endocrine cells: 4.6;Ito cells: 6.2;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	44	"pons and medulla: 15.7"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;HaCaT: 6.9;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in single"	35	"pons and medulla: 6.1"	"Region enriched"	"Detected in single"	27	"pons and medulla: 7.7"	HPA078220			Approved	Nucleoplasm,Vesicles		Yes	NA			"Nucleoplasm, Vesicles"		"HPA078220: AB_2686880"	"unprognostic (7.30e-2)"	"unprognostic (4.90e-4)"	"unprognostic (2.81e-1)"	"unprognostic (7.43e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.98e-9)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-2)"	2.7	1.6	0.3	1.9	0.1	0.0	2.6	0.1	0.2	1.4	4.5	0.2	8.7	1.5	3.4	9.7	8.3	6.3	4.9	1.8	0.1	0.0	4.2	0.7	4.7	1.9	0.3	0.1	3.8	0.4	9.6	0.1	0.1	15.7	2.8	3.5	0.1	0.1	4.1	1.2	2.7	4.3	2.4	18.1	2.9	3.7	0.8	0.1	3.8	2.2	2.9	3.3	3.2	3.5	0.0	0.0	1.8	0.3	0.0	0.1	0.0	1.2	0.8	4.2	16.8	0.0	0.0	0.0	0.2	0.1	0.0	0.1	2.2	4.1	0.2	1.9	0.2	2.3	6.9	0.2	0.0	0.0	0.0	2.4	0.0	0.1	0.4	1.9	0.1	0.3	1.0	0.0	3.6	3.4	0.0	2.8	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.1	1.0	0.7	0.0	5.5	0.7	1.2	0.0	0.2	0.0	1.1	0.3	0.0	0.0	2.8	0.0	0.2	1.2	0.6	0.0	0.0	0.1	0.1	0.7	3.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.1	15.7	0.1	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	4.6	6.2	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.3
HOXA3	"HOX1, HOX1E"	ENSG00000105997	"Homeobox A3"	O43365	7	27106184-27152581	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 9.2;Mucus-secreting cells: 14.6;Proximal tubular cells: 11.0;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"pons and medulla: 6.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.1;CACO-2: 12.3;CAPAN-2: 32.9;HEK 293: 14.7;WM-115: 17.6"	"Region enriched"	"Detected in single"	31	"pons and medulla: 2.9"	"Region enriched"	"Detected in single"	34	"pons and medulla: 5.0"	HPA029157	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029157: AB_10601020"	"unprognostic (1.32e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.05e-2)"	"unprognostic (8.61e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.82e-2)"	5.3	2.6	0.5	11.0	0.5	0.0	8.9	0.5	0.5	3.9	13.7	0.7	9.8	3.9	7.5	7.2	6.9	16.0	4.7	4.7	0.5	0.0	9.9	1.5	5.2	3.5	1.3	0.5	5.5	0.6	5.4	0.5	0.5	6.6	5.6	4.9	0.5	0.5	4.2	7.2	3.8	7.8	3.6	4.7	2.5	6.3	2.7	0.5	6.7	2.5	9.8	2.7	9.4	6.0	0.5	1.3	3.8	1.1	1.3	0.5	0.3	5.7	6.8	0.0	19.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	12.3	32.9	0.9	9.5	0.5	2.6	7.7	0.3	0.8	0.0	0.2	14.7	0.2	0.1	9.9	0.6	0.3	0.3	1.2	0.0	1.5	1.8	0.0	1.8	0.8	0.6	0.1	0.7	0.3	0.0	0.5	0.0	1.6	4.2	6.8	2.2	0.0	5.6	2.6	2.8	0.0	1.0	0.0	2.7	0.3	0.5	0.4	8.1	0.0	1.0	2.0	1.5	0.0	0.0	0.3	0.6	1.2	17.6	1.7	0.2	0.7	0.5	0.2	0.0	0.5	0.3	0.5	1.3	0.1	0.0	0.3	3.8	1.3	1.1	0.1	0.5	0.3	0.5	0.5	0.5	0.5	0.5	0.0	1.3	0.5	6.6	0.5	0.0	0.0	0.0	3.0	1.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	6.5	1.4	5.0	0.0	0.0	0.0	1.1	2.2	1.1	0.0	0.1	0.0	4.1	9.2	0.3	7.3	0.6	0.0	3.3	0.0	14.6	0.0	0.0	7.0	0.0	11.0	0.0	0.0	4.2	1.2	0.4	1.1	0.0	0.0	13.6	2.6
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130799	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 13.3;Ito cells: 12.3;Proximal tubular cells: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	18	"pons and medulla: 26.7"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 19.1;HEK 293: 14.5;REH: 13.4;WM-115: 19.0"	"Region enriched"	"Detected in single"	47	"pons and medulla: 11.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 24.6"	HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	8.9	6.2	0.4	2.2	0.3	0.2	11.6	0.3	1.2	2.7	7.5	0.4	8.2	3.5	3.9	10.3	27.5	18.1	5.7	4.8	0.3	0.0	9.6	2.0	10.5	3.0	1.4	0.3	8.8	1.1	17.6	0.3	0.5	26.7	4.1	1.7	0.3	0.7	5.6	29.8	3.5	5.2	4.9	25.8	5.5	9.3	1.6	0.4	0.3	2.3	3.4	1.2	5.5	10.9	0.9	1.4	0.1	0.5	0.1	0.3	0.2	6.0	2.0	0.0	19.1	0.0	0.0	1.2	0.5	0.6	2.0	2.0	3.8	1.2	1.6	0.1	1.8	1.8	2.6	0.7	0.3	1.6	0.0	14.5	0.0	0.6	8.7	2.2	2.0	3.6	2.1	1.6	6.8	0.5	0.0	6.7	0.5	0.0	0.0	6.5	1.6	0.0	7.1	0.0	2.1	4.7	13.4	2.9	0.1	9.6	1.4	0.9	0.0	1.9	0.0	7.0	0.7	0.4	1.0	8.8	0.0	3.1	5.0	0.1	0.0	0.0	0.7	4.1	3.3	19.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.5	1.4	0.0	0.2	0.4	0.3	0.3	1.2	0.3	0.0	1.4	0.3	26.7	0.4	0.0	0.0	0.0	2.9	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.4	1.9	0.7	0.0	0.0	0.5	0.3	0.6	0.0	0.0	0.2	0.0	2.9	12.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	10.1	0.0	0.0	2.1	0.2	2.7	1.1	0.1	0.0	2.0	2.4
HOXA5	"HOX1, HOX1C"	ENSG00000106004	"Homeobox A5"	P20719	7	27141052-27143668	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 42.0"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 16.0;Paneth cells: 15.9;Proximal tubular cells: 21.3;Undifferentiated cells: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	46	"pons and medulla: 16.3"	"Group enriched"	"Detected in some"	4	"basophil: 3.0;neutrophil: 1.6;NK-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.0;NK-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.1;HEK 293: 56.5;RPTEC TERT1: 12.8"	"Region enriched"	"Detected in single"	88	"pons and medulla: 23.0"	"Region enriched"	"Detected in single"	22	"pons and medulla: 5.5"							NA	NA						"unprognostic (2.43e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.80e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.00e-1)"	6.8	42.0	0.2	2.1	0.2	1.2	10.9	0.2	0.3	1.9	6.6	1.0	16.0	1.1	6.0	25.0	12.3	22.1	2.5	1.4	0.2	0.0	16.8	1.8	23.9	1.5	0.2	0.2	9.3	1.3	2.0	0.5	0.3	16.3	3.9	3.3	0.2	0.2	7.1	5.6	3.4	6.8	3.0	19.4	4.4	5.6	2.6	0.2	0.2	1.3	0.2	0.2	6.6	3.3	0.2	0.4	3.0	0.5	2.5	0.2	0.1	1.9	1.0	0.0	33.1	0.0	0.0	0.1	0.5	0.4	0.6	0.5	0.6	3.4	1.0	4.9	1.0	0.7	2.6	1.8	0.1	0.6	0.4	56.5	0.7	0.4	1.9	0.3	1.2	0.8	3.7	0.2	1.1	1.9	0.0	7.3	1.9	0.1	0.0	1.1	0.6	0.0	0.3	0.0	0.7	1.0	4.5	0.1	0.0	12.8	2.6	3.9	0.0	2.5	0.0	1.1	0.1	0.4	0.4	2.9	0.1	0.4	2.0	1.3	0.0	0.0	1.1	0.2	3.6	3.6	3.0	0.4	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	0.1	1.6	2.5	0.5	0.4	0.1	0.1	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	16.3	0.2	0.0	0.6	0.0	3.8	3.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	5.1	9.3	0.0	0.0	0.0	1.3	2.2	0.0	0.0	0.6	0.0	8.6	16.0	4.1	0.0	0.3	0.9	1.7	1.0	8.4	0.0	0.0	15.9	0.0	21.3	0.0	0.0	3.3	0.2	0.7	2.5	0.1	0.0	18.1	5.0
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.8"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 111.0;Proximal tubular cells: 39.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"pons and medulla: 9.2"	"Cell type enriched"	"Detected in some"	5	"NK-cell: 7.7"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 7.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 19.7;RPTEC TERT1: 24.4;SCLC-21H: 19.7"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	10	"pons and medulla: 2.9"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	6.5	14.5	0.2	4.8	0.2	0.0	11.2	0.3	0.6	7.3	10.0	0.2	7.9	0.0	5.0	15.4	3.0	12.2	0.5	0.2	0.2	0.0	25.4	0.4	2.6	3.5	0.2	0.2	6.2	0.2	0.3	0.2	1.3	9.2	8.2	7.2	0.2	0.2	8.9	27.8	8.2	6.1	8.1	14.3	3.7	3.2	2.7	0.2	1.6	0.9	0.2	1.1	11.4	6.7	0.2	0.9	0.0	0.0	7.7	1.6	0.2	6.9	2.4	0.0	7.5	0.0	0.0	0.4	2.5	4.3	5.2	6.0	3.6	2.7	4.8	7.0	1.9	0.2	4.8	19.7	0.0	3.1	0.0	12.4	0.3	2.8	0.1	0.5	0.4	0.2	4.1	0.2	0.6	7.0	0.0	9.8	8.4	0.0	0.0	1.9	1.2	0.0	1.1	0.3	5.0	0.7	2.5	4.6	0.0	24.4	4.8	19.7	0.0	13.6	0.0	0.0	1.4	0.2	1.9	0.8	0.0	4.7	14.0	2.4	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	7.7	0.0	0.6	0.4	0.2	0.2	0.2	0.3	0.6	0.2	0.0	0.2	0.2	9.2	0.2	0.0	0.0	0.0	7.5	8.0	0.0	0.3	0.0	0.0	0.0	12.2	0.0	0.4	111.0	0.0	15.9	2.2	3.0	0.0	0.0	4.6	2.7	4.0	0.0	0.0	0.2	0.0	15.5	0.0	0.0	2.1	0.6	0.5	3.3	0.0	11.2	0.0	0.1	10.4	0.0	39.0	0.0	0.0	7.3	0.4	0.2	10.8	0.2	0.9	15.7	2.6
HOXB2	"HOX2, HOX2H"	ENSG00000173917	"Homeobox B2"	P14652	17	48540894-48544989	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 53.1"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 50.6;Distal tubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	6	"pons and medulla: 12.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 21.0;EFO-21: 20.3;HEK 293: 23.0;HMC-1: 45.9;WM-115: 20.1"	"Region enriched"	"Detected in single"	34	"pons and medulla: 4.7"	"Region enriched"	"Detected in single"	29	"pons and medulla: 5.4"	HPA047857			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047857: AB_2680184"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.89e-1)"	9.2	11.0	0.2	6.3	0.3	1.9	24.2	0.3	0.2	14.5	15.4	0.4	53.1	2.4	6.9	32.5	19.3	12.2	12.8	4.5	0.5	0.1	25.6	2.8	6.4	4.4	2.0	0.3	6.4	1.6	8.9	0.9	1.7	12.9	8.2	1.7	0.8	0.6	33.2	6.1	3.7	6.4	7.5	19.4	6.8	6.7	2.7	0.2	2.4	3.0	3.9	2.6	7.9	16.3	0.8	6.0	5.0	0.4	2.2	9.5	1.3	0.0	0.7	21.0	0.0	4.8	5.6	0.0	1.9	0.0	0.0	0.0	0.3	0.1	0.0	20.3	5.8	0.0	0.0	3.1	0.0	0.0	0.1	23.0	7.9	0.8	0.0	8.5	0.0	45.9	3.5	0.0	9.1	3.6	0.2	3.3	0.0	15.5	0.0	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	0.0	15.0	1.8	0.0	0.0	1.5	0.0	12.0	1.5	11.0	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.0	0.0	8.2	0.0	20.1	5.0	0.4	0.0	4.2	0.4	1.3	0.2	6.2	4.7	1.9	0.8	9.5	3.9	0.0	2.2	0.3	6.0	7.3	1.3	0.2	0.3	0.3	0.2	0.5	0.1	2.0	0.3	12.9	0.2	3.0	1.4	5.2	6.2	6.3	0.0	0.8	0.0	1.4	2.3	50.6	0.0	14.4	132.6	0.8	0.6	5.6	0.0	0.0	0.2	23.9	18.1	7.9	20.7	0.0	6.8	0.0	2.4	21.5	12.6	0.9	0.0	11.9	11.8	6.4	1.3	0.0	0.1	1.1	0.0	17.2	0.0	0.0	30.9	1.7	6.8	5.0	20.8	27.4	0.7	21.3
HOXB5	"HOX2, HOX2A"	ENSG00000120075	"Homeobox B5"	P09067	17	48591257-48593961	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.4;ductus deferens: 25.9;seminal vesicle: 27.6"	"Cell type enhanced"	"Detected in some"	16	"Collecting duct cells: 50.6;Distal tubular cells: 21.6;Mucus-secreting cells: 13.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 28.1"	"Region enriched"	"Detected in single"	33	"pons and medulla: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.5;RPTEC TERT1: 16.1"	"Region enriched"	"Detected in single"	90	"pons and medulla: 24.0"	"Region enriched"	"Detected in single"	128	"pons and medulla: 14.7"	"HPA043851, HPA074454"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA043851: AB_2732509, HPA074454: AB_2686690"	"unprognostic (6.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.48e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.10e-2)"	"unprognostic (9.64e-2)"	"unprognostic (7.61e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.86e-2)"	"prognostic favorable (8.59e-5)"	3.4	3.1	0.2	2.1	0.2	0.0	5.0	0.2	0.7	5.4	10.5	0.2	25.9	1.5	2.2	18.5	0.6	7.2	0.2	0.7	0.2	0.0	16.0	0.4	5.2	0.8	0.2	0.2	1.9	0.5	0.9	0.2	1.2	25.4	1.3	4.7	0.2	0.6	27.6	0.2	0.5	9.5	1.6	22.5	2.0	4.3	0.7	0.2	0.2	0.7	0.2	0.2	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.8	0.0	2.5	2.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	5.2	2.7	0.6	0.0	0.2	0.0	0.0	0.0	21.5	0.9	5.6	0.0	4.2	0.0	1.2	1.4	0.0	2.9	0.0	0.8	1.4	0.1	1.6	0.0	3.3	0.0	0.0	0.0	0.0	2.7	1.7	0.0	1.0	0.0	16.1	1.6	0.0	0.0	0.1	0.0	2.3	0.1	0.4	0.0	5.3	0.7	2.1	0.5	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	25.4	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	50.6	0.0	0.0	21.6	0.0	0.6	2.4	8.9	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.5	0.0	4.1	9.2	5.0	0.0	0.0	0.0	1.7	0.0	13.9	0.0	0.0	3.5	0.4	0.4	0.0	0.0	1.0	7.2	10.8	0.3	0.0	0.0	11.5	0.0
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607227-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 62.3"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 82.0;Distal tubular cells: 126.0;Enterocytes: 102.1;Mucus-secreting cells: 73.3;Paneth cells: 56.1;Undifferentiated cells: 65.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.4;OE19: 26.5;RPTEC TERT1: 24.2;SK-MEL-30: 28.8"	"Region enriched"	"Detected in single"	45	"pons and medulla: 6.0"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.5"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	8.3	8.3	0.0	7.3	0.3	0.1	17.2	0.1	0.6	10.0	8.1	0.1	24.1	0.5	4.1	62.3	0.8	4.2	0.3	1.1	0.0	0.0	23.7	0.8	1.7	2.4	0.1	0.3	2.3	0.6	0.4	0.5	4.1	4.1	5.2	7.0	0.1	0.1	22.1	2.4	2.2	12.4	3.5	20.1	2.2	4.6	3.0	0.2	0.1	0.5	0.1	0.6	5.8	15.1	2.2	1.8	0.0	0.0	2.0	4.7	0.5	16.9	7.4	0.0	0.1	5.3	8.0	0.0	0.0	0.0	0.1	0.3	11.3	0.3	0.3	30.4	7.1	8.8	2.5	0.0	0.0	0.0	7.8	5.5	2.6	5.8	0.0	4.4	0.0	5.5	5.2	2.3	5.2	0.0	1.3	16.0	5.3	2.8	0.1	16.8	4.4	0.3	0.1	0.0	26.5	0.0	0.0	14.4	1.9	24.2	5.7	0.0	0.0	5.7	0.0	28.8	0.4	1.4	1.6	13.7	0.0	9.3	7.5	13.1	0.9	2.2	0.0	0.1	0.0	21.3	0.0	0.0	0.0	3.8	0.0	1.9	1.9	0.7	2.1	0.0	2.2	0.0	1.4	0.0	2.0	0.0	1.8	4.7	0.5	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.3	4.1	0.2	0.0	0.0	3.7	0.8	4.8	0.0	0.3	0.0	0.0	0.0	82.0	0.0	6.2	126.0	0.0	0.1	2.2	102.1	0.0	1.1	14.9	8.2	0.7	4.7	0.0	8.8	0.0	35.1	1.3	7.8	0.0	0.6	2.8	23.6	2.8	73.3	0.0	0.5	56.1	0.0	27.8	0.0	0.0	8.0	1.4	23.4	1.8	1.5	1.0	65.0	3.1
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 83.7;Distal tubular cells: 61.3;Intestinal endocrine cells: 42.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;HDLM-2: 9.4;HEK 293: 21.6;LHCN-M2: 11.0;RPTEC TERT1: 23.0"	"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.3	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.9	3.3	0.4	0.0	0.0	0.0	0.0	9.4	21.6	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	0.4	1.4	0.1	6.2	0.0	11.0	0.0	0.0	0.2	0.0	7.0	0.0	0.0	2.1	0.0	23.0	0.6	0.0	0.0	0.3	0.0	3.1	0.0	0.2	0.0	5.2	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	83.7	0.0	0.0	61.3	0.0	0.1	0.5	1.3	0.0	0.0	0.7	0.4	0.2	0.0	0.0	0.2	0.0	42.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.3	0.5	9.6	0.0	0.0	0.0	4.1	0.0
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;ovary: 31.6"	"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 3.5;Leydig cells: 2.8;Proximal tubular cells: 2.4;Sertoli cells: 6.5;Spermatocytes: 2.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	27	"pons and medulla: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.1;HDLM-2: 18.1;HEK 293: 19.9;SH-SY5Y: 16.9"	"Region enriched"	"Detected in single"	24	"pons and medulla: 9.9"	"Region enriched"	"Detected in single"	13	"pons and medulla: 3.7"	HPA053910			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	16.2	4.4	0.7	3.2	0.7	0.0	17.9	0.7	0.7	1.3	2.3	0.6	1.4	0.9	11.5	17.8	6.0	20.9	1.0	1.0	0.7	0.7	15.4	0.8	0.9	3.2	1.1	0.0	31.6	0.7	0.0	0.7	5.8	29.7	2.4	0.0	0.3	0.7	1.3	8.1	4.2	9.2	4.4	10.5	1.2	2.6	8.3	0.9	0.0	1.0	0.0	1.8	2.1	3.4	1.1	0.5	0.0	0.0	0.0	1.1	0.0	3.0	3.1	0.0	14.1	5.9	3.0	0.0	1.4	1.5	1.4	1.0	0.1	2.6	12.2	0.1	10.7	0.0	2.7	0.2	0.3	0.9	18.1	19.9	0.1	1.4	0.0	0.7	1.4	0.4	7.8	1.4	8.5	1.4	0.0	0.2	4.0	0.6	0.0	5.4	0.1	1.7	0.3	0.1	0.5	0.0	3.9	4.5	0.0	6.1	0.0	0.0	16.9	2.2	0.7	7.9	0.7	10.6	0.7	0.0	7.4	4.2	0.6	7.5	3.2	3.5	6.3	0.4	1.3	7.7	0.0	0.0	0.0	0.8	0.0	0.8	1.1	0.0	0.8	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.5	0.6	0.0	0.7	0.7	0.7	0.7	0.7	0.7	1.1	0.0	29.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.4	0.0	6.5	0.0	2.8	0.4	0.0	0.2	0.7	0.0	0.0
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.2	0.0	8.5	5.1	6.2	0.0	0.5	0.4	1.0	0.7	3.6	0.5	0.0	0.6	2.5	0.0	1.4	0.2	0.0	0.3	2.7	3.0	0.0	1.0	0.1	0.2	0.0	0.1	5.8	0.6	4.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.3	0.6	0.2	4.4	1.2	1.7	0.1	0.0	1.5	0.9	3.2	0.3	0.0	0.0	0.0	0.2	0.2	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	2.1	3.2	0.6	0.6	0.2	0.0	0.0	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell type enhanced"	"Detected in many"	12	"Distal tubular cells: 14.9;Fibroblasts: 27.4;Leydig cells: 20.8;Peritubular cells: 14.2;Spermatocytes: 39.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.1;fHDF/TERT166: 19.0;HDLM-2: 31.8"	"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.5	1.8	0.0	38.1	13.9	13.3	0.4	1.9	1.9	3.1	2.9	1.6	2.9	1.1	2.5	19.0	0.9	4.3	1.5	0.2	2.8	31.8	11.0	2.0	4.9	0.0	1.5	0.2	4.8	12.6	2.0	6.2	2.2	0.0	0.1	0.1	1.3	0.0	11.0	0.6	0.0	1.2	0.0	0.3	1.6	0.0	1.4	0.0	9.6	0.1	0.0	4.7	2.9	2.8	7.8	3.4	6.7	0.5	0.0	4.0	8.6	4.3	2.7	0.3	0.3	0.0	1.4	0.3	8.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.3	14.9	0.0	1.1	0.2	0.0	0.0	0.0	2.5	27.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	20.8	0.4	11.8	0.0	0.0	0.2	0.0	0.0	14.2	7.8	1.9	6.5	5.0	39.3	1.1	3.4	0.2	0.0	0.0	0.0
HOXD12	HOX4H	ENSG00000170178	"Homeobox D12"	P35452	2	176099730-176101193	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7"	"Cell type enriched"	"Detected in single"	17	"Cardiomyocytes: 1.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	41	"basal ganglia: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 4.0;REH: 6.9;SCLC-21H: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059444	Uncertain					NA	NA					"HPA059444: AB_2684020"		"unprognostic (1.00e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.32e-2)"	"unprognostic (3.53e-2)"		"unprognostic (1.71e-2)"	"unprognostic (1.36e-2)"			"unprognostic (7.11e-2)"		"unprognostic (4.54e-2)"	"unprognostic (7.29e-2)"		"unprognostic (1.44e-2)"	0.1	0.0	0.1	0.1	4.3	0.0	0.1	0.1	0.1	1.4	3.5	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.8	3.4	0.1	0.1	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.1	0.1	0.9	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.9	0.1	1.0	0.5	0.0	0.1	6.9	0.0	0.0	0.0	0.1	1.9	0.1	0.6	0.0	0.9	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell type enhanced"	"Detected in some"	17	"Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1"					"Region enriched"	"Detected in single"	28	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.8	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.3	1.6	0.4	0.1	1.5	0.0	0.2	0.0	22.1	0.2	0.0	0.0	0.3	0.0	0.0	5.0	1.5	0.0	0.2	0.1	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	16.4	2.6	1.3	2.2	0.3	0.0	6.1	0.4	0.0	0.0	2.8	0.2	0.1	1.4	1.2	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	3.7	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	4.4	0.0	1.7	0.0	0.6	0.0	0.1	0.0	2.8	5.3	0.0	6.5	0.5	0.2	0.2	0.5	0.0	0.0	1.2	0.0
HPCA		ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"brain: 118.9"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 146.4;Early spermatids: 133.0;Late spermatids: 89.6"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 10.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 1321.6;hippocampal formation: 1344.5"	"CAB012340, HPA043245"	Enhanced					NA	NA					"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	1.2	1.5	13.5	1.2	118.9	1.1	1.2	4.8	82.2	1.4	1.5	2.2	0.0	1.2	1.4	1.2	1.1	1.4	1.3	1.2	42.5	2.8	1.3	1.1	1.1	1.2	3.7	14.5	1.5	1.2	1.1	0.0	1.2	0.0	1.3	1.5	0.6	1.3	1.3	1.1	1.2	1.4	1.3	0.8	1.2	1.2	2.5	12.2	0.0	1.3	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.4	0.3	0.4	0.0	0.1	0.1	0.2	0.3	0.9	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.6	0.1	0.0	0.1	0.7	0.0	0.0	10.2	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	1.0	0.8	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13.5	118.9	4.8	40.4	42.5	2.8	3.7	14.5	0.0	12.2	0.0	0.0	0.0	1.0	0.0	146.4	0.4	0.0	0.0	0.0	0.0	5.9	0.1	0.0	0.3	133.0	0.1	1.0	0.0	0.4	0.3	0.2	1.3	0.0	0.0	0.1	12.7	17.2	0.0	0.0	89.6	1.1	0.0	0.0	0.0	2.5	5.0	0.5	2.9	0.4	0.6	18.2	0.0	0.1	3.1	7.8	0.3	0.1	0.0	2.1	0.9
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 267.5"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1077.2;Proximal tubular cells: 1892.6"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enriched"	"Detected in single"	29	"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	4	"eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;granulocytes: 9.8"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 107.2"	"Region enriched"	"Detected in single"	8	"amygdala: 0.4"	"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		23000000	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	0.1	0.5	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.2	0.1	2.1	0.3	0.0	0.3	0.4	0.1	0.7	0.2	0.3	0.4	0.0	51.3	267.5	0.2	0.4	0.1	0.0	0.7	0.7	0.0	0.1	0.0	13.7	0.5	0.0	3.8	0.0	0.8	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.1	5.0	9.8	1.4	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	107.2	2.5	0.3	3.5	0.8	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.8	9.8	0.0	1.0	0.1	0.1	0.1	0.1	1.3	0.1	0.3	0.2	4.8	0.0	1.4	5.0	0.0	0.3	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.0	13.7	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.3	48.4	0.0	0.0	87.2	0.0	0.6	164.2	0.3	33.1	0.0	0.0	0.0	14.8	0.2	0.0	0.0	0.0	1077.2	0.3	0.0	0.0	33.2	23.4	97.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.9	1892.6	0.0	0.0	0.0	1.7	1.1	0.0	0.9	0.0	0.0	0.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490177-174523154	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 193.3"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 3.8"	"Group enriched"	"Detected in many"	5	"basophil: 37.7;T-reg: 15.1"	"Group enriched"	"Detected in many"	71	"granulocytes: 37.7;T-cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA			Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	5.1	2.6	0.5	7.9	0.6	0.0	24.6	0.4	0.6	23.0	73.3	0.5	2.5	22.9	13.4	7.5	32.0	4.5	10.7	1.2	0.6	0.7	8.5	63.7	22.9	7.9	0.8	0.5	2.3	0.4	0.0	0.9	193.3	3.8	20.1	8.4	4.6	3.0	1.1	1.6	15.3	64.5	9.3	0.5	2.9	36.3	1.9	0.5	5.5	0.4	5.0	7.9	61.2	31.8	0.1	0.2	37.7	0.1	0.3	15.1	1.0	0.0	27.7	0.0	0.0	17.2	1.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	0.0	0.0	0.0	0.5	60.6	2.1	0.0	0.0	0.3	0.1	0.9	0.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	15.8	1.4	2.8	0.0	0.2	5.7	94.3	0.1	0.1	0.0	0.2	0.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	37.7	0.1	5.4	3.7	0.0	5.7	0.1	1.9	1.6	0.2	0.0	0.6	1.5	0.4	0.3	0.0	0.0	15.1	1.0	0.5	0.6	0.4	0.6	0.6	0.7	0.8	0.5	3.8	0.5	14.9	46.1	5.2	57.7	15.3	3.1	0.4	43.3	5.3	20.5	21.0	0.0	25.6	18.3	2.4	1.1	0.5	273.6	0.0	86.5	488.8	12.1	51.1	816.1	165.7	20.7	0.0	8.1	18.4	16.1	0.2	18.4	10.6	72.6	1.0	48.2	0.0	26.0	217.5	0.0	68.8	0.6	0.0	6.6	0.4	0.4	19.6	47.4	50.3	31.0	266.0
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429765	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;gallbladder: 31.9;ovary: 30.3"	"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"cerebellum: 27.4;cerebral cortex: 9.0"	"Group enriched"	"Detected in some"	39	"memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3"	"Group enriched"	"Detected in many"	99	"B-cells: 15.8;dendritic cells: 22.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (8.67e-4)"	2.3	2.9	1.6	2.8	2.2	2.8	2.0	27.4	9.0	3.3	2.7	1.1	3.6	3.5	4.3	5.0	10.2	4.3	31.9	2.2	1.7	1.8	10.4	0.9	3.4	2.1	1.9	1.5	30.3	1.1	0.7	8.9	1.0	2.4	3.2	1.7	1.7	3.7	2.4	0.7	0.8	2.9	1.7	2.2	3.0	7.0	3.0	0.3	3.8	1.8	7.0	7.4	7.3	2.4	15.8	22.3	0.1	0.1	0.0	0.1	0.6	4.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.4	0.0	0.0	4.3	0.0	2.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.9	1.2	1.0	0.0	0.0	12.6	10.3	3.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.6	1.6	2.2	27.4	9.0	1.7	1.8	1.9	1.5	2.4	0.3	3.0	8.0	2.2	9.8	8.0	1.5	2.4	15.3	64.3	83.0	19.2	3.9	0.5	0.0	17.1	0.8	23.4	3.0	0.0	1.8	31.9	5.0	4.1	93.6	0.0	37.3	1.6	2.4	9.2	2.7	0.8	8.1	9.0	1.7	7.2	5.6	39.8	32.0	2.6	84.8	3.7	2.2	0.0	6.4	6.0	5.5	7.0	1.1	0.9	3.7	90.2
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13495689-13601927	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Horizontal cells: 25.4;Ito cells: 8.0;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.0;cerebral cortex: 2.2;pons and medulla: 3.0"	"Cell type enhanced"	"Detected in many"		"T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.9;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 17.2;U-251 MG: 47.9;U-87 MG: 29.7"									"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	1.3	3.3	0.2	2.8	1.0	1.5	2.3	0.1	2.2	7.8	1.6	0.3	5.8	2.3	3.3	1.3	8.1	1.9	1.3	3.8	0.3	0.2	1.7	3.4	2.2	9.3	0.1	0.4	12.1	0.4	0.0	1.2	6.8	3.0	9.9	0.5	2.0	3.3	8.6	0.9	1.1	1.7	0.4	1.3	11.7	1.0	2.9	0.0	0.6	0.6	6.3	12.7	1.4	5.3	0.1	3.9	0.5	0.1	0.7	5.1	0.8	0.0	0.1	1.2	0.0	0.8	2.2	2.0	7.7	1.6	1.3	0.8	0.0	0.2	0.0	1.0	4.2	0.0	0.0	0.0	0.0	1.0	0.4	7.9	2.0	0.6	0.7	0.6	0.0	0.5	2.0	0.0	3.4	0.7	1.7	0.0	0.1	7.6	0.0	1.3	1.0	0.0	1.3	1.4	0.0	17.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	1.2	0.1	0.0	47.9	0.0	0.0	0.0	29.7	0.0	3.6	0.0	0.0	0.0	1.7	0.0	0.8	0.0	1.2	1.4	0.0	0.1	1.4	1.4	0.5	0.7	0.1	3.9	5.1	0.8	0.2	1.0	0.1	2.2	0.3	0.2	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.2	25.4	0.0	8.0	1.0	0.0	12.7	0.0	0.0	0.0	0.0	1.0	0.7	0.0	2.1	0.0	0.1	0.0	1.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301083-14349404	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;pons and medulla: 6.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 20.6;T-cells: 14.7"	"Cell line enhanced"	"Detected in many"		"AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2"									HPA064126			Approved	Vesicles		NA	NA			Vesicles		"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	1.4	1.4	0.6	8.7	0.8	1.3	3.0	0.9	2.7	3.8	1.8	0.0	0.8	1.4	1.0	0.3	2.8	1.7	2.6	2.0	0.6	0.7	3.6	29.1	3.7	26.6	0.6	0.0	4.7	1.3	0.4	1.4	33.5	6.0	2.4	1.9	5.3	12.6	2.5	1.8	2.2	2.5	0.6	2.9	4.9	1.4	0.7	0.0	13.2	1.5	2.5	5.9	1.5	5.3	0.4	20.6	0.5	0.4	3.8	14.7	2.7	0.0	0.3	15.5	0.0	4.7	5.3	11.1	4.4	6.4	4.0	4.2	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.4	2.4	2.0	1.3	3.2	0.3	2.0	13.5	6.2	0.5	2.3	15.4	0.8	1.4	3.7	0.9	0.0	0.8	4.6	0.0	3.2	0.8	0.7	0.6	0.5	0.1	0.4	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.3	0.4	0.0	3.9	0.0	0.0	14.2	0.0	0.0	0.0	3.0	0.0	0.9	0.1	0.2	0.0	6.3	0.4	5.0	0.4	7.6	4.9	0.4	0.4	7.7	7.5	0.5	3.8	0.4	20.6	14.7	2.7	0.6	0.8	0.9	2.7	0.6	0.7	0.6	0.0	6.0	0.0	0.0	0.6	1.4	0.2	10.2	2.0	2.2	2.5	4.0	1.2	7.0	37.3	5.1	0.0	0.6	11.1	2.5	0.0	0.0	0.2	10.4	9.0	0.7	0.0	32.1	1.4	7.9	0.0	34.4	3.7	1.4	2.6	4.3	1.7	1.8	0.0	6.0	0.1	0.0	1.1	0.0	15.2	12.9	2.7	0.6	0.4	12.9	30.3	11.7	0.0	0.1
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;kidney: 17.3;ovary: 18.2"	"Cell type enhanced"	"Detected in some"	16	"Cytotrophoblasts: 31.0;Leydig cells: 58.1;Peritubular cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.5"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.6;HeLa: 13.3;RH-30: 28.4;RT4: 14.1;SH-SY5Y: 35.5"	"Low region specificity"	"Detected in all"							"HPA034625, HPA034626"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034625: AB_10612119, HPA034626: AB_2674252"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.03e-4)"	0.4	3.2	6.5	0.9	29.5	0.1	2.6	3.0	6.7	1.0	0.8	0.8	0.6	0.3	4.5	3.2	5.0	2.5	0.5	0.4	4.1	9.1	17.3	0.2	1.0	0.3	3.5	0.9	18.2	6.5	0.1	1.3	9.9	3.3	5.4	1.2	0.0	1.1	1.6	6.7	0.3	0.2	2.0	3.3	0.2	1.1	7.9	0.7	0.7	0.6	1.7	2.7	2.3	0.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	4.3	0.0	6.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.1	0.0	0.0	6.5	0.0	0.0	0.2	9.2	0.0	0.0	0.0	19.6	0.0	13.3	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.2	0.1	0.0	5.0	3.0	0.2	0.0	28.4	0.0	5.7	14.1	0.7	35.5	6.2	0.0	0.0	10.7	0.0	0.0	0.0	0.0	1.1	4.1	9.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.5	29.5	3.0	5.8	4.1	9.1	3.5	0.9	3.3	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.0	13.4	7.9	3.5	0.0	31.0	5.0	0.0	0.4	0.4	0.0	0.0	1.6	1.3	2.2	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	58.1	0.0	0.0	0.0	0.0	5.3	1.2	0.0	33.2	0.0	0.0	0.0	0.3	0.2	1.2	0.3	14.5	0.0	0.0	0.2
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322906	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 158.8"	"Cell type enhanced"	"Detected in many"	17	"Ciliated cells: 61.6;Club cells: 78.5;Hepatocytes: 112.8;Urothelial cells: 30.7"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	8.0	0.1	0.1	0.2	0.1	0.3	1.8	1.0	0.1	1.3	0.3	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.9	0.1	0.0	0.1	158.8	0.8	0.1	0.1	0.1	0.1	2.4	0.0	0.1	0.3	0.1	2.4	0.1	0.1	0.2	0.1	0.1	1.4	0.1	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.1	0.3	2.7	1.8	0.6	3.7	0.7	0.8	0.8	0.1	0.2	0.3	0.8	0.9	1.1	0.8	0.6	0.1	0.3	0.0	0.1	0.0	1.8	0.6	0.6	0.3	0.1	0.4	0.2	0.2	0.2	0.6	0.3	1.0	1.1	1.8	0.8	2.6	1.1	0.4	0.0	0.0	0.1	0.9	0.3	0.9	0.8	0.9	0.3	0.3	0.4	4.9	0.4	1.4	0.5	0.8	1.0	0.3	0.3	0.5	0.5	2.1	0.6	0.4	0.2	0.5	0.2	1.6	1.0	0.5	2.7	0.7	0.4	0.5	0.3	0.5	0.3	2.0	1.0	3.7	0.7	1.5	0.4	0.2	0.4	1.8	0.4	0.4	0.1	1.1	0.8	0.7	2.8	0.8	0.3	0.6	0.4	0.1	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	5.4	0.0	19.6	2.3	0.0	0.3	2.5	61.6	78.5	1.8	0.0	0.1	0.0	0.0	2.1	0.4	0.0	0.0	0.4	0.2	1.0	1.1	0.0	112.8	0.2	0.0	1.7	1.3	1.6	1.8	0.0	0.5	0.0	0.0	0.7	0.3	0.2	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.6	30.7
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
HTR1A	"5-HT1A, ADRB2RL1, ADRBRL1"	ENSG00000178394	"5-hydroxytryptamine receptor 1A"	P08908	5	63960356-63962507	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 21.5;ovary: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 14.7;cerebral cortex: 10.7;hippocampal formation: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"NTERA-2: 5.4;SCLC-21H: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018073	Uncertain					NA	NA					"HPA018073: AB_1856704"					"unprognostic (1.81e-1)"													0.2	0.4	14.7	0.2	1.0	0.2	0.2	0.1	10.7	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.5	21.5	2.4	0.2	0.2	0.3	0.2	0.7	2.7	10.4	0.2	0.2	0.1	0.2	0.9	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	1.0	0.1	10.7	21.5	2.4	0.7	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 41.8;TIME: 18.4"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.1	0.8	41.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR2C	"5-HT2C, 5HTR2C, HTR1C"	ENSG00000147246	"5-hydroxytryptamine receptor 2C"	P28335	X	114584078-114910061	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"brain: 45.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 5.0;RPMI-8226: 2.4;U-266/70: 8.9;U-266/84: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (2.14e-1)"	"unprognostic (6.09e-3)"		"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"		"unprognostic (3.42e-2)"		"unprognostic (9.22e-4)"	"unprognostic (1.37e-1)"		"unprognostic (6.84e-2)"	0.5	0.5	2.4	0.4	45.3	0.5	0.5	0.0	9.4	2.3	0.4	8.5	0.0	0.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	9.8	0.5	0.5	0.5	0.4	2.0	1.2	0.4	0.4	0.4	0.3	1.0	29.7	0.9	0.4	0.8	0.4	1.1	0.4	0.4	0.4	0.4	1.7	0.4	0.4	0.6	2.4	0.0	0.4	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.3	1.2	0.0	0.0	0.0	2.4	0.0	1.4	0.0	0.0	0.1	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.9	0.0	0.0	8.9	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.4	45.3	0.0	4.6	2.4	9.8	2.0	1.2	29.7	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR3B	5-HT3B	ENSG00000149305	"5-hydroxytryptamine receptor 3B"	O95264	11	113904677-113946565	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"cerebral cortex: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.4"	"Not detected"	"Not detected"			HPA039559	Approved					NA	NA					"HPA039559: AB_10672779"					"unprognostic (1.60e-2)"	"unprognostic (8.37e-2)"			"unprognostic (2.84e-1)"	"unprognostic (3.28e-1)"				"unprognostic (1.71e-1)"	"unprognostic (2.46e-1)"			0.2	0.2	1.0	0.8	2.1	2.4	0.2	0.4	8.7	0.3	0.4	0.2	0.0	0.3	0.5	1.6	2.6	0.2	0.2	0.2	1.2	0.7	1.0	0.2	0.2	0.5	0.8	1.4	0.3	0.3	0.1	0.2	0.2	0.0	0.2	0.5	0.0	0.5	0.1	0.5	1.2	0.5	0.1	0.7	0.5	0.3	1.5	0.0	0.0	0.5	0.0	0.5	0.3	0.6	1.6	1.3	2.9	0.9	1.9	0.9	0.1	0.5	1.4	0.8	0.8	1.6	0.9	1.2	0.1	0.2	0.2	0.2	1.0	0.9	1.9	0.5	0.5	0.7	0.5	0.6	0.6	0.8	0.5	0.8	0.6	1.9	1.8	0.3	1.6	1.4	1.1	0.5	0.2	0.0	0.6	0.2	1.0	0.8	1.5	0.3	0.2	0.9	1.6	0.4	0.7	0.2	0.8	1.4	0.9	0.9	0.7	0.7	2.8	0.5	1.6	1.1	1.3	0.6	0.4	1.8	1.5	1.1	1.5	1.1	1.1	0.7	1.4	0.9	0.6	0.8	1.6	0.9	0.3	0.9	0.5	0.7	1.3	0.8	0.6	0.5	1.6	0.9	0.9	2.9	1.9	0.3	1.3	0.7	0.1	1.0	2.1	0.4	8.7	1.2	0.7	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR4	5-HT4	ENSG00000164270	"5-hydroxytryptamine receptor 4"	Q13639	5	148451032-148677235	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 4.3;Enterocytes: 2.8;Undifferentiated cells: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Cell type enriched"	"Detected in single"	8	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enriched"	"Detected in single"	5	"Karpas-707: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040591	Enhanced					NA	NA					"HPA040591: AB_2677028"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.74e-2)"		"unprognostic (2.37e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.68e-2)"			"unprognostic (1.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.83e-5)"	0.4	1.4	1.9	1.1	18.1	0.1	0.2	0.1	3.2	0.6	4.3	0.0	0.0	8.0	0.3	0.1	0.3	0.4	1.5	7.2	5.2	0.6	0.1	0.2	0.3	0.2	0.5	1.3	0.2	0.1	0.1	5.9	0.1	0.1	0.1	4.9	0.0	0.2	0.2	0.2	0.2	14.6	1.1	0.3	0.2	0.2	0.2	2.4	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	1.9	18.1	0.1	3.2	5.2	0.6	0.5	1.3	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0
HTR6	"5-HT6, 5-HT6R"	ENSG00000158748	"5-hydroxytryptamine receptor 6"	P50406	1	19665287-19679562	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 24.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 24.6;cerebral cortex: 6.6"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.5"	HPA068165	Uncertain					NA	NA					"HPA068165: "	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-5)"	"unprognostic (1.38e-4)"	"unprognostic (2.69e-2)"		"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.33e-3)"	"unprognostic (8.63e-2)"	"unprognostic (5.47e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.02e-1)"	0.4	0.5	1.2	1.4	24.6	0.4	0.4	0.2	6.6	0.6	0.4	0.0	0.0	0.6	0.6	0.5	0.5	0.6	0.5	0.4	1.4	1.0	0.3	0.3	0.3	1.4	0.5	2.2	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.3	0.0	0.5	0.3	0.3	0.8	0.5	0.5	0.2	0.4	0.5	0.8	3.2	0.0	0.3	0.0	2.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	1.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	24.6	0.2	6.6	1.4	1.0	0.5	2.2	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTRA3	"Prsp, Tasp"	ENSG00000170801	"HtrA serine peptidase 3"	P83110	4	8269765-8307111	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.9"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	9	"basal ganglia: 8.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-2197: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021187, HPA063810"	Approved		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"HPA021187: AB_1851311, HPA063810: AB_2685129"	"unprognostic (5.87e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.61e-9)"	"unprognostic (1.65e-3)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.34e-2)"	23.7	1.8	0.6	7.3	8.2	5.3	35.6	0.7	0.9	12.3	9.4	0.8	5.4	3.7	19.6	26.6	14.4	7.9	19.8	57.9	0.7	0.3	1.7	1.6	15.4	4.3	0.8	0.9	30.7	2.8	0.0	5.1	9.6	0.9	15.4	2.0	8.6	6.6	3.0	12.9	9.0	6.7	50.1	0.8	1.8	6.8	7.2	0.6	1.3	9.3	11.6	3.0	28.7	12.7	0.0	0.4	1.3	0.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	2.1	3.9	0.1	0.8	0.0	1.0	0.2	0.0	0.0	0.0	4.8	2.1	0.5	0.0	0.4	0.0	0.3	0.0	0.8	0.4	5.0	0.0	2.2	0.0	0.2	0.4	0.0	1.4	0.0	0.6	3.4	0.0	0.1	0.0	3.5	0.0	0.0	12.2	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.1	9.1	0.1	0.0	10.6	0.0	0.4	2.7	0.5	1.7	64.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.6	8.2	0.7	0.9	0.7	0.3	0.8	0.9	0.9	0.6	0.0	0.0	0.0	0.3	4.6	0.0	14.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.6	3.1	0.0	0.0	0.0	3.7	45.9	0.1	0.0	0.0	1.1	0.0	0.0	4.3	0.0	0.5	40.3	0.9	0.0	0.0	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.0	5.1	0.2	0.9	4.5	1.1	0.0	0.0	0.1
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286967-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 53.1;bone marrow: 13.7;lung: 13.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 75.3;Club cells: 34.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in many"	5	"non-classical monocyte: 53.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.1"	"Cell line enhanced"	"Detected in some"		"HEL: 36.1;HMC-1: 9.1;K-562: 18.6;NB-4: 15.5;U-937: 8.7"														"Intracellular and membrane"	NA	NA																							1.9	0.4	0.4	1.6	0.4	13.7	0.6	0.2	2.0	1.0	2.9	0.2	0.0	1.1	1.1	2.9	2.3	1.1	1.1	1.1	0.5	0.3	1.6	1.7	13.5	3.3	0.4	0.0	1.2	0.4	0.1	0.4	1.9	2.4	2.4	0.5	0.9	2.5	2.7	1.7	0.8	1.4	0.2	0.9	2.8	1.6	0.6	0.3	1.5	0.9	0.0	4.5	3.3	0.7	0.5	8.4	4.5	53.1	0.1	0.6	2.4	0.1	0.1	0.1	0.2	0.0	0.0	3.1	0.3	0.1	0.0	0.0	4.0	0.2	0.4	0.4	0.0	0.2	0.3	0.1	0.0	0.0	0.3	0.2	36.1	0.2	5.4	1.0	0.6	9.1	0.2	0.0	0.1	0.1	0.0	0.0	5.8	18.6	1.6	0.0	0.1	1.0	15.5	0.1	0.0	0.1	2.6	1.5	6.8	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.4	0.1	1.0	0.3	0.1	0.0	0.3	0.0	0.5	1.0	0.1	0.3	8.7	0.2	4.5	2.6	2.6	0.2	9.7	0.5	0.5	0.3	0.2	8.4	0.4	0.3	0.1	0.7	0.1	53.1	2.7	0.6	2.4	0.4	0.4	0.2	2.0	0.5	0.3	0.4	0.0	2.4	0.3	62.5	75.3	0.8	0.9	0.9	0.0	0.0	0.0	4.0	34.2	0.0	0.0	0.3	0.0	0.5	0.0	6.7	0.0	0.0	1.8	0.7	11.2	1.4	20.9	0.0	5.2	0.0	0.0	1.8	3.5	0.0	0.0	8.1	5.0	19.8	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.1	1.1	0.7	0.0	0.0	1.6
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289981-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 32.6"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 33.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	15	"amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.5;K-562: 10.8;RPMI-8226: 12.3;U-266/70: 14.8;U-87 MG: 8.8"	"Group enriched"	"Detected in many"	9	"amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4"	"Group enriched"	"Detected in many"	13	"amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5"	"HPA008943, HPA009083, CAB025178"	Enhanced					NA	NA		2400000			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.8	0.9	22.5	0.8	24.3	2.0	0.9	0.0	32.6	0.8	0.8	1.0	0.0	0.8	0.8	0.8	0.8	0.9	0.8	1.0	23.0	1.4	1.1	0.8	3.6	1.2	0.9	15.9	1.4	0.8	0.8	0.1	1.1	0.0	0.9	0.8	0.0	0.8	0.9	0.8	0.8	1.0	0.8	0.1	1.0	1.0	1.9	1.6	0.0	0.8	0.0	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.0	2.9	0.0	0.0	6.2	0.0	0.0	0.1	4.4	0.7	0.1	0.4	0.0	0.1	4.7	2.0	0.0	0.0	5.4	0.2	0.0	0.0	0.1	0.9	13.5	4.3	0.4	0.1	0.0	2.7	0.0	0.5	0.1	0.0	0.0	0.0	1.7	10.8	0.1	0.0	0.6	0.0	1.9	0.0	0.2	4.4	0.1	0.0	12.3	0.2	0.0	0.8	0.1	2.0	0.1	0.3	0.0	2.2	0.0	0.0	1.3	0.0	0.6	0.0	14.8	2.4	2.7	8.8	0.0	1.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	24.3	0.0	32.6	23.0	1.4	0.9	15.9	0.0	1.6	6.0	3.2	0.0	0.2	0.2	0.0	33.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.4	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.1	1.6	0.1	0.1	0.0	0.0	0.1
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 5.7;hTERT-RPE1: 5.9;NB-4: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	10000				"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA8	IFN-alphaB	ENSG00000120242	"Interferon alpha 8"	P32881	9	21409147-21410185	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"HeLa: 3.2"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNK		ENSG00000147896	"Interferon kappa"	Q9P0W0	9	27524314-27526498	"Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 1.9;skin 1: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cervical cancer: 0.5;head and neck cancer: 0.6;urothelial cancer: 0.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.8"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA							"unprognostic (5.58e-3)"				"unprognostic (4.64e-3)"								"unprognostic (1.06e-1)"				0.1	0.0	0.1	0.1	0.5	0.7	0.1	0.5	0.1	1.0	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.8	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.3	0.1	0.1	1.7	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF22	"FLJ37794, IGFN2"	ENSG00000179057	"Immunoglobulin superfamily member 22"	Q8N9C0	11	18704305-18726230	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"salivary gland: 22.7"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 22.7;Distal tubular cells: 18.3"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.9"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RH-30: 2.9"									"CAB026459, HPA037851"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB026459: , HPA037851: "	"unprognostic (4.05e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.99e-4)"	"unprognostic (9.35e-2)"	"unprognostic (3.72e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.94e-3)"	0.3	0.1	0.7	0.2	3.9	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.6	0.3	0.2	0.2	0.1	0.7	0.3	0.4	1.5	0.2	0.2	0.2	0.3	0.3	0.2	1.2	0.5	0.0	0.5	0.2	0.2	0.2	0.0	0.2	22.7	0.2	0.5	4.6	0.4	0.2	0.2	0.2	0.0	2.2	0.2	0.2	0.2	1.3	0.3	0.5	0.2	0.2	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.2	0.7	3.9	0.2	1.1	0.4	1.5	0.3	0.2	0.2	0.2	0.0	0.3	1.5	3.6	2.2	1.3	1.5	0.0	2.7	1.2	22.7	0.0	0.0	18.3	2.6	1.0	0.0	0.7	0.0	3.8	0.0	0.6	3.7	2.3	0.0	1.3	1.6	3.5	0.6	0.3	3.2	1.4	0.8	0.0	1.0	4.9	0.5	7.4	3.5	0.7	1.4	0.9	0.0	0.5	0.0	0.4	1.5	0.0	1.7	2.9	7.5
IGSF9B	KIAA1030	ENSG00000080854	"Immunoglobulin superfamily member 9B"	Q9UPX0	11	133908564-133956985	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7"	"Cell type enhanced"	"Detected in some"	11	"Basal keratinocytes: 3.1;Bipolar cells: 2.2;Cardiomyocytes: 2.6;Distal tubular cells: 1.7;Muller glia cells: 2.0;Suprabasal keratinocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 39.7"	"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"OE19: 8.2;SCLC-21H: 17.7;SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010744, HPA010802"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA010744: AB_2668357, HPA010802: AB_1079194"	"unprognostic (9.04e-4)"	"unprognostic (1.74e-2)"	"unprognostic (7.52e-3)"	"unprognostic (4.38e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.99e-4)"	"unprognostic (3.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-4)"	"unprognostic (3.12e-3)"	2.2	2.1	4.9	3.7	6.8	0.7	1.2	39.7	12.4	7.4	6.8	2.4	4.6	1.1	7.7	4.3	5.9	7.6	4.9	13.4	2.9	3.1	1.1	0.5	1.8	1.6	2.1	4.0	2.4	2.1	1.5	6.2	1.3	3.8	4.2	2.4	6.1	2.1	6.4	5.0	2.4	2.4	12.8	1.6	1.8	3.7	5.0	2.3	0.0	4.9	2.6	1.2	5.2	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.3	1.2	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	2.6	1.6	0.8	0.5	0.4	3.1	2.6	0.0	0.1	2.8	2.4	0.0	0.0	0.0	0.2	0.7	3.8	0.0	0.0	0.0	0.5	0.2	0.0	3.3	0.0	0.0	0.0	1.8	0.3	0.3	1.9	8.2	0.1	0.0	0.0	0.0	0.3	0.0	17.7	9.0	0.1	0.2	0.0	2.9	1.8	0.0	0.0	1.3	1.4	1.1	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	4.9	6.8	39.7	9.7	2.9	3.1	2.1	4.0	3.8	2.3	0.0	0.0	0.0	0.1	3.1	2.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.4	0.0	0.7	0.0	1.0	0.0	0.1	4.3	0.0	0.0	0.1	0.0
IL11	"AGIF, IL-11"	ENSG00000095752	"Interleukin 11"	P20809	19	55364389-55370463	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Group enriched"	"Detected in some"	8	"Ductal cells: 10.9;Pancreatic endocrine cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 9.2;hypothalamus: 3.7;pons and medulla: 2.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 18.3;BJ hTERT+: 20.8;hTEC/SVTERT24-B: 17.0;U-251 MG: 65.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	34800					"unprognostic (6.60e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.32e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.84e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (4.83e-2)"	"unprognostic (4.07e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.08e-2)"	1.1	0.1	0.6	7.7	0.9	1.5	0.6	9.2	1.0	0.6	0.6	1.8	0.6	0.3	6.1	0.6	2.3	0.0	5.9	0.6	0.6	3.7	3.4	0.6	0.9	0.6	1.2	0.6	0.6	0.6	0.0	5.3	2.3	2.7	3.7	0.2	0.6	0.6	1.1	0.6	2.5	0.6	0.6	0.6	0.6	2.8	1.4	0.6	0.6	0.6	0.6	0.6	2.3	0.6	0.7	0.3	2.8	0.3	0.8	0.4	0.0	0.7	0.4	0.1	0.3	0.0	0.0	0.1	18.3	20.8	9.7	12.8	0.3	0.4	0.2	0.8	1.6	5.0	0.9	0.1	0.4	13.0	0.7	0.5	0.0	1.1	1.2	1.0	0.0	0.1	0.1	0.4	17.0	0.1	4.1	0.0	0.0	0.1	0.5	1.1	0.5	0.0	0.1	0.3	0.6	1.5	0.0	6.1	0.0	0.1	0.1	0.9	0.6	2.3	0.3	0.4	2.3	0.2	0.1	0.2	5.8	7.0	0.0	65.9	0.3	0.7	0.1	12.5	0.1	2.9	1.4	0.3	0.5	0.3	0.2	0.2	0.7	0.3	0.1	0.1	0.7	0.3	0.4	2.8	0.8	0.1	0.3	0.2	0.0	0.6	0.9	9.2	0.8	0.6	3.7	1.2	0.6	2.7	0.6	0.0	0.3	0.0	0.3	2.9	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.8	0.2	0.0	0.0	2.3	0.8	1.9	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	0.0	0.2	37.7	0.2	1.4	0.0	0.2	0.0	0.4	0.3	0.9	0.5	0.2	0.0	0.2	0.3
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 169.7;Erythroid cells: 70.0;Kupffer cells: 59.0;T-cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HEL: 13.2;HMC-1: 23.8;RPMI-8226: 22.5;U-266/70: 28.3;U-698: 11.7;U-937: 15.8"	"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	37	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	Yes	NA	208000	14000	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	13.2	0.0	0.0	0.4	9.3	23.8	0.4	0.0	0.0	0.2	0.0	0.2	1.6	1.4	5.0	0.0	0.0	0.7	9.9	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	2.1	0.1	0.1	0.1	0.4	0.0	28.3	2.4	11.7	0.8	15.8	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5	3.0	10.0	169.7	0.1	7.2	0.0	1.2	10.2	8.1	3.4	1.8	0.0	0.2	0.0	0.1	1.3	4.9	0.0	70.0	0.2	0.2	6.6	0.1	25.5	2.4	16.6	0.0	0.0	36.2	59.0	0.7	10.0	30.8	27.0	0.0	0.3	0.4	0.0	0.3	17.0	0.3	0.6	6.5	3.7	2.1	4.7	3.1	0.3	92.0	0.0	0.0
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Peritubular cells: 12.4;Sertoli cells: 25.8;Smooth muscle cells: 8.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"midbrain: 8.9"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.5;Hep G2: 2.1;K-562: 1.7;Karpas-707: 3.7;NB-4: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000				"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	2.1	3.3	0.1	2.2	0.1	0.6	7.5	0.1	0.8	4.7	4.2	0.1	2.8	0.7	6.8	3.6	4.1	1.6	1.1	5.1	0.1	0.0	0.8	0.1	0.9	0.1	8.9	1.2	0.7	0.1	0.0	0.1	0.4	1.4	3.6	0.4	2.4	7.1	5.6	1.5	1.3	1.7	5.3	5.4	1.1	1.3	5.9	0.4	0.4	0.6	1.6	0.3	1.8	1.3	0.0	0.2	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.5	0.0	4.5	0.0	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	3.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.5	0.0	0.5	0.2	0.1	0.0	0.0	1.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.1	0.0	8.9	1.2	1.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	25.8	8.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0
IL17C	"CX2, IL-17C, IL-21, MGC126884, MGC138401"	ENSG00000124391	"Interleukin 17C"	Q9P0M4	16	88638591-88640473	"Predicted secreted proteins"	"Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.6"	"Cell type enriched"	"Detected in single"	6	"Exocrine glandular cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.6;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065051	Supported				"Secreted to blood"	NA	NA	30500				"HPA065051: AB_2685413"	"unprognostic (1.60e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.45e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.93e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.73e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.56e-3)"	"unprognostic (8.37e-3)"	0.1	0.0	0.1	0.1	0.6	0.8	0.1	1.2	0.1	1.0	0.1	0.1	0.1	0.0	7.6	0.1	0.8	0.2	1.4	2.3	0.1	0.0	0.1	0.1	3.6	0.2	0.1	0.1	0.1	0.1	0.2	0.3	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.9	0.5	0.1	0.1	1.3	0.9	2.0	0.1	0.1	0.1	2.5	0.1	1.2	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3
IL17RE	FLJ23658	ENSG00000163701	"Interleukin 17 receptor E"	Q8NFR9	3	9902612-9916402	"Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 55.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 71.8;Mucus-secreting cells: 43.2;Paneth cells: 38.6;Undifferentiated cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebellum: 19.0"	"Group enriched"	"Detected in some"	8	"basophil: 3.1;MAIT T-cell: 1.9;memory CD8 T-cell: 2.0"	"Group enriched"	"Detected in many"	19	"granulocytes: 3.1;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.0;ASC TERT1: 27.1;BEWO: 10.1;hTCEpi: 11.1;T-47d: 12.9"	"Region enhanced"	"Detected in single"		"cerebellum: 1.7"					HPA019011	Uncertain				"Intracellular and membrane"	NA	NA					"HPA019011: AB_1851667"	"unprognostic (1.08e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.43e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-2)"	7.6	0.9	0.6	6.9	4.3	0.0	7.8	19.0	0.7	4.5	39.3	0.0	1.9	15.5	2.4	4.0	10.4	1.9	18.3	1.4	0.7	0.8	3.4	1.0	13.5	0.5	0.7	0.1	0.9	12.7	3.6	1.7	4.6	2.5	4.7	10.5	2.6	17.7	3.9	1.0	16.8	55.7	1.2	0.7	1.3	12.4	0.6	0.4	5.1	4.8	6.8	5.3	2.1	4.4	0.0	0.0	3.1	0.0	0.1	2.0	0.0	1.9	0.2	0.0	0.0	11.0	27.1	10.1	1.5	0.9	0.2	0.6	2.0	1.5	0.0	0.5	1.9	0.0	4.5	0.0	4.1	0.0	0.0	0.1	0.5	0.3	4.6	0.3	0.0	2.0	1.9	11.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.5	2.2	0.3	8.1	0.4	5.3	0.4	0.0	0.0	0.0	2.0	2.3	0.5	0.1	0.0	4.3	0.0	0.2	12.9	0.5	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	4.9	0.1	3.1	0.0	0.0	0.0	0.0	1.9	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	4.3	19.0	0.7	0.7	0.8	0.7	0.1	2.5	0.4	6.0	0.6	3.0	10.3	12.9	3.0	0.8	15.3	0.0	1.2	15.7	0.0	3.9	6.6	2.7	0.1	1.0	71.8	0.0	4.1	1.1	3.8	9.2	0.0	13.6	2.2	1.6	32.2	1.8	0.0	0.0	2.0	1.4	5.0	0.0	43.2	2.7	2.3	38.6	3.2	5.6	1.0	19.4	6.4	1.0	1.9	12.9	0.7	1.3	36.3	2.7
IL17REL	FLJ41993	ENSG00000188263	"Interleukin 17 receptor E like"	Q6ZVW7	22	49994513-50012659	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.7;stomach 1: 4.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.9;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.2;SK-BR-3: 3.9"									HPA045546	Supported					NA	NA					"HPA045546: AB_10963836"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.65e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-2)"	0.1	0.1	0.3	11.7	0.3	0.0	0.1	0.2	1.9	0.3	0.4	0.0	0.0	1.7	0.2	0.9	0.2	0.3	0.0	0.1	0.2	1.4	0.1	0.1	0.8	3.9	0.4	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.5	0.0	2.0	0.0	0.1	0.3	3.3	0.0	0.1	1.9	4.6	0.6	0.0	8.1	0.2	0.6	8.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	3.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.9	0.2	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 131.3;Kupffer cells: 197.6;Macrophages: 236.7;Mucus-secreting cells: 105.1;Pancreatic endocrine cells: 123.7;Suprabasal keratinocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 102.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.1	0.0	102.2	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1	6.0	0.6	5.4	8.6	131.3	0.0	0.4	17.8	4.0	0.0	1.8	0.0	0.4	5.0	8.0	2.6	1.9	8.6	0.0	7.3	28.9	9.3	2.5	2.3	14.4	5.9	0.0	6.4	4.3	197.6	1.5	0.3	236.7	30.4	1.0	105.1	0.0	123.7	31.7	0.0	0.4	0.0	6.5	8.9	0.0	1.4	73.4	23.2	1.0	20.4	7.1
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Cell type enriched"	"Detected in many"	11	"granulocytes: 477.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	3.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.7	0.1	0.1	55.4	0.4	82.4	1.1	0.3	1.3	8.9	0.1	40.2	0.0	0.2	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3	8.9	22.8	0.0	15.1	7.6	0.0	1.8	0.0	12.0	13.6	1.8	0.0	0.0	0.0	0.0	0.2	29.2	0.0	0.0	0.4	0.1	4.2	8.9	477.2	0.0	0.0	0.0	0.0	44.2	0.3	0.9	0.9	11.2	3.3	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.2	38.8	5.2	0.0	0.0	4.4	0.0	4.3	0.0	11.1
IL27	"IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28"	ENSG00000197272	"Interleukin 27"	Q8NEV9	16	28499362-28512051	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antiviral protein, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;brain: 6.5;liver: 21.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 17.1;Syncytiotrophoblasts: 19.3"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 4.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 6.5"	"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.2;intermediate monocyte: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"BEWO: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB024722	Approved				"Secreted to blood"	NA	NA	521000				"CAB024722: "	"unprognostic (4.79e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (1.30e-4)"	"unprognostic (3.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (6.07e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.41e-7)"	"unprognostic (6.44e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	0.8	0.2	0.1	1.4	0.9	0.9	0.1	0.1	1.0	0.2	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.1	6.5	0.1	0.1	21.2	0.6	0.4	0.2	0.0	0.0	0.1	0.0	0.1	0.8	2.2	0.2	0.0	0.4	0.1	0.0	0.6	0.1	0.1	0.2	1.4	2.9	0.1	0.5	1.2	1.9	0.4	0.0	0.0	0.2	0.0	0.3	1.1	3.5	6.3	2.7	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	6.2	1.3	0.1	6.3	0.2	0.3	0.0	0.1	1.1	0.0	0.0	0.0	3.5	2.7	0.2	0.0	0.4	1.5	0.1	0.9	0.1	1.0	6.5	0.1	0.2	0.0	2.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	17.1	0.8	0.0	0.0	0.0	3.7	0.0	0.0	1.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7"	"Cell type enriched"	"Detected in some"	4	"monocytes: 309.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	6	"basophil: 30.3;T-reg: 55.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 30.3;T-cells: 55.4"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 157.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002419, HPA054622"	Enhanced					NA	NA		110000			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	16.5	2.5	0.3	10.9	0.6	0.1	1.4	0.3	0.3	0.6	3.1	0.1	0.0	1.3	0.8	4.9	1.9	0.8	2.2	1.9	0.4	0.5	2.6	1.3	4.0	50.4	0.5	0.0	0.6	1.0	0.0	1.8	1.8	2.4	1.1	1.6	3.4	2.2	0.5	0.8	0.6	10.3	3.5	2.2	56.7	1.4	0.4	0.0	4.5	4.2	2.0	16.8	5.0	0.6	3.6	0.0	30.3	0.0	2.9	55.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	30.3	0.0	4.5	0.1	0.0	0.5	3.6	6.8	0.7	0.0	1.5	0.5	0.0	0.2	2.9	0.0	0.0	55.4	0.7	0.3	0.6	0.3	0.3	0.4	0.5	0.5	0.0	2.4	0.0	0.0	2.6	7.5	0.1	0.8	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	74.4	0.0	0.3	0.0	0.0	0.6	5.6	0.0	0.0	3.7	3.3	309.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	7.7	0.0	0.1
IL31RA	"CRL, CRL3, GLM-R, Glmr, IL-31RA"	ENSG00000164509	"Interleukin 31 receptor A"	Q8NI17	5	55851379-55922853	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;tongue: 6.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 1.8;Spermatocytes: 2.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"amygdala: 10.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"GAMG: 25.6;HBEC3-KT: 7.8;hTERT-HME1: 9.4;U-2 OS: 13.9;U-87 MG: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.5;hippocampal formation: 1.1"	"HPA051532, HPA068114"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA051532: , HPA068114: AB_2732779"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.95e-3)"	"unprognostic (7.75e-5)"	"unprognostic (5.55e-2)"	"unprognostic (2.65e-6)"	"unprognostic (7.73e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.76e-2)"	0.3	0.1	10.3	1.0	0.1	5.3	0.2	0.1	0.4	0.2	1.5	0.0	0.0	0.4	1.2	1.8	1.7	0.1	0.2	0.4	1.6	0.2	0.3	0.3	0.5	0.1	0.1	0.0	0.5	0.7	0.0	0.7	0.7	0.0	1.0	0.4	0.4	1.3	0.2	2.6	2.5	0.8	1.8	0.1	0.3	0.5	5.9	0.0	1.4	0.5	6.4	0.5	0.5	2.2	0.0	1.2	0.2	2.2	0.0	0.1	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.4	0.1	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.2	25.6	0.0	0.0	7.8	1.6	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	5.2	2.6	3.7	9.4	0.4	2.9	0.0	0.0	0.3	1.2	0.0	0.0	1.2	0.0	0.0	5.2	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	1.3	0.4	13.9	0.0	0.8	0.0	0.0	0.0	16.1	0.0	2.2	0.1	2.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	10.3	0.1	0.1	0.4	1.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.1	0.9	0.0	0.0	0.0
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell type enriched"	"Detected in many"	9	"Smooth muscle cells: 589.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 208.4;GAMG: 141.1"					"Low region specificity"	"Detected in single"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.8	208.4	3.9	13.4	0.0	0.0	0.0	6.8	1.3	141.1	0.1	0.0	0.0	5.3	8.2	0.0	0.0	0.3	0.0	4.4	0.0	0.0	0.5	0.0	39.8	5.7	3.8	1.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.5	0.0	0.0	0.7	0.0	0.0	1.2	1.3	0.1	2.4	0.4	0.0	2.3	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2	6.0	27.2	7.2	1.9	39.6	0.0	0.9	0.0	13.4	20.5	3.5	0.0	0.5	0.0	5.8	0.3	40.7	0.0	0.0	2.4	3.1	63.9	7.3	5.8	0.0	4.2	0.0	0.0	3.1	6.1	0.0	0.0	46.2	38.8	7.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	589.1	0.0	0.0	29.2	1.1	0.0	0.0	9.0
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;urinary bladder: 10.9"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 4.6"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Group enriched"	"Detected in many"	25	"B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 76.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"	NA	NA					"HPA063240: AB_2732700, HPA064557: AB_2732716"	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.90e-7)"	0.3	0.1	0.3	1.1	1.7	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.7	3.0	0.3	0.5	0.4	0.9	0.3	0.3	0.2	0.3	0.5	1.3	3.2	0.3	0.3	0.3	0.3	0.0	0.3	0.3	4.7	0.4	1.2	0.3	0.4	0.3	0.3	0.4	2.4	0.3	0.3	3.5	0.8	0.3	1.5	0.3	0.4	0.3	2.9	10.9	0.3	4.1	0.0	6.3	0.0	0.1	2.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	7.0	0.0	0.0	0.0	0.1	76.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.0	0.2	0.0	0.3	2.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.8	0.8	1.3	0.0	4.1	0.0	0.0	1.8	0.1	0.0	0.0	2.4	0.3	0.3	1.7	0.4	0.3	0.3	0.2	0.3	0.3	4.7	1.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0
IMPG1	"GP147, IPM150, SPACR"	ENSG00000112706	"Interphotoreceptor matrix proteoglycan 1"	Q17R60	6	75921115-76072678	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 110.5"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 634.2;Rod photoreceptor cells: 409.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.1;AF22: 3.0;HaCaT: 4.1;TIME: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027142, HPA030332, HPA030333"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433"	"unprognostic (6.65e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-2)"	0.6	0.0	0.4	0.4	10.3	0.0	0.4	1.0	2.8	0.4	0.4	0.4	0.4	2.8	0.4	0.4	0.4	0.1	1.1	0.5	0.5	0.4	0.8	0.4	0.5	0.4	0.5	0.4	0.4	5.4	0.0	0.4	0.6	0.4	0.7	0.0	110.5	0.6	0.4	0.6	4.0	2.3	0.4	0.4	0.5	0.7	0.9	0.4	0.4	0.8	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.1	3.0	0.0	0.0	0.6	1.6	0.8	0.0	0.0	0.0	1.8	0.6	0.0	0.3	0.0	0.1	4.1	0.0	0.0	0.0	0.1	1.5	0.7	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.2	0.6	0.1	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.7	0.7	1.2	0.0	1.8	0.4	0.6	0.0	0.3	2.4	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.3	1.0	1.9	0.5	0.4	0.5	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	44.9	0.2	0.0	0.0	0.0	0.0	634.2	0.1	3.3	0.0	1.5	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.2	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	409.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INHA		ENSG00000123999	"Inhibin alpha subunit"	P05111	2	219569162-219575713	"Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 276.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB000047, HPA019141, HPA048834"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Golgi apparatus"	"CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: "	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	0.5	24.2	0.8	0.5	8.4	0.0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0.0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0.0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	2.5	0.8	0.2	4.5	0.5	0.4	0.7	0.2	0.3	4.3	0.0	0.3	1.0	0.7	2.6	0.3	0.7	0.0	0.0	0.8	5.6	2.0	3.0	0.4	0.0	0.0	0.9	1.3	0.0	0.7	2.5	0.0	0.0	3.3	0.0	0.1	3.0	0.0	0.2	1.7	0.2	1.1	0.1	0.2	0.0	0.7	0.3	0.4	1.0	1.6	12.8	0.4	6.6	0.8	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5	0.0	0.0	0.0	0.1	0.0	3.4	1.4	0.0	0.0	0.0	7.0	2.0	6.0	0.0	1.5	0.7	0.0	0.0	0.0	7.9	29.6	0.2	0.0	0.0	0.0	2.3	6.4	0.0	1.3	0.3	4.1	3.7	0.0	0.0	0.0	0.0	3.3	3.3	0.0	1.4	0.0	0.0	0.0	0.0	1.1	0.4	0.0	276.8	0.0	0.0	0.0
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721670-33746905	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 22.5;skeletal muscle: 87.9"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.9;Hepatocytes: 5.8;Horizontal cells: 9.5;Proximal tubular cells: 3.6;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.0;cerebral cortex: 6.2;midbrain: 22.5;pons and medulla: 7.7;thalamus: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 16.2;HSkMC: 5.8;LHCN-M2: 25.7;RH-30: 11.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Approved		Approved	Nucleoplasm,Cytosol		Yes	NA			Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	2.2	1.0	2.1	0.8	13.0	0.5	0.9	0.6	6.2	1.2	2.2	11.8	1.4	0.8	1.6	1.4	5.2	1.3	0.6	10.0	3.2	1.3	4.7	7.7	2.0	0.6	22.5	1.1	0.6	0.7	0.5	0.5	3.8	7.7	2.8	1.0	1.2	1.4	1.8	87.9	0.5	1.1	1.8	9.2	1.4	0.9	0.6	15.2	0.0	9.9	8.1	0.5	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.1	0.2	0.2	1.9	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	16.2	0.0	0.0	5.8	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.4	4.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	13.0	0.6	6.2	3.2	1.3	22.5	1.1	7.7	15.2	0.0	0.0	0.0	0.0	0.0	2.2	10.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	5.8	0.2	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.1	6.5	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.4	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.1	0.0	0.0	3.4	5.8	0.0	0.0	0.0	0.0	59.6	0.0	21.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	24.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	2.1	21.3	5.3	1.7	0.4	9.5	0.5	1.1	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3	14.9	7.2	0.8	177.1	344.0	0.0	23.2	40.8	46.8	50.0	33.2	0.0	79.7	23.2	31.5	0.9	4.3	54.6	0.0	16.8	20.9	7.3	126.3	2.3	30.2	7.1	0.0	57.5	1.3	1.2	0.0	0.6	2.3	33.7	1.8	54.2	5.2	36.6	51.8	0.0	10.3	0.4	0.0	10.3	9.0	3.6	482.8	135.1	0.0	36.4	297.3
IRS4	"IRS-4, PY160"	ENSG00000133124	"Insulin receptor substrate 4"	O14654	X	108732482-108736409	"Cancer-related genes, Predicted intracellular proteins"		Transducer	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pituitary gland: 56.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	7	"hypothalamus: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.0;NTERA-2: 1.7;RT4: 4.1;WM-115: 3.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 12.8;hypothalamus: 52.4"	"Group enriched"	"Detected in many"	6	"basal ganglia: 21.5;hypothalamus: 55.3"	HPA017372	Uncertain					NA	NA					"HPA017372: AB_2669600"	"unprognostic (3.74e-3)"				"unprognostic (3.27e-2)"			"unprognostic (1.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.65e-1)"		"unprognostic (1.05e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.28e-4)"	"unprognostic (8.71e-2)"	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.6	1.9	0.0	0.1	0.3	0.1	2.6	0.3	0.3	0.5	0.0	0.0	0.3	4.6	0.0	0.0	0.1	0.0	0.5	0.1	9.5	0.0	0.0	56.0	0.1	0.6	0.2	0.0	2.7	0.0	0.5	0.0	0.6	0.0	1.0	0.2	0.1	0.5	0.1	0.5	5.1	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.3	0.3	4.6	0.5	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 101.3;Alveolar cells type 2: 59.1;Basal keratinocytes: 179.6;Suprabasal keratinocytes: 114.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.5;BEWO: 24.3;HaCaT: 13.8;hTCEpi: 26.6;SK-BR-3: 16.3"	"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: AB_2682566"	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	40.5	0.0	2.2	1.6	24.3	2.4	1.3	2.0	1.6	4.8	0.0	0.0	0.0	4.5	0.0	13.8	0.0	9.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.6	0.9	8.2	0.0	0.0	0.0	0.0	0.0	1.4	7.8	0.0	0.0	4.5	10.5	0.0	0.0	2.5	0.0	9.0	0.0	1.5	0.0	7.9	16.3	0.0	6.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2	101.3	59.1	0.0	14.0	179.6	0.5	2.4	0.0	10.7	30.7	7.0	0.0	23.0	23.2	0.1	3.9	0.5	0.5	0.0	0.0	17.1	12.8	15.9	1.1	0.0	2.8	0.0	0.0	0.0	0.0	8.9	0.0	1.3	18.6	0.0	1.5	0.2	0.5	1.9	0.0	0.5	2.4	0.0	16.9	0.7	3.8	114.7	12.7	0.0	1.9	9.2
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell type enhanced"	"Detected in some"	21	"Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.5	0.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.7	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1	0.0	0.0	0.0	4.2	43.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.6	12.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	17.7	3.1	0.0	0.0	1.3
ISL1	"Isl-1, ISLET1"	ENSG00000016082	"ISL LIM homeobox 1"	P61371	5	51383391-51394738	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 30.3"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"SH-SY5Y: 82.3"	"Group enriched"	"Detected in some"	8	"basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5"	"Group enriched"	"Detected in some"	11	"basal ganglia: 8.5;hypothalamus: 8.6"	"HPA048613, HPA057416"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Mitochondria"		NA	NA			Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA048613: , HPA057416: AB_2683431"	"unprognostic (4.97e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.41e-3)"		"unprognostic (5.52e-2)"		"unprognostic (6.79e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.77e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.11e-3)"	"unprognostic (4.39e-3)"	2.2	1.5	0.0	0.0	4.0	0.0	0.1	0.0	0.2	14.4	1.6	0.0	4.2	2.3	1.3	0.5	0.2	0.0	0.2	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.4	0.0	2.8	10.0	2.0	13.2	2.5	6.4	1.0	30.3	0.1	1.1	0.7	0.6	0.1	0.0	10.7	1.6	0.7	3.1	0.3	0.2	0.4	2.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.6	1.2	0.9	0.0	0.0	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.8	0.0	0.0	0.0	5.3	82.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.0	0.0	0.2	0.0	5.5	0.0	0.0	2.0	0.7	0.0	0.0	0.0	3.5	1.3	118.7	0.3	0.0	0.0	0.0	0.0	3.9	20.5	0.0	0.0	13.2	0.1	0.0	0.0	0.0	8.9	0.4	1.2	0.0	0.0	2.3	41.3	87.9	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.6	3.4	6.8	0.0	0.0	0.0	11.3	0.0	0.1	0.7	0.7	0.9	28.6	0.0	0.0	3.7
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498850	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"placenta: 193.8"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"BEWO: 91.4"	"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Supported	Nucleoplasm	"Secreted in female reproductive system"	NA	NA			Nucleoplasm		"HPA039314: AB_10673239, HPA039742: AB_10673427"	"unprognostic (5.69e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.34e-1)"		"unprognostic (2.16e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.95e-1)"	0.7	0.0	0.2	0.2	4.2	0.0	0.1	0.1	0.3	1.1	0.2	0.1	0.3	0.1	2.7	0.9	0.2	0.5	0.1	0.1	0.1	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.5	193.8	0.2	3.2	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.2	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.1	0.3	0.1	0.8	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	240.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	440.1	0.3	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	148.4	0.0	0.0	0.0
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.8;intestine: 19.8;stomach 1: 10.7"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2"	"Cell type enriched"	"Detected in single"	8	"MAIT T-cell: 4.7"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.7;OE19: 12.5"	"Group enriched"	"Detected in many"	13	"amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9"	"Group enriched"	"Detected in many"	7	"amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6"	HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.4	3.0	12.3	1.1	21.2	0.8	0.4	3.0	28.8	0.6	8.5	0.3	0.0	19.8	0.6	0.5	0.4	0.6	0.6	0.7	10.4	0.9	0.4	0.8	0.4	0.4	1.6	8.2	0.6	2.5	1.7	0.0	0.7	0.3	0.8	3.4	0.0	2.1	0.8	1.4	0.4	19.7	0.7	0.2	0.4	10.7	3.5	0.6	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.3	4.7	0.0	4.7	1.3	0.2	5.6	0.0	1.8	10.2	3.0	2.4	2.0	2.1	11.2	0.2	0.0	2.5	0.2	4.5	0.5	2.4	0.2	0.1	4.5	3.0	6.8	3.0	22.7	9.2	2.3	0.3	0.1	0.1	1.9	0.6	1.1	0.1	0.9	8.6	1.3	0.7	3.1	0.2	4.4	0.6	12.5	4.0	1.1	1.0	0.4	0.2	0.3	0.5	1.1	2.2	0.0	0.2	0.0	0.6	3.4	0.2	4.9	5.1	5.4	8.1	0.7	7.1	0.0	9.1	9.0	1.6	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.3	21.2	3.0	28.8	10.4	0.9	1.6	8.2	0.3	0.6	0.0	0.0	0.0	0.4	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	36.6	0.0	34.8	0.0	0.6	0.4	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	119.2	2.3	0.0	0.0	0.0	12.0	7.3	0.4	19.3	1.4	0.0	0.1	6.5	0.7	1.9	3.0	0.0	0.1	0.0	14.4	0.1
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 146.2;Muller glia cells: 167.6;Suprabasal keratinocytes: 132.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 32.2;SuSa: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	5.2	3.6	15.0	8.6	1.8	1.8	14.9	1.5	3.6	2.0	2.5	3.8	4.1	2.8	5.4	3.0	3.0	2.7	3.5	8.7	1.8	5.4	5.3	9.8	4.3	4.8	2.0	9.9	11.5	2.6	5.5	2.9	11.7	6.0	2.1	32.2	12.7	4.7	1.1	5.2	19.7	18.7	16.0	2.6	1.6	8.8	4.6	7.8	1.8	5.5	11.6	6.6	3.1	10.9	13.7	36.6	3.8	10.7	3.6	9.2	5.1	5.0	5.2	3.0	7.2	4.9	3.1	9.3	11.5	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5	6.0	10.9	22.2	9.5	71.4	71.0	8.9	10.2	4.0	11.4	5.2	82.5	23.3	1.7	6.8	59.2	24.1	12.3	0.0	3.9	19.3	18.6	5.7	24.3	12.9	21.4	146.2	25.7	14.1	48.4	29.9	8.1	37.2	25.3	20.8	16.0	167.6	11.0	11.5	8.1	2.6	91.1	6.5	25.0	7.0	67.9	132.5	21.1	30.5	13.4	13.6
KANK4	"ANKRD38, KIAA0172"	ENSG00000132854	"KN motif and ankyrin repeat domains 4"	Q5T7N3	1	62236979-62319414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4"	"Cell type enhanced"	"Detected in some"	18	"Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014030	Uncertain		Uncertain	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA014030: AB_2128155"	"unprognostic (1.66e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.74e-6)"	10.6	0.7	0.9	1.0	3.1	0.1	3.1	0.5	2.2	0.6	1.2	8.9	1.0	0.4	0.3	1.0	0.4	0.7	0.6	0.6	1.9	2.7	1.7	3.6	2.9	0.1	11.1	0.1	0.4	18.4	20.4	0.4	14.4	23.2	1.8	1.2	2.6	10.4	0.8	0.5	0.8	0.6	0.2	13.4	0.8	2.4	1.0	4.9	0.1	0.7	0.8	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	23.5	0.1	0.0	0.1	0.0	3.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.7	0.4	0.0	21.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	3.1	0.5	2.2	1.9	2.7	11.1	0.1	23.2	4.9	0.0	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.2	0.0	0.0	0.0	7.3	14.9	0.8	0.0	0.0	0.5	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.3	0.0	3.5	0.2	0.3	0.0	1.7	0.0	0.1	0.0	4.6	0.0	0.6	0.0
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909893-4918256	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.1"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 10.8;Ciliated cells: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"LHCN-M2: 2.4;NTERA-2: 2.1;SCLC-21H: 3.9;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved					NA	NA					"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.8	0.7	1.5	0.7	13.7	0.7	1.3	23.8	21.1	1.6	0.9	0.9	0.0	0.9	1.0	0.7	0.7	0.7	0.9	0.7	4.6	1.1	0.7	0.7	0.8	0.7	2.2	3.5	0.7	0.7	4.0	0.6	0.7	24.1	0.7	0.9	0.0	1.9	0.8	0.7	0.8	0.8	1.1	1.1	0.7	1.0	0.7	1.4	0.2	2.0	0.0	0.7	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	13.7	23.8	21.1	4.6	1.1	2.2	3.5	24.1	1.4	0.0	0.0	0.0	0.0	0.3	10.8	1.4	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009741-30017023	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 16.5;brain: 39.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 9.6;Horizontal cells: 12.7;Muller glia cells: 6.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.6;WM-115: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA					"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			2.2	16.5	9.8	0.6	39.0	0.6	0.6	0.2	12.2	0.6	0.6	0.8	1.8	0.7	1.1	0.9	0.6	0.8	0.6	5.9	6.1	2.7	1.2	0.6	2.4	0.6	1.6	6.2	0.6	0.6	0.6	2.8	1.2	10.5	0.6	0.6	0.0	0.6	1.7	0.6	0.8	0.6	0.8	0.6	0.6	1.0	0.7	5.9	0.0	0.6	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	39.0	0.2	12.2	6.1	2.7	1.6	6.2	10.5	5.9	0.0	0.0	0.0	0.0	0.0	9.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNAB3	"AKR6A9, KCNA3B"	ENSG00000170049	"Potassium voltage-gated channel subfamily A regulatory beta subunit 3"	O43448	17	7921859-7929803	"Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 36.1;endometrium 1: 17.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 123.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"cerebellum: 36.1;cerebral cortex: 31.6"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 14.9;SH-SY5Y: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077993			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077993: AB_2686872"	"unprognostic (3.02e-2)"	"unprognostic (5.59e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.84e-4)"	"unprognostic (2.19e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.27e-4)"	"unprognostic (7.47e-3)"	"unprognostic (3.03e-6)"	"unprognostic (2.12e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.97e-2)"	"unprognostic (9.54e-3)"	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0.0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1.0	0.8	4.9	1.6	5.9	2.3	2.0	3.8	1.3	1.4	1.0	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0.0	3.3	1.0	1.0	0.1	1.7	0.5	0.2	0.0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	2.0	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.2	0.4	1.5	0.7	6.0	1.8	2.3	0.7	0.9	0.0	5.1	0.2	3.0	2.2	1.6	4.6	0.2	0.2	0.3	6.1	0.5	0.3	0.7	1.0	0.8	2.6	0.8	0.0	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.1	0.4	0.0	0.9	0.2	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	3.0	1.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.2	0.2	0.5	0.0	0.0	1.7	0.0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9	3.0	2.4	0.0	0.6	0.5	22.9	0.8	0.0	0.0	1.2	0.0	3.9	0.2	0.0	0.5	0.3	0.1	0.4	0.0	0.5	0.2	1.1	0.6	1.1	0.2	0.7	123.9	0.0	0.6	0.0	0.0	1.7	0.8	0.0	1.8	0.3	12.0	0.5	0.0	0.7	0.0	6.3	0.0	0.3	3.1	1.5	0.4	0.1	0.0	0.2	0.1
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 36.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.1	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	0.9	1.1	1.8	0.0	0.3	0.3	2.1	0.6	3.0	0.2	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.4	0.0	0.5	0.5	1.2	1.5	0.0	0.0	0.8	7.5	0.9	0.0	0.4	7.1	4.4	0.4	0.5	0.0	0.4	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	1.0	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0	0.0	0.0	0.0	0.0	0.0	36.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	7.5	0.0	0.0	8.4	0.3	0.0	0.0	1.0	0.0	1.5	0.2	0.0	0.0	0.1	7.4	0.0	0.4	5.4	4.5	0.0	0.0	0.0	0.0	0.0
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273668-120750331	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 41.1"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 2.9;Cholangiocytes: 5.1;Ductal cells: 2.5;Leydig cells: 3.4;Spermatocytes: 4.2;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.5;HSkMC: 4.1;NTERA-2: 3.2;RT4: 3.3;SCLC-21H: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA					"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	2.9	1.0	3.9	1.0	6.7	0.3	1.9	41.1	20.6	2.4	0.7	1.5	0.0	0.7	5.6	0.5	0.5	1.7	7.0	0.5	3.7	5.4	0.3	0.4	0.6	0.5	4.2	3.6	5.9	0.6	2.5	6.6	0.8	12.1	0.5	0.6	0.0	0.7	1.7	0.5	0.3	0.5	3.7	3.7	0.3	0.5	2.9	4.5	0.0	0.8	1.1	0.3	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	3.3	16.6	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.7	41.1	5.3	3.7	5.4	4.2	3.6	12.1	4.5	0.0	0.0	0.0	0.0	0.0	2.9	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.0	0.4	4.2	3.3	0.1	0.0	0.0	0.0	0.1
KCNE1	"ISK, JLNS2, LQT5, minK"	ENSG00000180509	"Potassium voltage-gated channel subfamily E regulatory subunit 1"	P15382	21	34446688-34512275	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 32.1;Cone photoreceptor cells: 23.6;Kupffer cells: 26.3;Macrophages: 15.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 10.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 6.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 3.0;CACO-2: 9.2;HBF TERT88: 2.3"															NA	NA						"unprognostic (8.24e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.30e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	9.3	0.4	0.7	1.3	0.9	1.6	4.8	0.1	0.5	1.8	3.2	2.7	0.0	0.4	0.8	4.0	0.7	17.6	0.4	9.2	1.3	0.8	3.4	4.3	12.0	10.6	1.7	0.0	2.9	0.2	1.0	1.3	3.5	10.6	1.0	0.4	0.5	0.8	0.3	0.2	0.4	0.6	0.7	0.5	7.3	0.5	4.8	0.3	0.2	0.7	0.1	0.3	1.6	14.8	0.0	0.5	6.8	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.5	1.1	3.0	1.0	9.2	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.1	0.1	1.3	6.8	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.0	0.0	1.5	0.0	0.0	0.4	0.7	0.9	0.1	0.5	1.3	0.8	1.7	0.0	10.6	0.3	3.0	2.6	0.0	0.6	0.7	1.4	3.1	0.0	32.1	1.2	0.0	23.6	0.0	0.0	0.6	3.1	1.8	0.0	0.0	0.3	0.3	0.6	0.3	0.0	3.4	3.7	0.0	0.0	1.8	26.3	1.8	0.3	15.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.8
KCNE2	"LQT6, MiRP1"	ENSG00000159197	"Potassium voltage-gated channel subfamily E regulatory subunit 2"	Q9Y6J6	21	34364024-34371389	"Disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"stomach 1: 66.8"	"Group enriched"	"Detected in some"	51	"Early spermatids: 28.5;Late spermatids: 11.6"	"Cancer enriched"	"Detected in some"	6	"stomach cancer: 2.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.2;SCLC-21H: 5.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 30.5"	"Not detected"	"Not detected"			"HPA029706, HPA051553"	Enhanced					NA	NA					"HPA029706: AB_2673159, HPA051553: AB_2681532"	"unprognostic (5.29e-4)"	"unprognostic (3.13e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.65e-5)"	"unprognostic (7.45e-2)"	"unprognostic (7.33e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.2	1.2	0.2	0.0	0.1	0.1	0.9	0.1	0.2	1.3	0.1	2.4	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.1	11.8	0.0	0.1	0.1	3.4	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	1.2	0.1	0.1	66.8	0.8	0.1	0.1	0.3	0.1	0.1	0.1	0.1	1.4	1.6	2.2	1.6	0.0	2.0	0.7	0.8	0.3	2.0	3.7	0.2	0.2	2.7	0.9	0.5	0.0	0.1	0.8	1.0	0.8	1.3	0.0	0.6	0.0	0.2	0.0	1.0	1.0	1.2	0.9	0.2	0.0	0.0	0.7	0.5	0.2	0.1	0.0	0.0	0.8	0.0	2.6	0.2	4.2	0.3	1.6	0.2	0.7	2.8	2.7	1.6	0.7	0.6	1.0	0.4	0.2	5.0	0.4	1.4	0.6	1.3	2.6	1.3	1.0	0.0	1.2	0.6	0.5	0.3	4.1	2.3	0.7	0.4	2.1	1.1	0.0	1.6	2.2	0.6	0.1	0.6	0.8	1.1	0.5	1.6	1.4	2.0	0.3	0.0	0.0	0.0	0.8	1.4	0.7	0.2	0.2	0.1	0.9	0.1	0.3	0.2	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0
KCNG3	Kv6.3	ENSG00000171126	"Potassium voltage-gated channel modifier subfamily G member 3"	Q8TAE7	2	42442017-42494097	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.4"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Intestinal endocrine cells: 1.7;Leydig cells: 1.7;Muller glia cells: 2.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"amygdala: 9.0;basal ganglia: 11.4;cerebral cortex: 7.1;hippocampal formation: 4.4;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.1;HMC-1: 17.7;NTERA-2: 11.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"amygdala: 3.9;basal ganglia: 4.7;cerebral cortex: 5.3;hippocampal formation: 6.6;midbrain: 3.0"	HPA041625			Approved	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA041625: "	"unprognostic (1.56e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.67e-3)"	"unprognostic (7.95e-2)"	"unprognostic (9.14e-3)"		"unprognostic (4.83e-3)"	"unprognostic (6.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.23e-1)"	0.4	5.2	9.0	2.5	11.4	0.3	0.5	0.2	7.1	0.8	2.3	0.1	1.6	0.4	1.6	0.7	0.4	0.5	0.7	0.3	4.4	0.9	1.2	0.3	1.2	0.4	1.2	3.6	0.9	2.9	0.3	1.8	0.3	0.5	1.2	1.3	0.6	0.3	1.7	0.3	0.6	0.5	0.6	0.3	0.4	0.3	3.3	1.1	4.9	0.3	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	5.1	0.0	0.0	0.0	2.7	0.0	0.5	0.9	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.9	0.0	11.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.6	0.7	1.1	1.7	0.5	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.4	0.2	7.1	4.4	0.9	1.2	3.6	0.5	1.1	3.0	0.6	0.0	0.2	1.1	1.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	2.1	0.2	0.0	2.5	0.0	0.0	0.0	0.4	0.2	1.0	1.0	0.1	0.0	0.0	0.1
KCNH4	"elk1, Kv12.3"	ENSG00000089558	"Potassium voltage-gated channel subfamily H member 4"	Q9UQ05	17	42156891-42181278	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;K-562: 6.0;RPMI-8226: 11.4;RT4: 4.3;U-266/70: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.07e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.36e-6)"	"unprognostic (9.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.72e-3)"	1.2	1.0	0.7	2.4	11.2	0.7	0.3	0.0	7.9	0.7	0.3	0.1	0.0	0.7	0.2	0.1	0.1	0.4	0.5	0.7	0.4	0.9	0.2	0.2	0.3	1.0	0.3	1.0	0.2	0.3	0.0	0.4	0.3	0.0	0.5	0.3	0.0	0.8	0.5	0.2	0.4	0.5	0.3	0.1	0.8	0.6	0.9	2.6	0.0	0.2	0.0	1.1	3.1	0.1	0.4	0.6	0.6	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	6.3	0.5	0.9	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	1.1	0.0	0.0	1.9	0.0	0.0	1.1	0.0	0.0	0.0	11.4	0.0	4.3	2.6	1.4	0.4	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.7	11.2	0.0	7.9	0.4	0.9	0.3	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium voltage-gated channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"kidney: 123.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 165.8"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.3"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	40	"RPTEC TERT1: 51.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA					"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.1	0.0	0.5	0.2	2.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	123.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	36.6	0.0	0.0	165.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3"	"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	3.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.5	0.0	6.3	0.0	1.0	1.6	0.0	0.0	7.3	0.4	3.7	0.0	1.5	8.0	0.0	0.0	2.8	0.0	0.5	6.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9	0.0	0.0	0.0	0.0	1.3	0.8	12.5	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.4	1.4	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.2	84.2	1.2	5.5	0.0	0.2	6.9	0.0	0.0	0.0	0.4	11.2	0.0	0.0	3.9	0.6	1.4	0.0	0.5	0.5	1.3	1.9	0.1	0.0	0.6	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Group enriched"	"Detected in some"	14	"Melanocytes: 20.3;Muller glia cells: 44.0"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.5	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.0	3.1	0.2	0.3	0.0	0.1	0.0	4.6	0.3	1.3	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.4	0.0	1.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	44.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium voltage-gated channel subfamily J member 3"	P48549	2	154698299-154858352	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;parathyroid gland: 22.1"	"Cell type enhanced"	"Detected in many"	21	"Cardiomyocytes: 43.7;Horizontal cells: 117.6;Intestinal endocrine cells: 29.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 5.4;SCLC-21H: 1.7;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in all"							HPA024231	Uncertain					NA	NA					"HPA024231: AB_1855558"	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.3	1.0	4.5	0.0	3.4	0.0	0.2	33.8	13.6	1.3	1.5	1.4	0.3	7.9	0.2	0.9	0.1	0.4	0.9	10.8	8.4	4.0	8.0	2.3	0.2	0.4	1.8	4.9	0.2	1.5	22.1	9.0	0.0	3.0	5.1	0.6	1.0	0.1	9.2	3.5	0.2	6.7	0.1	1.5	0.4	0.5	0.2	0.9	0.0	0.2	0.0	0.0	0.5	0.6	1.2	0.9	3.3	1.1	1.8	1.0	0.4	0.2	0.3	0.0	0.1	0.2	0.1	0.4	5.4	0.2	0.0	0.2	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	0.7	0.5	0.1	0.5	0.1	0.0	0.4	0.2	0.4	1.7	3.3	0.1	0.6	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.4	0.3	0.3	0.2	0.1	1.2	0.2	0.5	3.3	0.7	0.9	0.7	0.8	0.9	1.0	0.9	0.6	0.6	1.2	1.0	0.9	1.9	1.8	1.1	0.9	0.7	0.4	4.5	3.4	33.8	12.0	8.4	4.0	1.8	4.9	3.0	0.9	0.0	0.0	0.0	4.4	0.7	4.8	43.7	5.1	0.0	0.0	19.2	13.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	5.1	0.0	0.9	0.1	117.6	29.9	0.0	0.0	0.0	5.8	0.4	1.7	0.0	0.1	0.7	0.0	0.0	3.9	6.8	3.6	0.0	2.1	0.5	0.1	1.6	0.0	0.0	0.2	4.7
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614004-233672512	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 75.3"	"Cell type enriched"	"Detected in single"	98	"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in single"	98	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 236.2"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	1.9	3.3	15.2	2.2	12.7	0.3	4.5	75.3	22.8	5.5	11.5	7.9	5.1	12.5	4.5	22.9	12.0	8.4	9.3	20.8	10.3	5.2	7.2	10.8	3.4	0.8	8.9	11.1	3.8	4.4	2.5	11.3	5.0	22.3	4.6	10.6	2.6	7.2	9.3	0.5	8.7	9.6	3.2	12.3	0.8	28.0	0.7	7.8	0.0	5.6	1.6	3.2	4.3	6.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	10.3	5.6	0.0	0.0	0.0	0.0	15.8	2.8	0.0	0.0	0.0	0.0	17.0	0.0	6.7	2.0	2.3	15.0	2.8	4.9	0.0	0.0	4.9	0.0	21.0	0.0	0.1	0.0	0.5	1.2	5.3	0.0	3.9	0.3	0.0	5.7	2.4	4.5	0.0	3.8	3.7	0.0	3.4	12.1	12.8	0.0	0.8	1.1	4.9	8.6	19.8	3.9	10.3	4.5	0.0	0.3	1.3	0.0	0.0	0.0	8.4	0.0	0.3	45.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	15.2	12.7	75.3	17.1	10.3	5.2	8.9	11.1	22.3	7.8	8.9	15.6	0.0	117.0	56.2	1.2	37.7	5.1	28.1	33.0	17.4	3.9	0.2	1.7	19.6	0.9	0.7	34.8	0.0	42.5	13.5	15.3	169.9	0.0	8.2	0.6	189.1	28.2	0.0	0.8	0.0	1.4	0.8	10.1	0.0	45.4	65.8	61.4	22.8	0.0	11.3	5.0	0.0	3.4	0.4	0.7	41.7	0.7	1.5	21.1	247.4
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745780-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.2"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"MCF7: 32.2"	"Region enriched"	"Detected in single"	18	"olfactory region: 8.4"	"Region enriched"	"Detected in many"	8	"olfactory region: 9.3"	HPA064861	Uncertain					NA	NA					"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	6.0	4.5	0.4	1.3	3.4	0.5	5.9	0.0	1.2	6.2	2.3	0.0	24.2	1.1	4.3	10.6	3.2	15.1	10.7	3.8	0.6	0.4	3.5	7.0	3.0	2.2	0.6	0.0	12.6	7.4	0.6	4.2	1.1	1.1	2.7	0.8	2.1	3.4	9.6	2.6	2.0	0.9	3.8	0.3	0.6	4.1	10.6	0.0	0.0	6.5	0.5	0.9	2.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.3	0.0	0.9	0.4	3.1	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	0.0	1.2	0.6	0.4	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.6	5.1	0.0	0.0	8.7	0.0	0.0	0.0	3.2	0.2	0.7	0.0	0.0	6.4	0.0	1.3	2.3	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.6	0.0	0.0	0.8	7.0
KCNK3	"K2p3.1, TASK, TASK-1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692690-26733420	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 69.2"	"Cell type enhanced"	"Detected in many"	17	"Collecting duct cells: 97.7;Exocrine glandular cells: 82.2;Pancreatic endocrine cells: 31.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.0;cerebellum: 4.7;cerebral cortex: 6.2;hypothalamus: 4.0;pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.7;EFO-21: 10.0;HeLa: 3.4;SCLC-21H: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (3.09e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.24e-3)"	2.4	69.2	1.3	1.9	4.0	0.6	8.3	4.7	6.2	3.5	4.0	0.8	5.7	1.3	2.4	5.6	1.9	2.0	2.3	10.3	1.0	4.0	1.8	0.7	10.0	0.6	1.5	1.5	4.6	24.7	0.7	3.6	16.6	13.4	8.2	1.1	1.9	0.6	7.7	0.6	0.6	2.6	4.7	1.1	0.9	2.2	0.9	0.0	0.0	2.1	0.0	0.5	3.2	2.3	0.7	0.5	2.5	0.4	1.2	0.4	0.0	0.0	0.6	0.2	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	10.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.3	0.0	23.5	2.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.3	0.2	0.7	0.4	0.4	2.5	1.2	0.2	0.5	0.2	0.0	1.3	4.0	4.7	6.2	1.0	4.0	1.5	1.5	13.4	0.0	0.0	3.2	0.0	0.2	0.0	11.5	10.0	0.0	0.0	0.0	97.7	0.0	0.2	0.0	0.8	0.4	1.0	0.0	0.0	82.2	0.2	1.9	1.6	0.0	0.0	0.3	1.6	22.5	0.6	0.0	1.3	0.9	0.0	0.0	1.0	0.4	1.2	31.4	0.0	0.0	0.0	3.9	6.5	3.1	0.0	1.3	0.1	0.5	0.0	0.0	0.3
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139703056	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 9.4;brain: 15.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075842			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.2	9.4	0.5	0.5	1.0	0.1	0.1	15.4	7.7	1.3	0.5	0.0	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.2	1.6	1.4	0.1	0.1	0.1	0.1	0.7	1.7	0.1	0.1	0.1	1.1	0.2	6.6	0.1	0.2	0.2	0.1	0.1	1.4	0.1	0.1	0.6	0.6	0.1	0.3	0.5	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	2.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	15.4	3.7	1.6	1.4	0.7	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.2	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45092310-45101112	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 27.0"	"Cell type enriched"	"Detected in some"	6	"Cholangiocytes: 10.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 27.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.3	0.8	1.4	0.2	4.6	0.4	0.7	0.4	27.0	0.6	0.3	0.0	5.9	0.2	0.2	0.2	0.4	0.3	5.2	0.4	2.1	1.1	0.5	0.3	0.7	0.3	1.0	7.2	0.2	0.3	0.1	0.4	0.3	0.0	0.9	0.2	0.0	3.4	7.0	0.2	2.6	0.3	0.2	0.4	0.3	0.3	2.0	0.0	0.0	0.3	0.0	0.5	0.4	0.6	0.6	0.2	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.5	0.0	0.3	0.3	1.0	0.9	0.1	0.4	1.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.9	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.3	1.8	0.0	2.1	0.5	0.0	4.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.4	27.0	2.1	1.1	1.0	7.2	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.9	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.1
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98427022-98432848	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 20.9"	"Cell type enhanced"	"Detected in single"	20	"Leydig cells: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 4.0;SCLC-21H: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain					NA	NA					"HPA051417: AB_2681478"	"unprognostic (7.83e-2)"	"unprognostic (9.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-5)"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	1.6	1.4	2.9	0.6	6.6	0.3	0.7	0.7	20.9	2.0	1.0	0.1	0.5	0.4	1.3	1.7	0.9	1.0	1.5	0.4	1.9	2.8	0.7	0.3	0.7	0.4	0.8	6.4	1.9	0.8	0.8	1.2	4.4	3.4	0.9	0.9	0.1	0.3	3.3	0.2	0.3	0.7	0.6	0.9	0.3	1.5	1.0	0.4	0.0	0.5	0.0	0.3	2.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.3	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.6	0.7	20.9	1.9	2.8	0.8	6.4	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4"									"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.1	0.3	0.3	0.8	0.5	2.1	1.1	1.0	2.1	5.1	8.0	5.2	0.0	5.7	0.6	0.2	0.6	0.3	15.4	5.4	0.2	7.8	0.0	1.8	16.8	3.1	0.1	0.1	2.4	0.4	8.4	6.6	1.5	0.5	0.1	0.1	0.0	0.8	0.1	0.2	0.4	3.9	0.2	0.3	0.2	0.0	0.0	27.3	2.0	1.4	0.1	0.0	0.1	2.5	0.5	0.8	0.6	0.4	0.1	12.4	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8	3.0	9.6	0.0	9.5	0.3	0.0	0.0	2.5	0.0	5.7	5.2	0.0	0.6	3.3	2.0	0.1	0.0	2.5	0.0	14.8	1.2	0.8	10.5	1.1	4.0	0.2	0.0	4.6	0.0	0.0	0.0	3.1	0.0	1.7	0.0	15.2	1.7	12.8	7.0	4.9	11.3	0.0	0.0	1.9	0.2	0.2	0.1	0.6	0.0	8.5	5.8
KCTD16	KIAA1317	ENSG00000183775	"Potassium channel tetramerization domain containing 16"	Q68DU8	5	144170832-144485686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 25.1"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 12.9;Early spermatids: 7.6;Horizontal cells: 19.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Group enriched"	"Detected in many"	5	"amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 7.1;TIME: 13.4;U-87 MG: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044590, HPA050154"	Approved		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA044590: AB_2679008, HPA050154: AB_2681034"	"unprognostic (7.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.81e-5)"	"unprognostic (9.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (2.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.80e-3)"	"unprognostic (1.22e-2)"	1.0	2.0	11.4	0.7	14.5	0.6	0.9	0.7	25.1	1.5	0.8	0.4	0.0	1.0	0.9	1.5	0.8	1.2	1.4	0.9	14.5	3.2	2.9	0.8	2.4	0.7	1.7	12.0	1.0	5.2	0.8	1.7	0.9	1.3	0.8	0.7	0.0	0.7	1.1	0.6	0.7	1.2	0.9	1.6	0.7	0.8	4.4	2.4	0.0	2.2	0.0	0.7	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.1	0.7	0.0	1.9	1.6	0.6	0.8	0.4	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.3	0.9	0.2	0.1	0.0	0.5	0.1	0.2	0.1	0.0	0.4	0.1	1.2	0.1	1.5	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	7.1	0.3	0.1	0.0	0.1	0.3	0.0	0.0	13.4	1.1	0.7	0.2	0.0	0.2	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.5	0.7	25.1	14.5	3.2	1.7	12.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	12.9	0.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.7	7.6	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.0	0.7	2.4	0.0	0.8	3.8	1.9	0.0	0.0	0.0	0.0	0.0
KHDC1L	RP11-257K9.7	ENSG00000256980	"KH domain containing 1 like"	Q5JSQ8	6	73223544-73225770	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 8.9;lymphoid tissue: 4.1;testis: 7.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 32.2;Late spermatids: 64.6"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 33.6"	"Region enriched"	"Detected in some"	5	"basal ganglia: 8.9"	"Cell type enriched"	"Detected in single"	13	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"BEWO: 33.8"															NA	NA						"unprognostic (1.18e-1)"	"unprognostic (6.11e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-2)"		"unprognostic (9.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.01e-2)"		"unprognostic (1.31e-2)"	"unprognostic (4.13e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.17e-3)"	0.3	0.2	1.1	0.3	8.9	0.5	0.3	1.6	1.4	0.3	0.3	0.3	0.3	0.2	0.5	0.3	0.3	0.0	0.3	0.3	0.5	0.4	0.3	0.3	2.1	0.3	0.7	0.3	0.4	0.3	0.0	1.4	2.0	0.3	0.4	0.0	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	7.7	0.3	4.1	0.3	0.3	1.5	0.3	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.3	0.0	0.0	33.8	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	8.9	1.6	0.7	0.5	0.4	0.7	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	32.2	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.3	0.0	0.0	1.0	0.0	0.2	0.2	0.0	0.7	0.0	0.5	0.0	0.0	2.2	5.7	0.0	0.1	0.0	0.0	0.0
KIAA1024		ENSG00000169330	KIAA1024	Q9UPX6	15	79432516-79472290	"Predicted membrane proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 16.8;brain: 10.8"	"Group enriched"	"Detected in some"	12	"Horizontal cells: 15.9;Muller glia cells: 22.6"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"cerebellum: 10.8;pons and medulla: 8.5"	"Group enriched"	"Detected in some"	12	"eosinophil: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	12	"granulocytes: 2.5;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011545	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA011545: AB_1852361"	"unprognostic (5.45e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.82e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.66e-13)"	"unprognostic (7.08e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	0.1	16.8	0.8	0.2	0.6	0.7	0.5	10.8	2.0	0.6	0.2	0.4	0.1	0.0	0.4	0.5	0.5	0.1	0.6	0.1	0.5	1.4	0.2	0.1	0.1	0.6	1.2	1.5	0.2	3.5	0.0	0.7	0.5	8.5	1.2	0.3	0.7	4.2	0.2	0.6	0.2	0.2	0.2	1.7	0.3	0.2	1.1	1.0	0.1	0.2	0.1	0.4	0.2	0.1	0.1	0.1	2.5	1.9	0.0	0.1	0.0	0.4	0.3	0.6	0.8	1.8	1.7	0.7	0.9	1.5	0.7	0.8	0.0	0.4	1.1	0.2	1.3	1.0	0.3	1.5	0.1	0.5	1.3	1.7	3.0	0.7	0.0	1.0	4.1	1.5	0.7	0.3	1.2	0.2	1.5	0.8	1.4	0.2	0.0	0.3	0.0	0.6	1.5	0.7	0.7	0.7	0.6	0.2	0.6	0.2	0.0	3.1	1.6	0.3	2.7	1.6	1.3	0.4	2.0	0.5	14.5	0.5	0.0	3.0	1.8	2.1	0.5	1.4	2.3	1.7	0.0	0.0	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.8	0.6	10.8	2.0	0.5	1.4	1.2	1.5	8.5	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.3	1.5	0.0	0.0	0.0	0.4	0.1	0.3	0.3	0.0	0.0	0.1	15.9	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	22.6	0.3	0.6	0.0	0.0	0.5	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1
KIAA1211L	"C2orf55, MGC42367"	ENSG00000196872	"KIAA1211 like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;epididymis: 27.7"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 22.3;HDLM-2: 32.0;Karpas-707: 9.4;MCF7: 8.5;SiHa: 9.1;SK-BR-3: 12.2"					"Group enriched"	"Detected in many"	15	"amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"		Yes	No			"Microtubules, Centrosome"	"Cytokinetic bridge"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (2.22e-2)"	2.7	0.8	19.0	1.3	23.7	0.5	3.5	2.4	27.4	4.6	5.0	0.8	3.5	6.7	1.5	27.7	9.1	19.3	2.5	1.4	12.9	1.9	2.5	0.4	3.9	0.6	2.7	18.3	1.4	3.7	9.6	4.3	4.0	0.1	1.6	4.0	0.0	9.0	4.3	1.3	4.3	6.1	2.1	1.2	1.0	6.8	3.6	3.6	0.0	4.3	3.3	2.5	2.4	3.2	0.0	0.7	1.4	0.3	0.2	0.9	0.0	4.3	0.2	0.1	1.7	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.2	2.6	0.0	5.7	0.0	0.1	3.9	0.1	0.2	0.0	32.0	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.6	0.0	1.3	0.0	0.0	9.4	0.0	8.5	0.1	0.6	0.0	4.3	0.4	0.0	0.0	0.4	1.7	3.4	3.2	0.5	9.1	12.2	0.0	0.0	4.7	0.7	5.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.7	0.0	0.0	19.0	23.7	2.4	27.4	12.9	1.9	2.7	18.3	0.1	3.6	14.9	2.9	0.0	3.1	0.6	0.0	4.2	5.1	95.0	23.9	3.5	0.0	0.3	3.3	3.7	11.8	9.0	10.0	0.0	6.5	1.1	0.2	1.7	0.0	0.0	2.6	0.0	15.1	6.7	1.5	17.2	0.3	0.9	0.0	0.0	11.4	0.0	4.8	8.6	0.4	2.2	0.0	0.0	0.4	15.9	12.6	5.3	0.3	0.0	8.8	5.1
KIAA1614		ENSG00000135835	KIAA1614	Q5VZ46	1	180913154-180951614	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 58.8;retina: 23.8"	"Group enriched"	"Detected in many"	17	"Bipolar cells: 91.9;Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 171.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.8"	"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 12.3;SH-SY5Y: 31.1"					"Low region specificity"	"Detected in all"			"HPA028227, HPA061684"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"HPA028227: AB_10601765, HPA061684: AB_2684585"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.61e-5)"	"unprognostic (8.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.35e-2)"	4.6	1.5	2.4	1.4	2.6	0.1	2.2	58.8	11.3	4.5	4.6	1.8	0.8	3.0	5.2	1.6	4.6	3.5	3.1	7.5	2.7	1.4	3.0	0.4	3.2	1.1	1.5	3.8	6.3	2.1	0.0	1.3	3.6	3.3	3.5	0.5	23.8	4.6	2.8	2.1	3.0	2.5	4.1	1.4	2.6	2.2	1.2	2.5	0.4	7.6	0.9	0.4	4.3	5.1	0.5	0.5	4.4	0.5	0.5	0.6	0.3	1.1	0.5	0.9	2.1	3.0	7.5	3.3	2.2	2.6	1.1	0.6	1.0	1.2	0.5	2.1	2.7	0.5	2.2	0.2	0.0	0.3	0.6	0.9	1.6	0.4	1.4	4.1	1.0	1.2	3.5	0.1	0.1	0.0	1.8	1.5	1.7	1.3	0.8	1.0	0.9	1.3	0.4	2.3	0.3	0.3	0.7	12.3	1.6	1.8	1.0	8.5	31.1	0.7	0.8	4.9	1.0	0.9	1.4	3.5	2.4	1.8	2.8	0.9	1.6	2.0	1.0	0.3	0.8	1.6	4.4	0.5	1.2	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.4	0.6	0.4	0.7	0.5	0.1	0.5	0.2	0.3	2.4	2.6	58.8	11.3	2.7	1.4	1.5	3.8	3.3	2.5	0.0	2.6	0.0	0.8	0.3	91.9	2.8	0.0	0.0	2.3	1.8	123.7	0.2	1.7	0.2	3.4	1.7	0.0	0.0	0.2	0.4	2.8	0.3	1.1	0.0	1.4	3.2	0.0	2.5	0.0	1.3	7.2	0.0	3.3	1.8	0.0	7.6	1.0	0.0	5.3	1.3	171.7	6.5	1.4	0.7	0.2	0.3	0.2	0.0	0.0	0.0
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.8	1.5	0.9	0.4	1.0	0.0	1.2	2.0	0.7	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.4	1.0	0.0	0.1	0.6	0.0	1.8	0.1	0.0	0.0	2.5	0.1	1.8	0.0	0.1	0.0	0.6	0.0	0.7	1.5	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.6	5.1	0.5	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	2.7	0.0	1.8	3.9	0.1	0.0	0.0	35.8	12.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	4.0	0.0	0.0	16.5	1.5	60.3	1.1	3.3	1.7	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	19.4	1.4	1.5	4.2	1.1	1.4	0.0	0.0	0.1
KISS1		ENSG00000170498	"KiSS-1 metastasis suppressor"	Q15726	1	204190341-204196486	"Cancer-related genes, Disease related genes, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"placenta: 267.2"	"Cell type enriched"	"Detected in many"	41	"Syncytiotrophoblasts: 1117.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.2"	"Group enriched"	"Detected in some"	8	"basal ganglia: 11.3;hypothalamus: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"BJ: 55.9;U-2 OS: 22.8"					"Low region specificity"	"Detected in all"			"CAB017775, HPA035542"	Enhanced		Approved	Vesicles	"Secreted in female reproductive system"	NA	NA			Vesicles		"CAB017775: , HPA035542: AB_2674677"	"unprognostic (9.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"		"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.98e-12)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.29e-6)"	0.2	0.0	0.2	0.2	11.3	0.0	0.2	1.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	55.9	0.7	1.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	22.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.3	1.0	0.2	0.2	4.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	3.3	27.0	0.3	5.1	0.0	4.0	4.1	0.4	1.8	0.0	2.9	14.5	0.0	0.0	1.3	0.0	3.1	0.3	0.0	0.0	0.0	0.6	0.0	2.9	0.8	0.0	1.2	0.0	0.0	0.1	0.1	0.4	0.0	1117.8	0.0	1.9	2.2
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 99.7"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HMC-1: 5.1;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.8	0.0	1.4	1.2	12.2	0.0	0.1	5.0	0.0	1.7	1.8	0.9	0.0	0.0	0.1	0.7	4.4	0.0	0.0	2.1	0.0	15.6	0.0	0.8	0.0	0.3	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	99.7	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.6	0.1
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in some"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.3	7.4	0.0	0.1	0.2	0.4	8.5	3.1	7.3	1.4	1.7	6.9	27.5	0.1	16.7	2.7	0.5	31.5	9.6	27.5	2.2	0.2	2.5	0.1	15.7	0.6	2.0	2.5	0.4	2.0	39.3	0.4	15.4	1.4	0.0	0.9	0.3	0.5	6.3	1.8	0.5	0.1	0.3	59.4	10.6	0.4	7.0	0.6	21.8	33.2	0.7	0.3	28.0	4.5	1.9	3.6	0.6	0.6	0.0	1.9	5.7	0.0	1.3	0.9	0.4	0.9	2.7	0.5	2.3	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4	151.8	97.6	0.5	1017.1	460.9	0.4	5.6	79.0	128.5	151.2	34.9	2.0	57.7	18.3	30.8	305.6	1.1	308.2	0.0	40.2	87.3	46.1	522.9	3.5	2.9	5.4	9.5	195.2	0.6	0.0	162.5	6.1	6.1	55.6	5.4	327.8	0.0	63.9	284.0	1.4	2.6	0.0	0.0	28.8	7.2	25.9	599.6	48.5	0.7	397.9	1225.4
KLHDC7A	FLJ38753	ENSG00000179023	"Kelch domain containing 7A"	Q5VTJ3	1	18480982-18486126	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 36.4"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 7.6;Ciliated cells: 6.7;Collecting duct cells: 8.7;Hepatocytes: 5.7;Proximal tubular cells: 8.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.3;CAPAN-2: 10.4;EFO-21: 5.4;NTERA-2: 5.8;RPTEC TERT1: 11.9;RT4: 9.4;T-47d: 10.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA056616	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA056616: AB_2683193"	"unprognostic (4.63e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.81e-9)"	"unprognostic (4.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.88e-4)"	0.6	0.0	0.0	0.3	0.2	0.0	5.0	0.5	0.5	2.5	0.6	0.7	2.6	0.3	0.0	2.6	1.8	0.8	7.4	0.3	0.0	0.0	36.4	6.9	1.4	0.0	0.1	0.6	0.2	5.7	0.0	0.3	0.3	2.9	0.5	0.7	2.8	2.2	1.2	0.0	0.1	0.4	1.0	0.1	0.0	4.8	0.2	0.0	0.0	1.6	0.3	0.8	5.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	5.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.1	10.4	0.0	5.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.1	0.0	0.2	0.0	0.0	11.9	9.4	2.9	0.0	0.0	0.8	0.0	1.1	10.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.6	2.9	0.0	0.0	2.7	0.0	0.1	0.1	0.0	1.2	7.6	6.7	1.2	8.7	0.0	0.0	1.7	2.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.9	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736090	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 64.2"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 27.8;Early spermatids: 44.2;Late spermatids: 47.8;Muller glia cells: 46.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 6.3;RT4: 6.7;TIME: 14.8;U-266/70: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051291	Approved					NA	NA					"HPA051291: AB_2681423"	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.1	5.8	9.1	3.2	11.9	1.2	2.7	64.2	12.0	5.3	2.1	0.8	1.7	2.6	5.0	2.7	2.2	5.1	5.8	14.7	6.2	4.2	10.2	1.8	2.8	5.2	4.7	9.3	9.0	2.2	1.3	5.9	3.3	5.0	2.3	2.4	10.4	1.6	2.2	2.2	3.1	1.9	3.6	4.2	3.5	5.1	5.5	1.7	3.7	12.1	1.3	4.0	3.0	3.4	0.1	1.2	1.6	0.0	2.2	3.2	0.6	0.4	0.3	1.5	0.0	0.9	1.2	1.0	0.3	0.4	0.2	0.2	0.5	5.8	1.4	3.2	0.0	0.0	0.2	0.3	2.7	0.2	1.5	0.7	0.6	1.0	0.0	0.3	0.0	1.2	1.1	0.2	0.7	0.0	2.5	6.3	4.1	0.3	1.3	0.2	0.0	3.1	0.9	2.7	0.0	0.9	2.5	0.0	0.0	1.1	6.7	1.9	1.0	0.4	0.0	0.5	4.5	0.0	0.6	14.8	0.4	0.4	0.0	0.4	8.9	5.0	0.0	5.7	0.1	0.7	0.0	0.0	1.6	0.7	0.0	0.8	0.0	3.0	1.1	0.1	0.1	3.2	1.8	0.0	2.2	0.0	1.2	1.3	0.6	9.1	11.9	64.2	12.0	6.2	4.2	4.7	9.3	5.0	1.7	0.0	2.1	0.8	1.4	1.0	14.7	27.8	2.5	1.4	1.2	7.0	21.6	0.6	1.7	0.6	44.2	10.9	0.4	0.0	0.8	0.1	1.6	0.7	1.1	2.5	0.5	4.8	15.0	20.9	2.6	47.8	2.3	0.3	1.7	0.0	1.1	46.3	1.0	0.0	1.8	0.1	6.4	0.0	1.9	8.8	7.5	0.6	0.1	4.1	1.6	0.7
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 141.1;Glandular cells: 237.5;Late spermatids: 257.5;Suprabasal keratinocytes: 189.7;Urothelial cells: 143.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HaCaT: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	9.6	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2	80.4	7.2	0.0	141.1	94.9	0.0	0.4	63.7	26.8	108.1	0.0	0.0	0.0	0.0	2.9	105.3	2.2	0.0	0.0	118.6	0.0	8.9	237.5	1.1	0.0	0.3	0.0	19.4	0.0	0.0	257.5	2.6	2.6	8.5	0.0	2.8	0.0	49.0	0.0	0.4	0.0	1.4	0.0	0.3	2.1	2.5	189.7	0.0	0.0	0.3	143.9
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	115	"prostate: 447.4"	"Cell type enriched"	"Detected in some"	62	"Glandular cells: 3142.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	138	"BEWO: 22.4;NB-4: 18.9;RPMI-8226: 12.5;SH-SY5Y: 7.4;U-2197: 7.6"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA					"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		0.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	447.4	0.0	0.1	3.8	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3142.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 268.7"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 6515.6;Exocrine glandular cells: 4232.0;Extravillous trophoblasts: 4401.0;Pancreatic endocrine cells: 4358.9;Syncytiotrophoblasts: 6392.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 10.0"	"Cell type enriched"	"Detected in many"	5	"basophil: 28.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.6"	"Cell line enhanced"	"Detected in many"		"A549: 228.6;BEWO: 144.3;CACO-2: 251.4;CAPAN-2: 182.6;MCF7: 334.7;SK-BR-3: 185.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol		NA	NA		140000000	Cytosol		"CAB000008: , CAB000030: , HPA001605: AB_2666381"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	23.3	4.8	1.0	31.0	1.1	0.0	24.1	2.9	1.2	28.6	45.4	1.3	66.3	35.0	6.6	55.3	22.4	21.7	147.4	6.8	1.1	2.5	61.9	181.0	39.6	2.8	1.2	1.0	13.7	162.9	8.2	39.8	268.7	10.0	29.3	57.0	14.1	121.1	49.9	1.3	6.5	83.6	3.9	1.4	4.4	36.0	9.5	0.8	4.2	83.4	10.8	20.9	21.5	10.8	4.1	1.0	28.6	0.1	1.0	5.9	1.6	76.6	228.6	0.0	0.3	0.0	0.0	144.3	11.6	14.2	15.1	4.3	251.4	182.6	0.0	32.5	12.6	7.9	18.8	3.2	88.6	9.1	0.0	5.4	0.7	37.4	69.1	39.1	0.0	0.0	0.5	8.3	13.2	18.2	43.2	16.1	0.1	18.5	0.0	0.0	334.7	0.1	1.4	18.6	107.6	17.3	0.1	0.0	8.7	73.6	46.3	2.6	0.1	18.9	185.1	0.7	116.4	97.7	0.2	5.1	0.2	17.6	0.2	2.6	0.0	0.2	0.1	0.0	0.0	1.4	28.6	0.1	1.1	0.2	0.1	1.1	2.1	2.3	0.6	1.0	4.1	5.9	2.1	1.5	1.0	0.0	0.0	0.2	1.6	1.0	1.1	2.9	1.2	1.1	2.5	1.2	1.0	10.0	0.8	801.0	239.7	47.5	1382.6	13.2	0.0	4.9	1332.4	459.0	466.3	591.5	0.0	2872.9	233.8	6515.6	0.9	56.4	1517.2	0.0	4232.0	4401.0	68.2	910.9	48.4	492.5	270.7	1.6	616.3	87.8	9.9	2.3	9.8	37.0	197.4	71.3	2268.9	5.8	4358.9	1644.8	0.0	407.9	0.5	0.0	45.3	1.6	5.9	5.8	6392.2	10.7	1202.1	1262.3
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755332	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 44.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 8.0;Late spermatids: 6.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 5.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 9.7"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 8.3;hippocampal formation: 6.1"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			1.6	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782534	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 37.4"	"Cell type enhanced"	"Detected in some"	24	"Ito cells: 1.8;Melanocytes: 8.5;Muller glia cells: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 5.7;SK-BR-3: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 104.2"	HPA055114	Enhanced					NA	NA					"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	1.1	0.0	0.1	0.1	1.2	0.0	4.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	37.4	0.2	0.1	0.1	0.1	0.0	1.0	0.1	2.8	0.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.3	0.0	8.5	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.4	0.4	0.2	0.0	0.0	0.0
KRT31	"Ha-1, KRTHA1"	ENSG00000094796	"Keratin 31"	Q15323	17	41393724-41397592	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.2;skin 1: 72.1"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 34.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	22	"cerebellum: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 1.7"									"HPA049550, HPA055194"	Enhanced					NA	NA		560000000			"HPA049550: AB_2680813, HPA055194: AB_2682733"	"unprognostic (3.92e-2)"	"unprognostic (3.50e-1)"		"unprognostic (3.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.71e-2)"		"unprognostic (4.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.84e-1)"			"unprognostic (4.07e-1)"			"unprognostic (4.26e-2)"	"unprognostic (1.65e-1)"	1.5	0.0	0.0	0.0	0.2	0.0	1.0	21.2	1.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.5	0.0	5.5	72.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.2	0.9	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.2	34.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell type enhanced"	"Detected in some"	30	"Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		6500000000	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	120.8	0.0	216.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	494.5	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1	0.0	0.6	0.0	909.3	5214.3	0.0	0.6	0.0	30.8	153.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	28.8	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	271.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	66.8	0.0	0.0	1765.9	0.0	0.0	0.0	372.4
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 102.9"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 5778.2;Enterocytes: 4471.9;Exocrine glandular cells: 4777.1;Extravillous trophoblasts: 4560.4;Pancreatic endocrine cells: 3911.0;Syncytiotrophoblasts: 4406.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 13.7"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A549: 228.5;BEWO: 153.1;CACO-2: 284.3;CAPAN-2: 179.6;MCF7: 383.7;SK-BR-3: 195.0;T-47d: 164.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		NA	NA		920000000	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	13.4	4.8	2.0	11.0	1.5	0.0	13.9	2.7	1.3	15.1	90.2	2.1	29.8	87.2	11.1	18.3	19.3	10.4	20.3	17.6	1.1	0.2	28.8	55.8	20.1	18.4	1.4	1.2	10.6	75.9	4.0	31.8	28.9	13.7	25.2	45.0	12.1	36.9	46.0	3.7	5.0	102.9	5.2	3.3	14.3	61.8	5.1	1.2	2.9	27.6	9.2	11.6	27.1	10.5	0.7	4.9	3.2	0.7	1.6	0.6	0.5	101.4	228.5	0.0	0.3	0.0	0.1	153.1	0.4	1.8	0.2	0.2	284.3	179.6	0.0	43.4	0.5	0.2	35.5	0.6	28.1	0.2	0.1	4.9	0.1	47.6	81.3	8.3	0.0	0.0	0.3	0.4	0.5	1.9	16.2	0.6	0.0	17.4	0.0	0.0	383.7	0.2	0.3	15.9	100.9	5.0	0.1	0.0	0.5	45.2	50.4	4.9	0.1	39.7	195.0	0.3	50.7	164.0	0.3	0.7	0.2	17.2	0.3	0.3	0.0	0.2	0.2	0.1	0.0	0.5	3.2	0.5	0.6	0.6	0.7	0.4	0.3	0.4	0.3	2.1	0.7	0.4	0.5	1.4	1.6	0.3	4.9	0.5	0.5	2.0	1.5	2.7	1.3	1.1	0.2	1.4	1.2	13.7	1.2	372.2	157.7	26.9	1665.1	5.4	2.4	26.3	1065.0	434.9	350.3	465.9	0.0	1661.4	252.0	5778.2	13.8	28.9	4471.9	0.0	4777.1	4560.4	56.5	694.5	77.0	253.1	223.9	1.6	905.1	28.3	8.4	52.9	7.5	27.5	124.9	94.6	2325.6	3.9	3911.0	3583.7	1.8	388.7	3.8	0.0	11.3	1.1	4.1	1.5	4406.3	7.5	1775.0	1380.2
KRT83	"Hb-3, KRTHB3"	ENSG00000170523	"Keratin 83"	P78385	12	52314301-52321398	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 36.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.1"	"Group enriched"	"Detected in many"	5	"amygdala: 1.2;cerebral cortex: 1.2;pons and medulla: 3.3;thalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 17.0"									HPA049778	Supported					NA	NA		170000000			"HPA049778: AB_2680877"	"unprognostic (7.03e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.30e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-2)"		"unprognostic (2.43e-1)"	"unprognostic (1.12e-3)"	"unprognostic (7.49e-3)"		"unprognostic (2.16e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	0.8	0.0	1.2	0.0	0.0	0.0	1.5	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.6	0.1	0.0	36.3	0.0	0.0	2.1	0.0	0.0	0.8	2.7	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.4	0.0	3.3	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP1-1	"HB2A, KAP1.1, KAP1.1A, KAP1.1B"	ENSG00000188581	"Keratin associated protein 1-1"	Q07627	17	41040559-41041461	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"skin 1: 38.7"	"Cell type enhanced"	"Detected in some"	21	"Basal glandular cells: 5.4;Ductal cells: 3.9;Glandular cells: 1.2;Urothelial cells: 1.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.3;fHDF/TERT166: 1.9;LHCN-M2: 2.3;U-2197: 1.3"															NA	NA																"unprognostic (2.90e-1)"							0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	38.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7
KRTAP16-1	KAP16.1	ENSG00000212657	"Keratin associated protein 16-1"	A8MUX0	17	41307700-41309253	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skin 1: 16.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"cerebral cortex: 1.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"HDLM-2: 1.1;SCLC-21H: 1.6;U-87 MG: 1.7;U-937: 2.1"	"Not detected"	"Not detected"							HPA070954	Enhanced					NA	NA					"HPA070954: AB_2686327"													"unprognostic (3.65e-5)"	"unprognostic (4.61e-2)"				0.6	0.0	0.0	2.5	0.0	3.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	16.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.9	0.0	1.9	0.3	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.8	0.0	0.9	0.3	0.2	1.9	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP4-12	KAP4.12	ENSG00000213416	"Keratin associated protein 4-12"	Q9BQ66	17	41123091-41124167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skin 1: 21.4"	"Group enriched"	"Detected in some"	15	"Basal glandular cells: 1.4;Urothelial cells: 1.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"pons and medulla: 1.5"	"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.9"	"Cell line enriched"	"Detected in single"	5	"BJ: 4.0"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.9	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7
KRTAP4-8	KAP4.8	ENSG00000204880	"Keratin associated protein 4-8"	Q9BYQ9	17	41096981-41098141	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"skin 1: 20.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.1;BJ hTERT+ SV40 Large T+: 1.2;HBF TERT88: 4.1"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTAP9-8	KAP9.8	ENSG00000187272	"Keratin associated protein 9-8"	Q9BYQ0	17	41238045-41239004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"skin 1: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	60	"HDLM-2: 6.0"															NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 20.8;Leydig cells: 36.2;Peritubular cells: 65.0;T-cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"	NA	NA					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favorable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1	0.0	3.5	0.9	0.8	4.5	4.0	1.2	0.0	0.0	5.7	0.0	9.8	0.2	0.0	0.1	0.3	1.9	1.1	0.0	0.0	0.2	2.1	1.9	0.0	2.5	8.7	0.0	20.8	5.5	3.5	1.1	36.2	0.3	1.7	4.6	4.5	1.3	0.3	0.0	65.0	0.2	6.2	6.5	2.5	0.3	2.0	2.6	0.1	29.6	2.5	0.3
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.1;brain: 105.2"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"basal ganglia: 105.2"	"Cell type enriched"	"Detected in some"	15	"plasmacytoid DC: 42.1"	"Lineage enriched"	"Detected in many"	30	"dendritic cells: 42.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.1	21.6	1.5	105.2	2.0	1.0	2.3	28.6	9.1	1.3	0.6	1.8	1.3	4.6	6.0	0.6	9.7	2.9	0.6	18.7	4.1	0.9	0.5	1.1	4.8	4.5	7.7	21.2	1.3	0.3	2.0	0.4	23.2	2.3	1.4	2.6	1.4	3.6	0.3	0.5	1.4	3.8	6.7	1.4	1.6	1.1	4.8	0.0	1.1	0.0	4.7	1.2	0.6	1.4	42.1	0.9	0.5	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.1	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.9	0.5	0.0	0.0	0.1	0.0	1.4	0.0	0.0	2.8	0.1	0.0	0.0	0.1	0.0	0.0	42.1	0.0	0.7	21.6	105.2	2.3	19.1	18.7	4.1	4.5	7.7	23.2	4.8	0.0	1.4	2.2	0.0	0.1	7.5	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.6	5.8	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	1.1	57.2	0.0	0.0	1.2	5.6	0.6	0.2	3.3	8.2	0.0	4.0	0.2	0.0	0.0	0.0	4.9	0.0	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0
LARGE2	"FLJ35207, GYLTL1B, PP5656"	ENSG00000165905	"LARGE xylosyl- and glucuronyltransferase 2"	Q8N3Y3	11	45921621-45929096	"Predicted intracellular proteins"		"Glycosyltransferase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 38.9;placenta: 29.6"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 128.7;Syncytiotrophoblasts: 97.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 2.1"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.5;naive B-cell: 5.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.8;NTERA-2: 16.7;SK-BR-3: 12.0;T-47d: 36.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA056621	Approved				"Intracellular and membrane"	NA	NA					"HPA056621: AB_2683194"	"unprognostic (9.82e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (3.04e-12)"	"unprognostic (2.31e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	0.2	1.4	0.2	2.8	0.2	0.1	2.8	0.2	0.4	3.5	0.8	0.8	16.0	0.6	1.6	8.3	10.5	2.5	0.4	0.4	0.4	0.1	12.2	1.7	2.5	2.8	0.2	0.2	1.8	38.9	9.5	6.6	29.6	2.1	5.8	0.2	14.8	20.7	12.7	0.2	11.1	2.3	0.7	0.2	1.6	5.2	1.2	0.2	2.0	8.1	3.9	8.1	1.3	3.7	5.8	0.0	0.1	0.0	0.8	1.1	0.2	0.6	0.8	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	0.3	0.0	0.4	0.0	0.4	4.0	0.0	7.6	0.0	0.0	2.4	0.0	0.5	4.6	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	4.8	0.0	0.0	1.3	0.1	0.0	16.7	6.0	0.5	0.4	0.0	1.5	0.2	0.3	4.9	0.5	0.1	12.0	0.0	1.0	36.4	0.0	0.0	0.1	5.5	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	3.5	0.3	0.9	0.0	5.8	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.2	2.1	0.2	3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.0	0.0	128.7	3.3	3.5	0.0	0.0	0.0	0.0	5.5	5.5	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	97.1	0.0	0.0	0.0
LBX1	"HPX6, LBX1H"	ENSG00000138136	"Ladybird homeobox 1"	P52954	10	101226195-101229794	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	76	"brain: 11.8;skeletal muscle: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"cerebellum: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 5.0;RH-30: 6.4;SCLC-21H: 13.6"	"Group enriched"	"Detected in some"	24	"cerebellum: 1.8;pons and medulla: 3.2"	"Group enriched"	"Detected in some"	21	"cerebellum: 2.9;pons and medulla: 2.8"	"HPA002016, HPA002086, CAB079927"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB079927: , HPA002016: AB_2666518, HPA002086: AB_1079242"		"unprognostic (4.13e-1)"			"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"		"unprognostic (2.29e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.31e-1)"				"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"			0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.4	0.0	0.0	0.0	13.6	0.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.8	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 204.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 35.6;Hep G2: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.5	4.0	6.0	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4.0	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15.0	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0.0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2.0	6.0	0.0	1.6	0.0	4.3	0.0	0.0	0.9	2.7	7.1	2.9	1.1	204.0	2.1	0.0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0.0	7.5	1.4	0.0	8.1	0.0	0.5	12.9	7.1	1.0	1.5	2.3	10.2	0.0	0.0	1.4
LCE1E	LEP5	ENSG00000186226	"Late cornified envelope 1E"	Q5T753	1	152786214-152788426	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skin 1: 39.5"	"Cell type enriched"	"Detected in some"	9	"Suprabasal keratinocytes: 15.9"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enriched"	"Detected in single"	15	"cerebellum: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HaCaT: 14.9"															NA	NA							"unprognostic (9.92e-2)"				"unprognostic (9.50e-2)"			"unprognostic (2.30e-2)"								"unprognostic (2.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.3	39.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	14.9	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526532	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"tongue: 204.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-2 OS: 1.0;U-87 MG: 2.0"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		20000000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	16.8	3.3	0.0	0.7	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.4	15.8	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	204.2	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell type enriched"	"Detected in some"	54	"Intestinal endocrine cells: 377.4"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.7"					"Low region specificity"	"Detected in all"			HPA060584	Enhanced				"Secreted in other tissues"	NA	NA					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	377.4	0.0	0.8	1.7	0.0	0.0	1.7	0.0	0.7	0.0	0.0	7.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"epididymis: 72.1"	"Cell type enriched"	"Detected in single"	8	"B-cells: 2.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 5.3"	"Group enriched"	"Detected in some"	57	"memory B-cell: 5.3;naive B-cell: 9.3"	"Lineage enriched"	"Detected in single"	72	"B-cells: 9.3"	"Cell line enriched"	"Detected in some"	6	"REH: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA									"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"		0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.7	0.1	0.0	0.0	2.5	0.0	0.2	72.1	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.5	0.0	0.0	0.9	0.0	0.6	0.0	0.0	1.9	0.0	0.2	0.0	0.0	9.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	7.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	5.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	21	"Endothelial cells: 120.7;Ito cells: 249.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7"	"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.1"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;ASC TERT1: 9.3;fHDF/TERT166: 9.8;HAP1: 18.0;HUVEC TERT2: 34.0;U-138 MG: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	27.9	9.5	14.5	4.6	30.3	0.4	26.8	1.1	45.3	27.1	6.8	2.7	8.0	4.0	54.9	14.4	9.5	15.6	18.3	18.5	16.6	4.8	14.9	15.0	31.3	6.9	5.5	21.7	11.9	4.6	15.2	5.6	33.7	3.4	10.4	5.4	15.4	6.1	8.6	7.5	5.4	6.8	32.8	4.2	32.9	6.7	6.4	3.4	0.7	17.8	7.5	3.0	14.7	13.3	0.2	0.0	0.3	0.0	5.1	0.0	0.6	0.0	0.0	9.7	0.0	5.6	9.3	0.0	5.3	4.1	0.6	1.5	0.0	0.0	0.0	0.0	9.8	0.0	0.0	18.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.2	0.0	6.7	0.0	1.4	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	8.9	13.7	0.0	0.7	0.0	4.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.6	14.5	30.3	1.1	45.3	16.6	4.8	5.5	21.7	3.4	3.4	0.0	8.5	1.9	0.2	7.7	21.5	9.2	5.1	1.4	0.0	0.0	0.0	0.2	0.0	1.7	1.1	120.7	0.0	0.0	0.2	0.2	22.0	0.3	5.7	1.3	0.3	0.0	0.0	249.8	20.4	1.5	35.4	2.3	8.5	0.0	0.0	9.8	0.3	0.0	47.4	0.0	1.7	6.5	13.4	0.0	0.6	5.9	0.1	5.4	0.0	0.1
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 869.0;Late spermatids: 3077.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0	0.0	1.6	0.0	1.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	869.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3077.5	11.8	0.0	0.0	0.0	0.0	0.9	4.0	0.0	13.1	1.5	0.7	6.5	0.0	15.3	7.2	0.0	0.3	0.0	0.0	2.2
LENEP	LEP503	ENSG00000163352	"Lens epithelial protein"	Q9Y5L5	1	154993586-154994315	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.0"	"Cell type enhanced"	"Detected in single"	35	"Muller glia cells: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 1.7;hippocampal formation: 3.0;pons and medulla: 2.5"	"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.8;BEWO: 1.1;Daudi: 1.1;HaCaT: 1.6;HAP1: 1.6;Karpas-707: 1.2;MCF7: 1.1;PC-3: 1.4"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.03e-1)"	"unprognostic (3.60e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.32e-5)"	"unprognostic (5.26e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.00e-1)"	"unprognostic (9.08e-2)"	0.1	0.4	1.7	0.1	0.2	0.0	0.2	0.4	0.2	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	3.0	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.7	0.3	0.0	0.3	0.2	2.5	0.6	0.3	0.1	1.9	0.1	0.5	1.4	1.3	0.1	1.8	0.1	0.3	0.3	0.1	0.1	1.6	0.1	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.0	1.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.4	1.2	0.0	1.1	0.0	0.0	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.2	0.4	0.2	3.0	0.2	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Cell type enriched"	"Detected in some"	8	"granulocytes: 18.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.8;HL-60: 20.4;NB-4: 40.2;U-937: 43.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA021124			Approved	Cytosol		NA	NA			Cytosol		"HPA021124: "	"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	20.4	1.3	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	43.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LGALS13	"PLAC8, PP13"	ENSG00000105198	"Galectin 13"	Q9UHV8	19	39602501-39607476	"Predicted intracellular proteins"	Apoptosis	Hemagglutinin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"placenta: 58.9"	"Cell type enriched"	"Detected in some"	19	"Syncytiotrophoblasts: 267.5"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Group enriched"	"Detected in some"	7	"cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	73	"SuSa: 7.3"									HPA046803			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046803: AB_10965990"																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	58.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.2	0.0	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	267.5	0.0	0.0	0.0
LGALS16		ENSG00000249861	"Galectin 16"	A8MUM7	19	39655894-39660647	"Predicted intracellular proteins"	Apoptosis			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"placenta: 14.2"	"Cell type enriched"	"Detected in some"	76	"Syncytiotrophoblasts: 852.8"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"BEWO: 5.5;SuSa: 16.1"															NA	NA																							0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.6	0.5	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	852.8	0.0	0.0	0.0
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319977	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 5.2;liver: 9.3"	"Cell type enhanced"	"Detected in some"	9	"Ciliated cells: 4.0;Club cells: 3.4;Late spermatids: 2.2;Proximal tubular cells: 2.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 2.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 10.6;BEWO: 5.7;CACO-2: 3.4;HeLa: 3.9;Karpas-707: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	5.2	9.3	0.7	0.2	0.4	0.2	0.2	0.5	0.0	0.2	2.3	2.9	0.5	0.1	0.2	0.2	0.2	0.3	0.1	0.4	0.2	1.6	0.3	0.8	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	1.0	3.4	0.7	0.3	0.5	0.1	0.1	10.6	0.1	0.1	0.0	0.0	5.7	0.1	0.1	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.1	3.9	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.1	1.9	0.1	0.4	0.1	0.1	0.4	0.1	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	1.6	0.7	0.3	0.5	0.3	0.2	0.7	0.5	0.3	0.1	0.7	0.4	0.5	3.4	0.3	0.3	1.0	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.1	0.4	0.2	2.9	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	4.0	3.4	0.0	0.0	1.7	1.7	0.0	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.3	2.2	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.5	0.0
LHCGR	"HHG, LCGR, LGR2, LHR, ULG5"	ENSG00000138039	"Luteinizing hormone/choriogonadotropin receptor"	P22888	2	48686775-48755730	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 10.3;testis: 18.8"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 1.1;Leydig cells: 1.1;Suprabasal keratinocytes: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;HSkMC: 1.0;NTERA-2: 1.6;SuSa: 1.0"									CAB009814	Uncertain					NA	NA					"CAB009814: AB_2135467"	"unprognostic (8.57e-2)"				"unprognostic (1.08e-1)"			"unprognostic (1.54e-1)"		"unprognostic (1.41e-1)"			"unprognostic (3.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.22e-2)"		3.6	2.9	0.3	1.4	6.1	0.0	1.6	0.3	0.4	0.2	0.5	0.2	0.0	0.2	0.4	0.3	2.1	0.2	1.8	0.6	0.7	0.4	0.9	0.1	0.4	0.1	2.6	0.0	5.0	0.1	0.0	2.7	0.1	1.4	0.4	0.2	0.3	1.0	0.1	0.2	0.6	0.3	1.0	10.3	0.1	0.6	18.8	0.0	0.4	2.2	0.1	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	6.1	0.3	0.4	0.7	0.4	2.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0
LHX2	"hLhx2, LH-2"	ENSG00000106689	"LIM homeobox 2"	P50458	9	124001670-124033301	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 44.7;retina: 17.0"	"Cell type enriched"	"Detected in some"	9	"Muller glia cells: 245.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5"	"Group enriched"	"Detected in many"	6	"amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2"	"Group enriched"	"Detected in many"	5	"amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7"	"Group enriched"	"Detected in many"	6	"amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5"	HPA000838		Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000838: AB_2666109"	"unprognostic (3.60e-3)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.52e-1)"	"unprognostic (9.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.66e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.77e-1)"	0.9	1.0	30.7	1.1	20.5	0.9	1.1	0.0	44.7	0.8	0.9	4.7	0.0	1.0	0.8	0.8	0.8	0.8	1.0	0.8	23.6	2.4	0.8	6.1	0.9	1.1	1.5	16.1	1.1	0.8	0.8	4.6	5.1	0.0	0.8	1.1	17.0	1.1	0.8	0.8	2.2	0.9	0.8	0.2	0.9	0.9	4.0	4.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	4.9	0.1	15.7	0.0	0.2	1.6	0.4	0.2	1.2	0.1	4.9	0.0	0.1	2.1	0.9	12.3	0.1	15.7	0.0	0.6	0.0	3.4	0.0	10.9	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	7.8	0.0	0.1	19.5	0.0	4.6	4.2	0.0	0.0	0.0	0.0	6.4	0.0	4.0	0.0	0.0	0.1	5.6	2.0	0.0	10.2	0.4	2.9	0.7	0.2	3.2	0.0	0.6	2.2	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	30.7	20.5	0.0	26.6	23.6	2.4	1.5	16.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.0	7.9	0.0	6.7	0.0	16.0	0.0	0.0	0.0	0.0	0.0	245.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.6	0.0	0.1	0.0	0.0	0.0
LHX5		ENSG00000089116	"LIM homeobox 5"	Q9H2C1	12	113462034-113472280	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.0;stomach 1: 2.1;testis: 2.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"cerebellum: 4.8;hypothalamus: 6.7;pons and medulla: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HMC-1: 4.6;K-562: 1.2;SiHa: 3.3;U-2 OS: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053908			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA053908: AB_2682304"		"unprognostic (5.20e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.06e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.56e-1)"			"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.54e-3)"	0.0	0.1	0.0	0.0	0.3	0.0	0.0	4.8	4.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.0	6.7	1.2	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Cell type enhanced"	"Detected in single"	26	"Spermatogonia: 2.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.8;U-266/70: 8.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	8.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF, interleukin 6 family cytokine"	P15018	22	30240447-30246851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 58.9;granulocytes: 63.7;Smooth muscle cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.7"	"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"GAMG: 27.0;hTEC/SVTERT24-B: 34.3;hTERT-RPE1: 31.7;U-138 MG: 38.2;U-251 MG: 27.6;U-87 MG: 30.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	20.3	1.7	1.4	21.6	3.3	0.6	5.2	0.9	4.3	4.4	3.9	1.8	1.6	3.7	6.9	2.6	2.0	7.3	28.7	14.2	1.2	0.6	5.7	3.4	17.4	3.8	2.2	0.5	7.9	7.5	0.2	7.3	1.3	11.7	8.6	4.7	3.5	3.2	1.2	1.9	6.0	5.2	4.6	4.3	1.6	4.1	2.0	1.8	0.9	3.4	2.2	5.4	20.8	1.7	0.0	0.0	0.0	0.0	1.2	0.2	0.1	8.4	14.2	0.4	3.1	0.0	1.2	5.2	1.2	5.1	1.5	3.7	2.3	13.8	0.0	3.1	0.0	27.0	2.1	0.3	3.8	2.1	2.0	0.6	1.0	4.8	3.1	1.4	0.0	11.1	1.3	0.7	34.3	1.0	31.7	0.0	0.0	0.2	0.0	6.6	6.3	0.1	0.0	0.5	7.7	8.8	0.2	4.8	0.0	12.2	3.2	0.0	0.1	1.4	0.1	2.5	1.6	0.3	0.1	0.1	38.2	14.1	14.4	27.6	0.0	0.0	0.0	30.2	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.4	3.3	0.9	4.3	1.2	0.6	2.2	0.5	11.7	1.8	20.8	58.9	0.0	12.0	3.1	0.0	0.2	17.8	4.0	13.6	5.2	0.0	0.1	0.0	27.7	0.1	0.5	3.5	0.0	3.0	0.4	11.3	13.8	63.7	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	2.9	1.2	24.9	0.0	0.0	0.6	0.1	0.0	39.8	0.0	0.2	2.5	0.2	0.5	5.5	18.0
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 458.2;Basal keratinocytes: 492.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		160000	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	50.3	19.8	6.6	22.3	6.8	0.9	34.1	73.6	6.6	30.9	49.2	10.4	21.3	35.2	31.1	22.1	25.0	18.0	31.1	12.6	6.6	5.1	29.3	11.1	23.3	11.8	7.2	4.1	21.1	12.4	12.4	18.6	42.0	15.4	28.2	42.8	20.7	27.0	22.1	10.5	16.3	90.5	33.8	10.4	23.6	30.3	11.8	6.0	12.1	17.0	20.7	18.0	41.8	21.4	0.6	4.4	1.3	2.1	5.8	13.6	2.7	24.5	0.7	7.8	11.5	36.2	36.3	29.7	61.7	43.5	49.7	39.8	9.3	36.2	1.1	5.7	85.0	16.7	28.0	7.0	57.0	43.6	15.6	7.4	10.3	2.8	3.2	23.2	3.6	14.6	24.3	16.8	17.4	50.3	15.0	17.4	4.6	7.1	5.0	16.0	4.2	4.5	1.1	4.0	13.0	3.3	4.5	19.2	0.3	11.5	29.3	5.9	12.6	8.4	17.1	26.4	8.7	8.1	2.2	27.1	21.3	16.4	19.7	10.0	2.7	0.3	4.5	23.2	4.1	9.1	0.1	0.2	1.3	6.4	1.0	2.5	0.1	8.1	7.8	4.4	0.6	3.3	5.9	0.1	5.8	2.1	1.1	13.6	2.7	6.6	6.8	73.6	5.6	6.6	5.1	7.2	4.1	15.4	6.0	41.7	69.6	5.7	458.2	492.0	15.2	4.8	91.7	64.3	190.0	113.4	151.2	92.0	13.3	118.0	57.4	79.0	270.8	0.0	268.0	306.1	86.4	160.9	24.3	17.8	31.1	6.4	118.0	121.5	12.4	9.6	69.9	18.4	86.0	15.4	122.6	21.8	175.8	221.0	72.9	21.7	85.9	64.7	111.9	28.1	7.0	254.8	53.5	31.6	178.0	293.9
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LMAN1L	"ERGIC-53L, ERGL"	ENSG00000140506	"Lectin, mannose binding 1 like"	Q9HAT1	15	74812716-74825758	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 45.5;heart muscle: 18.0;lymphoid tissue: 13.5;prostate: 37.0;salivary gland: 17.3"	"Group enriched"	"Detected in some"	4	"Glandular cells: 9.7;Spermatocytes: 6.5"	"Cancer enriched"	"Detected in single"	45	"prostate cancer: 2.2"	"Region enriched"	"Detected in some"	22	"cerebellum: 45.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.8;HEK 293: 2.4;SCLC-21H: 2.5;SK-BR-3: 2.5;U-698: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (4.51e-1)"							"unprognostic (2.44e-1)"		"unprognostic (4.26e-2)"	"unprognostic (3.09e-1)"			0.1	1.1	0.2	4.8	0.2	0.0	0.1	45.5	0.9	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.0	0.5	18.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	2.0	37.0	0.0	0.1	17.3	0.1	0.1	0.0	0.2	0.1	0.3	13.5	2.5	0.7	0.1	0.1	0.1	0.3	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.9	0.3	0.0	1.1	0.0	0.5	2.5	0.1	0.0	2.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.6	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	45.5	0.9	0.1	0.0	0.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.5	1.1	0.0	0.0	0.0	0.0	0.1
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 93.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 61.8;Extravillous trophoblasts: 58.3;granulocytes: 89.2;Late spermatids: 58.6;monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 23.4;pons and medulla: 6.3"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757"	Supported		Supported	"Nuclear membrane"		NA	NA		3300000	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	3.9	2.0	2.5	36.8	3.5	21.1	7.0	23.4	2.5	3.1	10.6	0.5	3.9	8.2	2.2	3.2	15.8	2.4	4.3	3.3	3.0	2.7	2.4	5.0	9.7	25.4	2.1	1.7	2.9	2.9	1.0	3.4	5.2	6.3	1.9	9.9	1.7	4.1	5.7	1.8	6.2	11.1	2.6	8.8	15.3	5.7	2.5	2.3	93.1	2.0	9.3	20.3	4.1	5.1	3.8	13.2	8.5	12.2	1.9	10.5	4.9	25.3	8.4	26.3	25.1	0.6	1.9	34.1	11.9	3.5	13.2	14.3	21.9	21.2	44.1	20.7	4.1	6.3	14.2	17.9	8.1	14.6	30.9	22.0	28.3	10.0	12.8	0.2	33.6	19.1	0.5	0.1	6.9	3.2	2.5	10.8	18.1	16.4	17.2	9.2	20.9	60.8	66.7	19.8	10.4	11.9	29.1	52.0	17.8	7.2	11.6	30.5	16.1	19.2	8.3	7.2	9.5	15.1	38.9	9.1	9.9	26.9	7.3	25.4	11.4	8.7	38.7	5.0	47.8	14.6	1.2	12.2	4.0	1.9	5.0	1.5	3.8	4.0	2.5	13.2	2.9	2.9	2.6	8.5	1.9	1.2	4.0	10.5	4.9	2.5	3.5	23.4	2.5	3.0	2.7	2.1	1.7	6.3	2.3	0.0	7.0	22.9	2.4	4.4	6.1	0.8	7.6	2.7	4.5	0.0	7.9	14.6	1.7	1.9	61.8	3.8	2.3	0.0	0.7	58.3	2.9	1.0	89.2	2.4	18.5	4.8	5.8	1.8	18.2	58.6	2.0	12.5	1.7	77.5	13.5	2.8	0.9	10.5	0.4	1.7	16.5	0.0	4.2	2.8	8.1	4.6	3.9	20.8	25.7	0.4
LMX1A	"LMX1, LMX1.1"	ENSG00000162761	"LIM homeobox transcription factor 1 alpha"	Q8TE12	1	165201867-165356715	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 7.3;pituitary gland: 8.0"	"Group enriched"	"Detected in some"	33	"Early spermatids: 29.1;Intestinal endocrine cells: 40.3;Late spermatids: 14.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA028051, HPA030088"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA028051: AB_10599731, HPA030088: AB_10601106"	"unprognostic (1.73e-1)"		"unprognostic (9.57e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.82e-1)"		"unprognostic (2.63e-1)"	"unprognostic (3.22e-2)"			"unprognostic (2.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.82e-3)"		2.2	0.0	0.0	2.0	0.0	0.0	1.2	2.6	0.5	0.5	1.7	3.4	3.1	4.0	0.1	1.3	1.1	0.5	0.2	0.2	0.9	1.5	0.0	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	8.0	0.0	7.3	0.2	2.1	0.5	1.5	0.3	1.4	0.3	2.2	0.9	0.1	0.0	0.2	4.3	0.3	0.0	0.3	3.5	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.5	2.2	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126614443-126701032	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5;salivary gland: 35.3"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.4;Early spermatids: 1.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Region enriched"	"Detected in single"	4	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 17.2;OE19: 10.9;T-47d: 10.6"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.4"	"Region enhanced"	"Detected in some"		"midbrain: 7.9"	HPA073716			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA073716: AB_2686630"	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	1.3	0.1	0.0	0.1	0.0	0.1	7.5	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	1.9	0.1	0.2	1.4	0.0	0.1	0.0	0.6	0.0	0.1	0.8	0.0	0.6	0.0	2.9	0.1	0.0	16.5	35.3	0.0	0.4	1.5	0.2	0.0	2.4	0.0	0.1	3.1	0.0	0.0	0.9	0.1	0.0	0.2	0.1	0.6	0.4	1.2	0.3	0.9	0.5	0.0	2.4	1.1	0.4	3.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	0.5	0.0	2.8	1.2	3.8	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.5	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	17.2	0.0	0.0	0.0	10.9	0.2	0.0	3.2	0.0	0.0	0.3	0.0	1.5	0.3	0.1	0.4	0.1	10.6	0.2	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.1	0.2	0.3	0.3	0.2	0.1	0.6	0.5	0.4	1.2	0.9	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.5;epididymis: 9.7;testis: 22.0"	"Group enriched"	"Detected in some"	84	"Early spermatids: 168.6;Late spermatids: 330.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"THP-1: 3.5;WM-115: 1.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.0"	HPA077128			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077128: "	"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	1.7	0.0	0.4	0.0	2.4	2.7	0.4	0.1	1.9	0.0	0.1	0.2	15.5	0.0	0.0	9.7	0.1	1.7	0.1	0.5	0.2	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.4	4.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.0	0.7	0.1	22.0	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.4	2.4	0.1	1.9	0.2	0.1	0.0	0.0	0.0	1.1	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	1.7	0.0	168.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	330.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.8	1.5	0.0	0.0	0.0	0.0	0.0
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 46.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"		NA	NA			"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavorable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	17.9	5.0	6.5	20.3	5.9	7.2	15.2	46.4	7.2	17.5	14.6	4.6	11.5	7.0	24.6	9.8	10.6	11.9	14.1	8.0	6.3	5.9	13.8	10.9	14.3	13.5	6.6	4.9	9.5	5.1	5.2	13.1	24.1	8.0	12.8	9.3	8.4	11.3	14.5	5.3	18.1	12.0	20.9	8.5	13.7	14.6	5.0	6.0	31.7	7.8	6.4	13.7	16.6	18.3	6.2	2.3	1.8	2.0	5.1	3.6	1.8	4.3	6.3	5.7	5.9	4.2	8.0	14.7	7.5	9.9	9.4	8.9	14.2	7.5	14.0	2.1	7.1	6.1	6.3	4.3	7.6	13.6	14.4	4.1	12.6	2.5	6.6	5.2	8.1	21.6	5.1	6.0	8.6	10.5	7.7	8.0	9.5	2.4	4.3	6.9	8.5	8.7	10.2	3.2	27.7	3.3	4.8	6.2	3.7	17.5	4.6	9.1	9.1	4.2	4.2	11.2	10.6	3.2	11.0	7.6	5.5	3.7	6.8	7.1	0.8	2.1	6.3	6.4	7.2	6.6	1.5	2.0	1.8	3.6	1.6	2.1	5.3	2.7	2.6	1.9	6.2	2.1	2.1	0.7	5.1	1.2	2.3	1.9	1.8	6.5	5.9	46.4	7.2	6.3	5.9	6.6	4.9	8.0	6.0	6.0	6.7	15.1	9.1	33.3	8.2	6.7	25.5	1.4	6.8	21.0	21.6	11.1	8.3	7.2	1.2	25.9	6.9	0.0	3.5	10.0	10.5	7.9	27.6	7.9	11.4	3.2	1.7	16.5	16.7	1.1	12.0	9.9	28.7	5.4	9.7	6.4	9.5	5.8	15.9	7.3	8.9	12.9	21.7	0.7	3.2	29.1	8.1	10.2	6.5	7.8
LRGUK	"CFAP246, FLJ32786"	ENSG00000155530	"Leucine rich repeats and guanylate kinase domain containing"	Q96M69	7	134127299-134264591	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5;pituitary gland: 11.5;testis: 22.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 26.8;Early spermatids: 14.4;Spermatocytes: 8.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.1;SH-SY5Y: 4.9;SK-MEL-30: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029505, HPA029506"	Uncertain					NA	NA					"HPA029505: AB_10599606, HPA029506: AB_10601752"	"unprognostic (4.08e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.85e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.28e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.22e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.10e-2)"	0.7	0.6	2.3	0.6	6.4	1.3	1.2	0.5	1.4	1.2	0.5	4.1	0.3	0.5	1.5	4.0	0.4	9.1	0.7	0.4	2.4	1.2	1.2	0.9	3.4	0.4	0.3	0.6	2.4	1.9	0.4	11.5	0.4	12.5	1.6	0.7	2.2	1.3	0.5	0.2	1.2	0.5	0.5	1.6	1.3	0.6	22.4	0.9	0.0	2.2	0.0	0.6	0.5	0.4	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.7	1.1	0.1	0.3	0.3	0.0	0.1	0.5	0.4	0.0	1.0	0.2	0.3	0.1	1.0	0.3	0.4	0.1	0.8	0.5	0.5	0.1	0.3	0.2	0.1	0.2	0.6	0.3	0.7	0.9	0.0	0.1	0.2	0.7	0.2	0.8	0.8	0.2	0.3	0.6	5.1	0.2	1.2	0.7	0.1	0.0	0.8	0.4	1.6	4.9	1.5	0.0	5.1	0.7	0.2	1.1	0.0	0.3	0.6	0.3	0.6	1.2	1.7	1.5	1.4	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	6.4	0.5	1.4	2.4	1.2	0.3	0.6	12.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	26.8	2.3	0.0	0.0	0.0	0.0	0.2	14.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	1.7	0.0	0.0	1.4	0.0	0.0	0.4	0.0	1.8	0.0	0.0	8.3	0.7	0.4	0.2	0.0	0.0	0.1
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220495-84225589	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"retina: 25.4;skin 1: 8.5"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 5.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced					NA	NA					"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.1	0.2	0.2	0.1	3.4	0.0	0.1	0.1	2.2	0.1	1.6	0.1	0.1	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	25.4	0.1	0.1	0.1	8.5	0.7	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.1	0.5	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 20.1;Muller glia cells: 7.8;Sertoli cells: 19.4;Smooth muscle cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.2;RH-30: 13.2;SCLC-21H: 6.8"	"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli		No	NA			Nucleoplasm	Nucleoli	"HPA047619: AB_2680106"	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	6.8	0.6	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	20.1	4.5	1.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	7.8	0.1	0.0	0.0	0.0	0.0	19.4	11.8	0.5	0.9	0.3	0.1	0.0	0.0	0.0
LRRC38		ENSG00000162494	"Leucine rich repeat containing 38"	Q5VT99	1	13474977-13514048	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 16.0;skeletal muscle: 60.8"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 1.4;Cardiomyocytes: 1.9;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"cerebellum: 4.1;cerebral cortex: 3.0;pons and medulla: 1.1"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.9;MOLT-4: 14.6;PC-3: 10.5;U-138 MG: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038778	Approved					NA	NA					"HPA038778: AB_10673294"	"unprognostic (5.13e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"		"unprognostic (1.72e-1)"		"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.23e-1)"		"unprognostic (7.81e-2)"	"unprognostic (4.47e-2)"		"unprognostic (1.05e-1)"	0.4	16.0	0.1	0.1	0.3	0.2	0.7	4.1	3.0	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.4	0.2	0.2	1.0	0.2	0.1	0.2	0.1	0.2	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.7	1.1	0.4	0.2	0.8	0.5	0.2	60.8	0.8	0.2	0.2	6.8	0.2	0.2	0.5	0.0	5.7	0.2	10.0	0.3	0.2	0.5	0.1	1.8	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	10.5	0.0	0.1	1.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	17.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.3	4.1	3.0	0.2	0.1	0.4	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0
LRRC46	MGC16309	ENSG00000141294	"Leucine rich repeat containing 46"	Q96FV0	17	47831627-47837713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 51.2;testis: 94.4"	"Cell type enhanced"	"Detected in some"	24	"Ciliated cells: 239.6;Early spermatids: 97.9;Late spermatids: 46.8;Spermatocytes: 76.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.4"	"Region enriched"	"Detected in many"	4	"pons and medulla: 14.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 6.4;T-47d: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021882, HPA074893"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA021882: AB_1853320, HPA074893: AB_2732271"	"unprognostic (1.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.14e-1)"	0.3	0.4	1.8	0.3	3.3	0.6	0.5	0.4	0.5	2.3	0.3	5.2	1.6	0.4	1.5	13.8	0.4	51.2	0.5	0.5	2.0	2.4	0.7	0.4	11.8	0.5	0.3	0.1	8.8	0.5	0.3	4.2	0.4	14.0	0.5	0.3	1.8	0.4	1.3	0.3	0.3	0.3	0.3	0.6	0.5	0.3	94.4	1.1	1.2	1.4	0.0	0.4	0.3	0.1	0.6	2.5	4.4	1.6	2.4	1.0	0.5	1.5	6.4	0.8	3.2	0.5	1.4	1.8	0.2	1.7	1.7	3.3	3.0	1.4	0.7	4.1	0.8	1.7	1.4	0.8	1.1	2.6	2.8	2.8	1.3	1.8	1.0	0.3	0.1	1.5	0.0	1.0	3.5	1.3	0.5	0.3	1.1	1.2	0.8	2.3	2.4	2.1	0.3	0.2	0.5	1.3	2.0	0.2	1.3	2.8	1.1	2.7	2.0	0.7	0.0	0.9	0.3	7.6	0.2	0.5	3.5	1.3	0.6	0.4	1.4	1.3	1.3	2.4	0.5	0.3	4.4	1.3	2.0	0.2	1.6	0.0	0.6	0.1	1.0	2.5	0.4	0.7	0.0	1.6	2.4	1.5	1.3	0.2	0.5	1.8	3.3	0.4	0.5	2.0	2.4	0.3	0.1	14.0	1.1	0.0	2.9	0.0	0.3	0.0	0.6	0.3	0.0	239.6	27.3	5.2	2.0	0.1	0.0	0.3	97.9	0.0	0.0	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	46.8	2.6	0.7	0.0	1.0	0.1	0.9	0.5	0.0	1.8	1.0	5.4	0.0	0.1	76.7	4.0	0.0	0.1	0.0	0.0	0.1
LRRC71	"C1orf92, FLJ32884"	ENSG00000160838	"Leucine rich repeat containing 71"	Q8N4P6	1	156920650-156933094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;fallopian tube: 16.9;testis: 26.4"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 96.4;Early spermatids: 207.3;Late spermatids: 442.9"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.4;PC-3: 3.8;TIME: 3.4;U-2 OS: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-3)"	"unprognostic (5.43e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.02e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.18e-1)"	"unprognostic (1.68e-7)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	0.3	0.8	1.1	0.1	4.0	0.1	0.1	0.0	0.3	1.1	0.1	5.6	0.0	0.1	0.5	5.6	0.1	16.9	0.1	0.1	1.7	1.8	0.1	0.1	3.0	0.1	0.2	0.4	3.6	0.1	0.1	0.0	0.3	9.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	26.4	1.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	4.0	0.0	0.3	1.7	1.8	0.2	0.4	9.5	1.2	0.0	2.6	0.0	0.0	0.0	0.2	0.4	0.0	96.4	18.2	0.0	0.0	0.0	0.0	0.0	207.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	442.9	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	10.9	2.3	0.0	0.0	0.0	0.0	0.0
LRRC72		ENSG00000205858	"Leucine rich repeat containing 72"	A6NJI9	7	16526880-16581568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 15.6"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 117.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA020554	Uncertain					NA	NA					"HPA020554: AB_1859508"															"unprognostic (1.58e-2)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
LRRC74B		ENSG00000187905	"Leucine rich repeat containing 74B"	Q6ZQY2	22	21045960-21064168	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.1;epididymis: 5.6;fallopian tube: 11.4"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 132.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.7;U-87 MG: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049947	Uncertain					NA	NA					"HPA049947: AB_2680966"	"unprognostic (3.43e-2)"	"unprognostic (1.76e-1)"		"unprognostic (3.28e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.44e-3)"		"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.57e-9)"	"unprognostic (4.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.92e-2)"	0.2	0.2	2.1	0.2	2.3	0.2	0.2	0.4	1.6	1.5	0.2	3.7	0.0	0.4	0.3	5.6	0.2	11.4	0.2	0.2	1.5	1.2	0.2	0.2	1.9	0.2	0.1	0.7	1.9	0.2	0.2	0.9	0.2	17.1	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	0.4	1.6	1.5	1.2	0.1	0.7	17.1	0.3	0.0	2.6	0.0	0.6	0.0	1.0	0.4	0.0	132.5	22.7	0.0	3.9	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.1	1.6	0.0	0.6	0.0	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.7	2.1	0.0	0.2	0.0	0.0	0.0
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;pituitary gland: 13.9;testis: 14.3"	"Group enriched"	"Detected in some"	9	"Early spermatids: 98.5;Late spermatids: 64.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 7.3;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.6	0.4	0.6	0.1	7.3	0.2	0.1	0.2	1.1	0.3	0.1	3.2	0.0	0.1	0.2	1.4	0.1	3.4	0.1	0.1	1.4	1.2	0.2	0.2	0.1	0.1	0.5	1.3	1.0	0.2	4.8	13.9	0.1	16.4	1.3	0.1	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.9	0.1	0.2	14.3	2.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.2	1.1	1.4	1.2	0.5	1.3	16.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	64.1	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	8.8	0.9	0.0	0.1	0.0	0.0	0.0
LRRIQ1	"FLJ12303, KIAA1801"	ENSG00000133640	"Leucine rich repeats and IQ motif containing 1"	Q96JM4	12	85036314-85263224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5;pituitary gland: 24.9;testis: 20.1"	"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 433.6;Cone photoreceptor cells: 174.7;Early spermatids: 267.1;Late spermatids: 186.4;Rod photoreceptor cells: 250.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"pons and medulla: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 6.5;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046162	Uncertain					NA	NA					"HPA046162: AB_10963055"	"unprognostic (3.55e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.69e-2)"		"unprognostic (4.81e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.35e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.64e-1)"	0.4	1.2	2.4	0.5	8.2	0.3	1.5	0.4	3.1	2.0	0.5	2.2	2.0	0.2	1.9	8.2	0.3	13.4	0.9	0.5	4.7	3.7	5.3	0.3	4.6	0.3	1.0	3.4	4.7	0.7	3.1	24.9	0.3	21.5	1.8	0.3	1.0	0.6	1.0	0.2	0.3	0.3	1.0	1.0	0.4	0.6	20.1	3.4	0.0	2.8	0.2	0.3	0.3	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.8	0.0	1.0	2.0	0.4	0.6	0.6	1.7	0.4	0.0	0.1	0.0	0.2	0.4	2.3	0.1	1.4	1.7	0.4	0.0	2.5	0.6	0.2	0.0	0.0	0.0	0.0	1.0	2.7	1.3	1.9	2.0	0.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.4	0.0	0.6	0.0	6.5	0.0	2.4	4.3	0.2	0.2	0.2	0.7	1.9	0.0	0.0	3.6	1.0	1.4	0.2	0.0	1.1	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	8.2	0.4	3.1	4.7	3.7	1.0	3.4	21.5	3.4	3.0	4.5	0.0	1.3	0.3	9.6	0.8	2.5	433.6	76.2	15.7	174.7	0.0	8.3	7.9	267.1	0.7	0.0	0.0	1.1	0.0	0.7	5.8	1.1	0.0	0.1	0.0	11.1	0.0	0.0	186.4	4.0	0.5	3.3	0.0	0.0	15.1	2.3	0.0	3.9	4.4	250.0	12.9	0.3	126.2	42.6	0.0	0.1	0.0	0.0	0.3
LRRN4	"C20orf75, dJ1056H1.1, NLRR4"	ENSG00000125872	"Leucine rich repeat neuronal 4"	Q8WUT4	20	6040778-6054049	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 9.5;kidney: 13.0;lung: 36.4"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 8.9;Alveolar cells type 2: 3.8;Ductal cells: 3.6;Proximal tubular cells: 2.2"	"Group enriched"	"Detected in many"	7	"lung cancer: 4.6;ovarian cancer: 3.6;renal cancer: 11.7"	"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"RPTEC TERT1: 40.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA075974			Uncertain	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		32000	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA075974: AB_2686770"	"unprognostic (6.16e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.40e-3)"	"unprognostic (9.04e-3)"	"unprognostic (5.95e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.79e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.84e-3)"	9.5	0.1	0.0	2.4	1.1	0.1	0.1	0.0	0.2	0.7	2.2	0.0	0.0	0.1	0.1	2.8	0.1	1.5	0.1	1.1	0.0	0.2	13.0	0.4	36.4	0.1	0.0	0.0	1.6	2.6	0.1	0.0	3.4	0.0	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	40.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.8	0.4	0.2	0.9	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.9	3.8	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	1.8	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918237-54967088	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3"	"Cell type enriched"	"Detected in many"	14	"Bipolar cells: 403.4"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Region enriched"	"Detected in single"	7	"pons and medulla: 2.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.3	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0.0	18.8	2.1	0.4	22.5	0.1	0.3	0.0	1.0	12.2	0.1	0.3	0.0	0.0	0.1	15.3	0.5	0.1	0.1	0.7	1.0	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0.0	1.8	0.0	0.5	0.9	1.6	0.3	1.3	0.0	0.8	0.8	0.0	1.0	0.4	1.5	0.6	1.0	0.2	4.3	1.1	0.9	0.2	0.5	1.1	1.8	0.4	0.7	0.2	0.1	0.1	0.3	0.1	1.6	0.3	0.2	0.4	2.3	1.5	0.0	0.5	0.1	0.3	1.3	0.2	0.7	0.5	0.7	0.5	2.3	0.3	0.7	1.2	0.3	0.0	0.7	0.9	0.7	0.1	0.0	1.0	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1.0	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.3	403.4	0.4	0.0	0.0	0.0	1.8	15.7	7.8	0.0	0.0	2.0	0.2	0.0	0.0	0.3	1.1	0.8	0.4	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	16.2	1.4	0.0	4.2	0.0	28.5	0.0	1.0	3.0	2.2	0.4	18.5	0.0	0.0	0.4
LSMEM1	"C7orf53, FLJ39575"	ENSG00000181016	"Leucine rich single-pass membrane protein 1"	Q8N8F7	7	112480853-112491062	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 51.3;tongue: 19.2"	"Group enriched"	"Detected in many"	6	"Early spermatids: 43.6;Late spermatids: 47.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 3.6"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA013753, HPA047988"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA013753: AB_1848926, HPA047988: AB_2680229"	"unprognostic (6.87e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.47e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.42e-2)"	1.1	0.7	0.6	0.6	0.6	0.8	0.9	3.6	0.7	0.6	0.6	0.6	0.6	1.3	0.6	1.7	0.7	0.4	0.6	2.1	0.7	0.8	1.4	3.5	1.8	0.6	0.7	0.6	0.6	2.8	0.3	0.9	0.6	0.6	0.9	0.8	0.6	1.9	0.6	51.3	0.8	0.8	0.6	0.6	1.9	0.8	1.1	0.6	0.6	0.9	19.2	1.5	0.6	0.6	0.0	0.1	2.7	0.1	0.0	0.2	2.2	0.8	1.3	0.7	2.8	2.9	3.2	0.1	1.3	0.9	0.6	0.5	2.2	1.9	1.2	1.9	0.3	1.9	0.7	0.8	1.0	1.2	0.6	0.8	0.8	12.5	2.3	1.3	1.2	0.7	2.2	3.8	0.8	0.8	2.7	0.8	1.1	0.9	2.8	0.4	1.1	1.0	3.7	0.6	1.1	0.9	0.4	0.2	0.6	2.4	1.5	2.7	1.4	2.3	1.1	1.5	3.4	0.4	0.5	0.5	2.8	1.0	0.8	1.1	0.9	1.7	1.1	0.8	0.8	0.9	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.0	2.2	0.6	0.6	3.6	0.7	0.7	0.8	0.7	0.6	0.6	0.6	0.0	3.2	0.8	2.4	4.8	2.2	7.7	5.1	1.4	2.3	1.8	2.0	1.2	0.0	0.6	43.6	2.9	7.1	0.0	0.8	0.7	2.8	7.4	0.0	1.0	3.2	0.0	2.9	1.8	2.7	47.7	0.9	1.3	1.7	2.8	4.0	0.3	1.0	4.3	0.4	0.1	3.4	0.0	6.6	0.5	0.6	4.1	1.6	0.7	3.2	2.2
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 25.3"	"Group enriched"	"Detected in some"	4	"B-cells: 13.7;T-cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;MOLT-4: 3.6;U-266/84: 1.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	NA	NA	8150				"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.4	0.1	0.2	25.3	0.6	1.1	0.1	1.3	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.1	0.3	0.4	2.0	7.2	0.1	0.0	0.3	0.1	0.1	0.1	0.3	0.0	0.6	0.4	0.2	2.4	0.5	0.3	0.2	2.8	0.2	0.3	10.0	0.4	6.0	0.0	11.2	0.2	0.5	17.5	0.7	0.1	0.2	0.0	0.5	0.6	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.5	0.1	0.6	0.0	0.1	0.0	0.2	0.6	1.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.6	13.7	0.0	0.1	0.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.0	2.1	0.5	0.4	0.0	7.5	0.0	0.0
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"bone marrow: 4.3;brain: 5.2;lung: 3.9;skin 1: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 2.9;cerebral cortex: 5.2;hippocampal formation: 1.7"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	111	"HEL: 23.1"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.3	0.0	2.9	0.0	0.5	4.3	0.0	0.0	5.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.3	0.2	1.7	0.1	0.0	0.3	3.9	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.6	2.2	0.0	0.1	0.2	0.4	0.4	0.8	1.1	0.4	0.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.6	0.2	0.4	0.4	0.4	0.7	0.4	0.0	0.2	0.3	0.4	1.1	0.1	0.3	0.8	0.7	1.0	2.9	0.5	0.0	5.2	1.7	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell type enhanced"	"Detected in some"	21	"Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8"	"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	9	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.8	4.0	0.0	0.0	0.6	2.4	0.0	2.1	1.8	0.1	0.0	5.3	1.7	1.5	0.8	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.3	0.0	5.7	0.0	0.0	7.0	0.0	9.2	0.0	6.0	0.0	0.0	0.0	7.7	0.0	1.3	0.2	7.4	6.4	0.0	0.0	36.7	4.2	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.2	0.0	0.5	24.8	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5	0.0	0.0	0.0	0.6	1.1	1.5	1.0	0.0	0.0	0.0	0.0	3.9	6.1	1.7	0.0	0.4	0.7	0.0	0.0	0.0	1.6	1.0	0.1	0.0	0.0	0.8	19.1	0.0	0.0	0.0	0.4	1.1	0.0	18.6	0.0	0.0	0.9	0.0	0.0	0.4	0.2	17.9	64.7	10.5	0.2	1.1	0.1	0.7	0.0	0.0	0.0
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150581922-150584693	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.2;intestine: 59.8;smooth muscle: 15.2"	"Cell type enhanced"	"Detected in some"	24	"Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Region enriched"	"Detected in some"	18	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTERT-RPE1: 46.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.6	3.1	0.2	8.6	0.4	0.0	0.1	0.2	0.2	0.2	59.8	0.1	0.0	6.8	0.1	0.9	0.9	0.2	0.5	0.7	0.2	0.6	0.1	0.5	0.1	0.6	1.0	0.0	0.1	0.2	0.0	0.3	0.0	19.2	0.2	8.1	9.0	2.2	0.0	0.3	0.2	14.7	15.2	4.5	0.1	0.3	0.1	0.0	0.2	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.6	1.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.8	12.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MAFA	"hMafA, RIPE3b1"	ENSG00000182759	"MAF bZIP transcription factor A"	Q8NHW3	8	143419182-143430406	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 25.6"	"Cell type enriched"	"Detected in some"	8	"Intestinal endocrine cells: 41.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"amygdala: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;MCF7: 4.5;RH-30: 2.7;SCLC-21H: 6.5;T-47d: 6.2;U-2 OS: 4.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.92e-3)"	"unprognostic (9.89e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.42e-8)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-2)"	0.2	0.1	2.5	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.2	0.0	0.0	0.1	0.1	0.3	0.6	0.1	0.1	2.1	0.4	0.2	0.3	0.1	0.7	0.1	0.1	0.2	0.1	2.2	0.2	0.5	1.8	0.9	0.3	0.1	0.7	0.4	0.1	25.6	0.1	0.1	0.1	0.7	0.1	0.1	3.4	0.0	0.4	2.5	5.5	0.4	0.1	0.1	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	2.8	0.9	0.0	0.0	0.1	1.9	1.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	4.5	0.1	0.6	0.6	0.0	0.4	0.6	2.7	0.4	0.0	0.0	6.5	0.2	1.6	0.0	0.0	1.2	6.2	0.1	0.0	0.2	4.3	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	2.5	0.2	0.0	0.6	0.4	0.2	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.4	0.5	1.2	4.9	0.0	0.0	0.0	3.5	2.0	0.2	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.1	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.2	0.6	0.0	0.0	2.2	0.0	0.9	0.6	2.3	1.0	0.2	0.0	0.4	0.1
MAGEA12	"CT1.12, MAGE12"	ENSG00000213401	"MAGE family member A12"	P43365	X	152733779-152737669	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 4.1;testis: 8.3"	"Cell type enriched"	"Detected in some"	6	"Spermatogonia: 19.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.8"	"Region enhanced"	"Detected in some"		"cerebral cortex: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 45.5;HMC-1: 18.4;K-562: 26.7;OE19: 34.5;SH-SY5Y: 15.3;U-2 OS: 27.9;U-266/70: 22.0"															NA	NA										"unprognostic (3.47e-2)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-1)"		"unprognostic (1.60e-3)"		"unprognostic (8.57e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.78e-1)"		"unprognostic (4.06e-2)"	0.2	0.0	0.7	0.0	1.1	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	34.5	13.1	0.0	0.0	0.3	0.0	0.0	1.0	15.3	0.0	7.6	3.9	0.0	0.2	0.0	0.1	0.0	27.9	4.0	1.9	22.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.1	4.1	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	19.4	0.0	0.0	0.0	0.0	0.0
MAGEL2	"NDNL1, nM15"	ENSG00000254585	"MAGE family member L2"	Q9UJ55	15	23643544-23647841	"Disease related genes, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	Repressor	"Autism spectrum disorder, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6;pituitary gland: 13.0"	"Cell type enhanced"	"Detected in some"	12	"Horizontal cells: 3.2;Ito cells: 1.3;Leydig cells: 2.6;Muller glia cells: 1.9;Peritubular cells: 1.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.3"	"Group enriched"	"Detected in many"	5	"basal ganglia: 20.6;cerebral cortex: 6.4;hypothalamus: 19.4;pons and medulla: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.2;JURKAT: 2.7;NTERA-2: 4.4;SuSa: 5.4;U-2 OS: 2.3"	"Region enhanced"	"Detected in many"		"hypothalamus: 20.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.51e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.96e-9)"	"unprognostic (1.66e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.79e-2)"	1.5	1.3	3.0	0.9	20.6	0.3	0.7	0.3	6.8	6.7	0.5	1.0	0.2	0.3	4.9	1.2	0.5	1.6	1.2	0.6	2.9	19.4	0.5	0.4	0.5	0.4	2.1	1.6	7.2	2.2	0.3	13.0	4.3	8.9	1.0	0.4	2.5	0.6	1.9	0.5	0.7	0.6	2.2	0.9	1.0	0.5	4.2	1.4	0.0	2.5	0.0	0.4	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.9	0.0	0.5	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	20.6	0.3	6.4	2.9	19.4	2.1	1.6	8.9	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.2	0.0	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.9	0.3	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAJIN	C11orf85	ENSG00000168070	"Membrane anchored junction protein"	Q3KP22	11	64937517-64972085	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 43.7"	"Group enriched"	"Detected in some"	15	"Distal tubular cells: 3.3;Proximal tubular cells: 4.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebellum: 4.9"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.1;naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Group enriched"	"Detected in some"	9	"CAPAN-2: 12.5;SiHa: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.37e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.69e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-2)"	0.2	0.2	0.2	1.2	0.7	0.0	0.2	4.9	0.4	0.3	0.2	0.1	0.7	0.0	0.2	2.2	0.2	1.1	2.9	0.4	0.1	0.1	1.4	1.0	0.2	1.5	0.2	0.0	0.1	1.7	0.0	1.5	0.0	0.7	0.3	0.1	0.5	0.3	0.6	0.1	1.2	0.6	0.0	0.2	1.6	0.2	43.7	0.0	0.0	0.8	0.1	1.2	0.3	0.5	4.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	4.9	0.4	0.1	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 347.5;Early spermatids: 112.5;Rod photoreceptor cells: 298.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	2.9	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.6	0.0	0.6	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.1	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.4	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7	0.0	5.4	0.0	2.4	0.3	11.3	0.6	0.0	57.6	7.9	3.5	347.5	0.4	0.0	0.3	112.5	1.1	0.0	0.0	0.2	0.7	0.4	1.2	2.3	0.0	0.2	4.8	0.0	1.3	0.0	27.7	0.6	0.9	1.7	0.0	0.0	15.7	0.1	0.0	0.4	0.0	298.8	0.0	1.0	7.0	6.0	0.4	0.7	0.0	0.0	0.8
MAMDC4	"AEGP, DKFZp434M1411"	ENSG00000177943	"MAM domain containing 4"	Q6UXC1	9	136850943-136860799	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;liver: 48.9"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 19.8;Hepatocytes: 16.6;Horizontal cells: 15.9;Mucus-secreting cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	10	"cerebellum: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB026377, HPA059977"			Approved	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"CAB026377: , HPA059977: AB_2684186"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.37e-2)"	"prognostic favorable (1.88e-6)"	"unprognostic (8.22e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	2.0	1.6	1.2	1.9	1.5	1.4	1.2	14.9	1.2	1.2	2.3	1.2	1.2	5.0	1.2	1.2	1.2	1.7	1.2	1.6	1.2	0.4	2.6	48.9	1.2	2.5	1.2	1.2	1.2	3.4	0.5	7.2	1.2	1.2	3.2	0.9	1.2	3.5	1.4	1.7	1.5	6.1	1.2	1.2	5.1	2.3	6.5	1.2	1.2	5.1	1.2	1.2	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	1.6	2.6	1.5	2.9	0.6	0.1	18.9	2.7	0.3	0.3	0.6	2.0	1.6	1.4	0.6	0.7	0.8	2.2	0.3	1.3	0.0	2.1	0.9	0.8	5.3	2.3	1.2	0.2	4.9	0.8	1.7	1.4	0.6	1.4	0.6	2.5	2.7	1.2	0.2	4.2	1.0	3.7	1.4	1.1	0.7	1.6	0.4	2.5	0.9	1.4	1.7	2.1	0.6	1.3	1.1	1.0	4.4	0.9	0.8	7.6	4.8	1.5	0.4	3.1	1.6	0.4	1.7	2.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	14.9	1.2	1.2	0.4	1.2	1.2	1.2	1.2	0.0	4.3	0.0	0.8	0.7	5.4	6.2	12.7	2.7	0.0	1.8	0.0	2.2	1.7	0.8	1.7	1.4	19.8	0.0	4.4	2.8	2.6	1.3	0.0	16.6	2.4	15.9	0.0	2.5	2.4	1.9	1.7	2.2	0.0	1.0	19.5	2.6	0.9	12.5	1.4	2.1	7.4	0.0	1.4	1.2	2.2	0.4	1.9	1.3	10.3	0.7
MAML3	"CAGH3, GDN, KIAA1816, MAM2, TNRC3"	ENSG00000196782	"Mastermind like transcriptional coactivator 3"	Q96JK9	4	139716753-140154184	"Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 29.1"	"Cell type enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 11.5;SCLC-21H: 12.1;SH-SY5Y: 18.5;WM-115: 15.4"	"Low region specificity"	"Detected in many"							HPA037717	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA037717: AB_10794323"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.83e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.89e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (7.60e-5)"	"unprognostic (3.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.88e-1)"	5.9	5.5	6.0	10.3	4.2	3.9	6.4	29.1	4.1	10.0	6.3	5.4	8.3	6.8	19.4	11.5	10.5	8.4	11.2	3.7	3.2	3.6	4.2	4.8	6.8	6.0	4.9	2.8	13.3	11.3	7.4	16.7	7.2	5.8	8.4	5.7	5.5	15.3	16.2	2.5	12.9	6.2	9.2	7.8	4.9	6.0	6.5	5.1	13.5	6.2	5.9	6.8	8.9	8.9	0.6	1.8	11.0	1.9	3.9	0.6	1.3	0.4	6.1	4.2	2.1	1.7	3.5	3.8	0.7	3.4	0.3	0.2	2.4	1.7	1.3	0.4	0.6	0.2	0.1	1.6	1.4	0.2	0.0	0.9	4.3	1.4	0.2	0.3	2.0	6.8	3.4	1.2	0.1	0.7	2.6	11.5	0.1	1.1	0.0	0.2	0.6	0.4	0.9	1.0	2.7	2.7	2.6	0.4	2.6	1.9	8.4	12.1	18.5	0.0	3.2	4.1	3.4	1.8	0.6	9.8	0.5	1.1	0.0	1.4	2.3	2.5	0.0	0.6	6.9	15.4	11.0	1.9	3.5	0.0	1.3	0.2	0.0	0.0	0.0	1.8	0.6	0.6	0.5	4.5	3.9	1.2	1.5	0.0	1.3	6.0	4.2	29.1	4.1	3.2	3.6	4.9	2.8	5.8	5.1	3.0	8.6	1.7	7.0	7.1	5.7	2.8	15.3	9.4	12.5	5.2	17.7	4.4	5.0	4.4	3.5	8.8	9.2	0.0	4.5	6.2	4.2	9.2	18.5	16.3	6.9	11.1	14.3	8.6	21.2	7.2	3.7	15.8	3.3	2.8	12.8	2.8	2.5	11.8	3.5	4.3	3.3	0.0	6.2	0.5	1.7	11.8	6.9	1.3	11.0	5.8
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 17.3;brain: 13.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 1.9;Cardiomyocytes: 2.5;Collecting duct cells: 5.2;Cone photoreceptor cells: 3.9;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"pons and medulla: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;HAP1: 7.9;HEK 293: 6.7;JURKAT: 3.9;REH: 4.1;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA004006			Approved	Vesicles		NA	NA			Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.1	17.3	0.5	0.4	0.3	0.5	0.1	2.3	0.1	0.1	0.1	5.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.5	3.6	0.1	0.5	0.0	0.1	0.0	1.3	4.1	0.4	5.7	0.0	13.2	0.1	0.0	4.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	2.6	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.4	0.0	7.9	0.0	0.0	1.3	6.7	2.7	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.2	0.0	2.1	2.0	0.0	0.8	4.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.3	0.1	0.4	0.5	0.1	0.0	13.2	0.0	0.0	1.9	0.0	0.6	0.1	0.6	2.5	0.0	0.0	0.0	5.2	3.9	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0
MAP3K19	"FLJ23074, RCK, YSK4"	ENSG00000176601	"Mitogen-activated protein kinase kinase kinase 19"	Q56UN5	2	134964491-135047468	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 18.3;fallopian tube: 23.9"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 151.3;Early spermatids: 55.2;Late spermatids: 74.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 18.3"	"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.5"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.1;U-266/70: 2.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 20.2"	HPA011388			Uncertain	Cytosol		NA	NA			Cytosol		"HPA011388: AB_1848822"	"unprognostic (7.12e-3)"	"unprognostic (6.55e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.04e-6)"	"unprognostic (1.50e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.83e-4)"	0.1	0.2	1.7	0.2	6.2	0.1	0.1	0.0	0.5	1.1	0.2	7.3	0.0	0.2	1.0	6.7	0.2	23.9	0.1	0.1	2.9	3.8	0.2	0.2	5.6	0.2	0.5	1.5	7.3	0.1	0.1	1.0	0.1	18.3	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	7.6	3.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	4.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	6.2	0.0	0.5	2.9	3.8	0.5	1.5	18.3	3.1	0.0	0.6	0.0	0.0	0.0	0.2	0.4	0.0	151.3	17.0	0.0	9.8	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	74.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.1	0.0	0.0	0.0	0.0	0.1
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 85.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.2	0.0	1.3	0.0	0.0	5.4	0.1	0.2	0.0	1.1	1.6	0.0	14.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.3	2.7	0.0	0.0	13.9	0.0	0.0	2.0	1.2	1.1	0.0	3.0	0.4	0.9	1.3	4.0	4.0	0.0	2.8	0.0	0.2	12.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0.0	8.3	0.0	0.2	0.3	0.0	0.8	0.0	85.6	13.6	0.0	0.0	0.0	0.0	0.6	12.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.3	0.1	0.0	0.1	0.0
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell type enriched"	"Detected in some"	68	"Hepatocytes: 541.9"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.5	0.8	0.0	0.0	0.0	1.3	1.1	2.4	0.7	0.0	0.6	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.6	20.5	0.0	2.2	1.7	0.0	0.0	0.1	0.0	2.0	0.0	1.9	0.8	0.5	0.0	0.6	0.6	1.2	0.4	0.2	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	1.8	0.6	1.3	1.2	0.9	0.6	1.0	0.6	0.8	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.0	3.4	0.2	0.8	0.0	0.4	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	541.9	0.1	0.0	0.0	8.0	7.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 2.9"	"Group enriched"	"Detected in some"	5	"classical monocyte: 36.5;neutrophil: 16.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.6;monocytes: 36.5"	"Group enriched"	"Detected in some"	6	"THP-1: 19.2;U-937: 59.8"									HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	2.2	0.3	0.3	10.0	0.5	30.9	0.5	0.4	0.9	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.3	1.2	0.2	4.8	0.2	0.2	0.6	1.3	66.4	11.8	2.9	0.0	0.4	0.4	0.0	0.1	0.8	0.6	0.4	0.0	0.1	0.6	0.0	0.2	0.1	0.3	2.4	0.9	24.2	0.6	0.7	0.3	0.3	0.7	0.0	0.1	0.5	2.9	0.0	5.3	16.6	36.5	0.2	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.8	0.0	0.0	36.5	0.9	0.1	2.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.1	16.6	0.2	0.1	0.3	0.1	11.6	0.3	0.5	0.4	0.9	0.2	0.2	2.9	0.0	0.6	0.3	17.9	34.6	1.4	0.0	0.0	0.0	0.3	0.0	9.4	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.0	0.0	30.0	0.0	0.0	0.0	41.3	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
MCHR2	"GPR145, MCH2, MCH2R, SLT"	ENSG00000152034	"Melanin concentrating hormone receptor 2"	Q969V1	6	99919910-99994247	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	15	"brain: 14.9;testis: 5.5"	"Cell type enriched"	"Detected in single"	5	"Early spermatids: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.3;cerebral cortex: 14.9;olfactory region: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HMC-1: 1.9;U-266/70: 1.8"					"Region enhanced"	"Detected in single"		"cerebral cortex: 0.9"							NA	NA										"unprognostic (5.76e-2)"													0.2	0.2	1.9	0.3	6.3	0.3	0.2	0.2	14.9	0.2	0.5	0.0	0.0	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.7	0.6	0.2	0.2	0.2	0.3	0.5	4.4	0.3	0.2	0.2	0.2	0.2	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.3	0.5	0.2	0.2	0.2	0.3	5.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.3	0.2	0.6	0.2	0.5	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.5	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.2	0.0	0.4	0.1	0.1	0.2	0.2	1.8	0.9	0.3	0.0	0.1	0.0	0.6	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.3	0.0	0.3	0.1	0.1	0.3	0.5	0.0	0.2	0.2	0.1	1.9	6.3	0.2	14.9	0.7	0.6	0.5	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		1400000	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	8.2	6.5	6.3	9.4	6.1	12.3	9.8	41.0	6.8	7.0	19.8	4.1	8.5	19.1	10.9	7.4	13.4	7.8	11.5	6.9	4.8	4.3	11.1	7.2	10.1	7.4	3.4	4.1	5.8	12.1	8.2	5.5	8.8	5.5	4.6	21.9	5.1	9.5	5.8	41.4	9.0	23.0	11.0	3.8	4.9	29.4	4.7	3.5	4.9	5.4	14.9	7.3	10.1	15.0	3.4	5.4	16.6	7.6	1.9	4.6	3.6	19.7	32.0	8.3	6.0	12.7	14.3	8.5	12.2	17.4	12.2	13.1	19.0	18.9	8.4	9.8	14.9	6.6	18.1	10.9	14.5	16.4	9.2	10.2	10.5	12.0	10.5	9.9	26.3	8.9	14.5	12.4	10.9	23.4	19.2	14.6	9.0	6.5	6.3	11.3	11.5	7.1	5.7	9.2	21.6	6.7	7.4	17.8	2.2	16.5	10.8	8.9	3.9	15.0	16.8	3.6	10.5	3.3	6.9	11.8	5.9	10.2	12.7	8.1	4.7	5.9	5.9	7.9	13.2	4.5	1.7	6.1	16.6	2.9	6.7	3.1	3.4	3.0	3.5	5.4	1.7	2.3	2.6	8.2	1.9	7.6	1.9	4.6	3.6	6.3	6.1	41.0	6.8	4.8	4.3	3.4	4.1	5.5	3.5	32.8	13.4	2.7	10.4	10.4	3.0	5.9	10.2	18.7	26.1	17.4	2.0	6.4	1.7	7.2	10.7	7.4	22.6	0.0	22.1	8.3	6.7	8.1	8.1	5.0	6.3	0.0	8.1	8.6	6.3	4.7	4.9	3.7	8.5	2.8	24.0	4.8	27.5	8.6	3.9	6.1	3.3	12.9	8.9	3.9	4.9	10.8	7.8	2.5	20.4	20.7
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 94.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	17	"cerebellum: 94.7"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 3.1"	"Group enriched"	"Detected in many"	22	"B-cells: 1.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;HaCaT: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	1.5	3.7	3.4	3.1	2.4	0.0	1.0	94.7	5.1	3.0	1.3	1.5	1.0	0.0	3.0	1.5	1.8	2.1	3.4	1.2	5.0	2.0	0.8	0.5	3.5	3.4	1.7	2.4	8.4	2.6	6.6	2.6	0.5	5.4	1.5	1.1	3.4	0.7	1.2	0.9	6.7	1.5	2.6	4.1	3.9	1.2	1.4	1.3	0.6	1.1	1.7	2.7	1.1	3.1	1.1	0.0	0.0	0.0	0.0	3.1	0.4	0.1	3.8	6.9	2.6	13.8	5.6	3.0	2.7	2.7	3.4	3.9	0.7	0.0	0.9	0.6	1.7	3.6	8.9	0.5	0.0	1.1	6.9	4.0	0.0	0.5	0.0	0.6	0.0	0.9	1.0	0.1	1.4	0.0	8.0	0.0	0.1	0.1	0.0	1.2	0.1	0.0	0.5	0.0	0.1	0.4	7.3	2.4	0.0	0.8	4.2	6.3	0.0	1.5	0.4	3.3	0.2	3.2	0.6	0.5	3.7	1.2	1.3	5.0	0.0	0.1	0.0	5.8	1.1	2.4	0.0	0.0	0.0	1.4	0.0	0.4	1.1	1.2	0.8	0.0	1.0	3.1	0.8	0.0	0.0	0.0	0.0	1.8	0.4	3.4	2.4	94.7	2.7	5.0	2.0	1.7	2.4	5.4	1.3	8.9	0.3	0.0	1.7	2.1	31.7	5.2	0.0	2.7	1.2	3.5	47.1	0.1	0.0	0.6	1.9	1.0	0.0	0.0	0.0	1.2	2.4	1.5	0.0	0.0	0.1	54.0	1.7	1.8	0.0	0.0	9.5	0.0	1.7	0.0	0.0	2.3	0.6	0.0	4.6	0.1	1.3	0.0	3.4	2.3	1.0	2.6	0.6	0.5	0.0	3.8
MEDAG	"AWMS3, C13orf33, FLJ14834, MEDA-4"	ENSG00000102802	"Mesenteric estrogen dependent adipogenesis"	Q5VYS4	13	30906191-30925572	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 63.0"	"Cell type enhanced"	"Detected in some"	16	"Fibroblasts: 43.8;Leydig cells: 17.5;Smooth muscle cells: 18.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.6"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC diff: 77.9;ASC TERT1: 21.9;U-2197: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (8.69e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.41e-3)"	"unprognostic (7.52e-2)"	63.0	1.9	0.1	7.4	0.3	0.2	43.8	0.1	0.4	9.0	10.0	0.3	7.5	1.2	10.2	24.8	13.3	14.5	7.2	18.6	0.4	0.4	2.0	0.4	5.3	7.3	0.4	0.5	17.9	6.8	0.5	2.2	6.4	2.6	3.6	3.2	4.6	6.0	1.7	27.1	8.0	3.5	10.8	2.4	0.4	5.2	9.5	0.1	0.0	15.3	12.7	3.6	21.5	10.5	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	77.9	21.9	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	9.2	0.0	11.1	0.0	0.0	10.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	9.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	11.1	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.4	0.4	0.4	0.5	2.6	0.1	0.0	0.3	0.0	0.0	10.2	0.0	4.2	0.0	1.4	2.3	0.0	0.0	0.1	0.0	1.2	1.0	6.7	0.0	0.0	0.0	0.4	43.8	1.0	0.0	0.0	0.9	0.0	0.0	1.3	0.0	1.3	17.5	0.6	10.1	0.0	0.0	0.0	0.3	0.0	9.2	0.1	0.0	0.0	18.8	0.0	0.0	9.2	0.2	0.0	0.0	0.5
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 34.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 34.2;cerebral cortex: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.0"					"Group enriched"	"Detected in some"	4	"amygdala: 1.3;basal ganglia: 0.7"	"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"	NA	NA		24000000			"HPA038003: AB_2675780, HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.2	0.2	34.2	0.2	5.2	0.3	0.5	0.0	10.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	2.4	1.7	0.3	0.2	0.3	0.2	0.5	5.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	5.2	0.0	10.0	2.4	1.7	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MFRP	"C1QTNF5, FLJ30570, NNO2, rd6"	ENSG00000235718	"Membrane frizzled-related protein"	Q9BY79	11	119338942-119346673	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Microphthalmia, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"brain: 54.9;retina: 112.9"	"Cell type enriched"	"Detected in single"	27	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	10	"pons and medulla: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.5;JURKAT: 1.0;NB-4: 1.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9"	"Low region specificity"	"Detected in some"									NA	NA																							0.9	0.3	0.6	0.0	0.4	0.1	0.1	0.2	2.8	0.2	0.1	14.6	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.2	5.5	0.5	0.2	0.1	0.3	0.2	0.8	0.0	0.1	0.1	2.0	0.5	0.6	54.9	0.1	0.0	112.9	0.1	0.1	0.5	0.1	0.2	0.4	0.4	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.4	0.2	2.8	5.5	0.5	0.8	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MFSD2B		ENSG00000205639	"Major facilitator superfamily domain containing 2B"	A6NFX1	2	24010081-24063321	"Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.4;brain: 7.5;placenta: 7.5"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 46.7;Glandular cells: 24.5;Urothelial cells: 32.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 7.5"	"Cell type enriched"	"Detected in some"	4	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	14	"HEL: 13.1;K-562: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044145	Enhanced					NA	NA					"HPA044145: AB_2678833"	"unprognostic (5.67e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.84e-1)"	"unprognostic (5.35e-5)"	"unprognostic (2.82e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.87e-6)"	"unprognostic (7.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-1)"	0.2	0.1	0.1	0.6	7.5	17.4	0.2	0.1	0.3	0.3	0.4	0.0	1.1	0.3	0.5	0.3	0.1	0.2	0.2	0.5	0.1	0.4	0.1	0.4	3.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	7.5	0.3	1.2	0.2	0.2	1.0	0.1	0.5	0.2	0.2	0.1	0.3	2.3	0.2	2.0	0.0	0.1	0.1	0.0	0.4	0.8	1.8	0.0	0.2	5.5	0.0	0.2	0.0	3.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	5.6	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.0	3.4	0.1	7.5	0.1	0.3	0.1	0.4	0.3	0.0	0.3	0.0	0.0	2.2	1.5	12.3	9.0	0.6	3.9	2.5	0.0	0.0	0.0	3.9	5.7	3.3	1.2	0.5	1.4	0.9	46.7	1.6	3.6	1.8	24.5	4.7	0.0	2.8	0.0	1.2	0.0	0.8	0.2	0.0	1.1	0.0	0.0	3.3	0.2	6.3	2.9	0.0	0.0	1.3	0.0	0.9	0.6	2.5	9.8	6.3	1.5	4.7	32.0
MGARP	"C4orf49, CESP-1, HUMMR, OSAP"	ENSG00000137463	"Mitochondria localized glutamic acid rich protein"	Q8TDB4	4	139266163-139280338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 88.9;retina: 30.7"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;cerebellum: 8.0"	"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4"					"Low region specificity"	"Detected in some"			"HPA015994, HPA070835"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA015994: AB_2630370, HPA070835: "	"unprognostic (2.68e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.36e-1)"	3.2	88.9	1.0	0.5	4.5	0.4	1.2	8.0	1.2	3.6	1.0	2.1	1.1	0.4	2.6	3.0	0.5	0.8	1.3	6.1	0.8	1.4	1.0	0.4	0.5	0.6	1.0	0.0	20.1	0.5	0.4	15.3	0.5	1.5	2.0	0.5	30.7	0.4	2.0	0.6	0.5	0.4	2.3	0.7	0.6	0.4	5.9	0.5	0.0	0.5	0.0	0.5	2.1	1.0	0.5	0.0	0.0	0.3	0.5	1.7	0.3	0.0	0.5	0.3	0.2	0.8	0.4	0.0	10.7	0.0	1.6	0.0	0.0	0.1	0.0	0.1	15.9	4.6	0.2	2.3	0.0	0.9	0.0	1.0	0.0	0.0	0.1	12.9	0.1	0.1	3.9	0.3	1.7	0.1	3.8	32.4	0.1	0.2	0.2	2.6	0.0	0.4	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	4.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	1.7	0.4	0.0	0.3	1.6	0.7	0.0	0.5	0.2	0.0	0.3	0.3	1.0	4.5	8.0	1.2	0.8	1.4	1.0	0.0	1.5	0.5	0.0	0.0	0.0	0.7	1.4	140.5	2.5	0.0	0.0	0.0	0.0	7.9	0.2	1.7	0.0	0.2	0.2	0.0	0.0	0.0	0.1	2.4	0.3	0.0	0.0	0.5	197.0	0.0	0.6	0.0	0.0	15.8	0.0	0.0	0.0	0.0	424.1	0.1	0.0	23.3	7.6	28.7	0.0	0.4	0.7	0.3	0.6	0.2	0.0	0.0	0.3
MGP		ENSG00000111341	"Matrix Gla protein"	P08493	12	14881181-14885926	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Developmental protein"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Fibroblasts: 1780.1;Ito cells: 1289.1;Leydig cells: 1866.9;Peritubular cells: 1223.8;Sertoli cells: 827.9"	"Cancer enhanced"	"Detected in all"		"breast cancer: 845.3"	"Group enriched"	"Detected in many"	4	"olfactory region: 7.9;pons and medulla: 22.5"	"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 4.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.8"	"Cell line enriched"	"Detected in some"	5	"AN3-CA: 471.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013949	Approved				"Secreted to blood"	NA	NA		15000000			"HPA013949: AB_1853599"	"unprognostic (5.71e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.97e-3)"	97.0	82.5	0.7	53.2	2.2	0.0	303.5	1.6	3.2	190.5	93.5	5.7	145.0	5.1	149.5	404.0	94.1	118.3	82.0	156.2	1.9	1.1	120.8	6.8	109.2	24.7	3.5	7.9	86.5	22.9	4.8	54.4	18.8	22.5	189.7	21.3	195.1	245.8	96.5	33.3	20.1	45.2	160.5	13.0	11.0	55.8	143.0	0.8	2.1	203.9	58.8	16.0	183.7	135.7	0.0	4.8	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	471.2	79.7	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.6	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	1.4	0.0	0.4	0.0	0.1	86.3	0.0	1.0	0.5	0.0	0.1	1.3	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.7	2.2	1.6	3.2	1.9	1.1	3.5	7.9	22.5	0.8	17.9	88.3	12.5	172.0	132.6	0.6	41.2	0.0	45.5	342.4	109.9	3.9	17.9	1.7	1.6	12.8	555.1	0.0	0.0	72.4	10.5	1780.1	99.4	12.8	2.6	28.3	0.0	0.0	1289.1	5.4	23.5	1866.9	34.3	214.2	4.6	0.0	27.6	1.3	0.0	1223.8	0.6	5.5	827.9	564.2	6.8	5.6	103.5	33.1	3.2	0.0	53.8
MIA	CD-RAP	ENSG00000261857	"Melanoma inhibitory activity"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 16.1;breast: 28.7;pituitary gland: 33.5;salivary gland: 22.7;stomach 1: 28.9"	"Group enriched"	"Detected in some"	10	"Melanocytes: 97.8;monocytes: 52.3;Pancreatic endocrine cells: 38.8"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Region enriched"	"Detected in some"	8	"midbrain: 16.1"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.0"	"Group enriched"	"Detected in some"	31	"AN3-CA: 21.8;CAPAN-2: 18.3;SK-MEL-30: 63.5;WM-115: 60.2"									HPA042369	Approved				"Secreted to blood"	NA	NA	8270000				"HPA042369: AB_10794420"	"prognostic favorable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	0.7	1.5	0.6	3.5	0.6	1.4	28.7	0.9	0.4	3.7	6.1	0.5	2.2	0.8	2.8	3.2	4.0	1.0	3.2	4.1	0.4	0.4	0.9	0.8	1.4	0.7	16.1	0.4	2.6	0.4	0.0	33.5	0.9	2.1	2.2	1.9	6.0	22.7	1.7	0.8	4.5	2.2	3.4	3.1	2.4	28.9	1.0	0.4	0.5	1.1	5.9	4.4	2.0	1.5	0.7	0.0	3.0	0.1	0.0	0.3	0.1	0.0	0.1	0.2	21.8	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	18.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	63.5	0.8	0.1	0.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	0.1	60.2	1.6	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.9	0.4	0.4	0.4	16.1	0.4	2.1	0.4	0.0	0.3	0.0	0.1	4.6	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.6	0.7	0.0	2.7	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.6	0.0	97.8	52.3	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.6	0.0	0.5	0.4
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.8	6.3	0.3	1.4	1.6	3.0	7.5	18.9	21.4	7.4	11.6	13.2	8.5	0.3	4.1	13.2	21.2	8.4	2.3	30.4	18.4	13.7	1.5	11.2	1.2	0.9	14.2	2.1	1.4	5.3	5.4	32.6	31.9	13.8	16.9	0.8	19.5	0.5	11.9	0.7	0.1	1.0	0.4	8.4	5.9	0.1	7.5	7.9	1.5	14.9	6.1	0.5	6.2	17.3	1.2	4.7	1.7	0.6	30.1	40.3	15.2	6.6	16.4	0.4	0.9	0.4	24.5	3.0	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6	38.7	29.6	4.2	6.7	9.0	2.8	28.1	7.6	5.3	11.4	3.5	0.0	2.1	0.0	9.6	73.9	7.1	31.5	23.3	12.4	9.5	4.5	7.0	1.1	17.8	3.0	0.0	21.7	11.1	11.1	128.9	19.5	8.9	5.0	8.2	10.0	0.2	29.0	14.1	106.1	0.6	1.6	12.9	27.6	0.9	0.9	8.3	1.9	9.2	9.9	9.7
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227054	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 23.9;lymphoid tissue: 8.9"	"Cell type enhanced"	"Detected in single"	17	"Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Group enriched"	"Detected in some"	5	"cerebellum: 5.1;cerebral cortex: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;Hep G2: 13.3;SuSa: 3.1;U-698: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA005662			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.6	0.2	0.6	8.9	0.4	0.3	0.3	5.1	1.8	0.7	1.4	0.4	0.0	2.7	0.4	0.1	0.6	0.3	0.2	0.4	0.6	0.6	0.3	0.6	0.5	8.2	0.6	0.0	1.2	0.2	2.3	0.3	0.3	0.6	1.0	1.1	0.2	4.9	0.4	0.2	0.3	1.3	0.0	0.5	7.8	1.4	2.2	0.0	1.0	0.4	0.7	7.0	2.6	0.3	7.5	7.7	23.9	12.2	14.6	9.5	4.0	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.1	2.7	0.0	0.2	0.0	0.1	0.2	0.2	13.3	0.7	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.2	1.9	0.0	0.1	0.1	0.0	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	3.1	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	23.9	4.7	8.4	4.8	7.1	9.5	7.5	5.6	5.4	4.8	7.2	7.4	7.3	12.9	14.6	12.2	7.7	7.1	4.0	0.6	0.4	5.1	1.8	0.6	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 71.4;Hepatocytes: 220.3;Intestinal endocrine cells: 86.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Region enhanced"	"Detected in many"		"cerebellum: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 30.1;K-562: 9.0;SCLC-21H: 16.2;T-47d: 7.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	30.0	18.0	4.2	0.8	3.9	0.5	10.9	20.4	6.8	1.1	16.5	0.4	2.6	33.2	0.4	22.1	1.0	3.5	5.5	1.8	3.2	1.7	11.6	103.6	0.9	0.4	1.2	4.0	2.0	6.5	4.0	3.9	0.4	5.0	0.9	1.3	1.1	2.7	0.9	24.7	1.2	27.1	0.7	1.2	0.4	3.5	5.7	0.0	0.0	2.0	7.7	0.4	0.8	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.6	0.0	3.7	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.1	4.6	0.0	2.5	30.1	0.8	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	3.5	0.0	0.0	0.4	4.8	0.7	0.0	0.0	0.7	0.0	0.0	16.2	0.4	0.5	2.5	0.0	0.0	7.3	3.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	20.4	6.8	3.2	1.7	1.2	4.0	5.0	0.0	0.0	14.4	0.0	4.4	1.0	3.5	2.1	71.4	5.3	7.9	3.5	19.6	0.1	1.7	1.8	1.7	1.5	5.2	0.0	0.9	0.1	2.5	2.1	0.0	220.3	0.4	1.6	86.4	12.3	11.6	0.2	2.6	1.7	6.8	0.0	7.7	2.8	2.2	4.2	1.1	9.9	7.4	0.0	1.9	3.6	0.9	0.6	0.5	2.9	10.3	2.5
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2632990	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 28.1;Early spermatids: 82.5;Late spermatids: 27.3;Paneth cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"	NA	NA					"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	1.5	0.5	0.8	1.8	8.5	0.6	1.8	0.4	0.6	4.3	4.2	0.4	1.9	3.2	0.8	10.3	3.0	3.0	9.6	1.3	1.0	2.6	1.4	0.4	1.4	1.4	1.7	0.4	1.1	7.3	0.3	0.4	0.7	0.5	4.2	1.4	0.4	2.0	2.0	0.4	0.3	2.6	0.9	0.7	1.4	7.9	30.2	0.9	0.8	1.1	0.8	0.8	3.7	1.6	0.6	1.1	6.6	5.1	2.3	6.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.5	0.0	17.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.5	6.6	0.5	3.9	0.3	0.6	1.7	0.7	1.1	0.0	4.5	2.2	1.0	2.3	5.1	0.2	6.1	2.2	0.8	8.5	0.4	0.6	1.0	2.6	1.7	0.4	0.5	0.9	0.0	0.0	0.0	4.6	0.0	0.0	0.8	28.1	10.7	2.3	17.4	0.0	0.0	0.0	7.1	82.5	0.6	15.7	0.0	3.1	0.0	0.3	12.4	0.0	0.0	1.3	0.0	1.2	0.6	1.5	27.3	1.7	0.5	0.0	0.0	14.9	0.5	2.7	37.7	1.1	0.0	0.0	0.0	0.4	0.5	0.9	0.0	0.0	0.0	9.7	10.9
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770503-102780628	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"endometrium 1: 89.4"	"Cell type enhanced"	"Detected in some"	14	"Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 102.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2"	"Not detected"	"Not detected"							CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000		Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.1	0.0	2.6	0.2	0.1	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.4	89.4	0.1	0.2	0.1	0.5	0.1	0.0	0.1	0.1	3.6	11.0	0.1	0.0	0.0	0.5	0.3	0.1	0.9	19.8	2.8	3.2	0.2	0.0	2.9	0.1	0.1	0.1	0.7	0.1	0.0	0.2	3.3	0.5	0.0	1.2	0.1	0.0	1.9	0.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	12.6	0.7	0.1	0.1	0.3	0.0	0.0	3.7	1.9	0.2	2.9	0.0	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.6	0.0	16.2	0.0	0.7	0.0	0.0	0.0	0.0	0.3	3.0	0.5	1.7	0.0	0.0	0.0	0.0	0.7	5.2	0.0	2.5	0.0	0.0	0.9	0.0	0.0	2.0	3.9	1.3	0.4	0.5	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	38.9	0.7	0.0	0.0	0.0	5.3	70.5	27.9	0.0	0.0	0.0	9.8	5.0	0.0	0.0	0.0	12.9	0.0	0.2	5.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	2.8	0.0	0.0	62.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	7.4
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	20.1	0.0	0.1	0.1	0.0	0.6	1.1	1.3	2.1	1.1	30.6	5.4	0.0	9.0	1.4	0.7	0.3	4.7	0.0	0.9	0.1	0.2	1.1	0.6	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	7.7	0.0	1.4	0.0	0.1	0.0	13.8	0.1	8.0	5.5	1.4	0.5	0.2	1.8	0.3	0.1	0.3	4.3	10.4	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4	14.9	1.0	0.0	0.1	0.1	3.6	0.6	12.7	0.0	2.3	1.8	0.0	0.0	5.0	7.5	0.6	0.7	0.3	0.0	0.8	0.1	0.2	0.4	0.0	0.2	0.0	14.3	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	0.2	2.1	0.0	0.0	7.3	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell type enriched"	"Detected in many"	6	"Ductal cells: 5335.6"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000		"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	129.5	0.0	30.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	56.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0.0	310.5	0.9	0.0	0.6	119.8	113.8	646.0	964.8	0.0	0.3	0.0	5335.6	3.9	0.3	0.0	0.0	184.1	0.2	0.4	323.2	2.3	0.0	103.8	0.0	0.0	0.0	0.0	6.5	10.9	7.3	0.0	113.6	0.0	0.0	723.2	0.0	0.0	6.0	0.0	0.0	0.4	0.0	0.1	2.0	0.7	0.0	0.0	640.3
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711795-102727050	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 119.3"	"Cell type enriched"	"Detected in single"	32	"Hofbauer cells: 4.3"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Group enriched"	"Detected in some"	32	"neutrophil: 1.4;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	32	"granulocytes: 1.4;monocytes: 4.9"	"Cell line enriched"	"Detected in some"	8	"WM-115: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA022935"	Enhanced				"Secreted to extracellular matrix"	NA	NA		83000			"HPA021221: AB_1854043, HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.1	9.0	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0.0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0.0	0.1	0.2	7.6	0.0	0.0	1.4	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	0.0	0.0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MNS1	"FLJ11222, SPATA40"	ENSG00000138587	"Meiosis specific nuclear structural 1"	Q8NEH6	15	56421544-56465137	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.2;testis: 36.4"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 285.0;Early spermatids: 279.9;Spermatocytes: 128.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039975, HPA040382"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA039975: AB_10793858, HPA040382: AB_10794740"	"unprognostic (7.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.20e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.71e-2)"	1.6	1.4	3.2	2.7	4.9	3.2	2.6	35.2	6.7	4.3	2.0	2.1	0.6	2.0	3.2	5.4	2.4	17.6	2.9	2.1	4.1	4.0	7.9	1.8	2.9	1.2	2.1	4.9	4.0	2.1	0.8	10.7	1.4	11.4	3.8	1.9	1.1	1.8	1.7	1.2	1.3	1.8	1.9	3.2	1.3	1.9	36.4	2.4	3.3	2.6	1.4	1.1	1.6	2.2	0.1	0.8	0.0	0.4	0.0	0.0	0.0	19.2	4.5	2.4	7.1	2.0	4.3	0.4	4.7	2.7	5.6	11.9	6.4	9.3	10.8	6.0	2.0	8.1	7.6	2.9	2.7	11.4	0.0	1.2	13.9	5.0	1.1	0.7	4.7	1.5	1.7	0.1	11.3	1.6	2.3	1.0	4.2	3.1	0.0	4.7	2.5	0.1	5.9	0.7	10.0	2.7	9.0	14.2	0.1	5.4	3.8	18.7	5.7	7.8	2.4	8.2	0.6	5.7	7.3	0.4	7.6	8.7	7.3	11.4	2.2	7.1	0.2	8.5	11.2	8.7	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	3.2	4.9	35.2	6.7	4.1	4.0	2.1	4.9	11.4	2.4	0.0	6.6	0.8	7.2	3.0	9.7	5.2	5.1	285.0	42.1	33.2	23.6	0.5	10.0	7.1	279.9	1.4	0.0	0.0	1.7	3.1	10.3	2.0	0.0	0.0	5.6	14.3	1.2	7.4	1.0	16.7	11.8	3.0	0.0	1.0	0.7	12.0	1.2	0.0	8.1	9.1	31.9	0.0	3.6	128.6	20.6	1.3	0.5	0.0	3.7	0.9
MPP3	DLG3	ENSG00000161647	"Membrane palmitoylated protein 3"	Q13368	17	43800799-43833170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 24.5;Early spermatids: 39.4;Late spermatids: 56.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 46.7;pons and medulla: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 6.6;SCLC-21H: 13.3;T-47d: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021818, HPA024742"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021818: AB_1854086, HPA024742: AB_1854087"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.23e-5)"	"unprognostic (4.59e-3)"	"unprognostic (5.63e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.02e-11)"	"unprognostic (9.98e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.75e-2)"	5.1	2.0	4.8	2.1	2.9	0.6	5.1	46.7	5.2	3.3	1.7	2.2	4.5	1.4	3.5	4.0	3.0	2.7	5.4	12.3	2.7	5.0	2.1	1.2	7.4	1.3	3.0	1.5	1.7	5.9	3.0	2.6	2.1	13.0	3.0	1.1	1.7	1.6	4.3	1.5	2.4	1.3	3.5	2.5	2.2	4.3	3.7	1.1	0.0	1.7	0.9	1.4	1.6	4.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.6	3.1	0.8	0.8	1.8	1.4	0.0	1.6	0.6	1.2	0.7	1.2	1.9	0.0	0.6	1.3	0.8	1.5	1.2	2.3	1.8	0.0	1.6	1.5	3.7	0.7	0.1	0.0	0.1	0.9	3.1	2.1	6.6	3.7	1.6	0.3	0.9	0.0	0.6	0.9	0.0	0.0	0.8	0.7	1.2	0.0	1.0	0.4	4.4	0.6	13.3	3.5	0.8	2.8	0.5	1.1	7.1	1.6	1.4	3.5	3.3	0.9	3.0	0.9	0.4	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	2.9	46.7	3.3	2.7	5.0	3.0	1.5	13.0	1.1	11.9	2.6	0.0	5.5	3.5	1.9	24.5	7.6	0.0	6.8	1.8	0.0	0.1	0.0	3.4	39.4	2.7	0.7	0.0	1.2	0.5	2.6	4.8	1.1	0.9	0.9	9.5	1.2	1.3	0.0	56.6	3.4	2.8	1.7	2.8	0.9	0.8	2.2	3.1	2.5	0.3	1.9	6.5	4.1	0.7	1.9	2.4	0.1	0.0	1.7	2.5
MPP4	DLG6	ENSG00000082126	"Membrane palmitoylated protein 4"	Q96JB8	2	201644870-201698694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"retina: 78.2"	"Group enriched"	"Detected in many"	41	"Cone photoreceptor cells: 1494.2;Rod photoreceptor cells: 807.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 11.2;hTEC/SVTERT24-B: 10.5;LHCN-M2: 42.4;TIME: 8.4;U-87 MG: 11.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 8.1"	HPA057393			Supported	"Actin filaments,Cytosol"		No	No			Cytosol	"Actin filaments"	"HPA057393: AB_2732612"	"unprognostic (1.42e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.33e-16)"	"unprognostic (1.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	0.4	1.7	0.3	0.5	0.6	0.0	0.3	4.9	1.1	1.2	0.2	0.2	0.2	0.0	0.8	0.4	0.3	0.1	0.4	0.2	0.5	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.0	0.7	0.7	0.3	0.3	0.3	78.2	0.2	0.5	0.6	4.1	0.2	0.3	0.2	3.8	0.1	2.2	0.2	0.2	0.6	0.6	0.2	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	5.5	1.3	3.4	3.3	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.0	10.5	0.0	1.6	6.2	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.4	4.3	1.3	0.9	3.8	0.0	0.0	0.0	11.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	4.9	0.6	0.5	0.4	0.2	0.2	0.3	0.2	3.0	10.4	0.0	0.0	0.3	13.4	0.3	2.5	12.0	11.4	1.8	1494.2	0.1	0.0	0.2	2.9	0.1	0.0	0.0	0.2	0.0	0.3	0.0	3.5	0.0	0.1	17.5	0.0	0.0	0.3	2.1	0.0	0.3	1.7	0.0	0.0	28.2	0.1	0.0	0.0	0.0	807.6	0.0	1.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0
MPPED1	"239AB, C22orf1, FAM1A"	ENSG00000186732	"Metallophosphoesterase domain containing 1"	O15442	22	43411196-43507848	"Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	10	"brain: 33.0;liver: 11.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 8.9;Peritubular cells: 7.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.6"	"Group enriched"	"Detected in many"	4	"amygdala: 9.3;basal ganglia: 11.0;cerebral cortex: 32.1;hippocampal formation: 16.2;olfactory region: 17.4"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;plasmacytoid DC: 1.8"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.8;granulocytes: 1.3"	"Group enriched"	"Detected in some"	5	"HaCaT: 11.9;SCLC-21H: 4.9"	"Group enriched"	"Detected in many"	5	"amygdala: 108.6;basal ganglia: 66.9;cerebral cortex: 165.8;hippocampal formation: 190.7"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 131.1;hippocampal formation: 116.7"							NA	NA						"unprognostic (1.15e-1)"	"unprognostic (4.29e-1)"		"unprognostic (8.17e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-1)"		"unprognostic (6.92e-3)"	0.5	0.8	9.3	0.6	11.0	0.5	0.8	0.5	33.0	0.6	0.6	0.8	0.0	0.7	1.2	1.2	0.5	0.7	0.5	0.7	16.2	2.2	0.6	11.0	0.5	0.6	3.8	17.4	1.9	0.5	0.5	0.9	0.5	0.7	1.2	0.6	0.0	0.6	0.6	0.5	1.4	0.7	0.6	2.9	0.6	0.9	2.1	0.1	0.0	0.5	0.0	0.6	0.6	0.1	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	9.3	11.0	0.5	32.1	16.2	2.2	3.8	17.4	0.7	0.1	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309972	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.7;retina: 60.6"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 5.4;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Region enriched"	"Detected in many"	4	"midbrain: 118.7"	"Group enriched"	"Detected in some"	6	"eosinophil: 1.9;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.9"	"Cell line enriched"	"Detected in some"	5	"WM-115: 68.2"	"Group enriched"	"Detected in some"	5	"olfactory region: 3.6;pons and medulla: 1.4"	"Region enriched"	"Detected in single"	58	"midbrain: 262.7"	HPA068925	Enhanced					NA	NA					"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	14.3	12.6	2.2	3.4	2.9	1.3	4.7	6.0	2.2	4.5	6.1	2.6	9.9	2.6	1.7	7.5	8.7	1.5	4.3	7.2	2.4	4.3	3.2	7.9	3.1	1.3	118.7	0.7	1.9	2.2	0.5	7.4	0.8	28.4	7.3	5.0	60.6	6.4	15.6	4.2	2.3	6.3	5.6	40.9	6.8	2.1	2.7	0.8	0.2	2.8	26.3	3.0	9.3	3.3	0.1	0.0	1.9	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.4	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.7	0.5	0.1	0.1	0.0	0.6	0.2	0.0	0.3	0.0	0.3	0.1	12.6	0.4	1.5	1.2	1.4	0.0	2.1	0.1	0.0	0.9	0.6	3.2	0.0	1.4	0.0	0.2	2.5	0.5	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	6.5	0.3	0.0	3.1	0.9	0.1	0.1	0.9	0.0	0.3	0.3	0.4	1.6	5.7	68.2	0.0	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.1	2.2	2.9	6.0	2.2	2.4	4.3	118.7	0.7	28.4	0.8	3.0	1.1	0.0	2.3	0.5	2.8	0.2	0.0	0.0	0.0	3.5	2.0	0.4	0.0	0.1	4.2	0.8	0.0	0.0	1.0	0.5	0.2	1.3	0.0	0.8	1.6	1.6	1.7	3.1	2.7	1.1	1.4	1.2	3.3	5.4	0.4	0.7	0.1	0.0	0.4	0.3	1.1	6.5	0.8	0.5	0.7	0.4	0.2	0.5	0.4	1.4
MRAP	"B27, C21orf61, FALP"	ENSG00000170262	"Melanocortin 2 receptor accessory protein"	Q8TCY5	21	32291813-32314784	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 41.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.6"	"Cell type enhanced"	"Detected in many"		"NK-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"Hep G2: 4.7;HSkMC: 5.4"									"HPA011024, HPA011093"	Uncertain		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA011024: AB_10599292, HPA011093: AB_10600889"	"unprognostic (1.38e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-1)"		"unprognostic (1.11e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.30e-6)"	"unprognostic (3.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.76e-2)"	28.3	52.7	0.0	1.6	2.6	0.0	68.6	0.3	0.1	0.0	3.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.6	0.2	1.8	0.2	0.1	0.8	0.1	0.0	0.0	1.1	0.3	0.1	0.1	0.2	1.7	0.0	0.9	0.2	1.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.1	0.6	4.3	1.8	1.5	0.0	0.5	5.5	1.8	0.1	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.9	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.7	1.8	0.7	1.2	0.5	1.4	0.8	1.6	0.0	5.5	0.3	1.5	1.8	0.1	0.0	2.6	0.3	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.3	0.1	41.3	0.0	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0
MREG	"DSU, FLJ10116, WDT2"	ENSG00000118242	Melanoregulin	Q8N565	2	215942805-216034096	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 56.9;monocytes: 36.9;Rod photoreceptor cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 24.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 42.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068583			Approved	Vesicles		NA	NA			Vesicles		"HPA068583: AB_2686009"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.85e-3)"	"unprognostic (8.11e-3)"	"unprognostic (8.93e-2)"	"unprognostic (6.38e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.92e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.99e-2)"	5.6	5.8	3.1	4.3	4.5	3.4	16.0	24.4	6.6	6.1	3.6	0.9	11.8	4.2	2.2	5.6	25.8	4.0	1.8	1.7	2.9	3.7	3.8	12.1	12.4	8.3	4.1	2.4	1.6	4.1	6.1	10.6	10.0	6.4	1.8	4.0	18.6	5.0	4.9	1.0	14.3	3.4	1.1	3.0	2.7	4.7	1.6	1.7	9.6	4.6	11.9	18.5	3.5	11.3	2.8	4.9	2.0	0.2	2.0	3.5	0.3	9.6	2.4	2.7	1.6	2.0	1.2	6.5	3.4	2.7	2.4	4.4	12.7	7.6	3.4	3.1	1.9	5.4	6.2	8.6	12.6	5.1	6.8	7.3	4.7	2.5	19.4	1.1	2.8	1.8	1.8	5.6	2.6	3.4	2.1	1.9	7.2	2.6	8.2	1.5	42.6	8.1	2.6	11.3	5.9	2.3	4.5	6.6	5.0	5.6	14.3	7.7	4.1	2.0	17.3	17.7	6.9	9.6	1.2	0.2	4.5	1.3	2.3	4.9	11.5	6.9	8.0	3.0	10.2	3.4	2.0	0.1	0.2	1.9	0.0	3.5	2.8	1.7	2.8	0.3	1.3	0.8	1.2	0.8	2.0	0.2	4.9	2.9	0.3	3.1	4.5	24.4	6.6	2.9	3.7	4.1	2.4	6.4	1.7	3.0	11.2	4.2	8.7	2.4	10.8	0.7	2.5	5.3	15.9	7.0	56.9	16.3	3.3	2.6	0.3	1.0	2.9	0.0	2.1	3.4	1.6	6.0	1.1	6.8	13.8	1.6	1.7	1.3	0.6	0.0	2.3	3.6	5.0	36.9	2.2	3.9	5.1	3.5	7.1	1.0	37.7	6.5	0.4	0.7	3.2	1.4	21.6	2.9	2.4	19.5
MRGPRE	"GPR167, mrgE"	ENSG00000184350	"MAS related GPR family member E"	Q86SM8	11	3227698-3232386	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 34.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in many"	14	"pons and medulla: 34.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 2.6;RPMI-8226: 5.0;SCLC-21H: 8.2"	"Low region specificity"	"Detected in many"							HPA046556	Uncertain					NA	NA					"HPA046556: AB_10961404"	"unprognostic (1.18e-1)"			"unprognostic (7.52e-4)"	"unprognostic (1.04e-1)"			"unprognostic (9.09e-2)"		"unprognostic (6.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.22e-2)"		"unprognostic (1.19e-1)"		0.1	0.8	0.1	0.1	0.3	2.1	0.8	1.5	2.0	3.5	0.8	0.0	0.0	0.0	2.0	0.7	0.6	1.7	0.5	1.1	0.6	2.3	0.1	0.0	0.3	0.0	2.5	0.0	0.1	0.3	0.0	0.5	1.8	34.9	1.1	0.0	3.9	1.6	1.3	0.1	0.3	0.3	0.5	1.5	1.9	0.1	0.2	0.1	0.0	0.9	0.2	0.0	0.6	1.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	8.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.1	0.3	1.5	2.0	0.6	2.3	2.5	0.0	34.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2"	"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.8	12.0	0.5	15.1	38.1	14.3	9.5	0.0	0.6	0.0	0.3	11.6	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.1	0.0	3.3	0.0	0.0	8.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	18.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6	0.0	0.0	0.0	0.2	4.4	0.0	0.6	2.5	0.0	0.0	10.4	0.0	0.6	0.0	0.0	3.6	0.6	0.0	0.0	0.0	0.6	34.7	0.3	0.0	3.4	0.9	0.0	0.0	5.5	0.0	5.2	61.2	0.0	6.8	0.0	0.0	2.8	0.1	0.0	94.7	0.6	0.2	51.8	90.4	1.0	0.5	3.3	0.9	0.0	0.0	0.2
MROH9	"ARMC11, C1orf129, FLJ23550"	ENSG00000117501	"Maestro heat like repeat family member 9"	Q5TGP6	1	170935471-171064765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 7.1;testis: 4.7"	"Cell type enhanced"	"Detected in some"	27	"Ciliated cells: 17.4;Club cells: 4.5;Early spermatids: 2.7;granulocytes: 3.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"pons and medulla: 1.9"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in some"		"BJ: 1.3;BJ hTERT+: 1.0;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;Daudi: 2.2;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (1.04e-1)"		"unprognostic (7.94e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.73e-2)"		"unprognostic (7.62e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.07e-5)"		"unprognostic (3.66e-8)"	"unprognostic (5.96e-2)"				0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	7.1	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	1.0	0.7	1.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.9	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.4	4.5	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071128	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 196.2;bone marrow: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	1061	"basophil: 196.2"	"Lineage enriched"	"Detected in single"	1963	"granulocytes: 196.2"	"Group enriched"	"Detected in some"	4	"HEL: 37.1;K-562: 31.7;NB-4: 25.7;THP-1: 75.0;U-937: 29.6"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.2	0.0	0.1	0.1	0.3	105.4	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	14.7	0.1	0.1	0.1	0.5	6.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	8.6	0.0	1.0	0.0	7.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	9.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	196.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSGN1	pMesogenin1	ENSG00000151379	"Mesogenin 1"	A6NI15	2	17816496-17817101	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 2.2;esophagus: 2.9;tongue: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.0;hippocampal formation: 2.2"	"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.3;REH: 1.1;RH-30: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (3.63e-2)"				"unprognostic (3.25e-2)"									"unprognostic (1.66e-1)"			0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	2.9	0.6	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.1	0.0	1.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.1	0.4	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.0	2.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSH4		ENSG00000057468	"MutS homolog 4"	O15457	1	75796882-75913238	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"testis: 33.0"	"Cell type enriched"	"Detected in some"	4	"Spermatocytes: 19.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.7;HDLM-2: 2.7;JURKAT: 3.0"	"Not detected"	"Not detected"													NA	NA						"unprognostic (6.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.58e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.88e-8)"	"unprognostic (5.33e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.63e-2)"	0.3	0.2	0.3	0.3	0.6	0.1	0.5	2.6	0.4	0.3	0.8	0.3	0.3	0.1	0.6	4.8	0.3	0.6	0.3	0.6	0.3	0.0	0.3	0.3	0.4	0.3	0.3	0.3	1.0	0.3	0.0	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.5	0.4	0.7	0.7	1.2	0.2	33.0	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.7	0.4	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.0	5.7	1.1	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.2	0.0	0.3	0.0	2.7	0.6	0.2	0.2	0.0	0.0	0.1	0.4	1.1	1.7	0.5	0.0	0.7	0.1	3.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.3	0.9	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.7	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	2.6	0.4	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	1.2	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.3	0.0	0.0	19.1	1.3	0.0	0.0	0.0	0.0	0.0
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	67	"Early spermatids: 95.5;Late spermatids: 142.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 35.1;PC-3: 44.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"	No	No			Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0	0.0	0.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	95.5	0.3	0.0	0.0	1.8	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	142.6	0.3	0.0	1.7	0.0	0.0	0.8	1.3	0.0	0.7	0.2	0.6	0.0	0.0	0.7	0.4	0.1	0.2	0.0	0.0	1.1
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054268-10428891	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 597.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 78.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		25000	"Nucleoplasm, Plasma membrane, Cytosol"	"Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	7.0	8.1	8.0	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4.0	3.9	6.0	5.0	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9.0	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0.0	0.8	3.0	7.2	2.9	0.5	0.2	1.7	0.4	0.0	0.5	1.7	2.5	5.3	1.0	15.2	0.5	3.9	0.4	0.0	1.8	0.9	0.3	0.5	0.3	5.9	0.2	0.0	0.3	0.8	3.9	1.0	1.8	1.7	2.3	1.3	1.3	3.1	2.0	5.4	0.2	0.7	0.6	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1.0	4.1	0.8	3.2	9.0	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8.0	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5	0.0	9.0	10.0	24.1	14.5	10.7	18.1	17.8	5.3	4.5	24.4	29.5	5.8	77.9	27.0	64.1	26.4	29.0	0.0	41.4	4.5	11.3	16.9	81.6	82.9	42.3	15.9	9.2	16.5	31.0	107.2	8.6	33.1	28.7	14.4	19.7	13.4	40.7	28.8	9.2	597.4	5.8	12.9	17.6	27.7	18.8	12.3	7.0	15.3	17.4	28.6
MSS51	"FLJ39565, ZMYND17"	ENSG00000166343	"MSS51 mitochondrial translational activator"	Q4VC12	10	73423579-73433561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"parathyroid gland: 34.4;skeletal muscle: 66.9"	"Cell type enhanced"	"Detected in some"	7	"Cardiomyocytes: 3.9;granulocytes: 4.7;Leydig cells: 2.8;Paneth cells: 2.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA038564			Uncertain	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA038564: AB_10674687"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.88e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.50e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-7)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-2)"	2.8	0.3	0.4	0.4	0.4	0.3	0.4	2.7	0.4	0.5	0.5	0.4	0.4	0.2	0.6	0.4	0.9	0.6	0.4	3.9	0.4	0.1	0.4	0.4	0.6	0.4	0.4	0.4	1.1	0.5	34.4	0.7	0.4	0.4	0.8	0.3	0.4	2.3	0.4	66.9	0.8	0.8	0.4	0.4	1.4	0.4	0.4	0.4	0.6	0.4	1.2	0.4	0.5	0.6	0.1	0.0	0.0	0.5	0.0	1.7	0.4	1.2	1.3	3.0	4.7	4.2	6.0	2.6	1.5	1.1	0.6	1.3	0.7	1.5	3.8	0.5	1.5	0.2	2.3	1.9	0.4	1.7	1.8	1.5	3.3	2.0	1.1	1.5	2.2	3.1	4.7	1.5	1.3	3.5	4.3	0.6	1.5	1.1	2.0	2.5	0.5	1.9	3.0	0.9	1.0	1.6	1.1	7.8	0.2	1.8	1.9	0.6	1.2	1.0	2.2	1.7	3.2	1.9	1.8	2.7	2.3	1.4	0.9	3.0	1.2	3.4	2.0	1.0	3.8	0.6	0.0	0.4	0.0	1.7	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.3	1.2	0.0	0.0	0.5	0.0	0.0	0.4	0.4	0.4	2.7	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	2.2	0.0	0.5	1.4	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.7	0.4	0.0	0.3	0.1	0.5	0.3	4.7	0.0	0.2	0.0	0.0	1.3	0.6	0.0	2.8	0.1	0.0	0.0	0.6	0.9	0.1	2.9	1.4	0.0	1.2	0.0	0.4	0.5	0.2	0.0	0.1	0.7	0.6	0.1
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 108.5;liver: 146.5;skeletal muscle: 111.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 251.4;Smooth muscle cells: 534.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 33.3"	"Group enriched"	"Detected in many"	7	"basal ganglia: 35.4;cerebral cortex: 14.5;hippocampal formation: 15.3;pons and medulla: 37.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.1;ASC TERT1: 14.0;HHSteC: 9.8;HMC-1: 14.4;hTEC/SVTERT24-B: 38.9;NTERA-2: 19.3"									"CAB002161, CAB013056"	Approved					NA	NA					"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	108.5	14.2	2.7	8.0	35.4	1.0	35.2	0.6	14.5	11.3	10.2	0.7	0.2	4.8	1.8	4.1	17.4	11.0	16.1	16.2	15.3	1.8	20.7	146.5	16.1	14.2	3.6	0.0	7.1	46.1	1.2	11.0	1.4	37.2	4.4	7.8	3.8	3.0	2.6	111.3	4.4	12.4	9.2	16.9	4.6	6.1	2.0	2.1	0.0	18.6	4.1	1.7	10.7	7.1	0.4	0.6	0.0	0.1	0.3	1.1	0.2	0.0	2.9	0.0	0.0	9.1	14.0	0.1	0.9	3.8	0.6	0.7	1.1	2.2	0.0	1.2	0.5	0.0	0.2	0.0	0.2	1.4	0.0	0.0	0.0	1.3	4.6	9.8	0.1	14.4	4.1	0.0	38.9	0.0	0.0	3.7	0.0	0.3	0.0	2.6	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.1	2.9	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	0.6	0.4	0.8	1.1	0.6	0.0	0.5	0.9	0.0	0.3	0.0	0.3	1.0	0.2	2.7	35.4	0.6	14.5	15.3	1.8	3.6	0.0	37.2	2.1	8.9	1.7	0.8	9.7	24.4	0.0	5.1	0.0	5.3	9.1	0.0	0.0	1.1	11.6	2.4	0.0	13.5	9.5	23.3	1.5	6.5	29.1	30.8	3.5	251.4	0.3	0.0	3.5	13.5	3.8	0.4	50.9	10.0	32.1	0.0	25.8	0.0	3.9	14.4	12.0	13.9	0.0	25.8	534.6	0.0	0.2	16.9	0.5	5.7	23.0	12.6
MTCL1	"CCDC165, KIAA0802, SOGA2"	ENSG00000168502	"Microtubule crosslinking factor 1"	Q9Y4B5	18	8705661-8832778	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 61.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 7.6;Early spermatids: 18.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 61.5"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	HPA046245	Uncertain					NA	NA					"HPA046245: AB_10962580"	"unprognostic (2.64e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.30e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (2.82e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.08e-2)"	1.4	1.2	1.8	3.2	3.4	0.4	1.4	61.5	10.0	5.5	8.5	2.4	4.1	2.3	3.4	2.0	3.8	1.3	12.5	3.8	1.7	2.4	1.4	1.3	1.4	0.9	2.4	3.8	1.3	3.4	4.8	2.7	3.0	5.2	1.7	2.3	8.4	1.5	4.4	2.4	1.6	2.7	7.0	3.3	1.1	4.9	8.2	1.2	1.4	1.1	1.1	0.6	9.9	4.8	0.6	1.1	0.0	0.0	0.0	0.0	0.0	8.7	18.8	9.4	5.5	4.2	7.9	0.3	12.2	9.1	10.2	7.4	5.5	3.1	5.5	7.0	8.5	7.6	1.3	2.9	5.0	4.7	1.1	2.4	2.7	5.0	4.9	6.1	0.0	4.0	4.6	3.7	5.7	4.0	6.6	7.9	4.7	0.6	9.6	4.7	2.6	0.3	1.3	4.3	21.1	8.2	7.3	6.8	2.0	14.6	15.9	21.5	4.8	5.6	1.6	1.4	8.2	0.5	0.3	15.0	18.7	9.8	14.9	12.5	1.8	1.4	2.7	4.6	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.8	3.4	61.5	10.0	1.7	2.4	2.4	3.8	5.2	1.2	0.0	0.6	0.0	2.4	0.0	0.0	5.7	7.6	0.0	1.2	1.8	0.0	3.7	1.7	4.6	18.9	0.5	0.1	0.0	3.1	0.4	0.9	1.3	2.3	0.9	0.5	0.0	1.2	5.5	1.2	6.3	1.1	0.0	0.0	0.0	1.1	0.0	6.4	0.0	0.4	1.0	0.0	0.0	0.6	1.0	6.6	0.0	0.8	0.0	1.0	1.0
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181315-135219173	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 44.2;granulocytes: 25.4;Intestinal endocrine cells: 16.9;Mucus-secreting cells: 26.5;Undifferentiated cells: 37.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 17.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.7"	"Group enriched"	"Detected in some"	4	"basophil: 5.6;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 39.5;MOLT-4: 72.0;NB-4: 37.5;REH: 44.5;THP-1: 62.8;U-937: 34.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.5	0.7	1.3	9.1	4.7	18.9	13.2	0.3	0.6	1.4	15.4	0.5	0.3	6.5	0.9	1.0	3.7	5.0	1.7	0.6	0.7	0.7	0.4	0.5	1.8	3.3	0.3	0.5	1.0	0.3	0.4	0.3	0.6	0.5	1.6	16.7	0.5	0.8	1.5	1.0	3.5	5.9	0.7	0.4	1.4	0.9	2.0	0.6	104.9	0.4	2.0	4.7	0.7	1.5	0.1	1.7	10.0	0.8	0.0	0.5	0.1	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.1	3.1	0.4	25.2	0.1	0.0	0.0	39.5	20.0	0.0	0.0	0.1	0.0	0.0	0.0	24.8	20.4	3.8	0.2	2.0	72.0	37.5	0.2	3.5	0.3	44.5	1.0	6.1	0.0	0.2	1.9	1.2	0.0	2.0	0.0	0.1	1.5	62.8	0.0	0.0	0.3	1.5	0.4	4.8	1.2	12.2	0.0	34.2	0.4	5.6	0.8	10.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	1.7	0.5	0.1	1.3	4.7	0.3	0.6	0.7	0.7	0.3	0.5	0.5	0.6	0.0	2.2	2.9	1.1	2.4	0.6	0.4	2.5	44.2	10.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	2.9	0.0	0.7	0.6	0.4	2.7	25.4	0.0	0.9	0.0	16.9	0.0	1.2	0.0	0.0	1.5	8.5	0.0	26.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	6.0	0.2	1.9	37.5	2.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46703369-46790407	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 162.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.8;hippocampal formation: 5.7"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 5.2"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	0.7	0.0	1.7	0.1	0.0	0.1	0.2	0.2	0.0	3.8	0.0	0.0	0.1	3.4	2.0	0.8	0.1	62.2	1.5	1.4	0.4	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1.0	0.0	0.0	1.3	0.0	20.8	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.3	0.0	0.1	31.1	1.1	0.1	0.0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	1.6	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0.0	3.5	0.0	0.7	0.0	0.5	162.4	0.0	16.0	6.8	0.0	2.0	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.2	0.4	1.4	0.6	1.1	0.0	0.4	0.0	0.0	0.6	0.0	3.2	0.6	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.2
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"intestine: 148.0"	"Cell type enhanced"	"Detected in some"	25	"Enterocytes: 221.7;Mucus-secreting cells: 59.5;Paneth cells: 51.8;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;monocytes: 1.2"	"Cell line enriched"	"Detected in some"	5	"OE19: 30.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.1	0.1	0.1	5.2	0.2	0.0	0.1	0.1	0.2	0.1	57.2	0.3	0.1	70.0	0.1	0.1	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	14.1	0.1	0.2	0.1	0.1	0.1	148.0	0.4	4.7	0.1	3.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	2.9	0.0	1.2	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	1.1	0.0	30.9	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.5	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	221.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.0	0.3	0.2	0.0	0.9	0.0	0.0	59.5	0.0	0.2	51.8	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	76.4	0.0
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051893, HPA075413"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"		No	No			"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA051893: , HPA075413: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	1.5	0.0	0.0	1.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8	0.0	0.3	0.0	0.3	1.5	0.9	0.6	0.0	0.0	4.5	0.0	0.0	0.0	1.7	0.5	127.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	34.5	1.1	0.0	0.0	0.0	0.2	68.5	0.3	0.0	1.1	1.4	3.4	0.0	0.0	20.0	5.8	0.9	0.0	0.0	0.0	0.1
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.1	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.5	0.0	1.2	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.0	0.0	0.0	5.2	0.0	0.2	3.3	0.8	12.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.2	0.9	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.4	0.5	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.0
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 28.8;Cone photoreceptor cells: 56.9;Horizontal cells: 25.4;Rod photoreceptor cells: 27.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.8;REH: 13.3;SCLC-21H: 16.6;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.5	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.0	0.3	13.3	0.0	0.0	0.0	0.0	16.6	4.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.9	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8	0.0	0.0	0.0	0.2	0.0	28.8	1.1	5.1	0.0	0.0	0.0	56.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	25.4	2.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.5	9.8	0.0	0.0	0.0	0.0	0.0
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591941-57685364	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.6;smooth muscle: 52.2"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 451.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 6.9;pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.7;naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 52.3;hTERT-HME1: 9.6;HUVEC TERT2: 11.5;OE19: 18.4;RT4: 10.1;TIME: 12.3"					"Not detected"	"Not detected"			HPA039827	Approved					NA	NA					"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	11.8	12.3	0.6	1.4	1.2	0.5	13.0	6.9	1.0	5.5	5.6	0.6	3.3	3.3	6.1	1.9	12.6	1.1	3.2	132.6	0.6	0.9	1.4	0.4	9.8	2.1	0.9	0.5	1.5	7.4	0.0	1.0	11.7	6.1	13.0	2.4	0.0	6.1	8.4	3.3	2.2	9.1	52.2	0.5	2.4	4.9	1.6	0.2	0.4	1.0	6.6	6.4	31.4	12.1	6.7	0.1	1.0	1.3	0.0	3.6	5.0	2.3	0.7	0.0	4.2	1.0	0.0	1.2	0.3	3.5	0.5	0.7	2.9	1.6	0.0	0.2	0.0	3.5	0.9	0.0	1.6	0.7	0.0	0.1	52.3	0.6	0.0	0.1	0.0	0.0	0.0	1.3	0.1	9.6	0.0	11.5	0.0	0.7	0.0	0.3	0.8	0.0	0.0	0.0	18.4	1.0	0.0	4.4	0.1	0.0	10.1	0.0	1.5	0.2	2.4	0.0	0.5	3.1	0.0	12.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.7	0.6	0.0	0.1	6.7	3.6	0.0	1.0	0.0	1.3	0.0	0.3	5.0	0.6	1.2	6.9	1.0	0.6	0.9	0.9	0.5	6.1	0.2	8.9	1.1	0.0	8.9	0.0	0.1	451.1	7.6	1.4	1.2	24.4	0.0	3.6	6.6	28.1	0.1	3.6	13.7	0.0	16.8	2.3	0.0	6.0	0.0	0.0	1.3	0.0	1.7	4.9	5.9	0.4	4.4	0.0	0.0	5.4	6.1	0.1	17.9	21.0	15.9	0.0	0.0	0.0	0.9	0.0	0.9	0.0	1.0	0.0	6.0	4.9
NAIP	"BIRC1, NLRB1"	ENSG00000249437	"NLR family apoptosis inhibitory protein"	Q13075	5	70968483-71025114	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.1;lymphoid tissue: 17.5"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 56.4;Kupffer cells: 123.5;Macrophages: 49.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.4"	"Group enriched"	"Detected in some"	10	"classical monocyte: 8.1;intermediate monocyte: 2.9;myeloid DC: 6.9;neutrophil: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 6.9;granulocytes: 5.9;monocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.0;SiHa: 4.6;T-47d: 5.0"									HPA042438	Approved					NA	NA					"HPA042438: AB_10796578"	"unprognostic (9.03e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.96e-2)"	2.4	1.0	0.8	4.7	0.8	2.4	0.8	0.8	2.6	0.8	0.8	0.8	0.8	0.1	0.9	1.2	0.8	1.6	1.6	0.8	0.8	0.6	0.8	0.8	3.9	3.4	1.2	0.8	0.8	0.8	0.2	0.8	0.8	6.4	0.8	0.7	0.8	0.8	0.8	1.0	0.4	2.3	1.1	2.3	17.5	3.0	0.8	0.8	0.8	0.9	0.8	0.8	3.6	0.8	0.3	6.9	5.9	8.1	0.4	0.2	2.0	0.0	0.0	1.1	0.5	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.8	0.7	1.6	0.2	1.5	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.3	0.6	0.2	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.3	0.1	0.3	0.0	4.6	0.0	0.3	0.9	5.0	0.0	0.0	1.2	0.3	0.2	0.0	0.9	0.0	0.6	0.2	0.1	0.9	0.2	8.1	0.0	0.2	2.9	0.1	0.1	0.0	0.1	6.9	0.3	0.2	0.1	5.9	0.4	0.5	0.3	0.1	2.0	0.8	0.8	0.8	2.6	0.8	0.6	1.2	0.8	6.4	0.8	17.9	8.9	0.8	2.3	3.2	15.4	2.7	17.8	9.4	12.5	5.2	21.6	2.9	0.0	1.6	40.1	7.1	2.0	23.3	1.9	1.7	4.3	2.3	4.7	4.5	56.4	15.9	10.3	9.8	123.5	10.1	10.0	49.1	1.7	1.0	6.0	6.5	1.6	0.0	6.7	0.6	35.7	6.5	2.6	15.2	4.3	3.3	2.4	3.1	3.4	1.4
NAT16	"C7orf52, FLJ39237"	ENSG00000167011	"N-acetyltransferase 16 (putative)"	Q8N8M0	7	101170493-101180276	"Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6"	"Cell type enriched"	"Detected in some"	45	"Horizontal cells: 276.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Group enriched"	"Detected in many"	4	"amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4"									HPA021918	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021918: AB_1848922"	"unprognostic (4.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.53e-5)"	"unprognostic (7.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.02e-5)"	"unprognostic (1.59e-1)"	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6.0	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0.0	4.6	0.0	0.0	0.1	0.0	1.2	0.7	2.2	0.6	1.3	0.8	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.3	0.5	0.5	0.1	0.1	0.8	0.0	0.6	0.2	0.1	4.6	0.1	0.5	0.1	6.9	0.0	0.3	5.2	0.5	0.3	0.0	0.0	0.4	6.1	0.5	0.1	0.1	0.0	0.1	3.4	0.0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0.0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2	0.0	0.0	0.0	0.0	0.0	1.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.2	0.0	7.0	5.7	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	23.2	0.4	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.4	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.7	0.0	0.1	0.2	10.3	39.6	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8	229.3	38.7	0.0	0.0	1.0	69.0	1.6	15.3	22.7	52.4	12.2	17.7	0.2	0.0	0.0	225.6	11.7	0.0	0.0	0.2	0.0	3.1	0.0	2.3	0.0	0.1	1.6	1.7	4.3	0.0	164.5	3.1	0.4	5.0	0.0	0.2	15.1	0.1	0.0	0.7	0.0	18.7	0.0	3.3	7.5	4.7	0.6	0.5	0.0	1.2	0.0
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258648	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 22.2;lymphoid tissue: 6.8;pituitary gland: 7.6"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 20.2;Horizontal cells: 6.4;Kupffer cells: 27.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 17.0;cerebellum: 22.2;cerebral cortex: 5.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA					"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.3	2.0	3.2	0.3	17.0	0.6	0.3	22.2	6.9	2.1	0.4	0.0	0.0	0.3	0.4	0.2	0.3	1.3	0.4	0.3	2.3	2.0	0.9	4.6	0.4	0.6	0.9	1.7	0.6	0.2	0.2	7.6	0.4	1.7	0.5	0.4	1.3	0.2	1.2	0.3	0.4	0.4	0.4	0.6	6.8	1.0	0.5	2.4	6.8	0.6	0.0	0.4	0.3	0.3	0.3	0.4	1.3	0.2	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.9	1.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.3	0.4	0.1	0.4	0.0	0.0	3.2	17.0	22.2	5.7	2.3	2.0	0.9	1.7	1.7	2.4	0.0	0.0	0.0	0.0	0.0	20.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.4	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	17	"pons and medulla: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011129	Uncertain					NA	NA					"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.1	0.0	1.3	0.0	1.7	0.0	0.1	0.2	3.4	1.4	0.3	0.3	0.3	0.1	1.5	0.0	0.1	0.1	0.3	0.1	0.7	1.9	0.1	0.0	0.1	0.0	1.3	1.4	5.7	0.1	0.0	0.6	0.0	34.6	1.5	0.1	0.0	0.5	0.6	0.1	0.2	0.1	1.6	1.0	2.5	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.2	1.7	0.7	1.9	1.3	1.4	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
NEFH		ENSG00000100285	"Neurofilament heavy"	P12036	22	29480230-29491390	"Disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 87.6;prostate: 116.0"	"Group enriched"	"Detected in many"	5	"Glandular cells: 29.5;monocytes: 59.5;Spermatogonia: 28.8"	"Group enriched"	"Detected in many"	7	"prostate cancer: 130.0;testis cancer: 31.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 87.6"	"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.4"	"Cell line enriched"	"Detected in some"	5	"SiHa: 63.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007786, HPA061615"	Enhanced					NA	NA					"CAB007786: AB_598179, HPA061615: AB_2684568"	"prognostic favorable (2.33e-6)"	"unprognostic (6.17e-3)"	"unprognostic (9.74e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.47e-1)"	1.0	8.4	3.3	1.4	5.4	1.0	1.4	7.1	31.6	0.9	0.9	2.2	0.0	0.9	1.0	1.1	0.8	0.8	0.9	0.8	8.3	17.1	1.2	0.9	0.9	1.1	34.8	2.3	10.0	0.8	0.8	3.9	1.0	87.6	116.0	1.0	4.0	1.1	1.0	0.8	0.8	1.0	1.2	17.9	1.2	0.8	3.6	0.1	0.0	0.8	0.0	1.2	0.8	0.0	0.2	1.1	0.0	7.4	0.4	1.6	1.2	0.0	0.0	0.8	0.2	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	3.4	0.0	0.0	0.0	0.0	3.0	12.0	0.0	8.8	0.0	0.5	0.0	3.7	1.3	0.0	0.1	0.0	0.0	0.4	0.0	9.3	0.0	4.1	0.0	4.0	0.4	6.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	6.9	63.4	0.0	0.0	2.2	0.0	3.4	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.8	4.8	1.6	0.2	0.9	0.7	1.1	0.1	0.3	1.0	0.0	0.4	7.4	0.3	0.4	1.2	3.3	5.4	7.1	31.6	8.3	17.1	34.8	2.3	87.6	0.1	0.0	0.0	0.0	1.2	0.1	2.8	0.7	0.0	0.0	0.0	1.8	2.0	1.0	0.0	0.1	0.3	0.7	0.0	0.0	0.3	0.8	0.6	29.5	1.1	0.0	5.0	7.9	0.0	0.0	1.3	0.6	5.5	3.1	1.7	59.5	0.0	3.3	0.2	0.0	2.8	1.0	6.5	6.5	1.0	2.9	28.8	0.1	0.3	0.0	0.0	0.7
NEUROD1	"BETA2, BHF-1, bHLHa3, MODY6, NeuroD"	ENSG00000162992	"Neuronal differentiation 1"	Q13562	2	181673088-181680876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"brain: 101.9"	"Cell type enhanced"	"Detected in some"	26	"Cone photoreceptor cells: 141.4;Intestinal endocrine cells: 408.1;Rod photoreceptor cells: 170.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.3"	"Region enriched"	"Detected in many"	16	"cerebellum: 101.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	72	"SCLC-21H: 81.2"	"Region enriched"	"Detected in many"	14	"cerebellum: 242.4"	"Region enriched"	"Detected in many"	20	"cerebellum: 447.6"	"HPA003278, CAB022450"	Approved					NA	NA					"CAB022450: , HPA003278: AB_1845331"			"unprognostic (1.29e-1)"		"prognostic favorable (1.34e-4)"						"unprognostic (6.92e-3)"			"unprognostic (1.27e-1)"				0.2	0.2	6.3	0.2	0.8	0.1	0.2	101.9	5.6	0.2	3.1	0.0	0.0	8.9	0.2	0.1	0.2	0.2	0.0	0.2	4.7	0.4	0.2	0.2	0.2	0.0	0.4	1.2	0.2	13.3	0.0	0.8	0.0	3.9	0.2	1.9	14.4	0.2	0.0	0.2	0.2	5.8	0.0	1.4	0.2	7.6	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.1	1.0	3.5	1.8	1.4	1.5	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.6	1.0	0.8	1.1	1.5	1.1	1.1	0.8	0.8	1.0	1.3	1.4	1.8	1.4	1.8	1.0	1.0	0.7	6.3	0.8	101.9	2.5	4.7	0.4	0.4	1.2	3.9	0.0	0.0	0.0	0.0	0.1	0.0	61.1	0.3	0.0	0.0	0.0	0.0	141.4	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	408.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	17.4	2.8	0.2	0.0	0.0	170.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	0.1
NEUROD6	"Atoh2, bHLHa2, Math-2, Nex1, NEX1M"	ENSG00000164600	"Neuronal differentiation 6"	Q96NK8	7	31337461-31340894	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"brain: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	119	"SCLC-21H: 11.8"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 99.2;hippocampal formation: 246.6"	"Group enriched"	"Detected in many"	9	"cerebral cortex: 26.0;hippocampal formation: 108.7"	HPA074530	Enhanced					NA	NA					"HPA074530: AB_2732257"					"unprognostic (3.68e-2)"													0.5	0.5	8.3	0.5	10.7	0.5	0.5	3.9	25.5	0.5	0.5	0.7	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	30.6	0.5	0.5	0.5	0.5	0.5	1.3	17.4	0.5	0.5	0.5	0.1	0.5	0.4	0.5	0.5	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	10.7	3.9	25.5	30.6	0.5	1.3	17.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535949	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.1;retina: 7.7;testis: 2.3"	"Cell type enhanced"	"Detected in single"	24	"Bipolar cells: 1.3"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 1.3;SCLC-21H: 1.1;THP-1: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA072232			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA072232: "															"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573238	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.5;intestine: 8.4"	"Group enriched"	"Detected in some"	49	"Cardiomyocytes: 4.8;Intestinal endocrine cells: 5.1"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Region enriched"	"Detected in single"	20	"hippocampal formation: 7.5"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;memory B-cell: 1.1"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;T-cells: 2.1"	"Cell line enriched"	"Detected in some"	5	"THP-1: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	7.6	0.0	0.0	8.0	0.0	0.0	0.9	0.0	1.8	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.3	7.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Apoptosis, Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.6;brain: 34.5;pancreas: 9.9"	"Cell type enhanced"	"Detected in single"	23	"Spermatogonia: 1.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"RPMI-8226: 7.7;SCLC-21H: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042615, HPA058596"	Enhanced					NA	NA					"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.4	15.6	4.2	0.7	4.8	0.3	0.3	1.2	14.2	0.3	2.1	0.5	0.9	0.7	0.3	0.5	0.6	2.9	0.3	0.3	1.7	34.5	0.3	0.3	0.3	0.3	2.0	6.4	0.3	9.9	0.3	7.0	0.3	8.0	0.3	1.3	0.0	0.3	0.3	0.3	0.3	0.9	0.5	1.4	0.3	0.3	0.7	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.7	0.0	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.8	1.2	14.2	1.7	34.5	2.0	6.4	8.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.5
NHLH1	"bHLHa35, HEN1, NSCL, NSCL1"	ENSG00000171786	"Nescient helix-loop-helix 1"	Q02575	1	160367067-160372848	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 10.8;skin 1: 4.2"	"Cell type enhanced"	"Detected in some"	11	"Cone photoreceptor cells: 2.0;Horizontal cells: 3.2;Intestinal endocrine cells: 1.7;Kupffer cells: 1.5;Rod photoreceptor cells: 1.3"	"Group enriched"	"Detected in some"	6	"glioma: 2.4;testis cancer: 0.8;urothelial cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 24.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"Region enriched"	"Detected in some"	12	"cerebellum: 37.9"	HPA017943			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA017943: AB_2732421"	"unprognostic (6.95e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-8)"	"unprognostic (4.09e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.36e-1)"	1.0	0.5	0.9	1.1	4.1	0.4	0.3	10.8	2.0	0.3	0.8	0.3	0.3	0.4	0.3	0.5	0.3	0.2	0.4	0.3	3.2	2.2	0.3	0.3	0.3	0.5	0.8	0.3	0.3	0.5	0.2	0.4	0.3	2.3	0.3	0.3	0.6	1.3	0.3	0.6	4.2	0.6	0.5	2.5	1.0	0.4	0.8	0.3	0.3	0.3	0.3	0.4	0.4	0.3	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.1	2.5	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.2	1.1	0.5	0.2	0.5	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.4	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.0	24.8	0.2	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.3	0.0	1.7	0.6	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	4.1	10.8	1.6	3.2	2.2	0.8	0.3	2.3	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	3.2	1.7	0.6	1.5	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	1.3	0.0	0.2	0.7	0.5	0.0	0.2	0.0	0.0	0.0
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"lung: 51.5;thyroid gland: 122.8"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 128.1;Alveolar cells type 2: 108.1;Club cells: 46.6"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.4;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 48.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.4;hypothalamus: 12.0"	"Group enriched"	"Detected in some"	13	"basal ganglia: 6.4;hypothalamus: 16.1"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	51.5	0.1	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	122.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.1	0.2	2.5	0.0	0.1	0.1	0.4	128.1	108.1	0.0	0.0	0.0	0.0	0.6	0.0	14.7	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell type enhanced"	"Detected in single"	18	"Basal glandular cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in many"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA062879: AB_2684892"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.5	10.0	0.0	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5	0.0	0.0	0.0	2.3	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.3
NKX6-3	FLJ25169	ENSG00000165066	"NK6 homeobox 3"	A6NJ46	8	41645178-41650669	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 13.8;intestine: 10.8;stomach 1: 33.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"endometrial cancer: 0.9;pancreatic cancer: 3.1;stomach cancer: 3.9;testis cancer: 1.6"	"Region enriched"	"Detected in some"	10	"cerebellum: 13.8"	"Cell type enriched"	"Detected in single"	17	"naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"	"Group enriched"	"Detected in some"	7	"Daudi: 11.0;THP-1: 5.1"															NA	NA						"unprognostic (1.87e-1)"	"unprognostic (9.91e-3)"		"unprognostic (4.04e-1)"	"unprognostic (5.73e-2)"			"unprognostic (1.98e-1)"		"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-1)"		0.2	0.0	0.4	0.2	0.5	0.0	0.2	13.8	1.3	0.2	4.6	0.2	0.2	10.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.8	2.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	33.7	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	13.8	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell type enhanced"	"Detected in some"	24	"Basal keratinocytes: 14.4;Erythroid cells: 23.3;Suprabasal keratinocytes: 64.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 81.3;K-562: 63.9;Karpas-707: 29.3"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in many"			HPA025926	Uncertain				"Secreted in other tissues"	NA	NA					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.5	0.0	4.7	1.2	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	13.1	18.9	1.8	0.0	1.8	81.3	9.8	0.7	0.5	1.1	5.3	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	2.2	0.0	1.3	63.9	29.3	0.0	2.0	0.2	0.0	2.5	1.5	2.4	0.0	0.0	0.1	0.4	0.0	4.2	10.7	6.5	0.1	0.0	0.9	4.5	0.0	0.5	0.0	6.1	0.0	11.4	8.5	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0	0.0	2.9	1.5	0.6	14.4	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.2	0.2	0.0	23.3	0.2	0.1	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.5	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	1.5	7.6	64.4	0.1	0.0	1.7	8.0
NNAT	Peg5	ENSG00000053438	Neuronatin	Q16517	20	37521215-37523693	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 117.2;pituitary gland: 165.1;placenta: 69.1"	"Group enriched"	"Detected in many"	9	"Early spermatids: 30.8;Late spermatids: 51.7;Muller glia cells: 77.7"	"Group enriched"	"Detected in many"	16	"glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 117.2"	"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"SH-SY5Y: 127.5"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.18e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.52e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.90e-2)"	17.0	11.6	35.4	2.6	117.2	2.3	3.5	4.9	68.4	2.3	7.0	11.1	0.0	3.4	4.6	2.5	2.6	2.8	4.2	1.7	35.0	21.4	1.4	1.1	1.7	1.9	4.9	14.0	1.3	1.6	1.0	165.1	69.1	7.9	2.4	3.9	1.5	3.4	1.5	8.0	3.8	3.2	4.4	2.1	1.8	2.1	2.9	3.8	0.2	1.5	0.0	1.1	3.3	0.6	0.7	0.7	0.3	0.3	0.0	1.0	0.0	0.3	0.2	2.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.0	0.2	0.0	0.6	0.0	0.0	3.2	0.3	127.5	0.1	0.7	0.0	0.1	0.2	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.3	0.0	0.0	0.7	0.0	0.0	35.4	117.2	4.9	41.0	35.0	21.4	4.9	14.0	7.9	3.8	0.0	0.0	0.0	0.7	3.5	3.7	0.0	0.0	1.4	1.2	0.0	0.0	0.5	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.4	1.0	2.2	1.1	0.0	1.4	0.0	0.0	0.0	0.0	51.7	0.6	0.0	1.7	0.0	0.0	77.7	0.0	0.0	1.1	0.0	6.0	0.0	0.4	1.1	3.8	0.9	0.2	0.0	0.0	2.3
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150990995-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 62.0;Endothelial cells: 23.5;Ito cells: 30.1;Late spermatids: 21.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3"	"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 5.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HUVEC TERT2: 22.1;K-562: 7.8;TIME: 40.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA					"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	11.4	4.5	3.1	7.5	32.4	1.9	25.6	1.8	12.4	4.6	3.2	1.7	1.0	4.0	8.3	2.5	4.7	5.0	6.6	35.2	18.8	3.4	5.5	5.4	14.0	10.3	4.7	1.7	4.5	4.1	2.7	4.8	11.5	35.3	5.2	2.5	5.2	3.0	3.2	6.0	4.9	4.0	5.4	25.9	70.6	3.6	4.5	1.6	0.0	5.9	2.1	2.4	5.1	7.3	1.1	0.5	0.7	0.4	0.5	5.3	1.2	0.2	0.0	0.6	2.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.1	1.0	0.2	1.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	3.0	0.3	0.2	5.1	0.0	0.1	0.0	0.0	0.0	22.1	2.5	7.8	1.8	0.0	0.0	0.1	0.2	0.8	0.3	0.0	1.4	0.0	0.8	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.2	0.1	0.7	40.2	0.1	0.4	0.2	0.0	1.2	4.1	1.0	0.0	3.6	0.0	0.3	0.3	0.2	2.5	0.4	1.5	0.8	3.9	2.2	0.5	1.1	5.3	2.1	0.7	0.5	0.4	0.5	4.4	1.2	3.1	32.4	1.8	12.4	18.8	3.4	4.7	1.7	35.3	1.6	8.9	2.1	0.0	0.0	0.8	0.0	2.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.5	62.0	23.5	0.0	0.0	0.0	0.1	3.1	0.2	5.7	0.0	0.3	0.0	0.0	30.1	0.6	21.4	0.9	0.4	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.1	0.3	0.0	1.0	3.7	2.5	0.5	3.0	0.0	0.0	0.2
NPBWR2	GPR8	ENSG00000125522	"Neuropeptides B and W receptor 2"	P48146	20	64105820-64107171	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"basal ganglia: 0.6;hypothalamus: 0.4;olfactory region: 1.5"							NA	NA															"unprognostic (1.44e-1)"								0.2	2.4	0.3	0.3	1.8	0.3	0.2	0.4	14.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	2.3	0.2	0.2	0.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.4	14.8	0.2	0.5	0.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"		Neuropeptide		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"epididymis: 154.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HHSteC: 17.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 11.9"	"Region enriched"	"Detected in all"	7	"cerebellum: 143.2"						"Secreted in male reproductive system"	NA	NA																							0.3	0.1	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.5	0.2	0.1	1.1	0.2	0.1	154.7	0.1	0.2	0.1	0.1	0.1	1.4	0.1	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.5	0.2	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.7	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.3	0.1	2.0	0.4	0.0	0.8	0.3	0.0	0.3	0.2	0.5	2.0	0.1	0.0	0.2	0.0	0.7	0.2	2.4	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.0	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPFFR1	"GPR147, NPFF1R1, OT7T022"	ENSG00000148734	"Neuropeptide FF receptor 1"	Q9GZQ6	10	70247329-70283676	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 34.9"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 15.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in all"	5	"basal ganglia: 10.2;cerebellum: 34.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 4.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 16.1;hypothalamus: 7.3"	"Low region specificity"	"Detected in many"			HPA037521	Uncertain					NA	NA					"HPA037521: AB_2675520"	"unprognostic (1.73e-3)"	"unprognostic (7.29e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.51e-1)"	"unprognostic (9.62e-2)"	"unprognostic (6.78e-2)"	"unprognostic (5.84e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	0.6	0.5	1.9	1.8	10.2	1.3	0.9	34.9	2.6	0.9	0.6	2.6	0.0	0.8	1.0	1.2	0.4	1.6	0.6	0.4	2.7	4.1	0.5	0.5	1.3	2.5	2.2	4.1	0.8	0.3	0.9	0.4	0.4	4.7	0.6	0.8	5.4	0.4	1.1	1.0	1.0	0.8	0.4	4.0	1.0	1.4	4.7	2.0	0.0	0.6	0.0	1.4	0.6	0.7	1.0	1.2	2.4	2.2	1.3	0.6	2.6	1.1	0.8	0.9	0.7	0.8	1.3	0.7	0.3	0.4	0.3	0.3	1.3	2.3	0.8	0.7	1.0	0.4	1.0	2.2	1.2	0.7	0.7	0.9	1.1	1.0	1.0	0.8	0.8	1.3	0.7	1.1	0.5	0.8	0.9	0.9	1.0	0.9	0.9	0.5	0.9	0.7	0.9	0.8	1.9	0.3	0.9	0.8	0.5	0.8	0.8	0.8	0.8	0.8	1.2	0.4	0.8	0.5	0.6	1.0	0.9	4.8	0.8	1.0	0.7	0.8	0.5	0.6	0.9	0.7	2.4	2.2	0.4	0.5	0.7	0.5	0.5	0.5	0.4	1.2	1.0	0.6	0.6	1.9	1.3	0.4	0.9	0.4	2.6	1.9	10.2	34.9	2.6	2.7	4.1	2.2	4.1	4.7	2.0	0.0	1.3	0.0	1.2	1.4	0.7	0.8	2.5	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.1	1.0	1.0	2.3	0.0	0.1	0.0	0.0	0.0	0.3	1.1	0.6	1.1	0.0	0.0	0.0	15.1	0.1	0.0	0.4	0.0	1.5	0.0	1.4	0.2	0.4	1.8	0.9	0.0	0.0	0.8
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 9.5;lymphoid tissue: 2.9;retina: 7.0"	"Cell type enriched"	"Detected in some"	44	"Muller glia cells: 336.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	95	"hypothalamus: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"hypothalamus: 7.2"	"Region enriched"	"Detected in some"	4	"hypothalamus: 3.8"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	336.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPY4R	"PP1, PPYR1, Y4"	ENSG00000204174	"Neuropeptide Y receptor Y4"	P50391	10	46461099-46465881	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 9.4;skin 1: 4.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Group enriched"	"Detected in some"	5	"cerebellum: 1.6;cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"A549: 25.5"									HPA027863	Approved					NA	NA					"HPA027863: AB_10602819"		"unprognostic (2.26e-6)"	"unprognostic (2.94e-1)"			"unprognostic (8.17e-2)"		"unprognostic (1.20e-1)"		"unprognostic (1.30e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-3)"	"unprognostic (6.58e-2)"			"unprognostic (9.79e-2)"	0.2	0.0	0.2	0.7	0.2	0.0	0.2	1.6	1.2	0.3	7.4	0.2	0.2	2.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.9	9.4	0.2	0.2	0.2	0.2	4.3	2.6	1.4	0.2	0.2	2.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	25.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.7	0.0	0.0	5.2	0.0	0.4	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.6	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238302	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"liver: 63.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 124.3"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA051365			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051365: AB_2616454"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.0	0.2	0.1	1.9	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	3.5	63.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.3	2.3	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.7	0.3	0.0	0.6	0.3	0.3	0.9	1.1	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	9.4	0.3	1.0	0.6	0.0	0.3	0.6	0.0	0.0	0.0	1.0	0.9	0.0	0.2	2.2	0.0	1.7	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.9	1.2	0.4	0.0	0.8	0.3	0.6	1.7	1.8	1.3	0.9	0.8	0.6	0.0	1.8	2.3	1.4	0.3	2.9	0.4	1.4	2.1	1.2	2.2	0.7	0.7	1.5	0.2	1.5	2.2	1.3	0.5	2.9	0.5	0.7	0.2	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.9	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	20.8	16.0	2.2	1.1	0.6	0.7	0.3	2.5	8.1	9.1	3.5	0.0	0.1	3.3	0.1	1.7	0.3	0.0	0.0	0.0	0.1	0.4	0.4	12.7	124.3	0.3	0.0	0.0	3.1	5.3	1.2	0.3	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.4	28.7	1.7	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.8
NREP	"C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17"	ENSG00000134986	"Neuronal regeneration related protein"	Q16612	5	111662621-111997464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 149.5"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 82.5;Cytotrophoblasts: 84.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 149.5"	"Group enriched"	"Detected in many"	5	"myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 70.3;SH-SY5Y: 76.1"									HPA000545	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA000545: AB_1845721"	"unprognostic (2.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (5.76e-3)"	4.2	14.4	14.1	5.0	21.9	7.1	6.4	149.5	45.5	8.2	8.5	6.7	4.3	3.5	21.7	4.1	5.2	4.6	16.0	17.2	15.7	10.5	11.7	11.7	6.3	3.3	11.0	21.5	10.4	2.9	1.7	5.0	28.2	27.8	13.1	5.9	16.1	8.3	18.2	39.6	4.7	3.9	13.1	8.0	8.3	5.6	3.0	4.3	34.1	4.7	8.6	3.8	7.4	6.4	0.9	16.2	0.0	2.6	4.1	1.1	1.4	0.1	1.1	70.3	14.9	3.3	7.9	3.3	23.4	13.9	22.2	36.9	0.1	0.4	11.5	7.3	11.3	3.1	0.0	14.6	0.8	11.5	4.6	2.1	9.0	5.9	12.4	4.7	11.9	0.1	7.6	3.7	21.5	7.4	52.5	25.1	13.1	0.1	1.2	23.1	0.2	47.4	8.4	39.8	0.0	5.4	51.0	28.4	3.1	8.5	0.2	16.0	76.1	5.1	0.3	0.5	38.6	2.9	33.1	4.9	27.1	9.1	13.2	2.5	5.6	4.5	14.6	6.0	25.3	5.3	0.0	2.6	0.0	0.0	1.3	0.0	0.9	0.1	0.1	16.0	0.8	0.8	1.1	0.0	4.1	0.6	16.2	0.0	1.4	14.1	21.9	149.5	45.5	15.7	10.5	11.0	21.5	27.8	4.3	6.0	25.0	2.7	1.4	16.1	66.2	29.9	10.2	0.0	9.1	12.2	82.5	84.9	28.2	13.3	2.0	15.7	1.1	0.0	4.9	16.2	34.0	0.8	4.7	8.5	30.5	19.1	20.7	33.7	14.5	0.8	7.8	6.9	13.5	1.8	7.6	12.1	7.6	0.0	21.9	42.5	28.6	12.9	22.3	0.9	11.3	11.0	26.3	4.9	10.7	0.1
NRGN	RC3	ENSG00000154146	Neurogranin	Q92686	11	124739846-124747210	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 223.3"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 53.1;Kupffer cells: 51.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 79.5;basal ganglia: 172.6;cerebral cortex: 220.7;hippocampal formation: 63.6;olfactory region: 71.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 2.5;granulocytes: 3.8;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"HEL: 49.3;PC-3: 40.0"	"Group enriched"	"Detected in many"	9	"amygdala: 797.3;basal ganglia: 614.3;cerebral cortex: 1197.5;hippocampal formation: 705.6"	"Group enriched"	"Detected in all"	5	"basal ganglia: 2514.3;cerebral cortex: 5912.4;hippocampal formation: 3143.5"	"CAB006908, HPA038171"	Enhanced					NA	NA		10000000			"CAB006908: , HPA038171: AB_2675878"	"unprognostic (1.37e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.14e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.03e-2)"	4.3	2.8	79.5	4.0	172.6	11.8	1.7	0.3	223.3	2.8	2.7	3.2	0.0	2.1	3.5	2.5	2.5	4.6	3.3	3.8	63.6	13.3	3.7	1.8	14.9	2.6	9.5	71.9	2.8	1.9	1.5	0.5	3.5	4.6	2.0	2.0	0.0	1.9	2.4	2.5	1.9	2.6	3.2	1.8	8.5	2.6	2.3	17.5	0.0	2.5	0.0	2.0	2.9	0.7	0.6	2.5	3.8	5.0	0.2	0.3	9.4	4.2	3.6	15.2	17.0	0.2	0.0	0.5	2.0	1.2	1.9	1.2	2.4	6.7	12.1	7.4	0.4	4.9	1.3	3.0	5.1	0.8	2.0	8.1	49.3	1.7	1.4	0.0	1.2	15.7	0.1	0.0	1.6	0.4	1.5	9.7	4.3	2.6	5.0	1.5	16.3	0.0	0.6	5.2	2.5	40.0	6.8	7.1	1.2	1.0	2.9	2.7	5.4	2.8	9.2	0.5	3.1	8.4	13.2	10.0	7.3	5.3	3.0	5.3	1.1	0.2	0.1	5.1	12.8	8.9	1.6	5.0	1.1	0.2	2.8	0.3	0.4	0.3	0.1	2.5	0.6	0.3	0.2	3.8	0.2	1.7	0.7	0.1	9.4	79.5	172.6	0.3	220.7	63.6	13.3	9.5	71.9	4.6	17.5	0.0	53.1	0.0	0.9	3.2	0.6	1.4	2.5	0.0	0.0	0.0	0.0	0.6	3.3	0.9	2.8	7.7	0.3	0.0	0.2	2.9	1.5	0.5	1.1	0.0	11.9	0.0	5.8	3.7	51.5	4.2	0.6	13.8	5.0	0.0	1.1	0.2	0.2	0.0	0.7	0.0	1.2	19.4	16.3	4.2	4.1	1.3	0.1	1.3	1.3	1.4
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1"	"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.9	0.0	0.0	0.0	1.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	0.0	18.9	0.3	0.0	0.1	0.0	1.0	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	56.0	16.6	0.2	0.9	0.3	0.0	0.0	0.0	7.2	0.5	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	56.8	0.0	0.0	0.1
NTF3	NGF2	ENSG00000185652	"Neurotrophin 3"	P20783	12	5432112-5521536	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 29.2"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 26.7;Basal keratinocytes: 16.5;Sertoli cells: 32.3;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;HBF TERT88: 15.0;RT4: 6.8"	"Group enriched"	"Detected in many"	5	"amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3"	"Low region specificity"	"Detected in all"			HPA032001	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA032001: AB_2674106"	"unprognostic (3.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.33e-3)"	"unprognostic (4.66e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.77e-4)"	"unprognostic (4.02e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.06e-3)"	"unprognostic (4.51e-3)"	4.9	2.7	0.5	2.4	0.5	0.0	5.4	29.2	0.6	12.9	4.7	0.3	5.6	2.7	9.2	6.8	5.0	2.2	5.3	4.1	1.7	0.2	4.3	10.4	2.5	1.0	0.7	0.2	16.8	0.4	0.1	1.3	2.7	1.2	8.9	1.5	8.9	4.6	3.7	3.6	3.7	6.6	11.5	0.4	8.5	3.0	3.5	0.0	0.2	1.2	3.9	2.0	10.4	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.5	0.0	0.0	0.0	0.0	3.4	9.2	12.1	16.2	0.1	0.2	0.0	5.5	5.7	0.0	2.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	3.8	6.8	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	29.2	0.6	1.7	0.2	0.7	0.2	1.2	0.0	0.0	0.0	0.0	26.7	16.5	0.0	0.6	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	5.2	4.7	0.0	2.4	0.0	0.0	0.0	8.0	0.0	0.0	7.8	0.9	6.8	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	32.3	32.7	0.6	0.7	2.9	0.1	0.0	0.0	3.9
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Group enriched"	"Detected in some"	8	"granulocytes: 56.4;Horizontal cells: 54.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 42.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	6.8	0.0	0.0	0.0	0.0	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5	0.0	2.2	0.0	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	56.4	0.0	0.1	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	2.5	0.1	0.0	0.0	0.0	0.0
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 115.3"	"Cell type enhanced"	"Detected in some"	19	"Club cells: 27.3;Collecting duct cells: 8.7;Ito cells: 11.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 70.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 81.8"	"HPA026664, HPA071012"	Enhanced		Supported	Vesicles	"Secreted to digestive system"	NA	NA		120000	Vesicles		"HPA026664: AB_2671936, HPA071012: "	"unprognostic (3.63e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	2.9	0.6	3.9	1.4	3.2	0.1	2.5	0.3	0.4	0.5	5.2	2.5	0.0	2.8	0.2	1.6	2.5	0.5	0.8	0.8	10.3	22.1	0.9	0.7	2.0	15.1	6.3	0.1	0.7	0.4	0.1	15.0	0.3	25.0	0.4	0.7	0.0	1.6	0.5	0.1	0.1	115.3	0.5	2.7	0.2	18.8	0.3	0.4	0.1	0.9	0.8	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	1.3	0.0	0.5	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	70.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.3	0.4	10.3	22.1	6.3	0.1	25.0	0.4	0.0	0.3	0.0	0.4	1.1	0.0	0.3	0.0	5.3	27.3	8.7	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.2	2.8	0.0	0.0	0.2	0.0	2.4	11.1	0.8	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	1.9	0.1	0.0	0.0	1.1
NUP62CL	FLJ20130	ENSG00000198088	"Nucleoporin 62 C-terminal like"	Q9H1M0	X	107123427-107206433	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 40.6"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 12.0;Distal tubular cells: 18.3;Spermatogonia: 9.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"pons and medulla: 18.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.3;NK-cells: 1.7;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.8;CAPAN-2: 14.9;HeLa: 19.9;K-562: 14.0"									HPA001884	Approved					NA	NA					"HPA001884: AB_1079512"	"unprognostic (1.62e-2)"	"prognostic favorable (5.66e-5)"	"unprognostic (8.80e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.52e-3)"	0.5	12.4	1.2	2.9	2.6	1.4	2.6	0.3	0.6	1.7	3.1	3.2	8.7	2.4	2.0	40.6	2.3	15.0	2.3	1.6	1.7	2.2	5.5	2.0	2.4	1.4	1.1	1.2	4.4	12.6	2.5	9.0	0.7	18.3	1.0	2.7	1.1	2.5	10.9	0.5	1.5	3.3	0.2	1.3	0.6	1.3	11.0	1.7	3.3	8.6	1.0	3.4	1.4	1.4	4.3	0.2	0.6	0.5	1.7	2.6	0.6	8.3	13.8	1.2	0.0	0.0	0.0	6.0	0.0	0.5	0.3	0.3	1.3	14.9	4.8	1.6	0.0	7.7	7.5	8.8	3.0	0.0	0.0	11.3	0.5	19.9	2.4	0.0	0.0	0.0	0.1	4.1	0.0	2.1	0.0	0.0	7.5	14.0	1.2	0.0	4.1	1.8	0.0	1.8	11.9	5.0	0.0	0.0	0.4	4.5	2.2	3.6	4.1	4.9	1.5	0.0	5.3	0.0	0.2	0.0	0.0	4.6	0.1	0.0	1.6	5.5	2.6	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.4	0.7	4.3	2.6	0.2	0.1	3.3	1.3	1.5	0.0	1.7	0.5	0.2	1.1	0.6	1.2	2.6	0.3	0.6	1.7	2.2	1.1	1.2	18.3	1.7	3.0	0.0	3.2	3.2	1.6	0.2	0.8	2.5	12.0	1.2	8.7	0.0	1.3	18.3	1.6	6.4	0.0	1.1	0.0	3.0	0.7	0.2	0.8	0.0	1.8	0.7	1.6	0.0	0.0	0.0	1.5	0.3	0.0	5.0	0.0	2.5	1.2	0.9	0.0	0.7	4.5	0.0	6.5	0.0	4.2	9.7	2.5	0.8	0.0	2.5	2.3
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 1.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	10.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NYNRIN	"CGIN1, FLJ11811, KIAA1305"	ENSG00000205978	"NYN domain and retroviral integrase containing"	Q9P2P1	14	24398786-24419288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.9"	"Cell type enhanced"	"Detected in many"	5	"Club cells: 12.5;Ito cells: 16.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 26.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.1;HEL: 9.1;HUVEC TERT2: 22.7;RT4: 18.7;TIME: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018945	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA018945: AB_1859538"	"unprognostic (9.41e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.43e-1)"	8.1	2.8	2.1	4.3	2.2	0.2	6.8	26.6	2.6	16.7	7.6	2.5	29.6	2.9	14.6	45.9	11.6	13.4	14.5	5.1	2.2	4.2	6.1	3.6	7.5	2.0	1.8	1.8	28.0	2.9	4.5	4.9	10.5	2.4	9.8	4.1	9.1	5.5	20.2	2.5	9.1	4.5	8.0	1.5	5.2	4.5	7.3	1.4	3.5	7.5	8.5	6.5	8.6	10.2	0.0	1.7	0.0	0.1	0.5	0.1	0.0	0.1	0.0	3.0	0.0	4.1	8.7	0.2	1.4	1.4	0.9	1.1	2.1	9.1	0.2	0.4	5.4	0.1	0.0	4.8	0.1	1.0	0.0	0.5	9.1	1.2	0.2	3.1	0.0	0.0	8.8	0.4	0.6	0.0	1.6	22.7	0.1	1.4	0.0	0.1	0.4	0.0	0.4	1.7	0.6	0.0	1.2	0.0	0.0	0.0	18.7	0.4	6.5	0.0	0.8	0.1	7.6	1.6	1.3	10.9	0.1	5.5	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	2.1	2.2	26.6	2.6	2.2	4.2	1.8	1.8	2.4	1.4	3.0	1.7	0.0	3.9	4.0	0.4	1.7	7.6	1.4	12.5	8.7	0.0	0.9	0.0	3.3	0.7	7.1	1.3	0.0	2.7	0.9	6.6	0.8	0.0	1.8	8.5	0.0	5.2	16.0	5.1	0.0	2.3	0.8	3.3	1.0	8.5	5.3	3.7	3.5	0.4	0.1	0.3	0.0	4.7	0.0	1.1	3.3	0.9	0.0	8.3	3.1
OC90	PLA2L	ENSG00000253117	"Otoconin 90"	Q02509	8	132024220-132059380	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"SK-MEL-30: 4.7"														"Secreted in other tissues"	NA	NA														"unprognostic (1.92e-1)"						"unprognostic (2.93e-1)"			0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.2	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OLIG3	"Bhlhb7, bHLHe20"	ENSG00000177468	"Oligodendrocyte transcription factor 3"	Q7RTU3	6	137492202-137494250	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.7;esophagus: 1.4;placenta: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;NTERA-2: 4.8;SuSa: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA018303, CAB024865"	Uncertain					NA	NA					"CAB024865: , HPA018303: AB_1854796"				"unprognostic (1.07e-3)"							"unprognostic (1.44e-1)"	"unprognostic (2.77e-1)"			"unprognostic (2.03e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	1.8	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435685-57491297	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;gallbladder: 60.7;intestine: 18.0"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 910.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3.0	3.7	0.2	16.5	0.0	0.0	15.0	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18.0	0.3	0.3	0.3	0.5	0.6	6.6	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	3.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.3	0.0	0.1	18.7	3.0	0.7	11.9	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.2	3.6	0.6	0.0	0.4	1.7	0.0	0.1	1.5	0.7	0.0	1.1	0.0	1.6	6.3	9.8	1.6	0.1	0.0	0.2	0.1	0.4	0.7	0.0	1.0	1.3	0.2	0.2	0.3	2.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	3.0	3.7	0.5	0.9	0.5	0.9	1.1	6.6	0.0	0.0	0.0	0.2	0.1	3.0	2.6	155.4	0.0	0.0	7.0	13.7	0.0	0.0	69.5	2.0	0.6	0.3	0.0	7.6	0.1	0.0	0.3	0.0	44.2	0.8	910.5	8.5	9.2	0.6	2.8	0.3	0.0	0.0	0.0	0.7	2.9	24.1	3.1	0.0	0.0	4.9	0.0	0.7	1.4	1.7	0.1	0.0	0.0	0.4	0.0
OPN4	"melanopsin, MOP"	ENSG00000122375	"Opsin 4"	Q9UHM6	10	86654557-86666848	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Biological rhythms, Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 21.2;skeletal muscle: 14.6"	"Cell type enriched"	"Detected in single"	34	"Cardiomyocytes: 3.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"PC-3: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039147	Approved					NA	NA					"HPA039147: AB_10673304"	"unprognostic (3.67e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.89e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.88e-3)"		"unprognostic (1.93e-6)"	"unprognostic (4.10e-2)"		"unprognostic (5.58e-2)"	"unprognostic (6.76e-2)"	3.5	0.3	5.4	0.4	21.2	0.2	1.1	0.0	5.1	0.6	0.9	0.0	0.0	0.5	0.4	0.4	0.6	0.4	0.5	3.1	3.0	0.1	0.3	0.2	0.3	0.2	0.2	3.3	0.3	0.4	3.6	0.6	0.5	0.0	0.2	0.7	1.2	1.6	0.2	14.6	1.2	1.1	0.5	0.0	0.3	0.5	0.5	2.0	0.0	1.4	2.7	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	21.2	0.0	3.5	3.0	0.1	0.2	3.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.9"	"Group enriched"	"Detected in some"	33	"Early spermatids: 24.0;Late spermatids: 23.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 37.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	24	"SH-SY5Y: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported				NA	NA					"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.5	3.4	7.0	0.6	17.5	1.8	0.9	37.9	7.6	0.5	0.6	0.8	0.0	0.6	0.7	1.4	3.7	0.5	1.0	0.5	2.6	2.3	0.5	0.5	0.5	0.9	0.6	9.3	0.8	0.7	0.4	0.6	0.5	5.2	0.7	0.4	0.0	0.6	0.2	0.9	1.8	0.5	0.3	1.9	0.6	1.0	8.0	0.5	0.0	1.0	0.0	0.3	0.5	0.5	0.5	0.2	2.1	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.5	0.3	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.0	0.3	0.5	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	13.1	0.0	0.1	0.3	0.4	0.3	0.1	0.3	0.4	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.0	0.2	0.1	0.6	0.6	0.0	0.7	0.2	0.3	0.5	0.1	0.5	0.4	0.1	2.1	0.1	0.0	0.2	0.3	0.0	7.0	17.5	37.9	7.6	2.6	2.3	0.6	9.3	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.1
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558698	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Disease mutation, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"bone marrow: 13.8;brain: 26.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 26.8"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 27.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved					NA	NA					"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.5	0.7	5.5	0.8	26.8	13.8	0.2	0.4	2.2	0.3	0.4	0.3	0.0	1.1	0.2	0.1	0.4	0.3	0.9	0.2	1.6	2.0	0.1	0.2	0.6	0.5	0.6	0.7	0.2	0.1	0.1	0.0	0.2	1.1	0.3	0.3	0.0	0.3	0.2	0.7	0.2	0.7	0.4	0.7	1.2	0.5	1.4	2.6	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.6	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	5.5	26.8	0.4	2.2	1.6	2.0	0.6	0.7	1.1	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380879	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 9.8;kidney: 13.3;pituitary gland: 21.0"	"Cell type enhanced"	"Detected in some"	24	"Cardiomyocytes: 6.1;Distal tubular cells: 1.7;Early spermatids: 1.1;Proximal tubular cells: 3.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	4	"amygdala: 3.5;basal ganglia: 4.3;cerebral cortex: 5.8;olfactory region: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 3.9;U-2 OS: 2.5;U-87 MG: 7.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 5.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.4	0.2	3.5	0.2	4.3	0.1	0.4	0.2	5.8	0.4	2.7	0.0	0.0	0.2	0.5	3.1	0.5	0.5	0.4	9.8	1.0	0.4	13.3	0.1	0.3	0.5	0.5	3.6	0.2	0.7	0.2	21.0	1.4	0.3	0.5	0.3	1.4	0.3	0.5	1.0	0.3	0.6	0.6	0.3	0.4	0.4	0.8	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.5	3.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.4	0.5	2.5	0.0	0.2	0.9	0.0	0.1	7.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.3	0.2	5.8	1.0	0.4	0.5	3.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56810479	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 27.7;retina: 78.2"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 181.3;Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 203.6"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;pons and medulla: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 63.9;NTERA-2: 53.5"	"Low region specificity"	"Detected in many"							"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.2	0.2	0.0	0.2	0.3	0.2	0.2	20.4	0.3	0.2	0.2	3.7	0.0	0.2	0.2	1.0	0.2	0.2	0.2	0.2	1.8	2.7	0.2	0.2	0.2	0.5	4.7	0.0	0.5	0.2	0.2	2.8	0.2	27.7	0.3	0.2	78.2	0.2	1.3	0.2	0.5	0.2	0.2	0.2	0.4	0.2	3.1	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.4	0.3	1.8	2.7	4.7	0.0	27.7	2.3	0.0	0.0	0.0	0.0	0.0	181.3	0.2	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 232.0"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 9.2;Hepatocytes: 37.5;Late spermatids: 23.3;Proximal tubular cells: 10.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in some"	59	"hypothalamus: 232.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;HL-60: 1.3;HMC-1: 3.8;PC-3: 2.7"	"Region enriched"	"Detected in some"	5	"hypothalamus: 210.0"	"Group enriched"	"Detected in some"	1042	"basal ganglia: 840.1;hypothalamus: 2453.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000				"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	5.0	0.2	0.0	0.1	3.9	0.2	0.2	0.0	0.3	0.1	0.0	0.4	0.0	2.6	0.0	3.8	0.0	0.0	0.0	0.0	0.1	232.0	1.6	24.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.6	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.2	2.4	0.0	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	1.5	6.3	0.4	0.4	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	6.3	0.8	0.4	1.0	3.7	1.7	1.1	0.9	3.6	3.2	3.6	1.1	0.4	0.0	1.5	2.4	0.9	0.0	3.9	0.0	0.3	0.1	232.0	0.0	0.0	0.2	0.0	0.0	2.6	3.7	0.6	0.7	0.0	0.2	0.0	1.4	2.3	5.2	0.0	0.0	1.7	0.1	9.2	0.0	0.3	0.0	0.0	0.0	1.3	0.1	0.0	37.5	0.2	0.0	0.0	0.0	0.3	23.3	0.9	0.3	3.3	0.0	0.3	0.0	0.2	1.4	1.1	10.5	0.0	0.0	1.0	0.9	4.5	0.9	0.0	0.0	0.0	0.1
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622386	"Disease related genes, Predicted membrane proteins"	"Hearing, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1"	"Cell type enriched"	"Detected in single"	5	"Peritubular cells: 2.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"amygdala: 6.1;hippocampal formation: 8.6"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	4	"MCF7: 6.7;T-47d: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	0.4	0.1	6.1	0.5	0.6	0.0	0.3	0.3	1.6	0.7	1.5	0.3	3.0	1.1	0.3	23.1	5.3	2.5	0.3	0.3	8.6	0.9	1.1	0.3	3.6	1.8	0.3	0.3	0.3	0.3	0.0	0.9	0.7	0.3	11.1	0.3	0.6	0.3	16.1	0.3	0.0	3.4	0.3	0.3	2.4	1.3	1.3	0.3	0.3	0.3	0.3	0.8	0.7	1.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	6.7	0.1	0.4	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.0	0.0	2.7	0.0	1.0	15.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.3	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.1	0.6	0.3	1.6	8.6	0.9	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152834693-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;placenta: 24.7"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 22.9;Kupffer cells: 17.8;Muller glia cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 29.1"	"Group enriched"	"Detected in some"	5	"basophil: 7.0;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.0;monocytes: 4.1"	"Cell line enriched"	"Detected in some"	5	"HEL: 30.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced					NA	NA					"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	2.9	1.7	4.7	5.9	29.1	4.8	2.0	3.1	6.3	6.7	8.7	4.9	0.6	3.3	8.5	0.8	19.4	2.3	2.2	2.9	8.4	2.3	1.1	1.6	10.4	2.1	1.8	6.1	9.6	3.6	0.5	2.3	24.7	2.4	8.0	6.9	2.6	5.6	2.6	7.1	8.8	6.1	4.8	3.8	2.4	1.7	1.3	3.3	3.0	1.5	9.9	3.5	3.0	9.5	0.0	0.9	7.0	4.1	0.0	0.0	0.2	0.0	0.5	4.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	6.0	0.0	0.0	0.5	0.0	0.7	1.0	2.6	0.8	0.2	0.0	2.3	30.3	0.0	0.0	0.0	3.5	2.8	0.4	6.0	0.0	0.3	2.4	0.0	1.0	0.9	0.0	0.0	0.0	0.5	0.1	4.4	0.0	3.7	0.0	0.1	0.8	0.0	2.0	0.8	0.0	0.0	0.0	0.6	1.1	0.0	1.6	0.0	0.5	1.2	0.0	2.5	0.0	0.0	0.0	3.1	0.0	3.5	7.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.2	4.7	29.1	3.1	6.3	8.4	2.3	1.8	6.1	2.4	3.3	0.0	0.3	0.8	6.8	1.6	8.2	6.3	22.9	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.6	10.5	0.0	0.0	0.2	2.7	6.6	9.3	0.2	6.2	0.0	0.0	12.9	17.8	0.0	13.8	6.3	0.0	0.0	8.4	16.6	1.1	10.5	5.6	0.0	1.0	0.0	0.5	0.5	0.4	1.8	0.1	0.0	6.6	4.2
P4HA3	C-P4Halpha(III)	ENSG00000149380	"Prolyl 4-hydroxylase subunit alpha 3"	Q7Z4N8	11	74235801-74311657	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.6"	"Cell type enhanced"	"Detected in some"	10	"Cone photoreceptor cells: 13.7;Early spermatids: 16.6;Erythroid cells: 23.3;Horizontal cells: 17.5;Rod photoreceptor cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.8;fHDF/TERT166: 6.2;HSkMC: 6.2;HUVEC TERT2: 25.4;TIME: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007897	Approved				"Intracellular and membrane"	NA	NA					"HPA007897: AB_2156427"	"unprognostic (2.74e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.31e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.54e-4)"	"unprognostic (9.65e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (3.34e-9)"	"unprognostic (1.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.83e-4)"	3.0	1.2	0.1	4.7	0.5	0.0	1.3	2.1	0.4	2.5	2.3	0.4	2.8	0.3	7.1	22.6	0.7	1.9	7.5	1.1	0.4	0.2	0.9	1.7	2.2	0.9	0.1	0.0	3.8	0.3	0.0	5.7	7.4	1.1	9.8	0.9	6.4	2.0	6.1	1.1	0.5	1.0	13.7	0.4	0.2	0.7	2.3	0.0	0.0	4.1	1.6	0.4	9.7	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	4.3	0.4	0.0	12.8	0.9	0.6	1.4	0.0	0.0	0.0	1.2	6.2	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.7	0.0	5.5	0.0	0.0	6.2	0.0	4.4	0.5	0.7	25.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	18.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.1	0.4	0.4	0.2	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.3	8.6	0.3	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.2	16.6	0.7	0.0	23.3	0.0	0.4	1.0	0.7	0.0	0.0	0.3	17.5	0.0	4.3	0.0	1.1	0.0	0.0	0.0	1.8	0.1	3.1	0.4	0.0	0.4	0.0	14.5	0.0	0.5	2.6	3.4	0.3	0.1	0.0	0.1	0.6
PANX3	Px3	ENSG00000154143	"Pannexin 3"	Q96QZ0	11	124611490-124620356	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;MCF7: 2.6;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																	"unprognostic (5.80e-2)"			"unprognostic (3.10e-1)"			0.1	0.4	0.1	0.1	1.8	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.0	0.1	1.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	2.6	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	2.8	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.5	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PASK	"KIAA0135, PASKIN, STK37"	ENSG00000115687	"PAS domain containing serine/threonine kinase"	Q96RG2	2	241106099-241150264	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 24.1;testis: 22.0"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 27.0;Peritubular cells: 23.0;Rod photoreceptor cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 24.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA016450, HPA021079"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA016450: AB_1854992, HPA021079: AB_1854993"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.99e-6)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.38e-3)"	1.5	1.1	2.4	10.3	24.1	8.9	3.1	6.3	5.2	2.2	2.1	2.2	2.1	3.8	2.9	6.7	3.1	7.2	3.3	1.1	2.9	2.7	3.7	1.3	3.0	14.5	1.3	1.6	1.9	3.3	4.4	4.9	1.1	3.6	12.1	2.8	4.7	2.7	1.8	2.0	4.9	3.9	1.4	1.6	4.4	3.4	22.0	7.2	9.0	4.8	1.9	9.9	2.7	1.9	7.1	1.1	4.8	1.0	2.7	6.0	3.0	5.0	6.8	9.2	11.6	0.8	1.4	12.3	4.8	1.5	4.5	6.3	5.5	5.1	2.6	1.0	1.1	10.0	12.6	10.4	4.2	3.3	10.6	9.9	7.2	12.6	9.7	0.5	9.8	11.3	0.7	3.3	4.6	1.3	1.9	3.2	11.2	9.3	3.6	3.1	5.7	11.6	10.3	10.2	5.9	4.1	18.5	9.3	3.2	1.7	11.4	16.3	4.9	2.9	5.6	2.1	5.1	4.7	7.1	4.2	6.1	5.6	7.8	6.4	4.8	4.9	12.4	3.8	7.4	5.6	4.8	1.0	0.7	1.7	0.6	1.5	7.1	5.9	5.3	1.1	6.6	3.7	3.9	1.3	2.7	1.0	0.7	6.0	3.0	2.4	24.1	6.3	5.2	2.9	2.7	1.3	1.6	3.6	7.2	3.0	9.3	10.6	1.0	2.4	2.3	2.8	2.5	6.7	1.2	3.5	3.9	0.8	0.0	1.2	7.7	2.4	1.8	0.0	1.8	1.5	0.9	2.5	3.5	1.0	1.6	1.6	0.0	27.0	5.3	2.2	5.5	1.9	11.8	1.0	2.9	1.6	0.6	0.0	23.0	1.0	17.7	0.0	0.3	14.7	12.7	1.3	0.2	13.1	2.7	0.7
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ, crumbs cell polarity complex component"	Q8NI35	1	61742406-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4"	"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1"	"Low region specificity"	"Detected in many"							"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	2.6	4.6	3.4	6.3	4.4	1.9	11.6	66.4	3.2	5.7	9.6	2.0	17.9	5.5	4.4	17.7	11.6	5.3	10.3	27.8	2.3	5.1	19.8	7.7	12.5	6.1	4.6	2.0	4.7	17.9	15.2	21.4	2.8	14.2	8.4	7.0	4.4	24.8	24.3	25.4	13.9	15.7	5.2	15.8	2.2	6.3	2.7	3.0	1.3	17.0	11.1	9.6	7.4	7.5	1.8	0.3	9.9	0.2	3.2	4.1	0.8	19.2	3.9	1.3	1.7	0.7	1.9	16.3	1.1	1.5	1.2	1.6	6.7	7.3	0.1	5.2	2.4	10.5	11.6	2.8	10.2	2.1	1.9	4.8	0.1	5.6	5.9	1.6	0.0	0.1	0.7	10.9	2.0	4.6	3.0	0.6	0.0	0.0	0.0	1.0	6.7	0.0	0.0	6.7	8.7	1.0	0.0	1.4	2.7	16.9	18.1	3.3	1.1	4.9	16.0	4.2	13.8	12.7	0.2	0.1	1.0	2.4	0.1	2.2	0.8	1.4	2.5	0.9	0.0	0.2	0.4	0.1	9.9	1.9	0.1	3.5	1.8	3.1	2.6	0.1	1.5	4.1	2.6	0.9	3.2	0.2	0.3	2.7	0.8	3.4	4.4	66.4	3.2	2.3	5.1	4.6	2.0	14.2	3.0	80.4	49.2	0.0	0.0	0.0	0.0	0.0	0.0	49.5	71.7	54.1	0.0	2.5	5.0	30.3	0.0	0.0	0.0	0.0	23.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735603-100829941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 137.9;Distal tubular cells: 41.4"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 1.0;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AN3-CA: 14.6;EFO-21: 20.2;RPTEC TERT1: 14.5"	"Group enriched"	"Detected in some"	9	"cerebellum: 1.5;pons and medulla: 3.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 8.1"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: AB_2686305"	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.1	3.1	0.1	0.0	30.5	0.0	1.5	93.7	0.1	9.1	0.0	0.1	0.1	0.1	43.1	0.1	0.1	0.0	0.2	0.0	1.5	0.3	0.6	0.7	0.0	1.8	0.8	0.0	0.5	0.1	19.4	0.1	0.1	0.1	0.0	1.7	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.2	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	14.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.1	0.1	0.1	0.2	0.0	1.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	137.9	0.0	0.0	41.4	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.0	18.8	0.4	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0
PAX3	"HUP2, WS1"	ENSG00000135903	"Paired box 3"	P23760	2	222199888-222298996	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;retina: 39.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 10.9;Late spermatids: 19.5;Melanocytes: 32.1"	"Cancer enriched"	"Detected in some"	24	"melanoma: 20.3"	"Group enriched"	"Detected in some"	6	"cerebellum: 19.1;pons and medulla: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 9.1;HBF TERT88: 6.7;RH-30: 13.1;SK-MEL-30: 23.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5"	"HPA063659, HPA069000"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063659: AB_2685080, HPA069000: AB_2686067"	"unprognostic (2.57e-2)"				"unprognostic (1.48e-2)"	"unprognostic (1.27e-2)"		"unprognostic (1.65e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.70e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.26e-1)"		"unprognostic (9.70e-2)"	0.8	0.1	0.0	0.1	0.8	0.1	2.9	19.1	0.2	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.2	2.2	0.0	0.1	0.2	0.1	0.0	0.1	7.8	0.4	0.1	39.6	7.9	0.2	8.6	7.9	0.1	0.1	4.2	0.1	0.2	2.9	0.8	0.0	0.1	3.9	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.2	5.1	7.6	9.1	0.0	0.5	0.0	0.0	3.5	0.1	0.0	0.0	0.0	6.7	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.4	0.1	0.0	0.0	0.0	13.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	23.1	5.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	19.1	0.1	0.0	0.2	2.2	0.0	7.8	0.8	0.0	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.9	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.4	0.0	0.0	0.0	0.0
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Cell type enriched"	"Detected in some"	27	"B-cells: 57.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Group enriched"	"Detected in some"	8	"Daudi: 21.5;REH: 62.5;U-698: 28.2"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: AB_2685997"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.1	62.5	0.1	0.1	0.0	0.0	4.4	1.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0	0.0	0.0	57.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1
PAX6	"AN, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31818062	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.3;retina: 29.4"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 249.5;Muller glia cells: 410.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 78.3"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9"	"Group enriched"	"Detected in many"	5	"cerebellum: 61.0;olfactory region: 41.2"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.8	2.0	12.6	0.8	10.4	1.1	1.0	78.3	23.5	0.8	1.1	9.3	0.0	3.5	0.8	1.8	0.8	0.8	0.8	0.8	16.0	3.7	0.9	0.9	0.7	0.9	3.9	9.1	0.8	15.8	0.8	4.6	0.8	10.8	0.8	1.4	29.4	0.8	0.9	1.9	1.6	2.0	0.8	16.1	0.8	19.4	2.8	9.8	0.0	0.8	0.0	1.0	1.1	0.3	0.2	0.2	1.6	0.4	0.4	0.5	0.1	0.0	0.1	9.4	12.1	2.9	4.0	3.6	0.0	0.0	0.1	0.0	0.7	2.2	0.0	3.8	1.2	5.5	0.2	1.0	0.0	0.2	0.0	11.3	5.3	8.8	5.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	32.3	0.0	3.3	4.2	0.0	0.1	0.0	2.2	0.3	0.2	0.0	6.1	0.0	4.4	0.0	0.5	0.3	0.4	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	3.2	0.2	0.0	9.9	0.0	0.1	0.0	5.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	0.2	0.3	1.0	0.4	0.4	0.2	0.1	0.1	12.6	10.4	78.3	12.2	16.0	3.7	3.9	9.1	10.8	9.8	0.0	0.0	0.0	0.0	0.5	15.4	4.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	249.5	71.5	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.1	410.0	4.1	0.6	0.0	0.0	27.5	0.0	0.3	3.7	2.9	0.0	0.0	0.0	0.0	0.0
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003084	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 32.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	6.0	5.4	5.7	6.2	5.0	9.7	6.3	32.3	5.7	7.8	5.5	5.8	4.5	5.2	6.5	6.7	7.1	5.7	5.0	4.7	6.0	3.4	5.7	6.9	4.7	9.4	5.7	1.4	7.1	8.4	7.2	8.7	7.9	5.6	7.7	5.7	6.9	6.6	5.4	7.1	7.4	6.9	9.3	4.2	6.4	5.9	10.4	6.2	31.2	6.4	4.7	6.9	6.1	5.9	2.2	3.3	1.4	3.1	2.9	6.5	2.5	9.9	8.2	10.9	18.4	4.8	4.0	9.7	4.4	4.7	6.1	7.2	9.0	7.9	13.1	5.6	5.3	12.7	7.9	13.9	7.0	7.6	13.1	10.9	9.9	5.9	7.7	3.4	13.5	13.3	3.8	5.3	6.1	2.5	3.5	5.8	13.3	13.6	8.8	6.1	13.9	28.7	11.3	17.6	9.8	5.6	16.4	11.1	14.2	6.3	8.4	8.7	5.6	11.8	8.8	5.5	10.3	6.7	11.6	2.9	5.1	0.9	7.3	10.6	9.0	5.2	18.0	12.6	16.0	13.8	0.7	2.3	1.4	2.5	2.6	3.8	1.3	4.0	2.9	2.6	2.2	6.5	1.7	1.0	2.9	3.1	3.3	3.2	2.5	5.7	5.0	32.3	5.7	6.0	3.4	5.7	1.4	5.6	6.2	6.0	7.5	6.5	4.7	5.7	18.0	6.1	7.6	4.0	9.1	8.7	9.8	7.4	5.0	3.5	1.5	5.0	4.7	0.0	2.9	6.4	6.0	6.1	2.3	8.9	3.9	3.2	2.4	3.1	4.0	2.7	8.1	3.6	3.3	3.6	8.7	9.3	4.0	2.9	8.9	3.1	12.8	0.0	2.5	15.2	19.9	6.0	5.1	3.9	9.9	3.5
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 47.4;pons and medulla: 23.0"	"Cell type enhanced"	"Detected in many"		"eosinophil: 5.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1"	"Region enriched"	"Detected in all"	5	"olfactory region: 280.8"	"Region enhanced"	"Detected in all"		"olfactory region: 184.8"	"HPA030247, HPA073145"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244, HPA073145: "	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	6.5	11.7	6.0	11.2	6.7	12.3	6.3	47.4	12.6	3.8	7.9	7.0	2.2	3.1	9.3	12.4	1.4	3.2	4.4	2.7	6.5	7.3	2.2	1.1	1.8	5.0	6.9	3.7	3.4	3.5	0.6	14.8	2.3	23.0	1.5	3.0	20.2	1.7	1.9	1.1	1.6	4.8	12.3	7.3	11.6	3.4	20.5	6.1	22.6	0.8	0.0	4.6	2.3	1.8	2.9	0.0	5.9	0.4	0.6	1.6	0.5	0.0	0.0	0.2	0.0	6.9	14.9	0.0	0.8	0.2	1.6	0.7	0.0	0.0	0.0	0.3	4.0	1.9	0.0	0.8	0.0	0.2	27.2	0.1	0.0	0.0	0.0	7.0	0.0	0.0	20.9	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.1	0.9	0.3	7.7	1.6	0.4	0.0	1.3	0.0	0.0	1.1	0.0	0.0	2.6	23.6	0.5	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	6.1	0.0	0.3	1.5	0.0	12.6	15.1	0.5	4.4	0.4	5.9	1.6	0.3	0.3	2.9	0.9	0.0	0.0	1.9	1.5	0.2	1.4	0.6	0.2	0.0	0.8	0.5	6.0	6.7	47.4	6.0	6.5	7.3	6.9	3.7	23.0	6.1	0.0	0.0	1.4	0.1	0.2	151.7	2.8	0.0	0.0	1.2	1.8	47.1	0.0	0.0	0.1	29.4	0.5	0.0	0.0	0.2	0.1	1.3	0.9	0.0	0.0	0.4	109.7	2.9	2.5	0.0	60.8	7.8	0.2	3.3	0.0	0.0	29.6	1.4	0.0	12.0	0.0	75.1	0.0	5.3	25.0	12.0	0.0	0.0	0.0	0.0	0.3
PCDH11Y	"PCDH22, PCDHY"	ENSG00000099715	"Protocadherin 11 Y-linked"	Q9BZA8	Y	5000226-5742224	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 21.9;seminal vesicle: 9.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 42.2;Ciliated cells: 17.4;Club cells: 25.0;Collecting duct cells: 14.0;granulocytes: 17.4;Horizontal cells: 44.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;RPMI-8226: 2.3;SuSa: 2.1;U-266/70: 2.2"															NA	NA										"unprognostic (9.26e-2)"							"unprognostic (1.84e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.55e-2)"			0.2	0.3	4.5	5.4	3.1	0.3	0.1	0.0	21.9	0.2	0.4	1.1	2.7	0.2	0.2	0.3	0.5	0.1	0.3	0.5	4.2	5.6	0.2	0.2	0.3	0.4	1.8	0.0	0.5	0.2	0.2	0.2	1.8	0.7	0.5	0.9	0.9	0.3	9.1	0.2	0.4	0.6	0.2	0.4	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.5	0.4	2.0	0.3	0.8	0.3	0.6	0.0	0.2	0.3	0.4	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.3	0.0	0.2	0.1	0.7	1.4	0.0	0.2	0.1	0.0	2.3	0.3	0.1	0.3	0.1	0.2	0.0	0.0	2.1	0.0	0.8	0.2	0.1	0.2	0.0	0.1	2.2	0.0	0.2	0.2	0.2	0.1	0.8	0.3	0.2	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.3	2.0	0.8	0.1	0.4	0.1	0.6	4.5	3.1	0.0	21.9	4.2	5.6	1.8	0.0	0.7	0.0	6.0	42.2	0.0	0.9	1.5	1.9	0.5	0.0	17.4	25.0	14.0	0.0	3.7	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	1.2	0.7	17.4	0.0	0.2	44.5	0.0	0.6	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	3.8	0.0	0.0	0.2	2.1	1.4	1.8	0.0	0.0	1.6
PCDHA12	PCDH-ALPHA12	ENSG00000251664	"Protocadherin alpha 12"	Q9UN75	5	140875302-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4"									HPA035812	Approved		Approved	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA035812: AB_2674796"	"unprognostic (3.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.74e-2)"			"unprognostic (2.24e-2)"		"unprognostic (2.08e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.98e-4)"	"unprognostic (3.18e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.97e-2)"	1.0	1.7	0.9	0.3	1.2	0.0	0.9	14.6	3.7	3.5	0.4	1.1	0.0	0.1	1.0	0.5	0.2	1.9	4.3	0.3	1.0	0.7	3.8	1.7	5.7	0.2	0.5	0.8	0.3	2.4	0.9	4.6	0.0	2.3	0.4	0.1	1.5	5.7	0.3	0.1	0.2	0.2	0.6	0.8	0.2	0.3	2.1	0.2	0.0	3.4	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	2.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	1.4	0.0	0.0	2.4	2.6	7.8	0.0	0.0	0.0	0.3	7.7	0.3	4.4	0.0	0.9	0.1	0.5	1.6	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	14.6	3.7	1.0	0.7	0.5	0.8	2.3	0.2	26.8	3.2	0.0	0.0	0.0	11.2	0.4	5.1	0.0	0.0	1.8	5.9	0.0	0.0	0.9	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.3	0.0	0.4	0.2	2.9	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633748	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 45.5;retina: 20.2;testis: 80.7"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 3770.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	14	"cerebellum: 45.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4"	"Region enriched"	"Detected in some"	43	"cerebellum: 2422.3"	"Region enriched"	"Detected in some"	18	"cerebellum: 135.0"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.5	0.4	0.5	0.5	0.5	1.9	3.3	45.5	0.6	1.0	0.5	0.5	0.5	0.6	0.5	2.0	0.5	1.3	1.2	0.5	0.5	0.0	2.5	1.0	1.2	1.4	0.5	0.5	0.5	1.6	0.3	0.5	0.5	3.2	2.0	0.0	20.2	10.6	1.0	0.5	4.2	0.5	0.5	1.9	1.1	0.9	80.7	0.5	0.5	1.9	0.5	0.6	0.5	0.5	1.0	1.7	2.6	0.3	0.7	1.2	5.2	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.7	0.8	1.2	0.0	0.0	1.4	0.0	0.2	0.0	0.8	0.6	2.8	2.5	0.1	0.0	0.3	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.6	0.0	0.3	0.4	18.4	0.4	0.3	0.0	0.8	0.2	0.7	0.9	0.1	0.1	0.0	1.5	1.6	0.0	0.4	4.0	3.4	0.2	0.0	0.6	0.4	0.1	1.6	0.6	0.2	0.0	2.1	0.0	0.0	0.3	0.0	0.9	0.1	1.2	0.4	0.5	0.5	0.5	1.0	0.8	1.0	2.6	0.7	0.0	1.7	0.2	5.2	0.5	0.5	45.5	0.6	0.5	0.0	0.5	0.5	3.2	0.5	0.0	2.9	0.0	0.8	0.7	166.8	0.0	0.0	0.0	2.3	5.2	21.6	0.2	8.3	0.6	765.5	0.0	0.6	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.4	22.3	0.0	0.0	1.2	3770.2	9.8	1.0	1.7	1.8	0.2	24.5	0.5	0.0	12.4	0.3	79.8	19.4	0.0	11.1	6.4	1.0	0.0	1.5	0.5	0.6
PCP4	PEP-19	ENSG00000183036	"Purkinje cell protein 4"	P48539	21	39867317-39929397	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 177.9;seminal vesicle: 234.5"	"Cell type enhanced"	"Detected in many"	23	"Bipolar cells: 431.9;Distal tubular cells: 547.2;Horizontal cells: 1320.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"basal ganglia: 177.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 57.7;SK-BR-3: 9.7;T-47d: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005792	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA005792: AB_1855086"	"unprognostic (6.82e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (5.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (9.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	2.1	11.0	5.6	1.4	177.9	1.0	2.6	15.8	15.8	39.3	10.6	11.4	50.8	1.9	11.4	65.7	38.4	2.9	1.7	1.7	8.3	14.0	9.7	1.0	1.1	1.0	11.6	3.7	1.2	2.1	3.4	1.0	1.3	20.0	60.9	6.9	49.0	1.7	234.5	1.0	1.4	1.5	93.5	3.7	1.5	1.1	1.2	37.5	0.0	39.2	0.0	1.2	65.6	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	57.7	0.0	0.0	0.1	0.1	0.0	9.7	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	177.9	15.8	15.8	8.3	14.0	11.6	3.7	20.0	37.5	0.0	1.0	0.0	0.5	2.7	431.9	8.1	5.1	0.0	0.0	73.3	58.9	0.2	547.2	0.3	1.1	0.3	0.0	0.0	0.2	0.2	1.5	4.0	0.0	0.0	0.2	1320.5	1.2	0.0	0.0	0.0	8.9	1.9	20.3	0.0	0.0	53.7	1.2	0.0	0.4	219.7	168.9	0.0	3.1	0.5	3.8	5.3	2.4	0.0	0.2	0.9
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258727-161285450	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;urinary bladder: 33.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 23.9;Bipolar cells: 34.5;Sertoli cells: 19.4;Urothelial cells: 42.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8"	"Group enriched"	"Detected in all"	5	"basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8"	"Cell type enhanced"	"Detected in single"		"T-reg: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Group enriched"	"Detected in some"	6	"RT4: 16.1;T-47d: 10.5"	"Low region specificity"	"Detected in all"							HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	3.2	1.0	5.7	1.3	67.7	0.6	2.2	4.4	28.9	4.3	4.3	1.4	1.5	2.2	2.2	3.3	16.5	2.1	3.9	1.3	3.9	6.3	1.0	4.3	5.0	0.7	7.8	4.6	2.6	0.5	0.6	21.9	0.9	30.8	5.5	3.2	5.9	1.2	17.8	1.0	2.8	3.3	6.8	7.5	0.8	1.2	2.3	5.3	0.0	1.0	0.0	3.0	33.2	4.1	0.0	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	16.1	2.2	0.0	0.0	0.3	0.0	0.2	10.5	0.4	0.2	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.7	67.7	4.4	17.9	3.9	6.3	7.8	4.6	30.8	5.3	3.0	5.4	0.0	23.9	0.0	34.5	0.2	0.0	0.0	7.9	0.0	5.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	0.2	1.8	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	1.8	0.0	4.1	19.4	9.5	0.2	0.2	0.3	1.5	0.0	0.0	42.7
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 15.3;Hepatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 29.1;CACO-2: 13.5;HaCaT: 38.9;HeLa: 33.9;RPTEC TERT1: 19.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	143000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	6.5	0.9	0.0	2.1	1.5	0.1	0.0	0.0	0.0	0.0	13.5	4.6	0.0	5.3	2.5	0.1	38.9	1.1	11.8	0.0	0.0	0.0	0.0	33.9	9.4	0.7	0.0	0.0	2.3	8.8	8.5	6.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	5.5	0.5	0.7	0.0	0.0	0.3	19.2	0.0	0.5	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0	14.9	15.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	1.3	0.0	0.4	0.1	0.0	17.0	0.1	0.0	4.1	1.8	1.6	0.2	0.0	0.0	1.7	0.0	2.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	2.9	0.2
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165986603	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.8"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 15.9;Muller glia cells: 21.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.7;LHCN-M2: 14.0;RH-30: 8.2;RT4: 8.5;SH-SY5Y: 8.6;TIME: 14.5;U-2 OS: 7.9"	"Region enriched"	"Detected in many"	11	"basal ganglia: 307.0"	"Group enriched"	"Detected in all"	4	"basal ganglia: 155.2;cerebellum: 80.7"	"CAB045998, HPA047200"	Supported					NA	NA					"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	3.1	1.9	1.7	1.0	36.8	0.0	3.4	4.5	6.9	2.2	1.0	1.1	4.3	0.8	2.9	7.5	0.7	3.1	3.2	3.6	2.6	2.1	8.8	0.9	4.3	1.4	2.7	1.1	3.4	0.8	1.2	2.5	5.3	1.7	2.6	0.5	0.6	0.7	4.9	0.9	0.6	0.8	4.3	1.1	2.5	1.2	8.7	16.0	0.0	12.2	1.0	0.8	7.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	5.0	0.0	2.8	0.0	0.0	0.0	3.4	0.0	7.7	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	7.5	0.0	0.0	0.0	14.0	0.1	1.1	0.0	1.5	0.0	5.6	1.7	8.2	0.0	7.4	8.5	2.2	8.6	0.0	0.0	0.4	0.6	0.0	0.0	14.5	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	36.8	4.5	6.9	2.6	2.1	2.7	1.1	1.7	16.0	0.0	0.0	0.0	2.8	0.3	8.8	6.9	0.0	1.4	1.2	5.2	2.0	6.0	3.3	1.7	8.9	10.3	0.0	0.0	0.0	5.2	2.0	11.7	1.1	0.0	0.7	15.9	0.0	9.8	0.0	11.8	0.0	0.0	1.7	0.0	0.0	21.0	0.2	0.0	0.4	6.5	0.6	0.0	2.1	6.6	0.5	0.3	2.4	0.0	0.0	2.2
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Kupffer cells: 11.5;Sertoli cells: 12.9;Smooth muscle cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;HL-60: 6.4;HMC-1: 12.3;NB-4: 8.1;THP-1: 7.8;U-937: 6.5"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced					NA	NA					"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.5	0.3	4.7	0.0	0.0	0.0	6.4	12.3	0.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.9	0.0	0.0	0.7	8.1	3.4	0.0	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.5	1.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7	0.0	0.6	0.0	0.2	0.9	0.1	3.1	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	4.8	0.3	0.0	23.3	0.0	0.0	0.4	0.3	0.0	0.0	7.3	4.8	1.7	0.0	11.5	3.4	2.0	5.2	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.1	12.9	9.5	0.9	0.5	0.4	0.2	1.5	0.0	0.1
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0;lymphoid tissue: 65.4"	"Group enriched"	"Detected in some"	6	"Endothelial cells: 33.1;Intestinal endocrine cells: 33.1;Ito cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 30.4;basal ganglia: 34.2;cerebral cortex: 48.0;hippocampal formation: 18.0;olfactory region: 27.0"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.7;T-cells: 9.6"	"Cell line enriched"	"Detected in some"	8	"HeLa: 107.5"					"Group enriched"	"Detected in all"	5	"amygdala: 111.5;basal ganglia: 166.3;cerebral cortex: 98.9;hippocampal formation: 120.9"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	27.8	18.4	30.4	3.0	34.2	2.5	25.4	1.0	48.0	8.9	7.7	3.8	1.9	3.5	9.4	4.9	10.2	11.6	12.0	11.3	18.0	6.1	7.0	10.4	5.1	3.8	3.8	27.0	3.4	2.4	4.4	3.4	6.6	6.7	4.8	5.2	3.0	2.3	6.3	6.6	4.8	4.2	10.3	2.1	65.4	4.2	2.9	7.4	0.1	7.0	3.9	2.2	8.3	11.2	3.7	1.2	0.2	1.0	0.1	9.6	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	107.5	0.1	0.2	0.0	1.6	0.0	0.2	0.5	4.4	0.2	2.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	2.9	0.0	0.0	0.2	0.0	0.0	9.6	0.5	0.0	0.0	0.4	0.1	0.0	0.0	13.7	0.0	2.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.8	0.0	9.6	1.0	5.6	3.7	5.7	5.6	1.2	2.5	3.7	3.0	0.2	0.1	0.5	0.0	2.3	1.9	30.4	34.2	1.0	48.0	18.0	6.1	3.8	27.0	6.7	7.4	0.0	0.3	0.0	0.0	2.3	2.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	33.1	0.0	0.0	0.0	0.2	0.9	0.1	1.1	0.9	0.5	1.6	33.1	118.4	10.0	1.5	0.3	1.0	1.7	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.4	0.0	4.3	1.4	0.8	2.5	0.0	0.0	0.0	0.3
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643723-14872044	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 42.6"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 34.7;Hepatocytes: 50.5;Spermatocytes: 45.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 5.0;T-cells: 8.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 13.6;Karpas-707: 15.7;THP-1: 16.7;U-266/70: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	42.6	1.0	2.3	12.6	2.2	6.7	17.0	19.2	3.0	2.9	21.8	0.9	0.8	2.2	0.9	1.4	2.6	1.0	6.9	4.7	2.2	2.1	2.4	18.2	10.2	14.1	1.6	1.6	0.9	7.3	0.3	5.1	5.5	1.5	10.7	8.1	1.9	16.5	1.3	0.8	0.9	6.3	9.7	2.1	8.7	3.0	12.5	0.8	7.8	1.2	2.3	7.1	10.5	4.5	0.3	0.4	5.0	1.2	0.1	8.7	1.8	0.0	1.5	3.4	5.5	6.8	0.0	1.3	0.4	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	1.6	0.0	5.1	0.0	0.0	0.1	11.3	0.1	8.3	10.2	2.4	13.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.0	11.9	15.7	0.0	0.1	2.7	6.6	4.6	1.8	2.5	6.5	1.5	10.3	0.0	1.1	5.2	9.7	1.3	8.8	3.0	1.6	0.0	16.7	0.0	0.0	0.8	0.0	0.0	17.7	5.4	0.4	0.1	2.3	1.0	0.0	0.7	2.9	1.4	0.7	2.9	0.3	4.2	3.2	0.4	0.2	8.7	7.5	5.0	0.1	1.2	0.1	4.2	1.8	2.3	2.2	19.2	3.0	2.2	2.1	1.6	1.6	1.5	0.8	14.9	9.9	1.9	0.8	0.2	0.4	8.2	0.0	6.7	11.4	1.8	0.0	1.0	1.7	0.0	12.4	2.2	2.6	23.3	4.3	1.9	8.5	3.4	34.7	50.5	6.3	0.0	1.2	7.4	14.0	10.1	1.4	12.3	0.0	1.0	13.1	4.5	2.9	17.5	8.5	1.9	0.3	0.0	0.1	45.1	11.1	0.1	2.1	11.7	9.7	0.9
PDE6C	"ACHM5, COD4, PDEA2"	ENSG00000095464	"Phosphodiesterase 6C"	P51160	10	93612588-93666010	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"retina: 12.8"	"Cell type enriched"	"Detected in some"	18	"Cone photoreceptor cells: 53.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.23e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.81e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.19e-7)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.80e-3)"	0.4	0.6	0.3	0.4	0.4	1.3	0.4	3.0	0.7	0.8	0.3	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.3	0.5	0.5	1.0	0.3	0.3	1.0	0.3	0.0	0.8	0.3	0.3	0.7	0.0	12.8	0.8	0.3	3.1	3.1	0.7	0.3	0.3	0.9	0.6	0.7	0.3	0.3	0.6	0.3	0.3	0.4	0.7	0.2	0.1	0.2	0.2	0.3	0.6	0.0	0.2	0.7	0.4	1.4	0.0	0.1	1.0	0.8	0.0	0.0	0.0	0.8	1.0	0.6	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.6	0.5	1.4	2.4	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.3	0.8	0.0	0.2	1.0	1.6	0.8	0.1	0.4	0.6	0.0	0.1	0.0	0.2	1.2	0.1	0.2	0.0	0.1	0.5	0.5	0.3	0.2	0.0	0.4	0.0	0.2	0.7	0.6	0.6	0.6	0.4	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.6	0.5	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.4	3.0	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283152-287215	"Enzymes, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"pancreas: 286.5"	"Cell type enriched"	"Detected in some"	6	"Exocrine glandular cells: 253.2"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.2;HEK 293: 11.6;Hep G2: 8.6;Karpas-707: 4.0;MCF7: 6.1;SH-SY5Y: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3.0	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3.0	0.2	0.2	0.2	0.2	4.0	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1.0	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.1	5.2	0.2	0.7	0.1	11.6	0.0	0.3	8.6	1.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.4	4.0	0.2	6.1	0.2	0.6	0.4	2.1	0.0	0.1	0.0	1.1	0.0	0.0	2.2	5.0	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.5	15.3	3.0	2.8	3.0	4.0	0.5	2.2	2.8	0.0	0.3	0.0	0.0	0.5	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	253.2	0.6	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.0	0.2	39.2	0.3	0.4	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.9	0.0
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 55.9"	"Group enriched"	"Detected in some"	102	"Early spermatids: 39.7;Late spermatids: 87.7"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;NTERA-2: 2.8;THP-1: 2.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 150.7;hypothalamus: 70.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 131.1"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA					"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.4	0.4	13.2	0.4	55.9	0.4	0.4	0.0	40.3	0.4	0.4	1.2	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	5.0	3.9	0.4	0.4	0.4	0.4	0.7	3.7	0.4	0.4	0.4	0.0	0.4	0.2	0.4	0.4	0.0	0.4	0.4	0.4	0.6	0.4	0.4	2.2	0.4	0.4	3.2	1.1	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	55.9	0.0	3.8	5.0	3.9	0.7	3.7	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 49.2;kidney: 124.3"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 758.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in single"	17	"cerebellum: 10.0"	"Cell type enriched"	"Detected in many"	4	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 7.6"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 43.1;T-47d: 112.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.1	0.6	0.2	0.2	0.3	0.0	5.8	10.0	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0.0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.0	1.1	0.5	0.2	7.6	1.8	0.5	1.3	0.2	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	18.9	0.1	0.1	0.2	1.1	0.0	0.6	0.0	0.1	0.1	1.8	0.3	0.1	0.4	7.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.1	0.1	0.2	0.2	0.2	0.5	0.0	1.3	0.2	43.1	0.0	0.1	1.2	0.3	0.3	0.0	1.2	112.0	0.1	0.1	0.2	0.2	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	1.5	0.2	0.6	1.0	0.4	1.8	0.2	1.0	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10.0	0.2	0.2	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.9	0.0	0.1	0.4	0.4	61.1	0.0	0.0	54.1	0.0	0.0	117.7	1.7	8.9	0.0	18.0	0.0	1.6	0.1	0.2	0.1	0.0	45.6	0.2	0.0	6.3	1.8	1.2	5.2	0.0	0.0	0.0	0.0	0.5	0.0	1.8	2.9	0.0	758.4	0.3	0.0	0.3	0.2	0.2	0.0	0.1	0.0	1.0	0.0
PEG10	"HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1"	ENSG00000242265	"Paternally expressed 10"	Q86TG7	7	94656325-94669695	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4"	"Group enriched"	"Detected in many"	13	"Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 143.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 130.3"	"Low region specificity"	"Detected in all"			"HPA021324, HPA029915, HPA051038"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.61e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.40e-2)"	2.3	67.5	32.0	2.1	143.8	1.4	10.6	25.6	16.8	4.2	2.1	7.4	0.0	1.5	3.3	1.9	2.0	5.1	2.4	1.8	21.0	47.0	4.0	2.0	7.3	2.9	13.1	21.3	27.0	5.4	2.3	102.6	171.4	27.4	2.2	1.9	1.8	4.3	2.2	1.9	1.4	1.6	2.6	14.4	1.8	2.1	19.8	11.1	1.5	5.4	0.0	2.3	1.8	1.0	2.6	0.0	0.0	0.0	2.7	0.7	0.2	2.6	13.4	95.0	40.1	2.0	3.6	5.5	7.3	4.3	5.2	7.1	22.3	4.4	0.2	0.2	8.4	10.8	0.8	123.3	5.2	7.3	0.3	13.0	0.0	15.3	95.0	1.5	15.1	0.0	8.0	1.7	13.0	9.0	4.6	3.1	0.0	0.0	29.8	10.2	0.6	0.0	0.0	43.5	2.2	8.5	5.7	30.4	7.9	23.9	9.9	60.4	3.4	0.0	2.0	7.2	24.9	12.9	0.0	0.0	4.2	0.2	0.5	5.5	8.0	5.3	11.8	9.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.7	0.0	2.6	0.0	0.1	0.0	2.7	0.0	0.0	0.1	0.2	32.0	143.8	25.6	14.4	21.0	47.0	13.1	21.3	27.4	11.1	142.9	64.2	2.4	7.4	0.7	70.4	25.2	7.6	16.0	126.3	15.7	7.9	1669.7	54.7	10.7	2.8	2.4	0.0	0.0	4.3	85.1	27.1	7.0	2.3	2.9	150.9	35.0	58.0	2.5	0.0	11.4	8.3	1.4	13.5	0.0	0.7	118.3	4.2	0.0	3.9	10.0	25.7	6.5	12.5	16.4	5.1	0.6	2388.4	0.5	0.1	0.6
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 19.3;JURKAT: 24.9;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.8	5.1	0.0	2.8	4.2	0.1	0.7	2.4	0.5	0.0	0.1	0.4	0.1	2.4	1.4	0.0	0.5	3.9	0.0	0.2	1.2	1.4	4.4	7.9	0.0	2.4	0.6	19.3	2.7	0.2	0.0	0.0	2.8	0.9	24.9	3.2	0.0	0.5	0.0	21.6	0.2	8.3	0.0	0.7	10.6	0.3	0.9	2.1	8.7	10.2	0.0	0.4	0.0	5.7	3.3	0.0	3.5	0.3	1.5	2.6	0.4	2.5	0.4	0.0	0.5	2.7	3.0	1.5	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2	0.0	7.7	2.7	11.0	12.7	30.0	1.9	7.6	14.7	10.3	12.2	27.5	0.0	3.3	4.4	2.3	10.9	8.4	0.0	12.2	0.1	5.6	7.0	5.7	0.8	1.1	20.6	6.9	11.1	16.5	4.1	15.8	11.1	16.9	2.8	7.4	10.0	8.6	3.7	17.0	8.8	18.5	12.9	22.1	1.4	27.2	15.9	0.1	3.5	3.0	9.7
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446734	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 124.3;brain: 171.5"	"Cell type enhanced"	"Detected in some"	32	"Leydig cells: 1053.7;Peritubular cells: 212.2;Spermatocytes: 309.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 171.5"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.6;ASC TERT1: 9.9;BJ: 9.2;THP-1: 8.6"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3244.3"	"Region enriched"	"Detected in all"	7	"basal ganglia: 1049.6"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		35000			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	2.5	124.3	2.8	1.7	171.5	0.3	0.9	3.9	7.8	14.3	2.2	0.9	0.1	0.6	3.0	0.9	0.9	2.6	4.0	9.1	1.2	9.1	0.3	0.2	1.0	0.3	2.5	0.4	8.2	0.6	0.2	1.5	1.1	8.4	11.7	0.9	2.2	0.9	8.1	1.1	0.5	0.9	1.7	7.0	0.3	1.1	29.9	14.7	0.0	0.6	0.3	0.3	0.5	0.6	3.1	1.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	16.6	9.9	0.0	9.2	2.9	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	171.5	3.9	7.8	1.2	9.1	2.5	0.4	8.4	14.7	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	56.7	0.5	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.9	1053.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.0	6.5	0.4	309.0	17.5	0.4	0.0	0.0	0.0	0.0
PGA3		ENSG00000229859	"Pepsinogen 3, group I (pepsinogen A)"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	28	"stomach 1: 1048.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Exocrine glandular cells: 5.8;Rod photoreceptor cells: 3.2"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enriched"	"Detected in single"	15	"cerebral cortex: 4.8"	"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HMC-1: 13.7;THP-1: 4.5"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA					"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.0	4.8	0.2	0.4	19.9	0.0	0.1	0.1	0.5	36.8	0.2	0.0	0.4	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.4	17.7	0.0	0.0	0.2	0.0	0.2	0.0	0.1	2.0	0.1	0.1	0.0	0.0	0.7	0.0	1.4	1048.8	0.1	0.0	0.0	0.1	3.8	0.0	0.1	0.0	0.3	0.3	1.1	6.7	0.5	1.5	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.3	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	4.3	0.2	1.5	6.7	0.9	0.2	0.5	1.4	0.3	0.3	0.2	1.4	1.1	0.5	1.7	0.2	0.1	3.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PHACTR1	"dJ257A7.2, KIAA1733, RPEL1"	ENSG00000112137	"Phosphatase and actin regulator 1"	Q9C0D0	6	12716805-13290484	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;brain: 80.3"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 134.6;Horizontal cells: 170.0;Kupffer cells: 97.1;Macrophages: 102.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 80.3"	"Group enriched"	"Detected in many"	13	"memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9"	"Group enriched"	"Detected in many"	17	"B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.7;SK-MEL-30: 15.7;U-266/70: 41.2;U-266/84: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029755, HPA029756, HPA029757"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870"	"unprognostic (7.86e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-4)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.16e-1)"	3.5	1.6	11.6	7.2	80.3	22.6	1.6	4.9	31.4	1.4	1.4	1.3	0.3	2.0	1.3	2.6	1.5	1.9	4.2	9.2	10.9	4.4	3.9	1.9	9.0	8.7	2.7	16.6	1.8	4.2	0.5	6.0	1.7	2.2	1.4	1.5	0.6	1.4	0.7	1.2	2.6	2.9	1.7	2.6	6.5	2.0	2.2	7.2	0.4	1.3	0.0	13.4	3.4	1.4	20.9	25.9	10.1	1.1	0.4	0.2	1.1	0.0	0.1	1.1	0.2	0.0	0.0	3.2	0.3	1.2	1.2	2.1	0.1	0.0	0.2	0.4	0.1	1.6	0.1	0.0	0.0	1.5	4.2	0.3	8.4	0.1	0.1	0.1	7.9	16.7	0.4	0.0	0.0	0.1	0.1	1.5	0.5	3.9	7.1	1.2	0.0	0.1	6.1	1.1	0.0	0.0	4.0	2.2	0.7	1.0	0.1	5.0	1.5	0.0	3.2	15.7	1.6	9.6	1.9	1.7	0.1	0.3	0.0	0.0	41.2	26.8	7.0	0.6	2.3	6.4	0.1	1.1	0.6	0.1	0.9	0.0	7.2	0.1	0.0	7.7	20.9	0.1	0.2	10.1	0.4	0.3	25.9	0.0	1.1	11.6	80.3	4.9	31.4	10.9	4.4	2.7	16.6	2.2	7.2	62.5	37.4	134.6	1.5	3.3	35.3	9.1	2.5	9.4	14.8	59.3	3.9	1.2	26.6	0.6	54.5	8.3	0.4	0.0	2.5	2.0	6.2	0.8	80.7	0.8	76.1	170.0	1.7	15.4	97.1	44.3	4.4	102.6	45.5	18.0	0.1	21.8	1.0	0.0	6.0	0.6	13.0	0.0	4.0	1.2	2.7	2.8	1.6	2.5	0.4	0.7
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase"	Q8TCT1	17	49223362-49230766	"Enzymes, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 80.0;testis: 52.3"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1098.7"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 10.2;pons and medulla: 8.2"	"Group enriched"	"Detected in some"	171	"eosinophil: 30.6;neutrophil: 80.0"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 80.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9"	"Low region specificity"	"Detected in all"							HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1.0	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1.0	1.7	1.3	1.0	0.9	2.5	2.0	2.1	1.5	1.1	1.0	0.1	0.8	7.6	8.2	0.9	0.0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0.0	0.8	0.1	0.1	1.4	1.3	0.0	0.0	80.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	2.0	0.1	0.2	0.0	0.3	0.4	0.0	0.1	2.7	0.0	8.6	5.8	0.0	3.3	0.0	1.6	0.5	0.1	6.1	0.2	1.2	1.1	0.4	0.0	0.0	1.1	0.4	0.0	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.6	0.1	0.0	0.4	0.0	0.3	1.6	1.7	3.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	8.9	0.2	0.1	3.5	0.4	2.8	1.9	0.0	0.2	0.3	0.6	2.5	3.3	0.3	0.0	0.1	30.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.0	0.0	0.3	0.0	0.0	0.1	1.1	1.9	1.0	10.2	1.7	1.3	2.1	1.5	8.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	185.3	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.6	0.0	1098.7	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.6	0.0	0.4	0.0	0.0	8.2	3.8	0.0	198.7	0.0	0.0	0.0
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2a"	O14813	11	72239077-72245664	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7"	"Cell type enriched"	"Detected in single"	9	"Spermatogonia: 3.6"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in single"	96	"pons and medulla: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	228	"SH-SY5Y: 115.5"	"Region enriched"	"Detected in single"	9	"pons and medulla: 0.8"	"Not detected"	"Not detected"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA			Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.4	24.6	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.5	0.0	0.4	0.1	0.0	1.4	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	12.1	0.9	0.7	1.7	0.7	3.7	0.0	0.0	3.2	0.3	2.1	0.1	1.6	5.2	0.0	0.0	0.0	0.0	0.0	2.6	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	115.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0
PHOX2B	"NBPhox, Phox2b, PMX2B"	ENSG00000109132	"Paired like homeobox 2b"	Q99453	4	41744082-41748970	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.5;brain: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	99	"pons and medulla: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"SH-SY5Y: 53.6"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	14.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	24.8	0.2	1.4	0.8	0.0	0.0	0.0	0.0	3.2	0.5	0.4	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PIFO	"C1orf88, FLJ23853, pitchfork"	ENSG00000173947	"Primary cilia formation"	Q8TCI5	1	111346288-111353013	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.9;fallopian tube: 96.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 720.1;Early spermatids: 388.2;Late spermatids: 350.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 55.9"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.5;hTERT-RPE1: 4.5;RPTEC TERT1: 6.2;RT4: 7.3;SuSa: 11.6;T-47d: 5.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (3.18e-3)"	"unprognostic (3.23e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.03e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.43e-4)"	"unprognostic (8.78e-7)"	"unprognostic (6.43e-3)"	"unprognostic (7.28e-2)"	"unprognostic (9.07e-3)"	"prognostic favorable (2.48e-4)"	"unprognostic (3.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.03e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.83e-2)"	1.1	2.0	6.6	1.2	10.1	0.8	3.8	0.7	3.9	4.4	3.0	15.9	3.5	1.1	4.9	15.5	2.8	96.8	2.7	6.4	8.6	8.6	5.4	0.8	10.8	0.9	5.0	6.5	9.2	4.2	5.1	13.8	4.3	55.9	7.5	1.4	4.2	2.2	4.3	0.9	1.6	1.1	3.4	4.2	1.0	2.6	26.5	5.4	0.4	8.8	0.1	1.1	5.4	0.6	1.6	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.1	0.7	0.8	0.8	0.9	1.4	0.0	1.7	0.4	0.0	1.3	1.4	0.0	0.3	0.0	1.5	0.0	1.2	0.2	0.0	1.8	0.2	0.0	0.2	1.1	0.7	0.0	0.0	0.9	4.5	0.0	0.0	4.5	0.0	0.4	0.2	0.1	2.6	0.1	0.7	0.0	2.6	0.1	0.0	0.0	0.0	0.0	6.2	7.3	3.1	0.3	0.0	0.2	0.2	11.6	5.1	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.5	4.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.3	1.6	0.9	1.0	0.0	0.9	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	10.1	0.7	3.9	8.6	8.6	5.0	6.5	55.9	5.4	3.0	14.4	0.0	7.4	3.8	0.8	12.3	0.0	720.1	70.5	5.2	3.9	7.2	18.3	11.6	388.2	0.9	0.0	0.0	1.9	3.6	3.9	10.1	0.0	0.0	1.1	0.0	2.9	0.0	0.0	350.3	5.5	2.0	8.5	0.0	0.0	10.4	1.5	0.0	3.2	19.3	5.4	6.5	2.0	97.0	7.2	2.5	5.8	0.0	0.0	2.6
PIH1D3	"CXorf41, MGC35261, NYSAR97"	ENSG00000080572	"PIH1 domain containing 3"	Q9NQM4	X	107206632-107244243	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;fallopian tube: 16.2;lung: 7.0;testis: 13.9"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 148.5;Early spermatids: 139.2"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.0"	"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"WM-115: 1.7"					"Region enhanced"	"Detected in many"		"midbrain: 4.6"	HPA072496	Enhanced					NA	NA					"HPA072496: AB_2732202"	"unprognostic (8.66e-2)"	"unprognostic (2.75e-3)"		"unprognostic (7.73e-4)"	"unprognostic (3.37e-1)"			"unprognostic (8.61e-2)"		"unprognostic (4.27e-1)"			"unprognostic (3.37e-2)"			"unprognostic (1.77e-2)"		0.0	0.1	0.9	0.0	4.0	0.2	0.0	0.0	0.1	1.3	0.0	1.9	1.0	0.1	0.5	4.5	0.1	16.2	0.1	0.1	1.6	1.5	0.2	0.0	7.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	13.9	1.3	0.1	0.4	0.0	0.1	0.0	0.0	0.5	0.3	2.1	0.3	0.6	0.2	0.2	0.3	0.9	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.8	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.2	1.0	0.0	0.2	0.0	0.8	0.4	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.3	1.7	2.1	0.3	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.2	1.2	0.6	0.2	0.3	0.1	0.2	0.9	4.0	0.0	0.0	1.6	1.5	0.0	0.0	8.0	1.3	3.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	148.5	12.5	0.0	0.0	0.0	1.7	0.0	139.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.5	8.8	0.0	0.0	0.0	0.0	0.0
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell type enhanced"	"Detected in some"	27	"Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1"	"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	17.2	10.6	0.0	14.2	0.6	0.2	4.4	3.4	5.0	1.7	0.6	40.4	10.2	19.4	5.5	0.2	4.2	5.9	2.3	8.3	0.1	0.2	15.0	4.8	33.0	11.1	5.2	1.7	0.0	0.4	6.0	0.0	1.9	0.1	0.0	3.0	32.2	0.0	0.5	5.3	0.1	3.8	0.0	1.5	9.5	5.7	0.3	0.3	0.2	5.4	6.6	0.0	15.1	8.2	0.0	0.1	48.1	1.1	0.6	1.9	4.8	1.0	5.3	0.0	0.0	12.7	2.5	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	84.7	1.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.4	0.0	0.3	0.0	0.4	2.0	0.9	52.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.0	0.0	0.3	0.0	9.9	0.3	0.0	0.0	2.0	0.0	1.4	1.4	4.1	5.9	6.4	0.0	0.6	214.7
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7"	"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.9	0.0	0.7	1.9	1.6	3.0	0.6	0.3	2.0	1.5	18.1	0.0	0.0	3.9	3.7	2.4	0.3	0.1	0.0	1.1	0.0	8.0	0.0	1.4	0.0	6.7	0.0	3.8	2.1	0.1	0.3	0.0	0.6	0.0	2.0	0.5	0.0	18.6	0.5	2.0	0.0	0.3	0.0	0.3	0.0	15.7	0.0	0.3	2.5	0.0	0.0	1.4	2.5	0.2	0.3	0.1	0.0	0.0	2.5	5.9	0.0	2.9	0.0	0.1	0.8	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	12.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	6.5	0.0	0.3	5.4	4.5	0.2	0.0	0.0	6.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	1.7	1.2	5.6	0.1	8.8	0.0	1.2	0.0
PITX3	ASMD	ENSG00000107859	"Paired like homeodomain 3"	O75364	10	102230186-102241474	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 19.9;tongue: 13.7"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 5.4;Late spermatids: 2.4;Spermatocytes: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"midbrain: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"RH-30: 26.3"	"Region enhanced"	"Detected in single"		"midbrain: 0.3"	"Region enriched"	"Detected in single"	5	"midbrain: 13.2"							NA	NA						"unprognostic (8.13e-2)"	"unprognostic (4.07e-1)"		"unprognostic (5.15e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-1)"		"unprognostic (6.04e-5)"	"unprognostic (6.30e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.36e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.13e-2)"	1.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.1	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.8	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	13.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	1.4	1.0	0.1	0.0	0.0	0.0	0.0
PKHD1L1		ENSG00000205038	"PKHD1 like 1"	Q86WI1	8	109362477-109530330	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"thyroid gland: 91.7"	"Group enriched"	"Detected in some"	7	"B-cells: 36.0;Ito cells: 10.4"	"Group enriched"	"Detected in some"	18	"endometrial cancer: 5.2;ovarian cancer: 1.9;thyroid cancer: 3.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	9	"memory B-cell: 1.8;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.2;HUVEC TERT2: 2.3;TIME: 4.7;U-266/70: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044458	Uncertain					NA	NA		5100000			"HPA044458: AB_2678949"	"unprognostic (9.07e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.61e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.76e-6)"	"unprognostic (4.56e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.73e-2)"	12.4	1.5	0.1	4.2	0.1	0.4	2.6	0.0	0.2	13.8	5.7	0.1	2.1	1.1	3.5	8.9	2.5	11.5	3.5	5.2	0.1	0.1	0.8	0.8	16.9	22.5	0.4	0.0	3.5	0.7	0.2	0.4	0.2	1.1	1.4	1.6	4.2	1.7	1.5	2.0	0.9	2.0	3.2	0.2	0.3	0.8	1.6	0.0	0.0	91.7	2.9	1.1	2.1	3.2	1.8	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.1	0.0	0.0	3.2	36.0	0.0	0.2	0.0	2.0	0.0	0.0	2.3	1.8	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.5	0.0	0.0	1.7	10.4	1.2	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 91.6;placenta: 140.9"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 457.3;Enterocytes: 299.8;Extravillous trophoblasts: 381.2;Syncytiotrophoblasts: 802.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 91.6"	"Cell type enriched"	"Detected in some"	11	"myeloid DC: 22.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 22.3"	"Cell line enhanced"	"Detected in many"		"AF22: 20.0;MCF7: 22.6;OE19: 24.5;PC-3: 31.8;RPTEC TERT1: 52.0;SCLC-21H: 44.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 92.0;olfactory region: 58.4"	HPA030156	Approved					NA	NA					"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	0.8	2.0	3.3	7.3	3.7	0.0	8.8	91.6	2.3	1.8	33.0	1.0	1.0	5.4	0.9	1.2	1.6	1.8	2.3	0.5	2.8	4.5	0.9	2.6	2.0	0.9	6.1	2.2	0.5	2.3	18.9	22.3	140.9	17.7	2.0	23.6	5.6	2.8	1.2	0.5	3.1	12.0	1.2	2.8	0.8	12.2	1.2	0.7	1.6	1.0	1.3	2.5	1.8	0.7	0.1	22.3	0.0	1.9	1.4	0.5	0.5	0.0	0.7	20.0	0.1	0.1	0.0	17.5	0.0	0.2	0.0	0.3	0.1	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.2	0.1	1.0	0.3	1.1	0.4	0.0	0.0	3.4	0.1	0.3	0.3	4.3	9.6	0.1	0.1	5.8	0.1	0.0	22.6	0.0	0.1	8.2	24.5	31.8	0.1	3.0	0.1	52.0	2.8	44.3	0.0	0.0	4.7	0.5	11.5	3.3	0.4	1.7	0.0	13.5	0.0	1.6	0.0	0.0	0.0	13.2	0.4	0.1	0.0	0.4	0.0	0.0	1.9	0.5	0.0	0.0	0.0	22.3	0.1	0.3	0.1	0.0	1.4	0.1	0.3	0.2	0.5	3.3	3.7	91.6	2.3	2.8	4.5	6.1	2.2	17.7	0.7	3.0	3.8	2.7	2.1	17.5	14.0	0.3	5.1	97.7	13.6	1.8	3.9	457.3	16.6	18.6	103.5	1.5	299.8	0.0	30.1	381.2	7.1	14.7	38.1	3.8	46.4	6.4	94.2	1.8	40.2	208.8	1.1	124.0	42.2	40.5	65.2	9.4	67.0	45.5	0.4	3.3	47.6	6.5	4.0	2.7	5.4	14.9	802.7	3.2	47.0	4.7
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"	NA	NA					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1	0.0	2.2	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.6	0.0	0.0	0.0	0.4
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.0;skin 1: 32.8;tongue: 56.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 1.9;Club cells: 2.3;Rod photoreceptor cells: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 10.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 11.0;T-47d: 5.9"															NA	NA						"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	1.8	1.2	1.8	1.8	2.2	3.4	3.6	10.8	2.1	6.1	1.8	1.8	1.8	1.9	2.7	2.3	19.3	2.0	1.9	1.8	1.8	2.5	2.5	2.6	2.2	3.3	1.8	1.8	4.2	3.5	1.4	3.2	1.8	1.8	4.8	1.1	1.8	7.0	2.7	1.8	32.8	2.4	1.8	1.8	3.0	1.8	1.8	1.8	2.2	4.8	56.0	36.0	2.0	5.9	3.0	0.5	0.2	0.8	3.9	1.5	0.1	1.3	0.7	0.0	0.0	0.1	0.0	3.7	0.4	1.2	1.3	0.1	0.3	0.7	0.3	0.1	0.7	0.1	4.4	1.5	0.5	0.3	0.0	2.5	1.1	1.4	3.4	1.7	0.2	1.4	0.9	4.9	0.2	1.3	0.1	0.6	1.9	1.7	0.2	0.4	2.1	1.0	4.1	1.0	5.5	1.2	0.0	1.2	0.9	1.0	11.0	0.2	1.1	0.0	2.0	1.0	0.9	5.9	1.8	0.0	0.0	1.0	1.0	0.1	3.4	0.0	0.9	0.3	5.0	0.0	0.0	0.8	0.0	1.5	0.5	0.9	0.1	0.4	0.8	0.5	3.0	0.9	0.8	0.2	3.9	0.2	0.5	1.2	0.1	1.8	2.2	10.8	2.1	1.8	2.5	1.8	1.8	1.8	1.8	0.0	1.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 31.4;Muller glia cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		99000	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.3	0.0	9.2	12.5	0.0	4.1	9.9	0.8	1.1	0.0	2.1	0.0	0.2	4.3	0.9	2.0	0.0	3.0	0.8	0.0	0.0	0.0	6.9	0.0	0.7	0.0	0.0	5.0	3.3	1.2	1.3	16.5	5.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.2	1.3	0.0	1.1	1.6	0.1	28.7	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2	6.0	3.2	0.0	2.2	8.4	0.8	3.6	5.1	6.7	2.3	31.4	0.0	4.3	0.0	0.7	0.0	3.6	2.6	0.0	1.8	1.1	6.7	2.3	1.1	0.0	0.5	15.9	1.2	8.0	0.0	0.9	15.0	0.0	6.8	0.0	6.1	30.3	3.2	5.8	15.6	1.1	1.1	6.5	2.2	0.0	0.6	4.6	1.3	0.0	6.5	2.2
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;retina: 40.2;salivary gland: 39.8"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 44.9;pons and medulla: 11.9"	"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.6"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	5.5	5.0	2.1	4.5	4.6	0.2	5.6	44.9	5.2	6.0	13.1	2.7	2.4	1.6	12.3	16.2	6.9	10.9	6.2	12.4	2.3	6.6	2.3	0.9	4.4	1.0	4.0	3.3	2.9	1.3	0.5	15.1	4.4	11.9	6.9	12.6	40.2	39.8	7.1	2.5	4.3	3.1	12.3	3.1	1.1	9.7	2.1	2.4	4.3	21.9	4.4	2.0	7.1	8.8	0.0	6.6	0.0	0.0	0.3	0.0	0.0	0.0	6.1	3.1	0.0	0.0	0.1	0.0	13.4	3.8	4.0	2.5	1.2	0.9	0.0	0.2	38.2	14.5	0.0	0.9	2.9	6.0	0.0	1.8	1.6	2.2	0.0	0.6	0.0	0.0	0.9	1.2	5.2	18.7	7.3	0.0	0.0	1.5	0.1	30.8	2.0	0.0	0.0	3.3	17.8	3.9	0.0	0.0	0.2	39.4	2.8	10.2	7.1	0.0	9.2	5.6	4.3	7.8	0.0	0.1	4.3	0.3	0.4	5.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	0.0	2.1	4.6	44.9	5.2	2.3	6.6	4.0	3.3	11.9	2.4	6.0	0.3	0.0	3.6	2.2	79.8	57.6	0.0	56.2	11.4	5.2	0.0	0.0	0.0	0.5	1.0	35.4	2.3	0.0	0.2	0.0	4.8	10.1	0.0	0.0	0.1	155.7	40.4	1.3	0.0	0.4	1.4	0.3	6.8	1.0	35.3	1.9	5.0	7.0	19.4	0.6	5.4	12.9	23.6	1.4	1.3	0.9	0.1	0.0	34.0	1.8
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.3"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 25.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 42.3;cerebellum: 24.6;cerebral cortex: 19.1;pons and medulla: 29.2"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 53.8"	"Low region specificity"	"Detected in many"							HPA007721	Approved		Approved	Cytosol		NA	Yes			Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	7.4	1.5	6.5	5.3	42.3	18.8	8.7	24.6	19.1	8.9	3.7	2.1	2.1	5.3	9.1	2.1	11.4	3.5	5.3	2.8	7.1	4.2	3.1	5.4	3.5	10.0	4.8	3.6	19.3	4.3	2.3	5.5	12.5	29.2	3.5	3.5	2.1	7.0	2.4	4.5	11.6	5.9	2.1	22.2	10.5	17.3	3.6	6.7	2.1	5.1	2.1	5.4	4.7	7.9	5.8	2.9	6.3	11.9	1.8	4.1	2.7	8.8	33.9	8.2	12.3	1.7	1.3	6.5	8.0	0.9	4.3	4.2	13.7	9.6	11.4	5.6	3.5	6.4	2.8	2.0	5.3	2.3	6.8	15.1	53.8	11.0	18.2	5.3	5.5	21.2	7.0	0.7	15.8	1.6	2.9	3.3	18.6	14.0	6.2	3.1	2.8	16.6	8.1	17.4	2.3	6.6	9.4	4.4	16.6	1.3	4.1	8.8	4.7	8.1	4.8	7.4	5.9	9.2	7.7	2.3	5.7	9.1	6.2	8.8	2.1	5.6	26.3	3.7	14.6	6.1	4.3	3.8	6.3	2.8	8.1	3.9	2.3	2.2	3.4	2.9	5.8	2.8	2.7	4.9	1.8	11.9	2.7	4.1	2.7	6.5	42.3	24.6	19.1	7.1	4.2	4.8	3.6	29.2	6.7	8.9	25.9	6.1	8.4	6.2	8.1	2.2	7.6	0.0	2.3	0.0	2.0	8.4	0.0	5.1	0.6	3.9	11.5	0.0	1.6	9.0	3.4	4.9	3.5	6.4	4.8	7.9	2.9	6.2	6.5	0.6	2.3	6.4	0.0	1.0	7.5	2.8	12.0	8.7	3.5	1.4	6.1	12.9	4.1	7.9	18.3	7.5	22.5	4.4	7.4	7.1
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306954-41510628	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4;heart muscle: 36.6;ovary: 27.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 124.0;Intestinal endocrine cells: 40.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 33.4"	"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.4;PC-3: 5.6;SH-SY5Y: 26.3;TIME: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	7.0	15.3	6.9	1.2	4.5	0.8	4.5	33.4	6.5	4.5	1.4	2.0	1.4	1.3	1.6	1.7	1.4	2.5	3.4	36.6	4.8	8.1	7.3	2.2	2.0	7.9	4.2	4.2	27.6	4.8	1.3	13.7	0.8	9.0	1.9	1.5	0.5	1.2	2.0	0.9	0.9	1.7	2.1	5.8	0.9	5.9	1.1	2.1	0.0	1.4	0.0	1.0	1.4	6.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.3	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	26.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	6.9	4.5	33.4	5.5	4.8	8.1	4.2	4.2	9.0	2.1	0.0	0.0	0.0	0.0	0.1	0.4	124.0	7.6	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.7	3.6	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.2	0.1	1.6	40.9	19.6	0.3	2.5	7.2	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.4	9.7	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PLD5	FLJ40773	ENSG00000180287	"Phospholipase D family member 5"	Q8N7P1	1	242082986-242524696	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 54.8;retina: 37.7"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Region enriched"	"Detected in all"	4	"cerebellum: 54.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028389, HPA050367"			Approved	Vesicles,Mitochondria,Cytosol		No	No			Mitochondria	"Vesicles, Cytosol"	"HPA028389: AB_10602145, HPA050367: AB_2681105"	"unprognostic (5.20e-2)"	"unprognostic (1.05e-1)"		"unprognostic (9.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-5)"	"unprognostic (2.79e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.44e-3)"	"unprognostic (2.18e-1)"	1.1	5.4	5.0	0.4	3.7	0.4	1.6	54.8	7.6	2.2	0.8	7.7	0.0	0.4	3.5	0.9	1.6	1.8	0.8	0.8	4.4	4.6	1.5	0.5	0.8	3.3	5.4	2.5	6.6	3.1	1.4	7.2	1.5	12.7	2.7	0.6	37.7	2.2	9.3	0.8	0.6	0.5	2.9	6.0	2.2	0.8	4.2	6.2	0.0	1.0	0.0	1.5	0.4	1.0	0.4	0.2	1.0	0.2	0.3	0.4	0.0	0.0	4.0	14.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.2	0.3	0.3	0.2	0.3	0.2	0.3	0.3	0.1	0.4	0.3	0.4	1.0	0.3	0.2	0.2	0.2	0.0	5.0	3.7	54.8	5.5	4.4	4.6	5.4	2.5	12.7	6.2	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	4.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.5	0.0	0.7	0.5	0.2	0.1	0.2	0.0	0.0	0.0
PLEKHD1	UPF0639	ENSG00000175985	"Pleckstrin homology and coiled-coil domain containing D1"	A6NEE1	14	69484692-69531551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 7.4;brain: 16.0"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 217.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"cerebellum: 16.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 7.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 7.4"	"Cell line enhanced"	"Detected in some"		"OE19: 2.8;SK-BR-3: 6.2;T-47d: 6.0;U-266/70: 2.8"	"Region enhanced"	"Detected in many"		"cerebellum: 33.7"	"Low region specificity"	"Detected in all"			HPA051875	Uncertain					NA	NA					"HPA051875: AB_2681648"	"unprognostic (8.73e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.42e-2)"	0.3	0.3	0.4	0.1	1.5	1.1	1.4	16.0	2.2	0.5	0.2	0.5	2.5	0.3	0.2	4.2	0.2	0.2	0.2	0.3	0.6	0.5	1.8	0.1	0.4	2.0	0.8	0.1	0.2	0.5	4.5	0.6	0.1	1.4	0.2	0.0	4.1	3.9	4.0	0.2	2.0	0.2	0.1	0.6	0.4	0.3	1.8	0.4	0.8	4.0	0.1	0.5	0.2	0.2	0.2	7.4	0.6	0.1	0.1	0.1	0.0	0.3	0.3	0.5	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.5	0.1	0.2	0.5	0.8	0.1	0.1	0.5	0.4	0.1	0.4	0.1	0.1	0.5	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.2	1.2	0.1	0.9	0.4	0.4	0.7	2.8	0.1	0.3	0.1	0.2	0.5	0.5	0.8	1.9	0.2	6.2	0.1	0.2	6.0	0.2	0.2	0.3	0.8	0.4	0.3	2.8	0.6	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.1	0.1	7.4	0.1	0.0	0.4	1.5	16.0	2.2	0.6	0.5	0.8	0.1	1.4	0.4	0.0	8.2	0.0	1.7	0.3	46.2	0.8	0.0	1.4	3.4	0.0	3.9	0.0	3.3	0.1	0.3	0.7	0.0	0.0	0.2	0.1	0.4	1.4	1.1	0.0	0.1	217.7	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	0.0	1.7	0.2	0.0	0.0	0.1	5.3	0.0	0.4	0.5	0.2	0.3	0.1	0.5	0.0	0.6
PLEKHG4B	KIAA1909	ENSG00000153404	"Pleckstrin homology and RhoGEF domain containing G4B"	Q96PX9	5	92151-189972	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 25.4;Club cells: 19.4;Collecting duct cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 8.5"	"Cell type enriched"	"Detected in single"	21	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 5.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.4;HAP1: 9.3;NTERA-2: 9.6;REH: 21.7;SCLC-21H: 9.7;SH-SY5Y: 8.7;SK-BR-3: 9.2;SuSa: 9.5;T-47d: 13.0"									"HPA036274, HPA058157"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036274: AB_10669668, HPA058157: AB_2683625"	"unprognostic (3.60e-2)"	"unprognostic (8.52e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.59e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (5.96e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.98e-7)"	"unprognostic (1.43e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-3)"	0.1	0.2	1.7	0.3	0.5	1.4	3.9	1.5	0.6	4.4	1.0	3.1	0.0	0.6	3.6	1.0	0.6	3.1	0.0	0.1	1.3	0.9	1.4	0.1	1.3	1.5	0.8	0.0	3.3	2.5	0.2	8.2	7.9	8.5	5.4	0.1	5.1	4.5	1.2	0.4	0.9	0.9	0.7	0.4	0.2	2.1	4.8	1.1	5.2	8.2	0.6	1.6	0.3	0.8	0.0	5.4	0.2	0.0	0.1	0.2	0.0	0.0	0.9	6.9	10.4	0.0	0.0	0.1	0.7	0.2	0.7	1.5	1.2	0.1	0.1	2.3	0.9	0.6	0.4	9.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.2	0.1	0.0	9.6	0.0	0.1	21.7	4.9	5.6	0.8	0.0	9.7	8.7	5.3	9.2	0.0	9.5	13.0	0.0	0.0	0.2	2.6	0.0	0.2	0.1	0.0	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	5.4	0.0	0.0	1.7	0.5	1.5	0.6	1.3	0.9	0.8	0.0	8.5	1.1	0.0	4.3	0.0	2.9	0.3	0.4	1.6	0.0	25.4	19.4	10.4	0.0	4.2	0.0	0.4	0.2	0.0	0.0	0.0	0.2	3.8	0.6	2.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.2	5.7	0.3	1.5	0.0	0.0	0.7
PLEKHG5	"GEF720, KIAA0720, Syx, Tech"	ENSG00000171680	"Pleckstrin homology and RhoGEF domain containing G5"	O94827	1	6466092-6520061	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.8;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 12.9;Suprabasal keratinocytes: 12.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 17.5"	"Group enriched"	"Detected in many"	4	"amygdala: 18.7;basal ganglia: 13.2;cerebral cortex: 26.7;hippocampal formation: 40.2"	"Low region specificity"	"Detected in all"			HPA049570	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049570: AB_2680818"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.50e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.85e-2)"	10.6	9.7	8.7	2.9	6.3	0.7	4.1	59.8	11.6	3.9	3.0	1.2	2.5	3.3	3.8	4.5	7.1	3.9	6.5	5.4	7.7	2.9	2.3	0.8	3.6	2.7	1.8	6.7	2.6	3.1	4.0	15.2	7.6	4.4	3.4	2.8	4.9	4.2	5.3	3.4	60.0	4.3	2.7	1.8	16.9	2.6	2.6	1.4	0.0	2.4	6.5	4.8	2.3	4.4	0.5	0.6	2.1	0.5	0.3	1.0	0.4	4.0	1.1	8.1	4.7	0.8	2.8	1.4	5.5	3.1	1.7	1.0	2.3	8.0	0.1	12.6	1.8	3.1	13.7	0.9	12.0	0.9	7.9	1.6	0.0	5.6	1.4	1.2	0.0	0.7	2.9	6.4	5.9	6.9	10.5	12.3	0.9	0.0	1.0	0.4	3.4	0.1	15.6	2.5	1.2	12.2	0.1	1.0	1.1	4.3	1.3	5.2	14.9	0.6	4.1	0.3	4.1	5.4	0.1	17.5	4.2	3.0	0.0	3.3	0.1	0.0	0.9	4.6	0.0	0.3	1.8	0.5	0.3	0.4	0.4	1.0	0.2	0.8	0.7	0.1	0.5	0.5	0.6	2.1	0.3	0.2	0.6	0.2	0.4	8.7	6.3	59.8	11.6	7.7	2.9	1.8	6.7	4.4	1.4	0.0	1.0	0.0	2.1	6.5	0.6	3.2	2.5	1.4	2.3	3.5	2.0	2.2	0.0	1.1	8.6	4.5	3.3	0.0	1.2	3.3	1.8	1.4	0.0	0.0	4.0	1.6	3.4	5.5	1.2	2.6	1.7	0.0	0.0	0.0	5.2	9.2	3.3	5.8	8.1	0.6	1.5	12.9	1.0	1.9	3.2	12.7	1.6	0.0	2.7	5.5
PLK5	"PLK5P, SgK384ps"	ENSG00000185988	"Polo like kinase 5"	Q496M5	19	1524074-1536046	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"brain: 50.1"	"Group enriched"	"Detected in some"	5	"Leydig cells: 33.6;Peritubular cells: 63.6"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	6	"cerebellum: 50.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.0"									HPA035024	Enhanced					NA	NA					"HPA035024: AB_2674418"	"unprognostic (4.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.69e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.01e-4)"	0.4	0.7	8.3	0.4	4.8	1.7	0.8	50.1	7.9	5.9	0.4	1.6	0.3	0.5	6.4	6.2	1.6	2.7	0.4	0.3	3.2	1.7	0.3	0.3	0.3	0.4	1.1	1.9	0.8	0.6	0.5	0.5	0.3	2.9	0.9	0.4	8.4	0.6	3.2	0.5	1.0	0.7	2.8	0.8	0.4	0.2	7.4	1.8	0.0	0.4	0.0	0.3	0.2	2.9	1.2	1.2	4.4	0.9	1.0	1.1	0.1	0.2	0.9	0.8	1.2	0.4	0.9	1.0	0.2	0.5	0.5	0.4	0.5	1.0	5.0	0.3	0.5	0.3	1.2	0.8	0.5	0.2	0.5	0.7	1.0	1.3	0.8	0.1	0.2	1.1	1.0	0.3	0.8	0.2	2.0	0.3	0.7	0.8	1.7	0.8	1.0	0.4	1.0	1.4	0.3	0.9	1.0	0.3	0.4	0.6	0.1	0.5	0.7	0.7	0.4	0.3	0.6	1.5	0.7	0.0	0.9	1.0	1.3	0.2	1.5	0.4	0.6	0.4	0.7	0.5	1.6	0.9	2.2	0.8	0.5	0.5	0.7	0.8	0.5	0.2	1.2	1.1	0.6	4.4	1.0	0.6	1.2	1.0	0.1	8.3	4.8	50.1	7.9	3.2	1.7	1.1	1.9	2.9	1.8	0.0	0.0	0.0	0.1	0.1	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	33.6	0.0	1.7	0.0	0.0	10.1	0.0	0.0	63.6	0.0	0.6	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.1
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146606216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;intestine: 1.8;parathyroid gland: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"SuSa: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047249	Uncertain					NA	NA					"HPA047249: AB_2679997"																		0.1	0.0	0.5	0.1	1.8	0.0	0.1	0.1	0.3	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.4	0.1	0.1	0.1	5.6	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.8	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.1	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197845	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 124.8"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 1.6;monocytes: 1.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enriched"	"Detected in some"	27	"hypothalamus: 124.8"	"Cell type enriched"	"Detected in some"	8	"T-reg: 11.3"	"Lineage enriched"	"Detected in single"	81	"T-cells: 11.3"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 31.3"	"Group enriched"	"Detected in some"	131	"hypothalamus: 737.6;thalamus: 373.6"	"Region enriched"	"Detected in some"	30	"hypothalamus: 98.6"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"	NA	NA	274000				"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.1	0.0	0.3	2.1	2.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.1	1.0	0.0	0.2	0.6	0.8	124.8	0.1	0.1	0.2	6.4	0.4	0.1	0.1	0.1	0.0	1.4	0.2	4.5	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.1	0.1	0.9	1.1	2.0	0.2	0.7	1.0	0.1	0.1	1.7	0.2	0.1	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.3	0.1	0.3	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.2	0.2	0.0	0.0	0.0	31.3	0.1	0.5	0.6	0.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.2	3.8	0.4	0.7	0.1	0.0	0.0	0.6	1.0	0.5	0.5	1.2	0.3	0.6	1.2	0.0	0.2	0.3	0.4	0.4	0.6	0.1	0.3	0.2	0.1	0.4	0.4	0.4	0.1	0.5	0.1	0.6	0.4	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	0.3	2.0	0.1	0.1	0.8	124.8	0.4	0.1	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 26.7"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 7.6;Early spermatids: 13.6;Late spermatids: 10.3;Spermatocytes: 11.1;Spermatogonia: 9.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basal ganglia: 5.7;cerebral cortex: 3.9"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.8;HAP1: 2.3;hTCEpi: 3.8;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA					"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.6	0.5	0.6	0.5	5.7	0.4	1.4	0.2	3.9	0.3	0.3	0.3	0.0	0.2	0.3	1.3	0.2	3.6	0.3	0.2	0.7	0.2	0.8	0.8	0.5	0.4	0.4	0.7	0.8	2.3	0.3	0.3	0.3	0.3	0.4	0.3	0.0	1.2	0.4	0.5	1.4	0.3	0.3	0.4	0.5	0.3	26.7	0.3	0.5	0.4	0.3	0.7	0.2	0.0	0.1	1.7	0.0	1.8	0.4	1.0	0.4	0.0	0.4	0.2	1.8	1.0	0.0	1.1	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.2	0.3	0.1	0.1	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	3.8	0.0	0.1	0.2	0.0	1.0	0.1	0.8	0.2	0.1	0.8	0.1	0.9	0.3	0.8	0.1	0.0	2.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.2	0.3	0.0	0.3	0.7	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.1	1.8	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	0.4	0.0	1.7	0.5	0.4	0.6	5.7	0.2	3.9	0.7	0.2	0.4	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	13.6	0.0	0.0	0.0	0.8	0.0	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	11.1	9.0	0.0	0.0	0.0	0.0	0.1
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 173.0;Late spermatids: 102.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 81.2"	"Low region specificity"	"Detected in all"							"CAB011616, HPA049104"	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"CAB011616: AB_731977, HPA049104: AB_2680632"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.65e-4)"	5.5	8.6	10.1	9.5	10.7	21.9	13.5	73.6	16.6	7.0	5.5	5.8	6.0	4.9	6.2	11.2	12.4	6.3	11.3	16.3	9.8	9.6	7.2	15.8	9.1	11.8	8.4	10.3	10.3	7.7	10.3	11.6	5.0	10.9	11.4	6.3	6.8	22.1	6.9	36.6	10.8	4.9	6.6	10.0	8.1	6.4	29.5	5.4	9.7	7.7	17.2	10.1	11.5	9.2	4.9	33.8	25.1	9.4	7.9	7.2	4.2	11.0	6.6	11.5	23.0	6.4	6.1	9.7	7.1	8.2	11.7	10.8	9.3	13.0	10.0	9.0	4.5	12.4	5.7	9.6	8.2	14.5	6.5	10.4	7.3	5.5	12.5	9.9	5.1	81.2	5.4	9.8	8.6	10.2	14.9	8.9	21.6	15.8	6.4	11.3	6.6	21.2	14.5	15.5	13.2	7.6	12.1	11.6	8.6	22.0	8.9	6.6	11.9	8.4	5.6	21.3	12.4	14.9	8.8	4.9	5.6	7.8	14.0	6.8	9.3	15.6	14.1	5.6	10.9	14.6	12.5	5.9	17.3	4.9	7.2	5.5	4.9	5.2	5.3	6.1	4.5	5.8	5.4	25.1	7.9	9.4	33.8	7.2	4.2	10.1	10.7	73.6	16.6	9.8	9.6	8.4	10.3	10.9	5.4	3.0	12.8	13.8	19.3	14.9	3.3	19.1	7.6	22.7	28.4	7.0	7.9	6.3	5.0	11.3	173.0	10.3	3.6	0.0	8.4	5.6	5.6	27.3	22.0	11.9	6.5	6.4	5.8	6.2	5.6	102.4	6.6	8.9	6.8	4.6	4.7	6.0	22.7	5.9	3.5	5.6	4.3	0.0	5.8	19.1	12.9	17.6	9.3	10.5	6.1	25.5
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687365	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 25.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 34.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.1	3.4	6.7	10.2	4.4	29.3	6.2	34.8	14.4	7.0	6.6	2.0	7.6	7.3	6.1	4.4	7.5	6.2	6.5	4.7	5.6	1.6	3.8	8.6	5.4	8.2	3.3	4.3	8.7	6.8	3.6	3.1	6.5	5.1	6.8	7.7	4.3	8.7	7.4	8.9	17.9	8.5	6.8	3.7	16.7	7.8	25.6	4.4	29.8	5.1	6.0	10.3	6.7	8.7	0.5	1.7	0.8	0.8	4.8	0.7	0.5	11.2	15.0	22.3	10.6	4.7	3.7	19.9	11.5	5.2	13.8	10.1	18.2	6.7	12.9	4.9	6.2	5.3	15.7	15.5	7.8	8.4	6.0	19.6	20.4	19.4	8.9	0.9	15.9	11.7	2.8	3.1	14.4	4.7	3.8	4.8	16.6	22.8	7.3	6.8	18.2	26.1	29.2	17.3	5.3	9.0	21.7	12.6	5.8	4.4	18.4	18.6	10.7	13.4	11.0	2.5	11.2	16.2	9.9	4.4	12.6	12.9	9.5	11.6	9.7	6.5	20.3	6.9	22.0	8.9	0.0	0.3	0.8	0.5	0.1	0.7	0.5	0.3	0.4	0.7	0.3	0.5	0.3	0.1	4.8	0.8	1.7	0.6	0.5	6.7	4.4	34.8	14.4	5.6	1.6	3.3	4.3	5.1	4.4	0.0	7.9	4.5	3.5	5.0	8.1	5.6	0.0	2.7	0.0	1.8	0.0	6.2	0.0	2.1	6.5	3.0	4.7	0.0	2.7	9.0	4.7	3.7	2.3	8.9	10.4	0.0	6.9	12.9	7.9	7.0	6.4	3.2	5.0	1.0	6.7	3.7	2.4	5.8	3.2	0.8	5.0	25.8	3.3	25.4	7.9	6.8	3.3	5.7	9.8	2.5
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"pituitary gland: 811.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 92.7;Late spermatids: 265.2;Spermatocytes: 70.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.7;HMC-1: 4.2;HSkMC: 1.2;NTERA-2: 1.2;THP-1: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hypothalamus: 77.9"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000				"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	1.0	3.2	0.3	0.8	0.3	0.5	0.3	0.3	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.3	0.0	0.3	0.3	0.3	1.8	0.5	0.3	0.3	0.6	0.3	0.3	0.3	22.2	0.0	811.1	0.9	0.3	0.3	0.0	0.3	0.4	0.3	3.6	0.9	0.3	0.3	0.3	1.3	0.4	2.9	0.3	0.3	0.3	0.4	0.3	0.3	0.3	13.7	22.2	6.6	10.1	12.6	10.5	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	4.2	1.2	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	9.9	6.6	9.8	10.1	7.7	12.8	7.5	9.3	12.5	13.7	9.9	10.5	3.1	12.6	5.9	22.2	7.9	7.6	0.3	0.3	0.3	0.3	0.3	1.8	0.3	0.3	0.3	0.3	0.0	2.1	11.0	1.4	3.9	1.8	2.6	0.0	0.0	1.2	0.0	0.0	0.3	13.3	7.0	92.7	6.9	0.0	0.0	14.7	5.6	3.3	3.9	6.9	1.3	29.5	6.4	0.0	9.8	6.3	265.2	4.4	7.2	16.9	8.2	0.0	4.1	9.1	0.0	12.4	2.1	7.1	12.9	3.1	70.4	22.9	4.8	0.3	8.7	0.0	3.0
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"	P49335	X	83508261-83512127	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"brain: 39.0"	"Cell type enriched"	"Detected in some"	6	"Collecting duct cells: 10.4"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	145	"AF22: 15.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062295			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062295: AB_2732681"					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.5	0.5	3.3	0.5	39.0	0.6	0.5	5.0	15.2	0.5	0.7	2.4	0.0	0.5	0.5	0.5	0.5	0.5	1.3	0.5	2.8	1.6	2.5	0.5	0.5	0.5	2.4	3.7	1.1	0.5	0.5	0.1	0.5	2.4	0.5	0.6	0.0	0.5	0.5	0.5	0.5	0.5	0.6	1.7	0.5	0.5	0.5	6.6	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	39.0	5.0	4.2	2.8	1.6	2.4	3.7	2.4	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU4F1	"BRN3A, RDC-1"	ENSG00000152192	"POU class 4 homeobox 1"	Q01851	13	78598362-78603560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.3"	"Cell type enhanced"	"Detected in some"	14	"Rod photoreceptor cells: 1.1;Spermatocytes: 1.6;Spermatogonia: 2.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	23	"pons and medulla: 25.3"	"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.9;HEL: 11.6;JURKAT: 9.3;REH: 8.2;RH-30: 14.0;SCLC-21H: 13.4;U-266/70: 12.6"	"Group enriched"	"Detected in some"	14	"midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4"	"Group enriched"	"Detected in some"	26	"midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5"	HPA068024	Enhanced	Approved				NA	NA					"HPA068024: AB_2685943"	"unprognostic (6.70e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.53e-1)"		"unprognostic (4.75e-3)"	0.1	0.0	1.1	2.3	1.0	1.2	1.0	0.2	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.2	1.0	1.0	0.0	0.5	0.1	2.3	0.7	0.0	0.0	0.1	0.1	0.0	0.9	25.3	0.0	0.3	6.3	0.2	0.0	1.8	0.4	0.3	0.0	2.5	0.3	0.3	4.4	0.4	2.7	0.0	0.2	3.5	0.3	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.5	0.0	3.9	0.0	0.0	0.0	10.9	11.6	0.0	1.4	0.0	5.7	3.4	0.0	0.1	0.0	0.0	0.0	0.0	9.3	2.3	0.0	0.5	0.0	0.8	1.0	0.0	1.5	0.0	8.2	14.0	0.0	0.0	0.0	13.4	0.2	0.0	0.0	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.2	0.0	12.6	3.8	0.0	0.0	6.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.1	1.0	0.2	0.4	1.0	1.0	0.7	0.0	25.3	0.4	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	1.1	0.0	0.0	1.6	2.5	0.4	0.0	0.0	0.0	0.0
POU4F2	"Brn-3b, BRN3B"	ENSG00000151615	"POU class 4 homeobox 2"	Q12837	4	146638893-146642474	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	13	"brain: 5.7;testis: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"midbrain: 1.8;pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;SCLC-21H: 6.4;THP-1: 1.0"	"Region enriched"	"Detected in single"	6	"midbrain: 5.2"	"Group enriched"	"Detected in some"	15	"midbrain: 4.7;pons and medulla: 1.3;thalamus: 1.8"							NA	NA										"unprognostic (4.18e-2)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
POU4F3	"BRN3C, DFNA15, DFNA42, DFNA52"	ENSG00000091010	"POU class 4 homeobox 3"	Q15319	5	146338839-146341722	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 2.0;SCLC-21H: 1.9;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	HPA038215	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038215: AB_10697245"	"unprognostic (8.41e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.03e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (7.82e-2)"	0.6	0.1	0.4	0.4	0.6	1.0	0.4	2.8	0.9	0.3	0.2	0.2	0.2	0.1	0.6	0.7	0.2	0.4	0.3	0.2	0.7	0.4	0.3	0.2	0.3	0.2	0.7	0.2	0.6	0.2	0.0	0.2	1.8	0.2	0.2	0.2	0.2	1.1	0.4	0.2	0.8	0.2	0.8	2.4	0.6	0.2	0.4	0.2	1.5	0.5	0.2	0.2	0.6	0.2	0.7	0.4	0.0	0.0	0.0	0.4	0.0	0.2	1.0	0.2	0.4	0.2	0.3	0.0	0.0	0.0	0.2	0.4	0.9	0.2	0.3	0.2	0.3	0.1	0.5	0.3	0.0	0.9	0.4	0.5	0.0	0.1	0.0	0.1	0.1	0.8	0.4	1.6	0.4	0.1	0.0	0.3	0.2	0.2	0.5	0.1	0.1	0.4	2.0	0.1	0.0	0.3	0.8	0.0	0.1	0.4	0.5	1.9	1.6	0.6	0.5	0.1	0.3	0.4	0.1	0.0	0.0	1.9	0.0	0.6	0.6	0.9	0.7	0.0	0.6	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.8	0.2	0.7	0.4	0.7	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 75.7"	"Group enriched"	"Detected in some"	22	"Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 518.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.1	0.0	0.0	0.2	0.4	0.2	0.3	3.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	75.7	0.0	0.0	0.3	0.4	0.1	0.1	0.1	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	3.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.2	518.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 32.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced					NA	NA					"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.4	0.0	0.1	1.9	0.0	0.3	0.3	0.4	0.9	0.7	3.1	0.3	0.3	0.3	1.6	1.7	0.2	0.8	0.6	1.4	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.4	0.1	0.4	0.0	12.8	0.0	1.5	0.1	0.3	6.2	1.0	0.5	0.9	0.9	0.0	0.3	1.3	13.2	2.1	0.0	0.0	2.5	3.2	0.8	0.1	1.0	1.2	0.2	0.6	0.0	4.7	2.8	0.1	0.0	8.3	0.2	0.1	12.1	0.6	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3	0.0	0.0	0.0	0.1	0.0	2.4	32.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	6.4	0.0	1.3	0.0	1.9	0.3	0.0	0.0	0.0	0.0	2.6	0.5	0.0	1.8	0.0	0.8	0.0	0.9	0.5	1.2	0.0	0.2	0.0	0.0	0.0
PPP1R17	"C7orf16, GSBS"	ENSG00000106341	"Protein phosphatase 1 regulatory subunit 17"	O96001	7	31686715-31708455	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 10.5;blood: 24.5;brain: 29.7"	"Group enriched"	"Detected in some"	126	"Early spermatids: 30.6;Late spermatids: 68.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in many"	6	"cerebellum: 29.7;hypothalamus: 8.5"	"Cell type enriched"	"Detected in some"	4	"non-classical monocyte: 24.5"	"Lineage enriched"	"Detected in many"	19	"monocytes: 24.5"	"Group enriched"	"Detected in some"	197	"NTERA-2: 15.7;SCLC-21H: 47.7"	"Region enriched"	"Detected in some"	32	"cerebellum: 483.2"	"Region enriched"	"Detected in many"	4	"cerebellum: 339.5"	"HPA047819, HPA073123"	Enhanced					NA	NA					"HPA047819: AB_2680166, HPA073123: AB_2732219"					"unprognostic (1.50e-1)"			"unprognostic (1.33e-1)"					"unprognostic (6.56e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.33e-1)"			0.6	10.5	0.9	0.6	1.3	0.8	0.1	29.7	4.6	0.1	0.1	1.7	0.0	0.1	0.8	0.3	0.1	0.1	0.1	0.4	0.6	8.5	0.1	0.2	1.1	0.1	1.1	0.9	0.1	0.1	0.1	2.9	0.1	2.6	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.4	1.0	0.3	0.3	1.7	3.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	1.2	0.0	24.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.4	0.9	1.3	29.7	3.3	0.6	8.5	1.1	0.9	2.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	68.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
PPP1R1B	"DARPP-32, FLJ20940"	ENSG00000131771	"Protein phosphatase 1 regulatory inhibitor subunit 1B"	Q9UD71	17	39626740-39636626	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 173.9;salivary gland: 105.3"	"Cell type enhanced"	"Detected in many"	12	"Melanocytes: 128.2;Mucus-secreting cells: 299.8;Undifferentiated cells: 342.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 173.9"	"Cell type enriched"	"Detected in single"	37	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.5;CAPAN-2: 8.7;HSkMC: 23.1;OE19: 10.7;SCLC-21H: 19.3"	"Region enriched"	"Detected in many"	8	"basal ganglia: 1113.7"	"Region enriched"	"Detected in all"	20	"basal ganglia: 1698.9"	"CAB004026, HPA048630, HPA061142"	Approved	Approved				NA	NA					"CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438"	"unprognostic (2.71e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.69e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.55e-1)"	26.2	10.0	25.6	5.8	173.9	0.6	23.3	14.6	24.1	7.4	64.1	16.2	39.4	25.7	1.8	2.2	1.9	9.4	4.6	0.7	17.3	11.2	2.0	0.5	5.1	0.5	21.9	22.2	2.6	19.1	0.6	1.7	0.5	17.9	19.9	63.3	6.9	105.3	49.6	0.5	5.7	20.9	4.1	12.4	0.5	13.6	4.6	40.0	0.0	0.5	0.3	0.8	3.6	1.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.3	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	10.7	0.6	0.0	0.0	0.4	0.0	0.0	19.3	0.4	0.0	1.0	0.0	1.8	0.4	0.7	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	173.9	14.6	24.1	17.3	11.2	21.9	22.2	17.9	40.0	0.0	26.7	0.0	99.4	1.1	0.3	1.1	0.0	0.0	0.0	1.8	0.0	0.0	102.8	13.3	0.7	0.1	36.6	0.0	3.1	0.0	1.3	59.5	4.6	0.0	0.2	0.0	92.9	3.1	0.0	2.2	31.9	1.0	128.2	0.0	299.8	28.7	1.0	94.7	5.3	0.4	0.9	0.0	0.6	0.5	3.2	0.4	0.0	0.0	342.5	101.6
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347146-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 196.7;liver: 112.7"	"Group enriched"	"Detected in many"	7	"Enterocytes: 2498.9;Hepatocytes: 739.9;Paneth cells: 1500.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 72.9;liver cancer: 348.8"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.1"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9;NK-cell: 3.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;NK-cells: 3.6"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 45.4"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		330000000			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.2	0.1	145.3	0.2	0.4	111.1	0.1	2.4	0.1	0.2	3.4	0.1	0.1	0.1	24.4	112.7	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	1.1	0.1	3.1	3.6	0.2	0.1	0.1	0.1	196.7	0.1	0.1	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.7	2.9	0.2	3.6	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	10.7	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	45.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	0.6	0.1	1.4	0.0	0.2	0.3	0.5	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.3	0.0	0.0	0.0	2.9	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.8	0.4	0.4	1.8	3.6	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.0	11.0	0.1	0.0	0.0	0.0	10.2	0.0	0.0	8.7	0.0	0.2	28.2	0.0	1.2	0.0	2498.9	0.0	0.2	0.2	0.0	0.1	9.2	739.9	0.2	0.0	17.6	11.6	15.9	6.1	1.1	0.0	0.0	0.0	55.9	0.0	0.2	1500.0	1.4	220.6	0.0	0.0	0.0	37.1	2.0	0.0	0.2	6.9	48.3	0.1
PRB1	"PM, PMF, PMS, PRB1L, PRB1M"	ENSG00000251655	"Proline rich protein BstNI subfamily 1"		12	11351823-11395566	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	80	"salivary gland: 605.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.7"														"Secreted to digestive system"	NA	NA																							0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	605.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PRB2	"cP7, PRPPRB1, Ps"	ENSG00000121335	"Proline rich protein BstNI subfamily 2"	P02812	12	11391540-11501041	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"salivary gland: 544.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.8"	"Cell type enriched"	"Detected in single"	23	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.2"	"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.3"														"Secreted to digestive system"	NA	NA										"unprognostic (1.36e-1)"	"unprognostic (1.01e-2)"		"unprognostic (2.61e-1)"	"unprognostic (2.07e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.51e-3)"			"unprognostic (1.97e-4)"	"unprognostic (1.51e-1)"			0.1	0.0	1.3	0.1	5.8	0.0	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.3	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	544.2	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.8	0.1	2.9	2.3	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRCD	RP36	ENSG00000214140	"Photoreceptor disc component"	Q00LT1	17	76527586-76553578	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"retina: 61.1"	"Cell type enhanced"	"Detected in many"	25	"Bipolar cells: 108.6;Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 413.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	12	"cerebellum: 14.8"	"Group enriched"	"Detected in some"	6	"memory B-cell: 1.0;naive B-cell: 1.8;NK-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 1.8;NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;ASC TERT1: 3.3;BEWO: 3.6;Hep G2: 5.0;HHSteC: 3.3;HSkMC: 4.1;PC-3: 2.1;SH-SY5Y: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA						"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.31e-4)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.19e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-2)"	1.6	2.2	0.7	0.7	0.7	0.0	1.5	14.8	1.1	1.2	0.7	0.7	0.7	0.7	1.5	3.5	0.7	1.1	1.5	2.0	0.7	0.5	0.7	0.7	1.1	1.4	0.7	0.7	1.3	0.8	4.1	0.7	1.4	1.2	1.1	0.0	61.1	2.3	1.2	1.2	1.5	0.7	0.7	1.0	2.3	0.4	0.7	0.7	0.7	1.0	1.0	0.7	1.7	1.9	1.8	0.0	0.2	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	3.4	3.3	3.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	5.0	3.3	0.0	0.0	4.1	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	1.8	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.7	0.7	14.8	1.1	0.7	0.5	0.7	0.7	1.2	0.7	0.0	0.0	13.0	0.1	0.5	108.6	3.5	0.0	0.0	1.2	0.0	143.3	0.0	0.0	0.2	2.4	4.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	35.0	0.0	1.3	0.0	6.8	5.8	0.0	6.8	0.0	0.0	64.0	0.1	0.0	1.8	0.0	413.5	6.5	1.0	0.5	1.1	0.3	0.2	4.3	0.0	0.0
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell type enhanced"	"Detected in some"	8	"Early spermatids: 2.9;Fibroblasts: 6.0;Late spermatids: 4.1;Melanocytes: 3.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;HEK 293: 9.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	7.0	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.0	1.4	0.0	0.0	0.3	9.8	2.1	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.5	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0	0.0	0.0	0.0	0.1	1.6	0.8	1.1	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.1	2.9	0.5	0.0	0.0	0.2	0.2	6.0	0.1	0.0	0.5	0.7	0.0	0.0	0.0	0.3	4.1	2.0	0.7	3.3	0.0	0.0	0.2	0.1	0.0	1.1	0.3	0.8	0.0	1.4	1.9	1.9	1.1	0.3	0.0	0.0	0.0
PRLR		ENSG00000113494	"Prolactin receptor"	P16471	5	35048756-35230589	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.3;placenta: 45.7;seminal vesicle: 42.7"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 26.1;Proximal tubular cells: 41.8;Syncytiotrophoblasts: 40.4"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 20.6"	"Region enriched"	"Detected in many"	7	"pons and medulla: 54.3"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 2.8"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.8"	"Cell line enriched"	"Detected in some"	18	"T-47d: 93.7"					"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA						"unprognostic (3.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.84e-4)"	"unprognostic (2.50e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.84e-5)"	"unprognostic (1.24e-1)"	0.5	13.3	1.8	0.2	5.6	0.3	13.3	0.4	1.4	23.5	5.3	10.7	36.6	3.5	25.1	10.0	1.1	2.1	2.0	0.6	7.6	2.4	17.8	5.9	0.6	0.0	0.6	0.2	3.2	4.3	11.5	15.7	45.7	54.3	3.2	3.0	0.5	1.8	42.7	0.4	2.6	10.1	6.4	0.7	0.4	3.3	2.0	0.4	0.1	0.5	0.5	0.0	1.4	6.2	0.0	0.2	0.1	2.8	0.0	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.7	0.1	0.4	0.3	0.8	0.3	0.1	0.0	0.0	0.0	0.5	0.3	0.0	1.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.2	93.7	0.7	0.0	0.5	0.5	0.1	0.3	0.0	0.0	0.0	0.9	0.0	0.2	0.1	2.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.8	5.6	0.4	1.4	7.6	2.4	0.6	0.2	54.3	0.4	0.0	1.3	0.0	0.3	2.6	0.0	0.8	2.5	0.0	0.0	3.5	0.0	26.1	6.6	0.8	0.0	0.2	12.7	0.0	4.4	2.6	3.5	2.2	0.0	9.7	7.5	0.0	8.2	0.6	1.3	0.0	8.1	0.6	0.0	9.0	16.5	0.0	2.4	20.9	12.0	41.8	0.0	0.0	3.8	0.0	0.1	4.4	40.4	0.0	19.8	0.1
PRND	"dJ1068H6.4, DOPPEL, DPL, PrPLP"	ENSG00000171864	"Prion like protein doppel"	Q9UKY0	20	4721910-4728460	"Predicted membrane proteins, Transporters"	Fertilization	Prion		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 80.2"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 1.7;Late spermatids: 7.4;Leydig cells: 2.0;Spermatogonia: 1.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Region enriched"	"Detected in single"	28	"pons and medulla: 6.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 2.2;NTERA-2: 3.2;U-698: 1.3"					"Not detected"	"Not detected"			HPA043373	Enhanced					NA	NA					"HPA043373: AB_2678450"	"unprognostic (1.69e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.63e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	1.1	0.7	0.2	0.0	2.5	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.1	80.2	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.9	0.5	2.2	0.5	0.6	0.4	0.1	0.2	0.4	0.1	0.3	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.3	0.0	0.0	0.6	0.1	0.3	2.2	0.5	0.0	1.1	0.2	0.2	0.1	0.3	3.2	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.3	0.4	0.0	0.1	0.1	0.2	0.3	0.1	0.4	0.3	0.7	0.4	0.1	0.3	0.1	1.3	0.2	0.2	0.0	2.2	0.5	0.5	0.3	0.3	0.2	0.6	0.4	0.2	0.2	0.9	0.3	0.3	1.4	0.6	0.5	0.5	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	2.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.0	0.0	0.1
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451200-110457354	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"ovary: 107.6;testis: 52.8"	"Group enriched"	"Detected in some"	50	"Leydig cells: 160.2;Peritubular cells: 627.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Region enriched"	"Detected in single"	9	"basal ganglia: 4.9"	"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.5;NK-cell: 1.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 1.0;T-cells: 1.5"	"Cell line enriched"	"Detected in some"	11	"ASC diff: 23.8"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	0.8	2.8	0.1	0.1	4.9	0.0	1.2	0.1	0.3	3.4	0.2	0.2	0.5	0.0	0.3	1.5	0.3	1.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	107.6	0.1	0.0	0.1	18.0	0.5	3.6	0.0	0.1	0.1	4.0	0.2	0.4	0.1	0.1	0.4	0.3	0.0	52.8	0.1	0.1	0.2	0.2	0.1	1.5	6.8	0.1	0.0	0.0	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	160.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	627.9	0.0	0.0	0.0	0.0	3.1	1.1	0.0	0.8	0.0	0.0	0.1
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 266.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	3400000000			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.3	42.8	31.9	0.8	1.5	3.5	0.8	3.1	6.1	0.9	0.2	9.3	2.3	7.8	0.1	0.8	0.6	1.1	0.1	2.7	16.6	1.1	17.0	3.6	0.6	0.8	28.9	0.6	1.8	0.6	24.2	3.5	2.1	11.5	0.2	16.6	0.2	0.1	0.0	2.0	1.5	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	46.2	0.8	0.1	8.1	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.2	10.6	9.9	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2	59.6	29.8	3.7	2.9	13.2	0.6	40.3	12.7	76.3	12.5	1.8	9.8	0.6	3.3	5.6	2.3	47.0	2.6	0.0	4.0	0.6	62.0	4.7	29.0	266.4	9.9	1.6	15.1	69.3	24.7	4.0	26.4	7.7	18.6	1.0	14.6	22.0	3.9	7.0	34.6	36.2	7.8	12.9	26.2	0.2	0.5	29.1	1.4	4.5	13.3	2.0
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.9;testis: 30.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 268.2;Late spermatids: 616.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	23	"pons and medulla: 44.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 91.5"	"Group enriched"	"Detected in many"	4	"hypothalamus: 22.7;pons and medulla: 36.8"	"Low region specificity"	"Detected in all"			"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA					"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	2.2	20.0	0.7	13.4	1.6	0.1	1.2	0.5	2.3	3.9	16.0	0.6	1.0	5.6	0.9	1.4	3.1	2.5	2.7	3.2	1.9	0.9	0.3	0.1	0.7	0.4	0.9	0.0	0.5	1.1	0.3	2.5	0.5	44.9	5.0	2.7	12.1	1.0	4.9	0.6	0.7	11.4	2.5	5.9	0.9	4.8	30.4	0.4	0.1	0.3	0.9	0.2	5.8	7.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	91.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.3	19.7	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.6	0.5	0.5	1.9	0.9	0.9	0.0	44.9	0.4	0.0	0.0	0.0	0.0	0.0	8.5	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	268.2	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	23.8	88.5	0.0	0.0	616.9	5.5	0.0	0.0	0.0	0.2	10.2	0.1	0.0	1.8	0.4	19.9	0.0	7.2	11.2	7.7	0.4	0.0	0.0	0.1	0.1
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 144.2;Enterocytes: 169.7;Mucus-secreting cells: 103.4;Paneth cells: 199.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"OE19: 67.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 19.0"	HPA022918	Approved		Approved	Cytosol		No	NA			Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	0.9	0.2	0.2	13.5	0.2	0.0	10.0	0.2	0.3	3.2	88.7	0.6	22.9	44.9	0.6	8.3	4.9	6.6	21.2	0.3	0.4	0.2	37.3	1.6	20.3	0.2	0.2	0.2	1.9	75.4	0.0	8.5	0.2	2.2	8.1	32.0	0.4	38.7	26.7	0.2	3.7	113.1	0.5	0.2	0.2	27.2	1.3	0.2	0.3	61.0	2.5	5.8	2.1	2.4	1.3	0.5	0.0	0.2	1.2	2.2	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.1	0.0	0.0	6.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.4	0.1	0.1	0.0	67.3	0.2	0.1	0.0	0.4	0.3	0.8	4.0	0.1	0.0	12.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	2.2	0.1	0.0	0.5	0.5	1.3	0.8	0.6	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	2.2	0.2	20.8	13.7	0.0	1.4	0.0	0.0	0.0	73.9	16.0	17.0	15.7	0.0	0.0	144.2	20.3	4.5	0.0	169.7	0.0	32.6	0.0	0.0	25.3	0.0	0.5	0.1	0.0	30.3	0.0	0.0	6.7	1.1	0.0	0.0	1.0	103.4	0.0	11.5	199.8	0.4	24.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	76.5	6.8
PRR26	"C10orf108, FLJ38681"	ENSG00000180525	"Proline rich 26"	Q8N8Z3	10	649948-669581	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 39.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;CAPAN-2: 3.3;EFO-21: 3.7;Hep G2: 2.5;hTERT-RPE1: 3.7;OE19: 2.1;RPTEC TERT1: 6.2"									HPA066037	Uncertain					NA	NA					"HPA066037: AB_2685601"	"unprognostic (2.29e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	18.5	0.2	0.5	3.5	0.6	0.2	3.2	0.6	0.3	3.4	18.8	0.0	1.9	8.4	5.1	1.3	7.1	1.8	18.0	10.2	0.6	0.4	9.6	13.6	0.7	0.9	0.5	0.0	2.6	17.9	0.0	2.9	0.2	2.9	5.3	7.2	2.5	0.3	3.1	2.5	0.5	15.9	8.2	0.5	1.8	6.8	1.5	0.0	0.0	0.5	0.3	0.0	4.9	3.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.9	3.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.3	0.0	0.5	0.3	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	6.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	0.3	0.6	0.4	0.5	0.0	2.9	0.0	0.0	0.3	0.0	0.6	0.1	2.3	4.3	7.6	2.7	0.0	1.8	3.9	0.0	0.0	5.3	0.5	0.7	12.1	0.0	7.6	0.1	0.0	0.2	0.0	6.8	0.0	4.8	39.9	1.3	0.0	0.4	1.1	0.0	1.7	0.0	11.8	3.2	2.9	11.5	3.2	3.1	9.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	9.2	0.9
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560422-565528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"brain: 51.1"	"Cell type enriched"	"Detected in some"	16	"Collecting duct cells: 34.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	27	"cerebellum: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 4.8"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	HPA069297	Uncertain					NA	NA					"HPA069297: AB_2686113"		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	13.4	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	0.0	187.4	20.6	0.0	0.2	33.1	8.1	23.9	15.7	0.0	30.9	1.7	101.8	0.0	0.0	4.2	0.0	86.5	19.4	0.8	63.4	0.0	0.0	2.0	0.0	3.5	0.0	0.0	0.0	0.0	0.9	6.8	1.8	5.3	0.0	242.0	10.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	24.1	8.8	0.0	5.2	517.3
PRSS56		ENSG00000237412	"Serine protease 56"	P0CW18	2	232520463-232525716	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;retina: 8.6;skeletal muscle: 16.2"	"Group enriched"	"Detected in some"	22	"Early spermatids: 30.4;Muller glia cells: 49.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Daudi: 4.8"	"Group enriched"	"Detected in some"	10	"basal ganglia: 1.6;olfactory region: 5.2"	"Region enhanced"	"Detected in many"		"olfactory region: 32.6"							NA	NA								"unprognostic (3.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.73e-3)"			"unprognostic (2.28e-1)"	"unprognostic (7.15e-2)"				"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"			0.1	0.1	0.3	0.1	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.2	4.4	0.1	0.1	0.1	0.1	2.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.2	0.1	8.6	0.1	0.1	16.2	0.1	0.1	0.1	0.8	0.2	0.1	2.6	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.1	1.0	0.2	4.4	2.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 330.0;Extravillous trophoblasts: 497.6;Syncytiotrophoblasts: 376.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 58.3;CACO-2: 38.3;CAPAN-2: 26.3;hTCEpi: 37.6;SK-BR-3: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	38.3	26.3	0.0	0.3	0.0	0.0	17.3	0.0	16.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	15.5	0.1	0.3	4.8	18.3	0.0	0.1	0.0	0.2	1.8	3.0	0.2	0.1	0.0	44.2	0.0	4.7	10.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3	92.3	62.1	0.9	60.6	33.7	0.6	0.3	53.5	9.4	53.4	40.1	0.0	127.8	24.9	145.8	0.0	0.7	330.0	23.3	197.1	497.6	3.6	80.0	6.9	12.8	20.5	0.0	9.2	0.0	0.3	0.0	0.6	2.5	3.3	7.2	109.4	0.3	182.1	150.8	0.0	24.9	0.0	0.0	3.1	0.0	0.1	47.2	376.9	1.3	110.4	79.5
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393768-40413366	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.1;lung: 31.7;retina: 20.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 10.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"midbrain: 42.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	21	"midbrain: 24.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	3.4	4.4	4.8	1.0	4.1	1.1	2.7	2.2	5.4	3.0	2.3	1.8	2.8	1.2	3.8	2.0	2.2	3.2	2.4	2.9	4.0	2.2	4.3	0.6	31.7	1.3	42.1	3.7	7.5	5.4	7.3	1.1	6.0	10.3	3.2	0.8	20.6	3.9	4.4	5.4	2.2	1.5	3.3	11.0	1.7	2.4	1.6	3.6	0.0	7.2	6.7	0.9	3.1	2.0	0.3	0.4	0.0	0.3	0.1	1.2	0.2	2.5	2.7	3.3	4.3	2.7	7.0	4.1	2.0	2.3	2.9	2.1	2.3	2.7	0.8	2.6	1.9	1.5	1.3	1.1	1.0	1.0	1.2	1.4	0.5	0.9	0.7	3.2	0.2	3.6	5.0	4.9	1.9	1.6	3.3	1.5	4.5	3.0	0.8	1.5	3.2	1.1	0.8	0.7	5.6	2.5	4.8	2.8	2.4	0.5	1.3	0.3	1.5	3.9	3.4	3.0	1.5	4.9	1.2	2.2	5.9	4.6	2.3	1.2	8.4	7.3	1.1	1.8	1.3	1.3	0.0	0.3	0.0	0.6	0.2	0.2	0.0	0.4	0.6	0.0	0.3	0.3	1.2	0.0	0.1	0.0	0.4	0.3	0.2	4.8	4.1	2.2	5.4	4.0	2.2	42.1	3.7	10.3	3.6	3.0	5.1	0.0	1.0	5.6	0.0	10.8	5.1	0.0	1.2	1.8	0.0	0.8	0.0	0.3	0.0	4.4	0.5	0.0	0.5	0.6	2.5	2.1	0.0	1.0	0.9	0.0	0.0	4.9	1.8	0.0	3.1	1.2	3.3	0.0	0.3	2.7	0.5	0.9	4.2	1.3	0.0	0.0	2.6	0.2	0.7	3.6	2.3	1.3	1.4	0.9
PTCHD1	FLJ30296	ENSG00000165186	"Patched domain containing 1"	Q96NR3	X	23334016-23404372	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Autism, Autism spectrum disorder"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.8"	"Cell type enhanced"	"Detected in some"	14	"Leydig cells: 6.1;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 27.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.4;RT4: 3.2;SuSa: 1.6;WM-115: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046110	Uncertain					NA	NA					"HPA046110: AB_2679541"	"unprognostic (1.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.68e-4)"	"unprognostic (5.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	1.6	2.3	6.6	0.9	5.5	0.7	6.0	27.8	8.9	6.2	8.4	1.0	3.5	1.4	5.1	2.1	4.5	0.9	0.8	0.8	5.3	2.7	0.8	0.6	1.2	0.6	3.1	5.8	0.8	0.8	0.5	1.7	0.5	6.5	4.4	2.9	0.0	1.8	11.7	1.1	0.8	1.8	10.2	2.6	1.4	3.4	1.1	3.8	0.0	1.0	0.0	0.6	5.4	2.9	0.7	0.4	1.2	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.4	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.4	0.0	1.5	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	10.6	1.2	0.3	0.4	0.3	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.3	0.3	1.0	0.3	0.2	0.4	0.1	0.0	6.6	5.5	27.8	6.5	5.3	2.7	3.1	5.8	6.5	3.8	0.0	1.3	0.0	2.0	0.2	1.3	1.7	0.0	2.7	3.4	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.2	0.0	2.0	2.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.4	12.9	2.3	0.5	1.5	0.0	1.8	0.0	0.0	0.7
PTER		ENSG00000165983	"Phosphotriesterase related"	Q96BW5	10	16436943-16513745	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 21.6;cerebellum: 8.9;cerebral cortex: 30.8;hippocampal formation: 22.7;hypothalamus: 8.9"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038044, HPA038045"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038044: AB_2675803, HPA038045: AB_10672616"	"unprognostic (5.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (6.52e-6)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.36e-3)"	11.1	5.4	21.6	10.6	2.9	1.3	8.7	8.9	30.8	6.2	12.1	1.6	14.5	9.2	5.8	8.1	6.9	3.4	3.8	7.8	22.7	8.9	31.3	21.9	9.2	12.6	4.2	1.3	5.3	17.9	11.1	3.4	11.2	3.1	11.3	5.4	6.8	10.6	12.9	6.2	4.0	21.9	5.7	2.6	11.8	9.2	2.9	1.5	17.2	12.0	3.9	9.6	7.7	10.9	15.3	11.7	6.9	16.7	7.6	19.5	9.4	16.1	9.7	0.1	2.9	4.1	8.1	9.7	4.8	0.5	1.8	2.7	8.9	15.3	17.0	4.0	3.2	1.0	7.4	5.5	3.2	2.7	16.6	7.2	15.8	4.6	3.6	4.9	5.1	4.8	5.9	10.4	5.5	0.9	0.0	0.8	15.4	10.8	6.0	2.8	5.4	11.9	5.1	3.9	11.1	2.4	8.9	1.3	8.9	25.5	5.1	12.3	0.8	8.5	2.4	14.0	3.5	5.7	16.2	2.1	0.1	4.3	3.9	0.1	4.5	5.6	18.0	2.0	9.4	6.0	3.5	11.7	6.9	12.7	16.7	13.5	15.3	14.6	12.6	11.7	8.8	11.0	10.9	2.2	7.6	14.5	9.9	19.5	9.4	21.6	2.9	8.9	30.8	22.7	8.9	4.2	1.3	3.1	1.5	26.8	19.9	5.7	12.7	9.7	0.8	22.7	15.3	17.4	28.4	27.9	0.0	17.1	44.7	19.3	0.2	7.1	13.2	0.0	29.9	14.6	7.8	8.8	23.1	21.2	13.0	0.0	11.1	10.4	11.6	0.0	0.9	17.5	8.5	9.0	12.4	13.5	21.4	28.8	0.0	86.8	8.0	6.5	10.3	0.9	6.8	10.8	10.1	12.5	16.8	19.7
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267713-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.1"	"Group enriched"	"Detected in some"	5	"T-cells: 31.9;Undifferentiated cells: 11.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"pons and medulla: 13.9"	"Group enriched"	"Detected in many"	5	"gdT-cell: 25.4;MAIT T-cell: 12.7;memory CD8 T-cell: 15.2;naive CD8 T-cell: 8.9;NK-cell: 30.1"	"Group enriched"	"Detected in many"	30	"NK-cells: 30.1;T-cells: 25.4"	"Group enriched"	"Detected in some"	4	"ASC diff: 1.4;HSkMC: 1.6;REH: 2.4;U-138 MG: 1.8"	"Low region specificity"	"Detected in many"							HPA049668	Enhanced					NA	NA					"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	3.9	0.9	0.7	9.6	2.5	1.8	9.3	1.4	1.4	5.5	10.0	0.7	0.9	1.1	4.1	2.2	2.1	2.5	4.9	2.3	0.8	0.8	1.5	1.8	3.4	8.9	1.0	3.5	2.3	0.8	0.8	4.5	0.4	13.9	2.1	12.8	11.2	2.6	3.5	0.9	1.3	2.4	2.0	3.6	10.9	2.0	0.9	0.8	1.8	2.5	0.1	3.1	3.3	3.2	0.0	0.0	0.9	0.1	30.1	25.4	4.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	25.4	0.0	12.7	0.0	3.5	15.2	0.0	0.0	0.6	8.9	0.9	30.1	0.1	0.0	0.0	4.1	0.7	2.5	1.4	1.4	0.8	0.8	1.0	3.5	13.9	0.8	3.0	0.0	0.8	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	1.2	3.1	2.1	0.0	0.0	0.2	1.7	0.0	4.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	31.9	11.2	0.0
PTGES3L		ENSG00000267060	"Prostaglandin E synthase 3 like"		17	42968088-42980433	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 18.3;skeletal muscle: 61.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 41.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.2"	"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.9;RH-30: 8.7;THP-1: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.80e-4)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.08e-2)"	0.5	0.2	0.7	0.8	4.2	1.1	0.5	0.3	1.2	1.3	5.1	0.2	0.0	0.6	3.5	2.2	2.2	1.1	3.3	18.3	0.5	0.7	0.2	0.1	0.4	0.5	0.6	0.7	0.6	0.2	0.2	0.4	0.2	0.3	1.8	1.5	1.5	1.0	2.2	61.3	0.5	1.2	10.0	0.2	0.3	1.7	0.6	0.1	0.4	0.4	13.6	0.6	4.7	1.3	0.7	8.9	1.3	0.3	0.6	0.3	0.8	0.7	0.6	1.9	3.6	0.1	0.3	1.6	1.3	0.8	1.1	0.6	1.5	0.7	0.6	0.5	0.5	1.1	1.4	1.5	1.4	1.7	0.5	0.6	5.2	3.0	3.1	0.1	0.8	8.9	0.7	1.0	2.4	1.7	0.7	0.3	3.3	1.8	1.6	3.4	1.0	3.2	2.0	2.1	2.8	0.5	1.3	8.7	0.7	2.1	1.4	1.7	5.9	1.6	3.2	2.6	2.1	1.7	22.7	0.7	1.9	1.8	0.6	1.2	3.9	2.5	0.9	0.3	0.9	0.7	1.3	0.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.7	0.3	0.3	1.2	0.6	0.2	8.9	0.2	0.8	0.7	4.2	0.3	1.2	0.5	0.7	0.6	0.7	0.3	0.1	0.0	0.0	0.5	0.6	0.0	0.9	41.4	0.0	1.4	0.0	0.0	7.9	0.1	0.0	1.4	8.6	0.1	0.9	0.0	0.2	0.5	0.2	0.6	0.0	0.0	1.0	0.0	1.7	1.3	0.0	3.3	0.6	0.2	0.0	2.8	0.6	0.7	0.7	2.9	0.4	0.3	2.5	0.0	4.2	5.2	4.1	0.0	0.1	0.0	1.0	0.3
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.6"	"Cell type enhanced"	"Detected in some"	19	"Ciliated cells: 4.0;Club cells: 1.2;granulocytes: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 5.3"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 5.3"	"Cell line enhanced"	"Detected in many"		"RH-30: 6.7;THP-1: 13.2"	"Low region specificity"	"Detected in all"							"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.7	0.1	0.7	1.2	4.5	1.2	0.5	0.6	1.6	1.5	5.5	0.3	0.1	1.7	4.7	2.4	2.2	1.6	3.6	13.8	0.5	0.7	0.3	0.2	0.6	0.7	0.6	0.8	0.7	0.3	0.4	1.5	0.4	0.4	2.0	3.2	1.6	0.7	3.1	46.6	0.2	1.6	10.6	0.2	0.4	2.4	3.8	0.2	0.5	0.5	14.4	0.8	5.1	1.4	0.1	5.3	0.0	0.0	0.0	0.0	0.4	1.0	0.0	2.7	2.7	0.3	0.0	0.8	2.2	2.0	1.2	1.1	1.7	0.3	0.3	1.7	0.2	0.8	0.0	0.4	1.1	1.9	1.0	0.4	5.6	2.2	4.1	0.0	0.5	4.0	0.1	0.7	1.9	0.1	0.8	0.6	1.8	2.0	0.4	2.2	0.0	1.8	1.4	0.7	3.5	0.5	1.5	6.7	0.7	0.3	0.5	1.3	3.5	1.4	0.5	1.5	3.5	0.9	13.2	0.0	0.9	1.7	0.0	0.7	3.7	1.1	0.4	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.4	0.7	4.5	0.6	1.6	0.5	0.7	0.6	0.8	0.4	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PTGFR	FP	ENSG00000122420	"Prostaglandin F receptor"	P43088	1	78303884-78539749	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 10.1;Club cells: 23.9;Fibroblasts: 9.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 10.1"	"Cell type enriched"	"Detected in single"	13	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 79.7;HSkMC: 24.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.89e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.61e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.46e-4)"	"unprognostic (2.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.21e-4)"	"unprognostic (8.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.21e-3)"	13.0	4.1	1.1	5.2	1.8	0.0	8.7	0.3	1.0	8.3	3.8	0.3	2.1	0.9	27.2	7.0	6.1	5.3	8.8	7.7	10.1	3.3	5.6	3.6	2.3	1.1	0.5	0.3	14.5	1.5	0.0	0.5	7.7	0.6	12.9	2.7	1.8	6.5	2.1	6.9	7.3	3.0	21.3	0.7	0.8	2.7	4.0	0.0	0.0	2.1	13.4	4.3	20.3	15.9	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	7.6	79.7	0.0	5.7	5.5	2.0	0.7	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	24.9	0.0	0.5	5.0	5.2	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.4	1.4	0.6	0.4	0.3	0.0	0.0	0.1	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	1.8	0.3	1.0	10.1	3.3	0.5	0.3	0.6	0.0	0.0	10.1	0.0	0.0	5.7	0.8	0.4	5.1	6.7	23.9	8.7	0.0	0.0	3.3	3.3	5.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	5.1	5.2	0.2	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	1.0	0.6	0.0	4.1	0.2	0.0	0.0	0.0
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 2.4;Distal tubular cells: 1.7;Endothelial cells: 2.4"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.7;NTERA-2: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	3.7	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	5.8	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3	0.0	0.0	0.0	0.0	0.1	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase, non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.5;lymphoid tissue: 63.7"	"Group enriched"	"Detected in many"	5	"B-cells: 40.6;granulocytes: 137.4;T-cells: 156.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basal ganglia: 9.4;thalamus: 2.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 17.0;NK-cells: 9.9;T-cells: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 16.7;HL-60: 36.3;HMC-1: 48.9;NB-4: 15.8;THP-1: 16.7;U-937: 26.2"	"Region enriched"	"Detected in single"	10	"basal ganglia: 5.5"	"Region enriched"	"Detected in all"	4	"basal ganglia: 10.9"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	2.6	3.1	0.5	27.1	9.4	24.5	0.6	0.4	0.5	0.6	2.3	0.6	0.0	3.0	0.7	0.6	1.7	0.8	2.9	0.5	0.6	0.8	1.1	0.9	3.2	16.5	1.2	0.2	0.6	0.6	0.0	0.7	0.4	0.8	1.3	1.9	0.7	5.3	0.3	0.4	0.6	3.7	0.9	1.6	15.4	1.4	12.7	2.9	63.7	0.9	0.6	24.8	2.9	0.8	2.6	2.6	17.0	1.1	9.9	10.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	16.7	0.0	0.0	0.0	36.3	48.9	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.7	1.5	0.0	0.0	4.9	15.8	0.0	0.0	0.0	0.7	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	7.4	1.8	10.5	0.0	26.2	0.0	11.5	1.1	17.0	10.6	1.1	9.5	1.9	7.1	10.5	2.0	2.6	5.3	6.4	7.1	9.9	0.4	2.6	9.0	2.8	0.5	9.4	0.4	0.5	0.6	0.8	1.2	0.2	0.8	2.9	3.0	9.0	40.6	1.0	2.1	2.4	0.7	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.2	0.4	2.9	0.0	0.0	0.0	0.1	1.7	0.5	137.4	0.5	15.6	0.0	0.0	4.9	6.2	1.3	4.9	23.4	8.5	9.0	0.0	5.6	0.1	0.0	2.1	0.6	4.4	0.0	0.9	0.9	0.4	2.0	0.7	156.8	0.0	0.5
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase, receptor type Q"		12	80402178-80680271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 12.6;urinary bladder: 19.2"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 14.9;Club cells: 7.9;Early spermatids: 7.0;Late spermatids: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	24	"basal ganglia: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.4;BJ: 6.2;HBF TERT88: 4.4;RH-30: 4.9;RT4: 5.4;SiHa: 3.1;U-2197: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA			Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	4.6	0.2	0.3	1.0	12.6	0.0	5.2	0.2	0.3	1.7	1.3	0.0	1.6	0.0	0.5	4.7	1.6	4.1	0.5	1.3	0.4	0.5	6.5	0.2	5.4	2.1	0.2	0.0	0.9	0.6	0.0	1.1	6.4	0.0	6.5	0.0	0.0	0.4	0.5	0.5	0.3	0.2	4.0	0.2	0.2	0.2	5.8	0.0	0.0	3.9	0.0	0.6	19.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	6.2	1.3	1.9	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.9	0.0	0.8	0.2	0.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	5.4	0.0	0.0	3.1	0.1	0.0	0.3	0.3	0.0	0.0	0.5	0.1	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.6	0.2	0.3	0.4	0.5	0.2	0.0	0.0	0.0	14.9	0.6	0.0	1.5	0.0	0.0	1.7	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 14.3;RT4: 27.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	27.4	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4	0.0	0.0	0.0	0.1	0.5	11.2	2.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.1	1.7	1.5	7.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.9	11.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.3
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell type enhanced"	"Detected in some"	10	"Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	310000	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	52.1	0.0	86.4	125.2	0.0	9.0	82.2	3.9	4.2	0.0	0.5	0.0	32.1	10.6	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	160.8	0.1	0.0	167.5	0.0	88.5	30.1	7.7	18.2	0.0	0.0	0.0	26.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	119.2	17.7	0.8	111.1	1.5	0.0	0.0	0.0	3.7	0.4	5.0	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2	0.0	1.7	0.0	1.1	1.4	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	6.0	1.9	2.0	0.0	0.0	0.0	0.0	10.1	0.4	0.0	0.0	2.6	0.0	0.0	3.1	4.6	0.8	0.3	5.9	13.5	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.4	0.9	0.2	0.0	0.0	0.1
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 125.0;parathyroid gland: 137.5"	"Group enriched"	"Detected in some"	10	"Distal tubular cells: 543.8;Horizontal cells: 1442.9"	"Group enriched"	"Detected in many"	10	"breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3"	"Region enhanced"	"Detected in all"		"cerebellum: 125.0"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.4"	"Cell line enriched"	"Detected in single"	198	"RPMI-8226: 134.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 2377.5"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.9	0.8	1.2	0.9	3.9	0.8	4.3	125.0	47.2	0.8	0.8	6.6	0.0	0.8	1.1	0.9	0.8	0.8	0.9	0.8	4.5	9.4	16.7	1.8	1.2	1.2	28.6	2.5	0.8	0.8	137.5	0.2	1.2	22.9	0.9	0.9	27.3	1.2	1.0	5.0	0.8	0.8	0.9	12.6	1.2	0.9	1.1	1.2	0.0	0.9	0.0	1.4	1.2	1.0	0.0	0.5	3.4	0.4	0.0	0.3	12.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	134.1	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.3	12.2	1.2	3.9	125.0	47.2	4.5	9.4	28.6	2.5	22.9	1.2	0.0	0.0	0.0	0.0	0.0	39.1	0.2	0.0	0.0	0.0	36.6	9.8	0.2	543.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.5	0.0	40.7	1442.9	0.0	40.5	3.7	0.0	0.6	0.9	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.8	104.1	0.0	0.0	0.0	0.6	0.0	0.3	1.0	0.0	0.0
RAB17		ENSG00000124839	"RAB17, member RAS oncogene family"	Q9H0T7	2	237574322-237601614	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.8;liver: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 100.1;Distal tubular cells: 116.0;Hepatocytes: 115.6;Proximal tubular cells: 151.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 16.5;MCF7: 18.0;SK-BR-3: 19.6;SK-MEL-30: 47.0;T-47d: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035176	Approved					NA	NA					"HPA035176: AB_10696368"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.68e-2)"	"prognostic favorable (4.14e-4)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.33e-13)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.51e-4)"	0.8	1.0	0.5	1.4	0.5	0.0	4.7	0.4	0.8	1.2	21.4	1.2	10.3	19.2	0.8	9.5	1.8	2.9	5.2	1.0	1.1	0.5	20.6	37.0	7.9	0.4	0.5	0.4	0.8	25.4	9.8	6.1	6.5	5.3	2.9	4.2	1.9	13.5	15.2	0.7	0.9	57.8	0.6	0.4	0.5	10.0	0.9	0.4	0.6	22.9	0.9	1.2	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	4.1	0.1	0.0	8.1	0.0	0.1	16.5	0.0	0.0	0.0	0.0	11.0	10.0	0.0	2.7	0.0	0.0	0.2	0.0	4.9	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	3.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	18.0	0.0	0.2	0.2	8.4	0.0	0.4	0.0	1.0	4.5	9.0	4.3	0.0	0.0	19.6	47.0	5.0	12.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	0.4	0.8	1.1	0.5	0.5	0.4	5.3	0.4	56.6	26.4	0.5	4.0	1.5	1.6	0.8	61.1	16.0	13.6	43.6	100.1	13.2	116.0	28.3	0.0	1.0	61.9	0.0	24.3	3.1	0.5	6.9	0.0	115.6	1.6	0.0	29.0	0.6	1.3	0.2	8.1	0.7	5.0	1.0	18.1	0.2	29.1	52.6	3.5	151.7	0.6	0.0	0.3	0.0	0.2	0.5	10.3	1.5	18.8	6.2
RAB37		ENSG00000172794	"RAB37, member RAS oncogene family"	Q96AX2	17	74670578-74747335	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.0;brain: 52.1"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 49.7;T-cells: 27.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 52.1"	"Cell type enhanced"	"Detected in many"		"basophil: 47.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 22.7;HMC-1: 24.8;OE19: 9.5;U-266/70: 36.2;U-937: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA		1100000				"unprognostic (2.10e-2)"	"unprognostic (7.04e-4)"	"unprognostic (5.95e-2)"	"unprognostic (9.80e-4)"	"unprognostic (3.49e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.62e-3)"	"unprognostic (9.47e-3)"	"unprognostic (3.05e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (8.80e-6)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (4.01e-2)"	1.3	1.2	1.3	7.5	2.1	15.5	1.0	52.1	9.8	1.5	3.9	0.3	0.0	2.6	1.2	1.0	1.3	1.5	3.5	1.4	4.1	2.8	1.4	9.3	4.8	12.8	2.6	2.7	0.8	1.0	0.0	1.0	1.1	14.7	3.5	3.8	2.1	2.2	0.9	0.9	1.2	6.5	1.6	1.6	11.3	4.6	0.8	0.0	15.8	1.0	1.0	10.9	4.2	2.0	3.4	1.8	47.0	10.8	11.1	12.7	9.8	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.1	0.0	1.7	24.8	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	6.3	0.0	0.1	6.6	5.5	0.0	9.5	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	1.3	0.1	4.7	0.0	0.0	0.1	0.0	0.0	36.2	1.4	0.5	0.0	15.3	0.0	47.0	3.1	43.0	12.7	6.6	3.2	3.4	5.6	9.1	1.8	3.4	3.3	7.4	14.5	11.1	10.8	0.3	9.2	9.8	1.3	2.1	52.1	9.8	4.1	2.8	2.6	2.7	14.7	0.0	3.0	5.6	11.5	0.2	0.1	1.9	1.4	5.1	2.7	0.0	0.0	5.9	0.0	0.0	1.1	0.0	0.3	0.3	0.0	0.8	0.0	0.8	0.1	49.7	9.6	0.6	3.2	5.2	1.8	0.8	0.0	0.6	0.3	0.0	0.0	4.1	1.2	0.5	0.8	1.1	1.1	0.8	6.5	0.3	0.0	1.2	0.1	0.0	27.7	0.5	0.2
RAB38	NY-MEL-1	ENSG00000123892	"RAB38, member RAS oncogene family"	P57729	11	88113242-88175467	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.5;tongue: 38.1"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 41.2;Cytotrophoblasts: 78.5;Melanocytes: 124.9;Suprabasal keratinocytes: 86.1;Syncytiotrophoblasts: 45.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 73.8"	"Region enriched"	"Detected in single"	5	"pons and medulla: 3.2"	"Group enriched"	"Detected in many"	5	"NK-cell: 15.3;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.2;NK-cells: 15.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.4;hTCEpi: 69.6;hTERT-HME1: 62.0;SK-MEL-30: 37.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071701			Uncertain	"Nuclear bodies,Mitochondria"		NA	NA			"Nuclear bodies, Mitochondria"		"HPA071701: "	"unprognostic (2.85e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.23e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	1.8	15.6	0.4	1.2	0.4	0.4	4.6	0.3	0.6	10.8	1.6	1.2	2.8	1.0	7.0	8.7	29.9	2.8	8.2	1.7	0.6	0.5	2.6	0.8	5.3	0.4	0.5	0.2	3.0	2.3	0.9	4.6	7.7	3.2	4.0	0.4	35.5	4.9	5.2	0.5	24.9	2.4	2.7	0.7	1.3	0.9	5.3	0.1	1.6	6.6	38.1	21.0	4.2	13.3	0.0	4.2	0.5	1.3	15.3	1.8	0.6	2.3	0.3	0.0	0.1	0.0	0.5	0.1	1.4	5.8	2.3	4.3	1.0	1.0	0.1	1.4	1.5	0.2	15.9	1.2	19.4	3.2	0.2	1.1	11.7	1.5	0.0	0.2	0.1	0.1	0.5	69.6	0.3	62.0	2.9	2.7	0.2	0.0	0.2	0.0	0.0	0.1	3.9	1.8	0.1	0.0	0.1	0.0	0.1	4.5	8.9	0.4	0.2	0.0	0.0	37.4	1.4	3.5	1.0	1.5	0.0	1.0	0.0	0.2	0.3	1.4	0.0	0.3	0.4	0.2	0.0	0.6	0.1	1.6	0.6	0.9	0.0	0.5	1.8	1.5	0.0	0.1	0.9	0.5	15.3	1.3	4.2	0.9	0.6	0.4	0.4	0.3	0.6	0.6	0.5	0.5	0.2	3.2	0.1	0.0	4.1	0.0	12.1	41.2	0.0	0.1	0.0	4.0	7.9	0.0	0.0	78.5	3.3	1.3	0.0	1.5	1.1	0.0	1.0	6.8	6.7	2.1	16.1	0.0	14.7	0.0	0.0	0.0	1.0	0.0	3.1	4.9	124.9	10.8	0.0	0.5	1.8	1.1	1.1	3.2	5.9	0.0	2.8	0.0	3.2	86.1	45.8	1.5	2.1	22.8
RAB40A	"Rar-2, RAR2A"	ENSG00000172476	"RAB40A, member RAS oncogene family"	Q8WXH6	X	103499130-103519489	"Cancer-related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 34.0"	"Cell type enriched"	"Detected in single"	7	"Peritubular cells: 5.6"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AF22: 6.5;NTERA-2: 7.2"									HPA076172			Uncertain	Vesicles		NA	NA			Vesicles		"HPA076172: "	"unprognostic (3.49e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.49e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.43e-1)"	"unprognostic (7.36e-4)"	"unprognostic (7.85e-3)"	"unprognostic (9.39e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.11e-3)"	2.0	1.4	0.6	0.6	4.2	0.0	0.8	0.6	1.1	2.8	0.8	0.6	11.9	0.5	5.5	34.0	10.6	2.6	2.9	0.6	0.6	0.9	1.3	0.6	2.0	1.7	0.6	0.6	5.4	0.6	0.6	2.4	0.8	0.8	5.5	0.4	0.6	0.6	6.2	0.6	0.7	0.9	1.3	0.6	0.8	0.5	7.8	0.6	0.6	0.6	0.6	0.6	1.5	2.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	1.7	6.5	0.2	1.5	1.9	3.2	1.9	0.4	0.3	0.5	1.3	0.9	1.6	2.5	0.3	2.0	0.1	0.4	0.1	0.3	0.0	3.8	0.5	3.0	0.3	0.6	0.1	0.3	1.5	0.3	0.6	0.4	2.5	0.3	0.5	2.3	1.0	0.6	0.4	0.4	0.2	7.2	0.0	1.0	0.0	0.5	0.1	0.1	0.6	2.7	3.4	0.6	0.1	1.4	2.0	0.0	0.2	3.2	2.7	1.5	4.1	1.8	1.2	0.7	1.2	3.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.6	4.2	0.6	0.6	0.6	0.9	0.6	0.6	0.8	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
RAD21L1	"dJ545L17.2, RAD21L"	ENSG00000244588	"RAD21 cohesin complex component like 1"	Q9H4I0	20	1226056-1296421	"Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 17.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 95.6;Late spermatids: 76.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 3.1;cerebral cortex: 1.2;olfactory region: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.7;BJ hTERT+ SV40 Large T+: 2.5;TIME: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA053282	Approved					NA	NA					"HPA053282: AB_2682099"	"unprognostic (2.90e-1)"				"unprognostic (3.35e-1)"			"unprognostic (1.62e-4)"		"unprognostic (2.04e-1)"			"unprognostic (8.87e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.84e-1)"		0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	0.7	0.0	0.0	17.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.6	4.7	2.5	0.9	0.0	0.0	0.0	0.4	0.8	1.9	0.0	0.0	0.1	1.3	0.8	0.2	0.1	0.1	0.0	0.8	0.0	0.7	0.1	0.0	0.6	0.0	1.2	0.7	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.8	0.1	1.1	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.1	0.1	1.2	0.3	0.1	0.1	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.0	0.0	0.0	0.0
RAD51AP2	FLJ17540	ENSG00000214842	"RAD51 associated protein 2"	Q09MP3	2	17510584-17518439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"testis: 19.1"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 222.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 2.6;CAPAN-2: 3.8;HaCaT: 2.9"					"Not detected"	"Not detected"									NA	NA						"unprognostic (3.87e-2)"	"unprognostic (3.31e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.84e-3)"		"unprognostic (2.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"		"unprognostic (6.26e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.15e-1)"	0.0	0.1	0.1	0.0	0.0	0.0	0.2	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.2	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	4.2	0.9	0.0	0.0	0.0	0.2	0.8	0.1	0.0	0.4	0.0	0.1	25.8	0.1	222.9	2.3	0.5	0.0	0.0	0.2	0.3
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1"	"Group enriched"	"Detected in some"	4	"Basal glandular cells: 5.9;Basal keratinocytes: 5.7;Glandular cells: 6.9;Suprabasal keratinocytes: 14.9;Urothelial cells: 6.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 19.7"															NA	NA						"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavorable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0	0.3	0.0	31.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.5	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.1	15.3	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.8	0.0	1.1	19.7	0.5	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	3.8	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.3	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	6.4
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.6;brain: 70.9"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 43.2;Endothelial cells: 30.4;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 68.3;basal ganglia: 31.5;cerebral cortex: 55.3;hippocampal formation: 70.9;olfactory region: 23.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.0;SCLC-21H: 7.0;U-266/70: 9.3;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	3.3	29.6	68.3	1.6	31.5	0.6	5.2	10.9	55.3	4.9	1.5	5.4	1.0	2.1	6.6	2.7	2.3	2.9	3.7	5.7	70.9	10.2	3.8	24.6	5.4	1.7	10.0	23.8	9.7	2.0	3.2	2.4	2.3	8.6	3.5	1.7	11.3	1.7	2.9	1.4	10.6	1.8	4.3	2.9	0.9	5.4	3.7	11.5	0.0	4.3	0.9	1.8	4.2	1.2	0.4	0.6	1.4	0.6	0.6	0.7	0.1	0.1	0.1	2.7	0.4	0.0	0.2	0.1	0.9	0.5	0.1	0.2	0.0	3.1	0.0	0.2	0.0	0.2	0.5	2.3	0.6	0.3	0.1	4.8	0.4	2.3	0.0	0.0	3.0	0.8	0.0	0.7	0.0	0.0	2.7	2.9	1.3	0.0	18.0	0.1	0.0	0.2	0.2	0.3	1.5	0.3	0.0	0.6	0.0	0.0	5.4	7.0	2.6	0.1	0.1	0.9	1.4	0.1	0.1	0.8	0.1	0.3	0.0	0.2	9.3	18.0	0.0	0.3	0.1	0.2	1.4	0.4	0.4	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.4	0.6	0.7	1.0	0.6	0.6	0.6	0.3	0.1	68.3	31.5	10.9	55.3	70.9	10.2	10.0	23.8	8.6	11.5	3.0	3.2	0.9	1.0	5.5	2.5	6.7	0.0	0.0	0.0	0.0	43.2	0.1	0.0	0.6	2.1	30.4	0.0	0.0	2.3	0.0	0.9	0.5	0.0	9.9	0.1	1.6	7.5	23.9	1.9	1.1	4.0	0.0	3.3	0.0	0.2	1.2	2.4	0.0	1.4	0.0	8.9	0.0	1.4	0.5	2.0	3.3	0.1	0.0	0.0	0.6
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1"	"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	0.9	0.6	3.1	7.0	1.8	0.0	0.8	0.4	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.5	0.1	0.1	0.0	3.7	0.0	0.0	0.0	41.7	6.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	4.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.5	0.0	1.1	3.4	0.1	0.0	0.0	2.8	0.1	18.1	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8	0.0	0.3	0.0	17.9	0.1	4.2	9.3	7.6	6.7	12.5	10.4	23.6	0.1	0.0	1.4	1.3	3.8	0.0	0.0	0.8	0.1	3.1	5.5	0.0	2.0	0.3	4.8	0.0	20.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	27.5	1.1	0.0	0.0	0.5	6.1	0.0	9.2	0.2	1.1	0.1	0.2	0.0	0.0	7.1
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5"	"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.8	0.0	0.5	0.0	0.0	0.1	0.7	0.2	1.1	0.9	0.1	0.5	0.0	0.2	2.4	4.3	0.1	0.2	0.0	1.0	0.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	0.2	3.3	2.2	0.3	13.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	1.3	0.0	0.9	0.0	0.0	2.0	0.3	2.2	7.6	0.0	0.2	0.6	0.2	0.1	1.8	4.4	0.2	0.8	1.9	0.6	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3	0.0	0.0	0.0	0.2	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.2	0.7	0.0	0.1	45.3	4.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1
RASSF9	"P-CIP1, PAMCI"	ENSG00000198774	"Ras association domain family member 9"	O75901	12	85800697-85836570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 36.1;Club cells: 58.0;Endothelial cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 19.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.9;hTERT-RPE1: 16.0;RPTEC TERT1: 4.8;U-138 MG: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039428, HPA039678"	Approved					NA	NA					"HPA039428: AB_10795251, HPA039678: AB_10796332"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.90e-5)"	7.9	5.1	1.7	4.1	4.6	0.1	9.1	0.5	0.6	14.4	3.2	4.7	3.1	3.1	15.8	6.3	10.6	11.6	4.4	7.4	3.0	2.8	7.1	3.9	17.1	7.6	4.4	1.4	7.6	4.1	1.2	2.6	0.7	19.1	6.6	2.1	2.5	4.2	6.1	5.0	7.1	3.0	5.5	4.6	10.4	2.6	3.1	2.8	2.6	14.8	8.1	4.6	6.8	12.1	0.7	0.4	1.1	0.5	0.6	0.3	0.0	0.1	1.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.1	2.0	0.2	0.2	0.0	2.7	0.0	0.0	0.4	0.0	4.9	0.0	0.2	0.0	0.0	1.9	2.6	0.8	0.1	16.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.5	0.0	3.6	1.2	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.5	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.1	0.7	0.3	0.3	1.1	0.6	0.1	0.4	0.3	0.0	1.7	4.6	0.5	0.6	3.0	2.8	4.4	1.4	19.1	2.8	14.9	13.1	0.0	5.5	4.2	0.0	2.4	15.3	36.1	58.0	3.5	0.0	0.0	1.7	5.6	0.3	18.5	0.0	0.0	1.4	0.0	1.6	6.3	0.0	0.0	0.1	0.0	0.0	16.0	2.1	0.0	2.3	0.7	0.0	0.0	0.0	12.3	3.5	0.0	0.4	0.0	0.3	0.0	1.4	0.0	1.7	2.9	0.0	0.0	0.0	3.3
RBFOX3	"FOX-3, HRNBP3, NeuN"	ENSG00000167281	"RNA binding fox-1 homolog 3"	A6NFN3	17	79089345-79516148	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.4;seminal vesicle: 21.5"	"Cell type enhanced"	"Detected in many"	12	"Glandular cells: 12.8;Peritubular cells: 9.9;Spermatogonia: 21.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 60.4"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"A549: 13.2;NTERA-2: 11.9;SCLC-21H: 19.2;U-2 OS: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030790, HPA075862, CAB078782"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB078782: , HPA030790: AB_10602305, HPA075862: "	"unprognostic (2.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-15)"	"unprognostic (8.92e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-1)"	0.5	1.0	10.2	0.6	23.5	0.6	0.2	60.4	33.2	0.5	15.2	0.3	0.2	1.5	9.3	3.0	8.3	1.0	0.3	0.3	8.6	3.3	0.4	0.2	0.3	0.4	1.8	3.5	0.3	0.5	0.2	0.9	0.3	5.5	13.2	2.2	0.2	0.2	21.5	0.3	0.3	1.3	8.1	2.3	0.4	0.5	7.2	5.6	0.2	0.3	0.2	0.2	15.2	1.0	0.7	0.2	0.0	0.7	0.0	1.4	0.2	0.0	13.2	0.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	11.9	0.0	0.2	0.2	0.5	0.0	0.0	0.0	19.2	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	9.0	0.5	0.0	0.8	0.0	0.3	0.4	0.3	0.0	0.0	0.7	0.0	1.4	0.3	0.0	0.7	0.1	0.4	0.2	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.2	10.2	23.5	60.4	19.5	8.6	3.3	1.8	3.5	5.5	5.6	0.0	0.0	0.0	4.7	1.8	2.5	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.4	0.0	0.0	0.0	0.1	1.0	12.8	0.0	0.0	0.1	4.8	0.0	0.0	0.8	7.1	0.3	0.7	5.0	0.0	0.0	1.0	0.0	0.0	9.9	0.0	3.3	0.0	2.3	0.7	21.3	1.3	0.1	2.1	0.0	2.0
RCAN3	DSCR1L2	ENSG00000117602	"RCAN family member 3"	Q9UKA8	1	24502351-24541040	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.0"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 73.6;Intestinal endocrine cells: 78.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 37.0"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 5.6;memory CD4 T-cell: 14.0;memory CD8 T-cell: 5.0;naive CD4 T-cell: 19.2;naive CD8 T-cell: 9.9;T-reg: 19.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 19.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034533, HPA064289"	Enhanced		Approved	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA034533: AB_10601481, HPA064289: AB_2685232"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.20e-3)"	"unprognostic (3.41e-3)"	"unprognostic (3.66e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.52e-3)"	"unprognostic (9.83e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.71e-2)"	3.2	1.5	2.7	15.8	4.0	4.7	7.6	37.0	3.7	3.9	5.0	7.6	3.2	5.2	3.2	7.7	12.6	11.2	6.5	3.1	3.3	7.8	5.3	2.1	8.1	27.2	5.5	1.9	2.0	15.0	5.5	15.0	7.0	7.6	27.7	5.2	6.1	17.4	4.8	1.6	10.0	6.7	2.6	7.9	7.9	13.2	2.6	2.9	17.2	11.7	8.6	23.2	6.0	6.3	2.8	1.5	1.4	0.9	1.9	19.2	4.2	10.5	8.3	0.1	2.6	2.3	5.3	9.6	7.2	3.9	5.7	5.4	2.4	14.1	7.9	6.6	12.1	4.2	10.0	7.5	9.1	6.2	7.6	4.5	0.8	2.2	7.2	1.4	2.6	7.0	1.9	6.8	1.9	3.0	5.0	1.2	9.9	1.1	0.3	2.6	3.5	6.9	4.0	11.1	8.2	6.1	2.8	0.1	0.2	4.3	9.1	22.6	5.6	5.7	7.5	22.2	5.2	7.7	5.4	8.2	6.8	8.2	0.4	4.9	10.7	12.8	10.1	2.8	10.8	7.9	1.4	0.9	1.1	0.7	0.5	5.6	2.6	14.0	5.0	1.5	2.8	19.2	9.9	0.3	1.9	0.2	1.1	19.2	4.2	2.7	4.0	37.0	3.7	3.3	7.8	5.5	1.9	7.6	2.9	17.9	14.1	12.6	24.9	12.6	37.2	5.9	15.3	73.6	18.2	19.2	60.9	2.9	11.6	18.2	0.9	7.5	6.5	0.0	24.5	9.2	6.2	52.5	16.1	1.1	8.7	23.8	78.8	7.4	7.9	0.0	1.7	18.6	28.7	34.3	13.5	9.4	32.0	11.2	1.1	0.7	32.8	0.0	8.1	0.5	12.8	19.1	4.5	35.7	11.0	21.8
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell type enriched"	"Detected in some"	15	"Ito cells: 182.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		59000000	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	2.4	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.4	0.0	0.0	0.0	8.4	9.1	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0	0.0	0.0	0.0	0.0	0.6	11.3	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	2.6	0.0	0.0	1.0	0.1	2.4	0.3	0.0	2.4	0.2	0.0	0.0	182.3	9.4	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.1	0.5	0.2	0.0	0.0	0.0
REM2	FLJ38964	ENSG00000139890	"RRAD and GEM like GTPase 2"	Q8IYK8	14	22883165-22887686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.4;brain: 23.9"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 11.9;Early spermatids: 28.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	8	"basal ganglia: 23.9"	"Cell type enriched"	"Detected in some"	4	"neutrophil: 7.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in some"		"AF22: 7.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.1"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.49e-5)"	"unprognostic (9.40e-2)"	"unprognostic (4.63e-5)"	"unprognostic (3.56e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	0.6	1.0	0.4	1.6	23.9	15.4	0.6	2.7	2.5	0.5	0.7	0.9	0.4	0.7	0.9	0.9	0.4	2.4	0.7	0.4	1.2	1.5	0.7	0.4	1.6	1.6	0.4	1.1	1.3	1.0	5.7	5.4	0.4	1.5	1.0	0.4	0.4	1.0	0.7	0.7	1.5	1.4	0.6	0.9	5.2	1.0	3.8	2.9	0.6	0.7	0.4	1.0	0.6	0.4	1.7	0.4	7.5	0.7	0.0	1.0	0.2	1.7	0.9	7.4	0.3	0.7	1.1	1.1	0.1	0.5	0.1	0.6	0.8	2.4	0.6	0.3	0.1	0.3	3.1	0.2	0.2	0.6	1.1	1.7	0.3	2.9	0.0	0.6	0.3	0.5	0.4	0.2	0.2	0.1	0.3	0.3	0.5	0.2	3.1	0.4	2.4	0.0	0.7	0.4	0.8	1.4	0.1	0.2	0.7	0.3	0.2	0.9	3.5	0.6	1.1	1.2	0.4	1.3	0.6	0.0	0.0	1.6	0.1	0.2	2.9	1.2	1.8	0.3	0.1	0.0	0.4	0.0	0.8	0.2	0.0	0.7	1.1	0.5	0.6	0.0	1.7	1.0	1.0	7.5	0.0	0.7	0.4	0.4	0.2	0.4	23.9	2.7	2.5	1.2	1.5	0.4	1.1	1.5	2.9	11.9	3.7	0.9	0.7	2.5	0.0	1.2	0.0	2.7	2.3	1.8	0.0	0.4	0.0	0.4	28.0	0.0	0.4	0.0	0.0	0.3	0.8	1.1	0.0	0.0	0.3	0.0	6.3	0.6	1.2	4.7	1.1	0.0	3.3	1.8	1.7	0.7	0.3	0.0	1.1	0.3	0.6	0.0	1.0	0.7	0.9	2.6	0.3	0.5	1.2	0.7
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 63.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 6.1;Late spermatids: 19.3"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Region enriched"	"Detected in single"	12	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.4;BJ: 4.9;HMC-1: 6.5;RT4: 1.8;SK-BR-3: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000				"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	0.4	0.3	0.0	0.0	1.2	0.0	0.5	0.0	0.0	3.1	0.2	0.0	0.8	0.1	4.4	13.5	0.1	0.3	0.0	0.6	0.0	0.0	63.6	0.4	0.3	0.0	0.0	0.0	11.6	0.0	0.0	0.4	14.4	0.0	0.3	0.1	0.4	0.3	0.5	0.0	0.0	0.1	1.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.2	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	4.9	1.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	4.6	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.2	6.1	0.0	0.0	0.0	1.0	0.2	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	2.7
RESP18		ENSG00000182698	"Regulated endocrine specific protein 18"	Q5W5W9	2	219327409-219333177	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"brain: 28.7"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 6.6;Intestinal endocrine cells: 3.4;Late spermatids: 18.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"basal ganglia: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"															NA	NA										"unprognostic (2.57e-2)"										"unprognostic (2.12e-1)"			0.4	0.4	2.6	0.4	28.7	0.4	0.5	0.1	7.5	0.4	0.4	0.3	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.1	4.0	0.4	0.4	0.4	0.4	3.6	1.0	0.4	0.4	0.4	0.0	0.4	2.3	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	2.4	2.5	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	28.7	0.1	1.8	3.1	4.0	3.6	1.0	2.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	18.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
RGS14		ENSG00000169220	"Regulator of G protein signaling 14"	O43566	5	177357837-177372601	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.9;brain: 76.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 61.1;Proximal tubular cells: 68.0;Suprabasal keratinocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 76.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 40.7;HMC-1: 36.4;NB-4: 16.0;RPMI-8226: 21.0"	"Group enriched"	"Detected in many"	11	"amygdala: 68.3;basal ganglia: 58.1;cerebral cortex: 46.1;hippocampal formation: 102.5"	"Low region specificity"	"Detected in all"			"HPA046847, HPA061819"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Intermediate filaments"		No	No			Nucleoplasm	"Vesicles, Plasma membrane, Intermediate filaments"	"HPA046847: AB_2679836, HPA061819: "	"unprognostic (6.05e-3)"	"unprognostic (1.65e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.95e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-2)"	1.9	1.5	7.7	12.5	76.1	17.5	1.3	0.4	8.8	1.7	2.6	1.9	0.6	5.1	1.3	1.4	3.2	6.6	3.4	0.7	17.1	1.9	2.1	6.9	4.3	15.5	2.5	3.6	0.8	1.5	0.1	0.9	1.0	0.8	1.2	0.5	0.7	5.2	1.8	1.6	3.5	5.7	1.2	0.7	12.8	3.7	0.7	4.4	24.2	4.3	1.7	12.9	4.9	1.6	9.2	12.2	43.9	12.3	6.5	20.7	12.4	1.9	0.4	0.7	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.2	1.2	3.8	4.8	2.7	0.0	0.4	3.9	0.0	1.2	0.0	40.7	0.1	7.5	0.1	1.5	0.2	5.8	36.4	0.6	0.3	0.2	0.2	0.0	0.2	5.5	1.3	9.8	0.0	0.1	7.8	16.0	0.6	1.9	1.0	3.6	0.0	21.0	0.4	0.1	0.1	0.7	0.0	0.1	3.0	0.0	1.3	9.2	0.3	0.0	0.7	0.0	3.5	5.2	2.5	2.1	0.6	11.0	0.9	18.6	12.3	43.9	20.5	11.4	20.7	9.2	19.1	18.7	12.2	8.0	16.0	14.3	43.0	6.5	11.6	5.4	18.2	12.4	7.7	76.1	0.4	8.8	17.1	1.9	2.5	3.6	0.8	4.4	6.0	4.1	20.7	25.0	61.1	0.4	1.6	40.8	14.7	4.5	10.4	2.0	3.2	26.6	10.5	0.5	6.0	7.5	0.0	14.4	8.2	5.3	12.3	24.3	55.7	21.0	0.0	4.6	7.4	13.7	0.8	2.6	16.9	20.3	0.0	5.3	8.0	12.8	14.4	2.1	68.0	1.9	0.0	5.1	0.0	15.1	100.6	2.7	40.0	3.3	13.7
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 47.3"	"Group enriched"	"Detected in many"	6	"gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	74	"NK-cells: 3.7;T-cells: 11.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 23.2;HEL: 9.5"	"Region enriched"	"Detected in many"	9	"basal ganglia: 222.4"	"Region enriched"	"Detected in all"	9	"basal ganglia: 79.8"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	1.1	1.9	3.3	4.4	47.3	1.0	2.3	4.1	8.9	3.4	5.2	7.2	2.7	3.3	4.2	7.2	4.1	9.5	3.9	1.3	5.4	7.4	2.0	5.0	5.9	5.3	3.5	3.7	6.7	3.7	7.3	7.9	3.0	4.5	8.6	3.4	24.1	3.2	9.2	1.6	1.5	3.6	4.0	3.4	4.3	3.7	1.7	6.6	0.4	4.2	0.5	7.5	5.1	2.4	0.0	0.0	0.0	0.0	3.7	11.0	1.4	0.2	0.0	1.1	0.1	0.1	0.2	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.7	1.6	0.0	0.0	0.1	0.0	0.1	0.2	23.2	0.5	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	2.8	0.0	1.0	7.4	0.0	0.0	0.0	3.6	0.0	3.7	0.0	0.0	0.0	1.4	3.3	47.3	4.1	4.5	5.4	7.4	3.5	3.7	4.5	6.6	3.0	1.0	0.0	0.9	0.3	21.5	0.4	0.0	1.4	2.3	1.8	306.3	0.0	3.3	6.8	0.6	0.3	0.0	0.0	2.8	0.1	2.3	0.2	0.0	0.0	0.1	49.3	57.3	1.8	0.0	1.7	0.9	3.2	1.7	33.3	2.2	27.8	3.9	0.0	4.6	8.1	472.2	0.0	0.9	0.0	0.4	0.1	0.1	9.2	0.4	0.1
RGS9BP	"FLJ45744, PERRS, R9AP, RGS9"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675407-32678300	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 38.3;skeletal muscle: 15.8"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"pons and medulla: 6.8"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;memory CD8 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 10.7;HMC-1: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.4	0.5	0.8	0.3	1.1	0.3	0.4	0.2	0.7	0.3	0.4	1.4	0.2	0.4	0.3	0.6	1.1	0.4	0.3	6.7	1.0	0.8	0.9	0.3	0.9	0.3	1.1	0.3	0.3	0.4	0.4	0.6	0.4	6.8	1.3	0.3	38.3	0.5	0.6	15.8	0.6	0.3	7.4	1.3	0.4	0.4	0.9	0.9	0.1	0.4	4.3	0.3	2.3	1.0	0.0	0.3	0.0	0.9	0.5	1.5	0.0	0.2	0.2	0.0	0.9	0.5	0.2	0.5	0.0	0.5	0.4	0.2	0.2	0.3	0.4	0.5	0.1	0.5	0.1	1.8	0.1	0.1	0.5	0.2	10.7	0.3	0.0	0.2	0.3	2.8	0.0	0.5	0.0	0.4	0.2	0.0	0.1	0.9	1.5	0.2	0.5	0.0	1.7	0.0	0.1	2.0	0.2	0.4	0.2	0.0	0.1	0.4	0.1	0.0	1.1	0.1	0.0	1.1	0.5	0.0	0.5	0.7	0.2	0.3	0.6	0.7	0.1	0.3	0.6	0.8	0.0	0.3	0.0	1.4	0.9	0.0	0.0	0.2	1.5	0.3	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.8	1.1	0.2	0.7	1.0	0.8	1.1	0.3	6.8	0.9	0.0	0.0	0.0	0.1	0.0	30.8	3.9	0.0	0.0	0.0	1.8	53.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.6	0.0	0.6	0.8	0.9	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.4	70.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0"					"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	21.0	0.0	0.0	16.6	0.3	10.7	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	4.3	0.1	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	1.0	0.0	1.1	0.1	0.0	0.4	0.9	0.0	0.0	0.0	2.2	0.4	0.4	0.0	0.0	0.0	0.0
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528640-129535169	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	151	"retina: 415.0"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 2822.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.6;cerebral cortex: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA					"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.2	0.0	0.0	0.0	0.3	0.0	0.1	1.6	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	415.0	0.3	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	2.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	290.1	0.6	0.0	0.0	0.0	0.0	428.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	206.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	393.2	0.0	0.0	0.0	0.0	2822.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109053-120115937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.1;brain: 9.2;testis: 27.8"	"Cell type enriched"	"Detected in some"	39	"Spermatogonia: 154.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Cell type enriched"	"Detected in some"	6	"T-reg: 8.1"	"Lineage enriched"	"Detected in single"	30	"T-cells: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8"									"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.2	3.9	0.4	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	8.1	0.0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	0.0	3.9	0.1	1.7	0.1	1.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.0	1.4	0.0	1.3	0.0	0.0	2.9	154.2	0.3	0.0	0.0	0.1	0.0
RIBC1	FLJ32783	ENSG00000158423	"RIB43A domain with coiled-coils 1"	Q8N443	X	53422690-53431120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 12.7;fallopian tube: 24.5;testis: 37.6"	"Cell type enhanced"	"Detected in many"	26	"Ciliated cells: 92.3;Early spermatids: 217.1;Late spermatids: 387.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 8.4;T-47d: 11.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001150			Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA001150: AB_2666211"	"unprognostic (1.08e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.39e-3)"	"unprognostic (9.88e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.29e-1)"	0.6	2.9	2.0	1.3	3.7	0.4	1.3	0.5	1.4	1.8	0.7	5.3	0.8	0.7	2.1	5.4	1.1	24.5	1.4	1.1	2.5	3.0	2.3	0.3	2.9	0.6	1.3	1.4	5.5	1.6	1.9	5.0	0.5	12.7	1.1	0.4	2.4	1.9	1.5	0.5	1.0	0.7	0.5	1.4	0.6	0.7	37.6	1.2	0.3	3.1	0.2	0.5	0.8	0.5	1.5	1.0	2.9	1.5	3.7	2.3	1.1	1.9	5.2	2.0	1.4	0.7	1.3	1.2	0.5	0.3	1.1	1.0	2.0	3.1	1.9	3.5	0.2	3.5	3.6	0.5	1.1	1.5	1.1	3.3	1.1	8.4	0.9	0.3	1.1	2.0	0.4	0.4	3.1	0.7	2.6	0.9	1.5	0.8	2.3	0.7	1.3	2.2	1.0	2.5	0.9	1.4	1.6	1.4	1.5	3.0	1.0	4.5	0.8	5.1	1.9	1.2	6.5	11.6	0.5	0.6	0.5	2.6	1.5	0.7	2.4	1.6	1.1	2.1	0.4	0.9	0.0	0.7	0.0	0.3	1.2	2.3	0.2	0.9	1.9	1.0	1.5	0.4	0.4	2.9	3.7	1.5	0.8	1.9	1.1	2.0	3.7	0.5	1.4	2.5	3.0	1.3	1.4	12.7	1.2	0.0	0.3	0.0	1.4	1.1	2.3	0.8	2.5	92.3	7.9	0.0	3.9	0.5	1.7	1.1	217.1	0.6	0.0	0.0	0.2	0.3	0.6	0.7	2.3	0.5	0.1	1.6	1.2	0.0	0.3	387.5	2.3	0.4	1.7	0.0	0.0	2.6	0.5	0.0	1.8	5.0	9.1	0.0	0.2	10.9	6.1	0.6	0.3	0.0	0.2	0.5
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 83.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 58.2;Horizontal cells: 58.8;Muller glia cells: 101.2"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;EFO-21: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 15.1;SH-SY5Y: 10.7;TIME: 5.2;U-138 MG: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076565	Enhanced					NA	NA					"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.5	2.3	10.5	1.5	9.8	0.4	1.2	83.1	27.7	0.9	0.6	0.5	0.0	1.5	0.8	0.5	3.7	0.5	6.2	0.6	9.3	3.6	0.5	0.4	0.7	0.5	2.8	11.7	0.5	0.8	5.0	4.6	0.4	7.2	4.9	0.6	0.2	1.9	0.9	0.6	0.4	0.8	1.4	1.5	0.4	1.4	5.9	2.7	0.0	0.5	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.2	1.3	0.0	0.2	0.0	0.0	4.9	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	1.6	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.4	15.1	0.0	0.4	10.7	0.0	0.0	0.0	0.3	0.6	0.0	5.2	5.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	9.8	83.1	12.9	9.3	3.6	2.8	11.7	7.2	2.7	0.0	0.3	0.0	0.1	0.0	58.2	1.5	0.0	5.3	9.1	0.0	0.0	0.0	0.0	0.0	12.0	0.5	0.0	0.0	0.7	0.0	0.2	1.0	1.1	0.0	0.0	58.8	0.0	0.6	0.0	6.5	0.3	0.0	3.3	0.0	0.0	101.2	0.8	0.0	1.4	0.0	7.1	0.0	0.2	16.3	13.0	0.1	0.0	0.0	0.0	0.4
RIPPLY3	DSCR6	ENSG00000183145	"Ripply transcriptional repressor 3"	P57055	21	37006150-37019659	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 9.6"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 2.6;Intestinal endocrine cells: 2.9;Ito cells: 2.5;Urothelial cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;EFO-21: 1.8;PC-3: 2.3;RT4: 1.4;SCLC-21H: 7.1;T-47d: 4.3"	"Not detected"	"Not detected"							HPA055541	Uncertain					NA	NA					"HPA055541: AB_2682840"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.57e-4)"	"unprognostic (2.69e-1)"	0.1	0.3	0.0	0.1	3.4	0.1	0.1	0.9	0.6	0.7	0.2	0.0	3.7	0.1	0.7	9.6	0.9	0.1	0.1	0.1	0.0	0.0	0.7	0.4	1.9	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.8	0.0	2.0	0.1	2.8	1.9	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.5	1.8	0.0	0.2	0.0	1.6	2.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	2.3	0.0	0.0	0.0	1.2	1.4	7.1	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.8	0.0	0.0	0.1	0.0	2.9	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.1
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 55.9"	"Cell type enhanced"	"Detected in some"	13	"Cytotrophoblasts: 1.3;Muller glia cells: 1.2;Rod photoreceptor cells: 2.3;Syncytiotrophoblasts: 1.7"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Region enhanced"	"Detected in many"		"cerebellum: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;SH-SY5Y: 1.7;SuSa: 2.6"	"Low region specificity"	"Detected in all"							HPA072174	Enhanced					NA	NA					"HPA072174: AB_2732195"					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.7	5.2	3.7	0.9	15.0	0.6	0.8	55.9	24.1	1.0	0.7	0.1	0.0	0.8	0.6	0.6	0.6	0.7	0.7	0.6	5.1	11.7	0.6	0.7	0.6	0.7	3.6	5.9	0.8	0.6	0.6	0.4	0.8	6.1	0.7	0.9	0.0	0.6	0.8	0.6	0.6	0.7	0.8	2.1	0.6	0.6	1.1	0.8	0.0	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.7	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	15.0	55.9	11.0	5.1	11.7	3.6	5.9	6.1	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell type enriched"	"Detected in some"	43	"Muller glia cells: 2424.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	37.3	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	2424.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.1	0.0	0.0	16.7	0.0	0.0	0.0
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334969-5339873	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"prostate: 25.4"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 6.8;Intestinal endocrine cells: 4.6;Spermatocytes: 2.3;Spermatogonia: 2.0"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.2;HEL: 4.8;SK-BR-3: 1.1"														"Secreted to blood"	NA	NA						"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	1.2	0.0	0.0	0.0	0.4	0.2	0.0	6.8	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.3	2.0	0.1	0.9	0.5	0.2	0.0
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299868-5304969	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 44.0"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 8.6;Spermatocytes: 10.5;Syncytiotrophoblasts: 11.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.7"	"Region enriched"	"Detected in single"	64	"basal ganglia: 44.0"	"Group enriched"	"Detected in many"	39	"gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0"	"Group enriched"	"Detected in many"	47	"B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;HEL: 20.2;T-47d: 5.8;U-266/84: 9.2"														"Secreted to blood"	NA	NA	24400					"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.6	0.0	0.6	1.6	44.0	0.0	3.2	0.6	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	7.5	0.6	0.6	0.6	0.6	2.0	0.6	0.7	3.5	0.6	0.6	0.6	0.9	5.2	5.8	0.7	0.6	6.2	0.3	0.6	0.6	0.7	0.6	0.4	0.8	0.6	0.6	1.4	0.4	4.2	0.6	0.6	0.9	0.6	3.0	0.6	0.6	2.8	0.0	0.0	0.0	4.9	6.5	1.4	2.8	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.9	0.3	1.5	5.2	0.4	0.0	0.0	0.9	0.0	2.7	0.7	4.1	1.9	20.2	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.5	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.6	2.7	2.9	0.0	0.6	0.1	0.2	5.8	0.1	0.2	0.0	0.5	0.0	0.1	1.3	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.5	2.8	4.3	3.5	0.0	2.1	6.2	4.6	0.0	4.9	0.0	0.0	2.0	1.4	0.6	44.0	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6	3.0	1.1	0.5	2.3	0.5	1.5	1.6	0.0	4.0	1.2	1.8	0.0	6.0	6.6	2.5	7.4	0.3	0.0	0.0	1.4	1.7	0.2	1.3	0.0	0.0	0.5	3.2	3.5	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.2	8.6	0.7	0.0	0.4	0.8	1.8	0.0	0.1	10.5	2.8	1.1	11.3	2.9	1.0	0.3
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58352500-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 33.4;Mucus-secreting cells: 39.0;Undifferentiated cells: 47.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 30.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 13.4;Hep G2: 26.2;OE19: 29.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008079	Uncertain					NA	NA					"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favorable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.4	9.4	2.2	6.2	3.5	1.9	4.5	30.6	4.3	3.4	26.4	0.9	21.3	18.5	1.7	9.1	10.0	3.9	8.1	3.3	1.9	1.3	8.0	7.0	6.1	2.7	0.8	1.1	1.6	13.2	3.0	13.3	8.7	4.1	8.0	16.3	3.8	13.7	19.0	0.5	8.9	29.0	0.9	0.8	0.9	4.9	3.1	0.7	3.0	1.8	5.7	6.6	4.0	4.4	0.9	1.1	1.7	1.8	5.6	3.6	1.2	0.6	9.3	1.7	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	13.4	4.5	3.8	4.8	0.0	1.1	2.6	0.3	3.6	0.0	7.9	6.5	3.0	0.4	26.2	0.0	3.7	2.7	0.0	7.4	0.0	1.1	0.5	0.0	1.2	0.2	3.3	0.0	0.1	2.0	3.5	0.2	29.2	0.6	6.2	0.0	2.0	3.3	5.1	1.0	0.3	0.8	0.4	0.3	3.2	1.1	1.0	0.0	0.1	1.1	0.0	0.0	3.4	1.6	2.9	0.3	0.4	2.2	1.7	0.2	1.6	3.1	0.8	3.2	0.9	2.5	3.6	0.4	0.9	2.3	3.0	0.8	5.6	1.8	1.1	1.2	1.2	2.2	3.5	30.6	4.3	1.9	1.3	0.8	1.1	4.1	0.7	3.0	6.2	0.5	15.7	8.5	2.4	3.5	10.2	4.0	3.4	17.4	2.0	19.4	13.3	5.6	1.2	0.7	33.4	0.0	2.4	2.2	0.6	8.7	0.0	8.7	2.3	4.8	14.9	0.6	0.6	1.3	0.3	0.7	13.5	2.8	39.0	11.7	4.5	24.6	0.4	2.2	2.8	0.0	0.4	1.1	0.5	5.4	4.9	3.9	47.8	5.4
ROPN1L	"ASP, FLJ25776, RSPH11"	ENSG00000145491	"Rhophilin associated tail protein 1 like"	Q96C74	5	10441524-10472029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.1;testis: 128.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 2516.4;Late spermatids: 2496.8"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 9.6;ovarian cancer: 3.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 7.7"	"Group enriched"	"Detected in many"	11	"basophil: 12.6;eosinophil: 18.3;neutrophil: 37.1"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 37.1"	"Cell line enriched"	"Detected in some"	5	"NB-4: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039193, HPA041830"	Enhanced					NA	NA					"HPA039193: AB_10673415, HPA041830: AB_2677695"	"unprognostic (2.39e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.84e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.22e-2)"	0.3	0.1	1.2	0.3	3.5	1.9	0.2	0.1	1.0	0.9	0.2	2.8	0.0	0.2	0.6	4.9	0.2	12.6	0.3	0.4	1.9	1.4	0.5	0.2	4.4	0.9	0.2	0.9	1.9	0.6	0.1	1.8	0.2	7.7	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.3	2.5	0.1	128.1	0.5	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	37.1	0.4	0.1	2.0	0.7	0.1	0.5	0.0	0.0	0.6	0.0	0.6	0.0	0.8	0.7	0.7	0.1	0.1	0.0	2.0	0.2	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.6	0.0	0.0	0.2	0.3	0.3	0.7	0.0	0.1	0.1	0.0	0.2	0.0	17.0	0.1	0.0	0.7	0.1	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.1	0.2	0.2	0.3	0.5	0.0	0.0	1.2	2.1	0.2	0.2	0.5	0.0	2.0	2.1	0.4	12.6	0.2	18.3	1.5	0.0	1.0	0.0	1.3	1.6	0.0	0.0	0.9	1.0	37.1	0.1	0.4	0.0	2.0	0.7	1.2	3.5	0.1	1.0	1.9	1.4	0.2	0.9	7.7	0.5	3.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	327.9	37.5	0.0	0.0	0.0	0.0	0.7	2516.4	2.9	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.0	0.1	3.2	0.0	7.4	1.6	2496.8	33.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	17.3	0.8	3.1	12.9	0.2	435.5	29.6	0.1	0.1	0.0	0.0	0.0
ROR1	NTRKR1	ENSG00000185483	"Receptor tyrosine kinase like orphan receptor 1"	Q01973	1	63774022-64181498	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Kinase, Receptor, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 31.2"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 47.6;Intestinal endocrine cells: 20.6;Leydig cells: 25.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 13.0"	"Group enriched"	"Detected in some"	5	"NK-cell: 3.3;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;NK-cells: 3.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.8;ASC TERT1: 24.8;CACO-2: 16.9;HHSteC: 18.8;HSkMC: 20.3;NTERA-2: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057016			Approved	Microtubules	"Intracellular and membrane"	NA	NA		2800000	Microtubules		"HPA057016: "	"unprognostic (5.15e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.87e-2)"	"unprognostic (5.15e-2)"	5.5	1.7	1.3	3.5	2.7	0.4	3.4	13.0	2.8	16.7	8.8	2.2	4.4	2.0	14.2	5.0	4.9	5.5	10.7	10.6	1.3	1.1	3.6	0.8	9.7	1.1	1.0	2.4	8.3	9.8	31.2	3.6	2.9	3.0	10.9	3.9	7.9	2.8	6.3	2.1	4.5	4.1	17.8	1.1	3.1	9.2	2.7	0.9	1.8	1.5	4.6	2.1	10.2	8.8	0.4	1.1	0.1	0.1	3.3	0.1	0.0	7.1	5.6	2.8	0.4	19.8	24.8	1.9	1.4	3.9	0.8	2.0	16.9	2.3	0.1	3.2	3.3	1.4	1.5	0.0	1.3	0.5	0.0	1.8	0.0	0.7	0.2	18.8	0.0	0.0	20.3	5.2	10.4	12.2	4.0	0.3	0.2	0.0	0.1	5.2	0.1	0.1	0.0	20.6	5.2	2.8	0.1	0.1	4.4	4.1	0.1	1.6	6.6	0.4	0.1	2.9	10.0	0.0	0.0	3.9	1.6	2.9	11.0	2.9	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	3.3	0.1	1.1	0.0	0.0	1.3	2.7	13.0	2.8	1.3	1.1	1.0	2.4	3.0	0.9	47.6	8.0	0.0	1.8	3.4	1.7	8.5	2.5	1.4	2.3	1.8	0.0	0.2	0.0	5.3	7.8	1.3	0.0	0.0	13.4	0.7	7.6	1.5	0.0	0.0	5.8	0.0	20.6	1.3	0.0	4.7	25.6	0.0	3.3	0.0	2.3	4.9	10.7	0.0	13.8	2.8	0.0	6.5	12.0	0.7	1.2	4.0	0.2	0.0	2.6	0.9
ROR2	"BDB, BDB1, NTRKR2"	ENSG00000169071	"Receptor tyrosine kinase like orphan receptor 2"	Q01974	9	91563091-91950162	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 9.7;Fibroblasts: 9.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 6.6"	"Cell type enriched"	"Detected in single"	6	"MAIT T-cell: 3.9"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.3;HHSteC: 32.4;HSkMC: 26.9;U-266/70: 18.7;U-266/84: 12.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 13.5"	HPA021868	Uncertain					NA	NA					"HPA021868: AB_1856406"	"unprognostic (9.38e-3)"	"unprognostic (4.69e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (9.86e-7)"	"unprognostic (2.16e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (1.25e-2)"	4.4	4.3	0.7	5.3	1.1	0.0	3.6	0.2	0.8	23.4	20.7	2.9	11.1	1.9	29.1	9.1	8.0	8.1	18.7	8.5	1.0	0.9	2.0	0.5	4.2	0.7	0.3	0.0	19.1	3.1	20.3	1.3	7.1	6.6	20.3	2.1	11.0	1.2	13.1	1.1	2.9	6.2	30.0	0.3	4.7	10.5	5.2	0.3	2.6	7.9	1.9	3.3	23.7	18.1	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.1	12.3	0.0	2.7	0.2	3.5	0.2	3.2	2.1	3.9	0.0	0.0	0.0	0.0	0.6	1.9	0.1	2.5	0.0	0.9	0.0	2.0	0.0	9.4	0.0	32.4	0.0	0.0	26.9	0.0	2.8	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.2	0.0	1.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.6	0.2	0.0	0.0	2.7	7.3	0.1	0.0	0.0	2.4	1.0	0.0	18.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.2	0.8	1.0	0.9	0.3	0.0	6.6	0.3	0.0	0.0	0.0	9.7	2.7	1.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	3.5	1.1	0.0	0.0	1.3	0.1	9.1	8.3	1.1	0.0	0.7	0.0	2.9	0.6	0.0	6.0	5.5	0.0	5.0	2.8	2.8	6.8	0.8	0.0	8.5	0.0	0.2	6.5	3.9	1.0	6.8	1.9	0.3	0.0	0.8	4.4
RORC	"NR1F3, RORG, RZRG, TOR"	ENSG00000143365	"RAR related orphan receptor C"	P51449	1	151806071-151831872	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 69.8;skeletal muscle: 63.8"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 29.9;Erythroid cells: 23.3;Hepatocytes: 48.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 7.0;pons and medulla: 2.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 28.3"	"Lineage enriched"	"Detected in single"	44	"T-cells: 28.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;Karpas-707: 11.2;MOLT-4: 5.7;RPMI-8226: 5.9;SK-BR-3: 5.1;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA065620			Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA065620: AB_2685521"	"unprognostic (6.51e-2)"	"unprognostic (7.78e-2)"	"prognostic favorable (1.83e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-4)"	"unprognostic (6.29e-5)"	"unprognostic (1.13e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (2.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-2)"	1.3	1.6	0.4	3.4	0.9	0.0	3.3	7.0	0.3	2.7	10.0	0.7	19.8	4.2	1.2	6.7	3.4	8.7	3.5	4.8	0.4	0.5	13.3	30.8	8.7	0.7	0.9	0.3	1.3	30.3	8.5	9.4	0.2	2.4	7.0	4.0	2.8	27.8	33.4	63.8	9.8	10.3	0.8	0.3	0.7	7.7	6.4	1.1	69.8	15.6	11.1	4.0	2.4	1.7	0.0	0.1	0.0	0.0	0.6	28.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	21.5	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	11.2	0.0	0.1	5.7	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.2	0.1	5.1	0.0	0.0	9.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	0.0	28.3	0.0	4.4	4.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	3.0	0.6	0.4	0.9	7.0	0.3	0.4	0.5	0.9	0.3	2.4	1.1	6.0	5.9	0.8	4.5	1.8	0.0	5.3	10.2	6.7	1.2	15.7	0.0	0.0	29.9	5.0	0.3	0.3	15.8	23.3	6.2	0.0	0.2	7.1	0.0	48.2	0.1	0.0	9.2	0.6	2.7	0.4	0.6	0.7	3.3	0.0	17.3	0.0	4.0	17.5	0.4	13.9	0.0	0.0	0.3	0.0	0.0	2.6	0.0	0.0	13.9	2.7
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.7	18.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	2.2	1.4	0.1	1.7	0.0	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0	14.9	56.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"RPE65, retinoid isomerohydrolase"	Q16518	1	68428822-68449959	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Isomerase"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"retina: 268.3"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 17.3"	"Group enriched"	"Detected in some"	10	"glioma: 5.8;head and neck cancer: 1.5"	"Group enriched"	"Detected in many"	5	"hypothalamus: 6.0;midbrain: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.2;PC-3: 10.6;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.15e-1)"		"prognostic favorable (9.75e-4)"	"unprognostic (4.55e-2)"		"unprognostic (5.91e-2)"	"unprognostic (6.59e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.48e-2)"	"unprognostic (8.40e-3)"	0.0	0.0	0.9	0.1	0.7	0.0	1.0	0.1	3.8	0.2	0.1	1.3	1.4	0.4	1.4	0.7	0.8	0.6	0.2	0.0	1.5	6.0	0.0	0.0	0.0	0.1	8.8	0.1	0.1	0.0	0.0	0.0	0.0	1.2	4.2	0.2	268.3	0.2	10.5	0.0	0.0	0.1	0.5	1.4	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.6	1.5	6.0	8.8	0.1	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head 4 homolog A"	Q5TD94	6	116616479-116632985	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7"	"Cell type enriched"	"Detected in many"	10	"Ciliated cells: 365.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.4;pons and medulla: 19.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 7.6;U-266/84: 5.5"	"Low region specificity"	"Detected in many"							"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA			Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3.0	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1.0	0.6	0.4	0.6	0.7	1.0	0.8	6.6	1.8	0.0	1.0	0.0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1.0	0.0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1.0	0.3	0.1	1.2	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0.0	0.8	1.1	0.4	0.2	1.0	0.2	0.1	0.0	0.9	0.2	0.1	0.6	0.2	0.7	0.1	0.6	0.1	0.1	0.8	1.6	7.6	3.2	0.4	2.8	1.2	0.2	0.2	0.5	0.3	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.5	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1.0	0.1	0.1	0.4	0.3	0.0	0.0	0.8	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	1.8	9.4	1.2	0.7	3.0	3.3	0.5	1.1	19.8	1.8	3.0	4.3	0.0	0.0	0.0	3.0	0.4	0.0	365.4	35.2	0.0	2.0	0.0	1.7	0.4	18.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	2.3	0.0	0.1	1.6	0.0	2.5	0.0	8.7	0.3	0.0	1.7	0.0	0.0	1.7	0.2	0.0	0.0	0.0	3.2	0.0	0.4	4.4	1.5	0.1	0.2	0.0	0.0	0.0
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118604-127197765	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Fibroblasts: 10.4;Ito cells: 16.0;Leydig cells: 25.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.7;hippocampal formation: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.5;BJ hTERT+: 4.1;hTERT-RPE1: 7.8;U-138 MG: 5.2;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 32.5"	HPA029957	Uncertain				"Secreted to blood"	NA	NA					"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	18.5	10.5	2.8	12.1	0.8	0.0	40.7	5.7	2.3	12.9	8.5	0.0	23.8	1.2	50.3	32.5	23.7	14.9	7.6	4.2	20.5	1.7	3.3	4.2	3.8	10.2	0.8	2.4	13.2	1.5	0.0	2.6	24.1	0.8	10.2	4.7	8.6	3.9	15.3	19.7	2.2	6.7	34.1	0.6	1.4	10.8	12.4	0.0	0.2	2.9	2.1	0.9	9.3	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.2	0.5	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	7.8	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	5.2	2.0	0.7	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.8	5.7	2.2	20.5	1.7	0.8	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	10.8	2.8	0.0	0.0	0.0	1.0	10.4	0.6	0.0	0.0	1.3	0.0	0.0	16.0	0.3	1.1	25.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	2.7	0.0	0.1	0.1	1.4	0.0	0.0	0.1
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460549-57477534	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 44.3;liver: 38.1;thyroid gland: 24.9"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 6.2;Cholangiocytes: 15.3;Hepatocytes: 12.4;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 17.7;basal ganglia: 17.9;cerebral cortex: 44.3;hippocampal formation: 12.4;olfactory region: 17.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 1.0;intermediate monocyte: 2.5;MAIT T-cell: 1.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.4;monocytes: 2.5;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 17.3;Karpas-707: 26.2;REH: 15.8;RPMI-8226: 50.4"	"Group enriched"	"Detected in many"	4	"amygdala: 23.2;basal ganglia: 10.6;cerebral cortex: 29.8;hippocampal formation: 23.6"	"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		25000000				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	2.7	0.9	17.7	0.9	17.9	1.4	2.4	1.6	44.3	1.5	1.0	1.0	0.0	1.8	1.5	0.8	1.2	1.2	3.8	2.1	12.4	1.5	2.0	38.1	1.9	1.0	2.0	17.6	1.0	2.8	5.4	2.5	2.7	1.0	1.9	0.7	1.9	2.8	1.0	2.3	5.3	1.2	1.4	0.7	1.3	1.9	1.5	0.1	1.0	24.9	0.5	1.0	1.3	1.2	0.0	3.4	0.0	2.5	0.0	1.1	0.0	2.7	3.8	2.9	5.0	1.2	1.7	0.4	0.0	1.1	0.1	1.1	0.5	0.5	0.1	0.1	0.1	1.6	0.0	4.6	0.0	0.0	0.6	1.8	0.8	0.3	2.7	1.7	0.6	17.3	4.7	0.5	0.4	0.4	0.5	0.0	4.9	0.6	26.2	0.0	0.5	0.1	2.0	5.2	0.2	2.9	15.8	2.1	50.4	0.0	0.1	5.5	0.5	0.4	0.2	2.9	0.2	3.3	0.7	0.0	0.2	9.1	1.2	0.9	1.6	3.3	0.5	6.6	2.7	2.2	0.0	1.0	0.0	0.2	2.5	1.1	0.0	0.3	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	17.7	17.9	1.6	44.3	12.4	1.5	2.0	17.6	1.0	0.1	0.0	0.0	0.0	0.4	5.0	6.2	0.2	15.3	0.0	0.0	0.0	0.0	0.0	3.3	0.9	1.3	1.3	0.0	0.0	0.5	1.7	0.6	0.8	0.0	12.4	0.4	0.0	1.7	1.3	0.0	0.0	0.3	0.0	1.7	0.0	0.3	0.8	1.2	0.0	1.1	1.0	1.3	6.5	2.3	0.9	1.8	2.5	0.0	0.0	0.0	0.1
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 translocation partner 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 57.8"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 122.4;Ito cells: 87.8;Leydig cells: 89.2;Peritubular cells: 93.0;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 13.2;fHDF/TERT166: 11.2;HEL: 24.1;HSkMC: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049852: AB_2680914, HPA070951: AB_2686326"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	9.6	4.6	7.7	4.5	11.5	0.4	6.9	57.8	13.0	14.0	7.8	1.1	2.0	2.0	11.8	5.9	4.1	7.7	7.8	12.3	5.8	4.0	2.5	1.3	6.0	2.0	3.6	9.6	7.7	1.8	1.7	8.6	8.7	4.2	4.2	4.0	5.3	4.7	4.1	5.5	3.6	3.6	10.3	3.0	2.9	4.2	5.6	3.7	0.0	5.2	3.3	1.8	5.7	5.9	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.3	3.5	5.1	0.0	5.2	7.9	3.5	5.4	0.0	0.0	13.2	0.0	11.2	0.0	0.0	2.8	0.3	2.3	0.0	2.2	24.1	0.0	0.0	1.4	0.0	0.0	9.7	0.0	5.8	0.3	0.0	7.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	4.2	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.3	0.0	0.6	0.0	2.6	0.0	4.2	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	7.7	11.5	57.8	13.0	5.8	4.0	3.6	9.6	4.2	3.7	0.0	0.6	0.0	0.1	5.6	122.4	43.1	0.0	0.0	1.2	0.0	15.7	1.1	1.7	0.0	2.0	49.6	0.0	0.0	0.2	0.2	62.1	0.3	1.1	0.5	1.7	33.4	45.7	87.8	4.9	4.0	89.2	0.8	10.1	0.0	0.0	3.9	0.3	0.0	93.0	0.0	7.1	64.7	41.5	3.0	13.0	4.3	0.9	0.0	0.0	0.0
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin/insulin like family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;placenta: 12.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	6	"basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 24.2;HEL: 8.0;RPTEC TERT1: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA027067	Approved					NA	NA					"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.5	6.5	2.1	0.5	10.4	0.2	0.4	0.4	19.7	4.0	0.5	0.0	1.1	0.3	9.0	1.6	0.5	1.3	1.2	0.4	2.0	1.7	2.9	2.1	5.1	0.7	0.8	12.4	0.8	0.6	0.2	0.6	12.2	0.0	1.0	0.3	0.6	0.4	4.2	0.4	0.4	0.9	1.3	0.4	0.6	0.6	0.6	0.0	0.0	2.4	0.0	0.6	0.5	2.2	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.1	10.4	0.4	18.5	2.0	1.7	0.8	12.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.1	0.0	0.0	0.0
RXFP2	"GPR106, GREAT, INSL3R, LGR8, RXFPR2"	ENSG00000133105	"Relaxin/insulin like family peptide receptor 2"	Q8WXD0	13	31739542-31803388	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.3;epididymis: 28.4"	"Cell type enriched"	"Detected in single"	32	"Early spermatids: 5.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.3"	"Cell type enriched"	"Detected in single"	11	"classical monocyte: 5.0"	"Lineage enriched"	"Detected in single"	23	"monocytes: 5.0"	"Group enriched"	"Detected in some"	6	"U-2197: 2.1;U-87 MG: 4.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.0"							NA	NA																					"unprognostic (1.77e-2)"		0.5	3.3	1.5	0.1	8.3	2.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	28.4	0.0	1.5	0.1	0.5	0.6	0.5	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	0.0	0.2	0.0	3.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.5	8.3	0.0	0.5	0.6	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAG	"ARRESTIN, RP47"	ENSG00000130561	"S-antigen visual arrestin"	P10523	2	233307816-233347055	"Disease related genes, Predicted intracellular proteins"			"Congenital stationary night blindness, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"retina: 215.8"	"Cell type enriched"	"Detected in some"	6	"Rod photoreceptor cells: 5320.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004946	Enhanced					NA	NA					"HPA004946: AB_2667304"	"unprognostic (4.76e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.95e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.12e-9)"	"unprognostic (2.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-5)"	0.0	0.0	0.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	215.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	490.5	0.8	0.0	0.0	0.0	0.0	818.8	1.4	0.0	0.0	32.2	0.4	0.6	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.1	319.4	0.0	0.0	1.9	85.0	0.9	0.3	0.0	0.0	0.0	667.1	0.0	0.0	0.0	0.0	5320.5	12.9	0.5	1.5	1.1	0.5	0.3	1.0	0.0	1.3
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell type enriched"	"Detected in some"	11	"Suprabasal keratinocytes: 889.6"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5"					"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	NA	NA		62000000	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.2	35.2	0.0	1.6	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	47.6	2.6	9.5	2.3	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	5.9	1.2	16.3	0.4	0.1	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	79.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	13.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	889.6	0.2	0.0	0.0	0.1
SCGB1D2	"LIPB, LPHB"	ENSG00000124935	"Secretoglobin family 1D member 2"	O95969	11	62242210-62244808	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 101.5;cervix, uterine: 315.2"	"Cell type enriched"	"Detected in some"	25	"Melanocytes: 781.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 625.1;endometrial cancer: 226.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 14.7"									HPA035318	Approved				"Secreted in other tissues"	NA	NA					"HPA035318: AB_10610421"	"unprognostic (8.76e-2)"	"unprognostic (2.14e-1)"		"prognostic favorable (3.46e-6)"	"unprognostic (2.39e-2)"				"unprognostic (5.89e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.43e-2)"	"prognostic favorable (8.03e-6)"		"unprognostic (1.55e-1)"	"unprognostic (1.15e-2)"		1.8	0.4	0.8	0.2	0.6	0.0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0.0	18.4	43.8	0.8	8.5	0.4	1.0	1.2	0.4	1.1	0.2	0.2	0.2	1.0	0.5	1.1	2.9	0.0	1.0	0.6	7.3	1.1	0.0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0.0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.7	0.2	0.0	2.5	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.9	0.5	1.2	0.4	1.0	0.5	7.3	0.5	0.0	0.0	0.0	5.0	24.4	0.5	6.5	0.0	0.0	0.0	7.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	31.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	781.1	0.0	0.0	17.0	0.0	0.0	0.0	13.2	0.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	1.0
SCGB3A2	"LU103, PNSP1, UGRP1"	ENSG00000164265	"Secretoglobin family 3A member 2"	Q96PL1	5	147870682-147882191	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 248.0"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 3186.5;Club cells: 12064.6"	"Cancer enriched"	"Detected in some"	10	"lung cancer: 211.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Cell type enriched"	"Detected in single"	40	"basophil: 30.1"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 30.1"	"Cell line enhanced"	"Detected in some"		"A-431: 22.2;EFO-21: 13.9;NTERA-2: 15.9;PC-3: 78.6;SuSa: 33.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (3.85e-1)"	"unprognostic (1.77e-1)"			"unprognostic (2.99e-2)"	"unprognostic (3.51e-2)"		"unprognostic (1.84e-2)"		"unprognostic (3.17e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.90e-8)"	"unprognostic (9.31e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.11e-2)"	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	248.0	0.1	0.1	0.1	0.1	0.3	0.0	0.6	0.1	1.0	0.1	0.0	0.1	1.7	0.4	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.2	0.3	30.1	0.5	0.7	0.2	0.0	22.2	0.3	0.3	0.5	0.3	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.3	0.1	13.9	0.0	0.2	0.2	0.6	0.3	0.1	0.0	0.4	0.8	2.4	0.0	0.0	0.1	0.8	0.3	0.2	0.1	0.0	0.5	0.0	0.0	0.6	0.3	0.0	0.4	0.2	0.2	15.9	0.0	78.6	0.0	0.2	0.0	0.3	0.1	1.1	0.3	3.1	0.3	0.0	33.3	0.3	0.1	0.4	0.3	9.3	0.4	0.3	0.4	0.3	0.1	0.1	0.3	1.0	30.1	0.5	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.1	574.7	3186.5	0.0	0.0	0.0	0.0	0.0	0.0	1145.6	12064.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	97.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell type enriched"	"Detected in some"	6	"Intestinal endocrine cells: 576.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.6"	"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA			Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	99.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.0	0.3	0.1	0.0	4.7	0.0	0.0	0.1	0.0	576.5	1.8	0.0	0.0	0.6	0.0	0.0	1.8	2.8	0.0	7.8	2.9	0.0	2.2	0.0	12.9	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 alpha subunit"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.4"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 108.2;Mucus-secreting cells: 167.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA					"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	0.9	3.7	0.4	7.5	0.4	0.0	10.1	0.4	0.9	22.0	20.6	2.2	60.9	5.6	8.1	15.7	47.3	19.3	7.0	0.4	1.1	0.1	100.4	2.2	53.6	0.4	0.5	0.4	5.9	14.2	0.0	10.2	1.6	9.4	15.0	21.5	6.2	53.1	55.5	0.6	14.4	11.8	1.0	0.4	0.4	20.3	2.8	0.4	0.9	74.7	21.1	41.3	10.3	13.8	0.0	3.0	4.4	0.5	0.0	1.7	0.3	5.0	0.9	0.0	0.4	0.0	0.1	4.3	0.0	0.0	0.0	0.0	1.4	71.8	0.0	0.1	0.0	0.0	3.3	0.0	48.2	0.0	0.0	0.0	0.0	4.0	0.7	5.2	0.0	0.0	1.2	20.7	0.0	15.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	4.2	9.1	0.1	0.0	0.0	0.1	25.2	27.0	0.3	0.0	0.5	23.3	0.0	4.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.0	0.0	0.2	0.6	0.5	0.0	1.7	0.3	4.4	0.0	0.1	3.0	1.3	0.3	0.4	0.4	0.4	0.9	1.1	0.1	0.5	0.4	9.4	0.4	68.5	63.0	0.0	21.9	1.6	0.8	0.8	68.8	26.8	47.8	108.2	3.9	1.2	5.0	41.1	0.4	1.4	57.4	0.0	30.8	0.2	2.4	31.3	2.3	2.4	0.3	1.6	26.0	0.6	1.9	0.2	1.7	2.1	0.0	1.8	167.5	0.3	24.0	47.5	1.4	4.2	1.6	0.0	1.0	1.4	2.1	7.8	1.4	1.9	31.6	33.3
SCNN1B	ENaCbeta	ENSG00000168447	"Sodium channel epithelial 1 beta subunit"	P51168	16	23278231-23381299	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 92.3;Club cells: 66.0;Collecting duct cells: 54.1;Enterocytes: 54.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 26.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 19.4;RT4: 10.4;U-266/70: 32.0;U-266/84: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015612	Uncertain					NA	NA					"HPA015612: AB_1856629"	"unprognostic (7.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.74e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.32e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-2)"	35.1	0.2	0.1	4.0	0.2	0.0	21.2	1.1	0.1	28.3	27.2	0.0	1.3	1.3	2.9	2.5	42.4	1.3	3.3	0.6	0.0	0.0	13.0	0.0	31.1	1.3	0.0	0.0	2.0	0.8	0.3	1.6	25.2	0.3	5.7	19.7	0.5	29.7	2.4	3.9	13.2	1.7	4.2	0.1	1.9	8.9	1.6	0.0	0.6	16.2	17.8	15.5	5.6	19.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	4.9	0.0	10.4	0.1	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	92.3	27.0	2.2	14.0	2.7	0.0	0.8	0.0	10.7	66.0	54.1	0.0	0.7	0.0	0.0	0.0	0.7	54.8	0.0	0.4	0.2	0.2	4.3	8.1	0.0	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	10.1	0.0	7.9	0.0	0.2	9.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	4.6	1.8	0.0	7.6	17.0
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 31.4;RT4: 14.2"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0	17.9	3.4	0.0	4.0	0.3	0.0	0.8	0.0	2.7	21.6	85.5	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4
SCRT2	ZNF898B	ENSG00000215397	"Scratch family transcriptional repressor 2"	Q9NQ03	20	661596-676179	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.9;retina: 6.1"	"Cell type enriched"	"Detected in some"	51	"Horizontal cells: 57.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.0"	"Group enriched"	"Detected in many"	4	"cerebellum: 8.8;cerebral cortex: 17.9"	"Cell type enriched"	"Detected in single"	25	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.4"	"Group enriched"	"Detected in some"	5	"Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA067697			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067697: AB_2685890"					"unprognostic (9.71e-2)"					"unprognostic (2.03e-1)"	"unprognostic (6.97e-2)"			"unprognostic (9.70e-2)"	"unprognostic (1.70e-1)"			0.3	0.3	0.7	0.3	0.7	0.3	0.3	8.8	17.9	0.3	0.3	0.6	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.6	0.3	0.3	0.3	0.3	1.9	0.0	0.3	1.3	0.3	0.0	0.4	3.2	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.6	0.3	0.7	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	8.1	0.0	0.0	3.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	8.8	17.9	0.7	0.6	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747427-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 48.0"	"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 45.9"	"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9"	"Group enriched"	"Detected in many"	4	"B-cells: 20.8;dendritic cells: 17.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 65.9;OE19: 49.9;U-698: 43.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 191.0"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	5.4	3.3	4.0	36.3	5.6	2.3	3.8	45.9	6.4	13.7	19.3	1.5	1.5	19.3	2.2	18.1	6.2	3.6	22.0	2.4	3.3	2.8	6.9	3.6	14.3	27.7	2.1	1.7	3.1	48.0	10.9	2.9	13.7	3.0	4.2	16.7	12.9	23.1	1.0	1.3	1.7	30.3	3.4	2.1	33.5	24.6	2.2	1.1	2.8	12.5	3.8	46.7	14.8	2.2	20.8	17.9	0.4	0.1	3.7	4.3	1.4	4.8	5.3	3.9	1.3	0.6	0.8	0.6	2.4	6.6	1.8	6.0	3.3	22.7	65.9	11.7	16.6	15.9	3.1	2.9	10.5	2.5	3.5	1.7	0.7	8.8	4.5	17.1	9.0	0.4	1.3	8.5	6.6	2.6	7.5	24.8	1.3	4.3	0.0	1.3	3.7	0.0	0.6	11.4	49.9	4.7	0.3	21.7	9.1	14.5	16.4	9.8	1.9	16.1	0.2	1.6	5.7	0.8	11.2	10.8	0.1	7.9	0.1	6.9	0.4	0.1	43.0	30.0	3.8	4.5	0.4	0.1	0.0	2.8	0.0	3.4	20.8	3.5	3.1	0.7	20.8	1.5	2.4	0.3	3.7	0.1	17.9	4.3	1.4	4.0	5.6	45.9	6.4	3.3	2.8	2.1	1.7	3.0	1.1	11.9	29.0	65.6	3.0	0.8	2.1	1.2	63.7	8.1	55.7	3.5	0.0	23.3	0.0	64.6	46.5	8.4	31.3	23.3	28.5	1.3	1.5	12.0	2.3	1.7	4.6	0.0	11.1	13.5	16.0	58.1	1.4	6.4	8.5	15.4	74.5	32.9	37.4	24.6	0.4	9.7	29.0	0.0	1.4	0.6	2.4	1.4	13.7	26.1	35.6	4.2
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722641-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 50.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 41.0;Endothelial cells: 101.9;Melanocytes: 43.9;Suprabasal keratinocytes: 41.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 5.3"	"Not detected"	"Not detected"							CAB002143	Enhanced					NA	NA	8140000	640000000			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	14.9	2.7	0.9	30.4	1.2	0.2	8.3	0.3	1.0	13.7	2.7	1.9	4.4	0.4	18.1	3.2	6.7	20.1	7.4	4.4	0.9	0.9	2.5	4.9	10.6	2.0	1.2	0.0	9.8	1.4	21.0	3.1	0.9	5.4	21.2	1.9	4.3	2.0	4.6	2.2	3.7	2.4	13.1	4.8	0.2	3.4	5.6	0.5	0.9	9.0	50.0	15.5	16.4	4.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.9	1.2	0.3	1.0	0.9	0.9	1.2	0.0	5.4	0.5	0.0	6.7	0.0	1.0	41.0	0.0	5.0	2.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	101.9	0.0	0.0	0.0	0.0	12.4	3.2	1.1	5.9	0.0	0.0	0.0	1.8	0.0	1.6	0.0	0.2	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.0	41.8	0.0	0.0	0.0	0.6
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	NA	NA		77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	4.6	5.0	5.4	2.6	0.0	0.0	0.0	1.4	17.0	0.1	17.3	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	6.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	4.5	1.2	5.5	4.0	1.7	0.0	0.1	0.6	0.0	0.0	0.2	8.9	0.2	0.0	26.5	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5	0.0	3.5	0.8	2.3	3.2	1.5	0.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	137.5	5.2	0.0	0.0	0.2	0.0	6.7	7.1	2.3	0.0	0.9	1.6	25.4	1.8	0.0	14.9	48.6	0.8	11.8	0.0	0.0	0.9	0.0	0.0	58.7	4.5	4.1	0.0	2.1	0.7	0.7	2.0	0.0	0.0	0.1	0.4
SEPT12	FLJ25410	ENSG00000140623	"Septin 12"	Q8IYM1	16	4777669-4788521	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 99.8"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 274.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enriched"	"Detected in single"	8	"cerebellum: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.6;SCLC-21H: 1.3;SK-BR-3: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041128			Uncertain	Microtubules		NA	NA			Microtubules		"HPA041128: AB_10796568"	"unprognostic (2.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.45e-2)"		"unprognostic (7.40e-2)"		"unprognostic (1.39e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-8)"	"unprognostic (7.41e-2)"	"unprognostic (9.87e-2)"		"unprognostic (8.36e-3)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	99.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	274.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	1.0	0.0	0.0	56.9	1.5	0.0	0.1	0.0	0.0	0.0
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1761959-1777574	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 360.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 695.7;Fibroblasts: 677.8;Hepatocytes: 664.1;Leydig cells: 1683.3;Peritubular cells: 982.9;Syncytiotrophoblasts: 447.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 105.5"	"Cell type enriched"	"Detected in some"	18	"plasmacytoid DC: 143.3"	"Lineage enriched"	"Detected in many"	119	"dendritic cells: 143.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.2;ASC TERT1: 96.9;Hep G2: 56.6;HHSteC: 41.5;HSkMC: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	85000000000			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	70.0	7.5	2.3	15.1	4.5	1.1	61.6	0.7	13.9	84.1	16.4	20.8	14.8	5.0	48.9	71.9	24.3	75.3	66.8	50.3	11.6	1.9	6.9	190.1	20.1	30.6	1.9	5.9	68.1	54.7	0.6	11.0	38.6	105.5	53.2	6.5	360.1	17.8	14.2	51.4	21.5	15.7	27.6	2.4	21.2	17.8	86.3	1.4	6.0	27.4	38.5	14.6	32.1	37.9	0.8	143.3	0.1	1.2	0.1	0.5	1.3	0.0	0.4	0.3	0.2	124.2	96.9	2.0	5.8	4.8	0.0	0.0	1.0	0.0	0.2	0.2	6.8	0.0	0.3	8.2	0.4	0.0	0.0	4.4	0.1	0.0	56.6	41.5	0.1	0.1	131.8	0.7	0.1	0.1	1.1	0.0	0.4	11.6	0.0	6.0	0.0	0.7	0.7	3.2	0.0	0.1	0.3	22.8	0.1	0.0	0.6	0.1	4.2	0.0	0.0	5.8	0.3	0.7	17.4	0.2	0.0	1.9	1.4	0.1	0.0	0.2	2.9	0.1	0.1	0.0	0.0	1.2	0.1	0.0	0.4	0.0	0.8	0.0	0.1	7.9	0.4	0.2	0.5	0.1	0.1	0.0	143.3	0.0	1.3	2.3	4.5	0.7	13.9	11.6	1.9	1.9	5.9	105.5	1.4	3.0	7.2	12.3	167.2	84.3	39.9	7.8	10.2	101.7	131.9	1.8	210.1	695.7	0.0	0.3	9.0	23.3	0.0	23.3	21.6	72.9	677.8	14.0	23.0	664.1	130.4	3.2	0.0	36.2	38.0	21.6	1683.3	71.6	102.9	131.7	0.0	6.1	9.4	0.0	982.9	12.9	32.6	19.4	143.0	6.5	5.6	68.6	447.3	7.5	0.0	47.8
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36673912-36697839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 8.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Group enriched"	"Detected in many"	7	"amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		5.0	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2.0	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1.0	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0.0	0.0	9.3	0.0	0.5	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	10.1	0.3	21.6	26.5	2.0	1.5	11.6	2.4	0.0	8.9	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell type enriched"	"Detected in some"	15	"Cholangiocytes: 226.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 16.3;RPMI-8226: 5.8;SCLC-21H: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	5.8	0.0	0.0	2.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3	3.0	2.2	0.0	0.0	0.0	0.2	6.7	226.7	0.0	1.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	15.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	1.7	0.0	0.0	1.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	6.1	0.0	0.0	0.0	0.0	0.0
SFTA3	"NANCI, SFTPH"	ENSG00000229415	"Surfactant associated 3"	P0C7M3	14	36473288-36513829	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	16	"lung: 45.2;thyroid gland: 55.4"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 321.6;Alveolar cells type 2: 451.3;Club cells: 171.8"	"Group enriched"	"Detected in some"	238	"lung cancer: 18.4;thyroid cancer: 52.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	173	"SCLC-21H: 21.5"														"Secreted in other tissues"	NA	NA													"prognostic favorable (8.29e-4)"				"unprognostic (3.95e-1)"				"unprognostic (3.21e-3)"		0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	45.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	321.6	451.3	0.0	0.0	0.0	0.0	0.0	0.0	53.5	171.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.0	0.0
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"lung: 757.8"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 1: 3391.6;Alveolar cells type 2: 11695.8;Club cells: 3546.5"	"Group enriched"	"Detected in many"	149	"lung cancer: 1306.7;thyroid cancer: 270.2"	"Region enriched"	"Detected in single"	17	"pons and medulla: 2.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;NB-4: 5.6;U-2197: 11.5;U-266/70: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"	NA	NA		71000000			"CAB002440: AB_564142, HPA034820: AB_2674347, HPA062148: AB_2684697"	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	757.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	1.1	1.4	2.6	4.1	0.8	1.5	1.2	0.2	0.4	0.4	0.8	0.5	0.9	4.9	0.4	0.3	0.1	0.1	0.5	1.1	0.2	0.4	0.1	0.5	3.3	0.4	0.1	0.1	0.6	0.4	0.5	1.1	0.4	0.1	0.2	2.4	0.0	0.5	0.3	0.2	0.9	0.0	0.7	0.4	0.8	0.2	0.5	1.8	5.6	2.7	0.8	0.7	2.1	0.4	0.5	0.3	0.5	0.7	0.5	0.1	0.8	0.3	0.6	0.6	0.5	0.1	0.3	1.1	11.5	0.2	4.2	0.9	0.3	1.0	0.8	0.2	0.9	2.5	0.8	0.9	4.1	0.7	1.0	1.0	0.8	1.4	1.1	1.4	0.8	2.6	0.8	2.5	0.7	1.5	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	3391.6	11695.8	0.0	0.1	0.0	0.0	0.4	0.0	341.3	3546.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	241.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SGCA	"A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1"	ENSG00000108823	"Sarcoglycan alpha"	Q16586	17	50164214-50175931	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.7"	"Cell type enhanced"	"Detected in many"	27	"Cardiomyocytes: 113.3;Early spermatids: 135.9;Late spermatids: 458.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.0"	"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.4;memory B-cell: 5.3;myeloid DC: 3.8;naive B-cell: 5.2;non-classical monocyte: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 5.3;dendritic cells: 3.8;monocytes: 3.1"	"Cell line enriched"	"Detected in some"	15	"LHCN-M2: 42.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007537	Uncertain				"Intracellular and membrane"	NA	NA					"HPA007537: AB_1079944"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.15e-2)"	2.8	0.6	0.1	2.5	0.2	0.2	0.8	3.0	0.4	6.8	10.0	0.0	8.6	1.6	7.9	10.5	10.8	3.4	10.7	32.2	0.2	0.1	0.6	0.9	5.7	0.3	0.2	0.3	3.4	0.5	0.2	0.1	1.9	0.4	10.9	1.1	7.1	2.3	8.0	144.7	2.6	3.0	30.3	0.3	0.7	5.7	1.4	0.0	0.0	1.6	39.8	2.3	20.1	4.3	5.3	3.8	0.2	3.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.2	0.0	2.4	0.0	5.3	0.0	0.0	3.8	5.2	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.7	0.1	0.2	3.0	0.1	0.2	0.1	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	7.7	0.0	113.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	135.9	2.1	0.0	0.0	5.2	0.1	41.4	0.2	0.0	0.0	0.5	0.0	0.0	1.8	0.0	458.2	2.8	1.4	8.5	0.0	0.0	0.0	2.4	0.0	3.5	1.4	0.0	12.9	49.5	2.1	1.5	8.7	0.2	0.0	0.0	0.1
SGCZ	ZSG1	ENSG00000185053	"Sarcoglycan zeta"	Q96LD1	8	14089864-15238339	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.2;ovary: 11.3;pituitary gland: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;REH: 2.5"	"Low region specificity"	"Detected in many"							HPA017585	Uncertain					NA	NA					"HPA017585: AB_1856799"					"unprognostic (3.83e-1)"						"unprognostic (1.41e-1)"			"unprognostic (5.87e-4)"	"unprognostic (1.21e-1)"			1.1	0.4	5.6	0.5	9.5	0.6	2.6	21.2	6.8	0.8	0.7	0.0	0.0	0.7	0.9	1.4	0.4	0.5	0.7	0.5	1.4	2.2	1.0	0.7	0.4	0.4	1.3	2.3	11.3	0.7	0.4	7.3	0.5	5.3	0.8	0.5	0.1	0.4	0.6	0.4	0.9	0.5	0.9	3.2	0.5	0.7	1.4	1.1	0.0	0.4	0.0	0.5	1.5	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	9.5	21.2	6.8	1.4	2.2	1.3	2.3	5.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SGMS2	"MGC26963, SMS2"	ENSG00000164023	"Sphingomyelin synthase 2"	Q8NHU3	4	107824563-107915047	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 144.6;Ciliated cells: 116.4;Club cells: 131.9;Urothelial cells: 179.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"pons and medulla: 17.0"	"Group enriched"	"Detected in some"	8	"classical monocyte: 5.7;eosinophil: 3.9;intermediate monocyte: 2.4;myeloid DC: 6.6;non-classical monocyte: 2.0"	"Group enriched"	"Detected in many"	32	"dendritic cells: 6.6;granulocytes: 3.9;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA015076	Supported					NA	NA					"HPA015076: AB_1857298"	"unprognostic (7.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (6.18e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.22e-3)"	7.5	3.3	1.9	8.6	2.9	2.1	8.0	1.7	1.9	8.3	22.2	3.4	5.6	11.4	12.5	9.7	14.9	7.5	24.9	7.8	2.5	2.6	13.2	12.6	20.7	6.4	2.7	1.4	5.4	8.4	4.6	48.5	30.7	17.0	8.0	6.4	11.8	14.2	3.2	5.0	4.5	38.1	18.5	4.6	1.5	9.8	8.6	1.0	0.2	22.0	12.2	5.3	10.7	11.2	0.1	6.6	3.9	5.7	0.0	0.1	1.4	10.0	3.8	0.6	2.9	6.7	15.6	0.2	12.4	9.4	5.9	6.2	1.7	21.0	0.7	4.9	19.7	5.1	3.8	7.2	10.9	10.6	2.8	2.8	0.4	8.5	0.6	7.7	6.8	0.0	5.4	7.7	11.5	14.0	12.4	13.0	0.1	0.1	0.2	9.3	3.4	0.2	0.0	0.3	5.9	4.3	0.2	5.0	1.4	15.7	4.9	1.0	0.0	9.5	13.6	1.6	1.6	7.3	0.1	22.1	7.1	11.2	10.1	5.7	0.7	0.2	0.4	9.5	1.6	2.9	0.0	5.7	3.9	0.0	2.4	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.0	0.5	0.0	2.0	0.0	0.0	1.4	1.9	2.9	1.7	1.9	2.5	2.6	2.7	1.4	17.0	1.0	80.4	97.5	2.7	144.6	49.7	0.4	17.1	28.1	116.4	131.9	15.7	0.0	0.8	3.3	16.4	47.7	9.0	30.7	0.0	16.7	0.6	20.1	102.6	9.3	20.2	5.9	1.6	8.5	4.9	31.9	5.9	2.3	23.7	8.5	1.0	19.0	0.0	26.8	38.6	0.4	9.1	0.0	0.0	30.9	0.5	2.8	63.7	11.6	1.3	9.3	179.5
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7204.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.2	2.8	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.1	0.8	34.6	9.5	0.0	5.4	0.4	15.3	9.5	0.0	11.2	2.0	0.1	0.1	0.0	4.1	4.6	0.6	0.0	0.0	0.1	6.0	3.2	7.6	17.2	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.8	8.5	0.7	0.0	0.1	0.0	4.4	1.0	0.0	0.0	0.6	0.2	0.2	0.5	3.3	0.0	4.9	0.4	8.9	0.7	3.3	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0.0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0.0	0.0	0.0	6.5	1412.5	1.5	27.7	0.0	7.6	0.0	0.5	1.3	1.1	8.3	0.2	0.0	1.2	0.6	0.0	7204.3	23.9	0.0	8.5	1.0	12.2	1.9	13.6	17.5	32.5	0.6	0.0	12.9	1.4	32.0	16.2	43.7	0.0	0.0	27.1	6.4
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178767	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 2: 16.0;Bipolar cells: 7.0;Muller glia cells: 6.1"	"Cancer enhanced"	"Detected in some"		"glioma: 5.1"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7"	"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 17.1;hTERT-RPE1: 18.9;RT4: 6.3;SH-SY5Y: 6.3;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.6	10.8	15.7	0.8	20.8	0.5	1.8	0.8	35.1	7.3	1.2	2.3	0.0	1.1	1.5	1.7	1.5	2.2	2.7	1.0	14.2	4.7	1.4	0.6	6.0	0.8	3.1	24.7	0.7	4.4	10.4	1.0	0.8	5.2	1.5	1.4	0.0	6.4	1.4	0.9	1.8	0.9	1.8	1.5	0.6	0.8	1.0	1.3	0.0	1.3	0.0	0.8	1.7	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	17.1	0.0	3.8	1.2	0.0	1.2	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.2	0.0	2.6	0.0	1.7	0.0	18.9	4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	2.2	0.2	0.2	0.2	0.0	3.5	3.7	6.3	2.3	6.3	0.4	0.0	0.0	0.1	0.0	0.3	2.6	0.7	0.1	1.0	0.1	0.0	0.0	0.0	9.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	20.8	0.8	31.5	14.2	4.7	3.1	24.7	5.2	1.3	0.0	16.0	0.0	0.2	0.1	7.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	0.0	0.8	0.1	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.9	1.4	0.0	1.7	0.0	0.0	6.1	0.1	0.0	3.5	0.3	0.4	0.0	0.8	0.2	0.1	0.5	0.3	0.0	0.0	0.9
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 84.3"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 84.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.7;SH-SY5Y: 22.6"	"Region enriched"	"Detected in all"	5	"cerebellum: 269.9"					HPA057381			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057381: AB_2683423"	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	2.9	19.3	6.9	3.3	10.4	0.6	3.3	84.3	14.5	7.3	6.3	3.9	2.2	10.5	8.5	4.0	4.1	6.2	5.3	4.5	5.9	7.2	1.8	18.9	2.9	1.8	4.5	6.7	20.5	2.5	2.5	3.5	1.5	7.1	5.3	4.4	6.3	5.3	5.2	2.6	6.5	7.9	6.3	5.2	2.3	2.9	4.1	3.2	1.6	4.9	2.4	1.8	5.8	5.5	3.3	2.6	2.5	1.9	5.1	4.2	1.5	0.0	0.6	10.0	0.3	0.7	0.4	4.7	1.2	0.8	2.8	4.0	1.4	4.7	0.5	4.0	1.7	2.7	0.8	3.8	0.3	1.3	0.8	1.7	0.3	0.9	9.8	0.4	0.0	3.3	0.9	0.2	0.3	0.0	2.1	2.1	4.9	1.9	0.2	3.9	1.6	2.1	0.3	3.9	1.8	0.2	6.0	7.9	0.2	0.9	0.2	50.7	22.6	0.3	0.3	0.2	3.2	0.5	0.9	0.1	0.3	4.3	0.3	0.1	0.4	0.3	0.4	0.1	0.2	1.5	0.3	1.9	1.2	3.8	1.7	4.2	2.4	1.6	2.4	1.8	3.3	2.2	1.7	2.5	5.1	1.7	2.6	0.3	1.5	6.9	10.4	84.3	12.1	5.9	7.2	4.5	6.7	7.1	3.2	0.0	1.1	0.0	4.9	3.2	46.9	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.9	6.1	3.7	4.2	0.0	1.1	0.4	3.0	2.5	2.3	9.7	0.6	9.5	12.5	3.7	1.0	9.8	4.0	2.8	8.5	0.0	8.6	5.7	0.5	5.8	3.9	1.0	4.5	6.5	5.0	4.7	2.7	2.3	0.6	0.7	4.5	7.1
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 42.2"	"Cell type enriched"	"Detected in some"	114	"Horizontal cells: 451.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	15	"cerebellum: 42.2"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"	"Cell line enriched"	"Detected in some"	7	"HEK 293: 20.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 8.7;olfactory region: 19.4"	"Group enriched"	"Detected in all"	4	"cerebellum: 61.4;olfactory region: 45.2"	HPA059173	Uncertain					NA	NA					"HPA059173: AB_2683938"	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.1	9.4	0.5	1.6	0.5	0.2	0.1	42.2	2.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.3	0.5	0.2	0.2	0.1	0.1	3.0	0.3	1.7	0.1	0.1	0.1	0.8	0.0	2.2	0.2	0.0	1.5	1.8	0.2	0.8	0.5	0.8	0.0	0.3	2.7	0.7	0.2	0.0	0.0	0.1	0.0	3.8	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	42.2	2.7	0.5	0.2	0.3	1.7	2.2	0.0	0.0	0.0	2.7	0.0	0.0	4.0	3.6	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	451.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.9	1.9	0.0	0.0	0.0	0.0	0.0
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633344-52669683	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 10.8;lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in single"	26	"Hofbauer cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.8;NK-cells: 5.7;T-cells: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.4;Karpas-707: 13.0;NB-4: 3.7;RPMI-8226: 17.1"	"Region enhanced"	"Detected in single"		"hypothalamus: 4.7"	"Low region specificity"	"Detected in many"			HPA030744	Uncertain					NA	NA					"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"	0.6	0.4	1.0	25.4	1.4	3.5	0.5	1.3	2.0	1.3	1.2	1.2	0.0	1.0	1.1	1.9	1.0	0.9	1.3	0.3	0.9	8.8	0.8	0.4	1.2	20.4	2.8	0.2	0.2	0.7	0.0	3.2	0.5	1.2	0.7	0.9	0.6	3.7	1.0	0.7	0.2	5.7	0.6	2.1	12.1	1.2	1.2	0.7	3.5	1.3	0.3	24.0	3.2	0.4	10.8	0.1	1.9	0.0	5.7	7.9	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	3.7	2.2	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.5	0.0	1.1	0.0	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	7.9	0.0	4.5	10.7	7.2	6.4	0.1	10.8	5.0	3.1	0.0	5.7	0.0	0.1	2.2	1.8	1.0	1.4	1.3	2.0	0.9	8.8	2.8	0.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SHISAL2B	FAM159B	ENSG00000145642	"Shisa like 2B"	A6NKW6	5	64690308-64718090	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 7.3;pancreas: 16.1;stomach 1: 7.7"	"Cell type enriched"	"Detected in single"	16	"Pancreatic endocrine cells: 1.6"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 3.9"	"Group enriched"	"Detected in some"	14	"basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 5.9;RPTEC TERT1: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011778	Enhanced					NA	NA					"HPA011778: AB_1848382"	"unprognostic (5.83e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.25e-1)"	"unprognostic (5.01e-2)"		"unprognostic (1.49e-1)"		"unprognostic (9.12e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.36e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.60e-1)"	"unprognostic (6.99e-2)"	0.1	0.0	0.3	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.3	0.2	0.0	0.2	0.0	0.2	0.0	0.2	16.1	0.0	0.1	0.5	4.9	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.6	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	12.4	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.3	7.3	0.2	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"BJ: 19.5;BJ hTERT+: 9.0"									"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.5	9.0	2.9	3.2	0.3	0.3	0.3	0.1	0.4	0.8	0.3	0.2	0.0	1.0	0.2	0.1	0.1	1.3	0.1	0.1	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.6	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
SHOX2	"OG12, OG12X, SHOT"	ENSG00000168779	"Short stature homeobox 2"	O60902	3	158095954-158106503	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 89.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"pons and medulla: 10.1;thalamus: 2.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;SH-SY5Y: 15.0;THP-1: 24.8"	"Group enriched"	"Detected in some"	5	"midbrain: 43.1;thalamus: 60.0"	"Group enriched"	"Detected in some"	36	"midbrain: 13.2;pons and medulla: 15.8;thalamus: 28.2"							NA	NA						"unprognostic (2.62e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.28e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.75e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	10.0	0.3	0.1	0.1	0.1	0.4	6.6	0.1	0.2	10.0	0.5	3.0	2.8	0.0	1.1	1.4	2.5	0.2	0.6	9.9	0.1	1.5	0.1	0.2	0.4	4.1	0.4	0.1	1.0	1.5	0.0	0.4	1.3	10.1	1.5	0.1	0.3	2.8	1.1	3.6	2.5	0.3	1.3	0.3	0.1	0.3	4.4	2.9	0.0	0.7	2.4	1.1	1.7	4.6	0.3	0.0	2.9	0.7	0.0	0.1	0.0	3.2	0.3	0.1	5.3	15.5	9.7	0.9	5.9	2.1	2.9	5.5	1.1	0.4	0.7	0.1	7.6	6.3	0.1	6.2	0.0	1.2	3.6	1.9	8.9	1.3	0.0	0.0	0.7	7.3	4.4	0.1	2.9	0.3	9.5	0.0	0.4	2.4	0.5	1.4	0.2	0.0	0.4	0.0	0.0	0.2	3.7	4.9	0.8	0.0	0.0	1.8	15.0	0.7	0.1	3.2	0.1	0.1	24.8	0.3	9.7	2.1	10.7	9.4	0.7	1.6	0.5	9.3	4.9	9.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	1.5	0.4	0.1	10.1	2.9	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.3	0.1	0.0	0.0	0.2	0.6	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	4.7	5.5	1.4	0.4	0.2	0.0	0.0	0.0
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 19.2;Distal tubular cells: 6.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.0;BJ: 12.8;BJ hTERT+: 18.7;BJ hTERT+ SV40 Large T+: 5.8;HDLM-2: 5.5;RPTEC TERT1: 14.7"	"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	8.0	0.0	12.8	18.7	5.8	5.4	0.0	0.0	0.0	0.0	4.0	1.2	0.0	0.0	0.0	4.9	5.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	19.2	0.0	0.0	6.6	3.0	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	1.6	0.0	0.4	0.0	0.0	0.0	0.0
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in some"	19	"Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.9	0.2	11.9	6.9	8.1	0.1	2.0	4.5	2.3	2.0	0.0	3.8	0.0	1.1	0.4	1.1	2.7	3.9	3.6	0.8	0.0	9.5	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.8	1.6	0.3	14.3	0.1	0.7	2.6	0.0	53.4	1.3	0.0	0.2	0.0	0.0	4.8	0.0	29.2	0.0	2.3	6.5	1.1	0.1	2.3	0.1	2.4	0.2	1.4	0.2	6.8	3.2	3.2	3.7	3.0	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0	3.0	1.0	0.0	23.3	0.1	0.0	0.8	0.0	65.6	33.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.8	24.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.1	0.0	0.3	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	14.9
SIX3	HPE2	ENSG00000138083	"SIX homeobox 3"	O95343	2	44941898-44946077	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 40.2;parathyroid gland: 32.1;pituitary gland: 30.9;retina: 66.5"	"Group enriched"	"Detected in some"	18	"Bipolar cells: 197.9;Horizontal cells: 174.8;Muller glia cells: 357.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 40.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 34.3;SCLC-21H: 31.9;SH-SY5Y: 12.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 38.7"	HPA067988			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067988: AB_2685939"	"unprognostic (1.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-2)"		"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.73e-2)"	0.4	0.4	3.7	0.5	40.2	0.5	0.5	0.7	0.7	1.5	0.4	1.5	0.0	0.5	0.4	0.4	0.5	0.4	0.5	0.4	1.6	7.2	0.4	0.4	0.5	0.5	1.1	2.7	0.4	1.0	32.1	30.9	0.4	0.1	0.4	0.4	66.5	0.4	0.4	1.1	0.5	0.4	0.4	0.0	0.4	0.5	0.8	6.5	0.0	0.4	0.0	0.4	0.4	0.0	1.1	1.1	4.5	2.2	1.9	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.3	0.0	5.9	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.3	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	31.9	12.7	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.6	1.2	1.0	1.1	1.7	1.1	1.1	0.8	0.8	1.1	1.3	1.4	1.7	1.9	2.2	1.1	1.3	0.7	3.7	40.2	0.7	0.7	1.6	7.2	1.1	2.7	0.1	6.5	0.0	0.0	0.0	0.0	0.0	197.9	0.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	174.8	1.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	357.8	0.0	0.0	0.0	0.6	13.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60508951-60512850	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cataract, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 43.3"	"Cell type enhanced"	"Detected in some"	33	"Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Region enriched"	"Detected in single"	8	"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 9.3;MOLT-4: 29.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"hypothalamus: 2.5"	HPA001403	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.4	0.0	10.6	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	29.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.8	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SKA1	"C18orf24, MGC10200"	ENSG00000154839	"Spindle and kinetochore associated complex subunit 1"	Q96BD8	18	50374995-50394173	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.5;testis: 28.0"	"Cell type enhanced"	"Detected in some"	14	"Erythroid cells: 23.3;Extravillous trophoblasts: 8.2;Spermatocytes: 15.8;Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.2"	"Not detected"	"Not detected"							HPA045495	Approved		Supported	Microtubules		NA	Yes			Microtubules		"HPA045495: AB_10960405"	"unprognostic (2.18e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.66e-3)"	"unprognostic (5.93e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (9.60e-8)"	"unprognostic (1.03e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.91e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.50e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	1.3	1.5	0.3	6.3	0.3	12.1	1.5	2.2	0.5	1.2	1.9	0.1	0.0	1.7	0.5	0.8	6.1	0.3	1.1	0.4	0.5	0.4	0.6	0.8	1.3	5.2	0.5	0.4	0.4	2.8	0.1	0.3	3.3	0.4	0.4	2.8	0.2	1.2	0.0	0.6	1.5	2.0	1.4	1.0	4.4	1.5	28.0	0.0	27.5	0.4	5.9	8.7	0.9	1.6	2.1	0.6	2.5	0.9	1.7	1.9	1.1	9.9	3.9	6.4	6.2	0.5	0.9	3.8	11.1	4.7	13.0	12.9	6.5	3.6	8.9	2.9	3.4	9.1	8.9	9.1	4.5	12.3	12.5	3.1	10.7	3.1	6.8	1.1	17.0	10.7	0.5	0.4	11.2	6.6	1.0	7.3	10.8	13.6	31.2	10.6	3.5	12.0	3.8	4.7	2.7	3.1	5.9	8.2	8.7	2.5	1.1	5.5	3.5	6.7	3.5	5.1	5.2	5.0	5.9	3.9	13.0	7.1	4.5	11.8	13.5	21.7	15.2	5.7	13.9	11.0	1.9	0.9	0.5	0.9	0.4	0.6	1.7	1.2	1.9	0.5	2.1	0.7	0.8	2.5	1.7	0.5	0.6	1.5	1.1	0.3	0.3	2.2	0.5	0.5	0.4	0.5	0.4	0.4	0.0	0.0	2.1	0.8	0.1	0.9	0.3	0.3	0.0	0.0	1.2	0.0	2.0	0.9	0.0	0.1	2.7	0.3	0.0	23.3	0.0	8.2	0.4	0.3	0.0	0.0	4.4	0.0	1.2	1.3	0.3	1.5	0.3	0.3	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.6	0.0	0.0	15.8	8.6	0.3	1.3	1.3	1.0	0.7
SKOR1	"CORL1, FUSSEL15, LBXCOR1"	ENSG00000188779	"SKI family transcriptional corepressor 1"	P84550	15	67819704-67834561	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 17.8"	"Group enriched"	"Detected in some"	6	"Early spermatids: 16.7;Late spermatids: 23.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"cerebellum: 17.8;pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 5.9;U-266/84: 4.7;U-698: 5.1"	"Group enriched"	"Detected in some"	11	"cerebellum: 4.2;pons and medulla: 1.3"	"Region enriched"	"Detected in some"	5	"cerebellum: 9.0"	HPA071150	Enhanced					NA	NA					"HPA071150: "	"unprognostic (8.98e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.44e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.40e-5)"	"unprognostic (5.51e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.13e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	1.1	0.6	0.7	0.4	1.3	1.7	0.7	17.8	2.4	0.5	0.7	0.4	0.4	1.4	1.0	0.5	0.4	0.6	0.7	0.4	0.6	1.1	0.5	0.4	0.7	0.4	0.5	0.4	1.2	1.3	0.1	1.3	0.9	4.4	0.8	0.3	0.4	0.7	0.9	1.5	0.7	0.9	0.6	5.4	0.7	0.4	2.4	0.4	0.4	0.5	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.4	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.0	0.1	0.2	0.4	0.0	0.4	0.9	1.0	0.3	0.0	0.2	2.4	0.7	0.1	0.2	0.0	0.1	0.4	0.0	1.8	0.1	0.8	0.0	0.2	0.5	1.0	0.0	0.2	0.2	0.6	0.3	1.3	0.0	0.1	0.2	2.1	0.1	0.0	0.4	0.3	0.3	1.1	0.3	0.1	0.5	0.2	0.3	5.9	4.7	5.1	0.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	1.3	17.8	1.2	0.6	1.1	0.5	0.4	4.4	0.4	0.0	0.0	0.0	0.0	0.1	0.6	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.2	0.4	0.0	0.0	0.0	0.0
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489196	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.3;brain: 19.0"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 1.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.6;HEL: 4.6;K-562: 10.6;SH-SY5Y: 28.2;THP-1: 4.6"					"Group enriched"	"Detected in many"	5	"basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5"	HPA028835	Uncertain	Supported				NA	NA					"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.4	12.3	1.4	2.7	7.3	3.4	0.5	0.5	6.4	2.9	1.6	0.7	0.0	0.8	0.4	0.2	0.4	0.4	0.6	0.6	1.2	6.3	0.3	0.2	1.1	0.3	19.0	0.8	0.3	0.3	0.4	7.5	0.4	15.3	0.4	1.5	4.0	4.9	0.9	0.9	0.4	1.3	0.6	1.1	0.4	0.8	1.2	0.7	0.0	1.5	0.0	0.3	0.4	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.1	0.0	10.6	0.0	0.1	0.0	2.3	4.6	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.7	28.2	0.5	0.0	0.1	0.6	0.0	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.5	6.3	1.2	6.3	19.0	0.8	15.3	0.7	0.0	2.7	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 85.4;placenta: 44.8;retina: 23.5"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 657.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA					"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4.0	8.9	1.2	0.3	34.0	0.0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1.0	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0.0	0.3	0.0	1.9	0.3	1.8	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	25.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.4	4.0	8.9	12.3	0.8	1.4	5.4	85.4	0.5	0.0	0.0	0.0	0.5	0.0	2.6	1.6	0.0	6.7	0.0	0.0	3.9	99.4	0.0	0.1	0.4	0.3	0.0	0.0	0.0	5.3	1.1	0.4	0.0	0.0	13.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.1	657.3	0.0	0.0	0.3
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"		10	89430299-89556641	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 28.0;kidney: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 25.0;Peritubular cells: 25.1;Proximal tubular cells: 55.2"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Region enriched"	"Detected in many"	6	"pons and medulla: 11.7"	"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.8;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria		NA	NA			Mitochondria		"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	2.3	1.3	1.0	0.1	0.7	0.0	2.4	1.3	0.6	4.9	1.6	2.6	6.2	0.1	2.0	28.0	0.5	2.2	0.1	4.0	1.8	0.8	55.6	1.0	3.3	0.1	0.8	0.3	1.8	13.3	0.0	5.0	5.9	11.7	1.4	0.1	16.3	0.9	7.9	4.4	1.1	0.8	0.5	0.6	0.1	1.7	2.4	0.3	0.0	3.8	0.7	0.0	1.8	1.5	0.7	0.5	1.8	0.3	0.9	0.3	0.0	0.2	0.0	0.1	0.1	3.0	22.8	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.1	3.7	0.0	0.0	8.1	0.2	1.1	1.4	1.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.8	0.0	2.7	0.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.7	0.2	0.3	0.8	0.9	0.1	0.5	0.0	0.0	1.0	0.7	1.3	0.6	1.8	0.8	0.8	0.3	11.7	0.3	3.0	3.8	0.0	1.5	0.0	0.0	2.0	2.5	8.1	4.5	14.0	0.0	14.3	13.3	0.0	3.0	1.1	0.0	0.0	3.7	0.6	1.1	0.8	1.1	1.7	1.1	3.2	17.4	0.6	0.0	3.0	25.0	1.0	0.0	0.0	0.0	0.0	3.5	0.0	25.1	55.2	0.3	12.9	1.4	0.1	0.2	0.3	7.6	0.0	0.0	1.4
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338097-22379503	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 75.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.3;Horizontal cells: 1.6;Muller glia cells: 1.3;Rod photoreceptor cells: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hypothalamus: 20.2;pons and medulla: 75.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	222	"SCLC-21H: 26.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7"	"Low region specificity"	"Detected in all"			"CAB037130, HPA039226, CAB078204"	Supported	Supported				NA	NA					"CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400"					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.5	0.5	7.6	0.5	1.1	0.5	0.5	0.2	13.8	0.5	0.5	1.3	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	1.1	20.2	0.5	0.5	0.5	0.5	7.1	2.1	0.5	1.5	0.5	5.3	0.5	75.2	0.5	0.5	1.4	0.5	0.5	0.5	0.5	0.5	0.5	5.9	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	1.1	0.2	8.4	1.1	20.2	7.1	2.1	75.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 25.4;intestine: 10.8"	"Cell type enriched"	"Detected in some"	37	"Intestinal endocrine cells: 133.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	4	"midbrain: 2.0"	"Group enriched"	"Detected in some"	12	"intermediate monocyte: 2.3;non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in single"	18	"monocytes: 6.0"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced					NA	NA					"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.0	25.4	0.2	0.8	0.1	0.0	0.0	0.0	0.2	0.2	8.8	1.3	1.3	1.4	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.0	2.7	0.0	0.0	2.8	0.0	0.0	10.8	0.0	0.1	0.3	1.1	0.2	0.0	0.2	0.2	0.0	0.1	1.3	0.4	0.0	0.3	0.2	6.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell type enriched"	"Detected in some"	22	"granulocytes: 603.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 91.2"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.2	91.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3	8.9	27.6	0.0	0.0	1.6	0.6	0.2	0.0	1.4	4.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.4	603.6	0.0	0.7	0.0	8.5	11.6	1.8	0.0	0.6	0.6	1.7	0.0	0.0	0.3	0.1	0.0	4.6	0.0	0.7	0.0	0.2	0.2	0.1	2.4	0.0	0.0	0.0	0.0
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610301-49612720	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 1.1;Syncytiotrophoblasts: 1.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 12.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	14	"basal ganglia: 17.7;pons and medulla: 20.9"	CAB079011		Supported				NA	NA					"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.1	0.3	0.0	2.2	8.8	0.1	0.1	0.0	0.5	0.1	1.5	0.0	1.1	1.3	0.3	0.1	0.1	0.1	0.2	0.1	0.0	3.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.7	3.4	11.9	0.4	0.3	1.4	0.4	0.6	0.2	0.1	1.9	1.5	3.1	0.1	1.2	0.2	1.2	0.2	0.1	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	12.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.8	0.0	0.5	0.0	3.4	0.1	0.0	11.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA			"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.1	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.2	6.6	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.5	0.0	0.3	5.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.6	0.0	1.1	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.6	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9	0.0	0.0	0.0	0.6	2.9	12.3	1.6	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	29.3	0.0	0.0	0.0	0.3	8.5	1.0	0.2	0.0	0.0	0.4	22.3	0.0	0.0	0.0	27.3	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.7	0.0	0.3	1.7	1.5	5.9	33.4	0.0	0.0	0.1
SLC22A31		ENSG00000259803	"Solute carrier family 22 member 31"		16	89195761-89201664	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	21	"brain: 39.3;lung: 50.7;pancreas: 69.7"	"Cell type enriched"	"Detected in some"	6	"Alveolar cells type 2: 129.3"	"Group enriched"	"Detected in many"	9	"liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4"	"Region enriched"	"Detected in some"	23	"cerebellum: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2"															NA	NA						"unprognostic (2.71e-3)"	"unprognostic (2.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.89e-1)"	0.1	0.3	0.0	0.3	0.4	1.1	0.1	39.3	0.1	0.3	0.5	0.0	0.0	0.6	0.2	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.3	50.7	2.5	0.0	0.0	0.7	69.7	0.1	0.0	0.1	1.7	0.2	0.1	0.4	0.7	0.2	0.1	0.3	0.3	0.1	0.3	1.0	0.5	1.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	1.1	0.0	0.0	23.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	19.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	9.7	0.6	0.2	2.4	0.0	2.6	11.4	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.1	0.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	39.3	0.1	0.1	0.0	0.0	0.0	1.7	0.0	6.0	129.3	0.0	0.0	0.0	0.0	0.4	0.0	4.0	14.8	0.0	0.0	0.0	0.0	0.1	20.8	0.0	0.0	0.0	4.2	0.1	0.0	0.2	8.1	0.2	0.6	0.0	0.0	0.6	0.3	23.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	2.8	0.1	0.0	0.0	0.0	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015839	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	341	"brain: 33.7;kidney: 127.3;retina: 93.5"	"Cell type enriched"	"Detected in some"	30	"Proximal tubular cells: 197.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enriched"	"Detected in some"	25	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA					"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.0	0.1	0.1	3.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	0.7	0.1	0.1	1.3	33.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	5.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A9	"FLJ23666, OAT4, OAT7, UST3"	ENSG00000149742	"Solute carrier family 22 member 9"	Q8IVM8	11	63369789-63410294	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 32.2"	"Cell type enhanced"	"Detected in some"	30	"Cholangiocytes: 2.5;granulocytes: 4.6;Hepatocytes: 12.7"	"Cancer enriched"	"Detected in single"	166	"liver cancer: 19.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.1;Karpas-707: 1.9;U-266/70: 2.4"															NA	NA											"unprognostic (2.45e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.86e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.08e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.09e-2)"	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	2.8	0.8	0.9	0.5	0.3	0.4	0.5	0.0	0.6	0.2	0.0	0.9	0.0	0.3	0.1	0.2	0.2	0.4	0.5	0.2	0.1	0.1	0.4	0.0	0.5	0.1	1.3	0.3	0.3	0.5	2.1	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.3	1.9	0.1	0.6	0.3	0.9	0.7	0.1	0.2	0.1	1.1	0.1	0.0	0.5	0.1	0.2	0.0	0.3	0.2	0.0	0.4	0.5	0.0	0.5	0.3	0.6	0.3	2.4	0.5	1.0	0.3	0.6	0.3	2.8	0.8	0.7	0.4	0.5	0.2	0.5	0.2	0.3	0.2	1.0	0.4	0.5	2.2	0.9	0.2	0.6	0.3	0.3	0.4	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.6	12.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 16.0;Paneth cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.8	0.6	1.4	1.9	0.9	0.8	0.7	1.8	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.1	0.5	0.6	0.4	2.2	0.8	2.7	1.0	0.5	2.2	0.4	4.6	0.6	3.2	0.6	1.8	3.7	2.0	2.9	0.4	1.0	1.9	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.4	3.4	1.9	2.5	1.7	1.7	2.2	2.3	0.6	3.8	3.5	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2	0.0	0.0	0.0	0.3	0.2	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.7	16.0	0.0	0.2	0.2	0.7	0.3	0.0	2.1	1.2	3.2	3.4	2.5	2.6	0.4	0.9	0.1	0.0	1.8	2.4	1.7	0.2	5.3	0.4	3.0	1.4	0.0	0.9	0.5	0.6	0.1	1.1	0.0	4.1	0.4
SLC25A52	MCART2	ENSG00000141437	"Solute carrier family 25 member 52"		18	31759562-31760880	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	17	"testis: 18.2"	"Group enriched"	"Detected in some"	10	"Early spermatids: 41.8;Late spermatids: 77.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"									"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (8.97e-2)"	"unprognostic (4.85e-2)"			"unprognostic (2.93e-1)"	"unprognostic (4.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.30e-4)"	"unprognostic (7.15e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.3	0.4	0.4	0.0	0.8	0.4	0.5	1.3	0.4	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.2	0.5	0.0	0.9	2.5	0.6	0.0	1.5	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.9	0.7	1.0	0.0	0.0	1.3	0.1	0.3	0.3	0.0	1.1	0.9	0.0	0.0	0.4	0.7	1.5	0.8	1.0	0.2	0.1	0.6	1.7	1.3	0.6	0.6	0.5	0.7	1.3	1.5	0.7	0.8	0.6	1.2	0.8	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.4	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	0.0
SLC26A10		ENSG00000135502	"Solute carrier family 26 member 10"	Q8NG04	12	57619527-57626151	"Predicted membrane proteins, Transporters"	"Antiport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 9.1;Peritubular cells: 4.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.0;HEK 293: 3.5;NTERA-2: 5.6;RH-30: 4.4;SH-SY5Y: 7.9;U-266/70: 5.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA044719	Uncertain					NA	NA					"HPA044719: AB_10962362"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-5)"	"unprognostic (3.22e-3)"	"unprognostic (2.65e-12)"	"unprognostic (1.28e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.40e-1)"	2.0	0.7	0.4	0.5	0.9	0.0	0.4	3.8	0.9	0.4	0.8	0.4	0.4	0.0	2.9	1.2	0.4	1.9	1.8	8.5	0.4	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.9	0.4	0.0	0.4	0.4	0.4	2.1	0.5	0.4	0.8	1.6	2.6	0.1	1.1	1.9	0.4	0.7	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.0	0.0	0.0	0.5	1.1	0.2	0.7	0.3	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.7	0.0	0.2	0.0	3.5	0.4	0.2	0.7	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	2.3	7.9	0.0	0.0	0.5	0.4	0.1	0.6	0.0	0.6	1.3	0.7	0.0	5.4	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	3.8	0.9	0.4	0.2	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.3	9.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.9	0.0	0.8	0.0	1.7	0.5	0.2	0.4	0.1	0.0	0.0	0.0
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446177	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 20.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"cerebellum: 20.4"	"Cell type enriched"	"Detected in single"	8	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"basal ganglia: 9.5"							NA	NA						"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	1.3	1.0	0.6	0.3	0.7	2.3	3.1	20.4	0.8	0.6	0.3	0.5	0.0	0.9	0.5	0.0	0.2	0.4	0.2	0.4	0.8	0.4	0.7	0.9	2.2	1.2	1.3	0.4	0.4	0.7	2.5	4.6	0.1	2.6	3.1	0.1	0.9	1.4	1.0	0.6	2.2	0.5	1.2	2.9	0.9	3.2	0.9	0.2	0.0	1.8	0.0	0.2	3.2	0.4	0.2	0.0	2.7	0.1	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.1	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	2.9	0.0	1.2	0.8	0.3	0.1	0.5	2.6	0.3	0.1	0.4	0.0	0.8	0.9	1.5	0.3	0.3	0.0	0.6	0.7	0.0	0.0	0.6	0.6	1.8	0.4	0.8	0.4	0.4	0.2	0.2	0.3	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.7	20.4	0.8	0.8	0.4	1.3	0.4	2.6	0.2	6.0	1.6	0.0	0.0	0.2	0.1	0.8	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 7.6;Ductal cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA					"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.9	0.0	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.5	0.0	0.1	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.7	7.6	4.0	1.2	1.8	0.0	0.1	0.0	17.3	1.0	0.0	0.3	0.0	2.6	0.1	0.1	0.1	1.1	0.0	1.9	0.0	2.9	0.0	2.4	1.3	0.0	0.7	0.0	1.8	3.4	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.0	2.4	0.1
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Group enriched"	"Detected in some"	18	"Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9"	"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	8.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.1	0.7	2.4	1.4	0.0	0.1	3.8	0.0	0.3	1.5	0.2	0.0	19.0	9.9	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.2	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	29.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.3	18.7	9.4	0.1	0.1	0.0	0.0	0.0
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922264-136925639	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 16.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Group enriched"	"Detected in some"	4	"basal ganglia: 9.9;hypothalamus: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 18.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 26.6;olfactory region: 10.4"	"Region enriched"	"Detected in many"	6	"basal ganglia: 24.4"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.1	4.9	0.0	0.4	9.9	1.2	0.1	0.0	0.4	2.0	0.4	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	0.4	0.0	4.8	4.0	0.0	2.1	0.0	1.7	0.0	0.8	1.2	0.0	0.0	0.1	0.5	4.3	0.6	16.4	0.2	0.1	0.0	0.2	1.3	0.3	0.0	0.2	3.2	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	18.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	9.9	0.0	0.4	0.0	4.8	1.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563922-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 29.5;seminal vesicle: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.5;U-87 MG: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.1	0.1	1.2	0.1	4.9	0.1	0.1	29.5	1.1	1.0	0.2	0.1	0.5	0.2	1.5	0.2	0.1	0.2	0.5	0.1	0.9	2.2	0.4	0.1	0.1	0.1	0.8	1.2	0.3	0.1	0.1	0.2	0.1	2.9	3.5	0.1	2.4	0.1	10.5	0.1	0.1	0.4	1.1	1.3	0.1	0.1	2.7	0.7	0.0	2.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	29.5	1.1	0.9	2.2	0.8	1.2	2.9	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	2.8	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 44.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;NB-4: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA044002, HPA062229"	Enhanced					NA	NA					"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.3	0.4	0.0	0.7	0.0	1.5	1.5	0.3	0.8	0.3	0.0	1.9	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.2	0.0	0.2	0.5	0.4	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.2	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042636	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.1;liver: 4.5"	"Group enriched"	"Detected in some"	8	"Early spermatids: 2.8;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Group enriched"	"Detected in some"	5	"amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;HMC-1: 2.2;SCLC-21H: 8.7;SK-MEL-30: 1.3;SuSa: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.2	0.1	6.1	0.2	0.6	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.2	0.0	0.2	1.4	0.6	2.5	0.2	4.5	0.2	0.2	0.7	0.2	0.2	1.3	0.5	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	2.3	2.4	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.0	1.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.6	0.2	2.6	0.6	2.5	0.7	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.6;kidney: 51.1;liver: 44.9"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 40.8;Proximal tubular cells: 54.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 11.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 12.2;plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.9;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 13.2;AN3-CA: 10.6;Hep G2: 25.4;U-266/70: 19.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA					"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	2.2	45.6	0.8	0.4	2.2	1.1	0.6	1.0	3.1	13.2	1.2	3.7	1.3	0.7	7.6	12.2	0.9	2.4	1.7	3.5	4.7	0.5	51.1	44.9	3.0	3.5	0.9	2.5	5.0	0.2	0.2	7.2	0.3	11.4	2.6	0.5	4.3	1.1	5.5	12.1	10.4	0.6	3.5	2.3	1.9	0.5	15.5	0.6	0.9	4.7	5.7	1.2	0.6	4.5	0.1	6.9	12.2	1.3	0.0	0.7	0.4	0.0	13.2	0.4	10.6	0.3	0.0	0.0	0.4	0.3	1.6	1.5	0.0	0.4	0.1	2.5	1.9	5.3	0.0	4.7	0.3	0.4	0.0	6.2	0.1	7.0	25.4	0.1	0.1	0.3	0.2	2.4	1.2	0.2	1.8	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.2	1.4	0.1	0.5	0.1	0.1	0.1	0.0	0.8	2.5	2.2	4.3	0.0	1.1	3.7	4.5	1.2	0.0	0.1	0.5	0.2	1.2	19.8	7.8	0.0	0.5	0.1	2.3	0.2	1.3	12.2	0.3	1.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.7	0.3	0.0	0.2	6.9	0.0	0.4	0.8	2.2	1.0	3.1	4.7	0.5	0.9	2.5	11.4	0.6	6.0	3.0	0.0	2.2	4.1	0.3	3.8	5.1	1.4	0.0	1.8	0.0	0.0	3.3	0.1	11.3	0.7	0.0	0.0	0.0	0.0	2.3	1.3	5.7	40.8	1.5	0.0	0.0	0.0	1.6	2.7	3.4	0.6	1.7	0.0	0.0	1.2	0.0	0.0	1.4	54.2	0.7	6.5	1.0	0.2	0.7	5.8	0.0	0.0	0.0	1.3
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 76.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.9	52.8	10.4	21.4	10.4	6.1	23.8	19.4	10.5	15.9	13.8	30.0	25.6	9.6	42.6	9.2	23.4	15.7	10.6	9.4	2.9	27.6	15.8	12.6	25.7	15.2	17.0	6.5	40.6	8.9	8.3	18.0	4.6	17.1	8.8	13.6	38.9	8.1	12.3	30.6	18.6	11.2	24.7	21.5	19.6	14.7	5.7	11.2	13.0	12.1	8.6	31.2	17.7	33.5	16.5	8.2	13.8	12.8	19.0	21.4	10.9	21.0	28.5	8.8	11.8	5.4	32.7	16.3	42.9	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5	8.9	10.9	6.7	4.5	9.8	7.9	3.6	17.8	1.4	2.3	19.2	23.6	28.5	14.9	31.0	0.6	9.8	17.3	0.0	30.9	9.0	16.2	5.0	48.3	31.4	23.1	14.3	26.5	14.7	15.1	1.3	12.7	9.9	25.3	9.0	11.1	22.3	39.3	14.0	18.7	18.9	8.8	12.9	15.5	3.2	7.7	6.0	76.5	8.3	18.9	3.1
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 109.1"	"Cell type enhanced"	"Detected in some"	28	"Cone photoreceptor cells: 33.4;Horizontal cells: 158.9;Rod photoreceptor cells: 43.4"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Group enriched"	"Detected in many"	5	"cerebellum: 3.4;pons and medulla: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA036621	Uncertain					NA	NA					"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.2	0.4	1.0	0.8	0.8	1.6	1.1	3.4	1.2	0.7	0.8	2.5	0.6	0.3	0.9	1.7	0.6	1.4	0.8	0.7	1.2	1.0	0.7	3.2	1.7	1.0	1.0	0.6	1.3	0.9	1.5	2.3	0.6	9.0	0.9	0.3	109.1	1.3	0.8	1.1	3.7	0.7	0.9	1.6	0.7	0.5	16.1	0.7	1.0	21.4	0.6	0.7	0.9	0.9	2.5	5.8	6.1	0.9	1.7	2.5	0.6	0.4	0.8	1.4	1.4	1.5	2.6	1.9	0.4	1.4	0.8	1.2	0.4	1.0	2.2	0.4	0.0	0.5	0.1	1.6	0.2	0.3	1.9	0.9	3.3	1.4	0.8	0.2	1.1	2.3	0.7	2.0	0.1	0.3	0.7	0.5	1.6	0.7	2.4	0.3	5.2	0.5	2.2	1.1	1.0	0.3	1.1	1.4	0.0	0.3	1.0	1.0	2.1	0.5	1.7	2.3	1.4	1.6	2.2	0.0	1.5	2.4	1.6	0.5	14.6	2.0	1.7	0.9	1.2	0.3	6.1	0.9	0.9	1.5	0.8	1.0	1.8	2.3	2.0	0.6	2.5	2.1	2.5	4.2	1.7	0.3	5.8	2.4	0.6	1.0	0.8	3.4	1.2	1.2	1.0	1.0	0.6	9.0	0.7	3.0	6.7	0.0	0.6	0.6	12.6	0.4	2.5	4.0	4.5	0.0	33.4	0.0	0.0	0.3	0.4	0.8	0.0	0.0	0.6	0.0	0.4	0.8	0.0	0.0	0.1	158.9	0.0	0.0	0.0	0.0	1.1	0.2	1.7	0.0	0.1	2.9	0.2	0.0	0.4	0.0	43.4	0.0	0.4	1.7	1.4	0.4	0.0	0.0	0.0	0.5
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 145.9"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0.0	0.6	0.1	1.1	2.0	0.3	1.7	0.2	0.0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0.0	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	3.5	0.0	0.1	8.3	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.3	0.0	145.9	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871973-17895174	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 31.5;salivary gland: 66.8;stomach 1: 32.7"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 5.3;Club cells: 7.9;Spermatogonia: 7.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 31.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA					"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.1	0.1	0.4	0.1	0.1	2.4	2.3	5.1	0.1	9.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	1.7	0.1	0.1	0.0	0.2	0.2	0.3	2.7	0.0	0.1	0.0	0.2	0.0	31.5	0.1	0.0	5.5	66.8	0.0	0.2	0.2	0.3	0.0	1.9	0.2	32.7	0.4	0.1	0.0	7.1	0.0	0.1	0.0	0.1	1.3	0.8	2.5	1.4	1.0	4.3	0.9	0.0	0.0	0.1	0.1	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.5	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.2	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	3.7	0.0	2.5	0.6	0.4	1.1	1.4	1.3	1.0	3.2	0.6	0.8	1.3	4.3	3.2	2.2	1.0	0.4	0.4	2.0	0.9	0.1	0.4	2.4	2.3	1.7	0.1	0.3	2.7	31.5	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.6	0.0	5.3	7.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.5	0.0	0.0
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"RT4: 8.9;SCLC-21H: 2.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 107.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.4	4.7	0.0	0.0	0.0
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.1;OE19: 7.1;SuSa: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain					NA	NA					"HPA029873: AB_10602403"	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.2	0.4	0.4	0.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0	1.6	1.4	0.2	1.1	0.0	0.3	3.1	0.1	0.0	0.2	0.1	0.2	1.3	1.2	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.0	0.5	0.2	0.5	0.0	0.3	0.5	0.3	1.4	7.1	0.3	0.5	0.1	0.4	0.2	0.3	0.4	0.4	1.5	0.2	0.0	10.3	0.3	0.1	0.1	0.5	0.4	0.4	0.3	0.8	0.3	0.1	0.2	0.3	0.1	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3	0.0	5.3	0.0	0.4	0.5	0.0	0.8	12.7	0.0	2.3	0.0	0.0	0.0	0.0	10.1	0.5	0.0	2.6	0.0	0.2	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.4	0.4
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392790-1445430	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 48.4"	"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 2.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	47	"midbrain: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8"	"Group enriched"	"Detected in some"	8	"midbrain: 96.4;thalamus: 31.8"	"Region enriched"	"Detected in single"	138	"midbrain: 362.2"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA			Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.2	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0.0	0.6	0.3	0.0	3.4	0.0	48.4	0.0	1.5	0.0	0.0	0.0	0.1	1.0	0.7	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	0.0	2.4	2.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	48.4	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7"	"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.7	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.7	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1	14.9	5.3	0.0	0.4	0.1	0.2	0.8	0.0	1.4	3.4	1.8	0.0	90.5	0.0	0.0	2.3	0.5	1.0	0.0	0.0	7.0	1.6	0.3	2.3	0.0	8.4	0.0	0.0	2.5	0.6	1.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.4	0.3	0.9	0.0	1.4	0.0	0.4	0.3	89.0	0.0	0.0	0.3
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 20.8;Late spermatids: 40.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported				NA	NA					"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 5.3;Late spermatids: 1.9"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Group enriched"	"Detected in some"	4	"HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	42.6	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.0	5.4	0.8	2.4	0.9	5.4	3.1	6.7	8.4	4.0	3.3	5.5	7.7	15.5	2.1	10.7	7.9	3.3	5.2	7.6	7.4	8.1	2.8	1.6	2.1	2.2	3.3	0.7	12.8	3.4	1.0	11.4	7.6	19.2	5.7	5.4	0.1	0.3	5.5	10.6	1.7	0.8	3.7	3.4	6.5	6.9	0.3	0.2	3.1	7.9	5.8	0.7	3.4	5.2	1.5	6.8	6.9	0.3	0.3	8.7	2.9	1.3	3.9	1.6	0.4	7.8	12.3	0.1	2.8	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2	3.0	8.0	17.9	7.5	0.6	10.1	4.5	2.5	0.0	3.4	15.7	3.9	5.5	0.0	15.3	0.0	0.5	0.0	0.0	12.2	0.3	0.4	18.2	0.0	4.9	6.6	12.7	2.4	0.6	4.7	0.4	0.9	9.1	1.7	9.0	1.0	6.6	12.5	0.0	0.4	1.7	3.4	6.5	0.8	0.0	0.9	0.9	6.1	0.5	0.8	11.2
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 14.0;Ciliated cells: 69.6;Club cells: 25.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.5;OE19: 10.9;RT4: 46.2;WM-115: 10.9"	"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		NA	NA		9500	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.5	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.9	0.9	0.1	0.0	0.0	0.0	46.2	0.4	0.5	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8	0.0	2.6	0.0	4.8	3.4	14.0	0.3	0.0	69.6	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	8.9	0.0	0.0	0.0	0.4	1.1	1.1	0.0	0.4	0.0	1.4	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	3.1
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 446.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 248.9;Muller glia cells: 330.7"	"Group enriched"	"Detected in many"	13	"glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HSkMC: 6.0;Karpas-707: 2.8;PC-3: 2.7;SuSa: 6.2;U-2 OS: 2.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 19.0"	"Not detected"	"Not detected"			CAB011628			Approved	Microtubules		NA	NA			Microtubules		"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	4.8	0.5	0.2	0.0	1.9	0.0	0.1	0.4	1.0	0.0	0.2	0.0	0.0	0.0	0.0	5.3	9.1	0.1	0.0	72.9	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	2.3	0.0	0.4	4.3	0.0	446.6	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.9	40.1	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.1	0.6	1.1	0.1	0.2	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.3	0.3	6.0	0.0	0.8	0.0	0.4	0.0	0.0	0.1	2.8	0.0	0.4	0.3	0.4	0.1	0.1	2.7	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	0.0	2.7	0.0	0.2	1.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	0.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.7	248.9	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	7.3	0.0	0.0	0.0	0.4	1.7	0.5	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	330.7	0.2	0.0	0.4	0.1	14.1	0.0	0.4	0.0	0.0	1.3	4.8	0.0	0.0	0.0
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 1679.4;Alveolar cells type 2: 2934.9;Basal glandular cells: 1025.0;Cholangiocytes: 1719.7;Ciliated cells: 2255.1;Club cells: 3002.8;Collecting duct cells: 3252.2;Urothelial cells: 2991.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 157.0;hTCEpi: 184.3;OE19: 67.0;SiHa: 55.2;THP-1: 46.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	26400000	2600000	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	28.4	0.0	157.0	0.0	2.1	11.7	0.0	5.6	0.0	0.7	0.0	0.0	21.0	0.0	30.3	0.0	0.0	0.8	184.3	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	67.0	10.7	0.0	0.0	0.0	32.0	1.2	0.0	0.0	55.2	11.8	0.1	0.0	0.2	46.6	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0	1679.4	2934.9	5.2	1025.0	89.4	0.0	0.9	1719.7	2255.1	3002.8	3252.2	0.0	1.3	0.0	285.2	390.2	5.3	69.3	23.3	231.9	0.9	101.8	495.3	70.9	353.5	5.8	0.0	192.4	19.6	6.7	55.8	23.6	30.6	37.1	9.0	72.4	0.0	552.6	410.1	0.0	1.1	0.0	0.0	22.7	1.0	1.6	121.5	1.7	5.3	161.1	2991.2
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 24.4;Enterocytes: 33.4;Pancreatic endocrine cells: 24.8;Paneth cells: 43.2;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;CAPAN-2: 17.8;NTERA-2: 13.7;RPMI-8226: 14.3;SK-BR-3: 23.0;T-47d: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		330000	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.6	1.2	0.0	0.1	0.0	0.0	23.1	0.0	0.5	0.3	1.7	5.9	17.8	0.8	4.2	0.0	0.3	2.9	1.9	1.6	0.3	0.0	11.8	3.8	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.5	0.2	0.5	0.5	0.1	0.5	0.2	0.0	9.3	0.0	0.4	13.7	2.0	2.1	0.2	0.1	14.3	12.4	4.6	11.9	0.2	0.0	23.0	0.6	2.5	16.6	0.7	0.0	0.0	3.9	0.0	0.0	0.1	6.0	0.3	0.4	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3	8.9	13.2	2.2	2.4	0.1	0.0	0.3	2.5	4.0	15.9	8.7	0.0	2.2	0.0	24.4	0.2	0.1	33.4	0.0	19.9	0.1	0.0	5.5	0.0	0.0	0.3	0.0	19.7	0.6	0.0	0.0	0.0	0.8	0.0	0.0	23.2	0.0	24.8	43.2	0.0	6.7	0.0	0.0	0.8	0.0	0.1	0.1	6.4	1.3	29.8	2.5
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067780-88113387	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4"	"Cell type enriched"	"Detected in single"	1107	"Cardiomyocytes: 207.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.6"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HSkMC: 5.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA062282	Enhanced					NA	NA					"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			2.7	0.0	0.1	0.1	0.3	0.0	1.2	0.0	1.4	0.0	4.6	0.0	0.0	0.4	0.0	3.4	2.5	0.0	0.2	45.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.4	0.0	1.5	0.0	103.7	0.0	4.4	6.3	0.1	0.0	2.6	0.1	0.0	0.0	0.2	36.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOCS1	"Cish1, JAB, SOCS-1, SSI-1, TIP3"	ENSG00000185338	"Suppressor of cytokine signaling 1"	O15524	16	11254405-11256200	"Cancer-related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.3;lymphoid tissue: 58.3"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 63.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 15.2"	"Cell type enhanced"	"Detected in many"		"basophil: 12.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HDLM-2: 48.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010355, HPA074108"	Approved		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			Nucleoplasm	"Cytoplasmic bodies"	"CAB010355: AB_2193144, HPA074108: AB_2686661"	"unprognostic (4.50e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-3)"	"unprognostic (5.31e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.67e-1)"	10.9	2.8	0.7	19.2	1.5	13.9	37.9	15.2	1.1	15.8	6.3	0.3	2.2	3.3	4.9	7.6	5.6	4.2	11.0	3.6	0.6	1.0	11.1	42.3	9.6	25.8	0.8	0.0	9.3	3.8	0.7	16.8	9.3	2.4	5.3	1.8	3.2	3.7	3.9	2.3	6.0	11.0	6.5	1.1	14.7	6.6	7.1	0.4	58.3	5.1	4.8	14.7	5.4	8.3	4.4	1.3	12.9	0.1	5.5	2.7	0.4	1.2	0.2	0.5	0.1	1.6	0.2	1.9	1.0	7.5	0.4	0.6	0.3	0.2	2.9	2.2	0.4	1.4	0.5	0.2	0.1	0.1	48.3	0.3	0.8	0.0	3.9	0.7	0.0	8.9	0.7	0.1	1.0	0.1	0.2	0.1	0.3	6.4	0.8	0.0	1.1	3.2	1.8	5.4	0.0	0.8	0.3	0.3	0.3	0.5	0.2	0.7	0.1	0.2	1.7	0.5	1.5	0.0	0.4	0.0	0.6	3.2	0.4	0.6	0.2	0.2	4.5	1.2	0.3	0.6	12.9	0.1	8.8	2.2	0.0	2.0	1.4	2.5	2.7	0.0	4.4	2.7	2.5	0.3	5.5	0.0	1.3	2.6	0.4	0.7	1.5	15.2	0.6	0.6	1.0	0.8	0.0	2.4	0.4	0.0	4.1	11.5	14.7	10.9	1.9	9.2	5.1	2.7	0.0	48.8	5.9	21.5	19.9	11.3	40.7	3.6	23.6	0.0	7.3	4.3	30.9	5.9	54.0	2.4	4.0	0.0	25.0	10.4	6.5	17.6	6.6	8.4	28.7	24.4	12.9	7.4	6.9	9.1	39.3	7.0	4.2	0.0	16.5	0.9	2.0	5.9	48.3	63.1	6.6	10.8
SOHLH1	"bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2"	ENSG00000165643	"Spermatogenesis and oogenesis specific basic helix-loop-helix 1"	Q5JUK2	9	135693407-135699528	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 21.1;testis: 21.5"	"Cell type enriched"	"Detected in some"	10	"Spermatogonia: 82.1"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CACO-2: 14.8;U-266/84: 22.8"									HPA059439			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA059439: AB_2684017"	"unprognostic (2.93e-1)"			"unprognostic (1.23e-3)"	"unprognostic (9.85e-3)"	"unprognostic (2.84e-2)"		"unprognostic (3.55e-1)"		"unprognostic (2.59e-3)"				"unprognostic (4.98e-3)"	"unprognostic (2.17e-1)"		"unprognostic (1.63e-1)"	0.2	0.1	4.4	0.2	3.2	0.1	0.2	1.7	21.1	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.1	0.2	0.2	9.4	1.4	0.2	0.2	0.2	0.2	2.0	0.2	0.3	0.2	0.3	1.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.2	21.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.2	1.7	21.1	9.4	1.4	2.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	8.0	82.1	0.0	0.0	0.0	0.0	0.0
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	"Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 17.1;retina: 7.2"	"Cell type enriched"	"Detected in single"	6	"Collecting duct cells: 1.8"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.0;cerebral cortex: 3.1"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Group enriched"	"Detected in some"	34	"HaCaT: 10.2;SuSa: 6.3"	"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"	0.3	0.1	0.1	1.4	1.0	0.1	0.1	0.1	3.1	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.1	0.1	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0	0.0	0.0	0.0	4.5	4.9	0.4	1.0	0.0	0.0	3.4	14.0	0.0	0.0	24.9	0.0	14.4	0.2	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	28.6	2.4	0.6	0.0	9.4	6.6	0.0	30.4	0.0	0.0	15.0	0.2	0.0	2.5	14.4	0.4	0.0	0.4	2.7	0.9	6.4	0.0	0.0	2.1	0.3
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894928-76898147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.3"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 1.4;Distal tubular cells: 1.7;Urothelial cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.8;CACO-2: 4.2;OE19: 6.7;RT4: 18.9;T-47d: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.3	0.6	1.2	2.1	1.1	0.0	0.9	0.5	7.9	1.7	6.9	0.2	7.4	5.1	0.3	0.7	9.7	0.9	4.3	0.2	1.0	1.1	6.9	16.3	1.6	0.0	0.7	2.0	0.2	7.3	5.6	0.9	0.6	1.4	2.2	5.8	0.3	11.1	2.7	0.2	2.2	12.6	0.0	0.4	0.2	4.2	0.2	0.2	0.0	3.9	2.3	4.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	4.2	2.6	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	6.7	0.0	0.0	0.0	0.0	0.5	18.9	0.1	0.0	0.0	1.4	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.5	7.9	1.0	1.1	0.7	2.0	1.4	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2
SOX14	SOX28	ENSG00000168875	"SRY-box 14"	O95416	3	137764284-137766338	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4;placenta: 15.1;prostate: 3.1"	"Cell type enriched"	"Detected in some"	4	"Cytotrophoblasts: 12.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 2.8"	"Group enriched"	"Detected in many"	15	"hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hypothalamus: 2.1;midbrain: 5.9"	"Group enriched"	"Detected in many"	7	"midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5"							NA	NA								"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"								"unprognostic (1.88e-2)"		"unprognostic (2.49e-3)"	"unprognostic (5.08e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	15.1	4.4	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	5.4	1.6	0.0	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
SP6	"Epfn, KLF14"	ENSG00000189120	"Sp6 transcription factor"	Q3SY56	17	47844908-47855874	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 45.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024516, HPA044469"			Supported	"Nucleoplasm,Mitotic spindle,Centrosome"		Yes	No			Nucleoplasm	"Mitotic spindle, Centrosome"	"HPA024516: AB_10960551, HPA044469: AB_10966430"	"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.79e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (1.22e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.59e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (3.33e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (5.72e-4)"	0.9	1.0	0.1	0.5	0.0	0.0	3.8	1.3	0.2	1.7	1.8	0.1	33.7	1.5	0.4	4.1	5.8	1.1	0.4	0.4	0.1	0.1	0.9	0.1	3.6	0.5	0.1	0.0	3.6	0.4	2.0	0.2	24.7	1.1	6.9	0.7	0.2	1.0	26.2	0.1	14.9	5.3	0.3	0.3	0.9	0.3	0.4	0.0	0.8	1.3	5.6	3.6	5.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.4	0.0	0.0	0.0	0.0	45.4	0.2	0.2	0.9	0.2	9.5	0.9	0.0	0.3	0.0	0.6	1.3	0.0	1.6	0.2	0.1	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.9	0.1	0.1	0.1	2.2	0.0	0.0	0.8	0.0	0.0	0.0	3.9	0.8	0.0	0.0	0.0	0.2	5.7	1.4	0.0	0.0	5.8	0.0	8.7	2.3	0.0	3.0	0.2	1.3	0.0	0.2	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	45.5	0.0	0.7	0.0	0.3	6.9	0.0	0.7	1.6	0.3	1.6	0.0	0.0	3.6	0.0	1.7	1.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	1.3	2.9	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.6	82.6	0.0	2.7	5.1
SPAG17	"CT143, FLJ34497, PF6, RP4-776P7.2"	ENSG00000155761	"Sperm associated antigen 17"	Q6Q759	1	117953861-118185223	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;epididymis: 16.3;testis: 24.7"	"Cell type enhanced"	"Detected in many"	20	"Ciliated cells: 444.4;Early spermatids: 203.6;Late spermatids: 292.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 24.1"	"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;HMC-1: 1.5;RT4: 2.7;SCLC-21H: 3.1;SuSa: 2.8;U-2 OS: 1.1"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 12.2"	"HPA028597, HPA028666"	Enhanced					NA	NA					"HPA028597: AB_10600221, HPA028666: AB_10602281"	"unprognostic (3.67e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-5)"	"unprognostic (4.81e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.67e-2)"	0.8	0.1	1.4	0.2	5.6	0.2	1.3	0.0	0.2	2.0	0.2	7.4	2.2	0.2	0.9	16.3	8.6	11.8	0.7	0.2	2.6	3.0	3.0	0.1	6.1	0.1	0.1	0.3	7.8	0.7	0.3	9.2	0.3	24.1	0.2	0.2	0.6	0.3	0.4	0.5	0.3	0.2	0.2	0.4	0.2	0.9	24.7	1.5	0.0	1.4	0.1	0.8	2.1	2.7	0.0	1.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.7	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.7	3.1	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.6	0.0	0.2	2.6	3.0	0.1	0.3	24.1	1.5	6.0	3.8	0.0	0.1	0.3	0.4	0.6	0.0	444.4	78.5	10.4	31.4	1.7	1.7	0.4	203.6	0.1	0.0	0.0	0.6	0.5	0.6	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	292.1	1.4	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.1	0.6	0.0	0.0	0.1	43.2	5.6	0.3	0.6	0.0	0.0	0.7
SPAG6	"CT141, pf16, Repro-SA-1"	ENSG00000077327	"Sperm associated antigen 6"	O75602	10	22345445-22454224	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;fallopian tube: 29.5;testis: 70.6"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 262.3;Early spermatids: 120.4;Spermatocytes: 275.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 31.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	28	"U-937: 48.8"					"Region enhanced"	"Detected in many"		"midbrain: 17.9"	HPA038440	Enhanced					NA	NA					"HPA038440: AB_10671742"	"unprognostic (5.02e-2)"	"unprognostic (9.52e-2)"		"unprognostic (8.94e-6)"	"unprognostic (2.21e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.78e-4)"	0.3	0.3	2.8	0.3	5.2	0.5	1.4	0.0	2.0	1.1	0.3	8.6	0.0	0.3	0.4	8.7	0.3	29.5	0.3	0.3	5.0	5.1	0.5	0.4	5.3	0.3	0.7	0.6	3.1	0.5	0.3	12.4	0.3	31.1	0.8	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.3	0.3	70.6	1.6	0.0	0.3	0.0	0.3	0.3	0.1	0.0	1.2	2.9	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	48.8	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.5	0.0	2.8	5.2	0.0	2.0	5.0	5.1	0.7	0.6	31.1	1.6	0.0	3.7	0.0	0.1	0.1	0.1	0.6	0.0	262.3	27.3	0.0	0.0	0.0	1.7	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	25.3	4.6	0.8	1.7	0.0	0.0	0.0	0.6	0.0	4.6	0.3	1.0	0.0	0.2	275.9	3.7	0.1	0.0	0.0	0.0	0.0
SPAG8	"BS-84, CT142, HSD-1, hSMP-1, SPAG3"	ENSG00000137098	"Sperm associated antigen 8"	Q99932	9	35808045-35812272	"Predicted intracellular proteins"	"Cell cycle, Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.7;epididymis: 9.7;fallopian tube: 30.0;testis: 23.6"	"Cell type enhanced"	"Detected in many"	18	"Ciliated cells: 95.0;Early spermatids: 32.1;Late spermatids: 22.4;Spermatocytes: 42.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basal ganglia: 8.6;pons and medulla: 32.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2"					"Low region specificity"	"Detected in all"			HPA068012	Enhanced					NA	NA					"HPA068012: AB_2685941"	"unprognostic (1.01e-4)"	"unprognostic (3.52e-3)"	"unprognostic (6.36e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-3)"	1.0	1.4	2.4	0.9	8.6	1.1	1.1	1.1	3.5	3.7	1.3	9.1	2.7	1.4	1.6	9.7	1.2	30.0	1.6	2.6	4.1	3.2	1.2	0.8	2.9	1.2	1.6	2.8	2.5	1.2	2.2	3.9	1.0	32.7	1.4	0.8	2.5	1.3	3.5	1.3	1.1	1.0	1.0	2.2	1.2	1.2	23.6	4.4	0.9	2.9	0.4	0.9	1.7	0.7	1.3	3.0	4.2	1.8	2.3	2.7	1.0	0.1	0.2	0.0	0.4	4.2	1.4	0.0	0.4	0.2	1.4	0.5	0.8	0.2	0.0	0.0	0.2	0.6	1.0	0.4	1.9	0.2	0.9	0.3	1.3	0.2	0.1	0.3	0.0	0.4	1.1	0.8	1.6	0.8	2.5	1.2	0.1	0.1	1.5	1.5	0.8	0.3	0.1	0.4	0.0	0.8	0.4	0.5	1.3	1.5	0.0	1.5	0.9	0.1	0.1	0.4	0.3	0.9	1.5	1.2	0.3	0.6	0.7	0.1	0.5	0.6	0.1	2.1	1.2	0.8	4.2	1.8	0.0	1.6	1.2	0.5	0.2	1.3	1.8	3.0	1.3	0.9	2.5	0.0	2.3	0.1	0.1	2.7	1.0	2.4	8.6	1.1	3.5	4.1	3.2	1.6	2.8	32.7	4.4	0.0	1.0	0.0	1.0	0.3	4.8	2.9	0.0	95.0	10.3	5.2	7.9	0.3	1.7	0.3	32.1	0.6	0.0	0.0	0.0	0.1	0.8	1.0	1.1	0.0	0.9	3.2	2.9	1.8	0.3	22.4	1.4	1.8	0.0	1.8	0.0	5.0	0.1	0.0	1.1	1.1	8.0	0.0	1.2	42.2	2.1	0.5	0.1	0.8	0.0	0.2
SPATA18	FLJ32906	ENSG00000163071	"Spermatogenesis associated 18"	Q8TC71	4	52051331-52097292	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"fallopian tube: 41.7;testis: 65.7"	"Group enriched"	"Detected in many"	10	"Early spermatids: 536.7;Late spermatids: 1836.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 12.5"	"Cell type enriched"	"Detected in single"	23	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	23	"B-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 20.1;BEWO: 15.1;BJ hTERT+: 9.7;HSkMC: 18.5;hTCEpi: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036854, HPA036855"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA036854: AB_10670927, HPA036855: AB_2675352"	"unprognostic (6.54e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.32e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"prognostic favorable (3.73e-9)"	"unprognostic (4.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.00e-2)"	2.1	4.2	2.6	1.2	3.3	0.0	3.7	0.1	1.1	6.8	2.3	3.6	5.3	1.2	2.5	9.9	4.9	41.7	11.5	1.5	3.1	2.8	3.7	4.4	12.0	0.3	0.6	0.6	7.6	1.6	4.2	6.1	1.8	12.5	3.5	3.5	1.4	13.2	6.0	1.1	4.3	2.8	1.8	0.8	0.5	2.9	65.7	0.8	1.3	1.6	4.1	3.1	2.3	2.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	0.0	8.0	20.1	15.1	5.6	9.7	0.3	0.4	0.0	0.9	0.0	0.0	7.4	0.1	0.1	0.0	4.3	0.2	0.0	0.6	0.0	0.0	4.7	7.1	0.0	0.0	18.5	17.8	0.6	2.8	3.2	4.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	1.2	0.6	0.0	0.0	6.3	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.3	0.1	1.1	3.1	2.8	0.6	0.6	12.5	0.8	8.9	4.0	0.0	6.6	4.6	0.0	2.4	7.6	115.1	18.2	0.0	0.0	1.4	1.7	0.9	536.7	0.4	1.1	0.0	2.4	1.1	2.3	5.1	2.3	1.7	0.3	0.0	1.7	2.5	1.2	1836.3	10.0	1.2	0.0	0.0	1.6	0.0	1.2	2.9	10.3	5.4	0.0	0.0	1.8	11.7	6.8	6.6	0.7	0.0	3.8	6.4
SPATA48	C7orf72	ENSG00000164500	"Spermatogenesis associated 48"	A4D263	7	50096036-50159830	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Cell line enriched"	"Detected in some"	12	"U-698: 15.3"					"Low region specificity"	"Detected in some"			HPA026094	Uncertain					NA	NA					"HPA026094: AB_1859516"																		0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342660-44377167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"fallopian tube: 9.0;testis: 33.5"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 17.4;Early spermatids: 25.7;Late spermatids: 6.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-MEL-30: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	1.5	0.0	0.0	0.1	4.8	0.1	9.0	0.0	0.0	0.7	0.7	0.0	0.0	1.5	0.0	0.4	0.0	1.6	0.0	0.2	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	1.0	0.0	0.4	0.7	0.7	0.4	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SPHKAP	SKIP	ENSG00000153820	"SPHK1 interactor, AKAP domain containing"	Q2M3C7	2	227979950-228181645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 64.0;heart muscle: 33.2"	"Cell type enriched"	"Detected in some"	13	"Cardiomyocytes: 75.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"cerebellum: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"BJ hTERT+: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042499, HPA048168"	Enhanced					NA	NA					"HPA042499: AB_2678027, HPA048168: AB_2680296"	"unprognostic (4.91e-3)"				"unprognostic (6.46e-2)"						"unprognostic (1.33e-1)"	"unprognostic (2.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-3)"		0.5	0.6	10.7	0.5	5.1	0.4	1.4	64.0	14.8	0.5	0.5	2.1	0.0	0.5	0.5	0.4	0.5	0.5	0.5	33.2	15.1	3.7	0.5	0.4	0.6	0.5	1.6	4.5	3.2	0.5	0.4	0.1	0.5	3.8	0.5	0.5	0.5	2.7	0.5	0.4	0.5	0.5	0.5	1.1	1.0	0.5	0.7	0.9	0.0	0.5	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	32.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	5.1	64.0	8.5	15.1	3.7	1.6	4.5	3.8	0.9	0.0	0.0	0.0	0.0	0.1	5.6	75.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Cell type enhanced"	"Detected in some"	19	"Basal keratinocytes: 1.3;Hofbauer cells: 2.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	84	"HeLa: 244.9;SiHa: 117.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011039	Uncertain				"Secreted - unknown location"	NA	NA					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favorable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	244.9	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell type enhanced"	"Detected in some"	19	"Ductal cells: 9.9;Hofbauer cells: 13.9;Pancreatic endocrine cells: 18.9;Urothelial cells: 44.4"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.9;hTEC/SVTERT24-B: 19.7;RT4: 33.2;TIME: 17.3;U-87 MG: 32.7"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: AB_2674008"	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.7	0.3	0.0	0.0	0.2	1.5	0.5	14.1	18.9	13.7	9.2	0.2	0.6	0.1	1.9	15.9	5.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.9	0.2	19.7	0.6	11.1	9.3	0.7	0.2	0.2	8.1	0.0	0.1	0.0	0.2	0.1	0.3	0.0	1.4	0.0	0.0	33.2	0.0	0.0	0.3	0.0	0.9	0.4	8.2	0.0	17.3	14.5	1.4	9.3	5.3	0.0	0.1	0.0	32.7	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6	0.0	5.9	0.0	4.0	0.1	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	9.9	0.2	0.1	0.0	0.0	8.9	0.5	0.4	1.7	1.1	0.0	13.9	0.0	1.7	0.6	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.2	0.0	0.0	44.4
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 238.3;Fibroblasts: 91.2;T-cells: 101.5"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 54.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 54.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.2;HSkMC: 97.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1600000	Vesicles		"HPA040170: AB_2676868, HPA066095: AB_2685615"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (9.22e-4)"	18.5	10.2	0.9	11.7	4.2	7.2	27.9	10.7	3.4	63.7	18.0	1.0	6.4	8.5	46.7	25.7	13.9	11.6	26.6	14.4	1.8	0.0	19.3	35.7	13.9	1.6	0.5	1.5	24.2	4.8	0.1	3.2	44.9	1.9	39.4	3.2	3.4	6.3	7.6	8.9	9.1	14.2	23.1	0.6	6.7	9.6	10.6	0.9	1.1	3.5	21.0	3.0	20.1	22.8	0.2	8.7	2.1	0.4	10.0	54.2	22.7	0.0	0.1	0.0	0.0	1.8	13.2	0.5	1.1	0.7	0.1	0.2	0.0	0.0	0.3	1.9	4.5	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	55.2	0.0	0.3	97.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.9	2.5	0.6	1.7	0.1	0.1	0.6	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.1	4.0	0.0	0.2	0.4	0.1	0.0	1.3	0.0	0.8	0.1	0.1	54.2	0.2	1.1	0.1	7.6	22.3	0.1	0.2	3.4	22.0	2.1	10.0	0.4	8.7	0.0	22.7	0.9	4.2	10.7	3.4	1.8	0.0	0.5	1.5	1.9	0.9	0.0	6.4	5.2	1.9	32.6	1.7	4.2	12.7	13.4	2.3	1.8	0.0	3.1	1.7	3.0	0.2	4.5	10.7	0.0	1.2	238.3	91.2	11.8	5.8	32.1	11.2	0.0	13.3	20.3	2.4	0.0	27.6	6.6	25.3	8.2	8.5	0.9	1.4	3.5	8.9	15.1	0.2	6.5	7.1	0.2	0.4	18.7	32.5	101.5	5.8	11.2
SPPL2C	IMP5	ENSG00000185294	"Signal peptide peptidase like 2C"	Q8IUH8	17	45844835-45847072	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"testis: 45.0"	"Group enriched"	"Detected in some"	132	"Early spermatids: 211.9;Late spermatids: 461.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.70e-4)"				"unprognostic (1.34e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6"	"Cell type enhanced"	"Detected in some"	22	"Erythroid cells: 46.7;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 23.5;K-562: 28.1;U-937: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		43000000	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	1.9	1.6	3.2	0.7	11.6	32.2	0.7	25.2	10.4	0.8	0.7	0.8	0.3	0.6	0.7	5.2	1.8	0.8	0.8	14.7	3.1	3.2	1.2	0.6	0.9	0.6	2.8	3.5	0.7	2.2	6.5	4.7	4.7	16.4	1.5	0.7	1.1	1.9	1.3	67.6	0.7	0.7	1.0	1.7	1.1	0.7	1.0	1.4	0.0	0.7	17.4	0.6	0.8	0.5	0.0	0.6	0.9	0.0	0.0	0.2	1.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	1.4	3.9	0.1	0.0	0.2	2.3	23.5	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.9	28.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	1.3	0.0	0.0	0.1	0.0	0.1	3.8	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	4.3	0.0	0.4	0.9	4.4	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.5	3.2	11.6	25.2	10.4	3.1	3.2	2.8	3.5	16.4	1.4	0.0	0.0	0.0	0.4	0.7	8.1	5.5	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	46.7	0.2	0.2	0.3	0.5	2.3	0.0	0.2	15.9	2.9	0.0	0.0	0.0	0.3	0.2	1.7	0.0	0.0	6.5	0.4	0.0	1.1	0.0	1.9	6.5	3.8	0.1	0.2	0.4	0.1	0.0	0.0	0.5
SPTBN5	"BSPECV, HUBSPECV, HUSPECV"	ENSG00000137877	"Spectrin beta, non-erythrocytic 5"	Q9NRC6	15	41848144-41894077	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Group enriched"	"Detected in some"	22	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 225.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebellum: 10.0;midbrain: 6.8;pons and medulla: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 4.6;SCLC-21H: 6.4;TIME: 16.5;WM-115: 5.2"					"Not detected"	"Not detected"			HPA055283	Approved					NA	NA					"HPA055283: "	"unprognostic (5.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.84e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.11e-2)"	1.4	0.3	0.7	1.4	0.7	0.7	1.2	10.0	0.8	0.7	0.7	0.7	0.7	0.6	0.7	1.8	2.0	0.2	1.9	4.6	0.7	0.3	1.2	1.9	1.2	1.2	6.8	0.7	1.2	2.6	1.8	2.3	0.7	3.7	1.8	0.2	7.4	6.8	0.7	1.4	1.8	0.7	0.7	1.0	0.7	1.2	1.9	0.7	0.7	2.6	0.7	0.7	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0	1.0	0.0	1.9	0.5	0.0	0.3	0.0	1.0	0.1	0.0	1.7	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.1	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.5	0.2	0.5	0.0	0.3	0.0	0.4	1.7	6.4	0.1	0.2	0.5	0.1	0.5	1.0	0.0	16.5	0.0	1.7	0.4	2.0	1.9	2.7	0.0	0.0	0.1	5.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.7	10.0	0.8	0.7	0.3	6.8	0.7	3.7	0.7	0.0	3.7	0.0	0.8	0.7	7.6	3.4	0.0	1.4	2.3	0.0	198.3	0.0	0.0	0.4	1.0	1.1	0.0	0.0	0.2	0.2	0.0	0.3	1.1	0.4	1.5	3.2	0.0	0.6	0.0	0.4	0.0	0.8	1.7	1.0	0.3	9.5	0.9	0.9	0.0	0.3	225.5	0.0	0.2	0.3	0.4	1.1	0.0	0.0	0.2	0.9
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008979-13169103	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 154.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 10.5"	"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.0;NK-cell: 4.1"	"Group enriched"	"Detected in many"	13	"NK-cells: 4.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	3.2	4.5	1.3	1.6	2.2	0.0	4.3	1.7	1.7	4.3	5.0	2.2	4.4	8.3	4.8	9.6	5.6	3.4	5.8	4.8	2.0	1.5	15.6	11.9	5.7	0.7	2.5	2.2	4.3	3.8	10.2	4.2	154.0	10.5	4.5	3.8	3.8	7.8	5.8	1.0	25.1	9.0	3.0	6.9	1.9	2.2	4.2	1.4	5.7	24.3	3.6	1.9	4.8	6.0	0.0	0.2	0.1	0.0	4.1	3.0	0.2	0.7	1.1	0.9	0.0	7.1	10.3	5.5	0.0	1.5	1.0	4.1	8.9	4.5	0.0	0.5	0.2	9.0	12.2	0.0	3.4	1.4	0.0	0.0	0.0	2.8	12.6	0.6	0.0	0.1	5.8	10.7	4.0	1.4	3.8	0.7	2.1	0.0	16.4	11.5	0.2	0.0	0.0	0.0	1.0	1.4	1.1	2.0	7.2	21.8	8.7	0.0	0.1	0.1	1.1	0.0	1.6	9.1	0.2	1.6	4.6	1.5	15.2	1.0	0.1	0.0	0.0	28.8	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.4	0.1	0.0	0.0	0.7	0.1	0.1	4.1	0.0	0.2	0.0	0.2	1.3	2.2	1.7	1.7	2.0	1.5	2.5	2.2	10.5	1.4	6.0	18.2	0.0	4.8	2.2	0.0	15.1	5.1	4.0	6.8	8.7	0.0	22.9	6.6	2.2	15.0	2.2	4.9	0.0	3.8	10.5	7.2	3.4	1.1	18.7	2.5	0.0	0.0	0.6	2.5	8.5	3.4	0.9	0.0	0.0	4.7	13.6	2.5	8.0	2.5	11.9	0.0	0.0	0.3	0.9	0.1	1.9	38.6	1.3	6.1	1.8
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526307-21537377	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.3;brain: 14.4;breast: 23.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 72.9;Proximal tubular cells: 131.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Region enriched"	"Detected in some"	9	"pons and medulla: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.1;HBEC3-KT: 7.2;hTERT-HME1: 9.8;SuSa: 11.2;U-2 OS: 4.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 65.0;hippocampal formation: 70.8;olfactory region: 47.5;pons and medulla: 40.3"						"Secreted to blood"	NA	NA	2650000					"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	34.3	0.0	0.2	0.0	0.3	0.0	23.1	0.1	1.4	0.0	2.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	1.5	0.4	0.7	7.1	0.7	0.2	0.5	1.5	0.0	0.0	7.8	0.0	0.0	12.7	14.4	0.0	0.0	0.0	6.4	0.0	1.3	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.2	1.3	2.7	0.4	0.0	0.1	0.0	0.1	0.6	0.5	0.0	0.0	0.2	1.5	0.0	0.5	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.8	14.1	0.0	0.5	0.2	0.0	0.2	0.0	0.0	7.2	0.8	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.0	3.0	0.3	0.1	9.8	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.4	11.2	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	1.5	0.2	0.3	0.1	0.3	0.4	0.7	1.5	0.0	14.4	0.2	0.0	0.0	0.5	0.0	0.0	3.4	24.8	0.0	0.0	0.0	24.4	0.0	0.0	72.9	0.2	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	1.0	0.0	1.7	4.0	0.0	0.0	131.0	0.5	0.0	0.3	0.0	0.4	0.0	0.3	0.0	0.0	0.0
SRRM4	"KIAA1853, nSR100"	ENSG00000139767	"Serine/arginine repetitive matrix 4"	A7MD48	12	118981495-119163051	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 62.1"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 330.0;Cone photoreceptor cells: 404.5;Rod photoreceptor cells: 360.9"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebellum: 62.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 6.7;SCLC-21H: 7.7;SH-SY5Y: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052783	Uncertain					NA	NA					"HPA052783: AB_2681945"	"unprognostic (2.44e-2)"	"unprognostic (2.66e-1)"		"unprognostic (2.40e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"		"unprognostic (1.37e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.61e-5)"	"unprognostic (1.10e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.61e-1)"	0.8	3.6	11.0	0.9	11.6	1.0	0.8	62.1	21.5	0.8	0.8	0.4	0.0	0.9	1.1	1.0	0.8	0.8	0.8	2.0	6.6	4.7	1.1	0.8	1.0	0.8	2.0	18.2	0.8	0.7	0.9	1.4	0.9	3.8	0.9	0.9	5.9	0.8	1.1	1.4	0.9	0.9	0.9	1.3	0.8	1.3	1.4	0.8	0.0	0.9	0.0	0.8	0.7	0.3	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	11.0	11.6	62.1	20.5	6.6	4.7	2.0	18.2	3.8	0.8	6.0	0.0	0.0	0.0	0.0	330.0	7.6	0.0	0.0	1.2	0.0	404.5	0.6	0.0	0.0	5.3	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	27.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	360.9	6.5	0.8	0.0	1.3	0.0	1.9	0.0	0.0	0.0
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565379-76586956	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 447.7;Late spermatids: 1248.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 19.2"	"Cell type enriched"	"Detected in some"	9	"neutrophil: 23.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 23.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 11.8;HBEC3-KT: 10.7;hTCEpi: 30.0;MCF7: 11.6;SK-MEL-30: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	4.3	1.7	0.6	2.7	1.8	0.4	7.0	0.4	1.3	8.6	7.2	6.0	3.6	0.4	2.6	8.8	17.2	28.3	2.1	4.6	2.1	1.3	10.6	1.3	11.3	1.7	4.0	1.0	5.0	3.6	1.5	2.1	18.3	19.2	6.7	3.4	78.2	6.6	6.1	11.3	27.3	2.5	4.7	3.7	2.0	3.5	17.1	1.3	0.7	17.7	12.4	6.9	8.3	7.6	0.0	0.2	23.5	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	9.6	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	11.8	0.1	10.7	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	30.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.1	0.0	1.3	0.0	39.0	0.6	7.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.1	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.5	0.0	0.1	0.0	0.0	0.1	0.6	1.8	0.4	1.3	2.1	1.3	4.0	1.0	19.2	1.3	0.0	1.0	0.5	34.2	29.2	6.0	4.8	5.1	9.4	6.8	0.0	25.5	7.7	0.0	0.1	447.7	3.1	1.3	0.0	0.0	15.3	3.4	4.5	1.1	0.8	2.8	0.0	0.0	9.2	5.6	1248.1	6.9	2.4	62.4	1.0	3.4	71.0	0.1	0.0	6.7	0.3	74.9	19.4	3.1	8.4	4.4	26.5	8.8	2.2	1.5	31.0
ST6GALNAC5	"MGC3184, SIAT7E, ST6GalNAcV"	ENSG00000117069	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5"	Q9BVH7	1	76867441-77065711	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enriched"	"Detected in some"	7	"Alveolar cells type 1: 50.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.9"	"Group enriched"	"Detected in many"	4	"amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065593, HPA070354"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA065593: AB_2685515, HPA070354: AB_2686260"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.66e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.69e-2)"	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0.0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3.0	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1.0	2.1	10.2	0.8	1.0	3.7	1.2	0.2	0.0	0.6	0.0	1.4	4.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	9.1	0.0	0.0	0.0	0.0	0.8	3.2	2.6	0.8	0.0	0.2	0.0	0.0	10.9	0.0	5.2	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.7	0.6	0.0	0.1	2.5	7.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	9.0	0.0	5.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3.0	14.2	4.7	0.2	50.6	0.3	0.0	0.0	0.0	7.3	0.4	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.1
ST8SIA2	"HsT19690, SIAT8B, ST8SIA-II, STX"	ENSG00000140557	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2"	Q92186	15	92393828-92468728	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 17.7;heart muscle: 10.0"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 4.5;Muller glia cells: 2.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 22.2;LHCN-M2: 6.5;RH-30: 10.1;RPMI-8226: 7.3;SH-SY5Y: 4.3;WM-115: 6.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054518, HPA057819"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA054518: AB_2682514, HPA057819: "	"unprognostic (4.70e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.87e-2)"		"unprognostic (2.32e-1)"	"unprognostic (1.28e-5)"	"unprognostic (3.91e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.00e-1)"	0.3	1.1	1.3	0.2	2.2	0.1	1.2	1.5	3.7	2.6	0.3	0.0	0.0	0.1	1.3	2.5	0.4	0.1	0.7	10.0	3.0	3.6	0.3	0.1	0.1	0.2	2.2	1.4	0.1	0.1	0.1	0.9	0.1	17.7	0.3	0.2	1.0	0.8	0.5	2.1	0.1	0.4	0.2	0.2	0.1	0.2	0.8	0.1	2.5	0.2	1.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	3.5	0.0	0.0	0.0	10.1	7.3	0.0	0.0	0.5	4.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.7	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.2	1.5	2.6	3.0	3.6	2.2	1.4	17.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.8;brain: 36.4"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"cerebellum: 36.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"WM-115: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"		NA	NA			"Plasma membrane, Midbody"		"HPA043813: AB_2678683, HPA046771: AB_2679798"	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.6	12.8	3.6	0.6	7.8	0.9	0.5	36.4	16.1	0.5	0.5	1.0	0.0	0.7	0.5	0.9	0.4	0.7	0.6	7.2	4.0	1.8	1.5	0.4	0.5	0.5	2.0	6.9	0.7	0.4	4.9	0.7	0.4	4.1	0.6	0.5	0.0	0.4	0.5	8.2	0.7	0.5	0.5	2.5	0.5	0.7	0.9	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.8	0.4	1.5	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.1	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	52.9	1.0	0.4	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.8	0.3	0.3	1.5	0.5	0.2	0.4	0.1	0.0	3.6	7.8	36.4	16.1	4.0	1.8	2.0	6.9	4.1	0.7	0.0	0.0	0.0	0.0	0.0	1.0	6.9	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380344-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	22	"Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 21.3"	"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	3.7	6.4	1.4	1.1	5.4	0.6	5.7	21.3	0.8	9.2	4.6	1.2	4.7	0.3	9.0	2.2	3.3	4.0	5.1	0.7	0.9	3.9	3.3	1.8	15.0	0.7	1.6	0.2	3.2	0.6	18.8	1.8	0.6	5.2	17.2	1.1	1.9	1.8	5.7	4.0	1.6	0.6	12.5	1.2	0.9	1.5	2.4	0.2	0.7	1.0	4.4	0.5	8.4	15.5	0.0	0.6	3.2	0.4	2.8	3.8	0.2	3.5	1.5	0.8	0.0	3.2	1.0	0.0	9.0	0.2	1.9	2.3	0.0	0.0	0.0	3.7	22.0	6.3	16.2	1.1	3.9	2.0	0.0	2.8	0.5	4.9	0.1	0.0	9.0	0.1	1.2	0.1	0.0	0.3	13.5	0.0	0.9	0.0	0.2	0.2	0.0	1.8	0.1	6.7	0.0	1.4	0.0	0.0	0.0	5.1	0.0	3.0	23.2	3.6	2.5	0.0	7.0	0.0	0.9	4.0	0.2	9.4	0.3	14.1	0.0	0.0	0.0	23.9	3.6	4.0	0.0	0.1	3.2	0.0	0.4	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.1	0.0	3.8	0.2	1.4	5.4	21.3	0.8	0.9	3.9	1.6	0.2	5.2	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.1	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.1	4.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.6	0.0	2.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 31.9;granulocytes: 75.5;Melanocytes: 15.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 63.5;U-698: 28.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	9.2	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0	0.0	10.1	31.9	0.0	0.2	0.0	0.0	0.0	1.4	1.2	5.2	0.0	0.0	8.3	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.6	0.0	0.0	0.0	0.0	5.2	0.3	0.6	15.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.9	0.0	0.0
STAR	"StAR, STARD1"	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38143649-38151265	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Steroidogenesis, Transport"		"Congenital adrenal hyperplasia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 311.3;ovary: 124.6"	"Cell type enriched"	"Detected in some"	5	"Leydig cells: 46.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in some"	8	"basal ganglia: 10.6"	"Cell type enriched"	"Detected in single"	11	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Cell line enriched"	"Detected in some"	5	"K-562: 101.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA023644, HPA027318, CAB032598"	Enhanced					NA	NA					"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	0.2	311.3	0.5	0.3	10.6	0.3	0.0	0.0	1.0	0.0	0.0	11.6	0.0	0.0	0.1	0.8	0.2	0.4	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.3	0.2	0.9	124.6	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.0	29.5	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.1	5.7	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.1	1.3	0.3	1.0	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	101.9	0.0	0.0	0.0	0.0	12.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	12.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	5.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.5	10.6	0.0	1.0	0.3	0.5	0.2	0.9	1.2	0.1	0.0	0.0	0.0	0.6	8.4	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.6	46.3	0.0	3.3	0.0	0.0	0.5	0.1	0.0	3.9	0.0	0.7	0.0	0.2	1.4	0.7	9.8	0.1	0.0	0.0	0.1
STARD5	MGC10327	ENSG00000172345	"StAR related lipid transfer domain containing 5"	Q9NSY2	15	81309053-81324183	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.6"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 22.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 20.8"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 7.8;RPMI-8226: 7.8;U-266/70: 9.5;U-937: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040662	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA040662: AB_10959593"	"unprognostic (5.35e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.08e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.84e-3)"	"unprognostic (7.55e-3)"	2.8	1.0	1.2	8.6	1.5	5.9	2.7	20.8	3.4	14.3	7.7	1.5	6.6	3.5	7.3	22.3	9.2	4.3	4.4	1.9	1.0	1.1	1.4	59.6	4.3	11.1	1.1	1.0	3.2	1.1	0.6	1.0	9.3	1.2	6.1	5.9	1.5	3.2	6.6	0.9	12.4	7.7	3.6	1.9	10.8	3.3	4.4	1.4	1.7	2.5	10.6	9.8	6.1	7.9	2.1	4.8	6.9	4.6	4.8	7.6	5.6	0.4	0.1	0.1	1.2	3.0	3.1	0.2	0.4	0.4	1.0	1.6	0.1	0.1	6.2	0.0	1.8	0.3	5.2	1.5	1.2	0.8	0.1	0.5	2.3	0.3	0.5	0.6	3.5	7.8	2.5	2.6	0.4	0.8	2.0	0.1	2.5	0.7	1.7	0.7	0.2	0.6	5.0	0.4	0.3	0.0	0.1	0.9	7.8	0.4	1.8	0.4	0.1	0.2	0.7	0.7	0.5	0.8	0.8	0.2	1.7	0.9	1.7	0.1	9.5	1.9	2.4	1.2	8.8	0.5	6.9	3.0	4.2	5.8	4.6	5.0	2.1	5.4	6.1	4.8	1.6	7.6	7.5	2.4	4.8	4.0	2.5	6.3	5.6	1.2	1.5	20.8	3.4	1.0	1.1	1.1	1.0	1.2	1.4	0.0	0.6	6.7	12.4	11.7	1.8	0.2	0.0	4.0	2.3	0.0	5.9	2.0	3.3	1.2	11.0	1.0	19.1	0.0	1.2	3.1	7.5	2.2	10.3	22.1	4.8	1.6	10.9	3.7	5.3	0.5	4.6	6.1	1.7	0.0	18.1	1.7	1.6	11.4	9.2	0.5	0.7	0.0	2.1	0.5	0.4	14.3	4.1	4.5	14.0	6.8
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Group enriched"	"Detected in some"	6	"HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	39.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.9	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	52.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4	50.6	320.5	0.0	6.3	8.4	1.1	4.0	0.0	97.7	178.6	0.0	2.0	0.3	0.0	11.7	12.9	8.9	0.0	0.0	8.2	9.0	11.1	62.8	15.1	0.4	2.1	0.0	0.0	19.0	5.1	1.9	106.4	7.7	5.0	0.0	0.0	2.4	16.5	0.0	8.5	0.0	0.2	452.7	115.4	0.9	0.2	16.4	9.2	0.0	0.0	12.2
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 78.5;T-cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.8	7.3	4.5	6.8	5.3	6.6	11.6	10.2	8.5	7.4	6.9	3.8	10.4	9.5	5.4	12.6	15.7	9.2	2.0	12.5	4.8	12.3	3.4	11.4	3.0	2.1	7.6	11.5	13.5	6.5	2.7	10.1	8.4	2.7	6.4	3.7	1.0	13.3	5.2	12.6	8.2	25.8	1.8	3.9	5.8	13.6	3.6	6.2	3.0	9.9	3.1	3.8	5.9	8.3	28.0	5.9	2.9	24.4	8.9	8.3	4.2	5.8	5.5	11.2	16.5	6.0	10.9	17.7	52.3	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5	3.0	12.8	25.0	7.9	6.0	3.8	3.6	2.5	5.3	5.7	1.8	5.9	2.8	1.7	4.4	1.7	17.8	8.4	0.0	5.3	25.1	7.4	6.7	26.7	2.1	30.8	44.5	11.5	20.3	78.5	2.7	2.6	39.2	8.5	9.0	15.0	3.1	7.9	7.0	1.4	1.5	2.2	12.9	8.2	5.7	6.8	3.6	4.2	70.5	4.7	9.5
STON1	"SBLF, stoned-b1"	ENSG00000243244	"Stonin 1"	Q9Y6Q2	2	48529383-48598513	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Muller glia cells: 34.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 11.9;midbrain: 6.8;pons and medulla: 20.7"	"Group enriched"	"Detected in some"	14	"basophil: 4.8;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.0;ASC TERT1: 18.4;HSkMC: 23.0;hTERT-RPE1: 10.6;SuSa: 12.8"									HPA005715	Uncertain					NA	NA					"HPA005715: AB_1080113"	"unprognostic (1.61e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.49e-3)"	16.0	4.4	1.6	10.6	2.1	0.5	12.5	11.9	3.4	26.4	24.0	5.1	8.8	2.9	35.7	8.3	23.3	12.8	13.9	5.6	1.9	2.6	7.8	1.7	8.7	3.3	6.8	0.0	21.8	2.2	2.2	3.1	14.3	20.7	24.5	7.1	9.7	2.6	16.6	3.7	3.6	6.5	52.4	37.3	11.0	11.9	5.6	2.6	2.6	6.9	2.2	1.2	53.5	24.6	0.1	0.1	4.8	0.1	0.1	0.2	0.1	0.0	0.0	5.3	0.1	15.0	18.4	3.1	0.6	5.7	0.5	1.3	0.0	0.0	0.0	0.2	7.3	2.8	5.5	5.1	0.1	1.1	0.0	1.4	0.8	0.4	0.0	8.6	0.0	0.3	23.0	1.1	1.5	0.6	10.6	10.0	0.4	0.1	0.1	3.5	0.3	0.4	0.2	5.0	0.0	0.0	0.8	1.1	0.0	0.5	4.0	0.2	1.2	0.4	0.9	2.4	12.8	0.4	0.2	5.3	1.9	1.5	0.0	0.4	0.3	0.0	0.0	1.0	0.0	1.2	4.8	0.1	0.2	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.1	3.0	0.1	0.0	0.1	0.2	0.1	1.6	2.1	11.9	1.3	1.9	2.6	6.8	0.0	20.7	2.6	0.0	0.3	0.5	13.7	2.2	1.7	1.6	0.0	0.0	1.2	5.2	2.0	12.1	3.3	0.5	0.2	3.1	0.0	0.0	0.3	0.5	11.7	13.4	0.0	0.0	2.2	12.7	2.4	8.0	2.1	0.2	11.2	1.8	0.0	1.0	0.3	34.8	0.4	0.0	9.6	1.5	1.9	25.8	10.0	0.3	1.5	2.0	10.5	1.3	0.4	13.3
STON1-GTF2A1L	SALF	ENSG00000068781	"STON1-GTF2A1L readthrough"		2	48529925-48776517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"urinary bladder: 31.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.8;Spermatocytes: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 6.3;midbrain: 3.2;pons and medulla: 12.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;ASC TERT1: 3.4;HSkMC: 2.4;hTERT-RPE1: 6.0;SuSa: 12.3"									HPA005715	Uncertain					NA	NA					"HPA005715: AB_1080113"	"unprognostic (5.66e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-3)"		"unprognostic (8.26e-2)"	"unprognostic (5.08e-2)"		"unprognostic (3.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-2)"	9.4	1.8	1.5	5.7	1.5	0.7	7.3	6.3	1.4	15.1	12.7	2.2	4.4	1.4	20.5	4.6	13.2	5.0	7.9	2.4	1.5	1.5	3.9	1.5	4.7	1.7	3.2	0.0	13.2	1.5	0.8	1.8	7.5	12.0	14.1	3.7	5.5	1.5	5.6	1.6	1.6	3.0	30.3	22.2	7.8	5.3	2.9	0.7	0.8	3.5	0.6	0.8	31.6	15.1	0.0	0.0	0.7	0.0	0.6	1.0	0.0	0.0	0.1	1.3	0.0	3.6	3.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	2.4	0.2	0.0	0.1	6.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	1.5	6.3	1.4	1.5	1.5	3.2	0.0	12.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.1
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434433-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;retina: 55.6;skeletal muscle: 27.4"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 37.1;Muller glia cells: 70.1;Spermatocytes: 32.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 36.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.8;U-2197: 23.7;U-87 MG: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019657	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.7	2.4	1.9	2.0	36.6	3.7	0.8	7.0	10.0	0.4	0.8	3.0	0.0	0.8	0.8	1.6	1.1	0.4	1.2	10.3	1.5	2.1	5.6	0.6	1.0	2.7	2.2	2.9	0.7	1.3	0.4	4.7	1.3	7.6	1.6	1.4	55.6	1.7	0.5	27.4	1.5	1.0	0.8	1.2	1.5	1.0	13.5	9.4	0.2	0.8	2.1	2.1	0.9	0.3	0.6	0.7	2.5	0.6	0.4	0.9	0.4	7.7	3.4	3.1	4.9	1.2	1.1	13.6	3.2	4.1	5.4	5.3	1.8	4.4	3.3	0.4	1.3	17.7	8.8	3.3	2.9	8.3	19.0	2.8	2.5	5.6	1.9	0.8	1.6	13.3	1.3	1.0	9.2	5.8	9.0	9.3	3.0	10.8	2.1	20.8	0.4	4.1	4.0	3.0	1.7	7.0	2.7	5.8	0.7	2.0	2.9	0.7	0.7	7.4	0.6	1.6	2.5	0.9	3.9	3.3	3.1	3.1	23.7	9.2	1.9	1.2	3.9	21.1	4.1	4.4	2.5	0.6	0.6	0.9	0.4	0.3	0.3	0.6	0.3	0.2	0.6	0.5	0.4	2.0	0.4	0.5	0.7	0.9	0.4	1.9	36.6	7.0	4.8	1.5	2.1	2.2	2.9	7.6	9.4	3.0	0.6	0.0	0.2	0.2	11.0	37.1	0.0	1.4	0.0	0.0	2.0	0.4	0.0	0.8	4.7	0.5	0.0	0.0	3.3	3.4	1.0	0.1	7.0	0.0	0.7	1.6	0.0	0.6	0.0	7.9	0.6	1.3	1.7	13.6	0.0	70.1	3.8	0.0	0.7	9.6	3.5	0.0	0.5	32.7	9.6	0.1	0.2	0.0	0.4	0.6
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014369-94028610	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 24.1;Enterocytes: 18.8;Mucus-secreting cells: 26.4;Paneth cells: 34.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 2.2;hTCEpi: 7.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.4	0.2	0.3	7.0	0.4	0.0	4.0	1.8	3.5	3.9	11.7	0.1	1.5	5.7	0.5	13.6	12.8	0.8	2.3	0.3	0.5	0.3	1.0	0.4	7.1	0.1	0.3	0.7	0.5	7.7	7.1	0.5	0.7	0.1	4.3	10.6	0.1	9.8	3.2	0.2	6.9	20.9	0.1	0.4	1.0	6.0	0.4	0.1	0.4	0.4	5.0	1.5	0.7	4.1	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.6	0.1	0.1	0.0	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	7.3	0.0	0.8	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.5	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.5	1.2	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	1.8	3.5	0.5	0.3	0.3	0.7	0.1	0.1	14.9	12.8	0.0	2.2	1.4	3.5	0.0	0.0	24.1	7.9	0.0	11.8	0.1	1.7	3.2	1.1	0.0	18.8	0.0	7.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.4	6.7	34.8	0.7	0.0	16.1	0.0	0.3	0.2	0.0	1.6	0.2	0.0	13.9	1.0
SULF1	"hSulf-1, KIAA1077, SULF-1"	ENSG00000137573	"Sulfatase 1"	Q8IWU6	8	69466624-69660915	"Predicted intracellular proteins"	Apoptosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Early spermatids: 194.1;Late spermatids: 80.8;Muller glia cells: 177.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 26.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ: 54.7;BJ hTERT+: 73.9;fHDF/TERT166: 90.5;U-2197: 22.8;WM-115: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054728	Supported				"Intracellular and membrane"	NA	NA					"HPA054728: AB_2682586"	"unprognostic (2.89e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (8.91e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.69e-2)"	19.9	1.6	1.8	11.7	3.6	0.0	7.6	2.3	2.9	15.7	30.4	5.6	14.6	4.8	30.5	28.9	9.6	10.2	16.0	11.7	2.2	4.4	7.4	1.5	7.3	2.8	2.0	3.5	18.9	2.2	0.5	10.7	3.6	26.2	27.7	10.8	47.4	4.8	22.6	5.1	2.9	12.9	36.5	2.6	1.2	4.0	6.7	0.7	0.0	26.1	8.0	3.2	20.9	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.1	0.0	1.1	5.0	0.0	54.7	73.9	1.9	0.3	0.0	0.2	0.0	0.0	90.5	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	6.5	0.6	3.2	1.2	2.7	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	13.3	0.0	0.0	5.2	0.1	22.8	0.0	0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	3.6	2.3	2.9	2.2	4.4	2.0	3.5	26.2	0.7	8.9	3.8	0.0	3.2	0.8	1.8	3.1	0.0	9.4	22.7	5.2	0.0	0.1	0.0	0.3	194.1	6.8	0.0	0.0	0.0	0.0	4.3	1.0	0.0	0.0	0.2	0.0	1.2	7.4	0.0	80.8	6.1	1.3	0.0	0.0	0.0	177.6	1.1	0.0	1.8	0.0	4.9	0.0	11.8	0.9	1.4	0.3	0.2	0.0	0.0	0.1
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.2;kidney: 58.4;stomach 1: 59.2"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 19.2;Distal tubular cells: 49.7;Proximal tubular cells: 60.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 24.1;RT4: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA					"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.5	0.1	0.2	2.2	0.2	0.0	0.4	0.1	0.2	0.8	1.5	1.0	0.5	10.6	0.8	13.3	0.4	1.0	69.2	0.5	0.2	0.2	58.4	1.5	2.5	0.6	0.4	0.3	0.3	3.2	0.2	4.6	0.6	2.2	0.3	1.9	18.6	3.5	4.9	0.1	0.2	1.8	0.6	0.6	0.4	59.2	0.4	0.0	0.4	10.3	0.4	0.3	0.6	0.4	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.2	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.2	0.0	24.1	6.9	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.4	0.3	2.2	0.0	3.0	13.1	0.0	1.2	1.3	1.2	1.9	17.8	1.4	4.5	19.2	2.0	0.2	49.7	2.5	0.0	2.7	4.9	0.0	0.2	0.2	3.9	2.3	1.1	0.5	14.2	1.6	0.0	3.1	0.0	0.0	0.0	2.2	0.0	0.0	6.3	0.0	3.8	7.0	0.0	60.0	0.6	0.0	0.3	0.3	0.2	1.6	0.1	0.0	4.7	0.8
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 47.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4"									"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	38.0	0.0	0.0	17.2	14.3	0.0	0.4	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1	0.0	0.0	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.2	0.1	0.0	0.0	47.0	0.2	0.0	0.0	1.8	1.0	0.0	0.3	0.0	1.7	0.0	0.2	0.0	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.3	0.0	0.0	0.1
SUSD2	"BK65A6.2, FLJ22778"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181259-24189110	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 100.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 232.3;Alveolar cells type 2: 121.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"SK-BR-3: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		3600000	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	6.0	4.2	0.3	1.4	0.9	0.5	11.3	3.8	1.4	10.5	10.5	2.5	1.3	7.8	7.1	8.3	2.8	6.9	5.3	10.8	0.6	2.9	19.5	1.2	100.1	1.4	0.6	2.6	2.6	2.4	1.3	3.6	3.5	9.6	2.8	1.0	2.2	7.9	4.0	3.0	11.8	32.4	2.4	3.0	1.6	2.5	1.9	0.7	0.1	12.7	5.9	1.5	2.3	4.7	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.7	1.5	0.0	0.0	3.0	3.9	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.2	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.2	0.0	0.0	3.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	0.1	138.9	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	3.8	1.4	0.6	2.9	0.6	2.6	9.6	0.7	232.3	121.0	0.0	0.2	0.2	0.0	2.8	0.0	5.3	33.0	1.8	0.0	14.1	5.0	0.0	0.0	0.3	1.6	0.0	0.0	0.4	3.5	0.8	3.5	0.0	0.9	0.0	1.7	4.3	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	24.9	0.0	0.0	15.1	0.9	0.9	2.4	22.1	0.0	0.0	0.5
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083172-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Cell type enriched"	"Detected in some"	4	"Intestinal endocrine cells: 19.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 52.2;pons and medulla: 26.6"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 4.2"	"Group enriched"	"Detected in some"	5	"Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0.0	1.0	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1.0	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1.0	5.8	0.6	1.6	1.0	6.7	0.0	0.5	0.0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7	0.0	0.0	0.0	0.5	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.1	0.0	19.0	0.6	0.0	0.7	0.0	0.0	3.3	0.0	0.5	0.8	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	1.1
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365251-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 141.1"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 33.2;Leydig cells: 38.9;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 51.6;ASC TERT1: 30.0;BJ hTERT+: 21.1;HHSteC: 18.9;HSkMC: 23.4"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	7	"cerebellum: 31.1"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	18.8	2.5	1.0	3.9	1.8	0.0	11.9	6.7	0.9	7.1	8.6	0.5	3.6	0.6	6.1	7.8	4.7	4.4	5.4	4.4	1.1	0.7	2.1	1.5	8.6	5.8	1.1	0.5	4.2	2.7	2.2	0.7	141.1	0.7	4.3	3.1	1.5	2.2	1.3	7.4	3.5	3.3	5.7	0.6	3.4	3.6	4.0	0.9	0.0	3.5	2.3	1.3	9.6	7.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	51.6	30.0	0.0	5.4	21.1	0.4	0.6	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.1	0.3	0.0	0.1	0.0	0.4	0.0	18.9	0.0	1.0	23.4	0.0	4.1	1.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.5	0.7	0.0	3.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.4	0.8	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	6.7	0.9	1.1	0.7	1.1	0.5	0.7	0.9	0.0	0.3	0.0	0.5	5.0	0.0	1.2	7.6	0.0	0.0	0.0	0.0	7.6	0.0	0.6	0.2	2.1	0.0	0.0	0.2	1.1	33.2	0.2	0.0	0.0	2.7	0.0	0.0	3.1	0.0	0.0	38.9	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.1	1.4	2.9	56.3	0.0	0.0	0.1
SYNDIG1L	"capucin, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405893-74426102	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	27	"brain: 78.1;epididymis: 20.1"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 2.4;Bipolar cells: 8.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 78.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.2;NTERA-2: 1.3;SuSa: 1.8;U-266/70: 1.7;U-266/84: 1.9"	"Region enriched"	"Detected in many"	8	"basal ganglia: 251.1"	"Region enriched"	"Detected in many"	6	"basal ganglia: 71.7"	"HPA042594, HPA048487"	Uncertain					NA	NA					"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.6	0.4	0.3	0.4	78.1	0.2	0.6	0.0	4.0	0.5	0.6	1.1	0.0	0.3	0.6	20.1	0.5	0.4	0.7	0.4	2.4	1.6	0.6	0.3	1.8	0.4	3.5	0.2	0.4	0.5	0.2	0.0	0.3	0.5	0.6	0.6	0.1	0.4	0.6	0.3	0.5	0.9	0.8	0.4	0.4	0.3	0.4	16.6	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	0.5	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.7	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.3	78.1	0.0	4.0	2.4	1.6	3.5	0.2	0.5	16.6	0.0	2.4	0.0	0.0	0.3	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63852983-64226433	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 111.4"	"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 579.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 15.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in many"		"eosinophil: 30.3"	"Group enriched"	"Detected in many"	10	"granulocytes: 30.3;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.8	4.5	2.3	18.0	2.8	5.5	29.7	15.8	3.3	16.1	13.4	1.9	7.7	3.6	18.8	13.6	17.2	7.1	8.6	27.3	2.3	2.4	35.6	13.0	15.2	11.0	2.7	2.1	22.8	22.4	60.1	17.6	14.1	16.3	13.7	4.8	13.0	9.8	9.2	111.4	24.1	10.6	10.2	2.3	16.0	6.9	14.3	1.9	16.9	30.9	29.7	15.8	11.1	26.4	2.3	1.1	30.3	0.1	1.5	16.3	1.3	17.7	6.0	8.9	2.8	8.9	2.6	11.8	1.2	1.2	2.0	3.6	2.0	3.7	44.5	1.9	1.2	2.2	8.6	5.8	2.3	2.5	6.7	2.3	0.2	4.4	0.5	1.7	0.7	0.2	3.7	8.4	2.6	2.4	2.0	4.6	5.7	0.2	3.6	1.5	9.9	4.7	0.2	4.0	5.7	1.8	5.6	8.4	1.4	13.5	8.5	8.2	6.1	14.1	3.3	3.8	3.8	3.9	0.1	4.0	3.3	5.3	1.1	3.7	4.9	2.1	16.9	0.9	0.0	4.7	0.2	0.0	30.3	16.3	0.1	11.0	2.1	10.0	10.8	0.0	2.3	4.9	7.4	13.3	1.5	0.1	1.1	11.1	1.3	2.3	2.8	15.8	2.6	2.3	2.4	2.7	2.1	16.3	1.9	285.9	119.8	37.9	110.7	98.9	26.4	222.5	107.0	271.7	293.5	191.9	172.8	136.2	16.6	78.5	6.5	155.5	34.5	0.0	48.5	56.0	55.6	45.4	24.4	28.8	14.9	6.4	44.4	68.7	4.7	8.1	93.5	7.9	45.5	4.6	57.4	99.5	65.8	10.5	50.2	64.2	579.2	109.9	65.5	13.6	7.8	76.5	187.3	96.2	67.0	63.0
SYNE4	"C19orf46, DFNB76, FLJ36445, Nesp4, Nesprin-4"	ENSG00000181392	"Spectrin repeat containing nuclear envelope family member 4"	Q8N205	19	36003299-36008793	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 28.4;Intestinal endocrine cells: 28.6;Syncytiotrophoblasts: 28.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.6;Hep G2: 16.1;MCF7: 18.9;SK-BR-3: 23.1;T-47d: 17.6"	"Region enriched"	"Detected in single"	15	"cerebellum: 7.6"	"Not detected"	"Not detected"			HPA060253	Uncertain					NA	NA					"HPA060253: AB_2684233"	"unprognostic (8.54e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.36e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (8.64e-9)"	"unprognostic (1.25e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.97e-2)"	0.1	0.2	0.2	0.4	2.7	0.1	6.3	15.3	2.0	3.1	1.8	0.3	16.9	3.5	1.0	10.3	1.3	4.6	3.5	0.1	0.2	4.4	6.5	9.0	4.2	0.1	2.1	0.1	1.0	7.5	14.1	18.1	3.3	10.0	9.5	1.7	1.4	10.9	12.6	0.2	0.9	4.4	0.4	1.0	0.3	2.6	0.3	0.6	1.4	14.4	0.7	1.0	1.3	1.1	0.0	0.0	0.8	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.1	2.4	0.0	0.0	0.1	0.1	18.6	2.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.2	16.1	0.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	0.8	0.1	0.1	0.0	18.9	0.3	0.0	0.0	0.1	0.1	0.4	0.0	0.2	1.2	0.6	2.8	0.0	0.0	23.1	0.1	0.0	17.6	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.7	15.3	2.0	0.2	4.4	2.1	0.1	10.0	0.6	6.0	10.8	0.9	16.1	0.5	0.5	0.4	12.7	12.0	10.3	27.9	3.9	28.4	21.6	18.4	0.0	0.1	2.9	0.0	7.6	19.4	0.9	19.6	1.1	10.9	2.2	0.0	28.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	10.0	0.0	12.8	14.4	0.0	16.3	0.4	0.0	0.2	0.0	0.5	0.4	28.4	0.0	6.8	5.8
SYNGR4		ENSG00000105467	"Synaptogyrin 4"	O95473	19	48364395-48376376	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 41.5"	"Cell type enriched"	"Detected in some"	5	"Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 4.1"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"A549: 9.1;SCLC-21H: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030075, HPA059286"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA030075: AB_10610559, HPA059286: AB_2683965"	"unprognostic (1.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.49e-4)"	"unprognostic (2.51e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.87e-2)"	"unprognostic (6.19e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.02e-7)"	"unprognostic (1.06e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	4.1	2.0	0.0	0.2	0.0	0.9	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.7	3.0	0.2	0.2	0.3	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	0.0	41.5	0.0	0.3	0.1	0.0	0.2	0.2	0.0	1.3	0.7	0.1	0.5	0.0	0.9	0.6	0.1	9.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.5	2.9	0.5	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	3.4	0.1	0.2	0.5	0.2	0.0	0.6	1.7	0.6	0.0	2.6	0.0	0.0	22.9	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.0	0.8	0.0	0.0	3.1	1.0	0.7	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.7	4.1	0.9	0.2	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	8.7	0.0	0.0	18.9	0.9	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	147.5	4.5	0.0	0.0	0.0	0.1	0.1
SYNPR	"MGC26651, SPO"	ENSG00000163630	Synaptoporin	Q8TBG9	3	63228315-63616921	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 99.9"	"Group enriched"	"Detected in some"	12	"Horizontal cells: 100.1;Muller glia cells: 40.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 99.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.3;SCLC-21H: 4.3;SH-SY5Y: 1.2;SuSa: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051368, HPA061671"	Enhanced					NA	NA					"HPA051368: AB_2681456, HPA061671: AB_2684582"			"unprognostic (1.69e-1)"		"unprognostic (3.77e-2)"			"unprognostic (3.14e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.89e-1)"		1.1	1.5	13.3	1.3	99.9	1.1	1.1	26.9	58.4	1.2	1.2	1.5	0.0	1.4	1.1	1.2	1.1	1.2	1.2	6.1	20.4	7.6	1.2	1.1	1.1	1.1	4.6	14.4	1.1	1.3	1.1	0.1	1.1	4.3	1.1	1.2	11.9	1.8	1.2	1.1	1.1	1.2	1.2	2.2	1.1	1.8	1.1	4.6	0.0	1.2	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.2	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	99.9	26.9	31.2	20.4	7.6	4.6	14.4	4.3	4.6	0.0	0.0	0.0	0.0	0.0	4.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	100.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYT2		ENSG00000143858	"Synaptotagmin 2"	Q8N9I0	1	202590596-202710417	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	Differentiation		"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 40.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 3.4;Cardiomyocytes: 2.4;Horizontal cells: 3.2;Leydig cells: 3.1;Rod photoreceptor cells: 4.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.8"	"Group enriched"	"Detected in many"	5	"cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;NTERA-2: 8.8;U-2 OS: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA063655	Enhanced	Supported				NA	NA					"HPA063655: AB_2685077"	"unprognostic (1.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.35e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.17e-3)"	1.1	6.1	0.4	1.1	5.9	0.5	0.3	36.2	14.7	0.6	0.7	0.3	0.0	1.1	1.7	4.1	0.4	0.8	1.1	1.5	0.6	1.5	0.5	0.4	0.6	0.7	5.5	0.4	3.1	0.4	0.2	0.3	0.5	40.1	0.9	0.7	1.6	1.1	0.5	1.1	0.7	1.3	0.5	7.1	1.2	0.7	2.4	1.1	0.0	0.6	0.0	0.5	1.0	0.3	0.1	0.0	2.4	0.1	0.1	0.2	0.0	0.0	0.2	12.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.4	5.9	36.2	14.7	0.6	1.5	5.5	0.4	40.1	1.1	0.0	0.0	0.0	1.3	0.5	3.4	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.2	1.3	0.5	0.1	0.0	0.2	2.0
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 70.0;Basal glandular cells: 70.0;Urothelial cells: 73.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 8.8;cerebellum: 30.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 20.2;CAPAN-2: 23.1;NB-4: 32.8;U-266/70: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA					"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	0.6	0.1	8.8	20.8	0.5	19.2	5.6	30.2	0.7	9.1	3.7	0.4	15.7	3.4	2.5	5.1	38.1	7.2	15.3	0.9	1.1	0.4	1.7	0.7	8.6	13.5	0.7	0.7	2.3	50.8	2.5	7.2	3.6	1.8	20.6	1.4	0.9	42.6	20.5	0.4	26.2	5.7	3.0	0.4	14.5	15.4	0.7	0.5	20.3	4.7	26.4	47.4	12.5	15.7	14.5	15.9	52.3	28.9	14.5	21.6	11.2	4.5	0.0	0.0	0.1	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.4	23.1	3.4	4.6	0.0	0.1	14.4	0.0	8.6	0.0	0.0	0.8	0.4	0.3	6.0	0.3	8.8	0.0	0.0	16.0	0.0	3.3	0.0	0.0	11.7	0.3	4.0	0.0	5.9	5.1	32.8	0.2	7.7	2.3	6.0	0.0	16.0	3.6	3.8	6.8	0.3	0.0	6.7	0.2	0.2	17.0	9.5	0.0	0.0	2.2	0.0	0.0	18.8	4.5	3.0	0.6	11.3	0.0	11.8	6.0	52.3	21.6	14.8	19.4	14.5	17.1	17.5	15.9	11.2	10.4	12.4	10.7	14.5	28.9	0.9	19.2	11.2	8.8	0.5	30.2	0.7	1.1	0.4	0.7	0.7	1.8	0.5	20.8	12.8	70.0	70.0	36.6	0.5	3.4	7.6	28.1	40.9	0.0	0.0	29.4	6.6	3.8	0.5	2.6	2.8	0.0	21.6	7.6	3.5	47.6	1.1	0.6	2.8	0.0	10.9	3.1	7.6	0.4	0.3	6.1	10.1	0.0	26.9	1.0	12.9	2.9	0.7	3.8	0.7	0.0	1.7	12.5	13.6	48.3	11.8	47.9	7.4	73.2
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97731908-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 61.3;lymphoid tissue: 62.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 7.6;Glandular cells: 3.3;Proximal tubular cells: 8.4;Smooth muscle cells: 2.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"U-266/70: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 557.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 312.7"	HPA014429	Enhanced				"Secreted to blood"	NA	NA					"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	1.8	6.5	4.1	7.7	61.3	0.3	1.7	0.3	39.8	0.7	3.7	0.1	0.0	6.0	0.9	1.6	0.3	0.7	4.9	0.5	9.3	21.5	1.6	0.6	0.3	0.3	8.0	4.5	0.3	0.7	0.3	0.3	0.3	24.5	1.0	2.9	0.3	4.5	2.0	0.4	1.2	7.6	5.3	6.7	62.9	0.9	0.6	9.4	0.0	1.6	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	61.3	0.3	9.2	9.3	21.5	8.0	4.5	24.5	9.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	8.4	0.0	0.0	2.1	0.1	0.4	0.1	0.0	0.0	0.5	0.1
TACR3	NK3R	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719816	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 14.4;urinary bladder: 5.5"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 1.1;Extravillous trophoblasts: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"BEWO: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain					NA	NA					"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.1	0.1	14.4	0.1	1.4	0.1	0.4	0.0	2.6	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.3	0.1	1.1	4.1	2.0	0.1	0.9	0.1	1.4	1.0	0.1	0.1	0.1	0.1	0.6	6.3	0.2	0.5	3.2	0.1	0.1	0.7	0.3	0.1	0.1	2.5	0.1	0.5	0.6	0.0	0.0	0.5	0.9	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	1.4	0.0	1.5	1.1	4.1	1.4	1.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
TAS1R3	T1R3	ENSG00000169962	"Taste 1 receptor member 3"	Q7RTX0	1	1331314-1335306	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.2;salivary gland: 17.9"	"Group enriched"	"Detected in some"	16	"Cardiomyocytes: 3.1;Muller glia cells: 1.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.9"	"Cell type enriched"	"Detected in single"	37	"memory B-cell: 5.2"	"Lineage enriched"	"Detected in single"	37	"B-cells: 5.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA053439	Uncertain					NA	NA					"HPA053439: AB_2682150"	"unprognostic (1.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.59e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-1)"	0.4	0.4	0.4	1.5	0.4	0.5	0.4	1.9	0.4	0.6	1.4	0.4	1.0	2.0	0.5	35.2	1.9	0.6	0.7	1.4	0.4	0.1	0.5	1.6	0.9	1.6	0.4	0.4	0.4	0.4	0.1	2.6	1.9	0.4	0.4	0.1	0.4	17.9	0.4	1.4	0.2	3.2	0.4	0.4	6.4	0.9	1.6	0.4	0.4	0.8	1.5	2.5	1.0	0.9	5.2	0.1	0.0	0.0	0.0	0.1	0.2	1.4	1.3	0.4	0.5	0.0	0.0	0.7	0.7	0.2	0.2	0.2	0.9	2.9	1.8	0.3	0.0	0.3	0.6	0.0	0.0	0.0	3.7	1.0	0.2	2.6	0.9	0.3	0.0	0.5	0.1	0.2	0.1	0.0	0.3	0.0	0.8	0.5	6.0	0.0	0.9	0.3	0.6	0.8	0.5	3.5	1.0	0.7	0.8	0.0	0.2	2.3	0.4	0.5	2.3	1.9	0.3	2.0	0.4	0.3	0.5	0.2	1.8	0.8	3.7	3.5	0.9	0.2	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	1.9	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TBX1	"CATCH22, VCF"	ENSG00000184058	"T-box 1"	O43435	22	19756703-19783593	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 36.5"	"Group enriched"	"Detected in many"	7	"Early spermatids: 42.8;Late spermatids: 139.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"basal ganglia: 3.0"	"Group enriched"	"Detected in some"	13	"basophil: 1.0;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.1;K-562: 48.7;NB-4: 11.5;TIME: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029330			Approved	"Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Nuclear bodies, Cytoplasmic bodies"		"HPA029330: AB_2673002"	"unprognostic (2.54e-1)"	"unprognostic (4.28e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.30e-3)"	"unprognostic (9.14e-2)"	"unprognostic (4.44e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (8.90e-4)"	1.4	0.2	0.6	0.6	3.0	0.0	3.7	0.6	0.6	2.5	2.3	0.6	0.6	0.4	0.9	0.6	2.5	2.8	0.6	0.6	0.6	0.0	0.6	0.6	2.2	1.7	0.6	0.6	0.7	0.6	3.7	0.6	0.6	0.6	2.3	0.2	0.6	3.4	0.6	36.5	4.6	0.8	0.6	0.6	0.6	0.1	7.0	0.6	0.6	5.3	0.6	1.9	1.1	3.3	0.0	0.1	2.7	0.0	0.0	0.1	0.0	6.0	0.6	0.1	4.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.6	0.3	5.2	4.5	0.0	0.2	10.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	48.7	0.0	3.3	1.1	0.1	11.5	0.7	0.0	7.1	0.1	4.6	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	1.4	2.1	3.1	15.6	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	1.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	3.0	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	3.2	0.0	1.1	2.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.8	3.0	0.0	0.0	0.2	0.7	0.7	0.9	2.3	0.0	1.5	0.0	0.0	1.3	1.0	139.3	2.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	1.9	13.2	2.0	0.1	0.0	0.0	1.6
TBX5	HOS	ENSG00000089225	"T-box 5"	Q99593	12	114353931-114408442	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.5;lung: 14.0;placenta: 19.7"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 62.0"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hippocampal formation: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008786, HPA064683"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008786: AB_10601720, HPA064683: AB_2685320"	"unprognostic (3.09e-2)"	"unprognostic (1.53e-1)"			"unprognostic (3.79e-2)"	"unprognostic (2.75e-1)"		"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-7)"	"unprognostic (2.29e-2)"	"unprognostic (1.68e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.38e-3)"	2.2	0.1	0.1	0.0	0.1	0.0	3.8	0.8	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	6.4	0.1	0.0	44.5	2.2	0.1	0.1	0.1	14.0	1.6	0.1	0.1	0.1	0.1	0.0	0.1	19.7	0.5	5.4	0.0	1.4	0.1	0.0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	6.5	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.1	29.2	6.8	8.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	11.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0.0	0.0	1.1	0.0	0.0	0.1	3.6	62.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"parathyroid gland: 12.2;pituitary gland: 5.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.0"	"Group enriched"	"Detected in some"	24	"naive B-cell: 2.3;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"B-cells: 2.3;NK-cells: 2.5"	"Cell line enriched"	"Detected in some"	4	"HeLa: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.3	0.0	0.1	2.0	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	5.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.4	0.0	1.9	0.0	0.0	1.2	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.5	0.9	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TDRD1	CT41.1	ENSG00000095627	"Tudor domain containing 1"	Q9BXT4	10	114179270-114232304	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.3"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 5.9;Spermatocytes: 18.4;Spermatogonia: 21.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.1"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 33.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037729	Enhanced					NA	NA					"HPA037729: AB_10670527"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.15e-2)"		"unprognostic (6.13e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.60e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.68e-1)"	0.3	0.2	0.2	0.3	0.2	0.0	0.4	0.2	2.1	0.2	0.3	0.0	0.0	0.2	0.6	0.7	0.3	0.2	0.6	0.8	0.3	0.2	2.8	0.7	0.2	0.2	0.2	0.4	0.5	0.6	0.0	0.3	0.0	0.4	2.9	0.1	0.0	0.3	0.2	0.4	0.2	0.3	0.2	0.7	1.6	0.3	35.3	0.0	0.0	0.2	1.0	0.2	0.2	0.2	0.8	4.5	0.2	0.2	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	0.1	0.5	0.2	0.8	0.8	0.0	0.2	0.4	0.0	4.5	0.2	0.0	0.2	0.2	0.2	2.1	0.3	0.2	0.2	0.4	0.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.8	0.0	4.0	0.0	0.0	0.0	0.3	0.0	0.2	5.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.7	0.7	0.0	0.0	0.0	18.4	21.3	0.0	0.1	0.0	0.0	0.0
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 37.9"	"Cell type enhanced"	"Detected in many"	23	"Early spermatids: 172.1;Spermatocytes: 66.0;Spermatogonia: 30.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 8.2"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 1.4"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;HeLa: 4.0;hTCEpi: 2.3;PC-3: 3.4;SCLC-21H: 1.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.4	0.7	2.6	1.3	0.0	0.7	8.2	1.3	0.7	0.7	0.7	0.7	0.3	0.7	2.9	0.7	0.3	1.7	0.7	1.0	0.8	0.7	1.3	0.7	3.0	1.1	0.7	0.7	0.7	0.4	1.8	1.1	0.7	1.6	0.0	0.9	0.9	0.7	1.5	2.9	0.7	0.7	0.9	1.9	0.3	37.9	0.7	0.7	5.2	0.7	0.7	1.6	0.7	0.0	0.7	0.1	2.4	0.0	0.0	0.4	0.0	0.0	0.2	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	3.4	0.0	0.0	0.0	0.9	0.7	1.7	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.3	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.7	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	1.3	8.2	0.9	1.0	0.8	1.1	0.7	0.7	0.7	8.9	0.3	0.0	0.4	0.5	8.3	2.9	0.0	0.0	6.8	7.0	5.9	0.0	1.7	0.1	172.1	0.6	0.0	0.0	0.2	0.0	0.5	0.5	0.0	1.6	0.1	4.8	4.1	0.0	0.3	17.5	3.7	0.0	3.3	0.0	0.0	1.4	0.1	0.0	4.2	0.0	6.2	12.9	0.5	66.0	30.6	1.4	0.0	0.0	0.5	0.1
TEDDM1	"EDDM9, Epdd1, HE9, TMEM45C"	ENSG00000203730	"Transmembrane epididymal protein 1"	Q5T9Z0	1	182398117-182400616	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"epididymis: 128.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 1.3"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;NB-4: 4.3"					"Not detected"	"Not detected"									NA	NA						"unprognostic (4.21e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"		"unprognostic (6.71e-4)"		"unprognostic (4.43e-3)"		"unprognostic (2.86e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.99e-3)"	0.1	0.0	0.1	0.1	0.2	0.0	0.4	1.3	0.1	0.5	0.1	0.1	1.8	0.0	0.4	128.3	0.1	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.0	0.3	0.0	0.3	0.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	2.3	0.1	0.1	0.3	0.1	0.1	0.1	0.6	0.9	0.4	3.8	0.5	0.4	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.4	0.1	4.3	0.2	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.4	0.3	0.4	0.2	0.1	0.2	0.4	0.4	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	1.3	0.5	1.0	0.6	0.1	0.4	0.1	0.2	0.1	0.1	0.9	0.5	0.3	3.8	0.4	0.5	0.4	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TENM1	"ODZ1, ODZ3, TEN-M1, TNM"	ENSG00000009694	"Teneurin transmembrane protein 1"	Q9UKZ4	X	124375903-124963817	"Predicted membrane proteins"	"Stress response, Transcription, Transcription regulation"	"Neuropeptide, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;liver: 10.5"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 8.0;Glandular cells: 16.3;granulocytes: 7.0;Hepatocytes: 15.3"	"Group enriched"	"Detected in many"	5	"glioma: 1.6;prostate cancer: 2.2;renal cancer: 1.6;testis cancer: 1.4;thyroid cancer: 7.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 17.0"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.0;hTERT-HME1: 2.7;MOLT-4: 9.8;RPTEC TERT1: 3.5;SCLC-21H: 3.4;U-138 MG: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002848	Uncertain					NA	NA					"HPA002848: AB_1079523"	"unprognostic (1.71e-3)"	"unprognostic (8.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.68e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.68e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.44e-2)"	1.9	3.0	1.4	0.4	2.4	3.5	1.0	17.0	4.4	0.4	1.1	0.9	0.4	0.1	1.4	2.3	0.4	1.5	2.0	0.4	2.3	2.7	1.8	10.5	0.9	0.9	1.0	4.2	0.4	0.4	0.0	3.5	0.4	3.3	4.8	0.3	1.5	0.9	3.8	0.5	1.6	0.7	1.1	2.6	0.6	0.5	2.3	0.4	0.4	3.1	0.4	0.7	0.4	0.4	0.0	0.0	2.4	0.1	0.6	1.6	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.0	0.0	2.3	0.0	1.2	0.0	0.0	9.8	0.0	0.5	0.0	1.5	0.0	0.0	0.1	3.5	0.0	3.4	0.0	0.0	0.7	0.0	2.3	0.8	0.0	0.0	5.8	0.2	0.0	0.4	0.3	0.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.9	0.0	0.9	1.0	0.0	0.0	1.6	1.1	2.4	0.6	0.0	0.0	0.2	0.1	1.4	2.4	17.0	3.9	2.3	2.7	1.0	4.2	3.3	0.4	0.0	0.0	0.0	0.1	3.0	8.0	0.8	2.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	5.4	16.3	7.0	15.3	0.0	6.4	0.0	0.6	0.6	0.0	4.6	0.3	3.3	0.0	0.0	0.5	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	3.4	1.6	0.0	1.0	0.0	0.1
TENM2	"KIAA1127, ODZ2, Ten-M2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.1;heart muscle: 24.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 142.6;Horizontal cells: 114.4;Peritubular cells: 58.0"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.7;HBEC3-KT: 17.5;HDLM-2: 17.1;U-138 MG: 31.3;U-2 OS: 27.2;U-251 MG: 20.0"	"Low region specificity"	"Detected in many"							"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No			Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.2	0.4	2.5	0.0	3.5	0.0	1.8	0.5	15.1	0.6	0.3	0.0	0.0	0.3	0.2	0.4	1.4	0.2	0.3	24.7	6.5	0.9	2.7	1.2	0.3	0.0	0.5	1.7	0.7	0.2	0.0	0.4	0.0	2.3	2.2	0.0	0.2	0.3	1.0	0.2	2.3	0.2	0.0	0.6	0.2	0.3	1.2	0.4	0.0	0.4	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	26.7	0.7	0.0	0.0	17.5	0.3	17.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	3.1	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.0	1.5	0.0	0.0	31.3	27.2	0.0	20.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.5	15.1	6.5	0.9	0.5	1.7	2.3	0.4	0.0	0.0	0.0	0.7	13.2	9.5	142.6	0.0	0.0	1.2	0.0	17.7	0.0	0.0	2.5	20.1	1.3	0.1	0.0	0.2	0.0	0.7	1.1	1.1	4.2	0.1	114.4	0.0	0.0	0.0	13.2	4.0	0.0	1.7	0.0	0.3	2.1	0.0	0.0	58.0	0.0	1.6	0.0	1.7	0.9	1.1	1.5	0.0	0.0	0.0	0.1
TESPA1	KIAA0748	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948018-54984746	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 45.1;brain: 56.9;lymphoid tissue: 27.8"	"Group enriched"	"Detected in some"	10	"granulocytes: 114.6;T-cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 56.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 45.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 67.8;HMC-1: 55.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA058823	Approved					NA	NA					"HPA058823: AB_2683828"	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.4	0.8	2.9	9.2	25.0	8.2	1.1	0.7	56.9	1.3	2.3	0.2	0.0	2.0	1.6	3.0	1.3	1.3	3.3	1.0	4.5	1.6	1.3	1.1	3.8	23.4	2.1	13.3	5.2	0.9	0.6	0.9	0.2	0.5	1.5	3.3	0.0	1.1	0.6	0.9	1.2	4.8	1.4	0.9	8.7	2.6	0.9	4.0	27.8	1.4	0.0	23.1	3.2	1.4	4.3	3.9	9.3	0.4	13.5	45.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	5.6	0.1	67.8	0.1	0.0	0.0	3.8	55.8	0.0	0.0	0.0	0.0	0.1	0.0	12.5	0.2	4.9	0.0	0.0	10.8	0.3	0.1	0.0	0.0	2.6	0.0	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	3.2	0.4	1.2	0.0	9.3	0.4	0.4	9.8	0.3	11.5	4.3	31.8	14.7	3.9	3.9	45.1	24.9	0.7	13.5	0.3	1.4	21.2	14.8	2.9	25.0	0.7	56.9	4.5	1.6	2.1	13.3	0.5	4.0	0.0	7.0	6.7	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	114.6	0.0	0.1	0.0	0.0	0.6	1.0	0.0	0.9	1.2	1.7	1.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	28.7	0.0	0.0
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.5;Late spermatids: 38.7;Spermatogonia: 62.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.9;HEL: 20.1;K-562: 5.6;NTERA-2: 3.8;OE19: 4.1;SCLC-21H: 4.3"					"Not detected"	"Not detected"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.0	0.0	8.9	1.1	0.0	1.2	3.2	20.1	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.6	0.0	0.0	0.1	0.1	0.1	3.8	4.1	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.3	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	38.7	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	4.2	0.0	0.0	12.9	0.0	14.2	62.1	0.0	0.1	0.0	0.0	0.0
TEX26	"C13orf26, MGC40178"	ENSG00000175664	"Testis expressed 26"	Q8N6G2	13	30932703-30975502	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 19.7;testis: 29.3"	"Group enriched"	"Detected in some"	48	"Early spermatids: 816.5;Late spermatids: 1222.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 19.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SuSa: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079709			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA079709: "					"unprognostic (2.80e-2)"			"unprognostic (1.10e-1)"			"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"		"unprognostic (1.53e-2)"	"unprognostic (9.27e-2)"			0.5	1.2	1.6	0.4	6.3	0.4	0.5	0.2	3.0	1.7	0.4	4.8	0.3	0.4	0.5	1.3	0.5	1.3	0.8	0.5	3.7	5.5	0.4	0.6	0.6	0.4	1.1	2.7	0.4	0.4	0.4	4.2	0.4	19.7	0.7	0.5	0.0	0.5	0.8	0.5	0.4	0.5	0.4	3.7	0.4	0.5	29.3	2.0	0.0	0.4	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	6.3	0.2	3.0	3.7	5.5	1.1	2.7	19.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	21.4	2.3	0.0	0.0	0.0	0.0	0.0	816.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1222.5	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	9.2	3.3	0.0	0.0	0.0	0.0	0.0
TEX29	"bA474D23.1, C13orf16, MGC35169"	ENSG00000153495	"Testis expressed 29"	Q8N6K0	13	111316184-111344249	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 36.8"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 596.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebral cortex: 6.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.8;memory B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	54	"U-698: 22.4"															NA	NA						"unprognostic (2.93e-1)"	"unprognostic (2.26e-2)"	"unprognostic (8.62e-4)"	"unprognostic (4.56e-1)"	"unprognostic (7.26e-2)"	"unprognostic (4.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.13e-9)"	"unprognostic (3.41e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.21e-2)"	0.3	0.2	2.7	0.3	1.7	0.0	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.4	0.1	0.3	0.3	0.9	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.5	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.5	0.1	0.4	0.3	0.3	0.3	0.2	36.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.3	0.6	1.8	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	22.4	0.3	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.1	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.1	2.7	1.7	0.3	6.1	0.9	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	596.2	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	114.3	4.4	0.0	0.0	0.0	0.2	0.0	1.7	0.2	3.9	0.0	0.0	0.0	1.2	1.9	3.1	0.4	0.5	0.0	0.0	0.4
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 130.5;retina: 48.1"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6"	"Region enhanced"	"Detected in single"		"cerebellum: 4.3"	"Region enhanced"	"Detected in single"		"cerebellum: 8.6"	"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.4	0.3	0.3	0.0	0.3	0.0	19.0	2.2	0.5	4.4	0.8	0.0	18.7	0.2	0.5	17.8	18.3	0.4	1.7	0.7	0.3	0.2	6.4	0.2	0.5	0.1	0.2	0.2	0.3	0.3	0.0	0.4	130.5	0.6	5.8	0.2	48.1	19.4	26.7	0.2	36.0	0.4	0.1	0.4	0.2	0.7	1.6	0.0	0.1	0.4	16.6	9.9	2.4	9.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	16.3	6.3	0.0	28.0	0.1	0.0	6.0	12.1	9.3	9.9	9.8	0.6	6.1	0.9	1.6	3.5	5.7	17.5	1.5	20.7	9.5	31.3	15.8	0.1	14.8	0.0	0.0	0.4	0.4	0.0	30.2	0.0	22.0	5.6	0.0	0.3	0.9	0.0	0.1	3.6	0.0	5.1	0.1	1.0	7.8	1.7	1.5	0.6	5.6	6.6	4.1	0.1	14.9	26.2	23.8	31.6	17.3	0.5	0.0	3.0	0.8	2.1	7.6	0.0	1.4	0.2	1.6	0.5	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.3	0.3	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	37.5	116.1	3.1	2.2	0.0	8.1	15.9	29.6	2.0	245.7	6.6	2.0	4.6	0.8	0.0	0.0	0.3	224.5	5.3	38.8	0.0	0.0	17.7	76.3	1.2	0.0	0.0	2.1	0.6	0.2	118.1	0.0	0.5	2.4	2.2	0.0	0.0	0.2	4.2	0.0	2.1	3.9	11.8	120.9	585.5	0.0	0.4	39.3
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847613	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 65.5"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 413.2"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in some"	41	"cerebellum: 4.7;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 32.4;SH-SY5Y: 60.4"	"Region enhanced"	"Detected in some"		"cerebellum: 11.2"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.2	3.0	0.0	0.0	0.0	0.0	9.4	4.7	0.0	0.2	0.2	0.0	8.8	0.0	0.0	65.5	5.8	0.0	0.0	0.1	0.0	0.1	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	6.3	0.1	0.0	12.2	7.0	0.6	0.0	6.3	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	60.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	10.4	6.9	0.6	0.0	0.0	0.0	48.8	7.9	10.5	46.4	0.0	11.5	0.3	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	1.0	413.2	0.0	0.0	0.0	0.5	0.0	0.0	101.3	0.0	0.0	2.3	0.0	0.0	0.4	0.7	9.7	0.0	0.0	0.5	0.0	3.8	4.1	0.0	0.0	0.0
TFAP2E	AP2E	ENSG00000116819	"Transcription factor AP-2 epsilon"	Q6VUC0	1	35573370-35595328	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 22.0;skin 1: 11.4"	"Cell type enhanced"	"Detected in some"	12	"Basal keratinocytes: 3.3;Bipolar cells: 9.1;Rod photoreceptor cells: 5.1;Suprabasal keratinocytes: 3.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 22.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 10.5;SK-MEL-30: 5.7;THP-1: 5.0;U-937: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (7.06e-4)"	"unprognostic (1.96e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.27e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.67e-15)"	"unprognostic (2.03e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.40e-2)"	0.6	0.5	2.5	2.6	4.3	4.7	1.3	22.0	3.4	1.2	1.3	1.1	0.6	0.3	1.3	1.8	0.7	1.3	0.7	0.6	4.8	2.9	0.6	0.6	8.2	3.0	2.2	0.6	1.7	0.6	0.2	1.5	0.7	4.7	1.2	0.4	2.2	1.1	0.7	0.6	11.4	0.6	0.7	4.3	1.9	1.0	1.7	2.9	0.6	0.6	0.6	1.6	0.6	1.3	1.4	1.2	5.2	3.1	3.5	3.1	1.6	0.4	0.4	0.6	0.3	0.5	0.9	1.8	0.3	0.3	0.2	0.1	1.2	1.0	0.2	0.8	0.3	0.1	0.4	0.1	0.0	0.3	0.5	1.2	4.3	0.8	1.1	1.3	0.7	0.3	0.3	0.9	0.6	0.4	1.8	0.0	0.9	0.1	1.3	0.0	0.7	0.9	10.5	0.9	0.0	0.6	0.4	0.3	0.3	0.0	0.1	0.4	0.8	1.2	0.5	5.7	0.6	1.6	5.0	0.5	0.3	1.8	2.6	0.7	2.2	1.1	0.1	0.3	8.8	1.6	1.6	3.1	5.2	3.1	1.1	1.5	1.4	1.8	2.5	1.2	1.3	0.8	2.5	0.0	3.5	1.4	1.0	2.1	1.6	2.5	4.3	22.0	3.4	4.8	2.9	2.2	0.6	4.7	2.9	0.0	2.2	0.0	0.1	3.3	9.1	0.3	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.6	0.6	1.0	2.0	0.6	1.7	0.0	0.0	0.2	0.2	0.0	0.7	0.0	5.1	0.0	0.3	1.1	0.3	3.9	0.1	0.0	0.5	0.1
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285207	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 52.2;salivary gland: 93.5;thyroid gland: 37.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 45.7;Collecting duct cells: 75.0;Enterocytes: 75.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"pons and medulla: 7.0"	"Cell type enriched"	"Detected in single"	7	"gdT-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.4;HEL: 9.4;hTCEpi: 10.8;RPTEC TERT1: 26.7;RT4: 19.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA			"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.0	0.2	0.6	4.0	1.1	0.0	12.9	0.6	0.9	8.7	8.5	1.2	6.3	0.2	0.8	8.2	6.0	1.5	8.7	0.1	0.6	0.1	52.2	0.1	12.3	1.5	0.4	0.0	0.6	2.8	0.4	1.5	4.7	7.0	6.1	10.5	0.8	93.5	2.9	2.4	13.1	1.3	0.4	0.4	0.9	6.2	0.8	0.3	0.4	37.3	7.2	6.3	1.4	4.1	0.0	0.1	0.1	0.1	0.4	2.9	0.0	0.0	1.0	0.0	0.1	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.4	0.0	0.4	0.2	2.7	2.7	0.0	0.0	1.9	9.4	0.0	0.0	0.0	0.0	0.3	0.0	10.8	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.3	1.2	26.7	19.3	8.3	0.0	1.0	0.0	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.1	0.6	0.9	0.6	0.1	0.4	0.0	7.0	0.3	6.0	20.8	0.0	45.7	1.4	0.0	2.2	25.5	0.0	12.5	75.0	0.0	23.2	26.6	2.2	0.1	0.1	75.7	0.0	1.3	1.2	0.6	33.2	0.0	0.2	4.3	0.0	9.8	0.0	5.4	0.0	0.3	2.1	6.8	0.0	37.4	0.4	4.7	34.0	0.0	23.2	0.0	0.0	0.1	0.0	0.2	2.9	16.9	0.0	34.7	33.5
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028895-136063818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 254.4;Kupffer cells: 259.4;Macrophages: 225.7;Pancreatic endocrine cells: 363.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 19.7"	"Group enriched"	"Detected in many"	30	"classical monocyte: 41.9;intermediate monocyte: 27.0;myeloid DC: 28.6;non-classical monocyte: 20.6;plasmacytoid DC: 61.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 61.2;monocytes: 41.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 157.9;GAMG: 129.4;HSkMC: 164.8;hTCEpi: 114.6;LHCN-M2: 131.0;U-2197: 114.5;U-87 MG: 219.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favorable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	51.3	16.6	1.8	30.4	3.9	4.3	32.2	1.1	6.5	14.1	24.2	5.2	16.2	9.2	30.2	71.9	21.1	15.2	94.9	53.0	4.1	2.9	21.7	47.5	42.5	65.1	3.7	2.4	27.0	10.5	3.3	23.7	90.0	19.7	27.0	16.9	21.8	21.1	13.1	24.1	63.8	22.4	56.5	10.1	41.6	21.2	18.2	2.1	21.2	12.0	40.1	18.8	46.3	24.4	0.2	61.2	0.9	41.9	1.2	0.3	15.1	5.7	23.6	0.0	0.2	66.7	22.0	0.0	17.6	2.2	12.1	7.3	10.6	74.2	0.0	10.8	157.9	129.4	28.5	0.0	56.7	10.8	0.1	0.0	0.0	28.3	28.6	44.6	0.0	0.2	164.8	114.6	4.5	5.1	43.6	10.3	0.0	0.0	0.2	131.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	1.2	0.1	5.7	0.5	0.0	0.0	27.8	0.9	0.2	24.0	0.2	6.3	43.5	82.5	3.5	114.5	62.9	0.0	0.0	0.0	219.3	0.0	62.9	0.2	41.9	0.1	0.1	27.0	0.2	0.2	0.2	0.3	28.6	0.0	0.0	0.2	0.9	1.2	20.6	61.2	0.1	15.1	1.8	3.9	1.1	3.0	4.1	2.9	3.7	2.4	19.7	2.1	3.0	25.0	13.3	3.2	106.1	0.1	6.4	7.6	4.0	9.1	1.8	0.0	6.6	0.0	39.9	1.8	14.7	0.0	23.3	98.6	5.6	70.4	0.9	4.7	21.2	254.4	1.6	3.4	32.5	259.4	1.3	9.5	225.7	47.2	8.2	2.0	0.0	363.6	0.0	2.1	1.6	0.2	25.8	143.8	0.2	0.8	48.7	16.2	2.5	0.4	2.0
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015159, HPA040171"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		430000	"Vesicles, Plasma membrane"		"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	13.1	0.3	0.2	0.7	1.3	0.9	1.3	0.8	1.7	1.0	0.2	18.0	2.1	1.5	0.5	1.4	2.5	1.0	11.8	4.1	0.6	0.6	1.1	1.1	7.1	0.4	1.5	0.4	0.5	2.5	0.7	0.8	0.5	12.9	0.5	1.4	0.2	0.8	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.2	0.2	16.0	0.0	1.1	1.1	0.8	0.6	0.8	3.8	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	11.9	1.4	0.0	4.2	0.2	0.8	0.8	0.0	0.0	6.8	0.0	0.0	1.1	24.9	1.9	0.1	0.0	0.0	0.0	0.8	0.6	0.6	3.1	4.6	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.4	0.1	0.6	0.0	0.3	0.0	0.8	1.6	1.0	0.0	0.0	4.6
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 107.8"	"Cell type enriched"	"Detected in some"	37	"Glandular cells: 201.3"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Region enriched"	"Detected in single"	254	"cerebral cortex: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;hTERT-HME1: 2.6;NB-4: 5.2;RPMI-8226: 3.7;SH-SY5Y: 2.9"	"Not detected"	"Not detected"							"CAB033571, HPA073290"	Enhanced					NA	NA					"CAB033571: AB_2287329, HPA073290: "	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	25.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	2.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.0	0.7	0.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.5	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	201.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.8	0.0	0.0	2.6
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171877	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"adrenal gland: 83.5;brain: 41.4"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 1.8;Extravillous trophoblasts: 7.9;Leydig cells: 3.1;Syncytiotrophoblasts: 1.8"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	6	"hypothalamus: 15.5;midbrain: 41.4;pons and medulla: 41.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"PC-3: 35.9;SK-BR-3: 12.8"	"Region enhanced"	"Detected in many"		"olfactory region: 220.1"	"Region enriched"	"Detected in many"	19	"midbrain: 692.0"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA			Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	1.3	83.5	0.0	0.3	5.4	0.2	0.2	0.0	0.7	1.8	0.2	6.2	0.0	0.2	0.3	0.3	0.2	0.3	0.4	0.2	0.3	15.5	0.2	0.2	0.2	0.2	41.4	0.0	0.3	0.3	0.2	0.2	0.9	41.2	0.6	0.2	0.3	0.2	2.0	0.2	0.5	0.4	0.2	0.0	0.3	0.2	0.3	1.5	0.0	0.2	0.0	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	35.9	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.3	15.5	41.4	0.0	41.2	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.1
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 194.3;granulocytes: 164.5;Smooth muscle cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.4;pons and medulla: 8.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 14.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.7;HUVEC TERT2: 160.1;LHCN-M2: 119.5;TIME: 233.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1600000000	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	79.6	15.2	0.9	81.4	3.4	19.3	41.0	0.7	1.3	25.7	42.7	2.5	6.6	5.0	72.8	30.5	22.7	40.8	57.7	49.0	1.0	1.0	23.4	27.2	118.4	38.8	1.1	0.8	60.9	14.0	1.3	7.7	38.1	8.1	31.9	18.3	8.4	38.0	13.2	22.6	9.2	23.0	63.5	4.5	58.0	46.5	27.5	0.2	0.6	14.0	21.4	18.4	111.8	78.9	0.0	0.5	14.1	7.4	7.5	2.6	8.6	11.7	4.0	3.1	1.1	13.3	15.7	0.0	68.0	55.6	18.7	12.3	11.6	8.9	0.0	25.7	164.7	3.6	41.9	0.1	33.2	9.5	3.0	0.0	3.0	2.3	2.9	2.9	0.0	0.9	35.0	2.4	15.5	35.1	73.9	160.1	0.1	0.1	0.1	119.5	0.9	0.0	0.2	0.5	1.1	1.4	0.0	8.3	0.0	28.1	29.9	0.0	0.0	19.3	1.1	1.1	4.1	11.9	0.2	233.4	65.5	15.5	77.1	78.1	0.1	0.1	0.1	2.1	0.0	70.0	0.2	7.4	14.1	0.8	0.8	2.6	0.0	0.4	0.5	0.5	0.0	0.1	0.1	1.4	7.5	0.1	0.3	0.0	8.6	0.9	3.4	0.7	1.0	1.0	1.0	1.1	0.8	8.1	0.2	23.8	25.3	10.7	130.6	85.1	0.0	35.0	25.5	14.7	26.1	66.3	5.9	2.2	0.0	18.5	0.2	39.3	91.3	0.0	111.9	1.8	194.3	54.9	164.5	7.2	5.9	0.0	3.5	67.5	123.1	0.0	1.7	83.3	37.1	3.6	27.1	0.0	117.5	21.5	0.4	50.2	0.8	6.5	246.9	0.2	0.3	44.5	1.7	5.7	29.3	27.8
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 109.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.1"	"Group enriched"	"Detected in many"	23	"gdT-cell: 11.3;MAIT T-cell: 14.5;memory CD4 T-cell: 14.5;memory CD8 T-cell: 20.5;naive CD4 T-cell: 13.1;naive CD8 T-cell: 25.2"	"Lineage enriched"	"Detected in single"	88	"T-cells: 25.2"	"Group enriched"	"Detected in some"	4	"HDLM-2: 16.8;JURKAT: 28.7;MOLT-4: 26.2;RPMI-8226: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	1.4	0.6	1.9	9.6	0.8	2.4	0.8	0.2	7.1	1.0	2.8	0.1	0.5	2.2	0.9	0.9	1.2	0.8	2.4	0.5	1.8	0.6	0.9	0.9	3.6	13.2	1.1	0.1	0.9	0.6	0.0	0.4	0.2	0.5	0.9	1.3	0.8	5.2	0.9	0.3	0.5	5.0	0.8	1.5	5.8	2.0	0.4	0.4	109.6	1.3	1.6	10.4	2.3	1.2	0.0	0.0	0.2	0.0	0.0	25.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	14.5	0.0	14.5	20.5	0.0	0.0	13.1	25.2	0.2	0.0	0.0	0.0	0.7	7.4	1.9	0.8	0.2	7.1	1.8	0.6	1.1	0.1	0.5	0.4	0.0	4.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.8	0.3	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	40.2	0.0	0.1
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 65.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Cell type enhanced"	"Detected in some"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"ASC diff: 42.5"	"Low region specificity"	"Detected in all"							HPA040642	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"	62.0	1.6	0.0	18.3	0.0	0.0	22.7	1.0	0.0	0.0	12.2	0.0	2.8	0.0	0.1	1.2	0.1	0.3	16.5	11.7	0.0	0.0	2.1	92.5	0.0	2.9	0.1	0.0	0.0	1.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	45.6	2.0	9.3	7.2	1.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.5	0.1	0.5	0.2	1.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	65.3	0.0	0.0	0.0	0.6	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 23.6;Horizontal cells: 85.8;Rod photoreceptor cells: 31.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Daudi: 10.3;SCLC-21H: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.3	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3	0.0	0.0	0.0	0.4	0.1	1.2	0.6	0.0	0.0	0.0	0.0	23.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	85.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	31.7	6.5	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.1
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	12.1	0.7	0.2	2.8	19.4	0.0	0.0	1.5	0.5	0.1	2.2	4.1	0.8	0.3	2.2	2.8	1.4	2.4	2.4	0.3	6.7	18.7	0.3	0.1	0.3	0.0	16.4	1.2	0.8	8.2	3.3	1.4	0.0	6.2	0.0	6.1	6.1	7.9	2.8	0.1	3.9	2.9	5.2	3.7	3.8	0.0	1.8	19.4	18.3	4.5	0.8	6.3	0.7	4.4	2.6	0.0	0.1	1.7	7.1	0.0	0.8	6.9	5.1	3.7	4.0	1.4	13.4	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1	3.0	2.9	0.8	40.5	74.4	1.2	1.1	2.5	0.0	18.2	0.0	2.0	7.6	0.0	1.5	10.0	15.8	0.0	0.0	0.6	25.1	7.6	16.1	23.1	3.6	8.2	69.9	5.2	50.3	22.7	9.0	31.9	28.4	10.1	18.0	0.3	39.3	1.1	10.7	54.8	0.0	4.4	6.5	2.1	1.4	6.1	125.3	8.9	6.9	0.9	72.7
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 23.3;Ito cells: 14.7;Sertoli cells: 32.3"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 54.7;ASC TERT1: 13.7;HSkMC: 23.7;NTERA-2: 13.6;U-87 MG: 13.9"	"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.0	0.2	0.0	54.7	13.7	6.7	0.2	2.2	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.5	0.2	8.5	0.0	0.0	23.7	0.5	1.4	0.0	0.4	0.0	0.0	0.1	4.4	0.0	0.1	0.0	0.0	13.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.9	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2	0.0	0.0	0.0	1.2	0.1	0.3	4.8	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.7	1.1	2.9	0.7	23.3	2.4	1.9	1.4	5.6	0.0	0.0	2.9	0.0	6.3	14.7	0.6	4.8	11.2	0.1	3.3	0.0	2.6	0.7	2.7	2.8	2.5	0.3	0.0	32.3	3.4	0.0	0.0	0.1	0.1	0.0	2.3	2.0
TLE2	"ESG, ESG2, FLJ41188, GRG2"	ENSG00000065717	"Transducin like enhancer of split 2"	Q04725	19	2997638-3047635	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 85.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 3.1;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.1;RT4: 20.0;T-47d: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049103	Enhanced		Supported	"Nuclear bodies,Focal adhesion sites"		NA	NA			"Nuclear bodies"	"Focal adhesion sites"	"HPA049103: AB_2680631"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.87e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.39e-6)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.49e-6)"	"unprognostic (2.66e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.88e-4)"	13.4	9.6	9.2	4.6	5.7	1.3	38.3	85.3	16.5	10.9	11.4	4.9	28.6	8.1	15.7	6.6	5.5	13.3	8.5	19.9	5.5	7.6	11.9	3.5	12.5	5.4	8.3	5.3	12.4	16.5	13.8	6.4	7.3	9.7	12.9	4.6	20.6	55.5	27.1	38.5	6.4	5.3	26.2	13.3	10.9	7.4	6.3	4.8	1.1	17.5	5.7	3.2	19.2	27.6	3.1	0.0	0.3	0.0	0.0	3.4	0.7	0.3	1.6	0.1	25.1	4.0	0.7	5.5	0.2	0.0	1.3	0.6	7.8	2.8	0.1	3.5	1.7	0.7	4.4	4.1	1.5	0.3	0.7	1.2	0.0	1.8	0.3	5.1	0.0	0.2	5.6	0.7	2.9	0.0	1.4	10.1	7.1	9.0	0.1	0.1	8.4	0.2	0.1	0.1	0.8	1.6	2.0	1.2	2.3	3.3	20.0	1.3	6.5	1.6	12.5	0.7	0.5	14.6	0.0	6.7	8.2	8.6	0.4	0.2	0.3	0.2	1.6	0.2	1.9	1.5	0.0	0.0	0.3	3.2	0.0	2.3	3.1	2.0	1.0	0.0	0.5	3.4	2.1	0.0	0.0	0.0	0.0	0.7	0.7	9.2	5.7	85.3	16.5	5.5	7.6	8.3	5.3	9.7	4.8	17.9	14.5	0.5	30.2	3.2	37.8	24.4	12.7	5.3	1.2	34.9	2.0	1.3	1.7	9.4	3.3	5.9	3.8	0.0	2.4	3.5	6.9	26.7	0.0	3.0	0.6	1.6	13.3	14.7	0.8	7.6	10.9	1.4	5.0	0.0	12.7	18.3	3.3	8.6	14.2	1.1	2.9	0.0	13.3	1.0	3.4	1.9	5.6	1.5	24.3	27.4
TLE6	"FLJ14009, GRG6"	ENSG00000104953	"Transducin like enhancer of split 6"	Q9H808	19	2977446-2995184	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 7.5;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"hypothalamus: 3.1"	"Cell type enhanced"	"Detected in some"		"NK-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.3;SK-BR-3: 11.4;U-266/70: 12.1;U-698: 12.7;U-937: 9.5"															NA	NA						"unprognostic (1.32e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.63e-5)"	"unprognostic (4.05e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.31e-4)"	"unprognostic (3.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-3)"	1.8	1.4	0.6	1.2	0.4	0.0	4.8	0.4	0.7	1.4	1.6	0.4	7.7	0.9	2.1	7.1	1.0	1.2	1.1	3.4	0.4	3.1	3.3	5.3	3.4	1.0	0.6	0.4	0.4	2.2	3.9	2.3	18.8	0.7	1.6	1.9	2.7	7.5	5.3	0.8	0.7	1.2	1.2	1.4	1.5	1.6	4.0	0.4	0.9	10.2	0.4	1.5	1.8	0.7	2.3	0.7	0.0	0.4	3.1	1.2	0.6	3.8	5.0	0.1	2.0	0.0	0.0	14.3	0.0	0.0	0.2	0.9	0.0	1.1	6.6	1.0	0.4	1.2	0.0	1.9	1.0	0.2	5.5	0.9	0.0	0.1	0.6	0.6	0.1	1.2	0.9	0.7	0.0	0.1	1.1	0.9	4.8	1.1	0.0	0.4	2.6	0.0	0.3	0.0	7.1	1.0	4.0	0.3	5.4	1.3	1.0	0.3	1.3	0.4	11.4	4.6	0.4	3.2	0.6	0.8	0.4	0.7	0.3	0.3	12.1	7.9	12.7	2.8	9.5	0.4	0.0	0.3	0.0	0.1	0.0	0.0	1.6	0.6	0.6	0.7	2.3	0.0	0.5	0.0	3.1	0.4	0.0	1.2	0.6	0.6	0.4	0.4	0.7	0.4	3.1	0.6	0.4	0.7	0.4	0.0	7.5	0.5	1.9	0.1	1.9	1.2	5.1	0.0	2.3	12.2	0.0	5.5	6.6	0.8	0.5	0.0	0.1	0.0	0.9	7.4	0.5	0.5	0.0	0.8	1.2	0.0	3.5	0.6	0.3	1.5	0.3	0.0	5.0	0.0	2.5	4.8	1.5	0.0	0.4	0.6	0.8	0.0	0.4	0.1	5.5	0.0	7.2	0.0	0.8	0.9
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.6	1.5	0.0	1.8	0.0	1.4	0.0	0.0	13.6	0.0	0.0	0.0	0.2	1.2	0.0	4.9	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1	0.0	1.1	0.0	0.2	1.5	15.1	4.1	0.0	1.4	1.2	0.0	0.0	3.9	0.0	1.5	0.0	11.3	0.0	0.0	1.9	0.9	1.6	0.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	4.2	0.8	0.5	0.0	0.3	0.1	0.0	1.5	1.6	0.0	0.0	0.1
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309284-171312134	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"brain: 46.6"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 5.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enriched"	"Detected in some"	22	"cerebellum: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 24.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.5"	"Region enriched"	"Detected in some"	10	"cerebellum: 48.1"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.4	0.5	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331217-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	15	"parathyroid gland: 66.9"	"Cell type enhanced"	"Detected in single"	24	"Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 1.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.0	0.1	0.0	1.7	0.0	0.3	0.2	0.4	1.4	1.5	1.5	0.0	0.0	0.2	0.8	4.6	0.7	0.8	0.2	0.2	0.0	0.1	0.1	1.3	0.0	0.1	0.0	0.0	0.2	0.2	66.9	1.5	0.7	1.6	1.0	0.1	0.4	0.2	2.9	0.0	0.2	0.5	1.7	1.9	0.1	0.8	3.0	0.0	0.0	1.5	0.0	0.0	1.3	3.6	1.6	0.7	0.2	0.2	0.2	1.8	0.7	0.9	1.0	0.5	2.7	0.4	0.2	1.9	0.8	0.3	0.2	0.3	0.7	1.9	2.3	0.1	0.0	2.4	0.7	0.3	0.2	0.1	1.7	1.4	1.9	1.1	0.9	0.3	1.5	1.1	0.5	0.1	0.4	0.3	1.2	0.0	2.8	0.6	2.8	0.2	0.8	1.0	1.4	1.5	0.8	0.9	0.7	1.0	4.3	0.2	0.6	1.1	2.0	0.9	1.0	2.0	0.6	2.3	1.1	0.4	1.5	1.8	1.3	0.5	4.6	1.8	1.4	1.1	2.5	0.9	0.1	0.0	0.2	0.7	0.1	0.6	1.2	0.8	0.4	0.1	1.6	1.8	1.3	0.2	0.2	0.2	0.7	0.9	0.7	0.0	0.0	0.4	1.4	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0
TMEM114		ENSG00000232258	"Transmembrane protein 114"	B3SHH9	16	8537605-8590193	"Disease related genes, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 60.1;seminal vesicle: 24.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"hypothalamus: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 1.5;U-2 OS: 2.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 9.6"							NA	NA									"unprognostic (3.72e-5)"	"unprognostic (2.26e-1)"	"unprognostic (3.98e-3)"		"unprognostic (7.33e-2)"			"unprognostic (2.19e-1)"			"unprognostic (2.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"		0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.4	0.0	60.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.4	0.0	0.0	0.0	24.7	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	8.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM120B		ENSG00000188735	"Transmembrane protein 120B"	A0PK00	12	121712752-121783001	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 23.1;cerebellum: 35.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014066	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA014066: AB_1845296"	"unprognostic (8.80e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.66e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.29e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.86e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.72e-2)"	7.9	7.0	5.6	4.7	23.1	9.3	5.6	35.6	6.9	11.1	4.4	3.3	8.6	4.2	10.0	5.4	2.8	12.2	4.5	3.9	5.9	3.8	4.5	4.7	5.3	4.0	4.5	4.3	5.0	14.3	5.9	11.6	2.4	6.0	5.2	3.1	5.5	14.9	6.2	17.2	5.7	3.8	8.0	2.9	4.3	4.9	3.4	5.8	1.9	10.6	4.0	3.8	3.6	7.1	4.1	4.0	3.6	1.6	2.4	3.4	1.3	4.8	16.6	3.9	11.4	4.9	6.5	8.0	6.4	7.4	6.2	5.0	10.5	5.6	5.2	4.0	6.5	6.1	8.3	9.1	7.7	3.3	3.1	8.4	7.2	5.2	6.5	6.7	5.1	5.7	6.0	6.9	7.0	5.1	11.0	3.8	11.6	6.4	3.8	3.7	7.8	8.4	7.0	7.0	3.3	10.3	10.0	16.1	6.9	3.2	5.3	15.0	10.7	6.3	5.0	5.6	7.5	11.3	4.1	5.3	8.3	9.4	5.3	5.6	8.9	3.1	3.8	10.6	6.6	8.3	3.1	1.4	1.7	3.4	1.6	2.8	2.9	3.3	2.7	1.6	4.1	2.4	2.8	3.6	2.4	1.5	4.0	2.8	1.3	5.6	23.1	35.6	6.9	5.9	3.8	4.5	4.3	6.0	5.8	23.8	12.6	12.3	4.4	5.8	35.4	6.1	12.7	4.0	7.9	10.4	21.6	5.6	6.6	7.6	14.5	4.9	21.9	0.0	10.8	5.8	6.5	5.4	4.6	2.9	5.1	12.7	6.3	1.8	4.0	26.1	6.1	8.5	1.7	36.9	3.0	2.5	19.5	4.5	6.0	4.9	21.7	6.5	7.1	6.2	4.9	6.0	9.5	28.8	3.6	3.9
TMEM145	FLJ90805	ENSG00000167619	"Transmembrane protein 145"	Q8NBT3	19	42313325-42325062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 74.5"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 57.8;Cone photoreceptor cells: 27.5;Horizontal cells: 65.2;Rod photoreceptor cells: 30.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 74.5"	"Group enriched"	"Detected in some"	8	"basophil: 4.5;neutrophil: 15.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 15.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.9;PC-3: 8.8;SCLC-21H: 22.7;SH-SY5Y: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060462	Enhanced	Approved	Approved	Vesicles		NA	NA			Vesicles		"HPA060462: AB_2684285"	"unprognostic (9.56e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.20e-4)"	"unprognostic (7.35e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.31e-2)"	1.6	6.2	8.0	1.2	7.7	2.5	1.3	74.5	30.5	0.6	1.2	3.8	0.0	1.7	1.1	1.6	1.0	1.1	1.4	1.3	5.8	8.5	0.9	1.4	0.8	1.5	5.1	7.6	1.2	3.7	3.0	6.4	0.6	9.3	1.2	1.2	2.8	1.1	0.9	2.3	3.3	1.1	1.2	3.9	1.5	2.0	3.3	3.2	0.0	1.3	0.0	1.1	1.0	0.3	1.3	0.8	15.5	0.9	0.6	0.9	0.8	0.5	2.8	2.1	6.5	0.2	0.2	0.9	0.2	0.1	1.0	2.6	0.5	0.7	1.5	0.3	0.7	0.6	0.2	1.5	0.4	1.2	6.8	1.7	2.8	2.6	2.4	0.2	1.7	11.9	0.6	0.5	0.4	0.6	0.2	1.1	0.8	1.5	5.6	0.1	0.6	0.4	1.9	1.3	2.0	8.8	0.2	0.6	5.3	0.1	1.0	22.7	10.8	1.0	0.7	1.4	0.1	2.0	1.9	0.3	1.9	1.9	1.3	0.7	1.2	3.1	1.4	0.7	1.1	5.2	4.5	0.9	0.9	0.6	0.8	0.3	1.0	0.6	0.4	0.2	1.3	0.6	0.9	15.5	0.6	0.7	0.8	0.4	0.8	8.0	7.7	74.5	18.1	5.8	8.5	5.1	7.6	9.3	3.2	0.0	0.0	0.0	0.4	0.2	57.8	0.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.3	1.1	0.0	0.3	65.2	0.0	1.8	1.2	0.0	0.0	0.0	5.0	0.0	0.0	11.9	0.1	0.0	0.4	0.0	30.8	0.0	0.0	5.1	17.9	0.1	0.0	0.0	0.0	0.0
TMEM155	FLJ30834	ENSG00000164112	"Transmembrane protein 155"	Q4W5P6	4	121758933-121765427	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Cytotrophoblasts: 15.1"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.6"	"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.3;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3"									HPA077585	Approved				"Secreted in brain"	NA	NA					"HPA077585: AB_2732353"	"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0.0	0.0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4.0	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0.0	0.0	0.3	0.0	0.6	0.5	0.3	0.0	0.0	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.1	0.0	1.4	0.3	1.0	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	3.4	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	10.5	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	3.8	0.0	0.0	0.0
TMEM158	"p40BBp, RIS1"	ENSG00000249992	"Transmembrane protein 158 (gene/pseudogene)"	Q8WZ71	3	45224466-45226278	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.8;endometrium 1: 31.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 21.8;Muller glia cells: 57.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 66.1;GAMG: 22.4;U-138 MG: 28.0;U-87 MG: 91.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 85.5"	"Low region specificity"	"Detected in all"			HPA074974	Approved					NA	NA					"HPA074974: AB_2732274"	"unprognostic (3.84e-1)"	"unprognostic (9.83e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.31e-2)"	"unprognostic (4.67e-3)"	"unprognostic (6.23e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.84e-3)"	"prognostic favorable (6.43e-5)"	"prognostic unfavorable (5.42e-9)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.49e-3)"	1.8	6.4	16.4	4.5	46.8	2.2	2.3	2.1	10.9	13.1	3.4	2.3	18.5	1.4	31.1	7.3	21.3	2.0	11.0	0.8	9.0	11.2	1.9	1.2	1.0	1.1	2.5	5.0	1.7	2.4	0.7	5.7	1.4	2.6	15.6	2.7	0.5	1.3	27.0	2.4	2.7	1.2	19.6	1.8	0.8	2.2	3.0	4.3	0.0	0.7	0.8	1.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.0	1.1	2.4	0.4	0.8	0.1	1.5	3.7	0.7	6.1	66.1	3.4	5.5	0.1	0.1	0.0	0.3	2.0	22.4	3.3	1.0	0.2	10.1	0.1	0.3	0.0	1.2	0.0	2.2	0.4	1.2	5.0	0.1	6.7	0.5	7.9	0.3	0.0	15.0	0.1	6.0	0.1	0.0	4.2	7.5	0.0	9.1	0.0	0.2	0.9	1.3	2.3	1.2	0.2	2.3	0.0	0.3	0.7	0.0	0.8	1.0	28.0	2.1	17.6	21.2	0.0	0.0	0.0	91.7	2.4	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	16.4	46.8	2.1	10.9	9.0	11.2	2.5	5.0	2.6	4.3	0.0	0.3	0.0	1.8	21.8	3.8	0.8	2.5	0.0	1.2	8.7	0.0	0.1	0.0	3.3	0.1	0.1	0.0	0.0	0.3	0.1	2.9	1.6	0.0	2.6	4.0	1.6	7.5	1.3	0.3	0.2	7.8	4.5	0.0	1.8	0.2	57.5	0.7	0.0	0.0	0.0	2.7	0.0	2.3	0.1	0.4	9.3	0.2	0.0	0.0	2.0
TMEM159	promethin	ENSG00000011638	"Transmembrane protein 159"	Q96B96	16	21158377-21180616	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Suprabasal keratinocytes: 131.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 14.6;cerebellum: 13.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018033, HPA063509"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA018033: AB_2204762, HPA063509: AB_2685026"	"unprognostic (7.62e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.68e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (8.11e-5)"	"unprognostic (8.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.57e-2)"	35.6	12.7	2.2	6.0	14.6	1.8	27.4	13.7	2.8	25.3	13.5	1.0	10.1	2.7	28.3	9.8	37.1	8.4	23.9	32.4	1.4	1.6	11.3	1.2	10.7	7.6	1.2	1.6	22.0	6.1	5.6	1.2	5.3	1.7	29.7	6.4	10.9	35.2	7.9	57.5	32.5	7.3	45.5	1.5	3.6	7.9	10.9	1.4	6.1	17.4	35.5	21.9	43.7	21.1	11.4	11.3	12.2	8.6	7.5	13.1	7.3	5.9	2.8	3.1	11.3	29.4	18.9	1.6	2.7	12.0	1.2	2.3	2.1	8.2	7.8	3.2	9.0	5.5	9.0	5.1	4.6	1.3	3.5	1.8	3.6	1.0	4.0	6.8	2.8	9.6	7.0	24.0	6.6	21.3	4.8	6.7	4.4	2.5	2.4	2.1	10.5	2.1	2.1	2.7	5.0	1.7	11.2	1.6	2.9	14.8	17.9	0.4	0.4	7.6	10.4	3.5	6.1	17.2	2.1	4.7	1.7	2.2	9.5	0.7	0.2	0.6	2.5	8.5	2.5	1.9	12.2	8.6	8.0	10.1	5.9	8.7	11.4	13.1	8.6	5.0	9.2	9.6	8.8	3.9	7.5	7.1	11.3	13.0	7.3	2.2	14.6	13.7	2.8	1.4	1.6	1.2	1.6	1.7	1.4	8.9	18.1	0.5	34.8	107.6	0.5	54.1	12.7	4.0	22.7	21.0	0.0	3.4	6.6	16.7	0.5	15.3	21.3	0.0	18.5	1.9	18.8	41.3	15.1	0.0	9.7	1.6	13.9	9.2	11.9	0.0	62.5	15.3	28.7	26.2	28.8	23.3	18.9	40.7	35.0	16.3	1.8	32.3	32.3	2.2	6.1	131.2	1.6	10.1	27.2	56.7
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 87.4"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 87.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	2.9	4.2	13.3	0.9	10.6	0.6	6.8	87.4	35.6	1.6	1.9	6.4	0.0	2.3	3.8	2.0	1.8	3.3	3.1	3.6	16.4	7.4	18.9	2.7	5.8	0.8	10.7	10.9	1.8	2.2	1.3	2.5	3.6	17.0	12.2	2.2	3.7	3.8	2.1	2.3	3.5	2.4	2.9	22.6	1.6	3.5	1.2	5.3	0.0	5.7	0.8	2.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.1	0.1	0.0	0.6	0.0	0.0	0.4	0.1	10.4	0.2	0.0	0.2	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.6	87.4	18.8	16.4	7.4	10.7	10.9	17.0	5.3	0.0	1.3	0.0	0.6	0.3	2.1	3.7	0.0	4.0	1.2	12.2	5.9	0.3	0.0	0.3	0.3	3.1	0.4	0.0	0.2	0.0	0.2	4.1	0.0	0.2	0.2	1.6	15.4	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.3	0.0	0.0	0.7	5.8	0.0	0.4	0.2	0.2	0.5	0.5	0.0	0.4	0.1
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376836-55378244	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 63.6;ovary: 17.7;testis: 21.5"	"Group enriched"	"Detected in some"	9	"Ciliated cells: 338.6;Early spermatids: 390.3;Late spermatids: 112.4"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.0;hTERT-RPE1: 5.0;SCLC-21H: 7.0"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"							NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.1	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0.5	5.7	0.1	0.5	0.1	0.1	1.4	1.1	0.1	63.6	0.1	0.1	0.6	2.7	0.1	0.1	11.8	0.1	0.1	0.1	17.7	0.1	0.0	3.0	0.3	1.0	0.1	0.0	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.5	21.5	0.3	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	2.5	0.0	0.5	0.0	0.0	0.2	0.7	0.3	0.6	0.1	1.8	1.5	2.6	0.2	0.7	0.4	4.5	0.0	0.0	0.0	4.3	0.2	0.0	2.7	14.0	0.9	0.0	0.1	0.2	0.0	0.1	0.0	5.0	0.0	0.2	0.0	3.4	0.0	2.0	0.3	0.0	0.5	1.7	0.8	0.2	1.6	1.4	0.0	1.3	7.0	1.3	1.4	1.8	0.6	1.3	0.8	0.0	0.0	0.2	1.1	0.2	0.7	0.5	3.2	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.6	2.7	0.1	0.1	1.0	0.3	0.0	5.8	0.0	0.0	0.0	0.4	0.0	0.0	338.6	33.0	0.0	0.0	0.1	0.0	0.1	390.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.1	0.0	0.1	0.0	8.5	0.0	0.0	112.4	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	2.4	1.7	0.0	0.3	0.0	0.0	0.0
TMEM200B	TTMB	ENSG00000253304	"Transmembrane protein 200B"	Q69YZ2	1	29119428-29123935	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 11.8;Melanocytes: 8.5;Peritubular cells: 14.2;Sertoli cells: 6.5;Smooth muscle cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.8;ASC TERT1: 13.2;BJ hTERT+ SV40 Large T+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 16.3;fHDF/TERT166: 15.4;HBF TERT88: 14.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 14.0;cerebellum: 23.9"					HPA055254	Uncertain					NA	NA					"HPA055254: AB_2682760"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-3)"	9.1	2.0	1.4	2.9	3.7	0.0	15.7	9.7	1.3	33.3	10.9	1.2	7.4	1.1	32.8	7.7	6.0	7.0	7.3	2.4	0.5	0.2	3.5	3.0	3.7	1.2	1.3	0.9	21.6	0.7	15.4	1.2	3.5	2.5	17.2	2.3	6.0	1.5	23.9	2.9	2.1	3.4	20.6	1.4	2.4	2.3	13.6	0.6	0.7	2.1	3.5	1.5	13.1	12.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	10.9	0.0	1.8	0.0	15.8	13.2	0.6	7.7	12.2	14.6	16.3	0.6	1.2	0.0	1.9	15.4	5.3	0.2	1.2	0.0	14.0	0.0	0.5	0.0	2.8	0.9	11.0	0.0	0.0	7.0	1.4	11.0	2.2	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	11.0	0.0	0.0	5.4	0.0	0.0	0.0	5.2	0.2	10.8	0.2	0.0	0.0	0.0	6.4	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.4	3.7	9.7	1.3	0.5	0.2	1.3	0.9	2.5	0.6	3.0	1.1	0.0	0.2	1.6	0.8	1.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	5.4	0.2	0.0	1.0	0.1	0.0	0.0	1.3	0.0	0.9	11.8	0.0	8.5	0.0	0.0	0.1	0.0	0.0	14.2	3.8	1.7	6.5	8.3	0.2	0.7	0.5	0.5	0.0	0.0	0.3
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.9	0.1	0.8	0.8	0.0	2.0	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0	0.0	0.0	0.0	0.9	0.0	2.6	0.0	0.0	2.7	0.0	1.8	9.8	12.8	1.7	0.0	5.9	0.0	0.0	0.0	0.2	1.7	0.7	0.8	0.0	0.0	4.2	1.6	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.5	7.6	6.5	0.0	0.5	2.1	0.0	4.9	0.0	0.0	0.4
TMEM61		ENSG00000143001	"Transmembrane protein 61"	Q8N0U2	1	54980792-54992293	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 22.1;pituitary gland: 29.1;salivary gland: 34.1"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 41.4;Intestinal endocrine cells: 46.4;Mucus-secreting cells: 52.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.2;pons and medulla: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 22.6"					"Low region specificity"	"Detected in many"			HPA030614	Uncertain					NA	NA					"HPA030614: AB_10603216"	"unprognostic (7.62e-2)"	"unprognostic (1.67e-3)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.63e-4)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.24e-2)"	"prognostic favorable (1.78e-7)"	"unprognostic (8.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-3)"	0.2	3.9	0.4	0.7	1.0	0.0	2.7	5.2	0.5	0.9	3.7	0.2	4.9	2.4	0.2	3.8	2.9	2.0	1.7	0.0	0.5	0.6	22.1	0.0	2.4	0.0	1.1	0.7	1.1	4.2	7.8	29.1	0.5	5.2	2.4	2.3	0.5	34.1	6.7	0.4	1.8	3.5	5.3	0.8	0.4	2.2	0.2	0.1	0.1	0.6	0.8	1.8	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	22.6	2.4	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	5.2	0.5	0.5	0.6	1.1	0.7	5.2	0.1	0.0	1.9	0.0	6.7	0.8	0.7	0.0	0.0	10.7	2.3	7.0	2.0	0.1	41.4	4.0	0.1	0.0	1.7	0.0	3.0	0.1	0.2	3.1	0.0	0.0	0.1	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	52.9	0.1	4.2	5.8	0.7	0.0	0.8	0.0	0.1	0.1	0.7	2.0	0.2	0.0	2.0	2.6
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.8;pituitary gland: 21.1"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.4	14.1	3.4	1.0	8.4	1.1	5.2	63.8	16.3	1.5	5.8	1.9	0.0	1.8	0.3	6.8	4.8	0.6	0.5	0.3	3.2	9.7	0.7	0.4	0.9	0.6	4.6	6.0	0.4	6.7	1.2	21.1	1.1	6.6	0.4	4.3	0.9	1.3	0.2	0.8	4.4	2.2	1.1	1.8	3.2	3.1	9.9	1.2	0.0	3.2	0.6	0.6	0.3	2.9	0.1	0.7	2.0	1.7	1.7	1.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	11.8	2.3	0.0	2.0	1.6	2.5	0.9	0.0	0.8	0.9	0.2	1.2	0.0	0.0	2.0	0.1	0.0	5.0	0.0	0.1	0.0	0.0	5.6	0.0	15.9	0.0	5.9	1.6	0.1	0.5	0.0	0.0	0.0	0.8	8.1	0.2	0.0	21.7	3.2	0.2	19.2	0.0	0.4	1.9	1.0	0.0	0.0	4.1	0.0	0.0	1.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.5	1.0	0.7	0.1	0.5	0.4	2.0	1.7	1.7	0.0	0.0	0.4	3.4	8.4	63.8	13.0	3.2	9.7	4.6	6.0	6.6	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.0	7.2	0.0	2.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	2.0	3.2	18.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.1	0.1	0.3	6.6	0.4	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911200-44937002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 46.5;retina: 17.1"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 26.2;Distal tubular cells: 28.2;Late spermatids: 11.4;Paneth cells: 8.6"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.2;pons and medulla: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	118	"RPMI-8226: 26.1;U-937: 16.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA039894, HPA062907"	Enhanced					NA	NA					"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favorable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.1	0.0	0.1	0.9	0.2	0.1	0.0	0.3	0.2	0.0	4.2	1.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.2	0.3	46.5	0.1	0.0	0.0	0.4	0.0	0.0	5.7	0.1	0.3	0.0	4.9	0.0	4.9	17.1	2.7	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.9	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	1.2	0.3	0.4	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	26.2	0.0	0.0	28.2	0.0	4.6	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.6	0.0	0.1	8.6	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.7	0.0
TMPRSS6	FLJ30744	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109563	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 59.3"	"Group enriched"	"Detected in some"	14	"Early spermatids: 60.9;Hepatocytes: 67.0;Late spermatids: 87.3"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enriched"	"Detected in single"	10	"basal ganglia: 1.8"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"Hep G2: 7.7;SCLC-21H: 13.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.2"							NA	NA						"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.0	0.1	0.1	1.8	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	59.3	1.9	0.1	0.1	0.1	0.5	0.9	0.0	5.3	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.6	0.1	0.1	0.1	2.3	2.6	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.2	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	2.3	0.3	0.1	7.7	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.6	0.0	1.3	0.0	0.0	0.3	0.2	0.1	0.5	0.2	0.3	0.0	0.0	13.2	0.4	0.2	1.0	0.0	0.2	0.1	0.0	0.6	0.5	1.6	0.1	0.0	1.6	0.4	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.2	1.3	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	60.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	67.0	0.1	0.0	5.1	2.5	2.9	87.3	0.3	0.0	0.0	0.0	1.0	0.0	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.6	0.0
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 81.3"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 25.0"	"Group enriched"	"Detected in many"	8	"eosinophil: 38.1;neutrophil: 29.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA007853	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		170000	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (1.44e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.06e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (7.04e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.98e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.17e-2)"	10.8	14.2	2.4	11.3	5.1	2.7	21.2	0.9	3.0	8.0	18.9	3.2	4.1	14.5	11.6	10.2	10.7	6.4	28.1	27.0	5.0	2.6	50.4	36.2	23.0	2.6	4.8	0.5	6.4	47.0	51.1	20.0	81.3	25.0	11.1	1.9	2.8	17.3	6.9	23.3	5.0	31.0	16.8	4.3	3.9	13.2	5.3	3.3	1.2	11.5	11.5	4.7	14.8	5.2	0.0	4.1	38.1	3.5	2.0	2.4	1.1	24.5	19.9	2.2	4.1	4.1	9.3	13.2	51.8	37.5	44.4	28.6	8.6	43.9	0.1	68.6	34.4	51.6	27.2	0.5	37.9	17.0	0.9	1.3	0.1	6.7	7.2	28.0	0.4	1.8	8.6	26.3	46.6	55.9	38.3	12.8	0.0	2.7	0.3	46.7	46.5	0.0	3.3	10.7	11.0	43.8	0.2	24.9	1.0	44.9	4.9	2.5	0.9	36.9	17.2	30.5	7.7	9.0	0.7	22.5	80.0	36.9	52.9	84.9	0.8	0.3	0.3	25.0	2.3	62.8	3.5	3.5	38.1	1.8	2.0	2.4	0.0	0.8	1.5	4.1	0.0	0.4	0.8	29.9	2.0	1.3	0.1	1.0	1.1	2.4	5.1	0.9	3.0	5.0	2.6	4.8	0.5	25.0	3.3	95.3	43.1	5.0	1094.9	544.0	0.9	57.7	163.1	50.9	130.8	172.7	2.0	112.5	54.7	954.3	0.6	22.7	41.3	0.0	607.7	131.7	179.4	600.3	58.8	15.3	38.1	0.0	26.1	28.8	4.6	0.4	5.8	29.4	106.3	16.2	4.6	20.6	874.5	25.8	6.3	93.5	5.1	6.5	212.1	7.7	4.1	314.4	158.1	8.6	12.4	560.0
TNFRSF25	"APO-3, DDR3, DR3, LARD, TNFRSF12, TR3, TRAMP, WSL-1, WSL-LR"	ENSG00000215788	"TNF receptor superfamily member 25"	Q93038	1	6461151-6466195	"Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 19.2;lymphoid tissue: 26.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 25.0;T-cells: 36.2;Undifferentiated cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	11	"cerebellum: 19.2"	"Cell type enhanced"	"Detected in many"		"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	10	"T-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.2;NB-4: 8.0;RPMI-8226: 19.7"	"Group enriched"	"Detected in some"	6	"amygdala: 1.2;cerebral cortex: 1.3;hippocampal formation: 2.3"	"Not detected"	"Not detected"			HPA069834			Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"	"Secreted - unknown location"	NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"	Nucleoplasm	"HPA069834: "	"unprognostic (8.09e-3)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.09e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.68e-3)"	2.2	1.6	1.2	20.3	1.6	0.4	1.4	19.2	1.8	1.4	13.4	0.7	0.6	2.8	1.2	0.6	4.1	2.4	2.1	2.3	1.8	0.9	1.4	2.3	6.3	13.9	1.1	0.6	1.1	0.6	1.4	14.0	4.1	1.3	1.9	1.3	1.1	10.5	2.3	0.8	24.1	11.2	0.6	0.6	18.9	0.8	1.0	0.8	11.7	1.1	3.2	26.0	3.2	1.5	0.0	0.4	0.0	0.9	0.6	9.5	1.3	1.4	0.3	0.8	1.6	0.0	0.4	0.8	0.6	0.4	0.2	0.0	1.3	2.2	0.0	3.0	0.0	1.0	3.2	0.4	3.7	0.0	20.2	1.5	0.8	1.1	0.0	0.6	0.0	0.0	0.0	2.4	1.2	3.2	1.9	3.2	0.9	0.0	0.0	0.0	1.6	0.0	8.0	1.0	1.1	5.5	0.6	0.2	19.7	0.8	0.5	3.9	5.4	0.0	1.9	0.1	0.3	1.7	2.2	1.7	1.0	1.5	0.0	1.5	0.0	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	0.3	8.0	0.0	6.9	3.2	0.4	0.0	6.4	1.1	0.0	0.6	0.9	0.0	9.5	1.3	1.2	1.6	19.2	1.8	1.8	0.9	1.1	0.6	1.3	0.8	3.0	5.3	0.5	1.8	21.9	0.8	0.8	2.5	2.7	2.3	1.8	2.0	0.4	0.0	0.1	0.3	5.5	16.9	0.0	0.4	1.6	3.2	1.1	6.9	1.1	3.2	4.8	6.4	9.8	1.6	0.0	2.6	2.1	6.8	1.0	17.6	11.2	0.9	11.5	8.9	0.3	9.3	0.0	0.8	0.5	1.1	25.0	0.1	36.2	28.4	6.7
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063377-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.3"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 2.8;Kupffer cells: 6.0;Late spermatids: 7.2"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enriched"	"Detected in single"	14	"basal ganglia: 13.1"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 21.7;non-classical monocyte: 33.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 33.3"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 112.6"					"Low region specificity"	"Detected in many"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	10.7	0.2	0.1	7.2	13.1	1.4	5.8	0.2	0.4	1.1	0.8	0.0	1.5	0.2	1.7	1.3	0.9	2.1	1.4	3.8	0.1	0.2	0.9	0.2	3.9	2.9	0.5	0.5	1.2	0.4	0.0	0.1	6.2	0.5	1.0	0.5	0.0	0.7	0.3	3.1	1.6	1.3	1.3	1.4	2.9	6.4	2.5	0.9	3.0	0.7	2.7	5.3	2.6	3.8	0.0	3.2	6.8	33.3	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	112.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	5.2	0.3	0.0	0.0	0.3	0.0	4.5	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	21.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.0	33.3	0.8	0.3	2.7	0.1	13.1	0.2	0.4	0.1	0.2	0.5	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4	0.0	0.0	1.3	6.0	7.2	0.3	1.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.2	0.0	0.0	0.0
TNFSF18	"AITRL, hGITRL, TL6"	ENSG00000120337	"TNF superfamily member 18"	Q9UNG2	1	173039960-173050963	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;tongue: 9.9"	"Cell type enriched"	"Detected in single"	8	"Hofbauer cells: 4.9"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hippocampal formation: 7.3"	"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Group enriched"	"Detected in some"	11	"EFO-21: 21.0;HUVEC TERT2: 31.6;TIME: 43.8"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.78e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.71e-4)"	"unprognostic (8.42e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.74e-2)"	0.9	0.4	0.4	0.3	0.8	0.0	0.4	1.1	4.6	0.4	0.4	3.2	0.0	1.1	0.3	0.0	3.6	0.3	5.0	1.5	7.3	0.4	0.7	1.9	1.0	0.2	0.4	1.0	0.3	0.3	2.2	0.7	1.3	1.4	0.4	1.0	0.2	0.3	0.0	0.3	0.4	3.5	0.1	0.6	0.6	0.4	0.3	0.0	0.0	0.7	9.9	1.4	0.6	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.0	0.2	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	31.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.4	0.8	1.1	2.4	7.3	0.4	0.4	1.0	1.4	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1
TNK1		ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 1.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HBEC3-KT: 7.0;hTCEpi: 7.9;T-47d: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.4	0.6	1.1	2.2	6.4	0.4	7.9	11.4	4.0	5.4	11.7	0.4	7.7	7.1	5.1	5.3	7.2	3.5	6.3	2.0	1.0	0.4	4.6	6.9	3.2	2.7	1.5	0.8	4.4	6.8	5.4	2.7	2.5	4.3	8.9	4.5	7.7	10.5	4.8	1.8	8.3	11.3	5.1	0.7	2.4	9.6	2.2	0.6	0.6	11.6	5.7	5.2	4.5	4.4	1.6	0.1	0.4	0.0	0.0	3.8	0.6	6.4	1.0	0.2	0.4	0.0	0.0	4.4	0.2	0.0	0.4	0.4	3.3	3.0	0.0	2.6	0.3	0.1	10.5	0.0	7.0	0.1	0.7	1.5	0.0	3.7	1.9	0.4	0.0	0.3	0.1	7.9	0.0	1.2	0.2	0.0	2.8	0.8	0.0	0.0	4.9	0.6	0.0	0.9	5.6	0.9	0.2	0.2	0.7	4.9	3.0	0.2	0.5	3.6	5.3	1.0	0.3	8.7	0.1	1.7	0.2	0.8	0.2	0.0	0.5	1.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	1.9	1.6	1.8	1.2	0.1	1.5	3.3	3.8	0.4	0.0	0.0	0.0	0.8	0.6	1.1	6.4	11.4	4.0	1.0	0.4	1.5	0.8	4.3	0.6	6.0	4.3	0.5	2.1	2.3	1.2	0.8	2.5	0.0	2.3	1.8	0.0	0.2	0.0	4.4	1.1	0.7	10.4	0.0	5.9	0.4	1.0	4.0	0.0	2.5	0.1	0.0	2.9	1.3	0.0	0.6	1.1	0.1	0.0	0.0	6.3	0.2	6.4	6.5	0.4	1.4	2.4	0.0	0.9	0.6	0.9	2.0	0.6	1.0	6.4	1.8
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041154-32115334	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 29.2;Endothelial cells: 24.3;Erythroid cells: 23.3;Fibroblasts: 26.1;Ito cells: 12.9;Leydig cells: 25.0;Melanocytes: 30.4;Suprabasal keratinocytes: 23.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.3;ASC TERT1: 18.5;U-2197: 14.9;U-87 MG: 7.4"														"Secreted to extracellular matrix"	NA	NA		1100000000				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	45.1	66.2	1.0	12.2	1.8	3.8	61.5	7.7	1.5	28.3	14.5	0.6	17.6	4.2	31.6	38.0	25.7	7.5	33.3	39.3	1.0	1.4	3.3	5.4	22.3	8.7	2.2	0.4	41.0	3.1	1.5	1.8	7.6	1.4	9.0	2.7	3.0	7.1	7.9	17.9	8.4	10.2	49.2	4.4	7.9	5.4	11.4	0.3	0.4	6.7	36.6	4.5	33.0	32.2	0.0	0.0	0.1	0.1	0.0	0.2	1.7	0.1	0.2	0.2	0.1	11.3	18.5	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.5	0.0	2.6	0.0	0.3	0.2	0.1	0.4	0.0	0.4	0.0	0.4	0.6	0.3	0.0	0.1	0.0	0.1	0.3	0.0	3.4	0.2	0.0	0.2	0.0	0.1	0.1	0.2	1.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	14.9	0.0	0.4	0.3	0.2	7.4	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	1.0	1.8	7.7	1.5	1.0	1.4	2.2	0.4	1.4	0.3	3.0	3.7	0.0	0.1	29.2	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	2.7	24.3	0.0	23.3	0.0	0.9	26.1	0.2	0.0	1.0	0.7	0.0	0.0	12.9	0.3	2.0	25.0	1.3	30.4	0.0	0.0	1.0	0.0	0.0	4.2	0.2	0.5	0.0	4.7	3.0	1.8	23.2	0.8	0.0	0.2	0.2
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652520-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Club cells: 7.9;Early spermatids: 18.5;Late spermatids: 10.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 25.7"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.2;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.4;RH-30: 9.3;SCLC-21H: 14.6;U-698: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	Yes			Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: AB_2672215, HPA044516: AB_2678971"	"unprognostic (5.71e-3)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.5	0.3	1.1	3.4	2.3	1.0	1.1	25.7	0.4	1.5	0.7	2.4	1.3	0.3	0.4	6.2	4.8	12.8	1.4	0.3	1.9	1.2	0.2	2.1	3.8	2.0	0.5	0.0	2.6	1.5	0.3	0.7	1.7	3.2	3.6	0.4	0.4	5.5	1.4	0.4	11.9	0.5	0.3	0.9	4.2	0.8	9.8	0.3	2.5	0.4	0.8	7.1	0.6	3.9	1.4	0.1	1.2	0.1	0.0	0.6	0.1	2.0	0.1	0.2	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.5	3.2	2.0	1.6	0.0	0.7	3.4	2.1	0.7	0.0	0.6	6.9	0.1	3.2	2.0	0.0	0.0	2.3	0.0	1.4	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.6	1.5	11.4	1.5	0.4	0.0	0.1	0.0	9.3	0.1	0.2	3.0	14.6	6.8	0.3	0.0	0.6	0.0	8.7	7.1	0.0	2.3	6.2	0.0	4.5	2.7	0.5	14.6	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	1.4	0.4	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.3	25.7	0.3	1.9	1.2	0.5	0.0	3.2	0.3	0.0	1.0	0.0	3.9	2.7	0.5	1.2	0.0	17.4	7.9	0.0	0.0	0.2	0.0	0.0	18.5	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.2	0.0	2.4	0.0	0.0	10.0	0.6	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.2	0.0	0.0	0.1
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3"	"Cell type enriched"	"Detected in many"	164	"Intestinal endocrine cells: 1412.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 4.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 4.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.7	0.0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1.0	0.7	0.0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1.0	9.1	0.7	0.7	1.0	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0.0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0.0	0.1	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0.0	4.5	1.2	0.0	1.8	0.2	0.6	0.3	0.7	2.7	0.9	0.8	0.1	0.5	1.0	0.7	0.5	0.1	0.3	1.7	0.3	0.0	0.0	1.0	1.3	0.9	0.2	0.4	0.9	0.2	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1.0	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7	0.0	0.0	0.0	0.4	0.3	4.7	0.4	0.0	1.4	0.0	5.2	2.0	0.2	0.0	0.2	0.7	0.3	1.0	0.0	0.5	0.0	0.7	2.0	0.0	0.0	0.2	1.6	1412.4	0.0	0.0	0.4	0.9	0.9	0.0	0.0	2.8	1.5	0.4	8.6	1.1	0.2	6.0	6.5	1.0	2.7	3.4	1.3	0.0	0.5	1.7	0.0
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938846-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 46.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.6;Late spermatids: 4.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	15	"pons and medulla: 46.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 2.9;NTERA-2: 3.1;SCLC-21H: 1.5;SuSa: 1.0"	"Group enriched"	"Detected in some"	32	"midbrain: 127.6;pons and medulla: 36.3"	"Group enriched"	"Detected in some"	10	"midbrain: 95.6;pons and medulla: 91.5"	CAB078198	Enhanced					NA	NA					"CAB078198: AB_2665804"	"unprognostic (1.19e-1)"	"unprognostic (6.01e-1)"		"unprognostic (3.46e-2)"	"unprognostic (2.31e-1)"				"unprognostic (5.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"			"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"			0.1	0.2	0.4	0.3	0.5	0.1	0.1	0.3	4.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	3.0	1.5	0.1	0.3	0.1	0.1	0.9	0.0	0.1	1.7	0.1	3.2	0.1	46.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.3	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	1.4	3.0	1.5	0.9	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.1
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47996895	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 34.3"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 7.4;Cholangiocytes: 10.2;Hepatocytes: 10.4;Proximal tubular cells: 20.3;Smooth muscle cells: 7.6"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 8.0;U-2197: 17.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA045817	Approved				"Intracellular and membrane"	NA	NA		22000			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	3.6	1.5	0.5	2.2	0.3	0.1	3.3	2.7	0.5	4.8	3.0	0.5	1.5	0.9	1.8	9.3	4.7	2.2	9.5	8.2	0.1	0.1	34.3	7.1	1.8	1.9	0.4	0.5	2.5	7.0	0.3	2.3	0.9	0.8	4.9	1.6	2.7	2.3	8.5	1.7	1.7	1.8	7.1	0.7	1.5	1.9	1.8	0.0	0.6	1.1	1.0	0.8	6.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.5	0.0	8.0	0.0	0.9	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.5	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	17.1	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.7	0.5	0.1	0.1	0.4	0.5	0.8	0.0	0.0	0.3	0.0	1.4	0.7	0.0	7.4	10.2	0.0	0.0	1.8	0.0	0.0	5.0	3.3	0.1	0.8	0.0	0.0	1.8	0.0	2.1	0.2	0.0	10.4	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	2.1	20.3	0.0	0.0	7.6	0.0	2.2	0.3	0.0	0.0	0.0	0.1
TRH		ENSG00000170893	"Thyrotropin releasing hormone"	P20396	3	129974305-129977938	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5"	"Cell type enriched"	"Detected in some"	31	"Muller glia cells: 222.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 13.3;endometrial cancer: 10.2"	"Group enriched"	"Detected in many"	14	"hypothalamus: 33.9;pons and medulla: 33.8"	"Group enriched"	"Detected in some"	11	"intermediate monocyte: 1.1;non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"REH: 2.6;SuSa: 4.0;T-47d: 2.4"	"Group enriched"	"Detected in many"	5	"hypothalamus: 204.6;olfactory region: 182.2"	"Low region specificity"	"Detected in many"			HPA035596	Enhanced				"Secreted in other tissues"	NA	NA					"HPA035596: AB_2674695"	"unprognostic (1.22e-1)"	"unprognostic (8.94e-2)"		"unprognostic (5.82e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.82e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2.0	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1.0	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0.0	0.8	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	4.0	2.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	2.4	0.3	1.7	2.0	33.9	0.4	0.8	33.8	0.0	0.0	0.0	0.0	0.5	0.7	6.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	222.3	0.0	0.0	0.0	0.0	7.1	0.0	0.4	0.4	0.4	0.1	0.1	0.0	0.0	0.5
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;pancreas: 19.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebellum: 30.3"	"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		6200000				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	6.2	2.2	2.9	1.0	4.7	1.0	7.6	30.3	12.3	10.2	2.4	0.1	2.5	4.8	2.7	1.7	0.9	2.5	2.5	2.2	7.3	2.8	9.9	1.5	3.0	0.6	1.2	5.5	6.5	19.4	0.4	1.6	0.7	1.5	5.5	1.5	1.0	2.4	5.8	0.7	0.8	4.2	1.2	0.9	4.8	1.1	1.7	0.5	0.0	0.5	0.4	1.0	2.8	7.6	0.2	0.0	1.0	0.3	0.3	0.0	0.0	2.4	0.0	0.4	0.0	1.1	0.0	6.7	20.8	20.2	2.0	1.4	0.0	0.0	0.0	10.9	3.0	2.1	0.2	3.8	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.0	0.0	0.0	0.0	6.9	4.6	2.0	0.0	0.0	0.0	0.0	0.4	0.0	4.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	2.9	4.7	30.3	12.3	7.3	2.8	1.2	5.5	1.5	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	1.4	0.0	1.8	0.0	0.0	3.3	0.0	30.7	0.0	6.9	0.0	2.2	0.3	0.5	0.2	0.0	1.3	0.2	0.0	0.0	0.0	0.0	47.8	27.3	0.3	0.0	0.0	1.5	0.3	2.1	2.9	12.7	7.4	0.6	0.0	0.4	0.1	0.7	0.0	0.1	0.0	0.7	0.1
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.4	0.0	0.8	0.0	0.1	54.2	0.0	12.4	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	72.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.5	0.2	0.9	40.5	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	97.6	241.7	0.0	1.1	2.5	33.5	13.6	0.0	0.0	37.9	0.0	1.3	21.4	0.4	2.1	0.0	3.9	5.0	5.4	34.5	1.1	0.0	4.4	0.0	2.4	0.0	0.0	78.0	0.6	1.7	21.9	0.0	2.3	0.0	33.2	0.8	0.0	0.2	0.0	0.0	7.2	0.6	1.4	402.6	20.7	0.0	1.4	144.0
TRIM43	TRIM43A	ENSG00000144015	"Tripartite motif containing 43"	Q96BQ3	2	95592018-95599778	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.8;stomach 1: 1.5;testis: 2.8"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 3.6"									"HPA042223, HPA042772"	Uncertain					NA	NA					"HPA042223: AB_10962361, HPA042772: AB_10964436"				"unprognostic (7.17e-3)"						"unprognostic (1.42e-1)"					"unprognostic (9.27e-2)"			0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282392-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 187.1"	"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 75.1;Exocrine glandular cells: 36.7;Pancreatic endocrine cells: 31.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Cell type enriched"	"Detected in single"	16	"NK-cell: 7.0"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 7.0"	"Group enriched"	"Detected in some"	9	"HAP1: 8.4;NTERA-2: 18.0"	"Region enhanced"	"Detected in some"		"amygdala: 3.2"	"Not detected"	"Not detected"			HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	2.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.9	0.1	6.3	1.6	0.0	0.0	35.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	187.1	0.0	0.4	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.3	40.3	2.2	0.1	0.0	0.3	0.0	0.0	0.0	7.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	8.4	0.0	0.0	0.0	0.3	0.0	1.5	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	18.0	0.0	0.0	0.6	0.7	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	12.7	0.0	0.0	3.5	0.0	0.0	0.0	3.6	1.0	0.0	2.0	0.0	36.7	0.0	0.0	0.2	4.6	0.0	0.1	0.0	0.0	0.6	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	31.1	1.9	0.7	2.1	0.0	0.0	0.2	3.7	1.9	0.0	0.0	0.0	2.9	0.3
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175487	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 34.3;liver: 22.0;skeletal muscle: 37.0;tongue: 24.4"	"Cell type enhanced"	"Detected in some"	26	"Cardiomyocytes: 96.0;Ciliated cells: 17.4;Hepatocytes: 28.0"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 3.3"	"Cell type enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"LHCN-M2: 97.8"	"Region enriched"	"Detected in single"	8	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	2.1	0.0	0.3	0.2	0.2	0.0	0.1	3.3	0.1	0.4	0.1	0.1	0.3	0.0	0.0	6.6	0.8	3.0	0.1	34.3	0.4	0.1	2.7	22.0	0.1	0.4	0.1	0.1	0.5	0.1	0.0	2.0	1.4	0.8	0.3	0.0	0.1	1.0	0.0	37.0	0.3	0.1	0.0	0.1	0.1	0.1	3.8	0.0	0.0	0.9	24.4	1.2	0.1	0.0	0.6	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	14.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	97.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.3	6.4	0.0	0.5	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	3.3	0.1	0.4	0.1	0.1	0.1	0.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	96.0	0.0	17.4	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.1	0.0	0.0	1.3	1.3	3.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.0	6.5	0.0	9.3	1.0	0.0	3.2	0.0	0.0	0.1
TRIM67	TNL	ENSG00000119283	"Tripartite motif containing 67"	Q6ZTA4	1	231162112-231221556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 14.4"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 65.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;HMC-1: 1.6;HSkMC: 1.4;SCLC-21H: 7.2;SH-SY5Y: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034776	Uncertain					NA	NA					"HPA034776: AB_10603997"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.93e-10)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.10e-3)"	0.3	0.7	1.3	0.2	1.3	0.1	0.1	13.3	14.4	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.3	1.2	1.9	0.2	0.1	0.1	0.2	1.5	0.0	0.2	0.2	0.1	1.9	0.4	1.9	0.1	0.2	1.7	0.2	0.1	0.1	0.4	0.3	0.2	0.9	0.2	0.2	0.5	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.0	0.0	7.2	1.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	13.3	1.9	1.2	1.9	1.5	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 15.9;Cardiomyocytes: 22.9;Sertoli cells: 12.9;Suprabasal keratinocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.4;HDLM-2: 24.1;PC-3: 13.3;TIME: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	3.0	0.0	0.3	0.5	0.5	0.2	1.4	0.0	0.5	1.2	0.3	8.1	0.4	4.3	1.7	2.6	11.4	3.3	9.3	0.1	24.1	1.3	0.5	7.9	0.1	1.6	0.0	1.4	0.1	7.2	0.2	4.6	1.8	2.6	1.1	0.3	1.3	0.2	0.8	0.3	0.2	0.0	9.7	13.3	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.2	4.1	0.1	0.7	0.2	11.0	0.1	2.4	0.4	4.3	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2	0.0	1.4	0.0	3.9	15.9	5.7	22.9	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.4	0.6	1.4	2.4	0.0	2.0	0.4	0.8	1.8	0.0	0.2	1.1	0.0	0.0	1.8	9.4	0.0	0.9	1.6	1.7	0.0	3.1	0.5	3.2	8.5	1.4	1.1	2.7	12.9	9.0	0.9	0.4	24.8	0.0	0.0	2.2	2.4
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214021-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 71.6;tongue: 37.7"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Club cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 3.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;LHCN-M2: 8.9;RH-30: 23.1;U-266/70: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	2.3	0.1	0.1	0.1	0.2	0.3	0.1	3.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.5	1.8	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	71.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.2	37.7	1.9	0.0	0.0	2.0	1.9	4.9	1.3	2.1	1.3	0.4	0.1	0.2	0.2	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.7	0.3	0.2	4.8	0.2	1.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.5	8.9	0.2	0.1	0.4	0.2	0.1	0.3	0.3	23.1	3.0	0.0	0.3	1.9	0.2	0.2	0.3	0.1	0.3	0.2	2.0	0.1	0.2	0.3	0.2	0.1	14.4	1.2	0.2	0.2	0.4	0.2	4.5	1.3	1.5	1.1	1.2	1.0	1.3	1.0	0.9	0.8	2.0	1.3	1.3	4.9	2.1	1.2	1.9	0.8	0.4	0.1	0.2	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	6.7	0.0	2.0	0.1	0.8	2.6	0.0	0.0	4.5	0.0	2.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	1.4	1.1	0.0	0.2	0.0	0.0	0.6	1.9	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	1.6
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell type enhanced"	"Detected in some"	17	"Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 58.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	12.6	0.0	0.0	0.0	0.0	7.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.3	2.4	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	58.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	18.8	0.0	0.0	0.0	0.0	5.5	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	0.0	7.4	0.0	0.0	0.3
TRMT9B	"C8orf79, FLJ36980, hTRM9L, KIAA1456, TRM9L"	ENSG00000250305	"TRNA methyltransferase 9B (putative)"	Q9P272	8	12945642-13031503	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 64.7;thyroid gland: 26.5"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 26.8;Club cells: 18.2;Collecting duct cells: 14.0;Distal tubular cells: 10.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.2"	"Group enriched"	"Detected in all"	7	"cerebellum: 64.7;pons and medulla: 31.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 7.1;BJ: 10.2;fHDF/TERT166: 13.7;RPTEC TERT1: 4.8;SCLC-21H: 5.2;U-266/84: 4.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 77.4"	HPA024673	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA024673: AB_1845788"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-4)"	"unprognostic (1.06e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.77e-7)"	"unprognostic (2.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.27e-3)"	"unprognostic (3.34e-2)"	2.1	0.9	2.0	1.1	4.1	1.2	3.5	64.7	6.0	2.0	1.8	6.6	0.8	1.4	1.9	2.5	1.3	2.4	2.7	6.0	6.7	2.9	2.7	1.7	1.7	1.0	2.0	2.8	0.6	1.7	2.3	1.2	7.1	31.5	1.2	2.1	5.8	2.3	1.9	4.4	5.1	1.5	0.9	1.9	1.6	1.5	1.8	1.0	0.0	26.5	1.3	0.7	1.3	0.9	1.0	0.6	2.8	0.6	1.9	0.6	0.0	0.1	0.2	7.1	0.0	0.0	0.0	1.7	10.2	2.3	1.4	0.7	0.1	0.3	0.2	0.5	13.7	1.3	0.3	0.1	0.3	1.5	0.1	0.4	0.4	0.4	0.1	0.0	0.2	0.7	0.2	3.6	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.3	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.1	4.8	0.2	5.2	0.1	0.1	0.1	0.2	2.4	0.2	0.0	0.0	0.2	0.9	1.0	0.2	0.4	4.9	0.1	0.1	0.2	1.8	2.6	0.6	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.2	1.0	0.5	0.6	2.8	1.9	0.3	0.6	0.2	0.0	2.0	4.1	64.7	5.0	6.7	2.9	2.0	2.8	31.5	1.0	6.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	26.8	18.2	14.0	0.0	0.9	10.0	0.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 16.7;Enterocytes: 10.8;Suprabasal keratinocytes: 21.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 3.6;BEWO: 5.4;CACO-2: 4.3;RH-30: 13.3;T-47d: 5.6;U-266/70: 3.5"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.6	0.0	0.5	0.1	0.3	0.6	5.4	0.2	0.0	0.0	0.0	4.3	1.0	0.2	1.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.3	0.5	0.1	13.3	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	5.6	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.8	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0	0.0	4.5	1.4	4.0	16.7	0.8	2.4	2.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.2	1.6	10.8	0.0	0.0	0.7	4.3	2.9	0.0	0.4	0.2	4.8	0.0	0.0	0.0	0.0	2.8	2.2	6.8	0.0	0.7	2.0	0.8	0.8	3.2	0.8	0.9	0.0	0.9	0.0	1.1	21.5	0.5	2.1	0.6	2.2
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783085-109833401	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 32.6"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 15.3;Cytotrophoblasts: 16.0;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	11	"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	7	"classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;BJ hTERT+: 9.3;EFO-21: 8.2;HaCaT: 14.8;HUVEC TERT2: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA					"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.3	0.9	0.3	0.9	0.4	0.1	3.3	0.2	0.6	2.3	0.4	3.2	0.0	0.6	0.8	3.7	9.5	5.6	5.2	1.6	1.3	0.2	11.6	7.8	2.6	1.8	0.2	0.0	0.6	7.1	0.1	4.3	11.1	15.0	6.2	0.3	12.6	32.6	1.4	0.2	6.5	0.3	0.9	0.3	3.5	0.9	0.7	0.1	0.2	0.9	2.6	8.7	2.6	1.7	0.0	0.4	0.0	3.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	1.9	1.9	9.0	4.3	9.3	1.3	0.5	0.0	6.4	0.0	8.2	5.5	0.0	14.8	1.1	0.0	0.3	0.0	2.1	0.0	0.0	3.6	0.7	0.0	0.0	3.3	2.0	3.3	0.0	0.5	8.4	0.0	0.8	0.0	0.4	5.4	0.0	0.0	1.7	0.0	0.3	0.0	0.5	0.0	0.0	5.2	0.0	0.0	0.3	0.6	2.6	4.1	1.2	0.4	5.1	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.6	1.3	0.2	0.2	0.0	15.0	0.1	0.0	0.0	1.3	8.2	3.0	0.0	1.1	15.3	5.3	6.8	10.4	0.0	16.0	3.3	2.2	0.2	0.5	0.0	0.0	8.4	4.3	0.7	3.7	0.0	6.4	3.6	0.0	0.0	0.6	10.7	0.0	0.9	1.6	6.8	1.0	0.0	0.0	1.5	0.0	0.0	11.1	0.0	0.0	0.8	0.2	1.3	3.3	17.6	0.0	0.0	2.0
TSPAN18	TSPAN	ENSG00000157570	"Tetraspanin 18"	Q96SJ8	11	44726465-44932421	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 24.2;Early spermatids: 32.7;Endothelial cells: 35.8;Ito cells: 55.3;Proximal tubular cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 28.1;hippocampal formation: 12.2"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.7;NK-cells: 1.0;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"AF22: 14.5;CAPAN-2: 23.9;GAMG: 14.1;HDLM-2: 19.4;NTERA-2: 13.6;RH-30: 15.2;SCLC-21H: 13.0;SH-SY5Y: 14.7;SuSa: 41.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.09e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-2)"	10.1	22.4	1.4	11.1	2.0	0.3	4.7	28.1	2.7	12.8	21.1	4.5	30.6	3.0	23.6	8.9	15.0	10.6	14.3	40.0	12.2	2.5	13.5	4.1	10.6	4.7	1.7	1.6	17.4	1.0	2.3	3.0	14.3	3.1	15.3	4.9	16.7	2.5	28.0	6.8	2.9	8.0	23.3	2.5	8.0	9.7	2.8	1.8	1.4	7.1	7.4	2.6	14.9	11.9	0.5	0.2	3.7	0.1	1.0	3.3	4.5	0.0	0.2	14.5	0.2	0.0	0.0	0.0	0.2	0.2	0.9	0.0	2.8	23.9	0.0	7.1	0.4	14.1	0.0	2.6	0.0	0.2	19.4	0.9	0.1	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.4	0.0	15.2	0.0	0.0	0.0	13.0	14.7	0.1	0.0	0.0	41.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	3.7	0.3	0.0	2.1	0.5	2.9	1.3	0.0	0.1	3.3	0.5	0.9	1.0	0.0	0.2	0.8	4.5	1.4	2.0	28.1	2.7	12.2	2.5	1.7	1.6	3.1	1.8	0.0	5.9	2.4	0.1	1.4	1.3	24.2	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.6	32.7	35.8	0.0	0.0	0.2	0.2	9.1	0.1	1.1	0.6	0.4	1.6	0.0	55.3	3.4	4.2	2.6	0.0	6.8	0.0	0.0	0.2	0.4	0.0	1.4	23.1	0.2	0.0	2.1	0.7	0.7	1.0	0.2	0.9	0.0	0.0
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 44.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 11.9"	"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.0;NK-cells: 25.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	3.7	0.6	1.1	4.7	2.5	9.6	3.2	0.9	2.0	20.1	31.0	1.5	8.9	2.5	30.6	6.9	12.3	14.2	10.6	6.1	1.1	2.6	4.0	0.6	3.0	1.5	1.9	1.9	6.5	2.0	6.4	2.0	1.5	11.9	15.2	6.2	1.9	2.2	15.7	2.0	1.6	7.0	44.6	1.6	2.2	10.0	4.4	0.8	2.6	4.0	4.9	0.9	25.4	7.0	0.2	1.2	35.0	2.9	25.9	7.4	3.8	8.5	0.1	0.7	0.0	0.0	0.1	0.0	1.4	0.5	1.4	2.2	1.7	5.2	0.0	35.1	1.9	1.9	1.2	1.1	0.0	1.5	1.7	0.7	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	9.8	0.0	6.9	0.0	0.5	0.0	0.4	4.6	0.7	8.0	1.7	0.9	0.0	0.5	0.0	0.2	3.2	1.8	2.9	2.1	0.9	0.1	4.9	0.1	0.3	0.1	0.1	3.4	0.2	8.0	7.3	0.2	0.0	0.0	15.4	3.8	27.8	2.9	16.6	5.9	0.0	1.9	0.2	7.0	7.4	1.2	0.1	1.2	6.0	35.0	25.9	0.0	1.2	0.9	3.8	1.1	2.5	0.9	2.0	1.1	2.6	1.9	1.9	11.9	0.8	0.0	1.1	0.0	22.5	7.1	0.2	9.2	0.0	10.7	2.3	10.4	0.0	0.1	0.0	16.3	10.8	15.0	0.0	0.0	2.2	3.1	3.1	10.9	0.0	0.0	0.6	0.0	37.7	5.5	0.8	2.7	0.6	0.9	3.3	0.0	0.8	0.0	7.7	0.0	2.8	1.0	0.4	6.5	20.2	0.1	0.9	2.4	0.2	5.0	1.0	9.2
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627109-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 88.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 313.3;Late spermatids: 1149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 34.2"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 43.2;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	27.0	9.8	7.0	4.4	6.6	0.1	33.0	2.9	4.9	15.9	17.8	12.6	6.4	9.7	11.1	10.4	27.1	24.2	10.0	5.7	7.4	7.3	26.7	68.2	8.3	3.6	6.9	4.1	27.6	25.1	19.6	17.7	23.6	34.2	15.5	20.3	16.7	88.4	6.7	3.5	4.7	11.6	4.7	10.4	8.6	8.0	17.5	6.6	2.9	24.6	11.0	19.8	17.2	11.5	0.3	0.2	0.8	0.2	0.3	6.6	1.4	7.9	10.6	28.7	14.5	12.6	6.8	11.6	4.5	7.1	9.0	21.1	23.8	13.9	0.0	19.1	4.6	6.2	6.5	0.1	8.6	10.6	0.0	15.4	1.4	6.9	26.5	7.0	0.0	1.1	13.3	4.2	7.9	3.1	13.1	19.1	0.0	0.0	0.0	9.2	8.2	0.0	0.1	43.2	12.0	8.0	0.0	13.6	0.0	14.1	65.2	1.8	7.8	4.5	3.9	6.0	24.1	5.7	1.0	5.3	5.6	8.6	9.2	2.9	0.0	0.0	0.0	5.0	0.0	4.0	0.5	0.1	0.2	1.0	0.1	3.5	0.3	2.4	0.8	0.0	0.2	6.6	3.8	0.8	0.3	0.2	0.2	0.1	1.4	7.0	6.6	2.9	4.9	7.4	7.3	6.9	4.1	34.2	6.6	3.0	8.5	7.8	36.0	6.4	0.7	7.3	61.1	115.1	21.6	89.0	0.0	26.5	19.9	64.9	313.3	22.2	51.9	0.0	11.1	33.5	17.7	46.5	0.0	94.2	3.8	0.0	32.3	58.9	11.8	1149.4	30.5	2.9	10.1	1.8	42.7	38.6	20.9	46.0	33.6	37.7	1.5	19.4	7.5	19.0	32.2	4.6	11.3	3.5	78.3	78.2
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.2;heart muscle: 58.5"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 66.4;Extravillous trophoblasts: 79.2;Syncytiotrophoblasts: 67.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.2"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RH-30: 63.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 125.3"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		1900000	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	12.7	5.3	2.6	4.0	5.9	0.3	16.2	58.2	11.5	17.6	6.6	3.0	16.1	3.6	20.9	11.2	6.8	8.8	13.8	58.5	2.9	2.7	21.3	25.3	13.6	3.9	2.8	3.3	15.3	6.5	17.4	3.8	27.7	4.5	10.7	2.7	21.8	8.4	17.7	7.1	13.3	5.4	9.5	2.6	8.4	5.6	5.7	2.3	6.0	9.4	9.4	4.3	8.1	13.6	0.0	0.0	0.6	0.1	0.0	1.1	3.6	0.4	3.5	6.0	5.1	4.9	4.7	14.1	6.8	20.6	4.4	5.8	8.2	3.2	0.2	6.8	3.9	4.2	0.9	2.4	2.5	2.6	1.1	2.7	9.3	2.7	5.8	13.5	0.0	0.7	6.0	2.2	9.1	4.2	14.8	15.0	0.3	0.2	0.2	3.8	5.3	0.0	0.2	8.4	2.1	1.9	2.7	63.6	0.8	18.4	1.6	10.7	7.2	4.5	11.5	4.4	12.9	4.0	0.0	8.8	2.4	7.3	3.9	6.4	0.0	0.0	0.0	6.1	0.1	2.6	0.0	0.1	0.0	1.1	0.1	0.3	0.0	0.2	0.6	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	3.6	2.6	5.9	58.2	11.5	2.9	2.7	2.8	3.3	4.5	2.3	0.0	2.6	0.9	10.8	17.1	66.4	45.8	10.2	1.4	3.4	12.2	2.0	49.9	5.0	16.1	1.4	32.2	2.4	0.0	7.8	79.2	21.2	16.1	0.0	33.3	5.4	31.8	5.8	38.1	3.3	2.4	16.1	0.9	11.8	1.0	2.6	3.3	9.1	0.0	16.3	18.2	4.2	19.4	19.5	1.4	3.4	10.5	67.5	0.0	1.9	9.7
TSPEAR	"C21orf29, DFNB98, MGC11251, TSP-EAR"	ENSG00000175894	"Thrombospondin type laminin G domain and EAR repeats"	Q8WU66	21	44497892-44711580	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 14.9"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 3.4"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	10	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.6;SH-SY5Y: 5.1;U-2 OS: 3.6"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.5"	"Region enhanced"	"Detected in some"		"olfactory region: 2.0"	"CAB034203, CAB034204, HPA052995"	Uncertain				"Secreted in other tissues"	NA	NA					"CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008"	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.86e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.86e-4)"	"unprognostic (2.13e-2)"	"unprognostic (4.80e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	0.3	0.1	0.2	0.3	2.5	0.0	0.5	0.2	0.9	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.2	1.1	0.2	2.7	0.2	0.1	0.5	1.4	1.4	0.8	0.2	0.2	0.2	0.2	2.6	14.9	0.2	1.0	0.2	0.0	0.2	0.2	0.2	0.2	3.9	0.5	0.2	0.2	0.6	0.3	4.6	0.2	0.5	2.8	0.2	0.4	0.2	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.2	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.1	0.0	0.0	1.1	5.1	0.0	0.1	0.0	0.4	0.1	0.3	1.4	0.0	3.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.2	0.9	0.2	0.1	0.2	0.2	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706638-146945882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 55.9"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 136.5;Early spermatids: 509.6;Late spermatids: 355.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;pons and medulla: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;hTERT-HME1: 3.2;Karpas-707: 2.3;U-266/70: 4.2;U-87 MG: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain					NA	NA					"HPA037006: AB_10670379, HPA061473: AB_2684534"	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.2	0.1	0.9	0.1	4.3	0.1	0.1	0.1	1.2	0.8	0.1	1.7	0.5	0.1	0.3	10.7	0.1	13.3	0.1	0.1	1.5	1.3	0.2	0.1	7.0	0.1	0.3	0.7	2.6	0.1	0.8	0.2	0.1	12.7	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.1	55.9	0.6	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.0	0.8	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.9	3.2	0.3	0.3	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.2	0.0	0.0	4.2	0.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.3	0.1	1.2	1.5	1.3	0.3	0.7	12.7	0.6	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	136.5	15.9	0.0	0.0	0.0	0.0	0.0	509.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	85.1	7.3	0.0	0.0	0.0	0.0	0.0
TTLL10	"FLJ36119, TTLL5"	ENSG00000162571	"Tubulin tyrosine ligase like 10"	Q6ZVT0	1	1173884-1197935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"testis: 48.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 234.3;Late spermatids: 619.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Cell type enriched"	"Detected in single"	29	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"NK-cells: 2.9"	"Cell line enriched"	"Detected in single"	24	"SCLC-21H: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042712	Uncertain					NA	NA					"HPA042712: AB_10797019"	"unprognostic (1.74e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.66e-3)"	"prognostic favorable (1.61e-5)"	"unprognostic (5.33e-2)"	"unprognostic (2.68e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.14e-3)"	"unprognostic (4.50e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.00e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.39e-2)"	1.2	0.0	0.1	0.1	0.5	0.0	0.6	0.1	0.2	1.7	0.1	1.0	0.1	0.0	0.2	1.1	0.1	10.9	0.1	0.1	0.3	0.3	0.1	0.1	3.1	0.1	0.1	0.3	0.7	0.1	0.0	1.3	1.5	2.2	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.5	48.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.2	0.3	0.3	0.1	0.3	2.2	0.3	0.0	0.3	0.0	0.5	1.5	0.0	0.6	2.5	54.9	2.3	0.0	2.0	0.0	0.0	0.2	234.3	0.5	0.0	0.0	1.2	0.7	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	619.5	4.9	0.0	0.0	0.0	3.1	0.2	0.9	0.0	4.2	0.0	0.0	6.5	0.0	2.8	2.1	1.8	0.1	0.0	4.1	1.0
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 22945.1"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 31.4;EFO-21: 11.1;Hep G2: 48.2;U-2 OS: 14.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	180000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.6	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	48.2	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	14.5	0.0	1.1	0.0	0.6	4.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6	0.0	0.0	32.7	0.0	0.5	25.4	1.4	973.2	0.0	0.0	5.2	153.2	0.2	5.0	2.7	5.4	0.1	1.1	163.5	1.6	0.6	0.6	0.2	0.0	22945.1	2.3	25.4	342.4	228.9	289.5	6.6	0.3	0.0	0.0	0.0	1.5	13.2	212.8	2.9	0.0	1.1	45.2	0.0	0.4	3.4	0.6	0.1	3.3	0.5	1.6	0.0
TULP1	"LCA15, RP14, TUBL1"	ENSG00000112041	"Tubby like protein 1"	O00294	6	35497874-35512938	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction, Vision"		"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"retina: 56.1"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 251.3;Rod photoreceptor cells: 308.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.4;CACO-2: 1.4;MCF7: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (7.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.60e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.12e-3)"		"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.66e-6)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.11e-2)"	0.3	0.2	0.3	0.6	0.5	0.0	0.3	0.3	0.3	1.0	0.3	0.3	0.3	0.0	1.2	2.3	0.7	1.4	0.3	0.3	2.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.0	0.6	0.8	0.4	2.7	0.0	56.1	1.1	1.9	0.3	2.5	0.3	0.3	0.3	0.3	0.2	0.9	0.3	0.3	0.3	0.3	0.3	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	7.4	0.1	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	4.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.5	0.1	0.2	0.0	0.1	1.1	0.0	0.0	0.4	0.3	0.0	0.1	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	2.4	0.0	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.6	0.0	27.7	0.6	0.0	0.0	0.0	0.0	251.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	38.4	0.0	0.0	0.0	0.0	308.3	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.2
TYRP1	"b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP"	ENSG00000107165	"Tyrosinase related protein 1"	P17643	9	12685439-12710290	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 277.3"	"Cell type enriched"	"Detected in some"	19	"Melanocytes: 2358.5"	"Cancer enriched"	"Detected in some"	262	"melanoma: 313.2"	"Region enriched"	"Detected in some"	5	"pons and medulla: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	52	"SK-MEL-30: 177.7"	"Group enriched"	"Detected in some"	5	"olfactory region: 5.6;thalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA000937, CAB002520"	Enhanced		Approved	Vesicles		NA	NA		16000	Vesicles		"CAB002520: AB_564153, HPA000937: AB_1080437"	"unprognostic (7.48e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.10e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.46e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-6)"	"unprognostic (1.27e-1)"	"unprognostic (5.99e-2)"		"unprognostic (1.95e-2)"	0.2	0.0	0.2	0.2	0.3	0.0	1.7	0.2	1.0	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	5.0	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	177.7	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	1.0	0.9	0.1	0.2	0.3	5.0	0.2	0.0	0.0	0.0	0.0	82.0	0.6	39.7	0.0	0.0	0.0	3.5	2.0	0.0	122.7	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.3	0.3	0.0	2358.5	0.0	0.0	15.4	0.0	0.0	0.0	0.8	1.3	0.0	3.1	0.5	0.7	14.6	0.0	0.0	0.0	0.1
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655675-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.5;lymphoid tissue: 27.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 29.2;Extravillous trophoblasts: 45.7;Hofbauer cells: 34.3;Kupffer cells: 31.7;Syncytiotrophoblasts: 39.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 32.5;pons and medulla: 21.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 42.6;HMC-1: 32.5;hTEC/SVTERT24-B: 26.5;REH: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038607"	Approved		Approved	"Plasma membrane"		NA	NA		2200000	"Plasma membrane"		"HPA038605: AB_10669648, HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	4.3	1.3	2.8	5.5	4.0	7.2	1.5	32.5	4.9	4.0	1.5	0.7	0.0	1.7	1.3	0.3	1.8	1.1	2.4	1.3	3.4	3.5	1.5	1.7	5.5	10.9	5.1	1.9	0.8	1.2	0.6	0.9	16.8	21.2	1.3	1.8	0.9	1.3	0.9	1.8	4.1	2.4	2.3	2.1	27.7	1.7	2.1	0.2	23.9	2.9	1.7	3.8	3.4	1.3	1.0	1.7	9.8	11.0	6.5	4.9	1.8	4.5	11.1	2.0	2.7	0.9	1.6	10.6	16.2	9.0	6.6	5.1	4.4	2.4	1.8	1.3	8.6	6.3	2.2	0.0	5.8	10.5	0.0	0.3	42.6	0.3	3.7	2.5	5.1	32.5	1.4	0.3	26.5	9.8	7.2	4.4	1.9	0.0	0.0	6.4	0.1	6.3	3.3	0.9	4.6	2.6	25.4	1.2	0.2	10.4	3.8	4.6	0.1	4.3	0.3	3.6	4.4	0.0	1.4	11.4	8.6	4.6	5.0	6.7	0.4	0.0	5.4	4.5	7.3	15.5	0.0	1.3	9.8	2.0	6.5	2.2	0.3	2.6	1.8	1.7	1.0	3.0	1.6	2.8	6.5	11.0	0.2	4.9	1.8	2.8	4.0	32.5	4.9	3.4	3.5	5.1	1.9	21.2	0.2	0.0	6.6	0.0	3.5	6.4	0.6	1.2	0.0	0.0	1.2	3.5	0.0	29.2	0.0	9.2	1.9	4.2	0.4	0.0	8.3	45.7	4.2	2.9	12.7	0.0	34.3	11.1	0.0	4.9	31.7	2.8	0.0	19.6	1.7	0.0	0.0	0.5	16.9	0.0	0.4	0.0	1.1	0.0	4.2	0.0	0.5	5.3	39.8	7.2	0.3	2.7
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559925	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.2"	"Group enriched"	"Detected in some"	16	"Ductal cells: 316.2;Exocrine glandular cells: 231.1;monocytes: 265.1;Pancreatic endocrine cells: 685.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RT4: 13.8"	"Not detected"	"Not detected"							HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.4	0.4	0.0	53.2	0.0	0.4	1.8	0.0	0.4	0.7	1.8	0.0	0.0	1.5	0.6	1.6	4.2	1.2	2.9	1.8	0.0	0.0	13.4	16.3	5.1	26.3	0.0	0.0	0.5	14.6	0.4	0.7	0.4	1.0	5.6	3.0	1.0	11.3	0.7	3.1	0.6	15.5	0.7	0.2	18.6	3.5	0.4	0.0	26.3	2.7	4.5	50.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	3.0	1.9	0.0	0.0	0.1	0.0	0.0	22.9	16.0	15.9	0.0	0.0	0.0	1.7	316.2	0.0	0.0	3.3	0.0	231.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	265.1	3.1	0.0	685.5	6.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.4;THP-1: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 14.7;Late spermatids: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.1	2.1	1.8	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.1	0.3	0.4	0.3	2.2	0.8	0.4	0.8	18.3	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.4	0.7	1.0	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.6	1.4	1.6	4.3	0.6	1.1	0.6	1.2	1.3	0.5	0.9	0.7	0.4	0.2	1.1	0.4	0.3	1.4	0.7	1.3	1.6	1.7	0.8	0.3	1.1	0.7	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.1	0.1	2.2	0.5	0.0	2.7	1.2	0.0	0.0	0.3	0.0	0.3	14.7	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.8	10.7	0.0	0.0	0.0	0.0	0.6	0.7	0.3	0.0	0.7	0.0	1.6	0.0	0.1	1.2	0.7	0.3	0.2	2.2	0.6	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 32.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6"									"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8"									HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.4	5.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.3	0.0	3.9	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	5.7	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 23.1;JURKAT: 17.8"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.6	1.4	2.6	7.7	2.7	3.6	1.1	1.6	2.8	1.8	3.1	2.7	2.9	12.4	6.6	2.6	23.1	4.5	4.3	12.0	3.8	0.2	0.9	0.0	13.6	0.1	1.0	8.4	5.6	11.4	3.0	1.3	2.3	17.8	2.2	0.0	4.0	3.2	2.8	0.0	0.9	1.7	4.2	1.2	2.4	0.3	4.9	2.0	0.9	0.3	5.3	3.3	0.8	1.6	2.6	5.3	1.9	1.3	2.3	5.1	3.2	0.4	0.4	2.5	7.9	4.0	3.3	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2	6.0	2.1	0.0	0.4	0.1	0.0	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	0.0	0.0	0.0	0.1
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232907-1237318	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	20	"cerebellum: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"NB-4: 47.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Region enriched"	"Detected in many"	8	"cerebellum: 19.3"	HPA063294			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.1	0.1	0.0	0.2	0.0	0.1	0.1	44.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	3.5	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	1.1	0.9	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 1: 113.2"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2"									HPA010506	Approved					NA	NA					"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.5	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.2	2.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	113.2	3.5	0.0	0.2	1.4	0.0	0.3	2.5	4.0	9.1	3.5	3.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	1.1	0.0	0.1	1.6	0.0	0.6	0.0	0.0	11.2	0.9	3.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.5	0.1	0.0	0.1	2.5
USH1G	"ANKS4A, FLJ33924, Sans"	ENSG00000182040	"USH1 protein network component sans"	Q495M9	17	74916084-74923256	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.9;epididymis: 11.4;esophagus: 11.8"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 7.8;Late spermatids: 12.2;Muller glia cells: 11.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.6"	"Region enriched"	"Detected in single"	20	"cerebellum: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.5;hTCEpi: 4.2;K-562: 3.1;MCF7: 4.8;OE19: 4.6;U-2 OS: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory region: 12.1"	"Low region specificity"	"Detected in some"			HPA024360	Uncertain					NA	NA					"HPA024360: AB_1858660"	"unprognostic (2.95e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.59e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-2)"	0.0	1.4	0.0	0.0	0.4	0.3	0.0	13.9	0.2	1.4	0.0	0.0	1.1	0.3	1.9	11.4	11.8	0.2	0.0	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.5	0.1	0.0	1.3	0.9	0.1	0.0	4.2	0.7	1.5	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	0.8	0.5	1.7	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.0	4.5	0.9	0.2	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.1	4.2	0.0	0.0	0.0	0.1	0.0	3.1	0.3	0.0	4.8	0.0	0.1	0.1	4.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.5	0.0	0.2	0.7	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.9	0.2	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.3	0.0	0.0	0.0	0.0	11.4	0.0	2.9	0.4	0.1	0.2	0.0	0.0	0.2	0.4	0.3	0.2	0.0	0.0	0.0
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 33.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	No	No			Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	16.0	9.0	5.9	20.4	6.5	38.6	21.3	33.4	6.6	12.7	19.1	6.0	16.8	16.2	18.1	13.3	13.6	10.4	14.2	7.6	6.6	4.4	12.9	10.8	17.5	28.2	8.1	3.9	19.5	27.1	7.1	8.2	10.2	7.9	12.4	11.5	8.2	18.5	14.8	12.4	15.9	19.0	16.1	8.0	23.6	14.7	10.3	7.8	22.7	12.5	11.4	22.5	21.3	17.9	11.4	20.6	52.6	28.1	7.2	12.9	13.4	9.2	30.2	15.6	9.8	7.7	12.6	13.8	7.9	9.9	7.7	9.5	11.8	17.3	9.4	12.6	7.9	5.1	11.7	14.6	12.3	7.5	15.3	7.9	10.6	10.8	12.7	6.6	6.3	12.8	9.0	16.3	9.3	16.2	7.8	16.7	16.9	14.1	12.0	4.9	14.3	13.1	10.2	19.7	18.9	13.1	19.2	9.4	16.6	9.2	31.7	13.7	10.6	4.9	16.2	9.7	8.9	9.7	12.3	15.8	8.9	18.6	5.2	10.5	10.8	19.9	20.8	8.6	17.5	7.4	28.8	28.1	3.5	8.4	22.6	9.3	10.3	11.9	8.6	20.6	11.4	12.9	9.3	52.6	7.2	18.7	4.1	9.1	13.4	5.9	6.5	33.4	6.6	6.6	4.4	8.1	3.9	7.9	7.8	35.7	60.4	35.8	31.2	46.8	31.1	9.1	20.4	36.1	43.3	15.7	11.8	17.3	34.9	36.4	19.7	20.3	33.9	0.0	32.3	46.8	16.4	35.8	25.5	20.8	22.8	12.7	42.1	11.1	75.5	53.6	14.7	64.4	40.5	27.1	32.5	24.6	35.0	31.7	17.3	19.9	17.8	12.9	25.2	10.2	41.8	51.6	28.5	37.4	34.7	33.1
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551490	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.8"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 343.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 10.9"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	39	"B-cells: 5.6;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"HEL: 10.0;JURKAT: 22.6;NTERA-2: 54.2"					"Low region specificity"	"Detected in some"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	1.3	1.0	0.7	1.2	1.3	0.5	1.4	10.9	2.1	1.7	1.7	1.7	1.4	0.5	3.0	1.0	0.9	1.6	1.1	1.0	0.7	0.6	1.9	0.2	4.7	1.9	1.3	1.2	1.6	3.6	4.8	4.0	0.3	1.8	1.7	0.6	2.3	1.8	2.6	0.4	0.6	1.3	1.2	0.6	1.9	1.0	26.8	1.2	0.8	1.7	0.0	1.6	1.1	2.3	5.6	0.1	0.1	0.0	0.1	8.6	1.3	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.4	1.3	0.5	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	10.0	0.0	0.0	2.3	4.0	0.2	0.0	0.0	0.3	0.0	0.2	0.2	22.6	1.5	0.0	0.0	0.0	5.1	0.0	54.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	3.5	2.3	0.0	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	1.5	0.0	3.4	5.6	2.3	2.0	0.0	4.4	8.6	5.5	0.1	0.1	0.0	0.1	0.3	1.3	0.7	1.3	10.9	2.1	0.7	0.6	1.3	1.2	1.8	1.2	11.9	19.9	0.0	2.9	0.9	6.2	1.2	0.0	0.0	6.8	7.0	5.9	2.1	0.0	3.9	343.6	2.3	0.0	0.0	2.7	0.3	1.0	2.7	0.0	0.0	0.1	0.0	0.0	1.3	0.3	78.5	5.2	0.4	3.3	1.0	0.0	3.4	1.3	0.0	3.2	1.1	8.6	6.5	3.1	10.0	5.2	0.6	0.9	1.7	0.0	1.6
UTS2	"PRO1068, U-II, UCN2, UII"	ENSG00000049247	"Urotensin 2"	O95399	1	7843083-7853512	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 25.4;brain: 19.8"	"Cell type enriched"	"Detected in some"	5	"granulocytes: 40.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	19	"hypothalamus: 5.2;pons and medulla: 19.8"	"Cell type enriched"	"Detected in many"	6	"T-reg: 25.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 25.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.8;HEL: 5.9;HMC-1: 5.0;THP-1: 21.5"									HPA017000	Uncertain				"Secreted to blood"	NA	NA	2590000				"HPA017000: AB_1858656"	"unprognostic (2.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-5)"	"unprognostic (1.09e-4)"	"unprognostic (4.95e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.30e-3)"	1.0	6.3	0.3	0.6	0.3	5.2	0.3	0.3	0.3	0.5	1.2	0.4	1.2	1.1	0.3	0.3	0.3	0.6	0.9	0.3	0.6	5.2	0.3	0.3	0.6	2.9	0.3	0.3	0.4	0.3	0.0	0.3	0.3	19.8	2.0	2.4	0.3	0.3	0.3	0.3	0.5	1.0	2.3	12.7	2.1	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.9	0.3	0.0	0.4	4.1	0.0	3.2	25.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.9	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.1	0.0	0.3	3.0	0.0	4.0	0.0	2.7	2.8	0.4	0.0	0.2	0.8	0.0	3.2	0.0	0.0	25.4	0.9	0.3	0.3	0.3	0.3	0.6	5.2	0.3	0.3	19.8	0.3	0.0	3.4	0.8	0.0	1.3	1.8	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	40.4	0.0	0.1	4.8	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.5	0.8	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.4	0.1	6.9	8.4	0.0
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 19.0"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Early spermatids: 5.1;Late spermatids: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"amygdala: 19.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.2;naive B-cell: 3.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"PC-3: 7.2"									HPA026992	Uncertain				"Secreted - unknown location"	NA	NA					"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.1	1.5	19.0	0.7	0.8	0.2	1.6	0.5	2.5	0.6	0.6	0.8	0.5	7.7	1.5	0.5	0.6	1.0	3.0	0.9	1.5	1.2	0.5	4.8	0.6	0.9	0.8	0.5	1.7	4.1	0.0	0.5	0.5	1.0	0.5	0.1	0.5	0.5	0.5	0.5	1.3	4.2	0.5	1.1	1.1	1.9	2.9	0.5	0.5	0.5	0.5	0.8	0.9	0.7	6.2	1.2	0.1	0.1	0.0	0.1	0.1	0.9	2.1	2.9	1.4	0.8	3.7	0.9	2.1	1.2	0.8	0.4	1.5	1.1	1.4	1.1	1.0	5.8	1.1	0.9	0.0	3.5	1.4	1.0	1.3	2.8	6.1	0.7	1.6	0.8	1.5	0.4	0.5	0.6	1.9	0.8	1.2	0.9	1.4	1.1	1.2	0.4	1.2	1.6	2.7	7.2	1.8	3.4	0.5	0.4	3.6	1.6	1.0	1.3	1.5	0.8	1.3	1.2	1.0	3.0	1.6	0.9	2.8	0.8	2.3	1.3	1.4	1.9	1.1	1.0	0.0	0.0	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	3.0	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	19.0	0.8	0.5	2.5	1.5	1.2	0.8	0.5	1.0	0.5	3.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.7	0.9	0.3	0.2	0.0	0.0	0.0
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 21.8"	"Cell type enhanced"	"Detected in single"	27	"Cardiomyocytes: 1.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 7.7;WM-115: 5.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8"	"Low region specificity"	"Detected in many"			HPA028946	Uncertain		Approved	"Nucleoplasm,Nucleoli rim"		Yes	NA			"Nucleoli rim"	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.4	0.4	1.4	0.4	21.8	0.4	0.4	0.0	7.0	0.5	0.5	9.5	0.0	0.4	0.4	0.4	0.5	0.4	0.5	0.4	1.5	5.2	0.4	0.4	0.4	0.4	0.7	4.3	0.4	0.4	0.7	0.5	0.4	1.2	0.4	0.5	0.0	0.4	0.5	0.7	0.4	0.5	0.4	1.3	0.4	0.4	2.1	2.9	0.0	0.4	0.0	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	21.8	0.0	7.0	1.5	5.2	0.7	4.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900590-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4;retina: 21.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 8.7;Cone photoreceptor cells: 15.7;Horizontal cells: 11.1;monocytes: 7.2;Muller glia cells: 7.2;Rod photoreceptor cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.6;MCF7: 7.5;RH-30: 6.5;SCLC-21H: 6.6;SH-SY5Y: 7.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"basal ganglia: 2.1;hypothalamus: 4.7"	HPA009708			Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA009708: AB_2668261"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	2.7	2.6	4.4	1.4	1.9	0.4	2.1	16.4	7.9	1.9	0.8	1.1	0.0	0.5	3.6	0.8	1.8	1.1	0.6	1.5	2.5	4.1	0.6	0.3	0.9	0.6	1.4	1.1	2.3	6.9	0.9	2.2	1.2	0.8	2.3	0.6	21.2	4.5	0.6	2.0	1.5	0.5	1.9	1.6	0.4	0.4	0.8	1.0	0.0	0.7	1.2	0.4	1.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.0	1.2	6.6	1.8	1.0	3.7	1.2	0.5	0.1	0.0	0.1	0.0	0.0	0.0	2.9	2.2	0.3	2.5	0.0	0.2	0.0	4.1	0.0	0.1	2.8	0.8	0.0	0.0	1.8	0.0	0.3	0.0	1.9	0.6	0.3	0.0	0.0	2.4	7.5	0.0	0.1	2.9	0.0	0.1	0.0	6.5	0.0	2.0	1.6	6.6	7.9	5.1	0.0	2.7	0.2	2.9	0.2	1.2	3.1	0.7	1.5	1.3	0.0	0.0	0.0	1.5	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.9	16.4	2.7	2.5	4.1	1.4	1.1	0.8	1.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	15.7	0.1	1.7	1.4	0.0	0.4	0.0	0.0	0.6	0.2	0.8	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	7.2	0.6	0.0	0.0	0.0	17.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.3	0.0	2.5	9.4	0.0	11.0	24.5	3.3	4.8	0.3	1.7	0.0	4.3	11.8	0.5	0.0	0.1	0.2	18.3	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	14.0	2.8	26.3	65.1	0.0	0.6	0.0	8.9	0.2	0.0	0.0	1.7	0.5	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	0.0	18.9	0.0	38.7	13.1	0.4	4.5	15.1	0.0	0.0	0.0	10.5	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2	247.1	124.4	0.0	0.2	1.5	0.0	0.3	12.7	14.7	26.1	29.6	2.0	1.6	39.7	5.5	67.1	0.0	0.0	0.0	8.7	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	63.8	1.4	0.4	27.0	1.0	0.2	0.8	2.0	2.8	0.4	24.1	0.3	0.0	0.0	0.3	0.6	0.4	0.0	0.0	0.6	0.1
VSIG8		ENSG00000243284	"V-set and immunoglobulin domain containing 8"	P0DPA2	1	159854316-159862657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 83.5"	"Cell type enhanced"	"Detected in some"	14	"Basal keratinocytes: 10.0;Collecting duct cells: 5.2;Intestinal endocrine cells: 3.5;Suprabasal keratinocytes: 4.0"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;endometrial cancer: 3.0;head and neck cancer: 4.6;urothelial cancer: 1.0"	"Region enriched"	"Detected in single"	13	"cerebellum: 4.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;Karpas-707: 1.7;U-2 OS: 1.1;U-266/70: 1.4;U-87 MG: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA023219	Uncertain					NA	NA					"HPA023219: AB_1845635"	"unprognostic (8.66e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.94e-7)"	"unprognostic (1.72e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.99e-1)"	0.4	0.1	0.2	0.2	0.3	0.0	0.2	4.2	0.2	2.2	0.2	0.2	0.2	0.2	0.2	0.2	2.5	1.0	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.2	0.2	0.2	1.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	0.2	4.3	0.2	0.2	18.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.4	83.5	9.2	0.2	2.0	0.6	0.0	0.1	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.1	0.2	0.2	0.4	1.0	1.1	0.2	0.0	1.4	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.5	0.6	0.3	0.5	0.0	0.0	0.7	0.5	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.3	4.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.5	10.0	2.6	0.0	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.3	0.1	1.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.2	0.0	3.5	0.6	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	4.0	0.1	0.5	1.1	0.6
VSX1	"PPCD, PPCD1, PPD"	ENSG00000100987	"Visual system homeobox 1"	Q9NZR4	20	25070885-25082365	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Developmental protein, DNA-binding"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 17.0;retina: 20.7"	"Cell type enriched"	"Detected in some"	20	"Bipolar cells: 345.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (6.63e-2)"		"unprognostic (9.68e-3)"	"unprognostic (4.33e-2)"		"unprognostic (2.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-9)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.38e-1)"	0.4	3.0	2.3	0.4	1.6	1.6	0.4	17.0	2.8	0.4	0.4	0.4	0.4	0.1	1.0	0.4	0.4	0.4	0.4	0.5	1.9	2.1	0.4	0.4	0.4	0.4	2.1	0.4	4.6	1.2	1.1	2.7	0.4	0.5	0.5	0.1	20.7	0.4	1.0	1.0	0.6	0.5	0.4	1.5	0.4	0.3	0.7	0.4	0.4	0.7	0.4	0.4	0.4	0.4	1.0	1.5	2.4	0.3	1.3	0.6	0.1	0.1	1.5	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	1.8	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.0	9.9	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.3	0.0	0.2	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.3	0.0	0.3	1.0	0.1	0.1	2.4	0.3	0.3	0.6	0.3	0.5	0.7	0.4	0.3	0.0	1.0	0.4	0.5	2.1	1.3	0.2	1.5	0.1	0.1	2.3	1.6	17.0	1.4	1.9	2.1	2.1	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	345.7	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	16.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
VWA3B	"DKFZp686F2227, MGC26733"	ENSG00000168658	"Von Willebrand factor A domain containing 3B"	Q502W6	2	98087116-98313299	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 24.4;testis: 51.9"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 178.0;Early spermatids: 410.6;Late spermatids: 741.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.7;hippocampal formation: 1.7;hypothalamus: 1.6;pons and medulla: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.0;U-138 MG: 1.7"					"Low region specificity"	"Detected in many"			"HPA036700, HPA036701"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036700: AB_2675261, HPA036701: AB_10673505"	"unprognostic (2.36e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.63e-7)"	"unprognostic (2.57e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.96e-2)"	0.0	0.0	1.0	0.2	1.7	0.0	0.0	0.0	0.2	1.1	0.2	2.0	0.0	0.0	0.5	4.3	0.0	24.4	0.5	0.4	1.7	1.6	0.0	0.0	4.0	0.0	0.1	0.1	2.3	0.0	0.0	1.1	0.1	3.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	51.9	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.1	1.7	1.6	0.1	0.1	3.2	0.3	0.0	0.6	0.0	1.1	0.2	0.6	0.8	0.0	178.0	19.4	1.8	29.5	0.0	0.0	0.0	410.6	0.0	0.2	0.0	0.4	0.1	0.4	0.3	0.0	0.0	0.2	0.0	1.7	1.8	0.0	741.4	4.4	0.9	0.0	1.0	1.3	0.3	0.1	1.5	5.3	0.0	0.5	0.0	0.3	16.1	5.4	0.4	0.0	0.0	0.8	0.5
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 7.7;Late spermatids: 6.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA			Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
WDR63	"DIC3, FLJ30067, NYD-SP29"	ENSG00000162643	"WD repeat domain 63"	Q8IWG1	1	84999147-85133138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 21.3;brain: 39.7;testis: 31.0"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 167.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 39.7"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.9;HBEC3-KT: 5.4;HSkMC: 7.2;hTCEpi: 8.7;LHCN-M2: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038526	Enhanced					NA	NA					"HPA038526: AB_2676063"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-4)"	"unprognostic (1.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.14e-5)"	"unprognostic (8.57e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	0.3	21.3	2.0	0.4	4.6	0.1	0.9	0.1	0.9	1.3	0.6	4.2	1.0	0.3	0.7	11.7	0.6	14.0	0.4	0.9	3.0	2.9	2.5	0.1	3.7	0.3	0.4	0.9	4.9	0.5	3.9	14.6	0.5	39.7	0.3	0.6	0.3	1.8	0.3	0.3	1.9	0.2	0.4	0.9	0.2	0.2	31.0	1.9	0.0	1.1	1.0	0.2	0.7	0.3	0.0	0.5	0.0	0.0	0.0	2.2	0.4	0.2	0.5	0.1	0.4	3.9	10.9	2.0	2.1	4.3	0.7	1.1	0.0	0.6	0.5	0.0	0.4	2.6	0.0	0.4	5.4	0.9	0.1	0.4	0.3	0.0	0.0	0.6	0.0	0.0	7.2	8.7	3.6	0.2	0.4	0.1	0.6	0.0	0.0	7.8	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.2	0.0	0.0	0.2	1.3	2.2	0.0	3.4	0.0	0.6	0.3	0.0	0.5	0.0	0.0	0.4	4.2	0.2	1.4	0.0	0.0	0.0	2.2	0.0	1.3	0.0	1.2	0.9	0.1	0.0	0.8	1.9	0.0	0.0	0.0	0.5	0.0	0.4	2.0	4.6	0.1	0.9	3.0	2.9	0.4	0.9	39.7	1.9	0.0	1.7	0.0	0.4	0.9	0.0	0.7	0.0	167.3	18.2	0.0	3.9	0.1	3.3	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.0	5.1	0.0	0.0	3.6	1.7	0.0	18.6	4.6	0.0	0.5	0.0	0.0	0.0	0.7	0.4	0.0	0.0	36.6	2.9	0.1	0.1	0.0	0.0	0.1
WDR97	KIAA1875	ENSG00000179698	"WD repeat domain 97"	A6NE52	8	144107726-144118315	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.1;testis: 7.8"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 6.5;Cone photoreceptor cells: 5.9;Horizontal cells: 4.8;Muller glia cells: 5.4;Rod photoreceptor cells: 9.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.2;NB-4: 1.1;PC-3: 2.8;U-2 OS: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA059409	Uncertain					NA	NA					"HPA059409: AB_2684005"	"unprognostic (3.95e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.58e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.01e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.11e-6)"	"unprognostic (2.79e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.73e-4)"	0.1	0.5	0.2	0.2	0.1	0.6	0.0	0.2	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.1	0.0	4.1	0.1	0.2	0.0	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.1	0.2	7.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.3	1.3	0.8	0.1	0.2	1.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.5	0.4	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.3	1.2	0.1	0.2	0.1	0.4	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.1	2.8	0.2	0.4	0.2	0.0	0.6	0.4	0.4	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.6	0.3	0.2	0.4	0.1	0.7	0.3	0.4	0.2	0.0	0.7	0.8	0.4	0.9	1.3	0.2	0.6	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.1	0.2	0.0	4.1	0.0	0.0	1.7	0.0	0.2	0.0	6.5	0.0	0.0	1.4	0.0	0.0	5.9	0.1	1.7	0.5	3.5	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.7	0.2	4.8	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.5	5.4	0.5	0.3	0.0	0.0	9.1	0.0	0.0	3.4	1.7	0.0	0.0	0.0	0.4	0.1
WFDC10A	"C20orf146, dJ688G8.3, WAP10"	ENSG00000180305	"WAP four-disulfide core domain 10A"	Q9H1F0	20	45629526-45631196	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 62.4"	"Group enriched"	"Detected in some"	4	"granulocytes: 4.6;Late spermatids: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;CACO-2: 2.5"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA								"unprognostic (1.76e-1)"											"unprognostic (2.95e-1)"				0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	62.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	1.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartic protease inhibitor, Protease inhibitor, Serine protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 1206.7;Ciliated cells: 1080.1;Club cells: 1101.0;Collecting duct cells: 1886.1;Mucus-secreting cells: 1147.4;Urothelial cells: 3035.7"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	9	"A-431: 26.9;CAPAN-2: 50.2;EFO-21: 42.0;HaCaT: 36.6;RPTEC TERT1: 38.9"					"Low region specificity"	"Detected in some"			HPA042302	Enhanced				"Secreted in other tissues"	NA	NA		1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	50.2	0.0	42.0	0.0	0.1	36.6	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.6	4.4	0.1	0.0	0.0	0.0	0.0	38.9	0.3	1.2	0.2	2.5	0.0	0.2	0.5	0.7	0.1	0.0	0.0	0.7	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5	157.8	201.9	2.7	1206.7	7.9	23.5	1.2	107.0	1080.1	1101.0	1886.1	21.6	0.7	187.3	214.0	0.9	0.6	87.9	0.0	117.6	0.6	4.1	847.7	9.3	1.1	1.6	0.0	406.4	3.1	1.2	2.7	33.4	5.6	10.1	10.0	1147.4	14.8	130.4	454.8	0.0	77.8	4.2	6.5	11.9	11.6	11.0	12.3	0.6	1.3	278.2	3035.7
WFIKKN2	"WFDC20B, WFIKKNRP"	ENSG00000173714	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2"	Q8TEU8	17	50834650-50842348	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 89.1;ovary: 56.4"	"Group enriched"	"Detected in some"	7	"Leydig cells: 8.3;Peritubular cells: 22.6"	"Group enriched"	"Detected in some"	5	"glioma: 0.7;testis cancer: 2.2"	"Region enriched"	"Detected in some"	10	"pons and medulla: 89.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;T-47d: 3.8;U-87 MG: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 6.0;pons and medulla: 13.1;thalamus: 6.8"						"Secreted in other tissues"	NA	NA		1700000				"unprognostic (7.31e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.54e-3)"		"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.14e-1)"	0.1	0.5	0.2	0.1	0.3	0.0	0.0	0.8	0.5	0.2	0.3	6.8	0.0	0.1	0.7	0.4	0.2	0.6	0.2	0.3	9.1	0.2	0.1	0.0	1.0	0.0	0.4	0.0	56.4	0.3	0.1	0.8	0.0	89.1	0.3	0.1	4.5	0.1	0.5	1.3	0.6	0.1	0.2	0.3	0.1	0.1	1.6	0.5	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.5	9.1	0.2	0.4	0.0	89.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
WISP3	CCN6	ENSG00000112761	"WNT1 inducible signaling pathway protein 3"	O95389	6	112054072-112070969	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 9.5"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 82.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.3;cerebellum: 5.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RT4: 11.2;THP-1: 3.6;U-2197: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA			Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.4	0.5	0.3	0.4	2.3	0.8	4.2	5.9	0.5	1.9	0.3	0.3	0.3	0.1	0.6	9.5	0.9	3.2	1.4	0.4	0.3	0.5	5.3	0.8	0.4	0.5	0.4	0.3	1.6	0.3	0.0	0.3	0.4	0.3	1.1	0.0	0.3	0.6	0.3	0.6	4.8	0.3	0.3	0.4	0.4	0.4	5.8	0.9	0.3	0.3	2.8	2.2	0.3	1.5	1.1	0.6	2.0	0.5	1.7	1.2	0.2	0.1	0.0	0.3	1.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.9	0.2	0.3	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.7	0.3	0.1	0.0	0.2	0.9	0.4	0.1	0.2	0.3	0.1	0.3	0.0	11.2	0.5	0.6	0.1	0.2	0.9	0.4	0.2	3.6	0.2	0.2	0.2	2.6	0.3	0.3	0.0	0.3	0.4	1.1	0.2	1.4	0.4	0.6	0.5	0.3	0.6	0.8	0.9	0.9	0.3	1.1	1.2	1.1	2.0	1.7	0.5	0.6	0.6	0.2	0.3	2.3	5.9	0.5	0.3	0.5	0.4	0.3	0.3	0.9	0.0	0.0	0.0	2.7	0.7	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	82.4	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.2	6.5	0.0	0.6	0.7	0.6	0.1	0.0	0.0	2.1
WNT1	INT1	ENSG00000125084	"Wnt family member 1"	P04628	12	48978453-48981676	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.7;brain: 6.5;placenta: 17.5"	"Cell type enriched"	"Detected in single"	36	"Cardiomyocytes: 3.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	8	"gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	24	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;JURKAT: 2.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1"						"Secreted to extracellular matrix"	NA	NA						"unprognostic (2.02e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-3)"	"unprognostic (5.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.76e-2)"	0.3	0.1	0.4	1.5	6.5	2.3	0.3	0.3	2.9	0.3	0.3	0.3	0.3	1.5	0.3	0.3	0.5	0.1	0.7	0.3	0.6	0.5	0.3	0.3	0.7	2.9	0.3	0.3	0.3	0.3	0.0	0.3	17.5	0.3	0.3	0.0	0.3	1.2	0.3	0.3	0.0	1.8	0.3	0.3	1.9	1.2	1.4	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.0	0.0	0.0	0.0	7.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	7.7	0.3	3.0	4.8	0.0	0.0	0.5	3.2	0.0	0.0	0.0	0.0	0.4	0.8	0.4	6.5	0.3	1.8	0.6	0.5	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WNT6		ENSG00000115596	"Wnt family member 6"	Q9Y6F9	2	218859821-218874233	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.4"	"Cell type enriched"	"Detected in some"	9	"Sertoli cells: 90.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.7"	"Group enriched"	"Detected in many"	7	"basal ganglia: 23.4;thalamus: 7.4"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.1;NK-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"BEWO: 28.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070759	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA070759: AB_2732164"	"unprognostic (1.86e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.34e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	2.5	3.5	0.8	1.4	23.4	0.6	15.0	0.9	2.1	4.0	5.7	0.2	1.1	1.3	2.3	2.0	3.1	2.3	2.1	4.8	0.9	0.3	1.6	0.7	0.7	1.3	2.1	0.1	2.9	1.7	0.6	1.7	9.8	1.4	4.0	0.9	4.3	1.9	2.1	2.4	2.3	2.3	2.0	2.4	6.4	2.3	3.7	7.4	0.0	0.7	0.8	1.2	1.5	11.1	0.7	1.1	0.0	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	28.1	0.0	0.0	0.0	0.0	2.6	0.4	0.0	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	4.1	1.3	0.0	0.0	3.2	0.1	3.7	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.0	0.8	23.4	0.9	0.9	0.9	0.3	2.1	0.1	1.4	7.4	0.0	0.0	0.5	10.5	0.5	0.8	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	1.6	0.0	0.0	0.0	0.0	1.5	0.8	3.2	0.0	0.0	0.7	1.6	0.0	3.1	0.0	3.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.8	90.5	3.3	2.1	0.3	0.1	0.6	0.0	0.0	0.9
WNT8A	WNT8D	ENSG00000061492	"Wnt family member 8A"	Q9H1J5	5	138083892-138092365	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;testis: 3.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 1.4;SuSa: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038539	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA038539: AB_10669646"					"unprognostic (1.11e-5)"					"unprognostic (4.11e-2)"					"unprognostic (4.11e-2)"	"unprognostic (5.32e-2)"		0.1	0.0	0.2	0.1	2.5	0.1	0.4	0.7	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	2.5	0.7	0.8	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
WSCD2	KIAA0789	ENSG00000075035	"WSC domain containing 2"	Q2TBF2	12	108129471-108250537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;seminal vesicle: 18.2;thyroid gland: 21.8"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 35.7;Horizontal cells: 20.6"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.6"	"Region enhanced"	"Detected in all"		"cerebellum: 44.0"	"Cell type enhanced"	"Detected in single"		"T-reg: 2.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.5"	"Cell line enriched"	"Detected in some"	21	"RT4: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013346, HPA048133"	Approved		Uncertain	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA013346: AB_1858865, HPA048133: AB_2797236"	"unprognostic (1.50e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.50e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.43e-3)"	"unprognostic (3.03e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.62e-3)"	1.4	1.2	6.5	0.5	12.5	0.4	1.0	44.0	15.2	5.4	1.7	1.6	0.0	0.7	6.9	3.0	3.8	2.0	0.5	0.5	10.0	3.0	1.3	0.4	0.8	0.5	1.3	6.0	0.6	2.1	0.4	0.9	0.6	1.9	6.0	0.7	9.9	0.5	18.2	0.5	0.6	0.9	9.2	1.5	0.5	2.0	0.6	2.0	0.0	21.8	0.2	0.5	3.0	0.9	0.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	6.5	12.5	44.0	15.2	10.0	3.0	1.3	6.0	1.9	2.0	0.0	0.0	0.5	0.0	0.1	35.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.6	0.0	1.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0
XKR7	"C20orf159, dJ310O13.4"	ENSG00000260903	"XK related 7"	Q5GH72	20	31968002-32003387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 28.0;pituitary gland: 12.3"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 4.0;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.0;Early spermatids: 1.3;Horizontal cells: 1.6;Rod photoreceptor cells: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 21.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.6"	HPA040854	Uncertain					NA	NA					"HPA040854: AB_10795481"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.03e-2)"	"unprognostic (3.74e-7)"	"unprognostic (4.29e-2)"	"unprognostic (9.34e-2)"		"unprognostic (1.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-5)"	"unprognostic (1.99e-1)"	0.5	1.5	2.9	0.6	4.4	0.5	0.4	28.0	10.0	0.4	0.5	0.0	0.0	0.6	0.4	0.5	0.4	0.5	0.5	0.4	1.2	1.5	0.5	0.4	0.5	0.4	0.8	4.6	0.4	1.8	0.4	12.3	0.4	3.5	0.4	0.6	2.0	0.4	0.5	0.4	0.5	0.5	0.4	0.6	0.5	1.7	1.2	0.0	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	21.7	4.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.9	4.4	28.0	8.7	1.2	1.5	0.8	4.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.8	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZAR1L	Z3CXXC7	ENSG00000189167	"Zygote arrest 1 like"	A6NP61	13	32303700-32315344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;gallbladder: 2.7;testis: 3.5"	"Cell type enhanced"	"Detected in single"	27	"Spermatocytes: 2.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"cerebral cortex: 2.2;thalamus: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;MCF7: 2.2;U-698: 2.4"	"Group enriched"	"Detected in many"	5	"amygdala: 1.0;basal ganglia: 1.8;cerebral cortex: 2.8;hippocampal formation: 2.2"	"Low region specificity"	"Detected in many"			HPA041319	Uncertain					NA	NA					"HPA041319: AB_10794407"	"unprognostic (4.03e-1)"	"unprognostic (1.79e-1)"		"unprognostic (4.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.33e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.66e-1)"				"unprognostic (8.34e-2)"	"unprognostic (3.73e-1)"		"unprognostic (7.51e-2)"	0.2	0.1	0.1	0.1	0.1	0.8	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.7	0.0	0.1	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	0.2	0.0	3.5	1.3	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.8	0.5	0.3	0.2	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.2	0.0	0.6	0.5	3.0	0.3	1.3	0.4	0.0	0.3	0.3	1.3	0.2	0.4	0.6	0.0	0.3	0.5	0.3	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.6	0.5	0.4	0.2	2.2	0.3	0.6	1.1	0.4	0.7	1.2	1.0	0.3	0.0	0.3	0.1	0.2	0.0	0.4	0.2	0.1	0.1	1.0	0.0	0.4	0.0	0.9	0.0	0.8	0.5	2.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.2	0.1	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.0	0.0	0.0	0.0
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 41.7"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.1	14.0	0.0	0.0	19.4	0.0	43.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	41.7	1.4	0.0	0.2	3.9	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.0	0.1
ZBTB18	"C2H2-171, RP58, TAZ-1, ZNF238"	ENSG00000179456	"Zinc finger and BTB domain containing 18"	Q99592	1	244048939-244057476	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 114.4;skeletal muscle: 40.3"	"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 114.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024656, HPA074019"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024656: , HPA074019: "	"unprognostic (3.48e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.69e-3)"	"prognostic favorable (1.34e-4)"	"unprognostic (6.83e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-3)"	"prognostic favorable (6.78e-6)"	4.1	3.4	20.1	7.3	14.7	13.4	4.7	114.4	26.0	4.1	4.7	5.4	8.1	6.9	3.5	10.3	3.0	4.6	3.8	7.4	24.8	6.3	6.4	10.0	5.1	8.8	7.1	19.1	4.0	13.0	3.1	2.7	4.9	11.7	5.5	5.8	4.6	5.2	6.7	40.3	4.1	6.2	5.9	7.5	10.0	5.8	11.4	4.6	16.4	4.4	2.8	8.1	6.5	9.3	2.4	2.2	5.8	1.5	0.3	1.4	0.2	11.7	4.2	16.2	0.6	2.1	2.2	11.3	6.6	4.9	10.7	6.5	3.2	9.5	8.9	0.6	12.7	3.4	1.2	10.3	3.3	13.4	3.1	9.1	1.5	1.4	1.5	3.3	1.8	4.7	1.8	2.8	6.4	4.0	12.9	11.5	9.9	1.1	3.8	12.6	0.1	15.3	7.5	8.3	3.6	1.9	4.5	11.0	2.5	6.7	4.1	23.9	23.3	2.7	0.1	7.3	7.1	0.2	13.6	17.1	5.5	6.7	3.4	13.9	1.6	0.2	3.5	5.5	5.8	11.1	0.2	0.7	2.9	0.3	0.7	0.4	1.6	0.7	0.5	0.9	2.4	1.4	0.9	5.8	0.3	1.5	2.2	0.5	0.2	20.1	14.7	114.4	24.1	24.8	6.3	7.1	19.1	11.7	4.6	8.9	21.0	6.4	3.0	10.0	5.1	19.9	12.7	10.7	11.4	17.4	11.8	1.2	0.0	4.0	2.6	13.2	6.2	0.0	4.5	1.7	2.8	5.0	5.8	37.6	5.2	6.4	18.6	13.5	24.1	2.2	2.0	13.3	3.3	2.8	18.3	48.1	7.3	7.0	4.6	10.1	24.2	12.9	8.1	10.0	6.6	17.2	0.8	3.2	12.8	3.1
ZFP42	"REX1, ZNF754"	ENSG00000179059	"ZFP42 zinc finger protein"	Q96MM3	4	187995771-188005050	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 4.7;placenta: 6.6;testis: 7.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 41.4;Extravillous trophoblasts: 49.9"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 40.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"BEWO: 47.2;SuSa: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025557	Uncertain					NA	NA					"CAB025557: "	"unprognostic (2.30e-1)"					"unprognostic (1.07e-4)"		"unprognostic (4.88e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.77e-1)"				"unprognostic (3.86e-1)"	"unprognostic (2.27e-1)"		"unprognostic (4.66e-3)"	0.5	0.2	0.2	0.3	0.2	1.3	0.2	0.2	0.3	0.3	0.9	0.2	0.2	0.6	0.2	0.5	0.2	0.5	0.2	0.2	0.2	0.3	0.4	0.2	1.1	0.8	0.3	0.2	0.2	0.2	0.0	0.2	6.6	1.3	0.2	0.3	0.2	0.4	0.2	1.9	1.8	0.2	0.2	0.2	1.1	0.5	7.1	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.9	1.2	4.7	1.0	2.3	2.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	47.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	33.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	4.3	1.0	1.2	2.0	0.8	1.5	1.7	1.6	1.3	0.4	1.9	1.7	1.7	4.7	2.3	0.9	1.2	1.5	0.4	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	41.4	0.0	0.0	0.0	0.0	49.9	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	7.9	0.0	0.0	0.1
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804532	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Gonadal differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0;ovary: 37.8"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 18.3;Early spermatids: 43.3;Late spermatids: 22.7;Leydig cells: 22.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 67.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.4;ASC diff: 5.6;BJ hTERT+: 13.9;HHSteC: 10.1;hTEC/SVTERT24-B: 5.7;HUVEC TERT2: 10.6;K-562: 5.7;TIME: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004094	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	10.7	3.8	7.9	3.9	2.7	0.6	15.4	67.0	8.2	8.4	4.2	0.7	2.0	1.1	16.6	7.3	5.5	14.2	6.8	11.2	14.8	3.5	1.8	3.5	5.6	8.2	3.4	4.9	37.8	1.4	1.2	2.5	5.0	9.3	3.3	2.9	0.9	1.5	2.9	23.3	2.0	2.3	19.8	3.5	3.5	3.5	4.9	2.0	0.0	8.0	6.5	2.1	7.6	9.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.4	0.0	5.6	1.8	0.0	0.5	13.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	5.0	1.6	0.0	0.0	10.1	0.0	0.0	0.6	0.0	5.7	0.0	1.9	10.6	0.0	5.7	0.0	1.4	0.0	1.4	0.0	0.2	0.1	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.5	4.4	0.0	6.4	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	2.7	67.0	8.2	14.8	3.5	3.4	4.9	9.3	2.0	0.0	1.1	0.0	0.2	3.2	0.6	18.3	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	43.3	6.2	0.0	0.0	0.0	0.1	8.7	0.4	0.0	0.0	0.3	7.9	0.0	8.6	0.0	22.7	22.2	0.0	1.7	1.0	0.0	0.0	0.1	0.0	12.7	0.0	0.6	6.5	3.1	0.7	1.4	2.5	0.3	0.0	0.0	0.3
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 28.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.2;NB-4: 12.1;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: AB_2683477"	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.2	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.7	0.0	1.9	3.2	2.6	3.8	1.2	0.3	0.6	9.7	1.3	0.2	4.3	0.3	4.4	0.7	11.2	3.0	0.6	1.1	0.1	7.0	3.1	1.0	1.8	8.2	0.9	2.2	0.1	12.1	0.1	2.0	8.2	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	0.1	2.5	0.3	0.5	1.8	0.0	5.5	0.1	12.8	9.3	0.2	5.4	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7	0.0	1.7	0.0	3.2	5.3	10.7	3.3	5.1	1.4	3.4	10.4	17.7	0.3	6.6	2.7	28.4	4.5	16.9	0.0	2.0	0.2	1.9	1.5	9.2	4.9	1.8	7.9	2.4	5.5	1.9	5.8	1.4	7.1	6.8	4.6	5.9	1.4	2.1	9.0	2.1	3.1	16.3	0.0	2.8	2.1	9.0	4.3	0.2	21.0	5.2	4.1
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 124.7"	"Cell type enhanced"	"Detected in some"	14	"Hepatocytes: 4.4;Leydig cells: 1.4;Muller glia cells: 4.2;Peritubular cells: 1.4;Rod photoreceptor cells: 1.5"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 124.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"AF22: 62.2"	"Region enhanced"	"Detected in many"		"cerebellum: 232.6"	"Region enriched"	"Detected in many"	9	"cerebellum: 491.0"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	0.7	0.6	1.5	0.5	8.6	0.5	0.8	124.7	25.5	0.5	0.7	12.3	0.0	0.9	0.6	3.8	1.0	0.5	0.8	0.5	6.2	5.2	0.5	7.3	0.7	0.7	5.2	8.0	0.9	0.5	0.6	0.6	0.5	15.3	0.5	0.7	3.0	0.5	0.6	7.4	4.1	1.9	0.5	10.0	0.5	0.5	1.0	4.5	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.2	0.0	6.5	7.2	3.5	4.0	4.8	4.3	3.6	0.0	0.0	0.0	3.2	0.3	3.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.2	0.0	0.0	1.0	0.0	3.8	15.0	0.0	0.0	0.1	0.3	0.0	0.0	6.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	6.5	0.0	10.1	3.8	0.0	0.0	0.0	4.8	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	8.6	124.7	5.2	6.2	5.2	5.2	8.0	15.3	4.5	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.4	0.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981772-99986773	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 63.0"	"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 1.8;Cone photoreceptor cells: 5.9;Muller glia cells: 8.4;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.7;HDLM-2: 13.3;HEK 293: 21.0;NTERA-2: 25.8;SCLC-21H: 58.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 214.5"	HPA055031			Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA055031: AB_2682676"	"unprognostic (6.43e-6)"	"prognostic favorable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.6	0.5	3.9	0.5	2.9	0.5	0.7	63.0	14.7	0.5	0.8	7.7	0.0	0.6	0.8	0.5	0.8	0.5	0.5	0.5	6.1	2.1	0.6	0.5	0.7	0.6	1.7	7.4	0.5	0.6	0.5	0.5	0.5	13.4	0.6	0.6	3.8	0.5	0.5	0.5	0.8	0.5	0.6	2.2	0.5	0.6	2.5	1.0	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.5	27.7	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	1.8	0.0	2.3	0.0	1.4	0.0	1.2	0.0	0.0	13.3	21.0	1.9	1.2	1.3	0.0	0.0	1.3	0.0	2.0	0.0	1.2	0.1	0.0	0.6	2.0	0.0	0.0	0.9	0.1	10.5	25.8	0.0	0.6	6.0	1.0	0.0	0.1	0.7	58.0	0.0	0.8	0.1	0.0	1.1	1.3	10.3	0.0	6.5	0.0	1.1	1.7	0.2	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.9	63.0	7.1	6.1	2.1	1.7	7.4	13.4	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.8	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.9	0.5	0.1	0.0	0.0	0.0	0.0
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566142-137577691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.6"	"Cell type enhanced"	"Detected in some"	27	"Muller glia cells: 7.1;Rod photoreceptor cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 2.7"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Region enriched"	"Detected in all"	8	"cerebellum: 50.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	35	"AF22: 24.0;NTERA-2: 26.7;SuSa: 16.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052936: AB_2681993, HPA069523: AB_2732136"					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.3	0.2	1.4	0.4	2.5	1.1	0.4	50.6	5.8	0.3	0.4	2.7	0.0	0.5	0.5	0.2	0.3	0.3	0.4	0.3	1.9	2.2	0.3	0.3	0.4	0.4	2.4	1.2	0.4	0.5	0.4	1.1	0.4	6.1	0.5	0.3	3.9	0.7	0.3	0.5	0.8	0.5	0.2	1.9	0.5	0.4	3.9	2.2	0.0	0.5	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	16.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	2.5	50.6	2.6	1.9	2.2	2.4	1.2	6.1	2.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	2.7	0.0	0.0	0.0	0.0	0.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 1.8;Early spermatids: 2.8;Late spermatids: 6.7;Muller glia cells: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.7;ASC diff: 5.3;BEWO: 4.0;MCF7: 5.3;SH-SY5Y: 5.6;U-2197: 4.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	0.0	5.3	2.2	4.0	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.4	5.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	0.0	4.4	2.0	0.0	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 48.9"	"Cell type enhanced"	"Detected in some"	29	"Muller glia cells: 1.7;Rod photoreceptor cells: 1.3;Spermatocytes: 5.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	24	"cerebellum: 48.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HEK 293: 6.4;NTERA-2: 7.6;SCLC-21H: 43.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 53.2"	HPA074045			Uncertain	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.1	0.0	1.2	0.0	0.5	0.0	0.1	48.9	4.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	11.2	0.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	1.0	0.0	1.6	0.0	0.5	0.0	2.2	0.0	0.0	1.9	6.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.0	0.8	7.6	0.0	0.1	0.9	0.4	0.0	0.0	0.0	43.8	0.0	1.2	1.0	0.0	0.8	0.0	1.4	0.0	0.6	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.5	48.9	1.3	1.5	0.5	0.4	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0
ZNF385C		ENSG00000187595	"Zinc finger protein 385C"		17	42025576-42098479	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"brain: 19.0;testis: 21.9"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 27.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"cerebellum: 19.0"	"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;JURKAT: 3.7;MOLT-4: 6.7;SCLC-21H: 5.5"	"Region enriched"	"Detected in single"	12	"cerebellum: 31.8"	"Region enriched"	"Detected in all"	7	"cerebellum: 44.2"							NA	NA						"unprognostic (1.58e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.05e-2)"	0.4	0.0	0.7	1.6	0.7	0.5	1.6	19.0	0.8	0.5	0.4	0.4	0.4	0.1	1.0	0.5	0.4	2.0	0.4	0.4	0.5	0.4	0.6	0.4	0.8	0.4	2.0	0.4	3.4	3.1	0.6	2.1	0.4	1.4	1.4	0.2	0.4	2.3	0.5	2.9	0.7	0.4	0.4	0.9	0.6	0.5	21.9	0.4	0.9	0.4	0.9	1.5	0.4	0.5	0.4	3.2	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.5	2.4	0.0	1.2	0.0	0.1	0.8	0.3	0.0	0.0	3.9	2.4	0.0	0.0	0.8	0.1	0.0	1.0	0.0	2.9	0.0	1.4	0.1	0.0	3.7	0.2	0.0	0.0	0.5	6.7	0.1	0.5	1.2	0.0	0.5	0.0	1.1	0.1	0.4	5.5	0.6	0.2	0.5	0.3	0.7	3.1	1.2	0.0	0.0	0.4	0.0	0.0	2.6	0.5	0.4	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.7	0.7	19.0	0.8	0.5	0.4	2.0	0.4	1.4	0.4	0.0	0.3	0.0	1.6	0.3	2.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.4	27.8	0.0	0.4	0.0	0.4	0.1	0.6	2.3	0.0	0.0	0.6	1.6	0.0	0.0	0.0	3.1	1.4	0.0	0.0	0.0	0.5	2.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	1.9	0.5	0.0	0.0	0.4	0.8
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412222-22373321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 17.7;brain: 59.5;testis: 18.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 137.4;Horizontal cells: 305.1;Late spermatids: 198.0;Muller glia cells: 119.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 59.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTERT-RPE1: 4.2;RPTEC TERT1: 6.7;U-87 MG: 12.6"					"Low region specificity"	"Detected in all"			HPA036190	Uncertain					NA	NA					"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	17.7	1.1	4.0	2.2	5.9	1.1	5.3	59.5	9.1	4.3	2.2	0.1	1.2	1.2	2.3	3.9	4.0	2.3	4.7	3.9	3.9	3.6	3.2	0.9	1.9	2.0	7.4	4.0	1.7	2.5	1.3	0.5	0.7	4.1	3.0	1.8	4.1	1.9	3.2	2.8	2.4	1.3	3.5	1.9	1.3	1.3	18.5	1.7	0.1	1.5	5.2	2.0	4.0	5.7	0.7	0.3	2.0	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.5	4.9	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	4.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	6.7	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.7	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.2	4.0	5.9	59.5	9.1	3.9	3.6	7.4	4.0	4.1	1.7	11.9	14.9	0.5	0.6	8.7	41.0	2.8	0.0	8.1	35.2	1.8	7.9	0.2	23.2	0.4	137.4	35.0	1.1	0.0	0.6	0.1	13.6	1.3	4.7	5.9	0.4	305.1	0.0	3.7	0.0	198.0	15.5	5.6	11.8	0.0	0.5	119.7	1.1	0.0	12.7	6.2	28.4	12.9	14.4	9.1	1.3	6.8	0.1	0.0	0.4	0.1
ZNF474	"4933409D10Rik, FLJ32921"	ENSG00000164185	"Zinc finger protein 474"	Q6S9Z5	5	122129513-122153571	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 11.4;fallopian tube: 21.4;testis: 22.9"	"Cell type enhanced"	"Detected in some"	26	"Ciliated cells: 30.8;Club cells: 6.8;Early spermatids: 13.5;Late spermatids: 8.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 3.3;CAPAN-2: 3.2;GAMG: 4.3;TIME: 3.8"	"Low region specificity"	"Detected in some"													NA	NA						"unprognostic (9.98e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.42e-2)"	"unprognostic (5.90e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-4)"	0.3	0.1	1.4	0.3	1.5	0.1	0.3	0.2	0.2	1.2	0.5	6.3	0.6	0.2	1.1	4.9	0.5	21.4	0.7	0.1	1.5	1.1	0.1	0.1	7.9	0.1	0.4	0.2	7.1	0.1	0.2	0.7	0.6	11.4	0.3	0.2	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.4	0.1	0.2	22.9	0.9	0.0	1.3	0.0	0.2	0.4	0.2	0.2	0.9	0.0	0.0	0.0	0.6	0.0	0.1	1.3	0.5	0.2	0.8	0.4	0.1	3.3	0.8	0.4	0.1	0.1	3.2	0.0	0.2	2.1	4.3	0.6	0.2	0.0	1.3	0.3	0.3	1.1	0.7	0.0	0.7	1.1	0.1	0.4	1.4	0.8	0.4	0.6	0.1	0.6	0.0	0.1	0.1	2.0	0.8	0.4	0.0	0.2	0.0	0.9	0.1	0.9	0.4	0.1	0.7	0.2	1.0	0.1	0.3	0.4	0.5	0.5	3.8	1.1	0.7	2.2	0.8	0.3	0.6	0.4	2.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.9	0.0	0.0	1.4	1.5	0.2	0.2	1.5	1.1	0.4	0.2	11.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.8	6.8	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF521	"EHZF, Evi3"	ENSG00000198795	"Zinc finger protein 521"	Q96K83	18	25061926-25352190	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.1"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 27.9;Endothelial cells: 22.4;Horizontal cells: 14.3;Ito cells: 14.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 69.1"	"Group enriched"	"Detected in some"	5	"basophil: 8.8;plasmacytoid DC: 9.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 9.8;granulocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"AF22: 32.0;fHDF/TERT166: 15.0;HUVEC TERT2: 21.9;THP-1: 17.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 105.4"	"HPA023056, HPA023849"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023056: AB_1859315, HPA023849: AB_1859316"	"unprognostic (8.80e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.82e-4)"	9.2	11.3	5.2	2.8	7.0	1.9	9.1	69.1	11.5	11.0	3.4	9.1	4.7	1.7	19.8	5.9	3.8	9.0	10.0	7.0	5.8	5.1	3.1	1.2	6.4	4.0	8.4	2.8	20.5	1.4	1.4	16.8	8.0	12.2	4.4	3.5	6.7	8.7	3.0	3.8	4.6	3.2	13.3	12.2	18.5	2.4	3.4	8.9	0.5	5.3	6.9	2.6	7.4	5.4	0.0	9.8	8.8	0.1	1.7	0.0	0.1	0.0	0.0	32.0	0.0	5.1	9.0	0.1	4.6	6.7	1.6	1.0	0.0	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	1.3	0.0	1.9	6.3	0.3	0.2	0.9	0.0	9.6	11.1	0.0	0.1	0.0	0.0	21.9	7.6	0.1	0.0	2.8	0.0	4.1	0.0	2.2	0.0	0.0	0.0	7.2	0.5	0.0	0.0	4.1	2.6	0.4	0.0	0.0	3.0	0.0	17.8	12.4	12.7	1.0	3.7	0.7	0.0	0.0	0.1	4.8	0.0	10.4	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	9.8	0.0	0.1	5.2	7.0	69.1	4.3	5.8	5.1	8.4	2.8	12.2	8.9	0.0	4.8	0.0	0.1	3.3	27.9	9.1	0.0	2.7	1.2	0.0	2.0	0.0	0.0	0.0	1.6	22.4	0.0	0.0	0.0	0.0	7.2	0.2	12.7	0.0	0.1	14.3	1.2	14.1	1.6	3.6	9.2	0.9	13.5	0.0	0.0	0.7	0.0	0.0	7.4	3.1	2.7	0.0	3.3	0.1	1.5	3.9	0.1	0.0	0.0	0.1
ZNF556	FLJ11637	ENSG00000172000	"Zinc finger protein 556"	Q9HAH1	19	2867335-2883445	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.6;brain: 22.3;ovary: 11.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 12.2;Ciliated cells: 8.1;Club cells: 9.1;granulocytes: 7.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 22.3"	"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 14.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;HBEC3-KT: 7.7;Hep G2: 12.1;RH-30: 18.0;THP-1: 6.5"									HPA060593			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060593: AB_2684328"	"unprognostic (1.36e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.23e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.54e-3)"	0.3	0.2	0.5	0.3	0.5	1.0	0.5	22.3	0.5	0.7	0.3	0.0	1.7	0.1	1.6	0.7	3.1	4.2	0.8	0.2	0.4	0.3	2.6	0.1	0.4	0.3	0.4	0.1	11.3	2.6	0.4	1.6	0.8	1.3	0.4	0.1	0.1	1.0	0.1	4.5	0.7	0.2	0.3	0.5	0.3	0.3	3.5	0.0	0.6	0.2	8.7	0.9	0.2	0.2	0.4	14.6	1.2	0.2	0.6	0.2	0.1	1.9	0.3	0.0	3.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.2	0.1	2.4	1.2	0.1	0.0	0.1	0.0	7.7	0.0	0.1	0.0	0.1	3.2	12.1	0.1	0.2	3.8	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	2.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	18.0	1.5	0.0	0.3	0.1	2.9	0.0	0.3	0.0	0.1	3.7	6.5	0.0	0.1	0.1	4.7	0.1	2.1	3.9	0.1	0.2	0.1	0.1	1.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.6	0.1	14.6	0.1	0.1	0.5	0.5	22.3	0.5	0.4	0.3	0.4	0.1	1.3	0.0	3.0	12.2	0.0	2.3	0.3	2.2	0.4	0.0	8.1	9.1	3.5	2.0	0.4	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.2	0.5	1.5	7.0	0.0	0.2	3.2	0.0	1.3	1.2	0.0	0.6	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.4	0.6	4.6	0.0	0.5	5.6	4.7	0.1	0.2	0.8	0.0	1.6
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.3;testis: 8.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 2.0;Extravillous trophoblasts: 3.7;Mucus-secreting cells: 2.0;Spermatocytes: 3.1;Spermatogonia: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 5.1"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.2"	"Low cell line specificity"	"Detected in many"											HPA024743	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.3	0.3	0.6	3.2	2.1	3.3	1.5	1.6	1.0	0.6	1.0	0.0	0.0	0.4	0.6	0.0	1.3	0.3	0.2	0.3	5.1	0.4	0.7	0.2	0.9	1.1	0.5	0.9	0.6	1.7	0.0	0.6	2.5	0.3	0.4	1.5	0.1	1.1	0.1	0.2	0.5	2.3	1.4	0.7	0.4	0.6	8.3	0.0	8.3	0.3	0.0	2.2	0.4	0.7	0.1	0.1	3.2	0.2	0.2	0.2	0.0	6.6	0.8	4.1	10.3	0.1	0.1	10.8	2.2	0.1	3.1	4.3	6.9	0.4	5.5	4.4	1.2	3.8	2.0	11.6	0.6	3.6	0.0	4.0	3.5	1.5	4.2	0.0	0.0	1.4	0.2	0.0	3.6	2.9	0.9	1.2	7.0	4.7	0.0	3.3	2.6	7.4	3.9	7.7	6.7	4.3	4.1	9.5	0.0	0.7	3.7	3.7	6.3	3.4	2.7	1.2	4.2	2.9	4.9	0.5	0.5	6.0	3.1	0.0	0.7	1.8	0.1	0.0	0.0	2.2	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	3.2	0.2	0.1	0.1	0.0	0.0	0.6	2.1	1.6	1.0	5.1	0.4	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	3.7	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.1	2.7	0.1	0.9	0.0	1.4	0.1
ZNF729		ENSG00000196350	"Zinc finger protein 729"	A6NN14	19	22286408-22317176	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 3.6;testis: 9.7"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.4;Distal tubular cells: 1.7;Spermatocytes: 4.1;Spermatogonia: 4.4"	"Cancer enriched"	"Detected in single"	41	"testis cancer: 5.3"	"Group enriched"	"Detected in many"	5	"amygdala: 1.2;cerebral cortex: 1.1;hippocampal formation: 3.6;olfactory region: 1.5;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;NTERA-2: 7.2;SuSa: 4.0;T-47d: 1.8"															NA	NA						"unprognostic (1.84e-1)"				"unprognostic (2.14e-3)"					"unprognostic (3.05e-4)"				"unprognostic (1.30e-1)"	"unprognostic (1.74e-1)"			0.2	0.1	1.2	0.1	0.3	0.0	0.5	0.1	1.1	0.1	0.1	0.0	1.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	3.6	0.1	0.7	0.1	0.1	0.0	0.1	1.5	0.2	0.1	0.4	0.1	0.8	1.5	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	1.5	0.1	0.1	9.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	7.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.3	0.1	1.1	3.6	0.1	0.1	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	0.0	0.2	0.0	0.0	0.0
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598366-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 31.6;lymphoid tissue: 9.6"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 31.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.6"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.4	1.0	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3.0	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0.0	4.4	0.0	2.9	1.8	2.1	2.0	1.2	1.0	1.7	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	4.9	1.6	1.5	0.0	0.0	20.8	0.0	0.0	2.1	0.0	0.3	0.0	3.7	0.1	0.0	5.5	0.8	0.1	8.2	5.2	0.0	2.5	0.0	0.0	1.3	2.5	3.9	0.0	0.0	0.9	0.0	0.0	0.0	4.9	0.0	0.0	3.3	0.0	14.3	0.8	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.1	0.0	10.5	0.0	5.3	0.1	0.2	2.1	2.2	0.0	15.5	6.1	1.5	1.7	0.0	1.1	0.0	0.0	1.7	0.0	2.0	0.0	0.0	1.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3.0	5.4	0.4	0.0	1.1	3.4	0.0	0.0	31.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	0.0	0.0	2.7	0.4	0.3	3.2	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	2.6	6.5	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	22	"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	35	"HDLM-2: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA011296	Enhanced				"Secreted in female reproductive system"	NA	NA					"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.1	0.0	0.0	0.0	0.0	1.1	35.2	0.1	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	1.6	0.0	0.1	0.0	3.1	0.0	0.0	0.1	1.5	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099317	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 3.9"	"Cell type enhanced"	"Detected in single"	25	"Cytotrophoblasts: 1.5"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 36.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076826			Approved	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA076826: "	"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.2	0.2	0.3	0.2	0.2	1.3	0.2	2.7	1.4	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.2	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.2	0.2	1.1	2.8	0.3	0.2	0.2	0.6	1.2	3.9	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.8	0.7	2.4	0.8	0.6	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	2.4	0.8	0.8	0.4	0.6	1.1	0.8	0.2	1.0	0.4	0.8	0.5	0.6	1.3	0.6	0.7	0.7	0.1	0.2	0.3	0.2	2.7	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.2;thyroid gland: 8.1"	"Cell type enhanced"	"Detected in some"	18	"Glandular cells: 1.7;Spermatocytes: 3.4;Spermatogonia: 6.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 10.6;hTEC/SVTERT24-B: 10.3;K-562: 9.9;SiHa: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.3	0.1	0.2	3.0	0.2	0.4	1.4	0.7	0.1	0.6	0.2	0.1	0.8	0.4	0.1	3.0	1.7	0.1	0.4	0.9	0.1	0.3	6.4	3.1	0.1	1.0	0.1	0.0	0.6	0.3	0.6	0.5	1.0	2.2	1.7	0.2	1.0	0.5	0.0	0.3	0.6	0.3	0.5	1.3	0.3	0.1	21.2	0.0	0.9	8.1	1.3	5.6	0.5	1.1	1.0	0.8	3.1	0.6	0.9	0.7	0.2	0.0	1.9	0.3	0.0	0.0	0.0	4.4	1.2	1.3	5.7	4.6	0.1	0.1	0.0	3.0	1.7	0.0	0.1	3.8	0.1	6.8	0.3	7.3	0.0	10.6	0.0	2.8	0.0	0.9	0.0	0.3	10.3	0.1	0.3	1.3	0.1	9.9	5.5	0.2	5.3	0.0	5.3	1.4	0.0	1.0	0.0	1.3	4.7	3.6	0.2	1.5	2.2	10.3	0.5	0.0	4.6	5.8	2.9	0.1	0.0	0.1	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.8	1.8	0.6	0.8	0.5	0.3	0.3	0.7	0.5	0.5	0.1	1.0	0.6	0.7	3.1	0.9	0.3	0.8	0.4	0.2	0.2	0.2	0.7	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	1.7	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	1.3	0.0	0.0	3.4	6.9	0.1	0.2	0.0	0.0	0.3
